Source,Target,Collaborations,Weight,Publication Type,Publication Name,Publication Date,Title,Co-authors,Keywords
clme0621,whgu0274,1,0.14285714285714285,Journal article,The Journal of Physiology,01/01/2012,Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: Insights from genetically modified mice,"Chen RL,Nagel S,Papadakis M,Bishop T,Pollard P,Ratcliffe PJ,Pugh CW,Buchan AM","Animals,Body Temperature Regulation,Body Weight,Brain Ischemia,Cerebral Arteries,Cerebral Cortex,Gene Expression Regulation,Genotype,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Knockout,Procollagen-Proline Dioxygenase,Protein Isoforms"
olin0081,path0084,2,0.11396011396011396,Journal article|Journal article,Chemistry and Biology|Gut,26/08/2015|07/03/2016,Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.|Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.,"Canning P,Ruan Q,Schwerd T,Hrdinka M,Maki JL,Saleh D,Suebsuwong C,Ray S,Brennan PE,Cuny GD,Uhlig HH,Gyrd-Hansen M,Degterev A,Bullock AN|Schwerd T,Pandey S,Yang HT,Bagola K,Jameson E,Jung J,Lachmann RH,Shah N,Patel SY,Booth C,Runz H,Düker G,Bettels R,Rohrbach M,Kugathasan S,Chapel H,Keshav S,Elkadri A,Platt N,Muise AM,Koletzko S,Xavier RJ,Marquardt T,Powrie F,Wraith JE,Gyrd-Hansen M,Platt FM,Uhlig HH",|
clne0024,univ1102,17,3.6702380952380955,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Magnetic Resonance in Medicine|Translational Stroke Research|Journal of Cerebral Blood Flow and Metabolism|Medical Image Analysis|Neuroimage|Magnetic Resonance in Medicine|Magnetic Resonance in Medicine|NMR in Biomedicine|Medical Image Analysis|Magnetic Resonance in Medicine|Journal of Magnetic Resonance Imaging|International Journal of Stroke|Magnetic Resonance in Medicine|Magnetic Resonance in Medicine|Medical Image Analysis|Magnetic Resonance in Medicine|Stroke,01/04/2011|01/01/2013|07/08/2013|04/07/2013|22/12/2011|24/09/2012|05/04/2012|10/06/2014|27/12/2011|01/01/2013|23/10/2012|01/04/2015|01/08/2013|13/01/2012|01/01/2012|01/01/2012|24/02/2011,"Partial volume correction of multiple inversion time arterial spin labeling MRI data.|Pseudo-Continuous Arterial Spin Labelling MRI for Non-Invasive, Whole-Brain, Serial Quantification of Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage|Cerebral blood flow quantification using vessel-encoded arterial spin labeling.|A theoretical framework for quantifying blood volume flow rate from dynamic angiographic data and application to vessel-encoded arterial spin labeling MRI.|Quantitative measurement of cerebral physiology using respiratory-calibrated MRI.|Quantitative Bayesian model-based analysis of amide proton transfer MRI.|Modeling dispersion in arterial spin labeling: validation using dynamic angiographic measurements.|Comparing different analysis methods for quantifying the MRI amide proton transfer (APT) effect in hyperacute stroke patients.|A fast analysis method for non-invasive imaging of blood flow in individual cerebral arteries using vessel-encoded arterial spin labelling angiography.|Modeling dispersion in arterial spin labeling: Validation using dynamic angiographic measurements|Evaluating quantitative approaches to dynamic susceptibility contrast MRI among carotid endarterectomy patients.|The dynamics of intracellular pH are associated with final tissue outcome in acute ischemic stroke|Quantitative Bayesian model-based analysis of amide proton transfer MRI|A kinetic model for vessel-encoded dynamic angiography with arterial spin labeling|A fast analysis method for non-invasive imaging of blood flow in individual cerebral arteries using vessel-encoded arterial spin labelling angiography|A kinetic model for vessel-encoded dynamic angiography with arterial spin labeling.|Intracranial hemodynamics is altered by carotid artery disease and after endarterectomy: a dynamic magnetic resonance angiography study.","Chappell MA,Groves AR,MacIntosh BJ,Donahue MJ,Jezzard P,Woolrich MW|Kelly ME,Rowland MJ,Okell TW,Westbrook J,Jezzard P,Pattinson KTS,Corkill R,Kerr RS,Chappell MA|Okell TW,Chappell MA,Kelly ME,Jezzard P|Okell TW,Chappell MA,Jezzard P|Bulte DP,Kelly M,Germuska M,Xie J,Chappell MA,Okell TW,Bright MG,Jezzard P|Chappell MA,Donahue MJ,Tee YK,Khrapitchev AA,Sibson NR,Jezzard P,Payne SJ|Chappell MA,Woolrich MW,Kazan S,Jezzard P,Payne SJ,MacIntosh BJ|Tee YK,Harston GW,Blockley N,Okell TW,Levman J,Sheerin F,Cellerini M,Jezzard P,Kennedy J,Payne SJ,Chappell MA|Chappell MA,Okell TW,Payne SJ,Jezzard P,Woolrich MW|Chappell MA,Woolrich MW,Kazan S,Jezzard P,Payne SJ,MacIntosh BJ|Crane DE,Donahue MJ,Chappell MA,Sideso E,Handa A,Kennedy J,Jezzard P,MacIntosh BJ|Harston G,Mathieson P,Reckless I,Schulz U,Shah K,Tee YK,Blockley N,Okell TW,Sheerin F,Payne SJ,Jezzard P,Chappell MA,Kennedy J|Chappell MA,Donahue MJ,Tee YK,Khrapitchev AA,Sibson NR,Jezzard P,Payne SJ|Okell TW,Chappell MA,Schulz UG,Jezzard P|Chappell MA,Okell TW,Payne SJ,Jezzard P,Woolrich MW|Okell TW,Chappell MA,Schulz UG,Jezzard P|MacIntosh BJ,Sideso E,Donahue MJ,Chappell MA,Günther M,Handa A,Kennedy J,Jezzard P","Artifacts,Cerebral Arteries,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Imaging,Three-Dimensional,Magnetic Resonance Angiography,Reproducibility of Results,Sensitivity and Specificity,Spin Labels||Adult,Blood Flow Velocity,Carotid Arteries,Cerebrovascular Circulation,Female,Hemodynamics,Humans,Image Processing,Computer-Assisted,Imaging,Three-Dimensional,Magnetic Resonance Imaging,Male,Signal-To-Noise Ratio,Spin Labels,Vertebral Artery|Blood volume flow rate quantification,Cerebral arteries,Dynamic angiography,Magnetic resonance imaging,Vessel-encoded pseudocontinuous arterial spin labeling,Adult,Algorithms,Blood Flow Velocity,Blood Volume,Blood Volume Determination,Brain,Cerebrovascular Circulation,Computer Simulation,Female,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Magnetic Resonance Angiography,Male,Models,Cardiovascular,Reproducibility of Results,Sensitivity and Specificity,Young Adult|Adult,Brain,Calibration,Cerebrovascular Circulation,Female,Humans,Magnetic Resonance Imaging,Male,Oxygen,Regional Blood Flow,Respiration|amide proton transfer,chemical exchange saturation transfer,magnetization transfer,Adult,Amides,Bayes Theorem,Body Water,Brain,Computer Simulation,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Magnetic Resonance Imaging,Male,Models,Neurological,Pattern Recognition,Automated,Protons,Reproducibility of Results,Sensitivity and Specificity,Young Adult|Aged,80 and over,Algorithms,Arteries,Blood Flow Velocity,Computer Simulation,Female,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Magnetic Resonance Angiography,Male,Middle Aged,Models,Cardiovascular,Peripheral Arterial Disease,Reproducibility of Results,Sensitivity and Specificity,Spin Labels|Humans,Protons,Amides,Image Interpretation,Computer-Assisted,Magnetic Resonance Imaging,Sensitivity and Specificity,Reproducibility of Results,Brain Chemistry,Algorithms,Aged,80 and over,Female,Male,Stroke|Algorithms,Blood Flow Velocity,Cerebral Arteries,Cerebrovascular Circulation,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Magnetic Resonance Angiography,Reproducibility of Results,Sensitivity and Specificity,Spin Labels,Vertebrobasilar Insufficiency||Aged,80 and over,Algorithms,Blood Flow Velocity,Blood Volume,Brain,Carotid Stenosis,Cerebrovascular Circulation,Contrast Media,Diffusion Magnetic Resonance Imaging,Echo-Planar Imaging,Endarterectomy,Carotid,Female,Gadolinium,Hemodynamics,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Magnetic Resonance Angiography,Male,Middle Aged,Putamen,Somatosensory Cortex,Statistics as Topic|||||Adult,Blood Flow Velocity,Brain,Cerebral Arteries,Cerebrovascular Circulation,Computer Simulation,Female,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Kinetics,Magnetic Resonance Angiography,Models,Cardiovascular,Neurological,Reproducibility of Results,Sensitivity and Specificity,Spin Labels,Young Adult|Aged,80 and over,Carotid Stenosis,Cerebral Arteries,Cerebrovascular Circulation,Endarterectomy,Carotid,Female,Hemodynamics,Humans,Magnetic Resonance Angiography,Male,Middle Aged"
clab0127,whgu0142,1,0.14285714285714285,Journal article,Proceedings of the National Academy of Sciences of USA,23/02/2012,The p53 cofactor Strap exhibits an unexpected TPR motif and oligonucleotide-binding (OB)-fold structure.,"Adams CJ,Pike AC,Maniam S,Sharpe TD,Coutts AS,Knapp S,La Thangue NB,Bullock AN","Amino Acid Motifs,Animals,Carrier Proteins,Chromatin,Crystallography,X-Ray,DNA Damage,E1A-Associated p300 Protein,Genes,p53,Humans,Mice,Models,Molecular,Neoplasm Proteins,Oligonucleotides,Protein Binding,Protein Conformation,Protein Folding,Protein Structure,Tertiary,Tumor Suppressor Protein p53"
clab0035,immd0330,9,0.7988455988455988,Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article,Leukemia|Leukemia|Leukemia|Leukemia Research: clinical and laboratory studies|Oncotarget|Leukemia|Haematologica: the hematology journal|British Journal of Haematology|British Journal of Haematology,01/05/2014|06/12/2014|01/01/2016|01/04/2015||24/12/2013|05/07/2013|01/01/2013|01/10/2013,Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia|Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression.|Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression|TARGETED RE-SEQUENCING ANALYSIS OF 31 GENES COMMONLY MUTATED IN MYELOID DISORDERS IN SERIAL SAMPLES FROM MYELODYSPLASTIC SYNDROME PATIENTS WITH DISEASE PROGRESSION|ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.|Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.|Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.|Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression|Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression,"Pellagatti A,Fernandez-Mercado M,Di Genua C,Larrayoz MJ,Killick S,Dolatshad H,Burns A,Calasanz MJ,Schuh A,Boultwood J|Pellagatti A,Roy S,Di Genua C,Burns A,McGraw K,Valletta S,Larrayoz MJ,Fernandez-Mercado M,Mason J,Killick S,Mecucci C,Calasanz MJ,List A,Schuh A,Boultwood J|Pellagatti A,Roy S,Di Genua C,Burns A,McGraw K,Valletta S,Larrayoz MJ,Fernandez-Mercado M,Mason J,Killick S,Mecucci C,Calasanz MJ,List A,Schuh A,Boultwood J|Pellagatti A,Roy S,Di Genua C,Burns A,McGraw K,Larrayoz MJ,Fernandez-Mercado M,Valletta S,Mason J,Killick S,Mecucci C,Calasanz MJ,List A,Schuh A,Boultwood J|Valletta S,Dolatshad H,Bartenstein M,Yip BH,Bello E,Gordon S,Yu Y,Shaw J,Roy S,Scifo L,Schuh A,Pellagatti A,Fulga TA,Verma A,Boultwood J|Pellagatti A,Fernandez-Mercado M,Di Genua C,Larrayoz MJ,Killick S,Dolatshad H,Burns A,Calasanz MJ,Schuh A,Boultwood J|Fernandez-Mercado M,Burns A,Pellagatti A,Giagounidis A,Germing U,Agirre X,Prosper F,Aul C,Killick S,Wainscoat JS,Schuh A,Boultwood J|Fernandez-Mercado M,Pellagatti A,Di Genua C,Boultwood J,Larrayoz MJ,Aranaz P,Calasanz MJ,Winkelmann N,Cross NCP,Burns A,Schuh A|Fernandez-Mercado M,Pellagatti A,Di Genua C,Larrayoz MJ,Winkelmann N,Aranaz P,Burns A,Schuh A,Calasanz MJ,Cross NCP,Boultwood J","|Humans,Myelodysplastic Syndromes,Disease Progression,GTP Phosphohydrolases,Ribonucleoproteins,Membrane Proteins,Nuclear Proteins,Repressor Proteins,Mutation,Genes,p53,Core Binding Factor Alpha 2 Subunit,High-Throughput Nucleotide Sequencing||||Chromosome Deletion,Chromosomes,Human,Pair 5,Exome,Humans,Leukemia,Myeloid,Acute,Myelodysplastic Syndromes|Adult,Aged,80 and over,Anemia,Macrocytic,Chromosome Deletion,Chromosomes,Human,Pair 5,Cohort Studies,Female,Gene Frequency,Gene Targeting,Humans,Male,Middle Aged,Mutation,Myelodysplastic Syndromes,Polymorphism,Single Nucleotide,Sequence Analysis,DNA,Young Adult||"
claridge,clme0494,1,0.16666666666666666,Journal article,Chemical Communications,01/01/2016,Cephalosporins inhibit human metallo β-lactamase fold DNA repair nucleases SNM1A and SNM1B/apollo.,"Lee SY,Brem J,Pettinati I,Claridge TD,Gileadi O,Schofield CJ,McHugh PJ",
immd0082,ocms0037,1,0.07142857142857142,Journal article,Haematologica: the hematology journal,28/05/2013,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary"
bioc0541,card0039,6,0.9226190476190476,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,The FASEB Journal|Methods in Molecular Biology|Methods in Molecular Biology|American Journal of Pathology|Methods in Molecular Biology|Proceedings of the National Academy of Sciences of USA,09/09/2011|01/01/2011|01/01/2011|16/04/2013|01/01/2011|26/03/2012,VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis.|Detection of brain pathology by magnetic resonance imaging of iron oxide micro-particles.|Molecular MRI approaches to the detection of CNS inflammation.|Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice.|Magnetic resonance imaging of brain inflammation using microparticles of iron oxide.|Molecular MRI enables early and sensitive detection of brain metastases.,"Serres S,Mardiguian S,Campbell SJ,McAteer MA,Akhtar A,Krapitchev A,Choudhury RP,Anthony DC,Sibson NR|Anthony DC,Sibson NR,McAteer MA,Davis B,Choudhury RP|Sibson NR,Anthony DC,van Kasteren S,Dickens A,Perez-Balderas F,McAteer MA,Choudhury RP,Davis BG|Mardiguian S,Serres S,Ladds E,Campbell SJ,Wilainam P,McFadyen C,McAteer M,Choudhury RP,Smith P,Saunders F,Watt G,Sibson NR,Anthony DC|McAteer MA,von Zur Muhlen C,Anthony DC,Sibson NR,Choudhury RP|Serres S,Soto MS,Hamilton A,McAteer MA,Carbonell WS,Robson MD,Ansorge O,Khrapitchev A,Bristow C,Balathasan L,Weissensteiner T,Anthony DC,Choudhury RP,Muschel RJ,Sibson NR","Animals,Brain,Contrast Media,Disease Models,Animal,Disease Progression,Encephalomyelitis,Autoimmune,Experimental,Endothelium,Female,Ferric Compounds,Gadolinium DTPA,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Multiple Sclerosis,Translational Medical Research,Vascular Cell Adhesion Molecule-1|Animals,Brain,Cell Line,Contrast Media,Ferric Compounds,Magnetic Resonance Imaging,Male,Mice,Particle Size,Rats,Wistar|Animals,Antibodies,Antigens,CD15,Central Nervous System,Endothelial Cells,Ferric Compounds,Inflammation,Magnetic Resonance Imaging,Mice,Rats,Statistics as Topic,Tumor Necrosis Factor-alpha,Vascular Cell Adhesion Molecule-1|Acute Disease,Animals,Antibodies,Monoclonal,Brain,Contrast Media,Drug Evaluation,Preclinical,Encephalomyelitis,Autoimmune,Experimental,Female,Gadolinium DTPA,Gene Expression Regulation,Interleukin-17,Magnetic Resonance Imaging,Mice,Biozzi,Motor Activity,RNA,Messenger,Remission Induction,Secondary Prevention,Severity of Illness Index,Treatment Outcome,Vascular Cell Adhesion Molecule-1|Animals,Encephalitis,Ferric Compounds,Magnetic Resonance Imaging,Mice,Particle Size,Vascular Cell Adhesion Molecule-1|Animals,Brain Neoplasms,Disease Progression,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Sensitivity and Specificity,Up-Regulation,Vascular Cell Adhesion Molecule-1"
path0636,smlea,4,0.7555555555555555,Journal article|Journal article|Journal article|Journal article,eLife|Developmental Cell|eLife|Nature Chemical Biology,01/01/2013|01/01/2014|23/05/2015|01/01/2011,Crystal structures of the CPAP/STIL complex reveal its role in centriole assembly and human microcephaly.|The centrosome-specific phosphorylation of Cnn by Polo/Plk1 drives Cnn scaffold assembly and centrosome maturation.|The homo-oligomerisation of both Sas-6 and Ana2 is required for efficient centriole assembly in flies.|SAS-6 oligomerization: the key to the centriole?,"Cottee MA,Muschalik N,Wong YL,Johnson CM,Johnson S,Andreeva A,Oegema K,Lea SM,Raff JW,van Breugel M|Conduit PT,Feng Z,Richens JH,Baumbach J,Wainman A,Bakshi SD,Dobbelaere J,Johnson S,Lea SM,Raff JW|Cottee MA,Muschalik N,Johnson S,Leveson J,Raff JW,Lea SM|Cottee MA,Raff JW,Lea SM,Roque H","C. elegans,CPAP,D. melanogaster,STIL,Zebrafish,centriole,centrosome,microcephaly,Binding Sites,Centrioles,Humans,Intracellular Signaling Peptides and Proteins,Microcephaly,Microtubule-Associated Proteins,Point Mutation,Proline,Protein Conformation|Brain,Cells,Cultured,Cytoplasm,Centrosome,Microtubules,Animals,Genetically Modified,Drosophila melanogaster,Protein-Serine-Threonine Kinases,Cell Cycle Proteins,Homeodomain Proteins,Drosophila Proteins,Proto-Oncogene Proteins,Recombinant Fusion Proteins,Spectrometry,Mass,Matrix-Assisted Laser Desorption-Ionization,Two-Hybrid System Techniques,Immunoprecipitation,Mitosis,Amino Acid Sequence,Sequence Homology,Amino Acid,Phosphorylation,Image Processing,Computer-Assisted,Molecular Sequence Data,Protein Multimerization|Centrioles,Animals,Drosophila melanogaster,Cell Cycle Proteins,Microtubule-Associated Proteins,Drosophila Proteins,Crystallography,X-Ray,DNA Mutational Analysis,Protein Conformation,Point Mutation,Protein Multimerization|Animals,Caenorhabditis elegans Proteins,Cell Cycle Proteins,Centrioles,Humans,Models,Molecular,Protein Conformation"
immd0100,immd0218,1,0.07692307692307693,Journal article,Arthritis and Rheumatism,01/11/2013,Endoplasmic reticulum aminopeptidase 1 (ERAP1) plays a critical role in determining the length and sequence of peptides bound and presented by HLA-B27,"Chen L,Fischer R,Peng Y,Reeves E,McHugh K,Ternette N,Hanke T,Dong T,Elliott T,Shastri N,Kollnberger S,James E,Kessler B,Bowness P",
ndos0461,raob0189,1,0.25,Journal article,British Journal of Cancer,29/01/2013,Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair.,"Groselj B,Sharma NL,Hamdy FC,Kerr M,Kiltie AE","Clinical Trials as Topic,Combined Modality Therapy,DNA Damage,DNA Repair,Histone Deacetylase Inhibitors,Humans,Neoplasms,Radiation-Sensitizing Agents,Signal Transduction"
clme0301,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0667,donc0120,2,0.14358974358974358,Journal article|Conference paper,Radiotherapy and Oncology|Journal of Clinical Oncology,|20/05/2015,"ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.|ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)-Mechanism and clinical outcomes.","Wilson JM,Fokas E,Dutton SJ,Patel N,Hawkins MA,Eccles C,Chu KY,Durrant L,Abraham AG,Partridge M,Woodward M,O'Neill E,Maughan T,McKenna WG,Mukherjee S,Brunner TB|Wilson JM,Dutton SJ,Hackett SL,Durrant L,Chu K-Y,Eccles C,Abraham AG,O'Neill E,Partridge M,Hawkins MA,McKenna WG,Maughan T,Brunner TB,Mukherjee S",|
cschof,univ0247,1,0.125,Journal article,Proteomics,05/06/2015,Expanding the yeast protein arginine methylome.,"Plank M,Fischer R,Geoghegan V,Charles PD,Konietzny R,Acuto O,Pears C,Schofield CJ,Kessler BM","Arginine,Saccharomyces cerevisiae Proteins,Proteome,Isotope Labeling,Systems Biology,Amino Acid Sequence,Methylation,Molecular Sequence Data,Tandem Mass Spectrometry"
gree0184,stat0004,1,0.013888888888888888,Journal article,Nature Genetics,01/01/2011,A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease.,"Peden JF,Hopewell JC,Saleheen D,Chambers JC,Hager J,Soranzo N,Collins R,Danesh J,Elliott P,Farrall M,Stirrups K,Zhang W,Hamsten A,Parish S,Lathrop M,Watkins H,Clarke R,Deloukas P,Kooner JS,Goel A,Ongen H,Strawbridge RJ,Heath S,Mal̈arstig A,Helgadottir A,Öhrvik J,Murtaza M,Potter S,Hunt SE,Delepine M,Jalilzadeh S,Axelsson T,Syvanen AC,Gwilliam R,Bumpstead S,Gray E,Edkins S,Folkersen L,Kyriakou T,Franco-Cereceda A,Gabrielsen A,Seedorf U,Eriksson P,Offer A,Bowman L,Sleight P,Armitage J,Peto R,Abecasis G,Ahmed N,Caulfield M,Donnelly P,Froguel P,Kooner AS,McCarthy MI,Samani NJ,Scott J,Sehmi J,Silveira A,Hellánius ML,Van 'T Hooft FM,Olsson G,Rust S,Assmann G,Barlera S,Tognoni G,Franzosi MG,Linksted P,Green FR,Rasheed A,Zaidi M,Shah N,Samuel M","ADAM Proteins,Adult,Aged,Asian Continental Ancestry Group,Case-Control Studies,Coronary Artery Disease,European Continental Ancestry Group,Female,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Lymphokines,Male,Middle Aged,Oligonucleotide Array Sequence Analysis,Platelet-Derived Growth Factor,Polymorphism,Single Nucleotide,Quantitative Trait Loci,Sterol Esterase,Transcription Factors"
clar0295,raob0128,1,0.030303030303030304,Journal article,Physical Review Special Topics: Accelerators and Beams,11/03/2013,Conceptual design of a nonscaling fixed field alternating gradient accelerator for protons and carbon ions for charged particle therapy,"Peach KJ,Aslaninejad M,Barlow RJ,Beard CD,Bliss N,Cobb JH,Easton MJ,Edgecock TR,Fenning R,Gardner ISK,Hill MA,Owen HL,Johnstone CJ,Jones B,Jones T,Kelliher DJ,Khan A,Machida S,McIntosh PA,Pattalwar S,Pasternak J,Pozimski J,Prior CR,Rochford J,Rogers CT,Seviour R,Sheehy SL,Smith SL,Strachan J,Tygier S,Vojnovic B,Wilson P,Witte H,Yokoi T",
donc0120,xxxx0009,6,1.626190476190476,Journal article|Journal article|Poster|Journal article|Poster|Journal article,International Journal of Radiation: Oncology - Biology - Physics|Clinical Oncology|Medical Physics|Radiation Oncology|Medical Physics|Radiation Oncology,01/10/2014|03/07/2014|01/06/2015|01/01/2014|01/06/2015|23/12/2014,Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.|The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies.|SU-E-T-69: A Radiobiological Investigation of Dose Escalation in Lower Oesophageal Tumours with a Focus On Gastric Toxicity.|Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer.|TH-AB-BRB-11: A Method of Unwrapping 3D Complex Hollow Organs for Spatial Dose Surface Analysis.|Comparison of Acuros (AXB) and Anisotropic Analytical Algorithm (AAA) for dose calculation in treatment of oesophageal cancer: effects on modelling tumour control probability.,"Warren S,Partridge M,Carrington R,Hurt C,Crosby T,Hawkins MA|Wilson JM,Partridge M,Hawkins M|Carrington R,Staffurth J,Warren S,Partridge M,Spezi E,Gwynne S,Hawkins M,Crosby T|Wilson JM,Mukherjee S,Chu KY,Brunner TB,Partridge M,Hawkins M|Witztum A,Warren S,Partridge M,Hawkins MA|Padmanaban S,Warren S,Walsh A,Partridge M,Hawkins MA","Lung,Heart,Humans,Esophageal Neoplasms,Dose Fractionation,Tumor Burden,Probability,Feasibility Studies,Models,Biological,Organs at Risk,Chemoradiotherapy|Humans,Gastrointestinal Neoplasms,Fluorodeoxyglucose F18,Radiopharmaceuticals,Positron-Emission Tomography,Tomography,X-Ray Computed,Individualized Medicine,Chemoradiotherapy||Humans,Adenocarcinoma,Pancreatic Neoplasms,Cisplatin,Fluorodeoxyglucose F18,Deoxycytidine,Antineoplastic Combined Chemotherapy Protocols,Radiopharmaceuticals,Positron-Emission Tomography,Tomography,X-Ray Computed,Neoplasm Staging,Prognosis,Radiotherapy Dosage,Radiotherapy Planning,Computer-Assisted,Follow-Up Studies,Clinical Trials,Phase II as Topic,Chemoradiotherapy,Multimodal Imaging||Humans,Esophageal Neoplasms,Tomography,X-Ray Computed,Radiotherapy Dosage,Radiotherapy Planning,Computer-Assisted,Probability,Retrospective Studies,Radiometry,Algorithms,Radiotherapy,Intensity-Modulated,Organs at Risk"
immd0100,immd0198,2,0.18803418803418803,Journal article|Conference paper,PLoS Pathogens|Lancet,01/05/2011|27/02/2013,The Antiviral Efficacy of HIV-Specific CD8+ T-Cells to a Conserved Epitope is Heavilydependent on the Infecting HIV-1 Isolate|Antigen-sensitive CD8 T-cell clones with tough HIV-1 suppression,"Ranasinghe SRF,Kramer HB,Wright C,Kessler BM,di Gleria K,Zhang Y,Gillespie GM,Blais ME,Culshaw A,Pichulik T,Simmons A,Rowland-Jones SL,McMichael AJ,Dong T|Glanville JM,Taylor S,Baban D,Gillespie G,Easterbrook P,Stewart-Jones G,Simmons A,Rowland-Jones S,Dong T,McMichael A",|
card0008,card0027,3,0.22549019607843135,Journal article|Journal article|Journal article,Genetics in Medicine|PLoS One|Mammalian Genome,21/05/2015|01/01/2012|27/04/2012,Exome sequencing identifies rare variants in multiple genes in atrioventricular septal defect.|Functional significance of SRJ domain mutations in CITED2.|Nprl3 is required for normal development of the cardiovascular system.,"D'Alessandro LC,Al Turki S,Manickaraj AK,Manase D,Mulder BJ,Bergin L,Rosenberg HC,Mondal T,Gordon E,Lougheed J,Smythe J,Devriendt K,Bhattacharya S,Watkins H,Bentham J,Bowdin S,Hurles ME,Mital S|Chen CM,Bentham J,Cosgrove C,Braganca J,Cuenda A,Bamforth SD,Schneider JE,Watkins H,Keavney B,Davies B,Bhattacharya S|Kowalczyk MS,Hughes JR,Babbs C,Sanchez-Pulido L,Szumska D,Sharpe JA,Sloane-Stanley JA,Morriss-Kay GM,Smoot LB,Roberts AE,Watkins H,Bhattacharya S,Gibbons RJ,Ponting CP,Wood WG,Higgs DR","|Alleles,Amino Acid Sequence,Amino Acid Substitution,Animals,Case-Control Studies,Cell Proliferation,Embryo,Mammalian,Embryonic Stem Cells,Enzyme Activation,Heart Defects,Congenital,Humans,Leukemia Inhibitory Factor,MAP Kinase Signaling System,Mice,Mitogen-Activated Protein Kinase 1,Molecular Sequence Data,Mutant Proteins,Mutation,Phosphorylation,Protein Structure,Tertiary,Repressor Proteins,Structure-Activity Relationship,Trans-Activators,Transcription Factor AP-2,Transcriptional Activation|Abnormalities,Multiple,Amino Acid Sequence,Animals,Cardiovascular System,Cells,Cultured,DNA Mutational Analysis,Female,GTPase-Activating Proteins,Gene Expression Profiling,Genetic Association Studies,Heart Defects,Congenital,Humans,Intracellular Signaling Peptides and Proteins,Male,Mice,Knockout,Molecular Sequence Annotation,Molecular Sequence Data,Myocardium,Nuclear Proteins,Phenotype,Polymorphism,Single Nucleotide,Promoter Regions,Genetic"
immd0100,path0642,1,0.1,Journal article,Science Signaling,01/01/2011,Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.,"Dushek O,Aleksic M,Wheeler RJ,Zhang H,Cordoba SP,Peng YC,Chen JL,Cerundolo V,Dong T,Coombs D,van der Merwe PA","Adaptive Immunity,Animals,Antigens,Humans,Lymphocyte Activation,Mice,Models,Chemical,T-Lymphocytes,Cytotoxic,Thermodynamics"
card0027,gree0184,2,0.04614695340501792,Journal article|Journal article,PLoS Medicine|Nature Genetics,01/02/2012|01/01/2011,"Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.|A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease.","Clarke R,Bennett DA,Parish S,Verhoef P,Dötsch-Klerk M,Lathrop M,Xu P,Nordestgaard BG,Holm H,Hopewell JC,Saleheen D,Tanaka T,Anand SS,Chambers JC,Kleber ME,Ouwehand WH,Yamada Y,Elbers C,Peters B,Stewart AF,Reilly MM,Thorand B,Yusuf S,Engert JC,Assimes TL,Kooner J,Danesh J,Watkins H,Samani NJ,Collins R,Peto R,MTHFR Studies Collaborative Group|Peden JF,Hopewell JC,Saleheen D,Chambers JC,Hager J,Soranzo N,Collins R,Danesh J,Elliott P,Farrall M,Stirrups K,Zhang W,Hamsten A,Parish S,Lathrop M,Watkins H,Clarke R,Deloukas P,Kooner JS,Goel A,Ongen H,Strawbridge RJ,Heath S,Mal̈arstig A,Helgadottir A,Öhrvik J,Murtaza M,Potter S,Hunt SE,Delepine M,Jalilzadeh S,Axelsson T,Syvanen AC,Gwilliam R,Bumpstead S,Gray E,Edkins S,Folkersen L,Kyriakou T,Franco-Cereceda A,Gabrielsen A,Seedorf U,Eriksson P,Offer A,Bowman L,Sleight P,Armitage J,Peto R,Abecasis G,Ahmed N,Caulfield M,Donnelly P,Froguel P,Kooner AS,McCarthy MI,Samani NJ,Scott J,Sehmi J,Silveira A,Hellánius ML,Van 'T Hooft FM,Olsson G,Rust S,Assmann G,Barlera S,Tognoni G,Franzosi MG,Linksted P,Green FR,Rasheed A,Zaidi M,Shah N,Samuel M","Bias (Epidemiology),Coronary Disease,Folic Acid,Genotype,Homocysteine,Humans,Methylenetetrahydrofolate Reductase (NADPH2),Polymorphism,Genetic,Risk Factors|ADAM Proteins,Adult,Aged,Asian Continental Ancestry Group,Case-Control Studies,Coronary Artery Disease,European Continental Ancestry Group,Female,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Lymphokines,Male,Middle Aged,Oligonucleotide Array Sequence Analysis,Platelet-Derived Growth Factor,Polymorphism,Single Nucleotide,Quantitative Trait Loci,Sterol Esterase,Transcription Factors"
clme0237,lina0435,4,0.09899816591641875,Journal article|Journal article|Journal article|Journal article,Nature Genetics|Human Molecular Genetics|PLoS Genetics|Nature Genetics,18/05/2015|25/01/2014|01/12/2012|23/12/2012,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis.|Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Martin HC,Kim GE,Pagnamenta AT,Murakami Y,Carvill GL,Meyer E,Copley RR,Rimmer A,Barcia G,Fleming MR,Kronengold J,Brown MR,Hudspith KA,Broxholme J,Kanapin A,Cazier JB,Kinoshita T,Nabbout R,WGS500 Consortium,Bentley D,McVean G,Heavin S,Zaiwalla Z,McShane T,Mefford HC,Shears D,Stewart H,Kurian MA,Scheffer IE,Blair E,Donnelly P,Kaczmarek LK,Taylor JC|Lise S,Clarkson Y,Perkins E,Kwasniewska A,Sadighi Akha E,Schnekenberg RP,Suminaite D,Hope J,Baker I,Gregory L,Green A,Allan C,Lamble S,Jayawant S,Quaghebeur G,Cader MZ,Hughes S,Armstrong RJ,Kanapin A,Rimmer A,Lunter G,Mathieson I,Cazier JB,Buck D,Taylor JC,Bentley D,McVean G,Donnelly P,Knight SJ,Jackson M,Ragoussis J,Németh AH|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Child,Preschool,Chromosomes,Human,Pair 9,Epilepsy,Genetic Predisposition to Disease,Genome-Wide Association Study,High-Throughput Nucleotide Sequencing,Humans,KCNQ2 Potassium Channel,Male,Membrane Proteins,Mutation,NAV1.2 Voltage-Gated Sodium Channel,Nerve Tissue Proteins,Pathology,Molecular,Potassium Channels,Proto-Oncogene Proteins c-cbl,Uniparental Disomy,Young Adult,WGS500 Consortium|Adult,Animals,Cerebellum,Chromosome Mapping,Cognition Disorders,Humans,Mice,Knockout,Mutation,Neurons,Purkinje Cells,Spectrin,Spinocerebellar Ataxias|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA"
bioc0212,chri0963,2,0.2857142857142857,Journal article|Conference paper,Proceedings of the National Academy of Sciences of USA|Biophysical Journal,19/02/2013|29/01/2013,Extramitochondrial domain rich in carbonic anhydrase activity improves myocardial energetics.|An Extra-Mitochondrial Domain Rich in Carbonic Anhydrase Activity Improves Myocardial Energetics,"Schroeder MA,Ali MA,Hulikova A,Supuran CT,Clarke K,Vaughan-Jones RD,Tyler DJ,Swietach P|Schroeder MA,Ali M,Hulikova A,Supuran CT,Clarke K,Vaughan-Jones RD,Tyler DJ,Swietach P","Adenosine Triphosphate,Animals,Carbon Dioxide,Carbonic Anhydrase II,Carbonic Anhydrase IV,Carbonic Anhydrases,Cell Compartmentation,Cytoplasm,Energy Metabolism,Fluorescent Dyes,Hydrogen-Ion Concentration,Kinetics,Male,Mitochondria,Heart,Myocytes,Cardiac,Rats,Wistar|"
ctsu0084,ctsu0165,1,0.02,Journal article,Lancet,01/01/2011,The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.,"Baigent C,Landray MJ,Reith C,Emberson J,Wheeler DC,Tomson C,Wanner C,Krane V,Cass A,Craig J,Neal B,Jiang L,Hooi LS,Levin A,Agodoa L,Gaziano M,Kasiske B,Walker R,Massy ZA,Feldt-Rasmussen B,Krairittichai U,Ophascharoensuk V,Fellström B,Holdaas H,Tesar V,Wiecek A,Grobbee D,de Zeeuw D,Grönhagen-Riska C,Dasgupta T,Lewis D,Herrington W,Mafham M,Majoni W,Wallendszus K,Grimm R,Pedersen T,Tobert J,Armitage J,Baxter A,Bray C,Chen Y,Chen Z,Hill M,Knott C,Parish S,Simpson D,Sleight P,Young A,Collins R,SHARP Investigators","Adult,Aged,Azetidines,Cardiovascular Diseases,Cholesterol,LDL,Confidence Intervals,Dose-Response Relationship,Drug,Double-Blind Method,Drug Administration Schedule,Drug Therapy,Combination,Ezetimibe,Female,Follow-Up Studies,Humans,Hypolipidemic Agents,Kidney Function Tests,Male,Middle Aged,Reference Values,Renal Dialysis,Renal Insufficiency,Chronic,Risk Assessment,Severity of Illness Index,Simvastatin,Survival Analysis,Time Factors,Treatment Outcome"
card0027,stat0004,4,0.04327856042540906,Journal article|Journal article|Journal article|Journal article,Nature Genetics|Nature Genetics|Nature|Diabetes,01/01/2011|18/05/2015|10/12/2014|01/01/2011,A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.|Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes,"Peden JF,Hopewell JC,Saleheen D,Chambers JC,Hager J,Soranzo N,Collins R,Danesh J,Elliott P,Farrall M,Stirrups K,Zhang W,Hamsten A,Parish S,Lathrop M,Watkins H,Clarke R,Deloukas P,Kooner JS,Goel A,Ongen H,Strawbridge RJ,Heath S,Mal̈arstig A,Helgadottir A,Öhrvik J,Murtaza M,Potter S,Hunt SE,Delepine M,Jalilzadeh S,Axelsson T,Syvanen AC,Gwilliam R,Bumpstead S,Gray E,Edkins S,Folkersen L,Kyriakou T,Franco-Cereceda A,Gabrielsen A,Seedorf U,Eriksson P,Offer A,Bowman L,Sleight P,Armitage J,Peto R,Abecasis G,Ahmed N,Caulfield M,Donnelly P,Froguel P,Kooner AS,McCarthy MI,Samani NJ,Scott J,Sehmi J,Silveira A,Hellánius ML,Van 'T Hooft FM,Olsson G,Rust S,Assmann G,Barlera S,Tognoni G,Franzosi MG,Linksted P,Green FR,Rasheed A,Zaidi M,Shah N,Samuel M|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Do R,Stitziel NO,Won HH,Jørgensen AB,Duga S,Angelica Merlini P,Kiezun A,Farrall M,Goel A,Zuk O,Guella I,Asselta R,Lange LA,Peloso GM,Auer PL,Girelli D,Martinelli N,Farlow DN,DePristo MA,Roberts R,Stewart AF,Saleheen D,Danesh J,Epstein SE,Sivapalaratnam S,Hovingh GK,Kastelein JJ,Samani NJ,Schunkert H,Erdmann J,Shah SH,Kraus WE,Davies R,Nikpay M,Johansen CT,Wang J,Hegele RA,Hechter E,Marz W,Kleber ME,Huang J,Johnson AD,Li M,Burke GL,Gross M,Liu Y,Assimes TL,Heiss G,Lange EM,Folsom AR,Taylor HA,Olivieri O,Hamsten A,Clarke R,Reilly DF,Yin W,Rivas MA,Donnelly P,Rossouw JE,Psaty BM,Herrington DM,Wilson JG,Rich SS,Bamshad MJ,Tracy RP,Cupples LA,Rader DJ,Reilly MP,Spertus JA,Cresci S,Hartiala J,Tang WH,Hazen SL,Allayee H,Reiner AP,Carlson CS,Kooperberg C,Jackson RD,Boerwinkle E,Lander ES,Schwartz SM,Siscovick DS,McPherson R,Tybjaerg-Hansen A,Abecasis GR,Watkins H,Nickerson DA,Ardissino D,Sunyaev SR,O'Donnell CJ,Altshuler D,Gabriel S,Kathiresan S|Strawbridge RJ,Dupuis J,Prokopenko I,Barker A,Ahlqvist E,Rybin D,Petrie JR,Travers ME,Bouatia-Naji N,Dimas AS,Nica A,Wheeler E,Chen H,Voight BF,Taneera J,Kanoni S,Peden JF,Turrini F,Gustafsson S,Zabena C,Almgren P,Barker DJ,Barnes D,Dennison EM,Eriksson JG,Eriksson P,Eury E,Folkersen L,Fox CS,Frayling TM,Goel A,Gu HF,Horikoshi M,Isomaa B,Jackson AU,Jameson KA,Kajantie E,Kerr-Conte J,Kuulasmaa T,Kuusisto J,Loos RJ,Luan J,Makrilakis K,Manning AK,Martínez-Larrad MT,Narisu N,Nastase Mannila M,Ohrvik J,Osmond C,Pascoe L,Payne F,Sayer AA,Sennblad B,Silveira A,Stancáková A,Stirrups K,Swift AJ,Syvänen AC,Tuomi T,van 't Hooft FM,Walker M,Weedon MN,Xie W,Zethelius B,DIAGRAM Consortium,GIANT Consortium,MuTHER Consortium,CARDIoGRAM Consortium,C4D Consortium,Ongen H,Mälarstig A,Hopewell JC,Saleheen D,Chambers J,Parish S,Danesh J,Kooner J,Ostenson CG,Lind L,Cooper CC,Serrano-Ríos M,Ferrannini E,Forsen TJ,Clarke R,Franzosi MG,Seedorf U,Watkins H,Froguel P,Johnson P,Deloukas P,Collins FS,Laakso M,Dermitzakis ET,Boehnke M,McCarthy MI,Wareham NJ,Groop L,Pattou F,Gloyn AL,Dedoussis GV,Lyssenko V,Meigs JB,Barroso I,Watanabe RM,Ingelsson E,Langenberg C,Hamsten A,Florez JC","ADAM Proteins,Adult,Aged,Asian Continental Ancestry Group,Case-Control Studies,Coronary Artery Disease,European Continental Ancestry Group,Female,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Lymphokines,Male,Middle Aged,Oligonucleotide Array Sequence Analysis,Platelet-Derived Growth Factor,Polymorphism,Single Nucleotide,Quantitative Trait Loci,Sterol Esterase,Transcription Factors|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|NHLBI Exome Sequencing Project,Humans,Myocardial Infarction,Genetic Predisposition to Disease,Triglycerides,Apolipoproteins A,Receptors,LDL,Case-Control Studies,Genetics,Population,Age Factors,Age of Onset,Heterozygote,Mutation,Alleles,Middle Aged,United States,Female,Male,Cholesterol,Coronary Artery Disease,National Heart,Lung,and Blood Institute (U.S.),Exome|Adult,Diabetes Mellitus,Type 2,Fasting,Female,Genetic Variation,Genome,Human,Genotype,Humans,Insulin,Male,Polymorphism,Single Nucleotide,Proinsulin"
card0008,card0025,1,0.125,Journal article,Journal of Biological Chemistry,21/08/2013,A pivotal role for tryptophan 447 in enzymatic coupling of human endothelial nitric oxide synthase (eNOS): effects on tetrahydrobiopterin-dependent catalysis and eNOS dimerization.,"Benson MA,Batchelor H,Chuaiphichai S,Bailey J,Zhu H,Stuehr DJ,Bhattacharya S,Channon KM,Crabtree MJ","Endothelial Dysfunction,Nitric Oxide Synthase,Superoxide,Superoxide Ion,Tetrahydrobiopterin,Tryptophan,Uncoupling,3T3 Cells,Amino Acid Substitution,Animals,Binding Sites,Biocatalysis,Biopterin,Blotting,Western,Catalytic Domain,Humans,Mice,Models,Molecular,Mutation,Nitric Oxide,Nitric Oxide Synthase Type III,Oxidation-Reduction,Protein Multimerization,Superoxides"
gree1620,raob0182,2,0.20833333333333331,Journal article|Conference paper,Oncotarget|European Journal of Cancer,28/02/2015|01/09/2013,Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen.|High throughput screening for genetic determinants of radiosensitivity,"Tiwana GS,Prevo R,Buffa FM,Yu S,Ebner DV,Howarth A,Folkes LK,Budwal B,Chu KY,Durrant L,Muschel RJ,McKenna WG,Higgins GS|McKenna WG,Tiwana GS,Prevo R,Budwal B,Ebner D,Howarth A,Chu KY,Durrant L,Higgins GS","Cell Line,Tumor,HCT116 Cells,Hela Cells,Humans,Neoplasms,DNA Damage,Pyrithiamine,Thiamin Pyrophosphokinase,Thiamine,Radiation-Sensitizing Agents,Colony-Forming Units Assay,Transfection,Radiation Tolerance,High-Throughput Screening Assays|"
immd0282,immd0282,1,0.5,Chapter,,01/06/2016,Ontogeny of the Hematopoietic System,"Ciau-Uitz R,Patient R,Medvinsky A",
clme0219,immd0106,1,0.16666666666666666,Journal article,Scientific Reports,01/01/2013,Linking genotype to phenotype on beads: high throughput selection of peptides with biological function.,"Huang LC,Pan X,Yang H,Wan LK,Stewart-Jones G,Dorrell L,Ogg G","Anti-HIV Agents,HIV Envelope Protein gp120,HIV-1,High-Throughput Screening Assays,Humans,Kinetics,Microbial Sensitivity Tests,Microspheres,Peptide Library,Peptides,Protein Binding,Receptors,CCR5,HIV,Reproducibility of Results,beta 2-Microglobulin"
clab0127,raob0122,4,0.33574660633484166,Conference paper|Journal article|Journal article|Journal article,Cancer Research|Cancer Cell|Cell Reports|Cell Reports,01/01/2016||11/06/2014|26/06/2014,WEE1 inhibition selectively kills histone H3K36me3-deficient cancers by dNTP starvation|Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.|SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability.|SETD2-Dependent Histone H3K36 Trimethylation Is Required for Homologous Recombination Repair and Genome Stability,"Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Zalmas L-P,Orlando G,Drobnitzky N,Dianov G,Ying S,La Thangue NB,D'Angiolella V,Ryan A,Humphrey TC|Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Orlando G,Mavrommati I,Pai CC,Zalmas LP,Drobnitzky N,Dianov GL,Verrill C,Macaulay VM,Ying S,La Thangue NB,D'Angiolella V,Ryan AJ,Humphrey TC|Pfister SX,Ahrabi S,Zalmas LP,Sarkar S,Aymard F,Bachrati CZ,Helleday T,Legube G,La Thangue NB,Porter AC,Humphrey TC|Pfister SX,Ahrabi S,Zalmas LP,Sarkar S,Aymard F,Bachrati CZ,Helleday T,Legube G,LaThangue NB,Porter ACG,Humphrey TC","|Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Neoplasms,Pyrazoles,Pyrimidines,Ribonucleoside Diphosphate Reductase,Histone-Lysine N-Methyltransferase,Nucleotides,Lysine,Cell Cycle Proteins,Nuclear Proteins,Histones,Blotting,Western,Xenograft Model Antitumor Assays,Reverse Transcriptase Polymerase Chain Reaction,Cell Survival,Gene Expression Regulation,Neoplastic,RNA Interference,Amino Acid Sequence,Base Sequence,Sequence Homology,Amino Acid,Nucleic Acid,Methylation,Molecular Sequence Data,Protein-Tyrosine Kinases|Humans,Genomic Instability,Histone-Lysine N-Methyltransferase,Histones,Transfection,DNA Repair,Protein Binding,Methylation,Rad51 Recombinase,Homologous Recombination,Recombinational DNA Repair|"
clme0993,olin0014,2,0.14646464646464646,Journal article|Journal article,Cancer Research|Nature Reviews: Cancer,03/02/2015|24/03/2016,Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer.|The importance of p53 pathway genetics in inherited and somatic cancer genomes.,"Grawenda AM,Møller EK,Lam S,Repapi E,Teunisse AF,Alnæs GI,Børresen-Dale AL,Kristensen VN,Goding CR,Jochemsen AG,Edvardsen H,Bond GL|Stracquadanio G,Wang X,Wallace MD,Grawenda AM,Zhang P,Hewitt J,Zeron-Medina J,Castro-Giner F,Tomlinson IP,Goding CR,Cygan KJ,Fairbrother WG,Thomas LF,Sætrom P,Gemignani F,Landi S,Schuster-Böckler B,Bell DA,Bond GL","Humans,Breast Neoplasms,Lymphatic Metastasis,Proto-Oncogene Proteins,Nuclear Proteins,Tumor Markers,Biological,Neoplasm Staging,Disease-Free Survival,Gene Expression Regulation,Neoplastic,Mutation,Female,Tumor Suppressor Protein p53|"
immd0180,whgu0274,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
clme0237,stat0054,7,0.4023435094301684,Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article,Leukemia|Nature Communications|Haematologica: the hematology journal|Blood|Blood|Nature Genetics|Nature Genetics,01/01/2012|01/01/2014|11/07/2014|06/12/2014|06/12/2014|18/05/2015|23/12/2012,Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.|Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.|Erythrocytosis associated with a novel missense mutation in the BPGM gene.|The Identification of Further Minimal Regions of Overlap in Chronic Lymphocytic Leukemia Using High-Resolution SNP Arrays|Towards Response Prediction Using Integrated Genomics in Chronic Lymphocytic Leukaemia: Results on 250 First-Line FCR Treated Patients from UK Clinical Trials|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.,"Knight SJ,Yau C,Clifford R,Timbs AT,Sadighi Akha E,Dréau HM,Burns A,Ciria C,Oscier DG,Pettitt AR,Dutton S,Holmes CC,Taylor J,Cazier JB,Schuh A|Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC|Petousi N,Copley RR,Lappin TR,Haggan SE,Bento CM,Cario H,Percy MJ,Ratcliffe PJ,Robbins PA,McMullin MF|Knight SJL,Clifford R,Robbe P,Ramos SDC,Burns A,Timbs AT,Alsolami R,Weller S,Hamblin A,Mason J,Oates M,Titsias M,Yau C,Holmes CC,Pettitt AR,Hillmen P,Taylor J,Shuh A|Clifford RM,Robbe P,Weller S,Timbs AT,Titsias M,Burns A,Cabes M,Alsolami R,Yau C,Hamblin A,Mason J,Oates M,Pettitt A,Holmes C,Hillmen P,Taylor J,Knight SJL,Schuh A|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I","Adult,Aged,80 and over,Biomarkers,Tumor,Chromosome Aberrations,Clone Cells,Female,Gene Dosage,Genome,Human,Genomics,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Loss of Heterozygosity,Male,Middle Aged,Neoplasm Recurrence,Local,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Prognosis|Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading|WGS Consortium,Humans,Polycythemia,Bisphosphoglycerate Mutase,Genotype,Mutation,Missense|||Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA"
immd0082,whgu0378,2,0.1341743119266055,Journal article|Journal article,Nature Genetics|Nature Genetics,18/05/2015|01/01/2012,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Schödel J,Bardella C,Sciesielski LK,Brown JM,Pugh CW,Buckle V,Tomlinson IP,Ratcliffe PJ,Mole DR","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|"
clab0018,clme0135,1,0.14285714285714285,Journal article,British Journal of Cancer,01/01/2011,Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases,"Jubb AM,Cesario A,Ferguson M,Congedo MT,Gatter KC,Lococo F,Mulè A,Pezzella F",
phpc0084,prhc0057,1,0.25,Journal article,"Clinical Chemistry (Washington, DC): international journal of molecular diagnostics and laboratory medicine",26/08/2014,Carcinoembryonic antigen monitoring to detect recurrence of colorectal cancer: how should we interpret the test results?,"Shinkins B,Nicholson BD,James TJ,Primrose JN,Mant D","Humans,Colorectal Neoplasms,Neoplasm Recurrence,Local,Carcinoembryonic Antigen,ROC Curve"
clme0240,engs0270,1,0.2,Journal article,Journal of Medical Engineering and Technology,01/01/2012,Photoplethysmographic derivation of respiratory rate: a review of relevant physiology.,"Meredith DJ,Clifton D,Charlton P,Brooks J,Pugh CW,Tarassenko L","Humans,Monitoring,Physiologic,Photoplethysmography,Respiration,Respiratory Rate"
card0027,clme0237,2,0.3425076452599388,Journal article|Journal article,Nature Genetics|Genetics in Medicine,18/05/2015|,"Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Reassessment Of Mendelian Gene Pathogenicity Using 7,855 Cardiomyopathy Cases And 60,706 Reference Samples","Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Thomson K,Watkins H,Farrall M,Taylor J","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|"
olin0014,whgu0172,1,0.05,Journal article,Cancer Cell,13/05/2013,Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
clme0301,whgu0378,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0670,raob0095,8,0.7704545454545456,Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper,"Journal of Nuclear Medicine|Journal of Nuclear Medicine|Metallomics: integrated biometal science|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Cell Death and Disease|Journal of Nuclear Medicine|PLoS One|Journal of Labelled Compounds and Radiopharmaceuticals",01/12/2014|12/12/2013|13/03/2015|01/05/2013|01/01/2012|07/10/2011|01/01/2011|01/02/2013,"Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.|A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.|A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation|Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality.|Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.|Imaging of hypoxia using CuATSM","Cornelissen B,Able S,Kartsonaki C,Kersemans V,Allen PD,Cavallo F,Cazier JB,Iezzi M,Knight J,Muschel R,Smart S,Vallis KA|Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ|Hueting R,Kersemans V,Tredwell M,Cornelissen B,Christlieb M,Gee AD,Passchier J,Smart SC,Gouverneur V,Muschel RJ,Dilworth JR|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Kersemans V,Thompson J,Cornelissen B,Woodcock M,Allen PD,Buls N,Muschel RJ,Hill MA,Smart SC|Kersemans V,Cornelissen B,Hueting R,Tredwell M,Hussien K,Allen PD,Falzone N,Hill SA,Dilworth JR,Gouverneur V,Muschel RJ,Smart SC|Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ","Animals,Mice,Inbred BALB C,Mammary Neoplasms,Experimental,Precancerous Conditions,DNA Damage,Disease Progression,Immunoconjugates,Radiopharmaceuticals,Tomography,Emission-Computed,Single-Photon,Magnetic Resonance Imaging,Tissue Distribution,Image Processing,Computer-Assisted,Female|64Cu-ATSM,64Cu-acetate,copper metabolism,hypoxia,Acetates,Animals,Anoxia,Cell Line,Tumor,Copper,Copper Radioisotopes,Female,Humans,Immunohistochemistry,Mice,Inbred CBA,Neoplasm Transplantation,Organometallic Compounds,Oxygen,Positron-Emission Tomography,Prognosis,Thiosemicarbazones,Time Factors|Cell Line,Animals,Humans,Mice,Neoplasms,Anoxia,Copper Radioisotopes,Organometallic Compounds,Thiosemicarbazones,Positron-Emission Tomography,Tomography,Emission-Computed,Single-Photon,Tissue Distribution,Female||Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|Animals,DNA Breaks,Double-Stranded,Histones,Jejunum,Liver,Mice,Positron-Emission Tomography,Quality Control,Radiation Dosage,Radiation Injuries,Experimental,Reference Standards,Time Factors,Tomography,Emission-Computed,Single-Photon,X-Ray Microtomography|Adenocarcinoma,Anesthesia,Animals,Anoxia,Copper Radioisotopes,Female,Fluorine Radioisotopes,Gases,Mice,Inbred CBA,Misonidazole,Muscles,Neoplasms,Experimental,Organometallic Compounds,Organotechnetium Compounds,Oxygen,Positron-Emission Tomography,Radiation-Sensitizing Agents,Radiopharmaceuticals,Thiosemicarbazones,Tissue Distribution,Tomography,Emission-Computed,Single-Photon|"
bioc0416,clne0024,3,0.43333333333333335,Journal article|Journal article|Conference paper,Magnetic Resonance in Medicine|Magnetic Resonance in Medicine|Neuropathology and Applied Neurobiology,01/08/2013|24/09/2012|01/03/2013,Quantitative Bayesian model-based analysis of amide proton transfer MRI|Quantitative Bayesian model-based analysis of amide proton transfer MRI.|Magnetic resonance spectroscopy for 2-hydroxyglutarate identifies IDH mutant gliomas,"Chappell MA,Donahue MJ,Tee YK,Khrapitchev AA,Sibson NR,Jezzard P,Payne SJ|Chappell MA,Donahue MJ,Tee YK,Khrapitchev AA,Sibson NR,Jezzard P,Payne SJ|Larkin SJ,Near J,Kudari M,Khrapitchev A,Sibson N,Jezzard P,Pfeffer I,Al-Qahtani K,Schofield C,McCullagh J,Ansorge O","|amide proton transfer,chemical exchange saturation transfer,magnetization transfer,Adult,Amides,Bayes Theorem,Body Water,Brain,Computer Simulation,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Magnetic Resonance Imaging,Male,Models,Neurological,Pattern Recognition,Automated,Protons,Reproducibility of Results,Sensitivity and Specificity,Young Adult|"
immd0316,raob0069,1,0.16666666666666666,Journal article,Lung Cancer,01/01/2016,Audit of palliative whole brain radiotherapy (WBRT) in patients with non-small cell lung cancer (NSCLC) treated at the Oxford Cancer Centre over 21/2 years,"Shakir R,Buffa F,Higgins G,Horne A,Stuart R,Vallis K,Panakis N",
immd0082,path0511,2,0.13333333333333333,Journal article|Journal article,Leukemia|Leukaemia,22/10/2012|,Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.|Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.,"Lutz C,Woll PS,Hall G,Castor A,Dreau H,Cazzaniga G,Zuna J,Jensen C,Clark SA,Biondi A,Mitchell C,Ferry H,Schuh A,Buckle V,Jacobsen SE,Enver T|Lutz C,Woll PS,Hall G,Castor A,Dreau H,Cassaniga G,Zuna J,Jensen C,Clark SA,Biondi A,Mitchell C,Ferry H,Schuh A,Buckle V,Jaconsen SE,Enver T","Cell Cycle,Child,Preschool,Female,Humans,Infant,Male,Neoplasm,Residual,Precursor Cell Lymphoblastic Leukemia-Lymphoma|"
card0025,card0027,2,0.14285714285714285,Journal article|Journal article,Circulation Research|Circulation Research,16/01/2013|01/01/2013,Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice.|Living without creatine: Unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice,"Lygate CA,Aksentijevic D,Dawson D,ten Hove M,Phillips D,de Bono JP,Medway DJ,Sebag-Montefiore L,Hunyor I,Channon KM,Clarke K,Zervou S,Watkins H,Balaban RS,Neubauer S|Lygate CA,Aksentijevic D,Dawson D,Ten Hove M,Phillips D,De Bono JP,Medway DJ,Sebag-Montefiore L,Hunyor I,Channon KM,Clarke K,Zervou S,Watkins H,Balaban RS,Neubauer S","Adenylate Kinase,Animals,Creatine,Exercise Tolerance,Female,Glycine,Guanidinoacetate N-Methyltransferase,Heart Failure,Mice,Inbred C57BL,Knockout,Mitochondria,Heart,Myocardial Infarction,Oxygen Consumption,Physical Conditioning,Animal,Physical Exertion,Ventricular Remodeling|"
immd0151,stat0054,1,0.07142857142857142,Journal article,Leukemia,01/01/2012,Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.,"Knight SJ,Yau C,Clifford R,Timbs AT,Sadighi Akha E,Dréau HM,Burns A,Ciria C,Oscier DG,Pettitt AR,Dutton S,Holmes CC,Taylor J,Cazier JB,Schuh A","Adult,Aged,80 and over,Biomarkers,Tumor,Chromosome Aberrations,Clone Cells,Female,Gene Dosage,Genome,Human,Genomics,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Loss of Heterozygosity,Male,Middle Aged,Neoplasm Recurrence,Local,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Prognosis"
clme0135,immd0031,1,0.125,Journal article,PLoS One,01/01/2014,Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.,"Snell CE,Turley H,McIntyre A,Li D,Masiero M,Schofield CJ,Gatter KC,Harris AL,Pezzella F","Animals,Binding Sites,Breast Neoplasms,Cell Line,Tumor,Female,Gene Expression Regulation,Neoplastic,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,Kaplan-Meier Estimate,MCF-7 Cells,Mice,Inbred BALB C,Neoplasm Transplantation,Neoplasms,Procollagen-Proline Dioxygenase,Prognosis,Proline,Up-Regulation"
claridge,dplb0149,5,0.9159090909090909,Journal article|Journal article|Journal article|Journal article|Journal article,Chemical Science|Journal of the American Chemical Society|Chemical Communications|Journal of NeuroImmune Pharmacology|Neurology,01/01/2012|18/01/2011|02/07/2015|22/09/2015|24/09/2014,Conformational effects in sugar ions: Spectroscopic investigations in the gas phase and in solution|Tuning the cavity of cyclodextrins: altered sugar adaptors in protein pores.|Glycosyldiselenides as lectin ligands detectable by NMR in biofluids.|NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.|A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.,"Sagar R,Rudić S,Gamblin DP,Scanlan EM,Vaden TD,Odell B,Claridge TDW,Simons JP,Davis BG|Li WW,Claridge TD,Li Q,Wormald MR,Davis BG,Bayley H|Pérez-Victoria I,Boutureira O,Claridge TD,Davis BG|Dickens AM,Larkin JR,Davis BG,Griffin JL,Claridge TD,Sibson NR,Anthony DC|Dickens AM,Larkin JR,Griffin JL,Cavey A,Matthews L,Turner MR,Wilcock GK,Davis BG,Claridge TD,Palace J,Anthony DC,Sibson NR","|Carbohydrate Conformation,Disulfides,Hemolysin Proteins,Kinetics,Magnetic Resonance Spectroscopy,Molecular Dynamics Simulation,Mutation,Porosity,Protein Binding,Protein Conformation,Stereoisomerism,beta-Cyclodextrins|Humans,Selenium,Isotopes,Organoselenium Compounds,Lectins,Ligands,Magnetic Resonance Spectroscopy,Molecular Structure,Models,Molecular|Animals,Mice,Biozzi,Multiple Sclerosis,Relapsing-Remitting,Encephalomyelitis,Autoimmune,Experimental,Disease Models,Animal,Disease Progression,Magnetic Resonance Spectroscopy,Models,Theoretical,Metabolomics|Humans,Multiple Sclerosis,Chronic Progressive,Relapsing-Remitting,Alzheimer Disease,Amyotrophic Lateral Sclerosis,Biological Markers,Magnetic Resonance Spectroscopy,Discriminant Analysis,Case-Control Studies,Cohort Studies,Reproducibility of Results,ROC Curve,Adult,Aged,Middle Aged,Female,Male,Metabolomics"
donc0228,raob0069,2,0.4,Conference paper|Journal article,Medical Physics|Medical Physics,01/06/2015|01/06/2015,Robustness Analysis of Proton Breast Treatments Using An Alpha-Stable Distribution Parameterization|SU-F-BRD-04: Robustness Analysis of Proton Breast Treatments Using An Alpha-Stable Distribution Parameterization.,"Van den Heuvel F,Hackett S,Fiorini F,Taylor C,Darby S,Vallis K|Van den Heuvel F,Hackett S,Fiorini F,Taylor C,Darby S,Vallis K",|
immd0180,raob0122,1,0.058823529411764705,Journal article,Cancer Cell,,Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.,"Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Orlando G,Mavrommati I,Pai CC,Zalmas LP,Drobnitzky N,Dianov GL,Verrill C,Macaulay VM,Ying S,La Thangue NB,D'Angiolella V,Ryan AJ,Humphrey TC","Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Neoplasms,Pyrazoles,Pyrimidines,Ribonucleoside Diphosphate Reductase,Histone-Lysine N-Methyltransferase,Nucleotides,Lysine,Cell Cycle Proteins,Nuclear Proteins,Histones,Blotting,Western,Xenograft Model Antitumor Assays,Reverse Transcriptase Polymerase Chain Reaction,Cell Survival,Gene Expression Regulation,Neoplastic,RNA Interference,Amino Acid Sequence,Base Sequence,Sequence Homology,Amino Acid,Nucleic Acid,Methylation,Molecular Sequence Data,Protein-Tyrosine Kinases"
clme0195,stat0004,1,0.07142857142857142,Journal article,Haematologica: the hematology journal,28/05/2013,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary"
ctsu0052,ctsu0165,24,3.673458347208348,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article,Lancet|Transplantation Research|Seminars in Dialysis|Nephrology Dialysis Transplantation|American Journal of Kidney Diseases|Clinica Chimica Acta|Seminars in Dialysis|P and T: journal for formulary management|Lancet|Lancet|American Journal of Kidney Diseases|Journal of the American Society of Nephrology|American Journal of Kidney Diseases|Nephrology Dialysis Transplantation|American Journal of Kidney Diseases|New England Journal of Medicine|American Journal of Kidney Diseases|Lancet|American Journal of Transplantation|Transplantation|BMC Nephrology|Clinical Journal of the American Society of Nephrology|Lancet|PLoS One,17/05/2012|01/01/2013|01/01/2014|18/08/2014|18/11/2015|30/09/2014|01/01/2015|01/01/2011|28/07/2014|28/02/2015|01/01/2014|01/05/2014|01/01/2014|01/05/2015|22/04/2016|12/09/2013|01/10/2015|01/01/2011|01/06/2014|15/07/2014|29/04/2015|13/03/2014|01/01/2011|01/01/2011,"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials|Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol.|Evidence for the prevention and treatment of stroke in dialysis patients.|Neprilysin inhibition in chronic kidney disease.|Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).|Use of gel-based separator tubes to stabilise phosphate in mailed blood samples.|Evidence for the Prevention and Treatment of Stroke in Dialysis Patients|Ezetimibe/simvastatin (vytorin) in heart and renal protection: The SHARP trial|Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.|Alemtuzumab induction therapy in kidney transplantation - Authors' reply.|Evaluating the contribution of the cause of kidney disease to prognosis in ckd: Results from the Study of Heart and Renal Protection (SHARP)|Effects of lowering LDL cholesterol on progression of kidney disease.|Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)|IMPACT OF EDUCATIONAL ATTAINMENT ON HEALTH OUTCOMES IN MODERATE-TO-SEVERE CHRONIC KIDNEY DISEASE|Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP).|Randomized clinical trials--removing unnecessary obstacles.|Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.|Benefits of lowering cholesterol in chronic kidney disease - Authors' reply|Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation|Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation|What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?|The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.|The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.|Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis.","Mihaylova B,Emberson J,Blackwell L,Keech A,Simes J,Barnes EH,Voysey M,Gray A,Collins R,Baigent C,Cholesterol Treatment Trialists' (CTT) Collaborators (writing committee)|Haynes R,Baigent C,Harden P,Landray M,Akyol M,Asderakis A,Baxter A,Bhandari S,Chowdhury P,Clancy M,Emberson J,Gibbs P,Hammad A,Herrington W,Jayne K,Jones G,Krishnan N,Lay M,Lewis D,Macdougall I,Nathan C,Neuberger J,Newstead C,Pararajasingam R,Puliatti C,Rigg K,Rowe P,Sharif A,Sheerin N,Sinha S,Watson C,Friend P,3C Study Collaborative Group|Herrington W,Haynes R,Staplin N,Emberson J,Baigent C,Landray M|Judge P,Haynes R,Landray MJ,Baigent C|Mihaylova B,Schlackow I,Herrington W,Lozano-Kühne J,Kent S,Emberson J,Reith C,Haynes R,Cass A,Craig J,Gray A,Collins R,Landray MJ,Baigent C|Herrington W,Clark S,Staplin N,Kumar A,Illingworth N,Sutherland S,Baigent C,Landray M,Haynes R,Hill M|Herrington W,Haynes R,Staplin N,Emberson J,Baigent C,Landray M|Alexander W,Gaigent C,Landray M|Haynes R,Harden P,Judge P,Blackwell L,Emberson J,Landray MJ,Baigent C,Friend PJ|Haynes R,Baigent C,Landray MJ,Harden P,Friend P|Haynes R,Staplin N,Emberson J,G Herrington W,Tomson C,Agodoa L,Tesar V,Levin A,Lewis D,Reith C,Baigent C,Landray MJ|Haynes R,Lewis D,Emberson J,Reith C,Agodoa L,Cass A,Craig JC,de Zeeuw D,Feldt-Rasmussen B,Fellström B,Levin A,Wheeler DC,Walker R,Herrington WG,Baigent C,Landray MJ|Haynes R,Staplin N,Emberson J,G Herrington W,Lewis D,Reith C,Baigent C,Landray MJ,Tomson C,Agodoa L,Tesar V,Levin A|Morton RL,Schlackow I,Staplin N,Gray A,Cass A,Haynes R,Emberson J,Herrington W,Landray M,Baigent C,Mihaylova B|Staplin N,Haynes R,Herrington WG,Reith C,Cass A,Fellström B,Jiang L,Kasiske BL,Krane V,Levin A,Walker R,Wanner C,Wheeler DC,Landray MJ,Baigent C,Emberson J|Reith C,Landray M,Devereaux PJ,Bosch J,Granger CB,Baigent C,Califf RM,Collins R,Yusuf S|Morton RL,Schlackow I,Staplin N,Gray A,Cass A,Haynes R,Emberson J,Herrington W,Landray MJ,Baigent C,Mihaylova B|Baigent C,Landray MJ,Reith C,Emberson J,Collins R|Haynes R,Harden P,Landray M,Baigent C,Friend P,Grp SC|Haynes R,Harden P,Landray M,Baigent C,Friend P,Grp SC|Kent S,Schlackow I,Lozano-Kühne J,Reith C,Emberson J,Haynes R,Gray A,Cass A,Baigent C,Landray MJ,Herrington W,Mihaylova B|Herrington W,Emberson J,Staplin N,Blackwell L,Fellström B,Walker R,Levin A,Hooi LS,Massy ZA,Tesar V,Reith C,Haynes R,Baigent C,Landray MJ|Baigent C,Landray MJ,Reith C,Emberson J,Wheeler DC,Tomson C,Wanner C,Krane V,Cass A,Craig J,Neal B,Jiang L,Hooi LS,Levin A,Agodoa L,Gaziano M,Kasiske B,Walker R,Massy ZA,Feldt-Rasmussen B,Krairittichai U,Ophascharoensuk V,Fellström B,Holdaas H,Tesar V,Wiecek A,Grobbee D,de Zeeuw D,Grönhagen-Riska C,Dasgupta T,Lewis D,Herrington W,Mafham M,Majoni W,Wallendszus K,Grimm R,Pedersen T,Tobert J,Armitage J,Baxter A,Bray C,Chen Y,Chen Z,Hill M,Knott C,Parish S,Simpson D,Sleight P,Young A,Collins R,SHARP Investigators|Mafham M,Emberson J,Landray MJ,Wen CP,Baigent C","||Humans,Intracranial Arteriosclerosis,Intracranial Thrombosis,Platelet Aggregation Inhibitors,Thrombolytic Therapy,Renal Dialysis,Risk Factors,Blood Pressure,Renal Insufficiency,Chronic,Stroke|Animals,Humans,Kidney Failure,Chronic,Proteinuria,Cardiovascular Diseases,Hypertension,Disease Progression,Thiazepines,Tetrazoles,Pyridines,Neprilysin,Angiotensin-Converting Enzyme Inhibitors,Treatment Outcome,Nephrology,Renin-Angiotensin System,Natriuresis,Clinical Trials as Topic,Heart Failure,Aminobutyrates|SHARP Collaborative Group|Humans,Phosphates,Gels,Blood Chemical Analysis,Blood Specimen Collection|||3C Study Collaborative Group,Humans,Opportunistic Infections,Recombinant Fusion Proteins,Immunosuppressive Agents,Antibodies,Monoclonal,Kidney Transplantation,Graft Rejection,Adult,Female,Male,Humanized|Humans,Recombinant Fusion Proteins,Immunosuppressive Agents,Antibodies,Monoclonal,Kidney Transplantation,Graft Rejection,Female,Male,Humanized||SHARP Collaborative Group,Humans,Kidney Failure,Chronic,Disease Progression,Azetidines,Simvastatin,Anticholesteremic Agents,Treatment Outcome,Drug Therapy,Combination,Renal Dialysis,Kidney Transplantation,Incidence,Follow-Up Studies,Aged,Middle Aged,Female,Male,Cholesterol,LDL|||SHARP Collaborative Group|Ethics Committees,Research,European Union,Evidence-Based Medicine,Government Regulation,Guidelines as Topic,Humans,Informed Consent,Multicenter Studies as Topic,Randomized Controlled Trials as Topic,United States|SHARP Collaborative Group,Humans,Vascular Diseases,Disease Progression,Simvastatin,Anticholesteremic Agents,Severity of Illness Index,Prospective Studies,Aged,Middle Aged,Educational Status,Female,Male,Renal Insufficiency,Chronic,Ezetimibe||||SHARP Collaborative Group,Humans,Kidney Failure,Chronic,Cardiovascular Diseases,Disease Progression,Hospitalization,Renal Dialysis,Kidney Transplantation,Severity of Illness Index,Linear Models,Prospective Studies,Aged,Middle Aged,Health Care Costs,Hospital Costs,North America,Europe,Australasia,Female,Male,Renal Insufficiency|SHARP Investigators,Humans,Thrombosis,Azetidines,Simvastatin,Anticholesteremic Agents,Catheterization,Drug Therapy,Combination,Renal Dialysis,Device Removal,Reoperation,Vascular Patency,Aged,Middle Aged,Female,Male,Renal Insufficiency,Chronic,Cholesterol,LDL,Vascular Access Devices|Adult,Aged,Azetidines,Cardiovascular Diseases,Cholesterol,LDL,Confidence Intervals,Dose-Response Relationship,Drug,Double-Blind Method,Drug Administration Schedule,Drug Therapy,Combination,Ezetimibe,Female,Follow-Up Studies,Humans,Hypolipidemic Agents,Kidney Function Tests,Male,Middle Aged,Reference Values,Renal Dialysis,Renal Insufficiency,Chronic,Risk Assessment,Severity of Illness Index,Simvastatin,Survival Analysis,Time Factors,Treatment Outcome|Cause of Death,Glomerular Filtration Rate,Humans,Risk Factors,Vascular Diseases"
clme0240,ndog0115,1,0.08333333333333333,Journal article,American Journal of Transplantation,01/05/2016,Using an Integrated -Omics Approach to Identify Key Cellular Processes That Are Disturbed in the Kidney After Brain Death.,"Akhtar MZ,Huang H,Kaisar M,Lo Faro ML,Rebolledo R,Morten K,Heather LC,Dona A,Leuvenink HG,Fuggle SV,Kessler BM,Pugh CW,Ploeg RJ",
immd0151,path0511,1,0.09090909090909091,Journal article,Journal of Experimental Medicine,21/02/2011,The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance.,"Mortensen M,Soilleux EJ,Djordjevic G,Tripp R,Lutteropp M,Sadighi-Akha E,Stranks AJ,Glanville J,Knight S,Jacobsen SE,Kranc KR,Simon AK","Animals,Apoptosis,Autophagy,Cell Proliferation,DNA Damage,Female,Hematopoietic Stem Cells,Male,Mice,Knockout,Microtubule-Associated Proteins,Mitochondria,Myeloproliferative Disorders,Reactive Oxygen Species,Stem Cells"
lina0435,whgu0378,2,0.035490101400289714,Journal article|Journal article,Nature Genetics|Nature Genetics,18/05/2015|23/12/2012,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA"
card0039,clme0670,2,0.23809523809523808,Journal article|Conference paper,Proceedings of the National Academy of Sciences of USA|Clinical and Experimental Metastasis,26/03/2012|01/02/2011,Molecular MRI enables early and sensitive detection of brain metastases.|Vascular co-option in brain metastasis,"Serres S,Soto MS,Hamilton A,McAteer MA,Carbonell WS,Robson MD,Ansorge O,Khrapitchev A,Bristow C,Balathasan L,Weissensteiner T,Anthony DC,Choudhury RP,Muschel RJ,Sibson NR|Muschel R,Ferjancic S,Carbonell WS,Balasthan L,Choudhury R,Sibson N,Serres S","Animals,Brain Neoplasms,Disease Progression,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Sensitivity and Specificity,Up-Regulation,Vascular Cell Adhesion Molecule-1|"
raob0051,raob0095,1,0.1111111111111111,Journal article,Journal of Nuclear Medicine,15/04/2011,ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.,"Cornelissen B,Darbar S,Hernandez R,Kersemans V,Tullis I,Barber PR,Smart S,Vojnovic B,Reilly R,Vallis KA","Active Transport,Cell Nucleus,Animals,Antibodies,Monoclonal,Humanized,Cell Line,Tumor,Cell Proliferation,Colony-Forming Units Assay,Dimethylallyltranstransferase,Electrons,Epidermal Growth Factor,Female,Humans,Imidazoles,Mice,Pentetic Acid,Protein Kinase Inhibitors,Protein Transport,Receptor,ErbB-2,Signal Transduction,Trastuzumab"
bioc0541,dplb0149,7,1.4754329004329003,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper,Journal of Peptide Science|Angewandte Chemie International Edition|Nature Communications|Methods in Molecular Biology|Neurology|Journal of NeuroImmune Pharmacology|Glia,01/09/2014|06/02/2012|01/01/2014|01/01/2011|24/09/2014|22/09/2015|01/08/2015,DISCOVERY OF A SELECTIVE LYSOSOMAL ALPHA-MANNOSIDASE INHIBITOR FROM AN IMINO-SUGAR LIBRARY|Selenenylsulfide-linked homogeneous glycopeptides and glycoproteins: synthesis of human hepatic Se metabolite A.|Creation of a gated antibody as a conditionally functional synthetic protein.|Molecular MRI approaches to the detection of CNS inflammation.|A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.|NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.|Multiplexed synchrotron X-Ray fluorescence imaging of brain inflammation using targeted heavy metal nanoparticles,"Chang Y-P,Muckeen M,Alonzi DS,Sagar R,Dickens A,Chapman TM,Butters TD,Anthony DC,Davis BG|Boutureira O,Bernardes GJ,Fernández-González M,Anthony DC,Davis BG|Gunnoo SB,Finney HM,Baker TS,Lawson AD,Anthony DC,Davis BG|Sibson NR,Anthony DC,van Kasteren S,Dickens A,Perez-Balderas F,McAteer MA,Choudhury RP,Davis BG|Dickens AM,Larkin JR,Griffin JL,Cavey A,Matthews L,Turner MR,Wilcock GK,Davis BG,Claridge TD,Palace J,Anthony DC,Sibson NR|Dickens AM,Larkin JR,Davis BG,Griffin JL,Claridge TD,Sibson NR,Anthony DC|Wals K,Anthony DC,Davis BG","free oligosaccharide,iminosugar,alpha-mannosidase,protein N-glycosylation|Animals,Glycopeptides,Glycoproteins,Humans,Models,Molecular,Rats,Selenium,Selenocysteine,Sulfides|Animals,Mice,Inbred C57BL,Muramidase,Antibodies,Enzyme-Linked Immunosorbent Assay,Antibody Formation,Protein Binding,Phosphorylation,Male,Chemistry Techniques,Synthetic,In Vitro Techniques|Animals,Antibodies,Antigens,CD15,Central Nervous System,Endothelial Cells,Ferric Compounds,Inflammation,Magnetic Resonance Imaging,Mice,Rats,Statistics as Topic,Tumor Necrosis Factor-alpha,Vascular Cell Adhesion Molecule-1|Humans,Multiple Sclerosis,Chronic Progressive,Relapsing-Remitting,Alzheimer Disease,Amyotrophic Lateral Sclerosis,Biological Markers,Magnetic Resonance Spectroscopy,Discriminant Analysis,Case-Control Studies,Cohort Studies,Reproducibility of Results,ROC Curve,Adult,Aged,Middle Aged,Female,Male,Metabolomics|Animals,Mice,Biozzi,Multiple Sclerosis,Relapsing-Remitting,Encephalomyelitis,Autoimmune,Experimental,Disease Models,Animal,Disease Progression,Magnetic Resonance Spectroscopy,Models,Theoretical,Metabolomics|"
immd0198,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0667,raob0182,2,0.20833333333333331,Journal article|Conference paper,Oncotarget|European Journal of Cancer,28/02/2015|01/09/2013,Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen.|High throughput screening for genetic determinants of radiosensitivity,"Tiwana GS,Prevo R,Buffa FM,Yu S,Ebner DV,Howarth A,Folkes LK,Budwal B,Chu KY,Durrant L,Muschel RJ,McKenna WG,Higgins GS|McKenna WG,Tiwana GS,Prevo R,Budwal B,Ebner D,Howarth A,Chu KY,Durrant L,Higgins GS","Cell Line,Tumor,HCT116 Cells,Hela Cells,Humans,Neoplasms,DNA Damage,Pyrithiamine,Thiamin Pyrophosphokinase,Thiamine,Radiation-Sensitizing Agents,Colony-Forming Units Assay,Transfection,Radiation Tolerance,High-Throughput Screening Assays|"
bioc0416,clme0946,1,0.043478260869565216,Journal article,Nature Cell Biology,01/11/2014,ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1.,"Wang Y,Bu F,Royer C,Serres S,Larkin JR,Soto MS,Sibson NR,Salter V,Fritzsche F,Turnquist C,Koch S,Zak J,Zhong S,Wu G,Liang A,Olofsen PA,Moch H,Hancock DC,Downward J,Goldin RD,Zhao J,Tong X,Guo Y,Lu X","Cell Line,Tumor,Animals,Humans,Mice,Neoplasm Metastasis,Homeodomain Proteins,Tumor Suppressor Proteins,Transcription Factors,Gene Expression Regulation,Neoplastic,Phosphorylation,Apoptosis Regulatory Proteins,beta Catenin,Kruppel-Like Transcription Factors,Epithelial-Mesenchymal Transition,Wnt Signaling Pathway"
vacc0036,whgu0172,1,0.16666666666666666,Journal article,Nature,22/07/2015,CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer.,"Zauri M,Berridge G,Thézénas ML,Pugh KM,Goldin R,Kessler BM,Kriaucionis S","Cell Line,Tumor,Animals,Humans,Mice,Neoplasms,DNA Damage,Cytosine,5-Methylcytosine,Cytidine Deaminase,Phosphotransferases,DNA-Directed DNA Polymerase,Nucleotides,DNA,Deoxycytidine,Cytidine,Uridine,Cell Death,Epigenesis,Genetic,Gene Expression Regulation,Enzymologic,Neoplastic,Up-Regulation,Substrate Specificity,Oxidation-Reduction"
ctsu0265,darby,12,1.7222906178788528,Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article,"Lancet|Lancet|International Journal of Radiation: Oncology - Biology - Physics|Journal of Clinical Oncology|Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital|Journal of Clinical Oncology|New England Journal of Medicine|Lancet|Journal of Clinical Oncology|European Journal of Cancer|Journal of National Cancer Institute|Lancet",21/06/2014|04/02/2012|01/05/2015|02/05/2016|01/06/2011|20/01/2016|14/03/2013|12/11/2011|19/01/2016|01/09/2013|01/04/2015|01/08/2011,"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.|Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.|Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation X-rays.|Reply to D. Vordermark and T. Pelz and R. Mazzola et al.|Risks of heart disease after radiotherapy.|Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.|Risk of ischemic heart disease in women after radiotherapy for breast cancer.|Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.|Inferring the Effects of Cancer Treatment: Divergent Results From Early Breast Cancer Trialists' Collaborative Group Meta-Analyses of Randomized Trials and Observational Data From SEER Registries.|Long-term risk of ischemic heart disease following Hodgkin lymphoma treatment|Risk of valvular heart disease after treatment for Hodgkin lymphoma.|Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","McGale P,Taylor C,Correa C,Cutter D,Duane F,Ewertz M,Gray R,Mannu G,Peto R,Whelan T,Wang Y,Wang Z,Darby S|Early Breast Cancer Trialists' Collaborative Group (EBCTCG),Peto R,Davies C,Godwin J,Gray R,Pan HC,Clarke M,Cutter D,Darby S,McGale P,Taylor C,Wang YC,Bergh J,Di Leo A,Albain K,Swain S,Piccart M,Pritchard K|van Nimwegen FA,Cutter DJ,Schaapveld M,Rutten A,Kooijman K,Krol AD,Janus CP,Darby SC,van Leeuwen FE,Aleman BM|van Nimwegen FA,Cutter DJ,Schaapveld M,Darby SC,Aleman BM,van Leeuwen FE|Cutter DJ,Darby SC,Yusuf SW|van Nimwegen FA,Schaapveld M,Cutter DJ,Janus CP,Krol AD,Hauptmann M,Kooijman K,Roesink J,van der Maazen R,Darby SC,Aleman BM,van Leeuwen FE|Darby SC,Ewertz M,McGale P,Bennet AM,Blom-Goldman U,Brønnum D,Correa C,Cutter D,Gagliardi G,Gigante B,Jensen MB,Nisbet A,Peto R,Rahimi K,Taylor C,Hall P|Early Breast Cancer Trialists' Collaborative Group (EBCTCG),Darby S,McGale P,Correa C,Taylor C,Arriagada R,Clarke M,Cutter D,Davies C,Ewertz M,Godwin J,Gray R,Pierce L,Whelan T,Wang Y,Peto R|Henson KE,Jagsi R,Cutter D,McGale P,Taylor C,Darby SC|Van Nimwegen FA,Schaapveld M,Krol ADG,Janus CMP,Cutter D,Darby S,Aleman BMP,Van Leeuwen FE|Cutter DJ,Schaapveld M,Darby SC,Hauptmann M,van Nimwegen FA,Krol AD,Janus CP,van Leeuwen FE,Aleman BM|Early Breast Cancer Trialists' Collaborative Group (EBCTCG),Davies C,Godwin J,Gray R,Clarke M,Cutter D,Darby S,McGale P,Pan HC,Taylor C,Wang YC,Dowsett M,Ingle J,Peto R","EBCTCG (Early Breast Cancer Trialists' Collaborative Group),Axilla,Humans,Breast Neoplasms,Lymphatic Metastasis,Neoplasm Recurrence,Local,Lymph Node Excision,Mastectomy,Female,Randomized Controlled Trials as Topic|Anthracyclines,Antineoplastic Combined Chemotherapy Protocols,Breast Neoplasms,Chemotherapy,Adjuvant,Female,Humans,Neoplasm Recurrence,Local,Randomized Controlled Trials as Topic,Survival Rate,Taxoids|Heart,Lymph Nodes,Spleen,Humans,Hodgkin Disease,Observer Variation,Case-Control Studies,Reproducibility of Results,Radiation Dosage,Adolescent,Adult,Middle Aged,Survivors,Female,Male,Young Adult,Organs at Risk||Animals,Cardiology,Cooperative Behavior,Delivery of Health Care,Integrated,Heart,Heart Diseases,Humans,Interdisciplinary Communication,Neoplasms,Patient Care Team,Radiation Dosage,Radiation Injuries,Radiation Oncology,Radiotherapy,Risk Assessment,Risk Factors|Heart,Humans,Hodgkin Disease,Coronary Disease,Radiation Injuries,Risk Factors,Case-Control Studies,Cohort Studies,Dose-Response Relationship,Radiation,Adult,Middle Aged,Survivors,Netherlands,Female,Male|Adult,Aged,Breast Neoplasms,Case-Control Studies,Chemotherapy,Adjuvant,Female,Heart,Humans,Mastectomy,Middle Aged,Myocardial Ischemia,Radiation Injuries,Radiotherapy Dosage,Radiotherapy,Risk,Risk Factors|Age Factors,Breast Neoplasms,Estrogen Antagonists,Female,Humans,Lymphatic Metastasis,Mastectomy,Segmental,Neoplasm Grading,Neoplasm Recurrence,Local,Radiotherapy,Adjuvant,Randomized Controlled Trials as Topic,Receptors,Estrogen,Tamoxifen|||Aortic Valve,Mitral Valve,Humans,Hodgkin Disease,Heart Valve Diseases,Radiation Injuries,Radiotherapy Dosage,Splenectomy,Odds Ratio,Risk Assessment,Risk Factors,Case-Control Studies,Retrospective Studies,Dose-Response Relationship,Radiation,Time Factors,Adolescent,Adult,Aged,Middle Aged,Female,Male,Young Adult|Antineoplastic Agents,Hormonal,Breast Neoplasms,Chemotherapy,Adjuvant,Female,Humans,Neoplasm Recurrence,Local,Neoplasms,Second Primary,Randomized Controlled Trials as Topic,Receptors,Estrogen,Progesterone,Selective Estrogen Receptor Modulators,Tamoxifen"
clme0670,raob0202,18,3.099278499278499,Journal article|Conference paper|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Conference paper,"Oncotarget|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Cancer Research|Modern Pathology|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Biochimica et Biophysica Acta: international journal of biochemistry and biophysics|Radiotherapy and Oncology|Cancer Biology and Therapy|Cancer Treatment Reviews|Cancer and Metastasis Reviews|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Cell Death and Disease|Journal of National Cancer Institute|Radiation Oncology|Laboratory Investigation|Cancer and Metastasis Reviews|Radiotherapy and Oncology|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",|01/05/2013|22/11/2011|01/02/2016|01/06/2012|06/12/2014|13/03/2014|01/09/2012|11/04/2013|24/07/2012|01/05/2013|01/01/2012|18/10/2011|27/03/2012|01/02/2016|01/01/2012|01/04/2014|01/07/2014,"The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma.|Dose- and schedule-dependent changes in vascular morphology after PI3K and PI3K/mTOR inhibition: in vitro vs. in vivo effects|Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy|Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.|Regulation of O2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia.|The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.|Targeting ATR in DNA damage response and cancer therapeutics.|The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation|Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|Delta-like ligand 4-notch blockade and tumor radiation response.|NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity.|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies|Regulation of O<inf>2</inf> consumption by the PI3K and mTOR pathways contributes to tumor hypoxia|The PI3K/mTOR pathway regulates tumor O-2 consumption and hypoxia","Wang LM,Silva MA,D'Costa Z,Bockelmann R,Soonawalla Z,Liu S,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Fokas E,Lechterier T,Hackl W,S-M M,McKenna WG,Hodivala-Dilke K,Muschel RJ|Fokas E,Im JH,Hill S,Yameen S,Stratford M,Beech J,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Fokas E,Prevo R,Reaper P,Charlton P,Pollard J,McKenna WG,Muschel R,Brunner T|Fokas E,O'Neill E,Gordon-Weeks A,Mukherjee S,McKenna WG,Muschel RJ|Kelly CJ,Hussien K,Fokas E,Kannan P,Shipley RJ,Ashton TM,Stratford M,Pearson N,Muschel RJ|Prevo R,Fokas E,Reaper PM,Charlton PA,Pollard JR,McKenna WG,Muschel RJ,Brunner TB|Fokas E,Prevo R,Hammond EM,Brunner TB,McKenna WG,Muschel RJ|Fokas E,McKenna WG,Muschel RJ|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Liu SK,Bham SA,Fokas E,Beech J,Im J,Cho S,Harris AL,Muschel RJ|Fokas E,Yoshimura M,Prevo R,Higgins G,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Fokas E,McKenna WG,Muschel RJ|Kelly CJ,Hussien K,Fokas E,Kannan P,Shipley RJ,Ashton TM,Stratford M,Pearson N,Muschel RJ|Kelly C,Fokas E,Hussien K,Kannan P,Shipley R,Ashton T,Stratford M,Pearson N,Muschel R","||Animals,Dose-Response Relationship,Drug,Humans,Mice,Neoplasms,Experimental,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Radiation Tolerance,TOR Serine-Threonine Kinases,Xenograft Model Antitumor Assays|||Animals,Humans,Mice,Carcinoma,Pancreatic Ductal,Pancreatic Neoplasms,Cell Transformation,Neoplastic,Disease Models,Animal,Inflammation,Cancer Vaccines,Immunotherapy,Drug Resistance,Neoplasm,Radiation Tolerance,Neoplastic Cells,Circulating|Cell Line,Tumor,HCT116 Cells,Spheroids,Cellular,Animals,Humans,Mice,Neoplasms,Aminopyridines,Imidazoles,Morpholines,Quinolines,Protein Kinase Inhibitors,Signal Transduction,Cell Hypoxia,Oxygen Consumption,Phosphatidylinositol 3-Kinase,TOR Serine-Threonine Kinases|Antineoplastic Combined Chemotherapy Protocols,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Checkpoints,Cell Cycle Proteins,Cell Hypoxia,Cell Line,Tumor,Combined Modality Therapy,DNA Damage,DNA Repair,Deoxycytidine,Humans,Pancreatic Neoplasms,Phosphorylation,Protein-Serine-Threonine Kinases,Pyrazines,Radiation-Sensitizing Agents,Signal Transduction,Sulfones|ATR,Cancer,Chemotherapy,DNA damage,Radiation,Replication stress,Therapeutics,Animals,Antineoplastic Agents,Ataxia Telangiectasia Mutated Proteins,Clinical Trials as Topic,Combined Modality Therapy,DNA Damage,DNA Replication,Humans,Molecular Targeted Therapy,Neoplasms,Protein Kinase Inhibitors,Protein Kinases,Signal Transduction|Angiogenesis Inhibitors,Animals,Cell Hypoxia,Humans,Neoplasm Invasiveness,Neoplasm Metastasis,Neoplasms,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,TOR Serine-Threonine Kinases,Tumor Microenvironment,Vascular Endothelial Growth Factor A||Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|Adenocarcinoma,Amyloid Precursor Protein Secretases,Animals,Antibodies,Monoclonal,Antineoplastic Agents,Blood Flow Velocity,Carcinoma,Squamous Cell,Cell Line,Tumor,Colorectal Neoplasms,Combined Modality Therapy,Dibenzazepines,Humans,Hypopharyngeal Neoplasms,Immunoblotting,Immunohistochemistry,Intercellular Signaling Peptides and Proteins,Luminescent Measurements,Mice,Nude,Necrosis,Neoplasms,Neovascularization,Pathologic,Radiation,Ionizing,Receptors,Notch,Signal Transduction,Transplantation,Heterologous,Ultrasonography,Doppler|Cell Line,Tumor,Endothelial Cells,Human Umbilical Vein Endothelial Cells,Humans,Imidazoles,Phosphatidylinositol 3-Kinases,Quinolines,Radiation-Sensitizing Agents,TOR Serine-Threonine Kinases||||"
card0018,card0039,40,4.408649928502869,Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Conference paper|Journal article|Conference paper|Conference paper|Journal article|Conference paper|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper,Circulation: Cardiovascular Imaging|JACC: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|Journal of the American College of Cardiology Cardiovascular Imaging|Journal of the American College of Cardiology|Heart|Atherosclerosis|American Heart Journal|Heart|European Heart Journal|Journal of Cardiovascular Magnetic Resonance|Heart|Heart|Journal of Cardiovascular Magnetic Resonance|JACC: Cardiovascular Imaging|Circulation|Journal of Cardiovascular Magnetic Resonance|Heart|Circulation|Heart|Journal of Cardiovascular Magnetic Resonance|Circulation|European Heart Journal|Heart|JACC: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|Circulation|Circulation|Journal of Cardiovascular Magnetic Resonance|American Heart Journal|Journal of Cardiovascular Magnetic Resonance|Circulation: Cardiovascular Imaging|Inflammation Research|JACC: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|Inflammation Research|Heart|Circulation|Circulation|Circulation,01/01/2011|01/10/2013|21/10/2011|01/01/2012|29/05/2012|01/06/2011|19/04/2012|01/01/2011|01/06/2011|01/08/2013|08/01/2014|01/05/2013|01/05/2013|01/02/2012|01/01/2013|07/02/2012|01/02/2012|01/06/2014|22/11/2011|01/05/2012|23/05/2014|22/11/2011|17/10/2013|01/05/2012|01/06/2013|06/02/2012|26/11/2013|01/01/2012|23/05/2014|01/01/2011|21/06/2012|29/03/2011|01/05/2013|01/04/2012|01/02/2012|08/03/2013|01/05/2013|20/11/2012|01/01/2012|22/11/2011,"Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index|T<inf>1</inf> Mapping for the diagnosis of acute myocarditis using CMR: Comparison to T<inf>2</inf>-Weighted and late gadolinium enhanced imaging|Multimodal cardiovascular magnetic resonance quantifies regional variation in vascular structure and function in patients with coronary artery disease: relationships with coronary disease severity.|Acute 3T Magnetic Resonance Imaging Reveals Features of Carotid Atherosclerotic Plaque Associated with Ipsilateral Cerebral Infarction in Minor Stroke and Transient Ischemic Attack.|Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla.|DYNAMIC CHANGES OF OEDEMA AND LATE GADOLINIUM ENHANCEMENT AFTER ACUTE MYOCARDIAL INFARCTION AND THEIR RELATIONSHIP TO FUNCTIONAL RECOVERY AND SALVAGE INDEX|Atherosclerosis and arterial stiffness in obstructive sleep apnea--a cardiovascular magnetic resonance study.|Ischemic heart disease: Comprehensive evaluation by cardiovascular magnetic resonance|3T MRI OF ACUTE ATHEROSCLEROTIC PLAQUE RUPTURE AND DOWNSTREAM EMBOLIC INJURY|Determination of myocardial injury in relation to angiographic lesions, in acute coronary syndromes: a prospective serial CMR study|Non-invasive imaging of carotid arterial restenosis using 3T cardiovascular magnetic resonance.|MYOCARDIAL INFARCTION CAUSES INFLAMMATION AND LEUKOCYTE RECRUITMENT AT REMOTE SITES IN THE MYOCARDIUM AND IN THE RENAL GLOMERULUS|THE DETECTION OF ACUTE MYOCARDITIS USING CARDIOVASCULAR MRI: A CLINICAL STUDY COMPARING T1-MAPPING, T2-WEIGHTED AND LATE GADOLINIUM ENHANCEMENT IMAGING|Characterization of acute myocardial infarction by pre-contrast T1 mapping.|T Mapping for the Diagnosis of Acute Myocarditis Using CMR. Comparison to T-Weighted and Late Gadolinium Enhanced Imaging|Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease.|The diagnostic performance of non-contrast T1-mapping in patients with acute myocarditis on cardiovascular magnetic resonance imaging.|121 High Diagnostic Yield in Patients Presenting with Acute Chest Pain, Positive Troponins but non-obstructive Coronaries by Cardiovascular Magnetic Resonance imaging with Conventional and Novel T1 Mapping Techniques.|T1-Mapping is Superior to T2-Weighted Cardiovascular Magnetic Resonance Imaging for the Detection of Acute Reversible Myocardial Injury|PRE-CONTRAST T1 MAPPING ALLOWS ASSESSMENT OF SEVERITY OF ACUTE ISCHAEMIC MYOCARDIAL INJURY|Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.|Non-Contrast T1-Mapping is a Novel Diagnostic Tool for Acute Myocarditis on Cardiovascular Magnetic Resonance Imaging|Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction.|T1-MAPPING HAS A HIGH DIAGNOSTIC PERFORMANCE IN PATIENTS PRESENTING WITH ACUTE MYOCARDITIS: A CARDIOVASCULAR MAGNETIC RESONANCE STUDY|Diagnostic value of pre-contrast T1 mapping in acute and chronic myocardial infarction.|Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction.|The Monocyte Genomic Response is Conserved Between Mice and Humans Following Acute Myocardial Infarction|Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease|Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents|Ischemic heart disease: Comprehensive evaluation by cardiovascular magnetic resonance|Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance.|Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index.|Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus|Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study.|T1-mapping accurately detects acute myocardial edema: a comparison to T2-weighted cardiovascular magnetic resonance imaging.|Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus.|THE USEFULNESS OF EARLY CARDIOVASCULAR MAGNETIC RESONANCE IN PATIENTS PRESENTING WITH ACUTE CHEST PAIN, POSITIVE TROPONIN AND NON-OBSTRUCTIVE CORONARY ARTERIES|Novel Techniques for the Diagnosis of Acute Myocarditis: A Clinical Cardiovascular Magnetic Resonance Study|Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease|CMR T1 Mapping at 3T Characterizes the Extent of Acute Ischemic Myocardial Injury: Comparison to Standard Techniques","Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Kylintireas I,Shirodaria C,Lee JM,Cunningon C,Lindsay A,Francis J,Robson MD,Neubauer S,Channon KM,Choudhury RP|Lindsay AC,Biasiolli L,Lee JMS,Kylintireas,MacIntosh,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury R|Arnold JR,Karamitsos TD,Bhamra-Ariza P,Francis JM,Searle N,Robson MD,Howells RK,Choudhury RP,Rimoldi OE,Camici PG,Banning AP,Neubauer S,Jerosch-Herold M,Selvanayagam JB|Dall'Armellina E,Karia N,Lindsay A,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast B,Banning AP,Channon K,Kharbanda RJ,Neubauer S,Choudhury RP|Kylintireas I,Craig S,Nethononda R,Kohler M,Francis J,Choudhury R,Stradling J,Neubauer S|Karamitsos TD,Dall'Armellina E,Choudhury RP,Neubauer S|Lindsay AC,Biasiolli L,Lee JM,Kylintireas I,Watt H,Kuker W,Handa A,Robson MD,Neubauer S,Kennedy J,Choudhury RP|Dall'armellina E,Adlam D,Ruparelia N,Kharbanda RK,Prendergast BP,Forfar JC,Banning AP,Neubauer S,Channon K,Choudhury R|Lindsay AC,Biasiolli L,Knight S,Cunnington C,Robson MD,Neubauer S,Kennedy J,Handa A,Choudhury RP|Ruparelia N,Digby J,Jefferson A,Medway D,Neubauer S,Lygate C,Choudhury R|Ferreira V,Piechnik S,Dall'Armellina E,Karamitsos T,Francis J,Ntusi N,Holloway C,Choudhury R,Kardos A,Robson M,Friedrich M,Neubauer S|Dall'armellina E,Piechnik SK,Ferreira V,Francis JM,Robson MD,Cuculi F,Kharbanda R,Banning AP,Choudhury RP,Karamitsos T,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Robson MD,Neubauer S,Kardos A,Friedrich MG|Cunnington C,Van Assche T,Shirodaria C,Kylintireas I,Lindsay AC,Lee JM,Antoniades C,Margaritis M,Lee R,Cerrato R,Crabtree MJ,Francis JM,Sayeed R,Ratnatunga C,Pillai R,Choudhury RP,Neubauer S,Channon KM|Ferreira V,Piechnik SK,Dall'armellina E,Karamitsos T,Francis JM,Choudhury RP,Kardos A,Friedrich MG,Robson MD,Neubauer S|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Banning A,Kardos A,Newton J,Friedrich M,Robson M,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Friedrich MG,Robson MD,Neubauer S|Dall'Armellina E,Piechnik S,Ferreira VM,Robson MD,Francis JM,Cuculi F,Kharbanda RK,Banning AP,Choudhury RP,Karamitsos TD,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Kardos A,Friedrich MG,Robson MD,Neubauer S|Cuculi F,Dall'Armellina E,Manlhiot C,De Caterina AR,Colyer S,Ferreira V,Morovat A,Prendergast BD,Forfar JC,Alp NJ,Choudhury RP,Neubauer S,Channon KM,Banning AP,Kharbanda RK|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Kardos A,Friedrich MG,Robson MD,Neubauer S|Dall'Armellina E,Ferreira VM,Kharbanda RK,Prendergast B,Piechnik SK,Robson MD,Jones M,Francis JM,Choudhury RP,Neubauer S|Dall'Armellina E,Piechnik SK,Ferreira VM,Si QL,Robson MD,Francis JM,Cuculi F,Kharbanda RK,Banning AP,Choudhury RP,Karamitsos TD,Neubauer S|Ruparelia N,Lee R,Dall'Armellina E,Godec J,Medway D,Forfar C,Prendergast B,Kharbanda RK,Banning AP,Neubauer S,Lygate CA,Channon KM,Haining WN,Choudhury RP|Cunnington C,Van Assche T,Shirodaria C,Kylintireas I,Lindsay AC,Lee JM,Antoniades C,Margaritis M,Lee R,Cerrato R,Crabtree MJ,Francis JM,Sayeed R,Ratnatunga C,Pillai R,Choudhury RP,Neubauer S,Channon KM|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Karamitsos TD,Dall'Armellina E,Choudhury RP,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Friedrich MG,Robson MD,Neubauer S|Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Ruparelia N,Digby JE,Jefferson A,Medway DJ,Neubauer S,Lygate CA,Choudhury RP|Lindsay AC,Biasiolli L,Lee JM,Kylintireas I,MacIntosh BJ,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury RP|Ferreira V,Piechnik SK,Dall'armellina E,Karamitsos T,Francis JM,Choudhury RP,Friedrich MG,Robson MD,Neubauer S|Ruparelia N,Digby JE,Jefferson A,Medway DJ,Neubauer S,Lygate CA,Choudhury RP|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Banning A,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Kardos A,Basagiannia C,Newton J,Friedrich M,Robson M,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Cunnington C,Van Assche T,Shirodaria C,Kylintireas I,Lindsay AC,Lee JM,Antoniades C,Margaritis M,Lee R,Cerrato R,Crabtree MJ,Francis JM,Sayeed R,Ratnatunga C,Pillai R,Choudhury RP,Neubauer S,Channon KM|Dall'Armellina E,Piechnik S,Ferreira V,Karamitsos TD,Francis JM,Cuculi F,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Robson MD,Choudhury RP,Neubauer S","||Aged,Analysis of Variance,Aorta,Aortic Diseases,Atherosclerosis,Brachial Artery,Carotid Arteries,Carotid Artery Diseases,Chi-Square Distribution,Compliance,Coronary Angiography,Coronary Artery Disease,England,Female,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Multivariate Analysis,Predictive Value of Tests,Severity of Illness Index,Vasodilation||Coronary Angiography,Coronary Artery Disease,Coronary Circulation,Electrocardiography,Equipment Design,Female,Follow-Up Studies,Humans,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardium,Oximetry,Oxygen,Oxygen Consumption,Prognosis,Regional Blood Flow,Reproducibility of Results,Severity of Illness Index||Abdominal Fat,Aorta,Thoracic,Aortic Diseases,Atherosclerosis,Carotid Artery Diseases,Carotid Artery,Common,Case-Control Studies,Compliance,England,Female,Humans,Linear Models,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Multivariate Analysis,Plaque,Atherosclerotic,Predictive Value of Tests,Prevalence,Pulsatile Flow,Risk Assessment,Risk Factors,Severity of Illness Index,Sleep Apnea,Obstructive||||Aged,Carotid Artery,Common,Carotid Stenosis,Contrast Media,Endarterectomy,Carotid,Female,Fibrosis,Humans,Lipids,Magnetic Resonance Imaging,Male,Observer Variation,Plaque,Atherosclerotic,Predictive Value of Tests,Recurrence,Reproducibility of Results,Severity of Illness Index,Time Factors,Treatment Outcome|||||Administration,Oral,Aged,Biopterin,Coronary Artery Disease,Double-Blind Method,Endothelium,Vascular,Female,Humans,Male,Oxidation-Reduction,Treatment Outcome|||Cardiac MRI,Cardiac mapping,Myocardium,Acute coronary syndromes,Troponin||Myocardium,Humans,Myocarditis,Edema,Cardiac,Acute Disease,Contrast Media,Magnetic Resonance Imaging,Stroke Volume,Case-Control Studies,Prospective Studies,Predictive Value of Tests,Ventricular Function,Left,Adult,Middle Aged,England,Female,Male|Cardiac MRI,Cardiac mapping,Myocarditis,Cardiovascular imaging,Magnetic resonance|Angioplasty,Blood flow,Magnetic resonance imaging,Microcirculation,Myocardial infarction,Coronary Circulation,Coronary Occlusion,Coronary Vessels,Endothelin-1,Female,Hemorrhage,Humans,Magnetic Resonance Angiography,Male,Microvessels,Middle Aged,Myocardial Infarction,Percutaneous Coronary Intervention,Prospective Studies,Recovery of Function,Stroke Volume,Vascular Resistance||Adult,Aged,Coronary Artery Disease,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Myocardial Infarction,Myocardium,Percutaneous Coronary Intervention,Predictive Value of Tests,Time Factors,Treatment Outcome|Analysis of Variance,Angioplasty,Balloon,Coronary,Chi-Square Distribution,Contrast Media,Edema,Cardiac,England,Female,Gadolinium DTPA,Humans,Logistic Models,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardial Infarction,Myocardium,Predictive Value of Tests,Prospective Studies,ROC Curve,Recovery of Function,Severity of Illness Index,Time Factors,Treatment Outcome|Genomics,Myocardial infarction,Gene expression,Leukocytes||||Acute Disease,Adult,Aged,Contrast Media,Diagnosis,Differential,Edema,Cardiac,Female,Follow-Up Studies,Humans,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardial Contraction,Myocardium,Reproducibility of Results,Takotsubo Cardiomyopathy|Angioplasty,Balloon,Coronary,Contrast Media,Edema,Cardiac,Female,Gadolinium,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Myocardial Infarction,Myocardium,Recovery of Function,Ventricular Function||Aged,Brain,Carotid Arteries,Case-Control Studies,Cerebral Infarction,Diagnosis,Differential,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Magnetic Resonance Imaging,Male,Plaque,Atherosclerotic,Prospective Studies,Risk Factors||Animals,Cytokines,Female,Glomerulonephritis,Kidney Glomerulus,Leukocytes,Mice,Inbred C57BL,Myocardial Infarction,Myocarditis,Myocardium,RNA,Messenger,Vascular Cell Adhesion Molecule-1||Cardiac MRI,Myocarditis,Cardiac mapping,Cardiac imaging,Magnetic resonance imaging||Myocardial infarction,STEMI,NSTEMI,Cardiac MRI"
clme0240,stat0054,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
bioc0416,immd0316,1,0.08333333333333333,Journal article,Current Biology,26/02/2015,"Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.","Vlahov N,Scrace S,Soto MS,Grawenda AM,Bradley L,Pankova D,Papaspyropoulos A,Yee KS,Buffa F,Goding CR,Timpson P,Sibson N,O'Neill E",
clme0670,clme0946,3,0.23809523809523808,Journal article|Conference paper|Conference paper,Oncotarget|British Journal of Urology (BJU) International|British Journal of Urology (BJU) International,19/12/2015|01/06/2015|01/06/2015,Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.|Altered expression of markers of epithelial-to-mesenchymal transition at the extraprostatic extension component of locally invasive prostate cancers|Altered expression of markers of epithelial-to-mesenchymal transition at the extraprostatic extension component of locally invasive prostate cancers,"Verrill C,Cerundolo L,Mckee C,White M,Kartsonaki C,Fryer E,Morris E,Brewster S,Ratnayaka I,Marsden L,Lilja H,Muschel R,Lu X,Hamdy F,Bryant RJ|Verrill C,Cerundolo L,McKee CM,White MJ,Gill PS,Morris EV,Brewster SF,Marsden L,Lilja H,Muschel RJ,Lu X,Hamdy FC,Bryant R|Verrill C,Cerundolo L,McKee CM,White MJ,Gill PS,Morris EV,Brewster SF,Marsden L,Lilja H,Muschel RJ,Lu X,Hamdy FC,Bryant R",||
clme1358,immd0237,3,0.12441492726122706,Journal article|Journal article|Journal article,Chemical Science|Journal of Medicinal Chemistry|Chemical Communications,01/08/2013|25/06/2012|01/01/2015,5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation|Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.|Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.,"Hopkinson RJ,Tumber A,Yapp C,Chowdhury R,Aik W,Che KH,Li XS,Kristensen JBL,King ONF,Chan MC,Yeoh KK,Choi H,Walport LJ,Thinnes CC,Bush JT,Lejeune C,Rydzik AM,Rose NR,Bagg EA,McDonough MA,Krojer TJ,Yue WW,Ng SS,Olsen L,Brennan PE,Oppermann U,Müller S,Klose RJ,Ratcliffe PJ,Schofield CJ,Kawamura A|Rose NR,Woon EC,Tumber A,Walport LJ,Chowdhury R,Li XS,King ON,Lejeune C,Ng SS,Krojer T,Chan MC,Rydzik AM,Hopkinson RJ,Che KH,Daniel M,Strain-Damerell C,Gileadi C,Kochan G,Leung IK,Dunford J,Yeoh KK,Ratcliffe PJ,Burgess-Brown N,von Delft F,Muller S,Marsden B,Brennan PE,McDonough MA,Oppermann U,Klose RJ,Schofield CJ,Kawamura A|Thinnes CC,Tumber A,Yapp C,Scozzafava G,Yeh T,Chan MC,Tran TA,Hsu K,Tarhonskaya H,Walport LJ,Wilkins SE,Martinez ED,Müller S,Pugh CW,Ratcliffe PJ,Brennan PE,Kawamura A,Schofield CJ","|Enzyme Inhibitors,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Plant Growth Regulators,Protein Conformation,Substrate Specificity,Succinates|Humans,Oxyquinoline,Oxygenases,Enzyme Inhibitors,Molecular Structure,Structure-Activity Relationship,Dose-Response Relationship,Drug,Models,Molecular"
bioc0541,clme0670,1,0.07142857142857142,Journal article,Proceedings of the National Academy of Sciences of USA,26/03/2012,Molecular MRI enables early and sensitive detection of brain metastases.,"Serres S,Soto MS,Hamilton A,McAteer MA,Carbonell WS,Robson MD,Ansorge O,Khrapitchev A,Bristow C,Balathasan L,Weissensteiner T,Anthony DC,Choudhury RP,Muschel RJ,Sibson NR","Animals,Brain Neoplasms,Disease Progression,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Sensitivity and Specificity,Up-Regulation,Vascular Cell Adhesion Molecule-1"
clme0946,cschof,2,0.325,Journal article|Journal article,Current Opinion in Structural Biology|Cell,13/06/2016|22/05/2014,Structure-function relationships of human JmjC oxygenases-demethylases versus hydroxylases.|A code for RanGDP binding in ankyrin repeats defines a nuclear import pathway.,"Markolovic S,Leissing TM,Chowdhury R,Wilkins SE,Lu X,Schofield CJ|Lu M,Zak J,Chen S,Sanchez-Pulido L,Severson DT,Endicott J,Ponting CP,Schofield CJ,Lu X","|Humans,Multiprotein Complexes,ran GTP-Binding Protein,Proteins,Ankyrin Repeat,Active Transport,Cell Nucleus,Protein Transport,Models,Molecular,Cyclin-Dependent Kinase Inhibitor p16"
stat0004,whgu0378,4,0.10905331979109431,Journal article|Journal article|Journal article|Journal article,Nature Genetics|Nature Communications|Nature Genetics|Nature Genetics,18/05/2015|01/01/2014|23/12/2012|09/09/2012,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.|Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I|Su Z,Gay LJ,Strange A,Palles C,Band G,Whiteman DC,Lescai F,Langford C,Nanji M,Edkins S,van der Winkel A,Levine D,Sasieni P,Bellenguez C,Howarth K,Freeman C,Trudgill N,Tucker AT,Pirinen M,Peppelenbosch MP,van der Laan LJ,Kuipers EJ,Drenth JP,Peters WH,Reynolds JV,Kelleher DP,McManus R,Grabsch H,Prenen H,Bisschops R,Krishnadath K,Siersema PD,van Baal JW,Middleton M,Petty R,Gillies R,Burch N,Bhandari P,Paterson S,Edwards C,Penman I,Vaidya K,Ang Y,Murray I,Patel P,Ye W,Mullins P,Wu AH,Bird NC,Dallal H,Shaheen NJ,Murray LJ,Koss K,Bernstein L,Romero Y,Hardie LJ,Zhang R,Winter H,Corley DA,Panter S,Risch HA,Reid BJ,Sargeant I,Gammon MD,Smart H,Dhar A,McMurtry H,Ali H,Liu G,Casson AG,Chow WH,Rutter M,Tawil A,Morris D,Nwokolo C,Isaacs P,Rodgers C,Ragunath K,MacDonald C,Haigh C,Monk D,Davies G,Wajed S,Johnston D,Gibbons M,Cullen S,Church N,Langley R,Griffin M,Alderson D,Deloukas P,Hunt SE,Gray E,Dronov S,Potter SC,Tashakkori-Ghanbaria A,Anderson M,Brooks C,Blackwell JM,Bramon E,Brown MA,Casas JP,Corvin A,Duncanson A,Markus HS,Mathew CG,Palmer CN,Plomin R,Rautanen A,Sawcer SJ,Trembath RC,Viswanathan AC,Wood N,Trynka G,Wijmenga C,Cazier JB,Atherfold P,Nicholson AM,Gellatly NL,Glancy D,Cooper SC,Cunningham D,Lind T,Hapeshi J,Ferry D,Rathbone B,Brown J,Love S,Attwood S,MacGregor S,Watson P,Sanders S,Ek W,Harrison RF,Moayyedi P,de Caestecker J,Barr H,Stupka E,Vaughan TL,Peltonen L,Spencer CC,Tomlinson I,Donnelly P,Jankowski JA,Esophageal Adenocarcinoma Genetics Consortium,Wellcome Trust Case Control Consortium 2","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA|Adult,Aged,Barrett Esophagus,Case-Control Studies,Chromosomes,Human,Pair 16,Female,Gene Frequency,Genetic Loci,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Linkage Disequilibrium,Major Histocompatibility Complex,Male,Middle Aged,Models,Genetic,Polymorphism,Single Nucleotide"
clme0220,whgu0378,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
clme0670,immd0316,2,0.16025641025641024,Journal article|Journal article,Oncotarget|Molecular Cell,28/02/2015|01/01/2011,Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen.|MiR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors,"Tiwana GS,Prevo R,Buffa FM,Yu S,Ebner DV,Howarth A,Folkes LK,Budwal B,Chu KY,Durrant L,Muschel RJ,McKenna WG,Higgins GS|Moskwa P,Buffa FM,Pan Y,Panchakshari R,Gottipati P,Muschel RJ,Beech J,Kulshrestha R,Abdelmohsen K,Weinstock DM,Gorospe M,Harris AL,Helleday T,Chowdhury D","Cell Line,Tumor,HCT116 Cells,Hela Cells,Humans,Neoplasms,DNA Damage,Pyrithiamine,Thiamin Pyrophosphokinase,Thiamine,Radiation-Sensitizing Agents,Colony-Forming Units Assay,Transfection,Radiation Tolerance,High-Throughput Screening Assays|"
immd0198,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
engs0357,radi0003,9,1.545238095238095,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Med Image Comput Comput Assist Interv|Lecture Notes in Computer Science|Lecture Notes in Computer Science|Medical Image Analysis|Medical Image Analysis|Journal of the Royal Society Interface|Med Image Comput Comput Assist Interv|British Journal of Radiology|Lung Cancer,01/01/2011|01/01/2013|01/01/2011|31/05/2012|01/01/2012|06/09/2014|01/01/2013|01/09/2012|01/01/2013,Non-local shape descriptor: a new similarity metric for deformable multi-modal registration.|The impact of heterogeneity and uncertainty on prediction of response to therapy using dynamic MRI data|Non-local shape descriptor: A new similarity metric for deformable multi-modal registration|MIND: modality independent neighbourhood descriptor for multi-modal deformable registration.|MIND: Modality independent neighbourhood descriptor for multi-modal deformable registration|Lung Cancer Assistant: a hybrid clinical decision support application for lung cancer care|The impact of heterogeneity and uncertainty on prediction of response to therapy using dynamic MRI data.|A computer-aided algorithm to quantitatively predict lymph node status on MRI in rectal cancer.|Lung Cancer Assistant: a decision support application in lung cancer care,"Heinrich MP,Jenkinson M,Bhushan M,Matin T,Gleeson FV,Brady JM,Schnabel JA|Bhushan M,Schnabel JA,Chappell M,Gleeson F,Anderson M,Franklin J,Brady M,Jenkinson M|Heinrich MP,Jenkinson M,Bhushan M,Matin T,Gleeson FV,Brady JM,Schnabel JA|Heinrich MP,Jenkinson M,Bhushan M,Matin T,Gleeson FV,Brady SM,Schnabel JA|Heinrich MP,Jenkinson M,Bhushan M,Matin T,Gleeson FV,Brady SM,Schnabel JA|Sesen MB,Peake MD,Banares-Alcantara R,Tse D,Kadir T,Stanley R,Gleeson F,Brady M|Bhushan M,Schnabel JA,Chappell M,Gleeson F,Anderson M,Franklin J,Brady SM,Jenkinson M|Tse DM,Joshi N,Anderson EM,Brady M,Gleeson FV|Sesen B,Tse D,Peake MD,Banares-Alcantara R,Gleeson F,Brady M","Algorithms,Humans,Image Interpretation,Computer-Assisted,Image Processing,Magnetic Resonance Imaging,Models,Statistical,Normal Distribution,Pattern Recognition,Automated,Radiography,Thoracic,Reproducibility of Results,Subtraction Technique,Tomography,X-Ray Computed|||Algorithms,Artificial Intelligence,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Imaging,Three-Dimensional,Magnetic Resonance Imaging,Pattern Recognition,Automated,Reproducibility of Results,Sensitivity and Specificity,Subtraction Technique,Tomography,X-Ray Computed||medical informatics,computerized decision support,lung cancer care|Algorithms,Colorectal Neoplasms,Computer Simulation,Contrast Media,Data Interpretation,Statistical,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Meglumine,Models,Biological,Organometallic Compounds,Outcome Assessment (Health Care),Prognosis,Reproducibility of Results,Sensitivity and Specificity,Treatment Outcome|Adult,Aged,Algorithms,Carcinoma,Female,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Lymph Nodes,Lymphatic Metastasis,Magnetic Resonance Imaging,Male,Rectal Neoplasms,Reproducibility of Results,Sensitivity and Specificity|"
immd0237,lina0435,2,0.035490101400289714,Journal article|Journal article,Nature Genetics|Nature Genetics,18/05/2015|23/12/2012,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA"
raob0087,raob0233,1,0.16666666666666666,Journal article,Lung Cancer,29/06/2015,Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture.,"Jiang Y,Allen D,Kersemans V,Devery AM,Bokobza SM,Smart S,Ryan AJ",
raob0072,raob0270,4,0.6637426900584795,Journal article|Journal article|Conference paper|Journal article,BMC Cancer|Journal of Clinical Pathology - Clinical Molecular Pathology|Journal of Clinical Oncology|BMC Cancer,01/01/2015|26/06/2012|20/05/2014|12/02/2015,NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.|Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now.|NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer.|NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.,"Mukherjee S,Hurt CN,Gwynne S,Bateman A,Gollins S,Radhakrishna G,Hawkins M,Canham J,Lewis W,Grabsch HI,Sharma RA,Wade W,Maggs R,Tranter B,Roberts A,Sebag-Montefiore D,Maughan T,Griffiths G,Crosby T|MacGregor TP,Maughan TS,Sharma RA|Crosby T,Mukherjee S,Hurt C,Gwynne S,Gollins S,Batrman AR,Lewis WG,Radhakrishna G,Hawkins M,Grabsch HI,Ray R,Sharma RA,Wade W,Maggs R,Tranter B,Roberts A,Hadlow S,Sebag-Montefiore D,Maughan T,Griffiths G|Mukherjee S,Hurt CN,Gwynne S,Bateman A,Gollins S,Radhakrishna G,Hawkins M,Canham J,Lewis W,Grabsch HI,Sharma RA,Wade W,Maggs R,Tranter B,Roberts A,Sebag-Montefiore D,Maughan T,Griffiths G,Crosby T","Humans,Adenocarcinoma,Esophageal Neoplasms,Antineoplastic Combined Chemotherapy Protocols,Clinical Protocols,Combined Modality Therapy,Preoperative Care,Chemoradiotherapy|Chemoradiotherapy,Consensus,Humans,Long-Term Care,Neoadjuvant Therapy,Neoplasm Grading,Neoplasm Metastasis,Neoplasm Recurrence,Local,Rectal Neoplasms,Remission Induction||"
clme0169,ndos0168,1,0.25,Journal article,BMJ Open,27/11/2013,A population-based survival analysis describing the association of body mass index on time to revision for total hip and knee replacements: results from the UK general practice research database.,"Culliford D,Maskell J,Judge A,Arden NK,COAST Study group",
bioc0801,cschof,4,0.18323845667299177,Journal article|Journal article|Journal article|Journal article,Chemical Science|EMBO Reports|Journal of Medicinal Chemistry|EMBO Reports,01/08/2013|01/04/2011|25/06/2012|01/04/2011,5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation|The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.|Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.|The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases,"Hopkinson RJ,Tumber A,Yapp C,Chowdhury R,Aik W,Che KH,Li XS,Kristensen JBL,King ONF,Chan MC,Yeoh KK,Choi H,Walport LJ,Thinnes CC,Bush JT,Lejeune C,Rydzik AM,Rose NR,Bagg EA,McDonough MA,Krojer TJ,Yue WW,Ng SS,Olsen L,Brennan PE,Oppermann U,Müller S,Klose RJ,Ratcliffe PJ,Schofield CJ,Kawamura A|Chowdhury R,Yeoh KK,Tian YM,Hillringhaus L,Bagg EA,Rose NR,Leung IKH,Li XS,Woon ECY,Yang M,McDonough MA,King ON,Clifton IJ,Klose RJ,Claridge TDW,Ratcliffe PJ,Schofield CJ,Kawamura A|Rose NR,Woon EC,Tumber A,Walport LJ,Chowdhury R,Li XS,King ON,Lejeune C,Ng SS,Krojer T,Chan MC,Rydzik AM,Hopkinson RJ,Che KH,Daniel M,Strain-Damerell C,Gileadi C,Kochan G,Leung IK,Dunford J,Yeoh KK,Ratcliffe PJ,Burgess-Brown N,von Delft F,Muller S,Marsden B,Brennan PE,McDonough MA,Oppermann U,Klose RJ,Schofield CJ,Kawamura A|Chowdhury R,Yeoh KK,Tian Y-M,Hillringhaus L,Bagg EA,Rose NR,Leung IKH,Li XS,Woon ECY,Yang M,McDonough MA,King ON,Clifton IJ,Klose RJ,Claridge TDW,Ratcliffe PJ,Schofield CJ,Kawamura A","|Cell Line,Tumor,Crystallography,Glutarates,Histone Demethylases,Humans,Inhibitory Concentration 50,Isocitrate Dehydrogenase,Jumonji Domain-Containing Histone Demethylases,Magnetic Resonance Spectroscopy,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Mutation,Neoplasms,Procollagen-Proline Dioxygenase,Repressor Proteins,Signal Transduction|Enzyme Inhibitors,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Plant Growth Regulators,Protein Conformation,Substrate Specificity,Succinates|"
whgu0172,wolf1833,2,0.16666666666666666,Journal article|Journal article,Proceedings of the National Academy of Sciences of USA|Journal of Molecular Biology,18/02/2014|13/05/2011,OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.|Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1).,"Singleton RS,Liu-Yi P,Formenti F,Ge W,Sekirnik R,Fischer R,Adam J,Pollard PJ,Wolf A,Thalhammer A,Loenarz C,Flashman E,Yamamoto A,Coleman ML,Kessler BM,Wappner P,Schofield CJ,Ratcliffe PJ,Cockman ME|Chowdhury R,Flashman E,Mecinović J,Kramer HB,Kessler BM,Frapart YM,Boucher JL,Clifton IJ,McDonough MA,Schofield CJ","2-oxoglutarate oxygenase,hypoxia,ribosome,translational control,Analysis of Variance,Carrier Proteins,Computational Biology,Fluorescent Antibody Technique,Gene Knockdown Techniques,Humans,Hydroxylation,Immunoblotting,Immunoprecipitation,Ketoglutaric Acids,Luciferases,Nuclear Proteins,Proline,Prolyl Hydroxylases,Protein Biosynthesis,Protein Processing,Post-Translational,Ribosomal Proteins,Yeasts|Amino Acid Sequence,Anoxia,Crystallography,X-Ray,Humans,Hypoxia-Inducible Factor 1,Hypoxia-Inducible Factor-Proline Dioxygenases,Molecular Sequence Data,Nitric Oxide,Procollagen-Proline Dioxygenase,Protein Structure,Tertiary,Spectrometry,Mass,Electrospray Ionization,Tandem Mass Spectrometry"
bioc0541,chem0068,3,0.29292929292929293,Journal article|Journal article|Conference paper,Journal of Nuclear Medicine|Annals of Clinical and Translational Neurology|Journal of Neuroimmunology,16/01/2014|01/09/2014|15/10/2014,Glial activation in the early stages of brain metastasis: TSPO as a diagnostic biomarker.|Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.|Anti-CD20 therapy down-regulates lesion formation and microglial activation in pattern I and pattern II rat models of multiple sclerosis,"O'Brien ER,Kersemans V,Tredwell M,Checa B,Serres S,Soto MS,Gouverneur V,Leppert D,Anthony DC,Sibson NR|Anthony DC,Dickens AM,Seneca N,Couch Y,Campbell S,Checa B,Kersemans V,Warren EA,Tredwell M,Sibson NR,Gouverneur V,Leppert D|Anthony DC,Dickens AM,Seneca N,Couch Y,Campbell S,Checa B,Kersemans V,Warren EA,Tredwell M,Sibson NR,Gouverneur V,Leppert D","SPECT imaging,TSPO,astrocytes,metastasis,microglia,mouse,Acetamides,Animals,Astrocytes,Biomarkers,Tumor,Brain Neoplasms,Female,Gadolinium,Gene Expression Regulation,Neoplastic,Green Fluorescent Proteins,Immunohistochemistry,Ligands,Magnetic Resonance Imaging,Mice,Inbred BALB C,Microglia,Microscopy,Fluorescence,Neoplasm Metastasis,Neoplasm Transplantation,Neuroglia,Protein Binding,Pyrazoles,Pyrimidines,Receptors,GABA,Time Factors,Tomography,Emission-Computed,Single-Photon||"
immd0330,lina0435,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0135,cschof,1,0.125,Journal article,PLoS One,01/01/2014,Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.,"Snell CE,Turley H,McIntyre A,Li D,Masiero M,Schofield CJ,Gatter KC,Harris AL,Pezzella F","Animals,Binding Sites,Breast Neoplasms,Cell Line,Tumor,Female,Gene Expression Regulation,Neoplastic,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,Kaplan-Meier Estimate,MCF-7 Cells,Mice,Inbred BALB C,Neoplasm Transplantation,Neoplasms,Procollagen-Proline Dioxygenase,Prognosis,Proline,Up-Regulation"
clme0975,hert0418,1,0.04,Journal article,Cancer Research,28/08/2014,Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.,"Gao S,Bajrami I,Verrill C,Kigozi A,Ouaret D,Aleksic T,Asher R,Han C,Allen P,Bailey D,Feller S,Kashima T,Athanasou N,Blay JY,Schmitz S,Machiels JP,Upile N,Jones TM,Thalmann G,Ashraf SQ,Wilding JL,Bodmer WF,Middleton MR,Ashworth A,Lord CJ,Macaulay VM","Cell Line,Tumor,Animals,Humans,Mice,Carcinoma,Squamous Cell,Head and Neck Neoplasms,Isoxazoles,Pyrimidines,ras Proteins,Receptor,IGF Type 1,Insulin-Like Growth Factor I,Adaptor Proteins,Signal Transducing,Phosphoproteins,Antineoplastic Agents,Xenograft Model Antitumor Assays,Inhibitory Concentration 50,MAP Kinase Signaling System,Gene Expression,Drug Resistance,Neoplasm,Male,Wnt Proteins"
chem0068,dplb0149,1,0.5,Journal article,Journal of the American Chemical Society,18/09/2013,Enhanced aqueous Suzuki-Miyaura coupling allows site-specific polypeptide 18F-labeling.,"Gao Z,Gouverneur V,Davis BG","Boronic Acids,Catalysis,Fluorine Radioisotopes,Hydrocarbons,Fluorinated,Isotope Labeling,Ligands,Methylguanidine,Models,Molecular,Molecular Structure,Palladium,Peptides,Water"
bioc0416,cschof,1,0.1,Conference paper,Neuropathology and Applied Neurobiology,01/03/2013,Magnetic resonance spectroscopy for 2-hydroxyglutarate identifies IDH mutant gliomas,"Larkin SJ,Near J,Kudari M,Khrapitchev A,Sibson N,Jezzard P,Pfeffer I,Al-Qahtani K,Schofield C,McCullagh J,Ansorge O",
clme0149,immd0084,2,0.2111111111111111,Journal article|Journal article,Autophagy|eLife,01/04/2012|01/01/2014,A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells.|Autophagy is a critical regulator of memory CD8(+) T cell formation.,"Phadwal K,Alegre-Abarrategui J,Watson AS,Pike L,Anbalagan S,Hammond EM,Wade-Martins R,McMichael A,Klenerman P,Simon AK|Puleston DJ,Zhang H,Powell TJ,Lipina E,Sims S,Panse I,Watson AS,Cerundolo V,Townsend AR,Klenerman P,Simon AK","Adult,Animals,Autophagy,B-Lymphocytes,Biological Assay,Cell Aging,Cells,Cultured,HEK293 Cells,Histones,Humans,Mice,Middle Aged,Reproducibility of Results,T-Lymphocytes|CD4-Positive T-Lymphocytes,CD8-Positive T-Lymphocytes,Mitochondria,Animals,Mice,Lymphocytic choriomeningitis virus,Reactive Oxygen Species,Microtubule-Associated Proteins,Viral Vaccines,Epitopes,Lymphocyte Count,Immunization,Secondary,Apoptosis,Cell Differentiation,Cell Proliferation,Cell Survival,Immunologic Memory,Phenotype,Autophagy,Glucose Transporter Type 1"
ctsu0165,gree0184,1,0.08333333333333333,Journal article,PLoS One,01/01/2012,"Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.","Cholesterol Treatment Trialists' (CTT) Collaboration,Emberson JR,Kearney PM,Blackwell L,Newman C,Reith C,Bhala N,Holland L,Peto R,Keech A,Collins R,Simes J,Baigent C","Anticholesteremic Agents,Cholesterol,LDL,Humans,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Neoplasms,Randomized Controlled Trials as Topic"
immd0024,immd0330,10,0.5989321847727137,Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Conference paper|Conference paper|Conference paper|Conference paper,British Journal of Haematology|Nature Genetics|Blood|Haematologica: the hematology journal|Cancer Cell|Leukemia|Blood|British Journal of Haematology|Blood|Blood,21/06/2011|18/05/2015|27/03/2013|01/06/2014|18/01/2011|06/11/2012|18/11/2011|01/04/2012|06/12/2014|18/11/2011,"Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Impact of isolated germline JAK2V617I mutation on human hematopoiesis.|10 YEARS EXPERIENCE OF TYROSINE KINASE INHIBITOR THERAPY FOR CML IN A SINGLE UK CENTRE: COMPARISON WITH PRE-TKI ERA AND EVALUATION OF 2013 ELN GUIDELINES|Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.|Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia.|Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia|Germline activating JAK2-mutation in a family with hereditary thrombocytosis|Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders|Germline Activating JAK2 V617I Mutation, in a Family with Hereditary Thrombocytosis","Roy NB,Myerson S,Schuh AH,Bignell P,Patel R,Wainscoat JS,McGowan S,Marchi E,Atoyebi W,Littlewood T,Chacko J,Vyas P,Killick SB|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Mead AJ,Chowdhury O,Pecquet C,Dusa A,Woll P,Atkinson D,Burns A,Score J,Rugless M,Clifford R,Moule S,Bienz N,Vyas P,Cross N,Gale RE,Henderson S,Constantinescu SN,Schuh A,Jacobsen SE|Khan D,Roy N,Bari V,Vallance G,Dreau H,Littlewood T,Peniket A,Vyas P,Foroni L,Schuh A,Mead A|Goardon N,Marchi E,Atzberger A,Quek L,Schuh A,Soneji S,Woll P,Mead A,Alford KA,Rout R,Chaudhury S,Gilkes A,Knapper S,Beldjord K,Begum S,Rose S,Geddes N,Griffiths M,Standen G,Sternberg A,Cavenagh J,Hunter H,Bowen D,Killick S,Robinson L,Price A,Macintyre E,Virgo P,Burnett A,Craddock C,Enver T,Jacobsen SE,Porcher C,Vyas P|Craddock C,Quek L,Goardon N,Freeman S,Siddique S,Raghavan M,Aztberger A,Schuh A,Grimwade D,Ivey A,Virgo P,Hills R,McSkeane T,Arrazi J,Knapper S,Brookes C,Davies B,Price A,Wall K,Griffiths M,Cavenagh J,Majeti R,Weissman I,Burnett A,Vyas P|Craddock CF,Goardon N,Quek L,Freeman S,Siddique S,Raghavan M,Schuh A,Grimwade D,Hills RK,Brookes C,Griffiths M,Cavenagh JD,Majeti R,Weissman IL,Burnett AK,Vyas P|Mead A,Rugless M,Woll P,Clifford R,Chowdhury O,Dusa A,Pecquet C,Atkinson D,Gatter K,Moule S,Bienz N,Wainscoat J,Vyas P,Gale R,Henderson S,Constantinescu S,Jacobsen S,Schuh A|Hamblin A,Burns A,Tham C,Clifford R,Robbe P,Timbs A,Mason J,Dreau H,Weller A,Jithesh P,Fox O,Tabiner M,Mead A,Peniket A,Vyas P,Henderson S,Schuh A|Mead AJ,Rugless M,Woll P,Clifford R,Atkinson D,Moule S,Bienz N,Wainscoat JS,Vyas P,Henderson S,Jacobsen SEW,Schuh A","Aged,80 and over,Biomarkers,Blood Transfusion,Female,Ferritins,Humans,Iron Overload,Liver,Magnetic Resonance Imaging,Male,Middle Aged,Myelodysplastic Syndromes,Myocardium,Retrospective Studies|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adult,Amino Acid Substitution,Animals,Cells,Cultured,Family,Female,Germ-Line Mutation,Hematopoiesis,Humans,Isoleucine,Janus Kinase 2,Male,Mice,Inbred NOD,Transgenic,Middle Aged,Myeloproliferative Disorders,Valine||Adult,Aged,80 and over,Animals,Antigens,CD,CD34,CD45,Cell Differentiation,Cell Lineage,Gene Expression Profiling,Graft Survival,Granulocyte-Macrophage Progenitor Cells,Hematopoietic Stem Cells,Humans,Immunophenotyping,Leukemia,Myeloid,Acute,Lymphoid Progenitor Cells,Mice,Inbred NOD,SCID,Middle Aged,Neoplastic Stem Cells,Transplantation,Heterologous,Young Adult|Adult,Aged,80 and over,Antimetabolites,Antineoplastic,Azacitidine,Female,Humans,Immunophenotyping,Induction Chemotherapy,Leukemia,Myeloid,Acute,Male,Middle Aged,Myelodysplastic Syndromes,Neoplastic Stem Cells,Prognosis||||"
gree1620,raob0069,2,0.3333333333333333,Journal article|Journal article,Lung Cancer|Lung Cancer,01/01/2015|01/01/2016,"Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): initial outcomes from 2 years' experience at the Oxford Cancer Centre, Oxford University Hospitals NHS Trust|Audit of palliative whole brain radiotherapy (WBRT) in patients with non-small cell lung cancer (NSCLC) treated at the Oxford Cancer Centre over 21/2 years","Hill E,Higgins G,Vallis K,Stuart R,Drummond L,Buckle A,Panakis N|Shakir R,Buffa F,Higgins G,Horne A,Stuart R,Vallis K,Panakis N",|
clme0494,clme1037,2,0.15263157894736842,Journal article|Journal article,Proceedings of the National Academy of Sciences of USA|Nature Reviews Drug Discovery,11/06/2013|01/03/2015,"Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states.|Preclinical target validation using patient-derived cells.","Shintre CA,Pike AC,Li Q,Kim JI,Barr AJ,Goubin S,Shrestha L,Yang J,Berridge G,Ross J,Stansfeld PJ,Sansom MS,Edwards AM,Bountra C,Marsden BD,von Delft F,Bullock AN,Gileadi O,Burgess-Brown NA,Carpenter EP|Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","ABC mitochondrial erythroid,X-ray crystallography,cardiolipin,human membrane protein structure,nucleotide complex,ATP-Binding Cassette Transporters,Adenosine Triphosphatases,Adenosine Triphosphate,Amino Acid Sequence,Animals,Binding Sites,Crystallography,X-Ray,Humans,Lipid Bilayers,Models,Molecular,Molecular Conformation,Molecular Dynamics Simulation,Molecular Sequence Data,Mutation,Nucleotides,Phosphatidylcholines,Phosphatidylethanolamines,Protein Binding,Protein Structure,Tertiary,Sequence Homology,Amino Acid,Sf9 Cells|SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
path0041,smlea,9,1.2339285714285715,Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article,Immunology|Nature Immunology|Immunobiology|Seminars in Cell and Developmental Biology|Journal of Biological Chemistry|Immunobiology|Immunology|Seminars in Cell and Developmental Biology|Nature Immunology,01/09/2012|01/01/2012|01/11/2012|01/01/2012|21/01/2013|01/11/2012|01/09/2012|04/02/2012|01/01/2012,Jagged1 is a CD46 ligand and disturbance in CD46/Jagged 1 interaction leads to abnormal Th1 function and infections in humans|The CD46-Jagged1 interaction is critical for human T H1 immunity|Identification of Jagged1 as a novel ligand for CD46: An interaction required for normal induction and regulation of human TH1 responses|Notch receptor-ligand binding and activation: Insights from molecular studies|Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.|The novel Jagged1/CD46 interaction: A prime target for immune modulation by viruses?|The novel Jagged/1CD46 interaction: a prime target for immune modulation by viruses?|Notch receptor-ligand binding and activation: insights from molecular studies.|The CD46-Jagged1 interaction is critical for human T H 1 immunity,"Le Friec G,Shamoun S,Couzi L,Fremeaux-Bacchi V,Baker A,Bugeon L,Dallman M,Handford P,Lea S,Kemper C|Le Friec G,Sheppard D,Whiteman P,Karsten CM,Shamoun SA-T,Laing A,Bugeon L,Dallman MJ,Melchionna T,Chillakuri C,Smith RA,Drouet C,Couzi L,Fremeaux-Bacchi V,Köhl J,Waddington SN,McDonnell JM,Baker A,Handford PA,Lea SM,Kemper C|Le Friec G,Sheppard D,Karsten CM,Whiteman P,Shamoun S,Laing A,Waddington SN,McDonnell JM,Fremeaux-Bacchi V,Couzi L,Koehl J,Baker A,Handford PA,Lea SM,Kemper C|Chillakuri CR,Sheppard D,Lea SM,Handford PA|Whiteman P,de Madrid BH,Taylor P,Li D,Heslop R,Viticheep N,Tan JZ,Shimizu H,Callaghan J,Masiero M,Li JL,Banham AH,Harris AL,Lea SM,Redfield C,Baron M,Handford PA|Sheppard D,Whiteman P,Le Friec G,Waddington SN,Smith R,Melchionna T,Kemper C,McDonnell JM,Handford PA,Lea SM|Lea SM,Sheppard D,Whiteman P,le Friec G,Waddington SN,Smith R,Melchionna T,Kemper C,McDonnell J,Handford PA|Chillakuri CR,Sheppard D,Lea SM,Handford PA|Le Friec G,Sheppard D,Whiteman P,Karsten CM,Shamoun SAT,Laing A,Bugeon L,Dallman MJ,Melchionna T,Chillakuri C,Smith RA,Drouet C,Couzi L,Fremeaux-Bacchi V,Köhl J,Waddington SN,McDonnell JM,Baker A,Handford PA,Lea SM,Kemper C","||||Amino Acid Sequence,Animals,Antibodies,Monoclonal,Blotting,Western,Calcium-Binding Proteins,Cell Line,Tumor,Drosophila Proteins,Flow Cytometry,HEK293 Cells,Humans,Intercellular Signaling Peptides and Proteins,Ligands,Membrane Proteins,Mice,Models,Molecular,Molecular Sequence Data,Mutation,Protein Binding,Protein Structure,Secondary,Tertiary,Receptor,Notch1,Receptors,Notch,Sequence Homology,Amino Acid|||Amino Acid Motifs,Animals,Binding Sites,Calcium-Binding Proteins,Cell Communication,Humans,Intercellular Signaling Peptides and Proteins,Membrane Proteins,Mutation,Protein Binding,Protein Structure,Tertiary,Receptors,Notch,Signal Transduction|"
corp0784,stat0054,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
raob0009,raob0095,1,0.1111111111111111,Journal article,Journal of Nuclear Medicine,15/04/2011,ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.,"Cornelissen B,Darbar S,Hernandez R,Kersemans V,Tullis I,Barber PR,Smart S,Vojnovic B,Reilly R,Vallis KA","Active Transport,Cell Nucleus,Animals,Antibodies,Monoclonal,Humanized,Cell Line,Tumor,Cell Proliferation,Colony-Forming Units Assay,Dimethylallyltranstransferase,Electrons,Epidermal Growth Factor,Female,Humans,Imidazoles,Mice,Pentetic Acid,Protein Kinase Inhibitors,Protein Transport,Receptor,ErbB-2,Signal Transduction,Trastuzumab"
immd0024,immd0036,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
card0027,lina0435,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0621,raob0097,1,0.00040551500405515005,Journal article,Autophagy,02/01/2016,Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).,"Klionsky DJ,Abdelmohsen K,Abe A,Abedin MJ,Abeliovich H,Acevedo Arozena A,Adachi H,Adams CM,Adams PD,Adeli K,Adhihetty PJ,Adler SG,Agam G,Agarwal R,Aghi MK,Agnello M,Agostinis P,Aguilar PV,Aguirre-Ghiso J,Airoldi EM,Ait-Si-Ali S,Akematsu T,Akporiaye ET,Al-Rubeai M,Albaiceta GM,Albanese C,Albani D,Albert ML,Aldudo J,Algül H,Alirezaei M,Alloza I,Almasan A,Almonte-Beceril M,Alnemri ES,Alonso C,Altan-Bonnet N,Altieri DC,Alvarez S,Alvarez-Erviti L,Alves S,Amadoro G,Amano A,Amantini C,Ambrosio S,Amelio I,Amer AO,Amessou M,Amon A,An Z,Anania FA,Andersen SU,Andley UP,Andreadi CK,Andrieu-Abadie N,Anel A,Ann DK,Anoopkumar-Dukie S,Antonioli M,Aoki H,Apostolova N,Aquila S,Aquilano K,Araki K,Arama E,Aranda A,Araya J,Arcaro A,Arias E,Arimoto H,Ariosa AR,Armstrong JL,Arnould T,Arsov I,Asanuma K,Askanas V,Asselin E,Atarashi R,Atherton SS,Atkin JD,Attardi LD,Auberger P,Auburger G,Aurelian L,Autelli R,Avagliano L,Avantaggiati ML,Avrahami L,Awale S,Azad N,Bachetti T,Backer JM,Bae DH,Bae JS,Bae ON,Bae SH,Baehrecke EH,Baek SH,Baghdiguian S,Bagniewska-Zadworna A,Bai H,Bai J,Bai XY,Bailly Y,Balaji KN,Balduini W,Ballabio A,Balzan R,Banerjee R,Bánhegyi G,Bao H,Barbeau B,Barrachina MD,Barreiro E,Bartel B,Bartolomé A,Bassham DC,Bassi MT,Bast RC,Basu A,Batista MT,Batoko H,Battino M,Bauckman K,Baumgarner BL,Bayer KU,Beale R,Beaulieu JF,Beck GR,Becker C,Beckham JD,Bédard PA,Bednarski PJ,Begley TJ,Behl C,Behrends C,Behrens GM,Behrns KE,Bejarano E,Belaid A,Belleudi F,Bénard G,Berchem G,Bergamaschi D,Bergami M,Berkhout B,Berliocchi L,Bernard A,Bernard M,Bernassola F,Bertolotti A,Bess AS,Besteiro S,Bettuzzi S,Bhalla S,Bhattacharyya S,Bhutia SK,Biagosch C,Bianchi MW,Biard-Piechaczyk M,Billes V,Bincoletto C,Bingol B,Bird SW,Bitoun M,Bjedov I,Blackstone C,Blanc L,Blanco GA,Blomhoff HK,Boada-Romero E,Böckler S,Boes M,Boesze-Battaglia K,Boise LH,Bolino A,Boman A,Bonaldo P,Bordi M,Bosch J,Botana LM,Botti J,Bou G,Bouché M,Bouchecareilh M,Boucher MJ,Boulton ME,Bouret SG,Boya P,Boyer-Guittaut M,Bozhkov PV,Brady N,Braga VM,Brancolini C,Braus GH,Bravo-San Pedro JM,Brennan LA,Bresnick EH,Brest P,Bridges D,Bringer MA,Brini M,Brito GC,Brodin B,Brookes PS,Brown EJ,Brown K,Broxmeyer HE,Bruhat A,Brum PC,Brumell JH,Brunetti-Pierri N,Bryson-Richardson RJ,Buch S,Buchan AM,Budak H,Bulavin DV,Bultman SJ,Bultynck G,Bumbasirevic V,Burelle Y,Burke RE,Burmeister M,Bütikofer P,Caberlotto L,Cadwell K,Cahova M,Cai D,Cai J,Cai Q,Calatayud S,Camougrand N,Campanella M,Campbell GR,Campbell M,Campello S,Candau R,Caniggia I,Cantoni L,Cao L,Caplan AB,Caraglia M,Cardinali C,Cardoso SM,Carew JS,Carleton LA,Carlin CR,Carloni S,Carlsson SR,Carmona-Gutierrez D,Carneiro LA,Carnevali O,Carra S,Carrier A,Carroll B,Casas C,Casas J,Cassinelli G,Castets P,Castro-Obregon S,Cavallini G,Ceccherini I,Cecconi F,Cederbaum AI,Ceña V,Cenci S,Cerella C,Cervia D,Cetrullo S,Chaachouay H,Chae HJ,Chagin AS,Chai CY,Chakrabarti G,Chamilos G,Chan EY,Chan MT,Chandra D,Chandra P,Chang CP,Chang RC,Chang TY,Chatham JC,Chatterjee S,Chauhan S,Che Y,Cheetham ME,Cheluvappa R,Chen CJ,Chen G,Chen GC,Chen G,Chen H,Chen JW,Chen JK,Chen M,Chen M,Chen P,Chen Q,Chen Q,Chen SD,Chen S,Chen SS,Chen W,Chen WJ,Chen WQ,Chen W,Chen X,Chen YH,Chen YG,Chen Y,Chen Y,Chen Y,Chen YJ,Chen YQ,Chen Y,Chen Z,Chen Z,Cheng A,Cheng CH,Cheng H,Cheong H,Cherry S,Chesney J,Cheung CH,Chevet E,Chi HC,Chi SG,Chiacchiera F,Chiang HL,Chiarelli R,Chiariello M,Chieppa M,Chin LS,Chiong M,Chiu GN,Cho DH,Cho SG,Cho WC,Cho YY,Cho YS,Choi AM,Choi EJ,Choi EK,Choi J,Choi ME,Choi SI,Chou TF,Chouaib S,Choubey D,Choubey V,Chow KC,Chowdhury K,Chu CT,Chuang TH,Chun T,Chung H,Chung T,Chung YL,Chwae YJ,Cianfanelli V,Ciarcia R,Ciechomska IA,Ciriolo MR,Cirone M,Claerhout S,Clague MJ,Clària J,Clarke PG,Clarke R,Clementi E,Cleyrat C,Cnop M,Coccia EM,Cocco T,Codogno P,Coers J,Cohen EE,Colecchia D,Coletto L,Coll NS,Colucci-Guyon E,Comincini S,Condello M,Cook KL,Coombs GH,Cooper CD,Cooper JM,Coppens I,Corasaniti MT,Corazzari M,Corbalan R,Corcelle-Termeau E,Cordero MD,Corral-Ramos C,Corti O,Cossarizza A,Costelli P,Costes S,Cotman SL,Coto-Montes A,Cottet S,Couve E,Covey LR,Cowart LA,Cox JS,Coxon FP,Coyne CB,Cragg MS,Craven RJ,Crepaldi T,Crespo JL,Criollo A,Crippa V,Cruz MT,Cuervo AM,Cuezva JM,Cui T,Cutillas PR,Czaja MJ,Czyzyk-Krzeska MF,Dagda RK,Dahmen U,Dai C,Dai W,Dai Y,Dalby KN,Dalla Valle L,Dalmasso G,D'Amelio M,Damme M,Darfeuille-Michaud A,Dargemont C,Darley-Usmar VM,Dasarathy S,Dasgupta B,Dash S,Dass CR,Davey HM,Davids LM,Dávila D,Davis RJ,Dawson TM,Dawson VL,Daza P,de Belleroche J,de Figueiredo P,de Figueiredo RC,de la Fuente J,De Martino L,De Matteis A,De Meyer GR,De Milito A,De Santi M,de Souza W,De Tata V,De Zio D,Debnath J,Dechant R,Decuypere JP,Deegan S,Dehay B,Del Bello B,Del Re DP,Delage-Mourroux R,Delbridge LM,Deldicque L,Delorme-Axford E,Deng Y,Dengjel J,Denizot M,Dent P,Der CJ,Deretic V,Derrien B,Deutsch E,Devarenne TP,Devenish RJ,Di Bartolomeo S,Di Daniele N,Di Domenico F,Di Nardo A,Di Paola S,Di Pietro A,Di Renzo L,DiAntonio A,Díaz-Araya G,Díaz-Laviada I,Diaz-Meco MT,Diaz-Nido J,Dickey CA,Dickson RC,Diederich M,Digard P,Dikic I,Dinesh-Kumar SP,Ding C,Ding WX,Ding Z,Dini L,Distler JH,Diwan A,Djavaheri-Mergny M,Dmytruk K,Dobson RC,Doetsch V,Dokladny K,Dokudovskaya S,Donadelli M,Dong XC,Dong X,Dong Z,Donohue TM,Doran KS,D'Orazi G,Dorn GW,Dosenko V,Dridi S,Drucker L,Du J,Du LL,Du L,du Toit A,Dua P,Duan L,Duann P,Dubey VK,Duchen MR,Duchosal MA,Duez H,Dugail I,Dumit VI,Duncan MC,Dunlop EA,Dunn WA,Dupont N,Dupuis L,Durán RV,Durcan TM,Duvezin-Caubet S,Duvvuri U,Eapen V,Ebrahimi-Fakhari D,Echard A,Eckhart L,Edelstein CL,Edinger AL,Eichinger L,Eisenberg T,Eisenberg-Lerner A,Eissa NT,El-Deiry WS,El-Khoury V,Elazar Z,Eldar-Finkelman H,Elliott CJ,Emanuele E,Emmenegger U,Engedal N,Engelbrecht AM,Engelender S,Enserink JM,Erdmann R,Erenpreisa J,Eri R,Eriksen JL,Erman A,Escalante R,Eskelinen EL,Espert L,Esteban-Martínez L,Evans TJ,Fabri M,Fabrias G,Fabrizi C,Facchiano A,Færgeman NJ,Faggioni A,Fairlie WD,Fan C,Fan D,Fan J,Fang S,Fanto M,Fanzani A,Farkas T,Faure M,Favier FB,Fearnhead H,Federici M,Fei E,Felizardo TC,Feng H,Feng Y,Feng Y,Ferguson TA,Fernández Á,Fernandez-Barrena MG,Fernandez-Checa JC,Fernández-López A,Fernandez-Zapico ME,Feron O,Ferraro E,Ferreira-Halder CV,Fesus L,Feuer R,Fiesel FC,Filippi-Chiela EC,Filomeni G,Fimia GM,Fingert JH,Finkbeiner S,Finkel T,Fiorito F,Fisher PB,Flajolet M,Flamigni F,Florey O,Florio S,Floto RA,Folini M,Follo C,Fon EA,Fornai F,Fortunato F,Fraldi A,Franco R,Francois A,François A,Frankel LB,Fraser ID,Frey N,Freyssenet DG,Frezza C,Friedman SL,Frigo DE,Fu D,Fuentes JM,Fueyo J,Fujitani Y,Fujiwara Y,Fujiya M,Fukuda M,Fulda S,Fusco C,Gabryel B,Gaestel M,Gailly P,Gajewska M,Galadari S,Galili G,Galindo I,Galindo MF,Galliciotti G,Galluzzi L,Galluzzi L,Galy V,Gammoh N,Gandy S,Ganesan AK,Ganesan S,Ganley IG,Gannagé M,Gao FB,Gao F,Gao JX,García Nannig L,García Véscovi E,Garcia-Macía M,Garcia-Ruiz C,Garg AD,Garg PK,Gargini R,Gassen NC,Gatica D,Gatti E,Gavard J,Gavathiotis E,Ge L,Ge P,Ge S,Gean PW,Gelmetti V,Genazzani AA,Geng J,Genschik P,Gerner L,Gestwicki JE,Gewirtz DA,Ghavami S,Ghigo E,Ghosh D,Giammarioli AM,Giampieri F,Giampietri C,Giatromanolaki A,Gibbings DJ,Gibellini L,Gibson SB,Ginet V,Giordano A,Giorgini F,Giovannetti E,Girardin SE,Gispert S,Giuliano S,Gladson CL,Glavic A,Gleave M,Godefroy N,Gogal RM,Gokulan K,Goldman GH,Goletti D,Goligorsky MS,Gomes AV,Gomes LC,Gomez H,Gomez-Manzano C,Gómez-Sánchez R,Gonçalves DA,Goncu E,Gong Q,Gongora C,Gonzalez CB,Gonzalez-Alegre P,Gonzalez-Cabo P,González-Polo RA,Goping IS,Gorbea C,Gorbunov NV,Goring DR,Gorman AM,Gorski SM,Goruppi S,Goto-Yamada S,Gotor C,Gottlieb RA,Gozes I,Gozuacik D,Graba Y,Graef M,Granato GE,Grant GD,Grant S,Gravina GL,Green DR,Greenhough A,Greenwood MT,Grimaldi B,Gros F,Grose C,Groulx JF,Gruber F,Grumati P,Grune T,Guan JL,Guan KL,Guerra B,Guillen C,Gulshan K,Gunst J,Guo C,Guo L,Guo M,Guo W,Guo XG,Gust AA,Gustafsson Å,Gutierrez E,Gutierrez MG,Gwak HS,Haas A,Haber JE,Hadano S,Hagedorn M,Hahn DR,Halayko AJ,Hamacher-Brady A,Hamada K,Hamai A,Hamann A,Hamasaki M,Hamer I,Hamid Q,Hammond EM,Han F,Han W,Handa JT,Hanover JA,Hansen M,Harada M,Harhaji-Trajkovic L,Harper JW,Harrath AH,Harris AL,Harris J,Hasler U,Hasselblatt P,Hasui K,Hawley RG,Hawley TS,He C,He CY,He F,He G,He RR,He XH,He YW,He YY,Heath JK,Hébert MJ,Heinzen RA,Helgason GV,Hensel M,Henske EP,Her C,Herman PK,Hernández A,Hernandez C,Hernández-Tiedra S,Hetz C,Hiesinger PR,Higaki K,Hilfiker S,Hill BG,Hill JA,Hill WD,Hino K,Hofius D,Hofman P,Höglinger GU,Höhfeld J,Holz MK,Hong Y,Hood DA,Hoozemans JJ,Hoppe T,Hsu C,Hsu CY,Hsu LC,Hu D,Hu G,Hu HM,Hu H,Hu MC,Hu YC,Hu ZW,Hua F,Hua Y,Huang C,Huang HL,Huang KH,Huang KY,Huang S,Huang S,Huang WP,Huang YR,Huang Y,Huang Y,Huber TB,Huebbe P,Huh WK,Hulmi JJ,Hur GM,Hurley JH,Husak Z,Hussain SN,Hussain S,Hwang JJ,Hwang S,Hwang TI,Ichihara A,Imai Y,Imbriano C,Inomata M,Into T,Iovane V,Iovanna JL,Iozzo RV,Ip NY,Irazoqui JE,Iribarren P,Isaka Y,Isakovic AJ,Ischiropoulos H,Isenberg JS,Ishaq M,Ishida H,Ishii I,Ishmael JE,Isidoro C,Isobe K,Isono E,Issazadeh-Navikas S,Itahana K,Itakura E,Ivanov AI,Iyer AK,Izquierdo JM,Izumi Y,Izzo V,Jäättelä M,Jaber N,Jackson DJ,Jackson WT,Jacob TG,Jacques TS,Jagannath C,Jain A,Jana NR,Jang BK,Jani A,Janji B,Jannig PR,Jansson PJ,Jean S,Jendrach M,Jeon JH,Jessen N,Jeung EB,Jia K,Jia L,Jiang H,Jiang H,Jiang L,Jiang T,Jiang X,Jiang X,Jiang X,Jiang Y,Jiang Y,Jiménez A,Jin C,Jin H,Jin L,Jin M,Jin S,Jinwal UK,Jo EK,Johansen T,Johnson DE,Johnson GV,Johnson JD,Jonasch E,Jones C,Joosten LA,Jordan J,Joseph AM,Joseph B,Joubert AM,Ju D,Ju J,Juan HF,Juenemann K,Juhász G,Jung HS,Jung JU,Jung YK,Jungbluth H,Justice MJ,Jutten B,Kaakoush NO,Kaarniranta K,Kaasik A,Kabuta T,Kaeffer B,Kågedal K,Kahana A,Kajimura S,Kakhlon O,Kalia M,Kalvakolanu DV,Kamada Y,Kambas K,Kaminskyy VO,Kampinga HH,Kandouz M,Kang C,Kang R,Kang TC,Kanki T,Kanneganti TD,Kanno H,Kanthasamy AG,Kantorow M,Kaparakis-Liaskos M,Kapuy O,Karantza V,Karim MR,Karmakar P,Kaser A,Kaushik S,Kawula T,Kaynar AM,Ke PY,Ke ZJ,Kehrl JH,Keller KE,Kemper JK,Kenworthy AK,Kepp O,Kern A,Kesari S,Kessel D,Ketteler R,Kettelhut IC,Khambu B,Khan MM,Khandelwal VK,Khare S,Kiang JG,Kiger AA,Kihara A,Kim AL,Kim CH,Kim DR,Kim DH,Kim EK,Kim HY,Kim HR,Kim JS,Kim JH,Kim JC,Kim JH,Kim KW,Kim MD,Kim MM,Kim PK,Kim SW,Kim SY,Kim YS,Kim Y,Kimchi A,Kimmelman AC,Kimura T,King JS,Kirkegaard K,Kirkin V,Kirshenbaum LA,Kishi S,Kitajima Y,Kitamoto K,Kitaoka Y,Kitazato K,Kley RA,Klimecki WT,Klinkenberg M,Klucken J,Knævelsrud H,Knecht E,Knuppertz L,Ko JL,Kobayashi S,Koch JC,Koechlin-Ramonatxo C,Koenig U,Koh YH,Köhler K,Kohlwein SD,Koike M,Komatsu M,Kominami E,Kong D,Kong HJ,Konstantakou EG,Kopp BT,Korcsmaros T,Korhonen L,Korolchuk VI,Koshkina NV,Kou Y,Koukourakis MI,Koumenis C,Kovács AL,Kovács T,Kovacs WJ,Koya D,Kraft C,Krainc D,Kramer H,Kravic-Stevovic T,Krek W,Kretz-Remy C,Krick R,Krishnamurthy M,Kriston-Vizi J,Kroemer G,Kruer MC,Kruger R,Ktistakis NT,Kuchitsu K,Kuhn C,Kumar AP,Kumar A,Kumar A,Kumar D,Kumar D,Kumar R,Kumar S,Kundu M,Kung HJ,Kuno A,Kuo SH,Kuret J,Kurz T,Kwok T,Kwon TK,Kwon YT,Kyrmizi I,La Spada AR,Lafont F,Lahm T,Lakkaraju A,Lam T,Lamark T,Lancel S,Landowski TH,Lane DJ,Lane JD,Lanzi C,Lapaquette P,Lapierre LR,Laporte J,Laukkarinen J,Laurie GW,Lavandero S,Lavie L,LaVoie MJ,Law BY,Law HK,Law KB,Layfield R,Lazo PA,Le Cam L,Le Roch KG,Le Stunff H,Leardkamolkarn V,Lecuit M,Lee BH,Lee CH,Lee EF,Lee GM,Lee HJ,Lee H,Lee JK,Lee J,Lee JH,Lee JH,Lee M,Lee MS,Lee PJ,Lee SW,Lee SJ,Lee SJ,Lee SY,Lee SH,Lee SS,Lee SJ,Lee S,Lee YR,Lee YJ,Lee YH,Leeuwenburgh C,Lefort S,Legouis R,Lei J,Lei QY,Leib DA,Leibowitz G,Lekli I,Lemaire SD,Lemasters JJ,Lemberg MK,Lemoine A,Leng S,Lenz G,Lenzi P,Lerman LO,Lettieri Barbato D,Leu JI,Leung HY,Levine B,Lewis PA,Lezoualc'h F,Li C,Li F,Li FJ,Li J,Li K,Li L,Li M,Li M,Li Q,Li R,Li S,Li W,Li W,Li X,Li Y,Lian J,Liang C,Liang Q,Liao Y,Liberal J,Liberski PP,Lie P,Lieberman AP,Lim HJ,Lim KL,Lim K,Lima RT,Lin CS,Lin CF,Lin F,Lin F,Lin FC,Lin K,Lin KH,Lin PH,Lin T,Lin WW,Lin YS,Lin Y,Linden R,Lindholm D,Lindqvist LM,Lingor P,Linkermann A,Liotta LA,Lipinski MM,Lira VA,Lisanti MP,Liton PB,Liu B,Liu C,Liu CF,Liu F,Liu HJ,Liu J,Liu JJ,Liu JL,Liu K,Liu L,Liu L,Liu Q,Liu RY,Liu S,Liu S,Liu W,Liu XD,Liu X,Liu XH,Liu X,Liu X,Liu X,Liu Y,Liu Y,Liu Z,Liu Z,Liuzzi JP,Lizard G,Ljujic M,Lodhi IJ,Logue SE,Lokeshwar BL,Long YC,Lonial S,Loos B,López-Otín C,López-Vicario C,Lorente M,Lorenzi PL,Lõrincz P,Los M,Lotze MT,Lovat PE,Lu B,Lu B,Lu J,Lu Q,Lu SM,Lu S,Lu Y,Luciano F,Luckhart S,Lucocq JM,Ludovico P,Lugea A,Lukacs NW,Lum JJ,Lund AH,Luo H,Luo J,Luo S,Luparello C,Lyons T,Ma J,Ma Y,Ma Y,Ma Z,Machado J,Machado-Santelli GM,Macian F,MacIntosh GC,MacKeigan JP,Macleod KF,MacMicking JD,MacMillan-Crow LA,Madeo F,Madesh M,Madrigal-Matute J,Maeda A,Maeda T,Maegawa G,Maellaro E,Maes H,Magariños M,Maiese K,Maiti TK,Maiuri L,Maiuri MC,Maki CG,Malli R,Malorni W,Maloyan A,Mami-Chouaib F,Man N,Mancias JD,Mandelkow EM,Mandell MA,Manfredi AA,Manié SN,Manzoni C,Mao K,Mao Z,Mao ZW,Marambaud P,Marconi AM,Marelja Z,Marfe G,Margeta M,Margittai E,Mari M,Mariani FV,Marin C,Marinelli S,Mariño G,Markovic I,Marquez R,Martelli AM,Martens S,Martin KR,Martin SJ,Martin S,Martin-Acebes MA,Martín-Sanz P,Martinand-Mari C,Martinet W,Martinez J,Martinez-Lopez N,Martinez-Outschoorn U,Martínez-Velázquez M,Martinez-Vicente M,Martins WK,Mashima H,Mastrianni JA,Matarese G,Matarrese P,Mateo R,Matoba S,Matsumoto N,Matsushita T,Matsuura A,Matsuzawa T,Mattson MP,Matus S,Maugeri N,Mauvezin C,Mayer A,Maysinger D,Mazzolini GD,McBrayer MK,McCall K,McCormick C,McInerney GM,McIver SC,McKenna S,McMahon JJ,McNeish IA,Mechta-Grigoriou F,Medema JP,Medina DL,Megyeri K,Mehrpour M,Mehta JL,Mei Y,Meier UC,Meijer AJ,Meléndez A,Melino G,Melino S,de Melo EJ,Mena MA,Meneghini MD,Menendez JA,Menezes R,Meng L,Meng LH,Meng S,Menghini R,Menko AS,Menna-Barreto RF,Menon MB,Meraz-Ríos MA,Merla G,Merlini L,Merlot AM,Meryk A,Meschini S,Meyer JN,Mi MT,Miao CY,Micale L,Michaeli S,Michiels C,Migliaccio AR,Mihailidou AS,Mijaljica D,Mikoshiba K,Milan E,Miller-Fleming L,Mills GB,Mills IG,Minakaki G,Minassian BA,Ming XF,Minibayeva F,Minina EA,Mintern JD,Minucci S,Miranda-Vizuete A,Mitchell CH,Miyamoto S,Miyazawa K,Mizushima N,Mnich K,Mograbi B,Mohseni S,Moita LF,Molinari M,Molinari M,Møller AB,Mollereau B,Mollinedo F,Mongillo M,Monick MM,Montagnaro S,Montell C,Moore DJ,Moore MN,Mora-Rodriguez R,Moreira PI,Morel E,Morelli MB,Moreno S,Morgan MJ,Moris A,Moriyasu Y,Morrison JL,Morrison LA,Morselli E,Moscat J,Moseley PL,Mostowy S,Motori E,Mottet D,Mottram JC,Moussa CE,Mpakou VE,Mukhtar H,Mulcahy Levy JM,Muller S,Muñoz-Moreno R,Muñoz-Pinedo C,Münz C,Murphy ME,Murray JT,Murthy A,Mysorekar IU,Nabi IR,Nabissi M,Nader GA,Nagahara Y,Nagai Y,Nagata K,Nagelkerke A,Nagy P,Naidu SR,Nair S,Nakano H,Nakatogawa H,Nanjundan M,Napolitano G,Naqvi NI,Nardacci R,Narendra DP,Narita M,Nascimbeni AC,Natarajan R,Navegantes LC,Nawrocki ST,Nazarko TY,Nazarko VY,Neill T,Neri LM,Netea MG,Netea-Maier RT,Neves BM,Ney PA,Nezis IP,Nguyen HT,Nguyen HP,Nicot AS,Nilsen H,Nilsson P,Nishimura M,Nishino I,Niso-Santano M,Niu H,Nixon RA,Njar VC,Noda T,Noegel AA,Nolte EM,Norberg E,Norga KK,Noureini SK,Notomi S,Notterpek L,Nowikovsky K,Nukina N,Nürnberger T,O'Donnell VB,O'Donovan T,O'Dwyer PJ,Oehme I,Oeste CL,Ogawa M,Ogretmen B,Ogura Y,Oh YJ,Ohmuraya M,Ohshima T,Ojha R,Okamoto K,Okazaki T,Oliver FJ,Ollinger K,Olsson S,Orban DP,Ordonez P,Orhon I,Orosz L,O'Rourke EJ,Orozco H,Ortega AL,Ortona E,Osellame LD,Oshima J,Oshima S,Osiewacz HD,Otomo T,Otsu K,Ou JH,Outeiro TF,Ouyang DY,Ouyang H,Overholtzer M,Ozbun MA,Ozdinler PH,Ozpolat B,Pacelli C,Paganetti P,Page G,Pages G,Pagnini U,Pajak B,Pak SC,Pakos-Zebrucka K,Pakpour N,Palková Z,Palladino F,Pallauf K,Pallet N,Palmieri M,Paludan SR,Palumbo C,Palumbo S,Pampliega O,Pan H,Pan W,Panaretakis T,Pandey A,Pantazopoulou A,Papackova Z,Papademetrio DL,Papassideri I,Papini A,Parajuli N,Pardo J,Parekh VV,Parenti G,Park JI,Park J,Park OK,Parker R,Parlato R,Parys JB,Parzych KR,Pasquet JM,Pasquier B,Pasumarthi KB,Patschan D,Patterson C,Pattingre S,Pattison S,Pause A,Pavenstädt H,Pavone F,Pedrozo Z,Peña FJ,Peñalva MA,Pende M,Peng J,Penna F,Penninger JM,Pensalfini A,Pepe S,Pereira GJ,Pereira PC,Pérez-de la Cruz V,Pérez-Pérez ME,Pérez-Rodríguez D,Pérez-Sala D,Perier C,Perl A,Perlmutter DH,Perrotta I,Pervaiz S,Pesonen M,Pessin JE,Peters GJ,Petersen M,Petrache I,Petrof BJ,Petrovski G,Phang JM,Piacentini M,Pierdominici M,Pierre P,Pierrefite-Carle V,Pietrocola F,Pimentel-Muiños FX,Pinar M,Pineda B,Pinkas-Kramarski R,Pinti M,Pinton P,Piperdi B,Piret JM,Platanias LC,Platta HW,Plowey ED,Pöggeler S,Poirot M,Polčic P,Poletti A,Poon AH,Popelka H,Popova B,Poprawa I,Poulose SM,Poulton J,Powers SK,Powers T,Pozuelo-Rubio M,Prak K,Prange R,Prescott M,Priault M,Prince S,Proia RL,Proikas-Cezanne T,Prokisch H,Promponas VJ,Przyklenk K,Puertollano R,Pugazhenthi S,Puglielli L,Pujol A,Puyal J,Pyeon D,Qi X,Qian WB,Qin ZH,Qiu Y,Qu Z,Quadrilatero J,Quinn F,Raben N,Rabinowich H,Radogna F,Ragusa MJ,Rahmani M,Raina K,Ramanadham S,Ramesh R,Rami A,Randall-Demllo S,Randow F,Rao H,Rao VA,Rasmussen BB,Rasse TM,Ratovitski EA,Rautou PE,Ray SK,Razani B,Reed BH,Reggiori F,Rehm M,Reichert AS,Rein T,Reiner DJ,Reits E,Ren J,Ren X,Renna M,Reusch JE,Revuelta JL,Reyes L,Rezaie AR,Richards RI,Richardson DR,Richetta C,Riehle MA,Rihn BH,Rikihisa Y,Riley BE,Rimbach G,Rippo MR,Ritis K,Rizzi F,Rizzo E,Roach PJ,Robbins J,Roberge M,Roca G,Roccheri MC,Rocha S,Rodrigues CM,Rodríguez CI,de Cordoba SR,Rodriguez-Muela N,Roelofs J,Rogov VV,Rohn TT,Rohrer B,Romanelli D,Romani L,Romano PS,Roncero MI,Rosa JL,Rosello A,Rosen KV,Rosenstiel P,Rost-Roszkowska M,Roth KA,Roué G,Rouis M,Rouschop KM,Ruan DT,Ruano D,Rubinsztein DC,Rucker EB,Rudich A,Rudolf E,Rudolf R,Ruegg MA,Ruiz-Roldan C,Ruparelia AA,Rusmini P,Russ DW,Russo GL,Russo G,Russo R,Rusten TE,Ryabovol V,Ryan KM,Ryter SW,Sabatini DM,Sacher M,Sachse C,Sack MN,Sadoshima J,Saftig P,Sagi-Eisenberg R,Sahni S,Saikumar P,Saito T,Saitoh T,Sakakura K,Sakoh-Nakatogawa M,Sakuraba Y,Salazar-Roa M,Salomoni P,Saluja AK,Salvaterra PM,Salvioli R,Samali A,Sanchez AM,Sánchez-Alcázar JA,Sanchez-Prieto R,Sandri M,Sanjuan MA,Santaguida S,Santambrogio L,Santoni G,Dos Santos CN,Saran S,Sardiello M,Sargent G,Sarkar P,Sarkar S,Sarrias MR,Sarwal MM,Sasakawa C,Sasaki M,Sass M,Sato K,Sato M,Satriano J,Savaraj N,Saveljeva S,Schaefer L,Schaible UE,Scharl M,Schatzl HM,Schekman R,Scheper W,Schiavi A,Schipper HM,Schmeisser H,Schmidt J,Schmitz I,Schneider BE,Schneider EM,Schneider JL,Schon EA,Schönenberger MJ,Schönthal AH,Schorderet DF,Schröder B,Schuck S,Schulze RJ,Schwarten M,Schwarz TL,Sciarretta S,Scotto K,Scovassi AI,Screaton RA,Screen M,Seca H,Sedej S,Segatori L,Segev N,Seglen PO,Seguí-Simarro JM,Segura-Aguilar J,Seki E,Sell C,Seiliez I,Semenkovich CF,Semenza GL,Sen U,Serra AL,Serrano-Puebla A,Sesaki H,Setoguchi T,Settembre C,Shacka JJ,Shajahan-Haq AN,Shapiro IM,Sharma S,She H,Shen CK,Shen CC,Shen HM,Shen S,Shen W,Sheng R,Sheng X,Sheng ZH,Shepherd TG,Shi J,Shi Q,Shi Q,Shi Y,Shibutani S,Shibuya K,Shidoji Y,Shieh JJ,Shih CM,Shimada Y,Shimizu S,Shin DW,Shinohara ML,Shintani M,Shintani T,Shioi T,Shirabe K,Shiri-Sverdlov R,Shirihai O,Shore GC,Shu CW,Shukla D,Sibirny AA,Sica V,Sigurdson CJ,Sigurdsson EM,Sijwali PS,Sikorska B,Silveira WA,Silvente-Poirot S,Silverman GA,Simak J,Simmet T,Simon AK,Simon HU,Simone C,Simons M,Simonsen A,Singh R,Singh SV,Singh SK,Sinha D,Sinha S,Sinicrope FA,Sirko A,Sirohi K,Sishi BJ,Sittler A,Siu PM,Sivridis E,Skwarska A,Slack R,Slaninová I,Slavov N,Smaili SS,Smalley KS,Smith DR,Soenen SJ,Soleimanpour SA,Solhaug A,Somasundaram K,Son JH,Sonawane A,Song C,Song F,Song HK,Song JX,Song W,Soo KY,Sood AK,Soong TW,Soontornniyomkij V,Sorice M,Sotgia F,Soto-Pantoja DR,Sotthibundhu A,Sousa MJ,Spaink HP,Span PN,Spang A,Sparks JD,Speck PG,Spector SA,Spies CD,Springer W,Clair DS,Stacchiotti A,Staels B,Stang MT,Starczynowski DT,Starokadomskyy P,Steegborn C,Steele JW,Stefanis L,Steffan J,Stellrecht CM,Stenmark H,Stepkowski TM,Stern ST,Stevens C,Stockwell BR,Stoka V,Storchova Z,Stork B,Stratoulias V,Stravopodis DJ,Strnad P,Strohecker AM,Ström AL,Stromhaug P,Stulik J,Su YX,Su Z,Subauste CS,Subramaniam S,Sue CM,Suh SW,Sui X,Sukseree S,Sulzer D,Sun FL,Sun J,Sun J,Sun SY,Sun Y,Sun Y,Sun Y,Sundaramoorthy V,Sung J,Suzuki H,Suzuki K,Suzuki N,Suzuki T,Suzuki YJ,Swanson MS,Swanton C,Swärd K,Swarup G,Sweeney ST,Sylvester PW,Szatmari Z,Szegezdi E,Szlosarek PW,Taegtmeyer H,Tafani M,Taillebourg E,Tait SW,Takacs-Vellai K,Takahashi Y,Takáts S,Takemura G,Takigawa N,Talbot NJ,Tamagno E,Tamburini J,Tan CP,Tan L,Tan ML,Tan M,Tan YJ,Tanaka K,Tanaka M,Tang D,Tang D,Tang G,Tanida I,Tanji K,Tannous BA,Tapia JA,Tasset-Cuevas I,Tatar M,Tavassoly I,Tavernarakis N,Taylor A,Taylor GS,Taylor GA,Taylor JP,Taylor MJ,Tchetina EV,Tee AR,Teixeira-Clerc F,Telang S,Tencomnao T,Teng BB,Teng RJ,Terro F,Tettamanti G,Theiss AL,Theron AE,Thomas KJ,Thomé MP,Thomes PG,Thorburn A,Thorner J,Thum T,Thumm M,Thurston TL,Tian L,Till A,Ting JP,Titorenko VI,Toker L,Toldo S,Tooze SA,Topisirovic I,Torgersen ML,Torosantucci L,Torriglia A,Torrisi MR,Tournier C,Towns R,Trajkovic V,Travassos LH,Triola G,Tripathi DN,Trisciuoglio D,Troncoso R,Trougakos IP,Truttmann AC,Tsai KJ,Tschan MP,Tseng YH,Tsukuba T,Tsung A,Tsvetkov AS,Tu S,Tuan HY,Tucci M,Tumbarello DA,Turk B,Turk V,Turner RF,Tveita AA,Tyagi SC,Ubukata M,Uchiyama Y,Udelnow A,Ueno T,Umekawa M,Umemiya-Shirafuji R,Underwood BR,Ungermann C,Ureshino RP,Ushioda R,Uversky VN,Uzcátegui NL,Vaccari T,Vaccaro MI,Váchová L,Vakifahmetoglu-Norberg H,Valdor R,Valente EM,Vallette F,Valverde AM,Van den Berghe G,Van Den Bosch L,van den Brink GR,van der Goot FG,van der Klei IJ,van der Laan LJ,van Doorn WG,van Egmond M,van Golen KL,Van Kaer L,van Lookeren Campagne M,Vandenabeele P,Vandenberghe W,Vanhorebeek I,Varela-Nieto I,Vasconcelos MH,Vasko R,Vavvas DG,Vega-Naredo I,Velasco G,Velentzas AD,Velentzas PD,Vellai T,Vellenga E,Vendelbo MH,Venkatachalam K,Ventura N,Ventura S,Veras PS,Verdier M,Vertessy BG,Viale A,Vidal M,Vieira HL,Vierstra RD,Vigneswaran N,Vij N,Vila M,Villar M,Villar VH,Villarroya J,Vindis C,Viola G,Viscomi MT,Vitale G,Vogl DT,Voitsekhovskaja OV,von Haefen C,von Schwarzenberg K,Voth DE,Vouret-Craviari V,Vuori K,Vyas JM,Waeber C,Walker CL,Walker MJ,Walter J,Wan L,Wan X,Wang B,Wang C,Wang CY,Wang C,Wang C,Wang C,Wang D,Wang F,Wang F,Wang G,Wang HJ,Wang H,Wang HG,Wang H,Wang HD,Wang J,Wang J,Wang M,Wang MQ,Wang PY,Wang P,Wang RC,Wang S,Wang TF,Wang X,Wang XJ,Wang XW,Wang X,Wang X,Wang Y,Wang Y,Wang Y,Wang YJ,Wang Y,Wang Y,Wang YT,Wang Y,Wang ZN,Wappner P,Ward C,Ward DM,Warnes G,Watada H,Watanabe Y,Watase K,Weaver TE,Weekes CD,Wei J,Weide T,Weihl CC,Weindl G,Weis SN,Wen L,Wen X,Wen Y,Westermann B,Weyand CM,White AR,White E,Whitton JL,Whitworth AJ,Wiels J,Wild F,Wildenberg ME,Wileman T,Wilkinson DS,Wilkinson S,Willbold D,Williams C,Williams K,Williamson PR,Winklhofer KF,Witkin SS,Wohlgemuth SE,Wollert T,Wolvetang EJ,Wong E,Wong GW,Wong RW,Wong VK,Woodcock EA,Wright KL,Wu C,Wu D,Wu GS,Wu J,Wu J,Wu M,Wu M,Wu S,Wu WK,Wu Y,Wu Z,Xavier CP,Xavier RJ,Xia GX,Xia T,Xia W,Xia Y,Xiao H,Xiao J,Xiao S,Xiao W,Xie CM,Xie Z,Xie Z,Xilouri M,Xiong Y,Xu C,Xu C,Xu F,Xu H,Xu H,Xu J,Xu J,Xu J,Xu L,Xu X,Xu Y,Xu Y,Xu ZX,Xu Z,Xue Y,Yamada T,Yamamoto A,Yamanaka K,Yamashina S,Yamashiro S,Yan B,Yan B,Yan X,Yan Z,Yanagi Y,Yang DS,Yang JM,Yang L,Yang M,Yang PM,Yang P,Yang Q,Yang W,Yang WY,Yang X,Yang Y,Yang Y,Yang Z,Yang Z,Yao MC,Yao PJ,Yao X,Yao Z,Yao Z,Yasui LS,Ye M,Yedvobnick B,Yeganeh B,Yeh ES,Yeyati PL,Yi F,Yi L,Yin XM,Yip CK,Yoo YM,Yoo YH,Yoon SY,Yoshida K,Yoshimori T,Young KH,Yu H,Yu JJ,Yu JT,Yu J,Yu L,Yu WH,Yu XF,Yu Z,Yuan J,Yuan ZM,Yue BY,Yue J,Yue Z,Zacks DN,Zacksenhaus E,Zaffaroni N,Zaglia T,Zakeri Z,Zecchini V,Zeng J,Zeng M,Zeng Q,Zervos AS,Zhang DD,Zhang F,Zhang G,Zhang GC,Zhang H,Zhang H,Zhang H,Zhang H,Zhang J,Zhang J,Zhang J,Zhang J,Zhang JP,Zhang L,Zhang L,Zhang L,Zhang L,Zhang MY,Zhang X,Zhang XD,Zhang Y,Zhang Y,Zhang Y,Zhang Y,Zhang Y,Zhao M,Zhao WL,Zhao X,Zhao YG,Zhao Y,Zhao Y,Zhao YX,Zhao Z,Zhao ZJ,Zheng D,Zheng XL,Zheng X,Zhivotovsky B,Zhong Q,Zhou GZ,Zhou G,Zhou H,Zhou SF,Zhou XJ,Zhu H,Zhu H,Zhu WG,Zhu W,Zhu XF,Zhu Y,Zhuang SM,Zhuang X,Ziparo E,Zois CE,Zoladek T,Zong WX,Zorzano A,Zughaier SM",
immd0237,raob0097,1,0.08333333333333333,Journal article,PLoS One,01/01/2011,Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α).,"Thalhammer A,Bencokova Z,Poole R,Loenarz C,Adam J,O'Flaherty L,Schödel J,Mole D,Giaslakiotis K,Schofield CJ,Hammond EM,Ratcliffe PJ,Pollard PJ","Anoxia,Cell Line,Dioxygenases,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Ketoglutaric Acids,Membrane Proteins,Nuclear Proteins,Oxygenases,Transcriptional Activation"
corp0784,immd0036,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
cschof,wolf1833,13,1.8861471861471861,Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Biochemical Journal|Angiogenesis|The Federation of European Biochemical Societies (FEBS) Journal|Journal of the American College of Cardiology|Journal of the American College of Cardiology|Nature Communications|Chemical Science|Biochemistry|Journal of Biological Chemistry|Journal of Antimicrobial Chemotherapy|Proceedings of the National Academy of Sciences of USA|Biochemical Journal|Journal of Molecular Biology,24/10/2012|01/07/2014|01/09/2012|29/10/2013|23/10/2012|01/01/2014|01/02/2015|31/03/2014|25/06/2015|16/10/2014|18/02/2014|14/08/2014|13/05/2011,"Investigations on the oxygen dependence of a 2-oxoglutarate histone demethylase.|Pro-angiogenic effects of proly-hydroxylase inhibitor FG-2216 and potential for use in a novel strategy of therapeutic angiogenesis for difficult cases of coronary total occlusion|Kinetic investigations on the reaction of a 2-oxoglutarate dependent histone demethylase with oxygen|The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.|Enhanced Endothelial Tubule Formation in Response to Proly-Hydroxylase Inhibitor FG-2216: A Step Towards Therapeutic Angiogenesis in Chronic Total Occlusions|Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases.|Studying the active-site loop movement of the Sao Paolo metallo-β-lactamase-1†Electronic supplementary information (ESI) available: Procedures for protein expression and purification, (19)F-labelling, crystallisation, data collection, and structure determination, table of crystallographic data, table of crystallographic parameters and refinement statistics, figures showing binding mode and distances, procedures for mass spectrometry measurements, differential scanning fluorimetry measurements, stopped-flow measurements and other kinetics measurements. See DOI: 10.1039/c4sc01752hClick here for additional data file.|Studies on deacetoxycephalosporin C synthase support a consensus mechanism for 2-oxoglutarate dependent oxygenases.|Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.|Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability.|OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.|Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen.|Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1).","Sánchez-Fernández EM,Tarhonskaya H,Al-Qahtani K,Hopkinson RJ,McCullagh JS,Schofield CJ,Flashman E|Barnett G,Kelly D,Flashman E,Schofield C,Gershlick A|Sanchez-Fernandez EM,Tarhonskaya H,Al-Qahtani K,Hopkinson J,McCullagh JSO,Candela-Lena JI,Schofield CJ,Flashman E|Barnett GA,Flashman E,Kelly DJ,Schofield CJ,Gershlick A|Barnett G,Wrigley B,Kelly D,Flashman E,Schofield C,Gershlick A|Tarhonskaya H,Rydzik AM,Leung IK,Loik ND,Chan MC,Kawamura A,McCullagh JS,Claridge TD,Flashman E,Schofield CJ|Brem J,Struwe WB,Rydzik AM,Tarhonskaya H,Pfeffer I,Flashman E,van Berkel SS,Spencer J,Claridge TD,McDonough MA,Benesch JL,Schofield CJ|Tarhonskaya H,Szöllössi A,Leung IK,Bush JT,Henry L,Chowdhury R,Iqbal A,Claridge TD,Schofield CJ,Flashman E|Tarhonskaya H,Hardy AP,Howe EA,Loik ND,Kramer HB,McCullagh JS,Schofield CJ,Flashman E|Makena A,Brem J,Pfeffer I,Geffen RE,Wilkins SE,Tarhonskaya H,Flashman E,Phee LM,Wareham DW,Schofield CJ|Singleton RS,Liu-Yi P,Formenti F,Ge W,Sekirnik R,Fischer R,Adam J,Pollard PJ,Wolf A,Thalhammer A,Loenarz C,Flashman E,Yamamoto A,Coleman ML,Kessler BM,Wappner P,Schofield CJ,Ratcliffe PJ,Cockman ME|Tarhonskaya H,Chowdhury R,Leung IK,Loik ND,McCullagh JS,Claridge TD,Schofield CJ,Flashman E|Chowdhury R,Flashman E,Mecinović J,Kramer HB,Kessler BM,Frapart YM,Boucher JL,Clifton IJ,McDonough MA,Schofield CJ","Biocatalysis,Dose-Response Relationship,Drug,Histones,Humans,Iron,Jumonji Domain-Containing Histone Demethylases,Ketoglutaric Acids,Kinetics,Lysine,Molecular Structure,Oxygen,Peptides,Spectrophotometry,Substrate Specificity,Succinates|||||Alcohol Oxidoreductases,Ascorbic Acid,Glutarates,Oxygenases,Succinic Acid,gamma-Aminobutyric Acid||Ketoglutaric Acids,Intramolecular Transferases,Oxygenases,Penicillin-Binding Proteins,Crystallography,X-Ray,Nuclear Magnetic Resonance,Biomolecular,Kinetics,Catalysis,Mass Spectrometry|Animals,Humans,Escherichia coli,Anoxia,Oxygen,Mixed Function Oxygenases,Ankyrins,Recombinant Proteins,Repressor Proteins,Signal Transduction,Gene Expression,Transcription,Genetic,Gene Expression Regulation,Amino Acid Sequence,Protein Structure,Tertiary,Kinetics,Molecular Sequence Data,Hypoxia-Inducible Factor 1,alpha Subunit,Biocatalysis,Hypoxia-Inducible Factor-Proline Dioxygenases|Humans,Bacteria,Escherichia coli,beta-Lactamases,Recombinant Proteins,Anti-Bacterial Agents,Microbial Sensitivity Tests,Cloning,Molecular,Mutagenesis,Site-Directed,Protein Conformation,Hydrolysis,Kinetics,Plasmids,Thermodynamics,Models,Mass Spectrometry,Genetic Variation,Protein Stability|2-oxoglutarate oxygenase,hypoxia,ribosome,translational control,Analysis of Variance,Carrier Proteins,Computational Biology,Fluorescent Antibody Technique,Gene Knockdown Techniques,Humans,Hydroxylation,Immunoblotting,Immunoprecipitation,Ketoglutaric Acids,Luciferases,Nuclear Proteins,Proline,Prolyl Hydroxylases,Protein Biosynthesis,Protein Processing,Post-Translational,Ribosomal Proteins,Yeasts|Cations,Divalent,Oxygen,Iron,Manganese,Zinc,Water,Ketoglutaric Acids,Isoquinolines,Oligopeptides,Mutagenesis,Site-Directed,Catalytic Domain,Protein Binding,Hydroxylation,Kinetics,Hypoxia-Inducible Factor-Proline Dioxygenases|Amino Acid Sequence,Anoxia,Crystallography,X-Ray,Humans,Hypoxia-Inducible Factor 1,Hypoxia-Inducible Factor-Proline Dioxygenases,Molecular Sequence Data,Nitric Oxide,Procollagen-Proline Dioxygenase,Protein Structure,Tertiary,Spectrometry,Mass,Electrospray Ionization,Tandem Mass Spectrometry"
immd0423,whgu0378,1,0.07142857142857142,Conference paper,Annals of Oncology,01/06/2012,CLINICAL DIAGNOSTIC IMPLEMENTATION OF AN INNOVATIVE CANCER CARE MODEL BASED ON COMPREHENSIVE MOLECULAR PROFILING OF TUMOUR-NORMAL PAIRS,"Kaur K,Henderson S,Cutts A,Domingo E,Woods J,Motley C,Dougherty B,Middleton M,Hassan B,Wang Y,Beasley E,Naley M,Schuh A,Tomlinson I,Taylor J",
clme0237,phpc0367,1,0.14285714285714285,Journal article,Journal of Crohn's and Colitis,01/09/2011,Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.,"Buchanan J,Wordsworth S,Ahmad T,Perrin A,Vermeire S,Sans M,Taylor J,Jewell D","Adult,Europe,Great Britain,Health Care Costs,Humans,Inflammatory Bowel Diseases,Models,Economic"
immd0421,whgu0378,8,0.6785519067495811,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Clinical Oncology|Journal of National Cancer Institute|The Journal-lancet|Human Molecular Genetics|Nature Reviews: Cancer|Journal of Clinical Oncology|Nature Reviews: Cancer|Clinical Cancer Research,03/03/2014|01/01/2015|31/05/2016|15/07/2013|01/02/2016|23/09/2013|15/05/2014|01/07/2015,"Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.|Prognostic significance of POLE proofreading mutations in endometrial cancer.|Somatic POLE proofreading domain mutation, immune response and prognosis in colorectal cancer: a retrospective, pooled biomarker study|DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.|A panoply of errors: polymerase proofreading domain mutations in cancer.|Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.|'Toxgnostics': an unmet need in cancer medicine.|POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer.","Rosmarin D,Palles C,Church D,Domingo E,Jones A,Johnstone E,Wang H,Love S,Julier P,Scudder C,Nicholson G,Gonzalez-Neira A,Martin M,Sargent D,Green E,McLeod H,Zanger UM,Schwab M,Braun M,Seymour M,Thompson L,Lacas B,Boige V,Ribelles N,Afzal S,Enghusen H,Jensen SA,Etienne-Grimaldi MC,Milano G,Wadelius M,Glimelius B,Garmo H,Gusella M,Lecomte T,Laurent-Puig P,Martinez-Balibrea E,Sharma R,Garcia-Foncillas J,Kleibl Z,Morel A,Pignon JP,Midgley R,Kerr D,Tomlinson I|Church DN,Stelloo E,Nout RA,Valtcheva N,Depreeuw J,ter Haar N,Noske A,Amant F,Tomlinson IP,Wild PJ,Lambrechts D,Jürgenliemk-Schulz IM,Jobsen JJ,Smit VT,Creutzberg CL,Bosse T|Domingo E,Freeman-Mills L,Rayner E,Glaire M,Briggs S,Vermeulen L,Fessler E,Medema JP,Boot A,Morreau H,Van Wezel T,Liefers GJ,Lothe R,Danielsen S,Sveen A,Nesbakken A,Zlobec I,Lugli A,Koelzer VH,Berger MD,Castellvi-Bel S,Munoz J,EPICOLON,de Bruyn M,Nijman H,Novelli M,Lawson K,Oukrif D,Frangou E,Dutton P,Tejpar S,Delorenzi M,Kerr R,Kerr DJ,Tomlinson I,Church DN|Church DN,Briggs SE,Palles C,Domingo E,Kearsey SJ,Grimes JM,Gorman M,Martin L,Howarth KM,Hodgson SV,NSECG Collaborators,Kaur K,Taylor J,Tomlinson IP|Rayner E,van Gool IC,Palles C,Kearsey SE,Bosse T,Tomlinson I,Church DN|Domingo E,Church DN,Sieber O,Ramamoorthy R,Yanagisawa Y,Johnstone E,Davidson B,Kerr DJ,Tomlinson IP,Midgley R|Church D,Kerr R,Domingo E,Rosmarin D,Palles C,Maskell K,Tomlinson I,Kerr D|van Gool IC,Eggink FA,Freeman-Mills L,Stelloo E,Marchi E,de Bruyn M,Palles C,Nout RA,de Kroon CD,Osse EM,Klenerman P,Creutzberg CL,Tomlinson IP,Smit VT,Nijman HW,Bosse T,Church DN","Antineoplastic Combined Chemotherapy Protocols,Capecitabine,Colorectal Neoplasms,Deoxycytidine,Dihydrouracil Dehydrogenase (NADP),Drug-Related Side Effects and Adverse Reactions,Fluorouracil,Genetic Markers,Humans,Polymorphism,Genetic,Predictive Value of Tests,Thymidylate Synthase|Humans,Endometrial Neoplasms,DNA Polymerase II,Prognosis,Disease-Free Survival,Odds Ratio,Predictive Value of Tests,Mutation,Adult,Female,Kaplan-Meier Estimate,Neoplasm Grading,Biomarkers,Tumor||Adult,Aged,Amino Acid Sequence,DNA Polymerase II,DNA Polymerase III,Endometrial Neoplasms,Female,Germ-Line Mutation,Humans,Microsatellite Repeats,Middle Aged,Molecular Sequence Data,Mutation,Protein Structure,Tertiary,Sequence Alignment,Young Adult|Humans,Saccharomyces cerevisiae,Neoplasms,Endometrial Neoplasms,Genetic Predisposition to Disease,DNA-Directed DNA Polymerase,DNA Polymerase II,DNA Polymerase III,Prognosis,DNA Replication,Mutation,Female|Adult,Aged,80 and over,Anti-Inflammatory Agents,Non-Steroidal,Aspirin,Chemotherapy,Adjuvant,Colectomy,Colorectal Neoplasms,Cyclooxygenase 2,DNA Mutational Analysis,Disease-Free Survival,Female,Genetic Predisposition to Disease,Humans,Kaplan-Meier Estimate,Lactones,Male,Middle Aged,Multivariate Analysis,Mutation,Neoplasm Recurrence,Local,Patient Selection,Phenotype,Phosphatidylinositol 3-Kinases,Proportional Hazards Models,Risk Assessment,Risk Factors,Sulfones,Time Factors,Treatment Outcome|Humans,Neoplasms,Neoplasm Proteins,Antineoplastic Agents,Tumor Markers,Biological,Risk Factors,Polymorphism,Genetic,Drug-Related Side Effects and Adverse Reactions|Lymphocytes,Tumor-Infiltrating,Humans,Endometrial Neoplasms,DNA Polymerase II,Fluorescent Antibody Technique,Immunohistochemistry,Cohort Studies,Polymerase Chain Reaction,DNA Mutational Analysis,Mutation,Female"
clme1037,molb0002,1,1.0,Journal article,New England Journal of Medicine,06/11/2013,Mutant prolactin receptor and familial hyperprolactinemia,Newey PJ,
bioc0416,newc0612,1,0.1111111111111111,Conference paper,European Journal of Cancer,01/07/2012,Isoenzyme-specific PFK-2/FBPase-2 Inhibition as an Anti-cancer Strategy,"Williams JG,Manzano A,Bensaad K,Collins JM,Serres S,Claridge TDW,Sibson N,Bartrons R,Russell AJ,Harris AL",
immd0180,whgu0378,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
clme0220,immd0180,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
clme0975,raob0270,1,0.05263157894736842,Conference paper,Journal of Clinical Oncology,20/05/2015,MErCuRIC1: A Phase I study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in RASMT and RASWT (with aberrant c-MET) metastatic colorectal cancer (mCRC) patients.,"Van Schaeybroeck S,Rolfo CD,Elez E,Kelly S,Houlden J,Collins L,Love S,Andre T,Lawler M,Di Nicolantonio F,Grayson M,Popovici VC,Bardelli A,Laurent-Puig P,Salto-Tellez M,Maughan T,Tabernero J,Peeters M,Wilson RH,Middleton MR",
chem0068,clme0670,4,0.3727272727272728,Journal article|Journal article|Journal article|Conference paper,Journal of Nuclear Medicine|Metallomics: integrated biometal science|PLoS One|Journal of Labelled Compounds and Radiopharmaceuticals,12/12/2013|13/03/2015|01/01/2011|01/02/2013,"A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.|A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.|Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.|Imaging of hypoxia using CuATSM","Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ|Hueting R,Kersemans V,Tredwell M,Cornelissen B,Christlieb M,Gee AD,Passchier J,Smart SC,Gouverneur V,Muschel RJ,Dilworth JR|Kersemans V,Cornelissen B,Hueting R,Tredwell M,Hussien K,Allen PD,Falzone N,Hill SA,Dilworth JR,Gouverneur V,Muschel RJ,Smart SC|Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ","64Cu-ATSM,64Cu-acetate,copper metabolism,hypoxia,Acetates,Animals,Anoxia,Cell Line,Tumor,Copper,Copper Radioisotopes,Female,Humans,Immunohistochemistry,Mice,Inbred CBA,Neoplasm Transplantation,Organometallic Compounds,Oxygen,Positron-Emission Tomography,Prognosis,Thiosemicarbazones,Time Factors|Cell Line,Animals,Humans,Mice,Neoplasms,Anoxia,Copper Radioisotopes,Organometallic Compounds,Thiosemicarbazones,Positron-Emission Tomography,Tomography,Emission-Computed,Single-Photon,Tissue Distribution,Female|Adenocarcinoma,Anesthesia,Animals,Anoxia,Copper Radioisotopes,Female,Fluorine Radioisotopes,Gases,Mice,Inbred CBA,Misonidazole,Muscles,Neoplasms,Experimental,Organometallic Compounds,Organotechnetium Compounds,Oxygen,Positron-Emission Tomography,Radiation-Sensitizing Agents,Radiopharmaceuticals,Thiosemicarbazones,Tissue Distribution,Tomography,Emission-Computed,Single-Photon|"
path0084,whgu0378,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
bioc0212,clph0059,1,0.07142857142857142,Journal article,Cancer Research,21/08/2012,MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.,"Walls GV,Lemos MC,Javid M,Bazan-Peregrino M,Jeyabalan J,Reed AA,Harding B,Tyler DJ,Stuckey DJ,Piret S,Christie PT,Ansorge O,Clarke K,Seymour L,Thakker RV","Adenoma,Adenoviridae,Animals,Cell Proliferation,Disease Models,Animal,Genetic Therapy,Genetic Vectors,HEK293 Cells,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,129 Strain,Inbred C57BL,Knockout,Pituitary Gland,Pituitary Neoplasms,Proto-Oncogene Proteins"
bioc0416,clme0220,1,0.1111111111111111,Conference paper,European Journal of Cancer,01/07/2012,Isoenzyme-specific PFK-2/FBPase-2 Inhibition as an Anti-cancer Strategy,"Williams JG,Manzano A,Bensaad K,Collins JM,Serres S,Claridge TDW,Sibson N,Bartrons R,Russell AJ,Harris AL",
bioc0756,magd1571,2,0.4,Journal article|Journal article,Bioorganic and Medicinal Chemistry|Bioorganic and Medicinal Chemistry,01/01/2014|01/10/2014,Love-Hate ligands for high resolution analysis of strain in ultra-stable protein/small molecule interaction.|Love-Hate ligands for high resolution analysis of strain in ultra-stable protein/small molecule interaction,"Fairhead M,Shen D,Chan LK,Lowe ED,Donohoe TJ,Howarth M|Fairhead M,Shen D,Chan LKM,Lowe ED,Donohoe TJ,Howarth M","Biotin,Streptavidin,Ligands,Crystallography,X-Ray,Binding Sites,Molecular Structure,Protein Binding,Models,Molecular|"
univ1923,whgu0139,1,0.03225806451612903,Journal article,Nature Chemical Biology,01/01/2012,Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.,"Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ","Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes"
clme0845,gree0184,7,0.7117856107927105,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Lancet Oncology|PLoS Medicine|Lancet|British Journal of Cancer|Circulation|Lancet Oncology|Lancet,01/01/2012|01/01/2012|09/05/2015|27/03/2014|12/03/2013|01/09/2012|26/10/2012,"Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies|Ovarian cancer and body size: Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies|Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.|Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom.|Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study.|Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies|The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK.","Hamajima N,Hirose K,Tajima K,Rohan T,Friedenreich CM,Calle EE,Gapstur SM,Patel AV,Coates RJ,Liff JM,Talamini R,Chantarakul N,Koetsawang S,Rachawat D,Marcou Y,Kakouri E,Duffy SW,Morabia A,Schuman L,Stewart W,Szklo M,Coogan PF,Palmer JR,Rosenberg L,Band P,Coldman AJ,Gallagher RP,Hislop TG,Yang P,Cummings SR,Canfell K,Sitas F,Chao P,Lissowska J,Horn-Ross PL,John EM,Kolonel LM,Nomura AMY,Ghiasvand R,Hu J,Johnson KC,Mao Y,Beral V,Bull D,Callaghan K,Crossley B,Goodill A,Green J,Hermon C,Key T,Lindgard I,Liu B,Pirie K,Reeves G,Collins R,Doll R,Peto R,Bishop T,Fentiman IS,De Sanjose S,Gonzalez CA,Lee N,Marchbanks P,Ory HW,Peterson HB,Wingo P,Ebeling K,Kunde D,Nishan P,Hopper JL,Eliassen H,Hankinson S,Gajalakshmi V,Martin N,Pardthaisong T,Silpisornkosol S,Theetranont C,Boosiri B,Chutivongse S,Jimakorn P,Virutamasen P,Wongsrichanalai C,Neugut A,Santella R,Baines CJ,Kreiger N,Miller AB,Wall C,Tjonneland A,Jorgensen T,Stahlberg C,Pedersen AT,Flesch-Janys D,Hakansson N,Cauley J,Heuch I,Adami HO,Persson I,Weiderpass E,Magnusson C,Chang-Claude J,Kaaks R,McCredie M,Paul C,Skegg DCG,Spears GFS,Iwasaki M,Tsugane S,Anderson G,Daling JR,Hampton J,Hutchinson WB,Li CI,Malone K,Mandelson M,Newcomb P,Noonan EA,Ray RM,Stanford JL,Tang MTC,Thomas DB,Weiss NS,White E,Izquierdo A,Viladiu P,Fourkala EO,Jacobs I,Menon U,Ryan A,Cuevas HR,Ontiveros P,Palet A,Salazar SB,Aristizabal N,Cuadros A,Tryggvadottir L,Tulinius H,Riboli E,Andrieu N,Bachelot A,Le MG,Bremond A,Gairard B,Lansac J,Piana L,Renaud R,Clavel-Chapelon F,Fournier A,Touillaud M,Mesrine S,Chabbert-Buffet N,Boutron-Ruault MC,Wolk A,Torres-Mejia G,Franceschi S,Romieu I,Boyle P,Lubin F,Modan B,Ron E,Wax Y,Friedman GD,Hiatt RA,Levi F,Kosmelj K,Primic-Zakelj M,Ravnihar B,Stare J,Ekbom A,Erlandsson G,Beeson WL,Fraser G,Peto J,Hanson RL,Leske MC,Mahoney MC,Nasca PC,Varma AO,Weinstein AL,Hartman ML,Olsson H,Goldbohm RA,van den Brandt PA,Palli D,Teitelbaum S,Apelo RA,Baens J,de la Cruz JR,Javier B,Lacaya LB,Ngelangel CA,La Vecchia C,Negri E,Marubini E,Ferraroni M,Pike MC,Gerber M,Richardson S,Segala C,Gatei D,Kenya P,Kungu A,Mati JG,Brinton LA,Freedman M,Hoover R,Schairer C,Ziegler R,Banks E,Spirtas R,Lee HP,Rookus MA,van Leeuwen FE,Schoenberg JA,Graff-Iversen S,Selmer R,Jones L,McPherson K,Neil A,Vessey M,Yeates D,Mabuchi K,Preston D,Hannaford P,Kay C,McCann SE,Rosero-Bixby L,Gao YT,Jin F,Yuan J-M,Wei HY,Yun T,Zhiheng C,Berry G,Cooper Booth J,Jelihovsky T,MacLennan R,Shearman R,Hadjisavvas A,Kyriacou K,Loisidou M,Zhou X,Wang Q-S,Kawai M,Minami Y,Tsuji I,Lund E,Kumle M,Stalsberg H,Shu XO,Zheng W,Monninkhof EM,Onland-Moret NC,Peeters PHM,Katsouyanni K,Trichopoulou A,Trichopoulos D,Tzonou A,Baltzell KA,Dabancens A,Martinez L,Molina R,Salas O,Alexander FE,Anderson K,Folsom AR,Gammon MD,Hulka BS,Millikan R,Chilvers CED,Lumachi F,Bain C,Schofield F,Siskind V,Rebbeck TR,Bernstein LR,Enger S,Haile RW,Paganini-Hill A,Ross RK,Ursin G,Wu AH,Yu MC,Ewertz M,Clarke EA,Bergkvist L,Anderson GL,Gass M,O'Sullivan MJ,Kalache A,Farley TMM,Holck S,Meirik O,Fukao A|Beral V,Hermon C,Peto R,Reeves G,Brinton L,Marchbanks P,Negri E,Ness R,Peeters PHM,Vessey M,Calle EE,Gapstur SM,Patel AV,Maso LD,Talamini R,Chetrit A,Hirsh-Yechezkel G,Lubin F,Sadetzki S,Allen N,Beral V,Bull D,Callaghan K,Crossley B,Gaitskell K,Goodill A,Green J,Hermon C,Key T,Moser K,Reeves G,Collins R,Doll R,Peto R,Gonzalez CA,Lee N,Marchbanks P,Ory HW,Peterson HB,Wingo PA,Martin N,Pardthaisong T,Silpisornkosol S,Theetranont C,Boosiri B,Chutivongse S,Jimakorn P,Virutamasen P,Wongsrichanalai C,Tjonneland A,Titus-Ernstoff L,Byers T,Rohan T,Mosgaard BJ,Vessey M,Yeates D,Freudenheim JL,Chang-Claude J,Kaaks R,Anderson KE,Folsom A,Robien K,Rossing MA,Thomas DB,Weiss NS,Riboli E,Clavel-Chapelon F,Cramer D,Hankinson SE,Tworoger SS,Franceschi S,La Vecchia C,Negri E,Magnusson C,Riman T,Weiderpass E,Wolk A,Schouten LJ,Van den Brandt PA,Chantarakul N,Koetsawang S,Rachawat D,Palli D,Black A,Berrington de Gonzalez A,Brinton LA,Freedman DM,Hartge P,Hsing AW,Lacey JV,Hoover RN,Schairer C,Graff-Iversen S,Selmer R,Bain CJ,Green AC,Purdie DM|Beral V,Gaitskell K,Hermon C,Moser K,Reeves G,Peto R|Bradbury KE,Balkwill A,Spencer EA,Roddam AW,Reeves GK,Green J,Key TJ,Beral V,Pirie K|Sweetland S,Parkin L,Balkwill A,Green J,Reeves G,Beral V,Million Women Study Collaborators|Beral V,Gaitskell K,Hermon C,Moser K,Reeves G,Peto R,Brinton L,Marchbanks P,Negri E,Ness R,Peeters PHM,Vessey M,Calle EE,Gapstur SM,Patel AV,Dal Maso L,Talamini R,Chetrit A,Hirsh-Yechezkel G,Lubin F,Sadetzki S,Banks E,Beral V,Bull D,Callaghan K,Crossley B,Gaitskell K,Goodill A,Green J,Hermon C,Key T,Moser K,Reeves G,Sitas F,Collins R,Doll R,Peto R,Gonzalez A,Lee N,Marchbanks P,Ory HW,Peterson HB,Wingo PA,Martin N,Pardthaisong T,Silpisornkosol S,Theetranont C,Boosiri B,Chutivongse S,Jimakorn P,Virutamasen P,Wongsrichanalai C,Tjonneland A,Titus-Ernstoff L,Byers T,Rohan T,Mosgaard BJ,Vessey M,Yeates D,Freudenheim JL,Chang-Claude J,Kaaks R,Anderson KE,Folsom A,Robien K,Hampton J,Newcomb PA,Rossing MA,Thomas DB,Weiss NS,Riboli E,Clavel-Chapelon F,Cramer D,Hankinson SE,Tworoger SS,Franceschi S,La Vecchia C,Negri E,Adami HO,Magnusson C,Riman T,Weiderpass E,Wolk A,Schouten LJ,van den Brandt PA,Chantarakul N,Koetsawang S,Rachawat D,Palli D,Black A,Brinton LA,Freedman DM,Hartge P,Hsing AW,Jr LJV,Hoover RN,Schairer C,Urban M,Graff-Iversen S,Selmer R,Bain CJ,Green AC,Purdie DM,Siskind V,Webb PM,Moysich K,McCann SE,Hannaford P,Kay C,Binns CW,Lee AH,Zhang M,Ness RB,Nasca P,Coogan PF,Palmer JR,Rosenberg L,Kelsey J,Paffenbarger R,Whittemore A,Katsouyanni K,Trichopoulou A,Trichopoulos D,Tzonou A,Dabancens A,Martinez L,Molina R,Salas O,Goodman MT,Lurie G,Carney ME,Wilkens LR,Hartman L,Manjer J,Olsson H,Grisso JA,Morgan M,Wheeler JE,Bunker CH,Edwards RP,Modugno F,Peeters PHM,Casagrande J,Pike MC,Ross RK,Wu AH,Miller AB,Kumle M,Gram IT,Lund E,McGowan L,Shu XO,Zheng W,Farley TMM,Holck S,Meirik O,Risch HA,Epidemiological CG,Canc NISO,Study NH|Pirie K,Peto R,Reeves GK,Green J,Beral V,Million Women Study Collaborators","||Collaborative Group On Epidemiological Studies Of Ovarian Cancer,Humans,Ovarian Neoplasms,Estrogen Replacement Therapy,Drug Administration Schedule,Incidence,Risk Assessment,Postmenopause,Middle Aged,Female|Million Women Study Collaborators,Humans,Neoplasms,Lymphoma,Non-Hodgkin,Sarcoma,Breast Neoplasms,Incidence,Prospective Studies,Middle Aged,Great Britain,Female,Self Report,Food,Organic|Cohort Studies,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Middle Aged,Postoperative Complications,Prospective Studies,Retrospective Studies,Risk Factors,Smoking,Venous Thromboembolism||Adult,Age Factors,Aged,Data Collection,Female,Great Britain,Humans,Middle Aged,Proportional Hazards Models,Prospective Studies,Risk Factors,Smoking,Smoking Cessation,Socioeconomic Factors,Time Factors,Young Adult"
clab0101,clme0220,1,0.09090909090909091,Journal article,Clinical Cancer Research,22/08/2013,The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.,"Nikitenko LL,Leek R,Henderson S,Pillay N,Turley H,Generali D,Gunningham S,Morrin HR,Pellagatti A,Rees MC,Harris AL,Fox SB","Adrenomedullin,Aged,Autocrine Communication,Calcitonin Receptor-Like Protein,Carcinoma,Renal Cell,Cell Line,Tumor,Female,Follow-Up Studies,Gene Expression Profiling,Gene Expression Regulation,Neoplastic,Humans,Kidney Neoplasms,Male,Middle Aged,Neoplasm Grading,Neoplasm Staging,Prognosis,Tumor Burden"
donc0120,raob0231,1,0.07142857142857142,Journal article,Clinical Oncology,11/03/2013,Oesophageal Chemoradiotherapy in the UK--current practice and future directions.,"Gwynne S,Falk S,Gollins S,Wills L,Bateman A,Cummins S,Grabsch H,Hawkins MA,Maggs R,Mukherjee S,Radhakrishna G,Roy R,Sharma RA,Spezi E,Crosby T","Chemoradiotherapy,Clinical Trials,Phase II as Topic,Esophageal Neoplasms,Great Britain,Humans,Neoadjuvant Therapy,Randomized Controlled Trials as Topic"
raob0096,raob0202,5,0.5888888888888889,Journal article|Journal article|Conference paper|Conference paper|Journal article,Oncotarget|Radiotherapy and Oncology|Modern Pathology|Laboratory Investigation|Biochimica et Biophysica Acta: international journal of biochemistry and biophysics,||01/02/2016|01/02/2016|06/12/2014,The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma.|ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.,"Wang LM,Silva MA,D'Costa Z,Bockelmann R,Soonawalla Z,Liu S,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Wilson JM,Fokas E,Dutton SJ,Patel N,Hawkins MA,Eccles C,Chu KY,Durrant L,Abraham AG,Partridge M,Woodward M,O'Neill E,Maughan T,McKenna WG,Mukherjee S,Brunner TB|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Fokas E,O'Neill E,Gordon-Weeks A,Mukherjee S,McKenna WG,Muschel RJ","||||Animals,Humans,Mice,Carcinoma,Pancreatic Ductal,Pancreatic Neoplasms,Cell Transformation,Neoplastic,Disease Models,Animal,Inflammation,Cancer Vaccines,Immunotherapy,Drug Resistance,Neoplasm,Radiation Tolerance,Neoplastic Cells,Circulating"
clme0667,raob0069,5,1.1818181818181817,Journal article|Conference paper|Conference paper|Journal article|Conference paper,"Cell Death and Disease|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|International Journal of Radiation: Oncology - Biology - Physics|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",01/01/2012|01/06/2011|01/06/2011|01/01/2011|01/05/2013,Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|A Comparison of contrast-reinforced lever Computed tomography (CECT) with FDG-PET-based Target volume definition in locally advanced Pancreatic Cancer (LAPC) for conventional and adaptive Radiochemotherapy (RCT)|Potential advantages and tradeoffs of intensity modulated radiotherapy for locally advanced pancreas cancer (including elective nodal volumes)|Comparison of Locally Advanced Pancreatic Cancer Target Definition Methods on 18FDG-PET images for Radiotherapy Treatment Planning|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation,"Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Eccles CL,Vallis KA,McKenna WG,Brunner TB|Eccles CL,Vallis KA,McKenna WG,Brunner TB|Eccles CL,Vallis KA,Brunner TB,McKenna WG|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB","Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents||||"
immd0282,olin0027,1,0.08333333333333333,Journal article,Proceedings of the National Academy of Sciences of USA,01/07/2013,Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development,"Sacilotto N,Monteiro R,Fritzsche M,Becker PW,Sanchez-Del-Campo L,Liu K,Pinheiro P,Ratnayaka I,Davies B,Goding CR,Patient R,Bou-Gharios G,De Val S","CSL,arterial-specific enhancer,Animals,Arteries,Chromatin Immunoprecipitation,Cloning,Molecular,Electrophoretic Mobility Shift Assay,Gene Expression Regulation,Developmental,Gene Knockdown Techniques,Immunoglobulin J Recombination Signal Sequence-Binding Protein,Immunohistochemistry,In Situ Hybridization,Intracellular Signaling Peptides and Proteins,Membrane Proteins,Mice,Transgenic,Receptors,Notch,SOXF Transcription Factors,Zebrafish"
bioc0416,univ1102,5,1.0833333333333333,Journal article|Journal article|Journal article|Journal article|Journal article,Magnetic Resonance in Medicine|Magnetic Resonance in Medicine|Journal of Magnetic Resonance|Magnetic Resonance in Medicine|Magnetic Resonance in Medicine,11/01/2013|01/08/2013|16/07/2012|24/09/2012|01/11/2013,Optimal sampling schedule for chemical exchange saturation transfer.|Quantitative Bayesian model-based analysis of amide proton transfer MRI|Evaluating the use of a continuous approximation for model-based quantification of pulsed chemical exchange saturation transfer (CEST).|Quantitative Bayesian model-based analysis of amide proton transfer MRI.|Optimal sampling schedule for chemical exchange saturation transfer,"Tee YK,Khrapitchev AA,Sibson NR,Payne SJ,Chappell MA|Chappell MA,Donahue MJ,Tee YK,Khrapitchev AA,Sibson NR,Jezzard P,Payne SJ|Tee YK,Khrapitchev AA,Sibson NR,Payne SJ,Chappell MA|Chappell MA,Donahue MJ,Tee YK,Khrapitchev AA,Sibson NR,Jezzard P,Payne SJ|Tee YK,Khrapitchev AA,Sibson NR,Payne SJ,Chappell MA","Bloch-McConnell equations,chemical exchange saturation transfer,magnetization transfer,optimal sampling schedule,Algorithms,Creatine,Magnetic Resonance Spectroscopy,Sample Size,Signal Processing,Computer-Assisted||Algorithms,Amines,Computer Simulation,Data Interpretation,Statistical,Electromagnetic Fields,Image Processing,Computer-Assisted,Magnetic Resonance Imaging,Models,Phantoms,Imaging,Protons,Water|amide proton transfer,chemical exchange saturation transfer,magnetization transfer,Adult,Amides,Bayes Theorem,Body Water,Brain,Computer Simulation,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Magnetic Resonance Imaging,Male,Models,Neurological,Pattern Recognition,Automated,Protons,Reproducibility of Results,Sensitivity and Specificity,Young Adult|"
immd0282,immd0700,2,0.06896551724137931,Journal article|Journal article,Nature Immunology|Nature Immunology,19/02/2012|01/01/2012,The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential.|The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential,"Luc S,Luis TC,Boukarabila H,Macaulay IC,Buza-Vidas N,Bouriez-Jones T,Lutteropp M,Woll PS,Loughran SJ,Mead AJ,Hultquist A,Brown J,Mizukami T,Matsuoka S,Ferry H,Anderson K,Duarte S,Atkinson D,Soneji S,Domanski A,Farley A,Sanjuan-Pla A,Carella C,Patient R,de Bruijn M,Enver T,Nerlov C,Blackburn C,Godin I,Jacobsen SE|Luc S,Luis TC,Boukarabila H,Macaulay IC,Buza-Vidas N,Bouriez-Jones T,Lutteropp M,Woll PS,Loughran SJ,Mead AJ,Hultquist A,Brown J,Mizukami T,Matsuoka S,Ferry H,Anderson K,Duarte S,Atkinson D,Soneji S,Domanski A,Farley A,Sanjuan-Pla A,Carella C,Patient R,De Bruijn M,Enver T,Nerlov C,Blackburn C,Godin I,Jacobsen SEW","Animals,B-Lymphocytes,Cell Lineage,Cell Separation,Flow Cytometry,Hematopoietic Stem Cells,Lymphoid Progenitor Cells,Mice,Inbred C57BL,Transgenic,Myeloid Cells,Oligonucleotide Array Sequence Analysis,Precursor Cells,B-Lymphoid,Real-Time Polymerase Chain Reaction,T-Lymphocytes,Thymus Gland|"
clme0439,corp0784,7,1.0930555555555554,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Science|Nature Immunology|Journal of Structural Biology|Developmental Cell|Nature Structural and Molecular Biology|Science|PLoS Biology,01/01/2013||06/05/2011|01/01/2011|10/07/2011|01/01/2011|01/01/2011,Structure of the Repulsive Guidance Molecule (RGM)-neogenin signaling hub|Initiation of T cell signaling by CD45 segregation at 'close contacts'.|Automation of large scale transient protein expression in mammalian cells.|Structural and functional studies of LRP6 ectodomain reveal a platform for Wnt signaling|Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1.|Proteoglycan-Specific Molecular Switch for RPTPσ Clustering and Neuronal Extension|A dual binding mode for RhoGTPases in plexin signalling,"Bell CH,Healey E,van Erp S,Bishop B,Tang C,Gilbert RJC,Aricescu AR,Pasterkamp RJ,Siebold C|Chang VT,Fernandes RA,Ganzinger KA,Lee SF,Siebold C,McColl J,Jönsson P,Palayret M,Harlos K,Coles CH,Jones EY,Lui Y,Huang E,Gilbert RJ,Klenerman D,Aricescu AR,Davis SJ|Zhao Y,Bishop B,Clay JE,Lu W,Jones M,Daenke S,Siebold C,Stuart DI,Jones EY,Aricescu AR|Chen S,Bubeck D,MacDonald BT,Liang WX,Mao JH,Malinauskas T,Llorca O,Aricescu AR,Siebold C,He X,Jones EY|Malinauskas T,Aricescu AR,Lu W,Siebold C,Jones EY|Coles CH,Shen Y,Tenney AP,Siebold C,Sutton GC,Lu W,Gallagher JT,Jones EY,Flanagan JG,Aricescu AR|Bell CH,Aricescu AR,Jones EY,Siebold C","||Automation,Laboratory,Cell Culture Techniques,DNA,Circular,HEK293 Cells,Hedgehog Proteins,Humans,Plasmids,Recombinant Proteins,Transfection||Adaptor Proteins,Signal Transducing,Amino Acid Motifs,Binding Sites,Glycosaminoglycans,HEK293 Cells,Humans,Lipid Metabolism,Models,Molecular,Protein Folding,Protein Structure,Tertiary,Repressor Proteins,Signal Transduction,Wnt Proteins||"
ocms0037,stat0004,1,0.07142857142857142,Journal article,Haematologica: the hematology journal,28/05/2013,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary"
newc0612,raob0097,1,0.0625,Journal article,Journal of Medicinal Chemistry,21/03/2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.","Hewings DS,Fedorov O,Filippakopoulos P,Martin S,Picaud S,Tumber A,Wells C,Olcina MM,Freeman K,Gill A,Ritchie AJ,Sheppard DW,Russell AJ,Hammond EM,Knapp S,Brennan PE,Conway SJ","Acetylation,CREB-Binding Protein,Cell Line,Tumor,Crystallography,X-Ray,Histones,Humans,Inhibitory Concentration 50,Isoxazoles,Ligands,Lysine,Nuclear Proteins,Protein Binding,Structure-Activity Relationship,Transcription Factors"
clab0127,raob0047,1,0.2,Journal article,Cell Death and Differentiation,29/08/2014,Cofactor Strap regulates oxidative phosphorylation and mitochondrial p53 activity through ATP synthase.,"Maniam S,Coutts AS,Stratford MR,McGouran J,Kessler B,La Thangue NB","Hela Cells,Mitochondria,Humans,Mitochondrial Proton-Translocating ATPases,Glucose,Neoplasm Proteins,Apoptosis,Oxidative Phosphorylation,Oxygen Consumption,Tumor Suppressor Protein p53,Transcriptional Activation"
raob0128,xxxx0009,1,0.3333333333333333,Journal article,Physics in Medicine and Biology,14/05/2015,Improved calibration of mass stopping power in low density tissue for a proton pencil beam algorithm.,"Warren DR,Partridge M,Hill MA,Peach K","Humans,Carcinoma,Non-Small-Cell Lung,Lung Neoplasms,Tomography,X-Ray Computed,Radiotherapy Dosage,Radiotherapy Planning,Computer-Assisted,Calibration,Monte Carlo Method,Phantoms,Imaging,Algorithms,Proton Therapy"
chem0068,raob0087,4,0.3727272727272728,Journal article|Journal article|Journal article|Conference paper,Journal of Nuclear Medicine|Metallomics: integrated biometal science|PLoS One|Journal of Labelled Compounds and Radiopharmaceuticals,12/12/2013|13/03/2015|01/01/2011|01/02/2013,"A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.|A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.|Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.|Imaging of hypoxia using CuATSM","Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ|Hueting R,Kersemans V,Tredwell M,Cornelissen B,Christlieb M,Gee AD,Passchier J,Smart SC,Gouverneur V,Muschel RJ,Dilworth JR|Kersemans V,Cornelissen B,Hueting R,Tredwell M,Hussien K,Allen PD,Falzone N,Hill SA,Dilworth JR,Gouverneur V,Muschel RJ,Smart SC|Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ","64Cu-ATSM,64Cu-acetate,copper metabolism,hypoxia,Acetates,Animals,Anoxia,Cell Line,Tumor,Copper,Copper Radioisotopes,Female,Humans,Immunohistochemistry,Mice,Inbred CBA,Neoplasm Transplantation,Organometallic Compounds,Oxygen,Positron-Emission Tomography,Prognosis,Thiosemicarbazones,Time Factors|Cell Line,Animals,Humans,Mice,Neoplasms,Anoxia,Copper Radioisotopes,Organometallic Compounds,Thiosemicarbazones,Positron-Emission Tomography,Tomography,Emission-Computed,Single-Photon,Tissue Distribution,Female|Adenocarcinoma,Anesthesia,Animals,Anoxia,Copper Radioisotopes,Female,Fluorine Radioisotopes,Gases,Mice,Inbred CBA,Misonidazole,Muscles,Neoplasms,Experimental,Organometallic Compounds,Organotechnetium Compounds,Oxygen,Positron-Emission Tomography,Radiation-Sensitizing Agents,Radiopharmaceuticals,Thiosemicarbazones,Tissue Distribution,Tomography,Emission-Computed,Single-Photon|"
immd0084,whgu0172,1,0.05555555555555555,Journal article,Cell death discovery,20/11/2015,Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia.,"Watson AS,Riffelmacher T,Stranks A,Williams O,De Boer J,Cain K,MacFarlane M,McGouran J,Kessler B,Khandwala S,Chowdhury O,Puleston D,Phadwal K,Mortensen M,Ferguson D,Soilleux E,Woll P,Jacobsen SE,Simon AK",
immd0024,ndos0168,1,0.03333333333333333,Journal article,Blood,06/12/2014,Functional and Genetic Heterogeneity of Distinct Leukemic Stem Cell Populations in CD34-Human Acute Myeloid Leukemia,"Quek L,Otto G,Garnett C,Lhermitte L,Lau I-J,Karamitros D,Doondeea J,Usukhbayar B,Goardon N,Ivey A,Gu Y,Allen CG,Gale RE,Davies B,Sternberg A,Killick S,Hunter H,Cahalin P,Price A,Carr A,Griffiths M,Virgo P,Mackinnon S,Grimwade D,Freeman SD,Russell N,Craddock C,Mead A,Peniket A,Porcher C,Vyas P",
clme0149,clme1037,1,1.0,Journal article,New England Journal of Medicine,06/11/2013,Mutant prolactin receptor and familial hyperprolactinemia,Newey PJ,
clab0127,clme0220,2,0.25,Journal article|Journal article,Oncogene|Oncogene,01/01/2011|30/05/2011,Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α|Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α.,"Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB|Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB","|Base Sequence,Cell Hypoxia,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Molecular Sequence Data,Nuclear Proteins,Promoter Regions,Genetic,Trans-Activators"
clab0025,smlea,1,0.0625,Journal article,Journal of Biological Chemistry,21/01/2013,Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.,"Whiteman P,de Madrid BH,Taylor P,Li D,Heslop R,Viticheep N,Tan JZ,Shimizu H,Callaghan J,Masiero M,Li JL,Banham AH,Harris AL,Lea SM,Redfield C,Baron M,Handford PA","Amino Acid Sequence,Animals,Antibodies,Monoclonal,Blotting,Western,Calcium-Binding Proteins,Cell Line,Tumor,Drosophila Proteins,Flow Cytometry,HEK293 Cells,Humans,Intercellular Signaling Peptides and Proteins,Ligands,Membrane Proteins,Mice,Models,Molecular,Molecular Sequence Data,Mutation,Protein Binding,Protein Structure,Secondary,Tertiary,Receptor,Notch1,Receptors,Notch,Sequence Homology,Amino Acid"
immd0237,whgu0172,15,1.5228422473583765,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,The Federation of European Biochemical Societies (FEBS) Journal|Nature Chemical Biology|Journal of Pathology|Cancer Cell|Chemistry and Biology|Journal of Proteomics and Bioinformatics|Proceedings of the National Academy of Sciences of USA|Molecular Cell|Journal of Biological Chemistry|Journal of Biological Chemistry|Proceedings of the National Academy of Sciences of USA|Nature Chemical Biology|EMBO Reports|Journal of Biological Chemistry|EMBO Reports,20/01/2011|01/01/2012|01/01/2011|18/10/2011|27/05/2011|27/12/2012|18/02/2014|30/01/2014|01/01/2011|22/02/2011|18/02/2014|01/01/2012|01/01/2012|30/07/2011|07/02/2012,Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.|A photoreactive small-molecule probe for 2-oxoglutarate oxygenases.|Modls: Post-translational modification localization scoring with automatic specificity expansion|OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.|Optimal translational termination requires C4 lysyl hydroxylation of eRF1.|Quantitative mass spectrometry reveals dynamics of factor-inhibiting hypoxia-inducible factor-catalyzed hydroxylation|Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors.|Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans|The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity|Quantitative mass spectrometry reveals dynamics of factor-inhibiting hypoxia-inducible factor-catalyzed hydroxylation.|The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity.,"Yang M,Chowdhury R,Ge W,Hamed RB,McDonough MA,Claridge TD,Kessler BM,Cockman ME,Ratcliffe PJ,Schofield CJ|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Adam J,Hatipoglu E,O'Flaherty L,Ternette N,Sahgal N,Lockstone H,Baban D,Nye E,Stamp GW,Wolhuter K,Stevens M,Fischer R,Carmeliet P,Maxwell PH,Pugh CW,Frizzell N,Soga T,Kessler BM,El-Bahrawy M,Ratcliffe PJ,Pollard PJ|Rotili D,Altun M,Kawamura A,Wolf A,Fischer R,Leung IK,Mackeen MM,Tian YM,Ratcliffe PJ,Mai A,Kessler BM,Schofield CJ|Trudgian DC,Singleton R,Cockman ME,Ratcliffe PJ,Kessler BM|Singleton RS,Liu-Yi P,Formenti F,Ge W,Sekirnik R,Fischer R,Adam J,Pollard PJ,Wolf A,Thalhammer A,Loenarz C,Flashman E,Yamamoto A,Coleman ML,Kessler BM,Wappner P,Schofield CJ,Ratcliffe PJ,Cockman ME|Yamamoto A,Feng T,Wilkins S,Sokolova E,Yates L,Muenzel M,Singh P,Hopkinson R,Fischer R,Cockman M,Shelley J,Trudgian D,Schoedel J,McCullagh JO,Ge W,Kessler B,Gilbert R,Frolova L,Alkalaeva E,Ratcliffe P,Schofield C,Coleman M|Singleton RS,Trudgian DC,Fischer R,Kessler BM,Ratcliffe PJ,Cockman ME|Tian YM,Yeoh KK,Lee MK,Eriksson T,Kessler BM,Kramer HB,Edelmann MJ,Willam C,Pugh CW,Schofield CJ,Ratcliffe PJ|Loenarz C,Sekirnik R,Thalhammer A,Ge W,Spivakovsky E,Mackeen MM,McDonough MA,Cockman ME,Kessler BM,Ratcliffe PJ,Wolf A,Schofield CJ|Ge W,Wolf A,Feng T,Ho C-H,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TDW,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,Mccullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Masson N,Singleton RS,Sekirnik R,Trudgian DC,Ambrose LJ,Miranda MX,Tian YM,Kessler BM,Schofield CJ,Ratcliffe PJ|Singleton RS,Trudgian DC,Fischer R,Kessler BM,Ratcliffe PJ,Cockman ME|Masson N,Singleton RS,Sekirnik R,Trudgian DC,Ambrose LJ,Miranda MX,Tian YM,Kessler BM,Schofield CJ,Ratcliffe PJ","Amino Acid Sequence,Ankyrin Repeat,HEK293 Cells,Histidine,Humans,Hydroxylation,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Protein Processing,Post-Translational,Protein Structure,Tertiary,Repressor Proteins,Sequence Alignment,Tankyrases|Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes|Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid|Adaptor Proteins,Signal Transducing,Animals,Antioxidants,Cell Hypoxia,Cytoskeletal Proteins,Fumarate Hydratase,Fumarates,Gene Expression Regulation,Neoplastic,Hypoxia-Inducible Factor 1,Kidney Diseases,Cystic,Mice,NF-E2-Related Factor 2,Procollagen-Proline Dioxygenase,Signal Transduction,Succinates|Cell Line,Cross-Linking Reagents,Dioxygenases,Enzyme Inhibitors,F-Box Proteins,Humans,Hydroxyquinolines,Jumonji Domain-Containing Histone Demethylases,Oxidoreductases,N-Demethylating,Photochemical Processes,Protein Structure,Tertiary,Small Molecule Libraries,Spectrometry,Mass,Matrix-Assisted Laser Desorption-Ionization||2-oxoglutarate oxygenase,hypoxia,ribosome,translational control,Analysis of Variance,Carrier Proteins,Computational Biology,Fluorescent Antibody Technique,Gene Knockdown Techniques,Humans,Hydroxylation,Immunoblotting,Immunoprecipitation,Ketoglutaric Acids,Luciferases,Nuclear Proteins,Proline,Prolyl Hydroxylases,Protein Biosynthesis,Protein Processing,Post-Translational,Ribosomal Proteins,Yeasts|Amino Acid Sequence,Animals,Catalysis,Cell Line,Tumor,Codon,Terminator,Gene Expression Regulation,HeLa Cells,Histone Demethylases,Humans,Hydrolysis,Hydroxylation,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Peptide Chain Termination,Translational,Peptide Termination Factors,Protein Biosynthesis,Protein Processing,Post-Translational,Protein Structure,Tertiary,Sequence Homology,Amino Acid||Animals,Cell Hypoxia,Drosophila melanogaster,Enzyme Inhibitors,Hep G2 Cells,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,K562 Cells,Male,Oxygenases,Protein Structure,Tertiary,Rats,Sprague-Dawley,Ubiquitin-Protein Ligases,p300-CBP Transcription Factors|2-oxoglutarate oxygenase,hypoxia,nonsense readthrough,ribosomal hydroxylation,translation,Chlorophyta,Codon,Terminator,Humans,Hydroxylation,Mass Spectrometry,Oxygenases,Protein Biosynthesis,Protein Processing,Post-Translational,Ribosomal Proteins,Ribosomes,Saccharomyces cerevisiae,Schizosaccharomyces,Species Specificity|||Animals,Ankyrin Repeat,Cell Hypoxia,HEK293 Cells,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,Mass Spectrometry,Mice,Mixed Function Oxygenases,Oxygen,Protein Binding,Protein Structure,Tertiary,Repressor Proteins,Transcription,Genetic|Cell Hypoxia,Cell Line,Cysteine,Gene Expression Regulation,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,Mixed Function Oxygenases,Peroxides,Repressor Proteins,Transcription,Genetic"
clme0667,raob0047,2,0.30000000000000004,Journal article|Journal article,Cancer Research|Clinical Cancer Research,22/11/2011|07/11/2011,Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.|Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo.,"Fokas E,Im JH,Hill S,Yameen S,Stratford M,Beech J,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|Qayum N,Im J,Stratford MR,Bernhard EJ,McKenna WG,Muschel RJ","Animals,Dose-Response Relationship,Drug,Humans,Mice,Neoplasms,Experimental,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Radiation Tolerance,TOR Serine-Threonine Kinases,Xenograft Model Antitumor Assays|Animals,Anoxia,Doxorubicin,Drug Delivery Systems,Female,Humans,Immunoenzyme Techniques,Indazoles,Mammary Neoplasms,Animal,Mice,Nude,Transgenic,Microvessels,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Sulfonamides"
clne0009,stat0004,3,0.0356467335952277,Journal article|Journal article|Journal article,Nature Genetics|Nature Genetics|Nature Genetics,05/02/2012|01/01/2012|01/01/2012,Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke|Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke|Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke,"Bellenguez C,Bevan S,Gschwendtner A,Spencer CCA,Burgess AI,Pirinen M,Jackson CA,Traylor M,Strange A,Su Z,Band G,Syme PD,Malik R,Pera J,Norrving B,Lemmens R,Freeman C,Schanz R,James T,Poole D,Murphy L,Segal H,Cortellini L,Cheng Y,Woo D,Nalls M,Muller-Myhsok B,Meisinger C,Seedorf U,Ross-Adams H,Boonen S,Wloch-Kopec D,Valant V,Slark J,Furie K,Delavaran H,Langford C,Deloukas P,Edkins S,Hunt S,Gray E,Dronov S,Peltonen L,Gretarsdottir S,Thorleifsson G,Thorsteinsdottir U,Stefansson K,Boncoraglio G,Parati E,Attia J,Holliday E,Levi C,Franzosi M,Goel A,Helgadottir A,Blackwell JM,Bramon E,Brown MA,Casas JP,Corvin A,Duncanson A,Jankowski J,Mathew CG,Palmer CNA,Plomin R,Rautanen A,Sawcer SJ,Trembath RC,Viswanathan A,Wood NW,Worrall BB,Kittner SJ,Mitchell BD,Kissela B,Meschia JF,Thijs V,Lindgren A,Macleod MJ,Slowik A,Walters M,Rosand J,Sharma P,Farrall M,Sudlow CLM,Rothwell PM,Dichgans M,Donnelly P,Markus HS|Bellenguez C,Bevan S,Gschwendtner A,Spencer CCA,Burgess AI,Pirinen M,Jackson CA,Traylor M,Strange A,Su Z,Band G,Syme PD,Malik R,Pera J,Bo N,Lemmens R,Freeman C,Schanz R,James T,Poole D,Murphy L,Segal H,Cortellini L,Cheng Y-C,Woo D,Nalls MA,Müller-Myhsok B,Meisinger C,Seedorf U,Ross-Adams H,Boonen S,Wloch-Kopec D,Valant V,Slark J,Furie K,Delavaran H,Langford C,Deloukas P,Edkins S,Hunt S,Gray E,Dronov S,Peltonen L,Gretarsdottir S,Thorleifsson G,Thorsteinsdottir U,Stefansson K,Boncoraglio GB,Parati EA,Attia J,Holliday E,Levi C,Franzosi M-G,Goel A,Helgadottir A,Blackwell JM,Bramon E,Brown MA,Casas JP,Corvin A,Duncanson A,Jankowski J,Mathew CG,Palmer CNA,Plomin R,Rautanen A,Sawcer SJ,Trembath RC,Viswanathan AC,Wood NW,Worrall BB,Kittner SJ,Mitchell BD,Kissela B,Meschia JF,Thijs V,Lindgren A,MacLeod MJ,Slowik A,Walters M,Rosand J,Sharma P,Farrall M,Sudlow CLM,Rothwell PM,Dichgans M,Donnelly P,Markus HS|Bellenguez C,Bevan S,Gschwendtner A,Spencer CCA,Burgess AI,Pirinen M,Jackson CA,Traylor M,Strange A,Su Z,Band G,Syme PD,Malik R,Pera J,Bo N,Lemmens R,Freeman C,Schanz R,James T,Poole D,Murphy L,Segal H,Cortellini L,Cheng YC,Woo D,Nalls MA,Müller-Myhsok B,Meisinger C,Seedorf U,Ross-Adams H,Boonen S,Wloch-Kopec D,Valant V,Slark J,Furie K,Delavaran H,Langford C,Deloukas P,Edkins S,Hunt S,Gray E,Dronov S,Peltonen L,Gretarsdottir S,Thorleifsson G,Thorsteinsdottir U,Stefansson K,Boncoraglio GB,Parati EA,Attia J,Holliday E,Levi C,Franzosi MG,Goel A,Helgadottir A,Blackwell JM,Bramon E,Brown MA,Casas JP,Corvin A,Duncanson A,Jankowski J,Mathew CG,Palmer CNA,Plomin R,Rautanen A,Sawcer SJ,Trembath RC,Viswanathan AC,Wood NW,Worrall BB,Kittner SJ,Mitchell BD,Kissela B,Meschia JF,Thijs V,Lindgren A,MacLeod MJ,Slowik A,Walters M",||
path0089,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0149,path0089,5,0.2717086834733894,Journal article|Journal article|Journal article|Journal article|Journal article,Blood|Journal of Infection|Mucosal Immunology|Blood|Blood,07/02/2013|07/02/2013|01/03/2016|01/01/2012|15/11/2011,"Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.|EARLY AND NON-REVERSIBLE DECREASE OF CD161++/MUCOSAL ASSOCIATED INVARIANT T CELLS IN HIV INFECTION|CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut.|Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8 <sup>+</sup> T cells|Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells.","Cosgrove C,Ussher JE,Rauch A,Gärtner K,Kurioka A,Hühn MH,Adelmann K,Kang YH,Fergusson JR,Simmonds P,Goulder P,Hansen TH,Fox J,Günthard HF,Khanna N,Powrie F,Steel A,Gazzard B,Phillips RE,Frater J,Uhlig H,Klenerman P|Cosgrove C,Ussher JE,Rauch A,Gaertner K,Kurioka A,Huehn MH,Adelmann K,Kang Y-H,Fergusson JR,Simmonds P,Goulder P,Hansen TH,Fox J,Guenthard HF,Khanna N,Powrie F,Steel A,Gazzard B,Phillips RE,Frater J,Uhlig H,Klenerman P|Fergusson JR,Hühn MH,Swadling L,Walker LJ,Kurioka A,Llibre A,Bertoletti A,Holländer G,Newell EW,Davis MM,Sverremark-Ekström E,Powrie F,Capone S,Folgori A,Barnes E,Willberg CB,Ussher JE,Klenerman P|Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P|Walker LJ,Kang YH,Smith MO,Tharmalingham H,Ramamurthy N,Fleming VM,Sahgal N,Leslie A,Oo Y,Geremia A,Scriba TJ,Hanekom WA,Lauer GM,Lantz O,Adams DH,Powrie F,Barnes E,Klenerman P","Adult,Anti-HIV Agents,Antiretroviral Therapy,Highly Active,Apoptosis,CD8-Positive T-Lymphocytes,Cells,Cultured,Cohort Studies,Escherichia coli,Female,Flow Cytometry,HIV,HIV Infections,Humans,Immunity,Mucosal,Immunohistochemistry,Interleukin-17,Leukocytes,Mononuclear,Lymphocyte Count,Male,Middle Aged,NK Cell Lectin-Like Receptor Subfamily B,Receptors,CCR5,CCR6,T-Lymphocyte Subsets,Time Factors||||Adult,Antigen Presentation,Antigens,CD8,Biomarkers,Blotting,Western,CD8-Positive T-Lymphocytes,Cell Differentiation,Cytokines,Fetal Blood,Fluorescent Antibody Technique,Gene Expression Profiling,Humans,Immunity,Mucosal,Infant,Newborn,Oligonucleotide Array Sequence Analysis,Protein Isoforms,RNA,Messenger,Real-Time Polymerase Chain Reaction,Receptors,Antigen,T-Cell,T-Lymphocyte Subsets,Th17 Cells"
immd0282,path0511,2,0.06896551724137931,Journal article|Journal article,Nature Immunology|Nature Immunology,19/02/2012|01/01/2012,The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential.|The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential,"Luc S,Luis TC,Boukarabila H,Macaulay IC,Buza-Vidas N,Bouriez-Jones T,Lutteropp M,Woll PS,Loughran SJ,Mead AJ,Hultquist A,Brown J,Mizukami T,Matsuoka S,Ferry H,Anderson K,Duarte S,Atkinson D,Soneji S,Domanski A,Farley A,Sanjuan-Pla A,Carella C,Patient R,de Bruijn M,Enver T,Nerlov C,Blackburn C,Godin I,Jacobsen SE|Luc S,Luis TC,Boukarabila H,Macaulay IC,Buza-Vidas N,Bouriez-Jones T,Lutteropp M,Woll PS,Loughran SJ,Mead AJ,Hultquist A,Brown J,Mizukami T,Matsuoka S,Ferry H,Anderson K,Duarte S,Atkinson D,Soneji S,Domanski A,Farley A,Sanjuan-Pla A,Carella C,Patient R,De Bruijn M,Enver T,Nerlov C,Blackburn C,Godin I,Jacobsen SEW","Animals,B-Lymphocytes,Cell Lineage,Cell Separation,Flow Cytometry,Hematopoietic Stem Cells,Lymphoid Progenitor Cells,Mice,Inbred C57BL,Transgenic,Myeloid Cells,Oligonucleotide Array Sequence Analysis,Precursor Cells,B-Lymphoid,Real-Time Polymerase Chain Reaction,T-Lymphocytes,Thymus Gland|"
clme0670,raob0047,5,0.675,Journal article|Journal article|Journal article|Journal article|Conference paper,"Radiotherapy and Oncology|Cancer Research|Clinical Cancer Research|Radiotherapy and Oncology|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",13/03/2014|22/11/2011|07/11/2011|01/04/2014|01/07/2014,Regulation of O2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia.|Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.|Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo.|Regulation of O<inf>2</inf> consumption by the PI3K and mTOR pathways contributes to tumor hypoxia|The PI3K/mTOR pathway regulates tumor O-2 consumption and hypoxia,"Kelly CJ,Hussien K,Fokas E,Kannan P,Shipley RJ,Ashton TM,Stratford M,Pearson N,Muschel RJ|Fokas E,Im JH,Hill S,Yameen S,Stratford M,Beech J,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|Qayum N,Im J,Stratford MR,Bernhard EJ,McKenna WG,Muschel RJ|Kelly CJ,Hussien K,Fokas E,Kannan P,Shipley RJ,Ashton TM,Stratford M,Pearson N,Muschel RJ|Kelly C,Fokas E,Hussien K,Kannan P,Shipley R,Ashton T,Stratford M,Pearson N,Muschel R","Cell Line,Tumor,HCT116 Cells,Spheroids,Cellular,Animals,Humans,Mice,Neoplasms,Aminopyridines,Imidazoles,Morpholines,Quinolines,Protein Kinase Inhibitors,Signal Transduction,Cell Hypoxia,Oxygen Consumption,Phosphatidylinositol 3-Kinase,TOR Serine-Threonine Kinases|Animals,Dose-Response Relationship,Drug,Humans,Mice,Neoplasms,Experimental,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Radiation Tolerance,TOR Serine-Threonine Kinases,Xenograft Model Antitumor Assays|Animals,Anoxia,Doxorubicin,Drug Delivery Systems,Female,Humans,Immunoenzyme Techniques,Indazoles,Mammary Neoplasms,Animal,Mice,Nude,Transgenic,Microvessels,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Sulfonamides||"
card0027,immd0198,2,0.049174311926605506,Journal article|Journal article,Nature Genetics|Journal of Biological Chemistry,18/05/2015|23/10/2015,"Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Resistance of Dynamin-related Protein 1 Oligomers to Disassembly Impairs Mitophagy, Resulting in Myocardial Inflammation and Heart Failure.","Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Cahill TJ,Leo V,Kelly M,Stockenhuber A,Kennedy NW,Bao L,Cereghetti G,Harper AR,Czibik G,Lao C,Bellahcene M,Steeples V,Ghaffari S,Yavari A,Mayer A,Poulton J,Ferguson DJ,Scorrano L,Hettiarachchi NT,Peers C,Boyle J,Hill RB,Simmons A,Watkins H,Dear TN,Ashrafian H","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Cells,Cultured,Animals,Mice,Myocarditis,Biopolymers,Dynamins,Oxidative Phosphorylation,Mutation,Heart Failure,Mitochondrial Degradation"
immd0082,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
molb0003,raob0051,1,0.125,Journal article,BMC Research Notes,01/12/2015,A prospective pilot study of detection of sentinel lymph nodes in gynaecological cancers using a novel near infrared fluorescence imaging system.,"Laios A,Volpi D,Tullis ID,Woodward M,Kennedy S,Pathiraja PN,Haldar K,Vojnovic B,Ahmed AA","Humans,Genital Neoplasms,Female,Indocyanine Green,Fluorescent Dyes,Spectroscopy,Near-Infrared,Sentinel Lymph Node Biopsy,Spectrometry,Fluorescence,Prospective Studies,Pilot Projects"
clme0220,clme0497,1,0.06666666666666667,Journal article,Oncogene,,The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.,"da Motta LL,Ledaki I,Purshouse K,Haider S,De Bastiani MA,Baban D,Morotti M,Steers G,Wigfield S,Bridges E,Li JL,Knapp S,Ebner D,Klamt F,Harris AL,McIntyre A",
card0027,immd0082,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
card0027,immd0330,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0330,phpc0367,2,1.0,Journal article|Journal article,Pharmacogenomics|The Patient: Patient Centered Outcomes Research,01/11/2013|,Issues surrounding the health economic evaluation of genomic technologies.|Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment.,"Buchanan J,Wordsworth S,Schuh A|Buchanan J,Wordsworth S,Schuh A","Cost-Benefit Analysis,Genomics,Humans,Technology|"
clab0127,immd0180,1,0.058823529411764705,Journal article,Cancer Cell,,Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.,"Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Orlando G,Mavrommati I,Pai CC,Zalmas LP,Drobnitzky N,Dianov GL,Verrill C,Macaulay VM,Ying S,La Thangue NB,D'Angiolella V,Ryan AJ,Humphrey TC","Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Neoplasms,Pyrazoles,Pyrimidines,Ribonucleoside Diphosphate Reductase,Histone-Lysine N-Methyltransferase,Nucleotides,Lysine,Cell Cycle Proteins,Nuclear Proteins,Histones,Blotting,Western,Xenograft Model Antitumor Assays,Reverse Transcriptase Polymerase Chain Reaction,Cell Survival,Gene Expression Regulation,Neoplastic,RNA Interference,Amino Acid Sequence,Base Sequence,Sequence Homology,Amino Acid,Nucleic Acid,Methylation,Molecular Sequence Data,Protein-Tyrosine Kinases"
clme0237,immd0330,11,0.6882094815500104,Conference paper|Conference paper|Journal article|Conference paper|Conference paper|Conference paper|Journal article|Conference paper|Journal article|Journal article|Journal article,Blood|Annals of Oncology|Leukemia|Blood|Blood|Blood|Blood|Blood|Blood|Nature Genetics|Blood,16/11/2012|01/06/2012|01/01/2012|16/11/2012|06/12/2014|06/12/2014|22/08/2012|06/12/2014|12/12/2013|18/05/2015|27/08/2015,"SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features|CLINICAL DIAGNOSTIC IMPLEMENTATION OF AN INNOVATIVE CANCER CARE MODEL BASED ON COMPREHENSIVE MOLECULAR PROFILING OF TUMOUR-NORMAL PAIRS|Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.|Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype|Mutational Landscape of 118 Relapsed Chronic Lymphocytic Leukemia Clinical Trial Samples; Evidence for a Multiple-Hit Profile Using Targeted Next Generation Sequencing|Whole Genome Sequencing, Targeted Deep Sequencing and Copy-Number Analysis Provide a Comprehensive Picture of the Mutational Landscape of 41 Clinically Annotated CLL Cases|Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.|Towards Response Prediction Using Integrated Genomics in Chronic Lymphocytic Leukaemia: Results on 250 First-Line FCR Treated Patients from UK Clinical Trials|SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.","Clifford R,Ackroyd S,Burns A,Timbs A,Maelfait J,Dreau H,Henderson S,Ross M,Bentley D,Hillmen P,Knight S,Taylor J,Hatton CSR,Rehwinkel J,Crow Y,Schuh A|Kaur K,Henderson S,Cutts A,Domingo E,Woods J,Motley C,Dougherty B,Middleton M,Hassan B,Wang Y,Beasley E,Naley M,Schuh A,Tomlinson I,Taylor J|Knight SJ,Yau C,Clifford R,Timbs AT,Sadighi Akha E,Dréau HM,Burns A,Ciria C,Oscier DG,Pettitt AR,Dutton S,Holmes CC,Taylor J,Cazier JB,Schuh A|Burns A,Clifford R,Dreau H,Hatton CSR,Henderson S,Taylor J,Schuh A|Robbe P,Guieze R,Clifford RM,de Guibert S,Timbs A,Dilhuydy M-S,Cabes M,Ysebaert L,Burns A,Nguyen-Khac F,Davi F,Veronese L,Combes P,Le Garff-Tavernier M,Leblond V,Merle-Beral H,Alsolami R,Weller S,Hamblin A,Mason J,Pettitt AR,Hillmen P,Taylor J,Knight SJL,Schuh A,Tournilhac O|Burns A,Weller S,Humphray S,Becq J,Alsolami R,Hamblin A,Clifford RM,Knight SJL,Robbe P,Cabes M,Mason J,Hatton CSR,Taylor J,Bentley D,Schuh A|Schuh A,Becq J,Humphray S,Alexa A,Burns A,Clifford R,Feller SM,Grocock R,Henderson S,Khrebtukova I,Kingsbury Z,Luo S,McBride D,Murray L,Menju T,Timbs A,Ross M,Taylor J,Bentley D|Clifford RM,Robbe P,Weller S,Timbs AT,Titsias M,Burns A,Cabes M,Alsolami R,Yau C,Hamblin A,Mason J,Oates M,Pettitt A,Holmes C,Hillmen P,Taylor J,Knight SJL,Schuh A|Clifford R,Louis T,Robbe P,Ackroyd S,Burns A,Timbs AT,Wright Colopy G,Dreau H,Sigaux F,Judde JG,Rotger M,Telenti A,Lin YL,Pasero P,Maelfait J,Titsias M,Cohen DR,Henderson SJ,Ross MT,Bentley D,Hillmen P,Pettitt A,Rehwinkel J,Knight SJ,Taylor JC,Crow YJ,Benkirane M,Schuh A|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Guièze R,Robbe P,Clifford R,de Guibert S,Pereira B,Timbs A,Dilhuydy MS,Cabes M,Ysebaert L,Burns A,Nguyen-Khac F,Davi F,Véronèse L,Combes P,Le Garff-Tavernier M,Leblond V,Merle-Béral H,Alsolami R,Hamblin A,Mason J,Pettitt A,Hillmen P,Taylor J,Knight SJ,Tournilhac O,Schuh A","||Adult,Aged,80 and over,Biomarkers,Tumor,Chromosome Aberrations,Clone Cells,Female,Gene Dosage,Genome,Human,Genomics,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Loss of Heterozygosity,Male,Middle Aged,Neoplasm Recurrence,Local,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Prognosis||||Alleles,Cell Transformation,Neoplastic,Clonal Deletion,Clone Cells,DNA Mutational Analysis,DNA,Neoplasm,Disease Progression,Evolution,Molecular,Gene Frequency,Genome-Wide Association Study,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Mutation,Neoplasm Proteins,Selection,Genetic,Sequence Analysis||Adult,Autoimmune Diseases of the Nervous System,Cohort Studies,Comparative Genomic Hybridization,DNA Damage,Gene Frequency,Germ-Line Mutation,HeLa Cells,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Male,Monomeric GTP-Binding Proteins,Nervous System Malformations,Young Adult,Hela Cells|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Humans,Neoplasm Recurrence,Local,Ribonucleoprotein,U2 Small Nuclear,Phosphoproteins,Prognosis,Treatment Outcome,Salvage Therapy,Prospective Studies,Mutation,Tumor Suppressor Protein p53,Leukemia,Lymphocytic,Chronic,B-Cell,Kaplan-Meier Estimate,High-Throughput Nucleotide Sequencing,Ataxia Telangiectasia Mutated Proteins"
immd0282,ocms0037,1,0.1,Journal article,eLife,01/01/2013,Epigenetic conservation at gene regulatory elements revealed by non-methylated DNA profiling in seven vertebrates.,"Long HK,Sims D,Heger A,Blackledge NP,Kutter C,Wright ML,Grützner F,Odom DT,Patient R,Ponting CP,Klose RJ","Chicken,Chromatin,CpG islands,DNA methylation,Epigenetics,Evolutionary conservation,Human,Mouse,Xenopus,Zebrafish,Animals,Base Sequence,Biological Evolution,Chickens,Chromatin Assembly and Disassembly,Conserved Sequence,CpG Islands,DNA Methylation,Databases,Genetic,Epigenesis,Gene Expression Profiling,Humans,Lizards,Mice,Platypus,Promoter Regions,Species Specificity"
clme0670,engs0357,2,0.14285714285714285,Journal article|Journal article,International Journal of Cancer|International Journal of Cancer,15/06/2012|01/01/2013,G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency.|G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency,"Im JH,Tapmeier T,Balathasan L,Gal A,Yameen S,Hill S,Smart S,Noterdaeme O,Kelly M,Brady M,Fu W,Kruse K,Bernhard EJ,Augustin HG,Muschel RJ|Im JH,Tapmeier T,Balathasan L,Gal A,Yameen S,Hill S,Smart S,Noterdaeme O,Kelly M,Brady M,Fu W,Kruse K,Bernhard EJ,Augustin HG,Muschel RJ","Adenocarcinoma,Angiopoietin-2,Animals,Antigens,CD11b,CD31,Capillary Permeability,Cell Line,Tumor,Cell Proliferation,Cytokines,Female,Granulocyte Colony-Stimulating Factor,Green Fluorescent Proteins,Liver,Liver Neoplasms,Mice,Inbred C57BL,Knockout,Neoplasm Transplantation,Neoplasms,Experimental,Neovascularization,Pathologic,Neutrophils,Receptor Protein-Tyrosine Kinases,Receptor,TIE-2,Statistics,Nonparametric,Vascular Endothelial Growth Factor A|"
corp0784,immd0330,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0220,immd0031,4,0.5708333333333333,Journal article|Journal article|Journal article|Journal article,Journal of Biological Chemistry|Frontiers in Oncology|PLoS One|Cancer Cell,21/01/2013|01/01/2014|01/01/2014|17/07/2013,Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.|The notch ligand JAGGED1 as a target for anti-tumor therapy.|Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.|A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.,"Whiteman P,de Madrid BH,Taylor P,Li D,Heslop R,Viticheep N,Tan JZ,Shimizu H,Callaghan J,Masiero M,Li JL,Banham AH,Harris AL,Lea SM,Redfield C,Baron M,Handford PA|Li D,Masiero M,Banham AH,Harris AL|Snell CE,Turley H,McIntyre A,Li D,Masiero M,Schofield CJ,Gatter KC,Harris AL,Pezzella F|Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM","Amino Acid Sequence,Animals,Antibodies,Monoclonal,Blotting,Western,Calcium-Binding Proteins,Cell Line,Tumor,Drosophila Proteins,Flow Cytometry,HEK293 Cells,Humans,Intercellular Signaling Peptides and Proteins,Ligands,Membrane Proteins,Mice,Models,Molecular,Molecular Sequence Data,Mutation,Protein Binding,Protein Structure,Secondary,Tertiary,Receptor,Notch1,Receptors,Notch,Sequence Homology,Amino Acid||Animals,Binding Sites,Breast Neoplasms,Cell Line,Tumor,Female,Gene Expression Regulation,Neoplastic,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,Kaplan-Meier Estimate,MCF-7 Cells,Mice,Inbred BALB C,Neoplasm Transplantation,Neoplasms,Procollagen-Proline Dioxygenase,Prognosis,Proline,Up-Regulation|Animals,Cell Growth Processes,Endothelial Cells,Female,Genetic Predisposition to Disease,HCT116 Cells,Humans,Mice,Nude,Neoplasms,Neovascularization,Pathologic,Receptors,G-Protein-Coupled,Signal Transduction"
bioc0416,olin0014,1,0.08333333333333333,Journal article,Current Biology,26/02/2015,"Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.","Vlahov N,Scrace S,Soto MS,Grawenda AM,Bradley L,Pankova D,Papaspyropoulos A,Yee KS,Buffa F,Goding CR,Timpson P,Sibson N,O'Neill E",
clme0667,raob0095,2,0.18181818181818182,Journal article|Conference paper,"Cell Death and Disease|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",01/01/2012|01/05/2013,Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation,"Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB","Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|"
immd0330,whgu0378,2,0.08060288335517693,Conference paper|Journal article,Annals of Oncology|Nature Genetics,01/06/2012|18/05/2015,CLINICAL DIAGNOSTIC IMPLEMENTATION OF AN INNOVATIVE CANCER CARE MODEL BASED ON COMPREHENSIVE MOLECULAR PROFILING OF TUMOUR-NORMAL PAIRS|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Kaur K,Henderson S,Cutts A,Domingo E,Woods J,Motley C,Dougherty B,Middleton M,Hassan B,Wang Y,Beasley E,Naley M,Schuh A,Tomlinson I,Taylor J|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
claridge,wolf1833,4,0.455988455988456,Journal article|Journal article|Journal article|Journal article,Biochemistry|Nature Communications|Chemical Science|Biochemical Journal,31/03/2014|01/01/2014|01/02/2015|14/08/2014,"Studies on deacetoxycephalosporin C synthase support a consensus mechanism for 2-oxoglutarate dependent oxygenases.|Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases.|Studying the active-site loop movement of the Sao Paolo metallo-β-lactamase-1†Electronic supplementary information (ESI) available: Procedures for protein expression and purification, (19)F-labelling, crystallisation, data collection, and structure determination, table of crystallographic data, table of crystallographic parameters and refinement statistics, figures showing binding mode and distances, procedures for mass spectrometry measurements, differential scanning fluorimetry measurements, stopped-flow measurements and other kinetics measurements. See DOI: 10.1039/c4sc01752hClick here for additional data file.|Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen.","Tarhonskaya H,Szöllössi A,Leung IK,Bush JT,Henry L,Chowdhury R,Iqbal A,Claridge TD,Schofield CJ,Flashman E|Tarhonskaya H,Rydzik AM,Leung IK,Loik ND,Chan MC,Kawamura A,McCullagh JS,Claridge TD,Flashman E,Schofield CJ|Brem J,Struwe WB,Rydzik AM,Tarhonskaya H,Pfeffer I,Flashman E,van Berkel SS,Spencer J,Claridge TD,McDonough MA,Benesch JL,Schofield CJ|Tarhonskaya H,Chowdhury R,Leung IK,Loik ND,McCullagh JS,Claridge TD,Schofield CJ,Flashman E","Ketoglutaric Acids,Intramolecular Transferases,Oxygenases,Penicillin-Binding Proteins,Crystallography,X-Ray,Nuclear Magnetic Resonance,Biomolecular,Kinetics,Catalysis,Mass Spectrometry|Alcohol Oxidoreductases,Ascorbic Acid,Glutarates,Oxygenases,Succinic Acid,gamma-Aminobutyric Acid||Cations,Divalent,Oxygen,Iron,Manganese,Zinc,Water,Ketoglutaric Acids,Isoquinolines,Oligopeptides,Mutagenesis,Site-Directed,Catalytic Domain,Protein Binding,Hydroxylation,Kinetics,Hypoxia-Inducible Factor-Proline Dioxygenases"
claridge,univ1923,6,0.7640040962621608,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Nature Chemical Biology|Angewandte Chemie International Edition|Nature Communications|ChemBioChem: a European journal of chemical biology|Phytochemistry|Biochemical Journal,01/01/2012|07/01/2013|01/01/2014|07/03/2011|18/07/2015|14/08/2014,Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.|Substrate selectivity analyses of factor inhibiting hypoxia-inducible factor.|Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases.|The 2-oxoglutarate-dependent oxygenase JMJD6 catalyses oxidation of lysine residues to give 5S-hydroxylysine residues.|The broad spectrum 2-oxoglutarate oxygenase inhibitor N-oxalylglycine is present in rhubarb and spinach leaves.|Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen.,"Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Yang M,Hardy AP,Chowdhury R,Loik ND,Scotti JS,McCullagh JS,Claridge TD,McDonough MA,Ge W,Schofield CJ|Tarhonskaya H,Rydzik AM,Leung IK,Loik ND,Chan MC,Kawamura A,McCullagh JS,Claridge TD,Flashman E,Schofield CJ|Mantri M,Loik ND,Hamed RB,Claridge TD,McCullagh JS,Schofield CJ|Al-Qahtani K,Jabeen B,Sekirnik R,Riaz N,Claridge TD,Schofield CJ,McCullagh JS|Tarhonskaya H,Chowdhury R,Leung IK,Loik ND,McCullagh JS,Claridge TD,Schofield CJ,Flashman E","Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes|Amino Acid Sequence,Ankyrins,Binding Sites,Biocatalysis,Catalytic Domain,Hydroxylation,Hypoxia-Inducible Factor 1,Magnetic Resonance Spectroscopy,Molecular Sequence Data,Peptides,Spectrometry,Mass,Matrix-Assisted Laser Desorption-Ionization,Substrate Specificity|Alcohol Oxidoreductases,Ascorbic Acid,Glutarates,Oxygenases,Succinic Acid,gamma-Aminobutyric Acid|Animals,Catalysis,Humans,Hydroxylysine,Jumonji Domain-Containing Histone Demethylases,Ketoglutaric Acids,Magnetic Resonance Spectroscopy,Molecular Structure,Oxidation-Reduction,Oxygenases,Stereoisomerism|Humans,Escherichia coli,Brassica,Spinacia oleracea,Rheum,Plant Leaves,Ketoglutaric Acids,Oxygenases,Alanine,Amino Acids,Dicarboxylic,Enzyme Inhibitors,Chromatography,Liquid,Magnetic Resonance Spectroscopy,Tandem Mass Spectrometry,HEK293 Cells|Cations,Divalent,Oxygen,Iron,Manganese,Zinc,Water,Ketoglutaric Acids,Isoquinolines,Oligopeptides,Mutagenesis,Site-Directed,Catalytic Domain,Protein Binding,Hydroxylation,Kinetics,Hypoxia-Inducible Factor-Proline Dioxygenases"
immd0036,stat0004,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0670,raob0087,18,1.8357725607725606,Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,International Journal of Cancer|British Journal of Surgery|Hepatology|Journal of Nuclear Medicine|Journal of Nuclear Medicine|Metallomics: integrated biometal science|Cancer Research|Hepatology|PLoS One|Theranostics|Journal of Nuclear Medicine|Journal of Labelled Compounds and Radiopharmaceuticals|Journal of Clinical Investigation|PLoS One|OncoImmunology|Hepatology|International Journal of Cancer|Proceedings of the National Academy of Sciences of USA,15/06/2012|01/05/2013|18/10/2012|01/12/2014|12/12/2013|13/03/2015|01/10/2014|08/04/2015|01/01/2015|01/01/2015|07/10/2011|01/02/2013|08/10/2012|01/01/2011|01/03/2013|01/01/2013|01/01/2013|20/07/2015,"G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency.|Myeloid cells are recruited by liver metastases and aid their development|Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis.|Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.|A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.|A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.|Accumulation of CD11b+Gr1 myeloid cells in liver metastases stimulates tumor growth and angiogenesis|Cd11b(+) myeloid cells support hepatic metastasis through down-regulation of angiopoietin-like 7 in cancer cells.|Improving In Vivo High-Resolution CT Imaging of the Tumour Vasculature in Xenograft Mouse Models through Reduction of Motion and Bone-Streak Artefacts.|Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates.|Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality.|Imaging of hypoxia using CuATSM|Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.|Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.|Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis.|Recruitment of a myeloid cell subset (CD11b/Gr1mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis|G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency|The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions.","Im JH,Tapmeier T,Balathasan L,Gal A,Yameen S,Hill S,Smart S,Noterdaeme O,Kelly M,Brady M,Fu W,Kruse K,Bernhard EJ,Augustin HG,Muschel RJ|Gordon-Weeks AN,Zhao L,Lim SY,Cao Y,Beech J,Allen D,Smart S,Muschel RJ|Zhao L,Lim SY,Gordon-Weeks AN,Tapmeier TT,Im JH,Cao Y,Beech J,Allen D,Smart S,Muschel RJ|Cornelissen B,Able S,Kartsonaki C,Kersemans V,Allen PD,Cavallo F,Cazier JB,Iezzi M,Knight J,Muschel R,Smart S,Vallis KA|Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ|Hueting R,Kersemans V,Tredwell M,Cornelissen B,Christlieb M,Gee AD,Passchier J,Smart SC,Gouverneur V,Muschel RJ,Dilworth JR|Lim SY,Gordon-Weeks A,Zhao L,Kersemans V,Allen D,Smart S,Muschel RJ|Lim SY,Gordon-Weeks A,Allen D,Kersemans V,Beech J,Smart S,Muschel RJ|Kersemans V,Kannan P,Beech JS,Bates R,Irving B,Gilchrist S,Allen PD,Thompson J,Kinchesh P,Casteleyn C,Schnabel J,Partridge M,Muschel RJ,Smart SC|Melemenidis S,Jefferson A,Ruparelia N,Akhtar AM,Xie J,Allen D,Hamilton A,Larkin JR,Perez-Balderas F,Smart SC,Muschel RJ,Chen X,Sibson NR,Choudhury RP|Kersemans V,Thompson J,Cornelissen B,Woodcock M,Allen PD,Buls N,Muschel RJ,Hill MA,Smart SC|Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ|McKee CM,Xu D,Cao Y,Kabraji S,Allen D,Kersemans V,Beech J,Smart S,Hamdy F,Ishkanian A,Sykes J,Pintile M,Milosevic M,van der Kwast T,Zafarana G,Ramnarine VR,Jurisica I,Mallof C,Lam W,Bristow RG,Muschel RJ|Kersemans V,Cornelissen B,Hueting R,Tredwell M,Hussien K,Allen PD,Falzone N,Hill SA,Dilworth JR,Gouverneur V,Muschel RJ,Smart SC|Lim SY,Gordon-Weeks AN,Zhao L,Tapmeier TT,Im JH,Cao Y,Beech J,Allen D,Smart S,Muschel RJ|Zhao L,Lim SY,Gordon-Weeks AN,Tapmeier TT,Im JH,Cao Y,Beech J,Allen D,Smart S,Muschel RJ|Im JH,Tapmeier T,Balathasan L,Gal A,Yameen S,Hill S,Smart S,Noterdaeme O,Kelly M,Brady M,Fu W,Kruse K,Bernhard EJ,Augustin HG,Muschel RJ|Tapmeier TT,Moshnikova A,Beech J,Allen D,Kinchesh P,Smart S,Harris A,McIntyre A,Engelman DM,Andreev OA,Reshetnyak YK,Muschel RJ","Adenocarcinoma,Angiopoietin-2,Animals,Antigens,CD11b,CD31,Capillary Permeability,Cell Line,Tumor,Cell Proliferation,Cytokines,Female,Granulocyte Colony-Stimulating Factor,Green Fluorescent Proteins,Liver,Liver Neoplasms,Mice,Inbred C57BL,Knockout,Neoplasm Transplantation,Neoplasms,Experimental,Neovascularization,Pathologic,Neutrophils,Receptor Protein-Tyrosine Kinases,Receptor,TIE-2,Statistics,Nonparametric,Vascular Endothelial Growth Factor A||Animals,Antigens,CD11b,Chemokine CCL2,Colorectal Neoplasms,Humans,Liver Neoplasms,Mice,Models,Animal,Myeloid Cells,Neoplasm Transplantation,Receptors,CCR2|Animals,Mice,Inbred BALB C,Mammary Neoplasms,Experimental,Precancerous Conditions,DNA Damage,Disease Progression,Immunoconjugates,Radiopharmaceuticals,Tomography,Emission-Computed,Single-Photon,Magnetic Resonance Imaging,Tissue Distribution,Image Processing,Computer-Assisted,Female|64Cu-ATSM,64Cu-acetate,copper metabolism,hypoxia,Acetates,Animals,Anoxia,Cell Line,Tumor,Copper,Copper Radioisotopes,Female,Humans,Immunohistochemistry,Mice,Inbred CBA,Neoplasm Transplantation,Organometallic Compounds,Oxygen,Positron-Emission Tomography,Prognosis,Thiosemicarbazones,Time Factors|Cell Line,Animals,Humans,Mice,Neoplasms,Anoxia,Copper Radioisotopes,Organometallic Compounds,Thiosemicarbazones,Positron-Emission Tomography,Tomography,Emission-Computed,Single-Photon,Tissue Distribution,Female||Myeloid Progenitor Cells,Tumor Cells,Cultured,Myeloid Cells,Animals,Mice,Inbred C57BL,Humans,Colorectal Neoplasms,Liver Neoplasms,Neovascularization,Pathologic,Angiopoietins,Antigens,CD11b,Culture Media,Conditioned,Cell Movement,Down-Regulation,Female|Animals,Mice,Inbred CBA,Neoplasms,Adenocarcinoma,Disease Models,Animal,Tomography,X-Ray Computed,Magnetic Resonance Imaging,Fluoroscopy,Transplantation,Heterologous,Artifacts,Image Processing,Computer-Assisted,Female|Cells,Cultured,Endothelial Cells,Animals,Mice,Inbred C57BL,Humans,Neoplasms,Neovascularization,Pathologic,Ferric Compounds,Oligopeptides,Magnetic Resonance Imaging,Microspheres,Protein Binding,Female|Animals,DNA Breaks,Double-Stranded,Histones,Jejunum,Liver,Mice,Positron-Emission Tomography,Quality Control,Radiation Dosage,Radiation Injuries,Experimental,Reference Standards,Time Factors,Tomography,Emission-Computed,Single-Photon,X-Ray Microtomography||Adenocarcinoma,Animals,Cell Line,Tumor,Gene Expression Regulation,Neoplastic,Hedgehog Proteins,Humans,Male,Mice,Knockout,Neoplasm Proteins,Neoplasm Transplantation,Neovascularization,Pathologic,Prostatic Neoplasms,Serpin E2,Signal Transduction,Transplantation,Heterologous|Adenocarcinoma,Anesthesia,Animals,Anoxia,Copper Radioisotopes,Female,Fluorine Radioisotopes,Gases,Mice,Inbred CBA,Misonidazole,Muscles,Neoplasms,Experimental,Organometallic Compounds,Organotechnetium Compounds,Oxygen,Positron-Emission Tomography,Radiation-Sensitizing Agents,Radiopharmaceuticals,Thiosemicarbazones,Tissue Distribution,Tomography,Emission-Computed,Single-Photon|CCL2,colon cancer,liver metastasis,myeloid cell recruitment|||Cell Line,Tumor,Spheroids,Cellular,Animals,Mice,Inbred BALB C,Humans,Neoplasms,Neoplasm Invasiveness,Disease Models,Animal,Acids,Membrane Proteins,Magnetic Resonance Spectroscopy,Sensitivity and Specificity,ROC Curve,Amino Acid Sequence,Hydrogen-Ion Concentration,Molecular Sequence Data,Mutant Proteins,Biomarkers"
clme0195,clme0494,1,0.07142857142857142,Journal article,Haematologica: the hematology journal,28/05/2013,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary"
raob0072,wolf1917,1,0.1111111111111111,Journal article,International Journal of Cancer,15/03/2014,XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection,"Hatch SB,Swift LP,Caporali S,Carter R,Hill EJ,Macgregor TP,D'Atri S,Middleton MR,McHugh PJ,Sharma RA",
immd0036,immd0198,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0845,gree1192,5,0.6646825396825398,Journal article|Journal article|Journal article|Journal article|Journal article,Growth Hormone and IGF Research|British Journal of Cancer|Growth Hormone and IGF Research|Scandinavian Journal of Work Environment and Health|Gut,15/01/2015|27/03/2014|01/01/2015|09/07/2012|02/01/2014,"The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women.|Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom.|The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women|Characteristics of the Million Women Study participants who have and have not worked at night.|Source of dietary fibre and diverticular disease incidence: a prospective study of UK women.","Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Bradbury KE,Balkwill A,Spencer EA,Roddam AW,Reeves GK,Green J,Key TJ,Beral V,Pirie K|Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Wang XS,Travis RC,Reeves G,Green J,Allen NE,Key TJ,Roddam AW,Beral V|Crowe FL,Balkwill A,Cairns BJ,Appleby PN,Green J,Reeves GK,Key TJ,Beral V,Million Women Study Collaborators,Million Women Study Collaborators","Million Women Study Collaborators,Humans,Birth Weight,Insulin-Like Growth Factor I,Body Weights and Measures,Postnatal Care,Diet,Risk Factors,Cohort Studies,Life Style,Breast Feeding,Postmenopause,Aged,Middle Aged,Great Britain,Female,Surveys and Questionnaires|Million Women Study Collaborators,Humans,Neoplasms,Lymphoma,Non-Hodgkin,Sarcoma,Breast Neoplasms,Incidence,Prospective Studies,Middle Aged,Great Britain,Female,Self Report,Food,Organic||Anthropometry,Female,Great Britain,Humans,Life Style,Middle Aged,Prospective Studies,Work Schedule Tolerance|diet,dietary fibre,diverticular disease,prospective,Aged,Diet Surveys,Dietary Fiber,Diverticulitis,Diverticulum,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Intestinal Diseases,Middle Aged,Prospective Studies,Risk,Surveys and Questionnaires"
card0018,immd0106,7,0.6031746031746031,Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article,Sexually Transmitted Infections|Circulation|HIV Medicine|Circulation: Cardiovascular Imaging|European Heart Journal|Journal of Cardiovascular Magnetic Resonance|Circulation,01/07/2013|01/07/2013|01/04/2012|01/03/2016|01/08/2012|16/08/2014|20/08/2013,"HIV IS AN INDEPENDENT PREDICTOR OF AORTIC PULSE WAVE VELOCITY|Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients.|Comprehensive Cardiac Magnetic Resonance Reveals HIV is Associated with High Burden of Myocardial Disease|HIV-1-Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema.|Infection with human immunodeficiency virus is an independent predictor of increased aortic stiffness|HIV is an independent predictor of aortic stiffness.|Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients","Wainwright EC,Rider OJ,Asaad M,Ntusi N,Hancock G,Pitcher A,Clarke K,Dorrell L,Neubauer S,Holloway C|Holloway CJ,Ntusi N,Suttie J,Mahmod M,Wainwright E,Clutton G,Hancock G,Beak P,Tajar A,Piechnik SK,Schneider JE,Angus B,Clarke K,Dorrell L,Neubauer S|Holloway C,Ntusi N,Suttie J,Mahmod M,Clutton G,Hancock G,Wainwright E,Angus B,Asaad M,Beak P,Clarke K,Neubauer S,Dorrell L|Ntusi N,O'Dwyer E,Dorrell L,Wainwright E,Piechnik S,Clutton G,Hancock G,Ferreira V,Cox P,Badri M,Karamitsos T,Emmanuel S,Clarke K,Neubauer S,Holloway C|Asaad M,Rider OJ,Ntusi N,Wainwright E,Pitcher A,Suttie J,Clarke K,Dorrell L,Neubauer S,Holloway C|Rider OJ,Asaad M,Ntusi N,Wainwright E,Clutton G,Hancock G,Banerjee R,Pitcher A,Samaras K,Clarke K,Neubauer S,Dorrell L,Holloway CJ|Holloway CJ,Ntusi N,Suttie J,Mahmod M,Wainwright E,Clutton G,Hancock G,Beak P,Tajar A,Piechnik SK,Schneider JE,Angus B,Clarke K,Dorrell L,Neubauer S","|HIV-1,fibrosis,heart function tests,imaging,diagnostic,myocardial fibrosis,Adult,Anti-Retroviral Agents,Cardiomyopathies,Case-Control Studies,Cross-Sectional Studies,Female,Fibrosis,HIV Infections,Heart,Humans,Lipid Metabolism,Magnetic Resonance Imaging,Magnetic Resonance Spectroscopy,Male,Middle Aged,Myocardium,Prevalence||||Humans,HIV-1,HIV Infections,Cardiovascular Diseases,Metabolic Syndrome X,Magnetic Resonance Imaging,Cine,Antiretroviral Therapy,Highly Active,Multivariate Analysis,Risk Factors,Case-Control Studies,Predictive Value of Tests,Age Factors,Blood Pressure,Adult,Middle Aged,Vascular Stiffness,Pulse Wave Analysis|"
corp0784,immd0237,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0485,whgu0172,1,0.08333333333333333,Journal article,Proceedings of the National Academy of Sciences of USA,20/04/2011,Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming.,"Kochan G,Krojer T,Harvey D,Fischer R,Chen L,Vollmar M,von Delft F,Kavanagh KL,Brown MA,Bowness P,Wordsworth P,Kessler BM,Oppermann U","Amino Acid Sequence,Amino Acid Substitution,Aminopeptidases,Antigen Presentation,Catalytic Domain,Crystallography,X-Ray,HLA-B27 Antigen,Humans,Models,Molecular,Mutagenesis,Site-Directed,Polymorphism,Single Nucleotide,Protein Conformation,Protein Processing,Post-Translational,Protein Structure,Tertiary,Recombinant Proteins,Spondylitis,Ankylosing"
immd0082,immd0198,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0075,ocms0037,2,0.26666666666666666,Journal article|Journal article,Mammalian Genome|Genome Biology: biology for the post-genomic era,27/04/2012|29/11/2013,Nprl3 is required for normal development of the cardiovascular system.|Chromatin signatures at transcriptional start sites separate two equally populated yet distinct classes of intergenic long noncoding RNAs.,"Kowalczyk MS,Hughes JR,Babbs C,Sanchez-Pulido L,Szumska D,Sharpe JA,Sloane-Stanley JA,Morriss-Kay GM,Smoot LB,Roberts AE,Watkins H,Bhattacharya S,Gibbons RJ,Ponting CP,Wood WG,Higgs DR|Marques AC,Hughes J,Graham B,Kowalczyk MS,Higgs DR,Ponting CP","Abnormalities,Multiple,Amino Acid Sequence,Animals,Cardiovascular System,Cells,Cultured,DNA Mutational Analysis,Female,GTPase-Activating Proteins,Gene Expression Profiling,Genetic Association Studies,Heart Defects,Congenital,Humans,Intracellular Signaling Peptides and Proteins,Male,Mice,Knockout,Molecular Sequence Annotation,Molecular Sequence Data,Myocardium,Nuclear Proteins,Phenotype,Polymorphism,Single Nucleotide,Promoter Regions,Genetic|Chromatin,Animals,Mice,Inbred C57BL,Histones,RNA,Messenger,Sequence Analysis,DNA,Evolution,Molecular,Gene Expression Regulation,Protein Structure,Tertiary,Transcription Initiation Site,Promoter Regions,Genetic,Genetic Loci,Transcriptome,Long Noncoding"
trin1371,univ0247,1,0.25,Journal article,Nucleic Acids Research,16/05/2012,Dynamic acetylation of lysine-4-trimethylated histone H3 and H3 variant biology in a simple multicellular eukaryote.,"Hsu DW,Chubb JR,Muramoto T,Pears CJ,Mahadevan LC","Acetylation,Amino Acid Substitution,Dictyostelium,Gene Deletion,Gene Expression,Histone-Lysine N-Methyltransferase,Histones,Hydroxamic Acids,Lysine,Methylation"
bioc0212,whgu0274,2,0.058823529411764705,Journal article|Journal article,Cell Metabolism|Cell Metabolism,01/01/2012|07/03/2012,Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway|Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.,"Ashrafian H,Czibik G,Bellahcene M,Aksentijević D,Smith AC,Mitchell SJ,Dodd MS,Kirwan J,Byrne JJ,Ludwig C,Isackson H,Yavari A,Støttrup NB,Contractor H,Cahill TJ,Sahgal N,Ball DR,Birkler RID,Hargreaves I,Tennant DA,Land J,Lygate CA,Johannsen M,Kharbanda RK,Neubauer S,Redwood C,De Cabo R,Ahmet I,Talan M,Günther UL,Robinson AJ,Viant MR,Pollard PJ,Tyler DJ,Watkins H|Ashrafian H,Czibik G,Bellahcene M,Aksentijević D,Smith AC,Mitchell SJ,Dodd MS,Kirwan J,Byrne JJ,Ludwig C,Isackson H,Yavari A,Støttrup NB,Contractor H,Cahill TJ,Sahgal N,Ball DR,Birkler RI,Hargreaves I,Tennant DA,Land J,Lygate CA,Johannsen M,Kharbanda RK,Neubauer S,Redwood C,de Cabo R,Ahmet I,Talan M,Günther UL,Robinson AJ,Viant MR,Pollard PJ,Tyler DJ,Watkins H","|Animals,Antioxidants,Dimethyl Fumarate,Fumarate Hydratase,Fumarates,Male,Mice,Inbred C57BL,Knockout,Models,Biological,Myocardial Infarction,NF-E2-Related Factor 2,Signal Transduction"
gree0184,gree1192,1,0.125,Journal article,British Journal of Cancer,27/03/2014,Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom.,"Bradbury KE,Balkwill A,Spencer EA,Roddam AW,Reeves GK,Green J,Key TJ,Beral V,Pirie K","Million Women Study Collaborators,Humans,Neoplasms,Lymphoma,Non-Hodgkin,Sarcoma,Breast Neoplasms,Incidence,Prospective Studies,Middle Aged,Great Britain,Female,Self Report,Food,Organic"
clme0494,cschof,5,0.6861111111111111,Journal article|Journal article|Journal article|Journal article|Journal article,Antimicrobial Agents and Chemotherapy|Genes and Development|Chemical Communications|Nucleic Acids Research|Journal of Biological Chemistry,19/10/2015|01/01/2011|01/01/2016|17/11/2015|11/06/2012,Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.|Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair|Cephalosporins inhibit human metallo β-lactamase fold DNA repair nucleases SNM1A and SNM1B/apollo.|The structures of the SNM1A and SNM1B/Apollo nuclease domains reveal a potential basis for their distinct DNA processing activities.|Characterization of the human SNM1A and SNM1B/Apollo DNA repair exonucleases.,"Brem J,van Berkel SS,Zollman D,Lee SY,Gileadi O,McHugh PJ,Walsh TR,McDonough MA,Schofield CJ|Wang AT,Sengerová B,Cattell E,Inagawa T,Hartley JM,Kiakos K,Burgess-Brown NA,Swift LP,Enzlin JH,Schofield CJ,Gileadi O,Hartley JA,McHugh PJ|Lee SY,Brem J,Pettinati I,Claridge TD,Gileadi O,Schofield CJ,McHugh PJ|Allerston CK,Lee SY,Newman JA,Schofield CJ,McHugh PJ,Gileadi O|Sengerová B,Allerston CK,Abu M,Lee SY,Hartley J,Kiakos K,Schofield CJ,Hartley JA,Gileadi O,McHugh PJ","|||Humans,DNA Damage,DNA Repair Enzymes,Exodeoxyribonucleases,Nuclear Proteins,DNA,Catalytic Domain,Protein Structure,Tertiary,Protein Binding,Models,Molecular|Chelating Agents,DNA,DNA Cleavage,DNA Damage,DNA Repair Enzymes,Single-Stranded,DNA-Binding Proteins,Enzyme Assays,Enzyme Inhibitors,Escherichia coli,Fluorescein,Fluorescent Dyes,Humans,Hydrogen-Ion Concentration,Hydrolysis,Magnesium,Nuclear Proteins,Plasmids,Protein Binding,RNA,Recombinant Proteins,Substrate Specificity"
robbins,whgu0256,2,0.25396825396825395,Journal article|Journal article,Blood|Blood,15/01/2016|30/11/2011,Suppression of plasma hepcidin by venesection during steady-state hypoxia.|Regulation of hepcidin expression at high altitude.,"Talbot NP,Smith TG,Lakhal-Littleton S,Gülsever C,Rivera-Ch M,Dorrington KL,Mole DR,Robbins PA|Talbot NP,Lakhal S,Smith TG,Privat C,Nickol AH,Rivera-Ch M,León-Velarde F,Dorrington KL,Mole DR,Robbins PA","|Adult,Altitude,Anoxia,Antimicrobial Cationic Peptides,Case-Control Studies,Erythropoiesis,Erythropoietin,Ferritins,Gene Expression Regulation,Growth Differentiation Factor 15,Hepcidins,Homeostasis,Humans,Iron,Iron Metabolism Disorders,Dietary,Transferrin,beta-Thalassemia"
bioc0416,donc0136,1,0.06666666666666667,Journal article,The EMBO Journal,27/05/2016,SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development.,"Raducu M,Fung E,Serres S,Infante P,Barberis A,Fischer R,Bristow C,Thézénas ML,Finta C,Christianson JC,Buffa FM,Kessler BM,Sibson NR,Di Marcotullio L,Toftgård R,D'Angiolella V",
raob0072,raob0231,1,0.07142857142857142,Journal article,Clinical Oncology,11/03/2013,Oesophageal Chemoradiotherapy in the UK--current practice and future directions.,"Gwynne S,Falk S,Gollins S,Wills L,Bateman A,Cummins S,Grabsch H,Hawkins MA,Maggs R,Mukherjee S,Radhakrishna G,Roy R,Sharma RA,Spezi E,Crosby T","Chemoradiotherapy,Clinical Trials,Phase II as Topic,Esophageal Neoplasms,Great Britain,Humans,Neoadjuvant Therapy,Randomized Controlled Trials as Topic"
clme0975,raob0047,1,0.08333333333333333,Journal article,Clinical Cancer Research,10/01/2012,Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors.,"Patterson DM,Zweifel M,Middleton MR,Price PM,Folkes LK,Stratford MR,Ross P,Halford S,Peters J,Balkissoon J,Chaplin DJ,Padhani AR,Rustin GJ","Adult,Aged,Angiogenesis Inhibitors,Antineoplastic Agents,Diphosphates,Female,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Neoplasms,Stilbenes,Treatment Outcome,Young Adult"
clab0127,raob0121,2,0.13574660633484165,Conference paper|Journal article,Cancer Research|Cancer Cell,01/01/2016|,WEE1 inhibition selectively kills histone H3K36me3-deficient cancers by dNTP starvation|Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.,"Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Zalmas L-P,Orlando G,Drobnitzky N,Dianov G,Ying S,La Thangue NB,D'Angiolella V,Ryan A,Humphrey TC|Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Orlando G,Mavrommati I,Pai CC,Zalmas LP,Drobnitzky N,Dianov GL,Verrill C,Macaulay VM,Ying S,La Thangue NB,D'Angiolella V,Ryan AJ,Humphrey TC","|Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Neoplasms,Pyrazoles,Pyrimidines,Ribonucleoside Diphosphate Reductase,Histone-Lysine N-Methyltransferase,Nucleotides,Lysine,Cell Cycle Proteins,Nuclear Proteins,Histones,Blotting,Western,Xenograft Model Antitumor Assays,Reverse Transcriptase Polymerase Chain Reaction,Cell Survival,Gene Expression Regulation,Neoplastic,RNA Interference,Amino Acid Sequence,Base Sequence,Sequence Homology,Amino Acid,Nucleic Acid,Methylation,Molecular Sequence Data,Protein-Tyrosine Kinases"
clab0247,whgu0210,1,0.14285714285714285,Journal article,Scientific Reports,01/01/2014,Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex.,"Sewell H,Tanaka T,El Omari K,Mancini EJ,Cruz A,Fernandez-Fuentes N,Chambers J,Rabbitts TH","Adaptor Proteins,Signal Transducing,Crystallization,Crystallography,X-Ray,LIM Domain Proteins,Models,Molecular,Mutation,Protein Binding,Protein Conformation,Proto-Oncogene Proteins,Transcription,Genetic"
donc0120,raob0072,5,0.30659983291562243,Conference paper|Journal article|Journal article|Journal article|Journal article,Journal of Clinical Oncology|Clinical Oncology|BMC Cancer|Clinical Oncology|BMC Cancer,20/05/2014|01/06/2013|01/01/2015|11/03/2013|12/02/2015,NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer.|Oesophageal Chemoradiotherapy in the UK-Current Practice and Future Directions|NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.|Oesophageal Chemoradiotherapy in the UK--current practice and future directions.|NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.,"Crosby T,Mukherjee S,Hurt C,Gwynne S,Gollins S,Batrman AR,Lewis WG,Radhakrishna G,Hawkins M,Grabsch HI,Ray R,Sharma RA,Wade W,Maggs R,Tranter B,Roberts A,Hadlow S,Sebag-Montefiore D,Maughan T,Griffiths G|Gwynne S,Falk S,Gollins S,Wills L,Bateman A,Cummins S,Grabsch H,Hawkins MA,Maggs R,Mukherjee S,Radhakrishna G,Roy R,Sharma RA,Spezi E,Crosby T|Mukherjee S,Hurt CN,Gwynne S,Bateman A,Gollins S,Radhakrishna G,Hawkins M,Canham J,Lewis W,Grabsch HI,Sharma RA,Wade W,Maggs R,Tranter B,Roberts A,Sebag-Montefiore D,Maughan T,Griffiths G,Crosby T|Gwynne S,Falk S,Gollins S,Wills L,Bateman A,Cummins S,Grabsch H,Hawkins MA,Maggs R,Mukherjee S,Radhakrishna G,Roy R,Sharma RA,Spezi E,Crosby T|Mukherjee S,Hurt CN,Gwynne S,Bateman A,Gollins S,Radhakrishna G,Hawkins M,Canham J,Lewis W,Grabsch HI,Sharma RA,Wade W,Maggs R,Tranter B,Roberts A,Sebag-Montefiore D,Maughan T,Griffiths G,Crosby T","||Humans,Adenocarcinoma,Esophageal Neoplasms,Antineoplastic Combined Chemotherapy Protocols,Clinical Protocols,Combined Modality Therapy,Preoperative Care,Chemoradiotherapy|Chemoradiotherapy,Clinical Trials,Phase II as Topic,Esophageal Neoplasms,Great Britain,Humans,Neoadjuvant Therapy,Randomized Controlled Trials as Topic|"
immd0237,ocms0064,1,0.047619047619047616,Journal article,Molecular Cell,30/01/2014,Optimal translational termination requires C4 lysyl hydroxylation of eRF1.,"Yamamoto A,Feng T,Wilkins S,Sokolova E,Yates L,Muenzel M,Singh P,Hopkinson R,Fischer R,Cockman M,Shelley J,Trudgian D,Schoedel J,McCullagh JO,Ge W,Kessler B,Gilbert R,Frolova L,Alkalaeva E,Ratcliffe P,Schofield C,Coleman M","Amino Acid Sequence,Animals,Catalysis,Cell Line,Tumor,Codon,Terminator,Gene Expression Regulation,HeLa Cells,Histone Demethylases,Humans,Hydrolysis,Hydroxylation,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Peptide Chain Termination,Translational,Peptide Termination Factors,Protein Biosynthesis,Protein Processing,Post-Translational,Protein Structure,Tertiary,Sequence Homology,Amino Acid"
corp0784,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0024,path0511,10,1.4379780280906687,Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper,Cancer Cell|Cell Stem Cell|Cancer Cell|British Journal of Haematology|Cancer Cell|Cell Reports|Blood|Proceedings of the National Academy of Sciences of USA|Epigenetics and Chromatin|Blood,14/05/2014|04/03/2011|18/01/2011|01/04/2012|16/06/2014|27/03/2013|27/03/2013|08/10/2012|01/01/2011|18/11/2011,"Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.|Clever leukemic stem cells branch out.|Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.|Germline activating JAK2-mutation in a family with hereditary thrombocytosis|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.|Impact of isolated germline JAK2V617I mutation on human hematopoiesis.|Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21.|Generation of bivalent chromatin domains during cell fate decisions.|Germline Activating JAK2 V617I Mutation, in a Family with Hereditary Thrombocytosis","Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SE|Vyas P,Jacobsen SE|Goardon N,Marchi E,Atzberger A,Quek L,Schuh A,Soneji S,Woll P,Mead A,Alford KA,Rout R,Chaudhury S,Gilkes A,Knapper S,Beldjord K,Begum S,Rose S,Geddes N,Griffiths M,Standen G,Sternberg A,Cavenagh J,Hunter H,Bowen D,Killick S,Robinson L,Price A,Macintyre E,Virgo P,Burnett A,Craddock C,Enver T,Jacobsen SE,Porcher C,Vyas P|Mead A,Rugless M,Woll P,Clifford R,Chowdhury O,Dusa A,Pecquet C,Atkinson D,Gatter K,Moule S,Bienz N,Wainscoat J,Vyas P,Gale R,Henderson S,Constantinescu S,Jacobsen S,Schuh A|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Mead AJ,Kharazi S,Atkinson D,Macaulay I,Pecquet C,Loughran S,Lutteropp M,Woll P,Chowdhury O,Luc S,Buza-Vidas N,Ferry H,Clark SA,Goardon N,Vyas P,Constantinescu SN,Sitnicka E,Nerlov C,Jacobsen SE|Mead AJ,Chowdhury O,Pecquet C,Dusa A,Woll P,Atkinson D,Burns A,Score J,Rugless M,Clifford R,Moule S,Bienz N,Vyas P,Cross N,Gale RE,Henderson S,Constantinescu SN,Schuh A,Jacobsen SE|Roy A,Cowan G,Mead AJ,Filippi S,Bohn G,Chaidos A,Tunstall O,Chan JK,Choolani M,Bennett P,Kumar S,Atkinson D,Wyatt-Ashmead J,Hu M,Stumpf MP,Goudevenou K,O'Connor D,Chou ST,Weiss MJ,Karadimitris A,Jacobsen SE,Vyas P,Roberts I|De Gobbi M,Garrick D,Lynch M,Vernimmen D,Hughes JR,Goardon N,Luc S,Lower KM,Sloane-Stanley JA,Pina C,Soneji S,Renella R,Enver T,Taylor S,Jacobsen SE,Vyas P,Gibbons RJ,Higgs DR|Mead AJ,Rugless M,Woll P,Clifford R,Atkinson D,Moule S,Bienz N,Wainscoat JS,Vyas P,Henderson S,Jacobsen SEW,Schuh A","Chromosomes,Human,Pair 5,Animals,Mice,Inbred NOD,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Genetic Predisposition to Disease,Antigens,CD,Prognosis,Flow Cytometry,Gene Expression Profiling,Mutation,Neoplastic Stem Cells,Heterografts||Adult,Aged,80 and over,Animals,Antigens,CD,CD34,CD45,Cell Differentiation,Cell Lineage,Gene Expression Profiling,Graft Survival,Granulocyte-Macrophage Progenitor Cells,Hematopoietic Stem Cells,Humans,Immunophenotyping,Leukemia,Myeloid,Acute,Lymphoid Progenitor Cells,Mice,Inbred NOD,SCID,Middle Aged,Neoplastic Stem Cells,Transplantation,Heterologous,Young Adult|||Animals,Cell Differentiation,Cell Transformation,Neoplastic,Disease Models,Animal,Flow Cytometry,Gene Expression,Humans,Leukemia,Myeloid,Acute,Mice,Microarray Analysis,Multipotent Stem Cells,Myeloid Cells,Signal Transduction,fms-Like Tyrosine Kinase 3|Adult,Amino Acid Substitution,Animals,Cells,Cultured,Family,Female,Germ-Line Mutation,Hematopoiesis,Humans,Isoleucine,Janus Kinase 2,Male,Mice,Inbred NOD,Transgenic,Middle Aged,Myeloproliferative Disorders,Valine|Cell Differentiation,Cell Lineage,Down Syndrome,Flow Cytometry,Gene Expression Profiling,Hematopoietic Stem Cells,Humans,Liver||"
donc0114,raob0005,1,0.06666666666666667,Journal article,Molecular Cell,29/12/2015,Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds.,"Zimmer J,Tacconi EM,Folio C,Badie S,Porru M,Klare K,Tumiati M,Markkanen E,Halder S,Ryan A,Jackson SP,Ramadan K,Kuznetsov SG,Biroccio A,Sale JE,Tarsounas M",
card0039,whgu0172,1,0.07692307692307693,Journal article,Circulation,26/11/2013,Integrated Plaque and Plasma Proteo-Lipidomics Reveal Novel Signatures of Coronary Atherosclerotic Plaque Disruption,"Lee R,Adlam D,Fischer R,Di Gleria K,Valli A,Charles P,McGouran J,Ruparelia N,Dawkins S,Kharbanda RK,Choudhury RP,Antoniades C,Kessler BM,Channon KM","Plaque rupture,Proteomics,Lipids,Extracellular matrix"
immd0036,whgu0378,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
bioc0801,clme1358,2,0.06559139784946236,Journal article|Journal article,Chemical Science|Journal of Medicinal Chemistry,01/08/2013|25/06/2012,5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation|Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.,"Hopkinson RJ,Tumber A,Yapp C,Chowdhury R,Aik W,Che KH,Li XS,Kristensen JBL,King ONF,Chan MC,Yeoh KK,Choi H,Walport LJ,Thinnes CC,Bush JT,Lejeune C,Rydzik AM,Rose NR,Bagg EA,McDonough MA,Krojer TJ,Yue WW,Ng SS,Olsen L,Brennan PE,Oppermann U,Müller S,Klose RJ,Ratcliffe PJ,Schofield CJ,Kawamura A|Rose NR,Woon EC,Tumber A,Walport LJ,Chowdhury R,Li XS,King ON,Lejeune C,Ng SS,Krojer T,Chan MC,Rydzik AM,Hopkinson RJ,Che KH,Daniel M,Strain-Damerell C,Gileadi C,Kochan G,Leung IK,Dunford J,Yeoh KK,Ratcliffe PJ,Burgess-Brown N,von Delft F,Muller S,Marsden B,Brennan PE,McDonough MA,Oppermann U,Klose RJ,Schofield CJ,Kawamura A","|Enzyme Inhibitors,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Plant Growth Regulators,Protein Conformation,Substrate Specificity,Succinates"
bioc0541,raob0096,1,0.16666666666666666,Conference paper,Clinical and Experimental Metastasis,01/03/2015,Cellular adhesion molecules and brain metastasis; how friends become foes,"Soto MS,O'Brien E,Serres S,Anthony DC,O'Neill E,Scrace S,Sibson N",
clme0670,ndos0532,1,0.07142857142857142,Journal article,Oncotarget,19/12/2015,Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.,"Verrill C,Cerundolo L,Mckee C,White M,Kartsonaki C,Fryer E,Morris E,Brewster S,Ratnayaka I,Marsden L,Lilja H,Muschel R,Lu X,Hamdy F,Bryant RJ",
clme0220,whgu0256,7,0.7447552447552448,Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article,British Journal of Cancer|European Journal of Cancer|Oncogene|Oncogene|EMBO Reports|Cancer Research|Molecular Cancer,28/02/2013|01/07/2014|20/08/2015|24/11/2014|21/12/2013|01/05/2015|01/01/2014,"miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.|Proffered Paper: Hypoxic regulation of the long non-coding transcriptome in breast cancer|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival.|Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2.|The non-coding transcriptome of hypoxic breast cancer: Novel insights of clinical relevant long non-coding RNA in hypoxia signalling|Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia.","McCormick RI,Blick C,Ragoussis J,Schoedel J,Mole DR,Young AC,Selby PJ,Banks RE,Harris AL|Choudhry H,Albukhari A,Schodel J,Oikonomopoulos S,Haider S,Ratcliffe P,Ragousis I,Mole D,Harris A|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR|Choudhry H,Schödel J,Oikonomopoulos S,Camps C,Grampp S,Harris AL,Ratcliffe PJ,Ragoussis J,Mole DR|Choudhry H,Schodel J,Albukhari A,Haider S,Buffa F,Ratcliffe PJ,Mole DR,Ragousis I,Harris AL|Camps C,Saini HK,Mole DR,Choudhry H,Reczko M,Guerra-Assunção JA,Tian YM,Buffa FM,Harris AL,Hatzigeorgiou AG,Enright AJ,Ragoussis J","Adult,Aged,80 and over,Basic Helix-Loop-Helix Transcription Factors,Carcinoma,Renal Cell,Cell Line,Tumor,Female,Gene Expression Regulation,Neoplastic,Humans,Hypoxia-Inducible Factor 1,Iron-Sulfur Proteins,Kidney Neoplasms,Male,MicroRNAs,Middle Aged,Mutation,Prognosis,Up-Regulation,Von Hippel-Lindau Tumor Suppressor Protein|||Animals,Humans,Mice,Breast Neoplasms,Cell Adhesion Molecules,Receptors,Cell Surface,Apoptosis,Cell Proliferation,Cell Hypoxia,Cell Survival,Female,Basic Helix-Loop-Helix Transcription Factors,Transcriptional Activation,RNA,Long Noncoding|Basic Helix-Loop-Helix Transcription Factors,Cell Hypoxia,Gene Expression Regulation,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,MCF-7 Cells,Promoter Regions,Genetic,Protein Binding,RNA Polymerase II,RNA,Messenger,Untranslated,Transcription,Transcriptome||Breast Neoplasms,Cell Hypoxia,Gene Expression Regulation,Neoplastic,Humans,Hypoxia-Inducible Factor 1,MCF-7 Cells,MicroRNAs,Oligonucleotide Array Sequence Analysis,Protein Binding,RNA,Messenger,Real-Time Polymerase Chain Reaction,Transcriptome"
immd0151,lina0435,1,0.03225806451612903,Journal article,PLoS Genetics,01/12/2012,Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development.,"Lise S,Clarkson Y,Perkins E,Kwasniewska A,Sadighi Akha E,Schnekenberg RP,Suminaite D,Hope J,Baker I,Gregory L,Green A,Allan C,Lamble S,Jayawant S,Quaghebeur G,Cader MZ,Hughes S,Armstrong RJ,Kanapin A,Rimmer A,Lunter G,Mathieson I,Cazier JB,Buck D,Taylor JC,Bentley D,McVean G,Donnelly P,Knight SJ,Jackson M,Ragoussis J,Németh AH","Adult,Animals,Cerebellum,Chromosome Mapping,Cognition Disorders,Humans,Mice,Knockout,Mutation,Neurons,Purkinje Cells,Spectrin,Spinocerebellar Ataxias"
corp0784,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0082,stat0054,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
card0008,whgu0210,1,0.2,Journal article,"Proteins: Structure, Function, and Bioinformatics",01/01/2012,"Structure of the DNA-bound T-box domain of human TBX1, a transcription factor associated with the DiGeorge syndrome","El Omari K,de Mesmaeker J,Karia D,Ginn H,Bhattacharya S,Mancini EJ",
clab0127,clme0975,1,0.1,Journal article,Cell Death and Differentiation,24/05/2013,A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.,"New M,Olzscha H,Liu G,Khan O,Stimson L,McGouran J,Kerr D,Coutts A,Kessler B,Middleton M,La Thangue NB","Apoptosis,Autophagy,Biomarkers,Tumor,Cell Line,DNA Repair Enzymes,DNA-Binding Proteins,Gene Expression Regulation,Neoplastic,Histone Deacetylase Inhibitors,Histone Deacetylases,Humans,RNA,Small Interfering,Transfection,Ubiquitin"
corp0784,whgu0378,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
kenn0163,path0089,1,0.125,Journal article,Journal of Allergy and Clinical Immunology,,Immune dysregulation in patients with PTEN hamartoma tumor syndrome – analysis of FOXP3 regulatory T cells,"Chen H,Hegazy A,Uhlig H,Travis S,Dustin M,Powrie F,Keith J,Walker L,Hegazy A",
clme0219,immd0100,2,0.3333333333333333,Journal article|Journal article,Journal of Immunological Methods|Journal of Immunological Methods,31/01/2014|03/12/2013,Combinatorial HLA-peptide bead libraries for high throughput identification of CD8+ T cell specificity|Combinatorial HLA-peptide bead libraries for high throughput identification of CD8⁺ T cell specificity.,"Pan X,Huang LC,Dong T,Peng Y,Cerundolo V,McGowan S,Ogg G|Pan X,Huang LC,Dong T,Peng Y,Cerundolo V,McGowan S,Ogg G","|Bead display,HLA library,T cells,Antigens,Viral,CD8-Positive T-Lymphocytes,Combinatorial Chemistry Techniques,Cytomegalovirus,HLA Antigens,Herpesvirus 4,Human,High-Throughput Screening Assays,Humans,Orthomyxoviridae,Peptide Fragments,Peptide Library,Phosphoproteins,Polymerase Chain Reaction,Trans-Activators,Viral Matrix Proteins"
clme0975,whgu0172,2,0.15000000000000002,Journal article|Journal article,Cell Death and Differentiation|Cancer Cell,24/05/2013|13/05/2013,A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.|Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"New M,Olzscha H,Liu G,Khan O,Stimson L,McGouran J,Kerr D,Coutts A,Kessler B,Middleton M,La Thangue NB|Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Apoptosis,Autophagy,Biomarkers,Tumor,Cell Line,DNA Repair Enzymes,DNA-Binding Proteins,Gene Expression Regulation,Neoplastic,Histone Deacetylase Inhibitors,Histone Deacetylases,Humans,RNA,Small Interfering,Transfection,Ubiquitin|Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
card0027,ctsu0165,2,0.06060606060606061,Journal article|Journal article,American Heart Journal|American Heart Journal,01/01/2015|27/07/2014,"Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration|Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration.","Pitcher A,Emberson J,Lacro RV,Sleeper LA,Stylianou M,Mahony L,Pearson GD,Groenink M,Mulder BJ,Zwinderman AH,De Backer J,De Paepe AM,Arbustini E,Erdem G,Jin XY,Flather MD,Mullen MJ,Child AH,Forteza A,Evangelista A,Chiu HH,Wu MH,Sandor G,Bhatt AB,Creager MA,Devereux RB,Loeys B,Forfar JC,Neubauer S,Watkins H,Boileau C,Jondeau G,Dietz HC,Baigent C|Pitcher A,Emberson J,Lacro RV,Sleeper LA,Stylianou M,Mahony L,Pearson GD,Groenink M,Mulder BJ,Zwinderman AH,De Backer J,De Paepe AM,Arbustini E,Erdem G,Jin XY,Flather MD,Mullen MJ,Child AH,Forteza A,Evangelista A,Chiu HH,Wu MH,Sandor G,Bhatt AB,Creager MA,Devereux RB,Loeys B,Forfar JC,Neubauer S,Watkins H,Boileau C,Jondeau G,Dietz HC,Baigent C","|Humans,Marfan Syndrome,Prospective Studies,Research Design,Female,Male,Meta-Analysis as Topic,Randomized Controlled Trials as Topic,Angiotensin Receptor Antagonists"
bioc0541,raob0095,1,0.14285714285714285,Journal article,Journal of National Cancer Institute,09/10/2013,Selective permeabilization of the blood-brain barrier at sites of metastasis.,"Connell JJ,Chatain G,Cornelissen B,Vallis KA,Hamilton A,Seymour L,Anthony DC,Sibson NR","Analysis of Variance,Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Blood-Brain Barrier,Brain,Brain Neoplasms,Breast Neoplasms,Contrast Media,Disease Models,Animal,Drug Administration Schedule,Female,Gadolinium DTPA,Gene Expression Regulation,Neoplastic,Humans,Immunohistochemistry,Lymphotoxin-alpha,Magnetic Resonance Imaging,Mice,Inbred BALB C,Permeability,Receptors,Tumor Necrosis Factor,Type I,Tomography,Emission-Computed,Single-Photon,X-Ray Computed,Trastuzumab,Tumor Necrosis Factor-alpha"
clme0975,immd0023,1,0.058823529411764705,Journal article,International Journal of Cancer,14/08/2014,NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.,"Chen JL,Dawoodji A,Tarlton A,Gnjatic S,Tajar A,Karydis I,Browning J,Pratap S,Verfaille C,Venhaus RR,Pan L,Altman DG,Cebon JS,Old LL,Nathan P,Ottensmeier C,Middleton M,Cerundolo V","CD4-Positive T-Lymphocytes,CD8-Positive T-Lymphocytes,Humans,Fowlpox virus,Melanoma,Cholesterol,Saponins,Phospholipids,Membrane Proteins,Vaccines,Synthetic,Adjuvants,Immunologic,Antigens,Neoplasm,Drug Combinations,Vaccination,Antibody Formation,Fowlpox,ISCOMATRIX,NY-ESO-1,cancer vaccines"
chri0963,clme0220,8,1.8083333333333331,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,PLoS One|Journal of Cellular Physiology|Journal of Biological Chemistry|Cancer Research|Current Pharmaceutical Design|Clinical Cancer Research|European Journal of Pharmacology|Philosophical Transactions of the Royal Society of London: Biological Sciences,01/01/2012|04/09/2012|24/07/2014|15/04/2013|23/02/2012|12/04/2012|09/02/2011|01/01/2014,"Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin.|Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia.|Intracellular carbonic anhydrase activity sensitizes cancer cell pH signaling to dynamic changes in CO2 partial pressure.|Hypoxic trans-activation of sodium dependent bicarbonate co-transporters regulates pH in 3D spheroids and promotes growth|Acid-extrusion from tissue: the interplay between membrane transporters and pH buffers.|Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.|Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX.|The chemistry, physiology and pathology of pH in cancer.","Swietach P,Hulikova A,Patiar S,Vaughan-Jones RD,Harris AL|Hulikova A,Harris AL,Vaughan-Jones RD,Swietach P|Hulikova A,Aveyard N,Harris AL,Vaughan-Jones RD,Swietach P|McIntyre A,Hulikova A,Ledaki I,Seden P,Turley H,Jones D,Russell A,Swietach P,Harris AL|Hulikova A,Harris AL,Vaughan-Jones RD,Swietach P|McIntyre A,Patiar S,Wigfield S,Li JL,Ledaki I,Turley H,Leek R,Snell C,Gatter K,Sly WS,Vaughan-Jones RD,Swietach P,Harris AL|Murri-Plesko MT,Hulikova A,Oosterwijk E,Scott AM,Zortea A,Harris AL,Ritter G,Old L,Bauer S,Swietach P,Renner C|Swietach P,Vaughan-Jones RD,Harris AL,Hulikova A","Antibiotics,Antineoplastic,Binding Sites,Cell Nucleus,Cell Proliferation,Doxorubicin,HCT116 Cells,Humans,Hydrogen-Ion Concentration,Models,Chemical|Acids,Biological Transport,Cation Transport Proteins,Cell Hypoxia,Cell Line,Tumor,Down-Regulation,HCT116 Cells,HT29 Cells,HeLa Cells,Homeostasis,Humans,Hydrogen-Ion Concentration,Neoplasms,Oxygen,Sodium-Hydrogen Antiporter|HCT116 Cells,Cytoplasm,Humans,Neoplasms,Carbon Dioxide,Bicarbonates,Protons,Carbonic Anhydrases,Signal Transduction,Hydrogen-Ion Concentration,Partial Pressure||Acid-Base Equilibrium,Buffers,Cell Membrane,Humans,Hydrogen-Ion Concentration,Membrane Transport Proteins|Angiogenesis Inhibitors,Animals,Antibodies,Monoclonal,Humanized,Antigens,Neoplasm,Bevacizumab,Carbonic Anhydrases,Cell Line,Tumor,Cell Proliferation,Female,Gene Knockdown Techniques,Glioblastoma,HCT116 Cells,HT29 Cells,Humans,Hydrogen-Ion Concentration,Mice,Necrosis,Neoplasm Transplantation,Transfection,Transplantation,Heterologous|Animals,Antibody Specificity,Antigens,Neoplasm,Carbonic Anhydrase Inhibitors,Carbonic Anhydrases,Cell Line,Tumor,Cell Membrane,Gene Expression Regulation,Neoplastic,Humans,Immunoglobulin Fragments,Neoplasms,Peptide Library,Spheroids,Cellular|buffering,carbonic anhydrase,diffusion,pH regulation,pH sensing,Acid-Base Equilibrium,Carbonic Anhydrases,Humans,Hydrogen-Ion Concentration,Membrane Transport Proteins,Neoplasms,Oxygen,Proton Pumps,Tumor Microenvironment"
lina0435,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0036,immd0237,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
raob0120,raob0128,6,1.6666666666666667,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Radiation Protection Dosimetry|Radiation Protection Dosimetry|Radiation Research|Radiation Research|Radiation Research|Nucleic Acids Research,16/04/2015|01/02/2011|10/06/2011|01/09/2011||24/09/2012,Stimulation of intercellular induction of apoptosis in transformed cells at very low doses of ionising radiation: spatial and temporal features.|Intercellular induction of apoptosis signalling pathways.|The role of radiation quality in the stimulation of intercellular induction of apoptosis in transformed cells at very low doses.|The role of radiation quality in the stimulation of intercellular induction of apoptosis in transformed cells at very low doses|Enhancement of Peroxidase Release from Non-Malignant and Malignant Cells through Low-Dose Irradiation with Different Radiation Quality.|The dynamics of Ku70/80 and DNA-PKcs at DSBs induced by ionizing radiation is dependent on the complexity of damage.,"Mariotti LG,Abdelrazzak AB,Ottolenghi A,O'Neill P,Hill MA|Abdelrazzak AB,O'Neill P,Hill MA|Abdelrazzak AB,Stevens DL,Bauer G,O'Neill P,Hill MA|Abdelrazzak AB,Stevens DL,Bauer G,O'Neill P,Hill MA|Abdelrazzak AB,Pottgießer SJ,Hill MA,O'Neill P,Bauer G|Reynolds P,Anderson JA,Harper JV,Hill MA,Botchway SW,Parker AW,O'Neill P","Cells,Cultured,Cell Line,Transformed,Fibroblasts,Animals,Humans,Rats,Coculture Techniques,Apoptosis,Dose-Response Relationship,Drug,Radiation,Ionizing,Models,Biological|Animals,Apoptosis,Cell Line,Cell Transformation,Neoplastic,Fibroblasts,Nitric Oxide,Rats,Signal Transduction|Animals,Apoptosis,Cell Line,Transformed,Dose-Response Relationship,Drug,Rats|||Animals,Antigens,Nuclear,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,DNA Breaks,Double-Stranded,DNA End-Joining Repair,DNA-Activated Protein Kinase,DNA-Binding Proteins,Kinetics,Protein-Serine-Threonine Kinases,Radiation,Ionizing,Tumor Suppressor Proteins"
clme0240,immd0024,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme1037,ndos0168,1,0.1,Journal article,Nature Reviews Drug Discovery,01/03/2015,Preclinical target validation using patient-derived cells.,"Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
mjawood,orie1154,1,0.05555555555555555,Journal article,"Nanomedicine: Nanotechnology, Biology and Medicine",04/02/2015,Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties.,"Nordin JZ,Lee Y,Vader P,Mäger I,Johansson HJ,Heusermann W,Wiklander OP,Hällbrink M,Seow Y,Bultema JJ,Gilthorpe J,Davies T,Fairchild PJ,Gabrielsson S,Meisner-Kober NC,Lehtiö J,Smith CI,Wood MJ,El Andaloussi S","Humans,Ultrafiltration,Chromatography,Gel,Cell-Derived Microparticles,HEK293 Cells"
path0084,stat0054,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clab0035,immd0151,1,0.07692307692307693,Journal article,PLoS One,01/01/2011,Genomic imbalances are confined to non-proliferating cells in paediatric patients with acute myeloid leukaemia and a normal or incomplete karyotype,"Ballabio E,Regan R,Garimberti E,Harbott J,Bradtke J,Teigler-Schlegel A,Biondi A,Cazzaniga G,Giudici G,Wainscoat JS,Boultwood J,Bridger JM,Knight SJL,Tosi S",
clme0497,raob0097,1,0.0625,Journal article,Journal of Medicinal Chemistry,21/03/2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.","Hewings DS,Fedorov O,Filippakopoulos P,Martin S,Picaud S,Tumber A,Wells C,Olcina MM,Freeman K,Gill A,Ritchie AJ,Sheppard DW,Russell AJ,Hammond EM,Knapp S,Brennan PE,Conway SJ","Acetylation,CREB-Binding Protein,Cell Line,Tumor,Crystallography,X-Ray,Histones,Humans,Inhibitory Concentration 50,Isoxazoles,Ligands,Lysine,Nuclear Proteins,Protein Binding,Structure-Activity Relationship,Transcription Factors"
mjawood,ocms0037,1,0.05555555555555555,Journal article,Nature Structural and Molecular Biology,12/10/2014,Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7.,"Tan JY,Vance KW,Varela MA,Sirey T,Watson LM,Curtis HJ,Marinello M,Alves S,Steinkraus BR,Cooper S,Nesterova T,Brockdorff N,Fulga TA,Brice A,Sittler A,Oliver PL,Wood MJ,Ponting CP,Marques AC","Cerebellum,Neurons,Retina,Cell Line,Tumor,Fibroblasts,Animals,Humans,Mice,Spinocerebellar Ataxias,Nerve Tissue Proteins,MicroRNAs,RNA,Messenger,Gene Expression Profiling,Signal Transduction,Gene Expression Regulation,Mutation,Female,Male,Feedback,Physiological,Transcription Initiation,Genetic,Long Noncoding"
immd0237,whgu0256,14,2.3377964141122036,Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article,Biological Chemistry: official scientific journal of the GBM|Nature Genetics|Blood|European Journal of Cancer|Nephrology Dialysis Transplantation|Cancer Research|PLoS One|European Urology|Oncogene|EMBO Reports|Cancer Research|Blood|Oncogene|PLoS One,01/04/2013|01/01/2012|29/03/2011|01/07/2014|01/05/2013|04/11/2014|01/01/2011|01/04/2016|24/11/2014|21/12/2013|01/05/2015|06/12/2014|20/08/2015|01/01/2015,"Pan-genomic binding of hypoxia-inducible transcription factors|Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression|High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq.|Proffered Paper: Hypoxic regulation of the long non-coding transcriptome in breast cancer|PAN-GENOMIC BINDING OF HYPOXIA-INDUCIBLE TRANSCRIPTION FACTORS IN RENAL CANCER CELLS|Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis.|Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α).|Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival.|Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2.|The non-coding transcriptome of hypoxic breast cancer: Novel insights of clinical relevant long non-coding RNA in hypoxia signalling|A Comprehensive Study of the VHL-R200W Chuvash Polycythemia Mutation Reveals a Gradual Dysregulation of the Hypoxia Pathway in Oncogenesis|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival|Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney Cancer.","Schoedel J,Mole DR,Ratcliffe PJ|Schödel J,Bardella C,Sciesielski LK,Brown JM,Pugh CW,Buckle V,Tomlinson IP,Ratcliffe PJ,Mole DR|Schödel J,Oikonomopoulos S,Ragoussis J,Pugh CW,Ratcliffe PJ,Mole DR|Choudhry H,Albukhari A,Schodel J,Oikonomopoulos S,Haider S,Ratcliffe P,Ragousis I,Mole D,Harris A|Schoedel J,Ratcliffe PJ,Mole DR|Couvé S,Ladroue C,Laine E,Mahtouk K,Guégan J,Gad S,Le Jeune H,Le Gentil M,Nuel G,Kim WY,Lecomte B,Pagès JC,Collin C,Lasne F,Benusiglio PR,Bressac-de Paillerets B,Feunteun J,Lazar V,Gimenez-Roqueplo AP,Mazure NM,Dessen P,Tchertanov L,Mole DR,Kaelin W,Ratcliffe P,Richard S,Gardie B|Thalhammer A,Bencokova Z,Poole R,Loenarz C,Adam J,O'Flaherty L,Schödel J,Mole D,Giaslakiotis K,Schofield CJ,Hammond EM,Ratcliffe PJ,Pollard PJ|Schödel J,Grampp S,Maher ER,Moch H,Ratcliffe PJ,Russo P,Mole DR|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR|Choudhry H,Schödel J,Oikonomopoulos S,Camps C,Grampp S,Harris AL,Ratcliffe PJ,Ragoussis J,Mole DR|Choudhry H,Schodel J,Albukhari A,Haider S,Buffa F,Ratcliffe PJ,Mole DR,Ragousis I,Harris AL|Gardie B,Couve S,Ladroue C,Laine E,Mahtouk K,Guegan J,Gad S,Le Jeune H,Lecomte B,Pages J-C,Benusiglio P,Bressac-de Paillerets B,Feunteun J,Dessen P,Hermouet S,Tchertanov L,Mole DR,Kaelin WG,Ratcliffe PJ,Richard S|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR|Salama R,Masson N,Simpson P,Sciesielski LK,Sun M,Tian YM,Ratcliffe PJ,Mole DR","ChIP-Seq,HIF,hypoxia,transcriptional regulation||Basic Helix-Loop-Helix Transcription Factors,Cell Line,Tumor,Chromatin Immunoprecipitation,Chromosome Mapping,Epigenesis,Genetic,Female,Genome,Human,Genome-Wide Association Study,Humans,Oxygen,Response Elements|||Humans,Pheochromocytoma,Carcinoma,Renal Cell,Kidney Neoplasms,Signal Transduction,Mutation,Polymorphism,Single Nucleotide,Basic Helix-Loop-Helix Transcription Factors,Von Hippel-Lindau Tumor Suppressor Protein,Molecular Dynamics Simulation,Carcinogenesis|Anoxia,Cell Line,Dioxygenases,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Ketoglutaric Acids,Membrane Proteins,Nuclear Proteins,Oxygenases,Transcriptional Activation||Animals,Humans,Mice,Breast Neoplasms,Cell Adhesion Molecules,Receptors,Cell Surface,Apoptosis,Cell Proliferation,Cell Hypoxia,Cell Survival,Female,Basic Helix-Loop-Helix Transcription Factors,Transcriptional Activation,RNA,Long Noncoding|Basic Helix-Loop-Helix Transcription Factors,Cell Hypoxia,Gene Expression Regulation,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,MCF-7 Cells,Promoter Regions,Genetic,Protein Binding,RNA Polymerase II,RNA,Messenger,Untranslated,Transcription,Transcriptome||||Cell Line,Tumor,Humans,Kidney Neoplasms,Anoxia,Prognosis,Signal Transduction,Gene Expression,Binding Sites,Protein Binding,Basic Helix-Loop-Helix Transcription Factors,Hypoxia-Inducible Factor 1,alpha Subunit,Protein Interaction Domains and Motifs,Transcriptional Activation"
bioc0212,raob0087,1,0.125,Journal article,Magnetic Resonance in Medicine,20/05/2015,Robust and high resolution hyperpolarized metabolic imaging of the rat heart at 7 t with 3d spectral-spatial EPI.,"Miller JJ,Lau AZ,Teh I,Schneider JE,Kinchesh P,Smart S,Ball V,Sibson NR,Tyler DJ",
donc0120,raob0270,6,0.38425551057130003,Conference paper|Conference paper|Journal article|Journal article|Conference paper|Journal article,Journal of Clinical Oncology|Annals of Oncology|Radiotherapy and Oncology|BMC Cancer|Journal of Clinical Oncology|BMC Cancer,20/05/2015|01/06/2015||01/01/2015|20/05/2014|12/02/2015,"ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)-Mechanism and clinical outcomes.|Clinical outcomes of a phase II study of nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy in locally-advanced pancreatic cancer - functional imaging is prognostic and provides proof of mechanism|ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.|NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.|NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer.|NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.","Wilson JM,Dutton SJ,Hackett SL,Durrant L,Chu K-Y,Eccles C,Abraham AG,O'Neill E,Partridge M,Hawkins MA,McKenna WG,Maughan T,Brunner TB,Mukherjee S|Wilson J,Hackett S,Durrant L,Dutton S,Chu K-Y,Eccles C,Abraham A,O'Neill E,Partridge M,Hawkins M,McKenna W,Maughan T,Brunner T,Mukherjee S|Wilson JM,Fokas E,Dutton SJ,Patel N,Hawkins MA,Eccles C,Chu KY,Durrant L,Abraham AG,Partridge M,Woodward M,O'Neill E,Maughan T,McKenna WG,Mukherjee S,Brunner TB|Mukherjee S,Hurt CN,Gwynne S,Bateman A,Gollins S,Radhakrishna G,Hawkins M,Canham J,Lewis W,Grabsch HI,Sharma RA,Wade W,Maggs R,Tranter B,Roberts A,Sebag-Montefiore D,Maughan T,Griffiths G,Crosby T|Crosby T,Mukherjee S,Hurt C,Gwynne S,Gollins S,Batrman AR,Lewis WG,Radhakrishna G,Hawkins M,Grabsch HI,Ray R,Sharma RA,Wade W,Maggs R,Tranter B,Roberts A,Hadlow S,Sebag-Montefiore D,Maughan T,Griffiths G|Mukherjee S,Hurt CN,Gwynne S,Bateman A,Gollins S,Radhakrishna G,Hawkins M,Canham J,Lewis W,Grabsch HI,Sharma RA,Wade W,Maggs R,Tranter B,Roberts A,Sebag-Montefiore D,Maughan T,Griffiths G,Crosby T","|||Humans,Adenocarcinoma,Esophageal Neoplasms,Antineoplastic Combined Chemotherapy Protocols,Clinical Protocols,Combined Modality Therapy,Preoperative Care,Chemoradiotherapy||"
bioc0416,bioc0541,26,3.9850288600288595,Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article,Annals of Clinical and Translational Neurology|Neuroimage|Journal of Cerebral Blood Flow and Metabolism|American Journal of Pathology|Neuroimage|Glia|Neuropharmacology|Journal of Nuclear Medicine|Journal of Cerebral Blood Flow and Metabolism|Journal of Neuroimmunology|Neuroimage|Journal of National Cancer Institute|Journal of Cerebral Blood Flow and Metabolism|Journal of NeuroImmune Pharmacology|Proceedings of the National Academy of Sciences of USA|Acta Neuropathologica Communications|Journal of Cerebral Blood Flow and Metabolism|Neuro-Oncology|Neuroimage|The FASEB Journal|Methods in Molecular Biology|Journal of Neuroinflammation|Methods in Molecular Biology|Clinical and Experimental Metastasis|Methods in Molecular Biology|Neurology,01/09/2014|01/07/2014|01/05/2014|16/04/2013|15/07/2013|01/07/2013|09/01/2014|16/01/2014|05/02/2014|15/10/2014|01/01/2014|09/10/2013|01/05/2013|22/09/2015|26/03/2012|13/06/2014|20/02/2013|04/12/2013|05/03/2013|09/09/2011|01/01/2011|28/11/2011|01/01/2011|01/03/2015|01/01/2011|24/09/2014,"Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.|Corrigendum to Systemic inflammation alters central 5-HT function as determined by pharmacological MRI [Neuroimage 75 (2013) 177-186]|T2-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS|Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice.|Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.|CNS-TARGETED METHYLPREDNISOLONE REDUCES PATHOLOGY IN MOUSE MODEL OF ALS|Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.|Glial activation in the early stages of brain metastasis: TSPO as a diagnostic biomarker.|T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS.|Anti-CD20 therapy down-regulates lesion formation and microglial activation in pattern I and pattern II rat models of multiple sclerosis|Systemic inflammation alters central 5-HT function as determined by pharmacological MRI (vol 75, pg 177, 2013)|Selective permeabilization of the blood-brain barrier at sites of metastasis.|Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis|NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.|Molecular MRI enables early and sensitive detection of brain metastases.|CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis.|Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.|Functional role of endothelial adhesion molecules in the early stages of brain metastasis.|Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.|VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis.|Detection of brain pathology by magnetic resonance imaging of iron oxide micro-particles.|The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation.|Molecular MRI approaches to the detection of CNS inflammation.|Cellular adhesion molecules and brain metastasis; how friends become foes|Magnetic resonance imaging of brain inflammation using microparticles of iron oxide.|A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.","Anthony DC,Dickens AM,Seneca N,Couch Y,Campbell S,Checa B,Kersemans V,Warren EA,Tredwell M,Sibson NR,Gouverneur V,Leppert D|Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC|Evans MC,Serres S,Khrapitchev AA,Stolp HB,Anthony DC,Talbot K,Turner MR,Sibson NR|Mardiguian S,Serres S,Ladds E,Campbell SJ,Wilainam P,McFadyen C,McAteer M,Choudhury RP,Smith P,Saunders F,Watt G,Sibson NR,Anthony DC|Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC|Stolp HB,Evans MC,Gaillard P,de Boer M,Appeldoorn C,Dorland R,Sibson NR,Turner MR,Anthony DC|Anthony DC,Sibson NR,Losey P,Meier DP,Leppert D|O'Brien ER,Kersemans V,Tredwell M,Checa B,Serres S,Soto MS,Gouverneur V,Leppert D,Anthony DC,Sibson NR|Evans MC,Serres S,Khrapitchev AA,Stolp HB,Anthony DC,Talbot K,Turner MR,Sibson NR|Anthony DC,Dickens AM,Seneca N,Couch Y,Campbell S,Checa B,Kersemans V,Warren EA,Tredwell M,Sibson NR,Gouverneur V,Leppert D|Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC|Connell JJ,Chatain G,Cornelissen B,Vallis KA,Hamilton A,Seymour L,Anthony DC,Sibson NR|Serres S,Bristow C,De Pablos RM,Merkler D,Soto MS,Sibson NR,Anthony DC|Dickens AM,Larkin JR,Davis BG,Griffin JL,Claridge TD,Sibson NR,Anthony DC|Serres S,Soto MS,Hamilton A,McAteer MA,Carbonell WS,Robson MD,Ansorge O,Khrapitchev A,Bristow C,Balathasan L,Weissensteiner T,Anthony DC,Choudhury RP,Muschel RJ,Sibson NR|Evans MC,Gaillard PJ,de Boer M,Appeldoorn C,Dorland R,Sibson NR,Turner MR,Anthony DC,Stolp HB|Serres S,Bristow C,de Pablos RM,Merkler D,Soto MS,Sibson NR,Anthony DC|Soto MS,Serres S,Anthony DC,Sibson NR|Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC|Serres S,Mardiguian S,Campbell SJ,McAteer MA,Akhtar A,Krapitchev A,Choudhury RP,Anthony DC,Sibson NR|Anthony DC,Sibson NR,McAteer MA,Davis B,Choudhury RP|Couch Y,Alvarez-Erviti L,Sibson NR,Wood MJ,Anthony DC|Sibson NR,Anthony DC,van Kasteren S,Dickens A,Perez-Balderas F,McAteer MA,Choudhury RP,Davis BG|Soto MS,O'Brien E,Serres S,Anthony DC,O'Neill E,Scrace S,Sibson N|McAteer MA,von Zur Muhlen C,Anthony DC,Sibson NR,Choudhury RP|Dickens AM,Larkin JR,Griffin JL,Cavey A,Matthews L,Turner MR,Wilcock GK,Davis BG,Claridge TD,Palace J,Anthony DC,Sibson NR","|||Acute Disease,Animals,Antibodies,Monoclonal,Brain,Contrast Media,Drug Evaluation,Preclinical,Encephalomyelitis,Autoimmune,Experimental,Female,Gadolinium DTPA,Gene Expression Regulation,Interleukin-17,Magnetic Resonance Imaging,Mice,Biozzi,Motor Activity,RNA,Messenger,Remission Induction,Secondary Prevention,Severity of Illness Index,Treatment Outcome,Vascular Cell Adhesion Molecule-1|||Blood–brain barrier,Central nervous system,Delayed-type hypersensitivity model,Fingolimod,Lesion,Multiple sclerosis,Animals,Blood-Brain Barrier,Brain,Capillary Permeability,Disease Models,Animal,Disease Progression,Fingolimod Hydrochloride,Immunosuppressive Agents,Lymphocytes,Macrophages,Male,Microglia,Multiple Sclerosis,Propylene Glycols,Rats,Inbred Lew,Sphingosine|SPECT imaging,TSPO,astrocytes,metastasis,microglia,mouse,Acetamides,Animals,Astrocytes,Biomarkers,Tumor,Brain Neoplasms,Female,Gadolinium,Gene Expression Regulation,Neoplastic,Green Fluorescent Proteins,Immunohistochemistry,Ligands,Magnetic Resonance Imaging,Mice,Inbred BALB C,Microglia,Microscopy,Fluorescence,Neoplasm Metastasis,Neoplasm Transplantation,Neuroglia,Protein Binding,Pyrazoles,Pyrimidines,Receptors,GABA,Time Factors,Tomography,Emission-Computed,Single-Photon|Amyotrophic Lateral Sclerosis,Animals,Astrocytes,Blood-Brain Barrier,Brain Stem,Disease Models,Animal,Humans,Magnetic Resonance Imaging,Mice,Transgenic,Microglia,Motor Activity,Mutation,Permeability,Spinal Cord,Superoxide Dismutase,Weight Loss|||Analysis of Variance,Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Blood-Brain Barrier,Brain,Brain Neoplasms,Breast Neoplasms,Contrast Media,Disease Models,Animal,Drug Administration Schedule,Female,Gadolinium DTPA,Gene Expression Regulation,Neoplastic,Humans,Immunohistochemistry,Lymphotoxin-alpha,Magnetic Resonance Imaging,Mice,Inbred BALB C,Permeability,Receptors,Tumor Necrosis Factor,Type I,Tomography,Emission-Computed,Single-Photon,X-Ray Computed,Trastuzumab,Tumor Necrosis Factor-alpha||Animals,Mice,Biozzi,Multiple Sclerosis,Relapsing-Remitting,Encephalomyelitis,Autoimmune,Experimental,Disease Models,Animal,Disease Progression,Magnetic Resonance Spectroscopy,Models,Theoretical,Metabolomics|Animals,Brain Neoplasms,Disease Progression,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Sensitivity and Specificity,Up-Regulation,Vascular Cell Adhesion Molecule-1|Central Nervous System,Neuroglia,Motor Neurons,Vacuoles,Animals,Mice,Transgenic,Humans,Amyotrophic Lateral Sclerosis,Disease Models,Animal,Body Weight,Polyethylene Glycols,Methylprednisolone,Superoxide Dismutase,Glutathione,Glucocorticoids,Drug Delivery Systems,Area Under Curve,Motor Activity,Cell Survival,Time Factors|Animals,Blood Volume,Brain,Encephalomyelitis,Autoimmune,Experimental,Immunologic Factors,Inflammation,Interferon-beta,Interleukin-1beta,Magnetic Resonance Imaging,Male,Multiple Sclerosis,Rats,Inbred Lew|brain,cellular adhesion molecules,endothelium,metastasis,mouse,neutralizing antibody,Animals,Antibodies,Neutralizing,Apoptosis,Blotting,Western,Brain Neoplasms,Breast Neoplasms,Cell Adhesion Molecules,Cell Movement,Cell Proliferation,Endothelium,Vascular,Female,Fluorescent Antibody Technique,Humans,Immunoenzyme Techniques,Integrin alpha4beta1,Mice,Inbred BALB C,SCID,Tumor Cells,Cultured,Xenograft Model Antitumor Assays|Animals,Autoradiography,Brain,Brain Chemistry,Chromatography,High Pressure Liquid,Fenfluramine,Fluorobenzenes,Image Processing,Computer-Assisted,Inflammation,Laser-Doppler Flowmetry,Magnetic Resonance Imaging,Male,Microdialysis,Piperidines,Rats,Sprague-Dawley,Serotonin,Serotonin Antagonists,Serotonin Uptake Inhibitors|Animals,Brain,Contrast Media,Disease Models,Animal,Disease Progression,Encephalomyelitis,Autoimmune,Experimental,Endothelium,Female,Ferric Compounds,Gadolinium DTPA,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Multiple Sclerosis,Translational Medical Research,Vascular Cell Adhesion Molecule-1|Animals,Brain,Cell Line,Contrast Media,Ferric Compounds,Magnetic Resonance Imaging,Male,Mice,Particle Size,Rats,Wistar|Amyloid beta-Peptides,Animals,Cell Death,Cell Line,Cytokines,Female,Inflammation,Interleukin-1beta,Lipopolysaccharides,Mice,Microglia,Parkinson Disease,Serum Albumin,Substantia Nigra,Transcription Factor RelA,Tumor Necrosis Factor-alpha,alpha-Synuclein|Animals,Antibodies,Antigens,CD15,Central Nervous System,Endothelial Cells,Ferric Compounds,Inflammation,Magnetic Resonance Imaging,Mice,Rats,Statistics as Topic,Tumor Necrosis Factor-alpha,Vascular Cell Adhesion Molecule-1||Animals,Encephalitis,Ferric Compounds,Magnetic Resonance Imaging,Mice,Particle Size,Vascular Cell Adhesion Molecule-1|Humans,Multiple Sclerosis,Chronic Progressive,Relapsing-Remitting,Alzheimer Disease,Amyotrophic Lateral Sclerosis,Biological Markers,Magnetic Resonance Spectroscopy,Discriminant Analysis,Case-Control Studies,Cohort Studies,Reproducibility of Results,ROC Curve,Adult,Aged,Middle Aged,Female,Male,Metabolomics"
immd0106,whgu0172,2,0.15555555555555556,Journal article|Journal article,Journal of Virology|European Journal of Immunology,25/03/2015|01/11/2015,Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.|Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.,"Ternette N,Block PD,Sánchez-Bernabéu Á,Borthwick N,Pappalardo E,Abdul-Jawad S,Ondondo B,Charles PD,Dorrell L,Kessler BM,Hanke T|Ternette N,Yang H,Partridge T,Llano A,Cedeño S,Fischer R,Charles PD,Dudek NL,Mothe B,Crespo M,Fischer WM,Korber BT,Nielsen M,Borrow P,Purcell AW,Brander C,Dorrell L,Kessler BM,Hanke T","T-Lymphocytes,Cytotoxic,Jurkat Cells,Humans,Vaccinia virus,HIV-1,Peptides,Vaccines,Synthetic,AIDS Vaccines,Histocompatibility Antigens Class I,Antigens,Viral,Chromatography,Liquid,Genetic Vectors,Time Factors,Tandem Mass Spectrometry|T-Lymphocytes,Cytotoxic,Cell Line,Humans,HIV-1,Histocompatibility Antigens Class I,Antigens,Viral,Chromatography,High Pressure Liquid,Tandem Mass Spectrometry"
bioc0764,bioc1078,2,0.3333333333333333,Journal article|Journal article,Molecular Cell|Molecular Cell,08/10/2013|07/11/2013,The BEG (PP2A-B55/ENSA/Greatwall) Pathway Ensures Cytokinesis follows Chromosome Separation.|The BEG (PP2A-B55/ENSA/Greatwall) Pathway Ensures Cytokinesis follows Chromosome Separation,"Cundell MJ,Nunes Bastos R,Zhang T,Holder J,Gruneberg U,Novak B,Barr FA|Cundell MJ,Bastos R,Zhang T,Holder J,Gruneberg U,Novak B,Barr FA",|
immd0023,molb0002,4,0.5625,Journal article|Journal article|Journal article|Journal article,Science Signaling|Biophysical Journal|European Journal of Immunology|Proceedings of the National Academy of Sciences of USA,01/01/2011|18/01/2012|17/03/2015|18/11/2013,Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.|Kinetics and Mechanics of Two-Dimensional Interactions between T Cell Receptors and Different Activating Ligands|T lymphocytes need less than 3 min to discriminate between peptide MHCs with similar TCR-binding parameters.|Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation.,"Dushek O,Aleksic M,Wheeler RJ,Zhang H,Cordoba SP,Peng YC,Chen JL,Cerundolo V,Dong T,Coombs D,van der Merwe PA|Robert P,Aleksic M,Dushek O,Cerundolo V,Bongrand P,van der Merwell PA|Brodovitch A,Shenderov E,Cerundolo V,Bongrand P,Pierres A,van der Merwe PA|Salio M,Ghadbane H,Dushek O,Shepherd D,Cypen J,Gileadi U,Aichinger MC,Napolitani G,Qi X,van der Merwe PA,Wojno J,Veerapen N,Cox LR,Besra GS,Yuan W,Cresswell P,Cerundolo V","Adaptive Immunity,Animals,Antigens,Humans,Lymphocyte Activation,Mice,Models,Chemical,T-Lymphocytes,Cytotoxic,Thermodynamics||T-Lymphocytes,Cell Line,Humans,Peptides,Receptors,Antigen,T-Cell,HLA Antigens,Epitopes,T-Lymphocyte,Protein Binding,Kinetics,Time Factors|autoreactivity,inflammation,innate immunity,lipid binding proteins,Antigen-Presenting Cells,Antigens,CD1d,Bacteria,Enzyme-Linked Immunosorbent Assay,HEK293 Cells,Humans,Immunity,Innate,Immunoprecipitation,Lipid Metabolism,Natural Killer T-Cells,Saposins,Scintillation Counting"
immd0237,whgu0274,7,0.944978354978355,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Pathology|The Journal of Physiology|Cancer Cell|PLoS One|Cell Reports|Blood|Oncotarget,01/01/2011|01/01/2012|18/10/2011|01/01/2011|01/05/2013|26/07/2013|06/11/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: Insights from genetically modified mice|Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.|Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α).|A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.|Hif-2α is not essential for cell-autonomous hematopoietic stem cell maintenance.|Novel insights into FH-associated disease are KEAPing the lid on oncogenic HIF signalling.,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Chen RL,Nagel S,Papadakis M,Bishop T,Pollard P,Ratcliffe PJ,Pugh CW,Buchan AM|Adam J,Hatipoglu E,O'Flaherty L,Ternette N,Sahgal N,Lockstone H,Baban D,Nye E,Stamp GW,Wolhuter K,Stevens M,Fischer R,Carmeliet P,Maxwell PH,Pugh CW,Frizzell N,Soga T,Kessler BM,El-Bahrawy M,Ratcliffe PJ,Pollard PJ|Thalhammer A,Bencokova Z,Poole R,Loenarz C,Adam J,O'Flaherty L,Schödel J,Mole D,Giaslakiotis K,Schofield CJ,Hammond EM,Ratcliffe PJ,Pollard PJ|Adam J,Yang M,Bauerschmidt C,Kitagawa M,O'Flaherty L,Maheswaran P,Özkan G,Sahgal N,Baban D,Kato K,Saito K,Iino K,Igarashi K,Stratford M,Pugh C,Tennant DA,Ludwig C,Davies B,Ratcliffe PJ,El-Bahrawy M,Ashrafian H,Soga T,Pollard PJ|Guitart AV,Subramani C,Armesilla-Diaz A,Smith G,Sepulveda C,Gezer D,Vukovic M,Dunn K,Pollard P,Holyoake TL,Enver T,Ratcliffe PJ,Kranc KR|Adam J,Ratcliffe PJ,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid|Animals,Body Temperature Regulation,Body Weight,Brain Ischemia,Cerebral Arteries,Cerebral Cortex,Gene Expression Regulation,Genotype,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Knockout,Procollagen-Proline Dioxygenase,Protein Isoforms|Adaptor Proteins,Signal Transducing,Animals,Antioxidants,Cell Hypoxia,Cytoskeletal Proteins,Fumarate Hydratase,Fumarates,Gene Expression Regulation,Neoplastic,Hypoxia-Inducible Factor 1,Kidney Diseases,Cystic,Mice,NF-E2-Related Factor 2,Procollagen-Proline Dioxygenase,Signal Transduction,Succinates|Anoxia,Cell Line,Dioxygenases,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Ketoglutaric Acids,Membrane Proteins,Nuclear Proteins,Oxygenases,Transcriptional Activation|Animals,Arginine,Argininosuccinic Acid,Cell Line,Citric Acid Cycle,Fumarate Hydratase,Fumarates,Kidney,Kidney Neoplasms,Metabolome,Mice,Knockout,Transgenic,Mitochondria,Mutation,Protein Isoforms,Urea|Animals,Basic Helix-Loop-Helix Transcription Factors,Cell Proliferation,Cell Survival,Female,Gene Deletion,Hematopoiesis,Hematopoietic Stem Cell Transplantation,Hematopoietic Stem Cells,Male,Mice|Animals,Cell Transformation,Neoplastic,Fumarate Hydratase,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Intracellular Signaling Peptides and Proteins,Kidney Neoplasms,Leiomyomatosis,Neoplastic Syndromes,Hereditary,Signal Transduction,Skin Neoplasms,Uterine Neoplasms"
clme0301,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0993,raob0096,1,0.125,Journal article,Cancer Research,09/03/2012,A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.,"Yee KS,Grochola L,Hamilton G,Grawenda A,Bond EE,Taubert H,Wurl P,Bond GL,O'Neill E","Adolescent,Adult,Age of Onset,Aged,80 and over,Alleles,Cell Line,Tumor,Cisplatin,DNA Damage,DNA Methylation,DNA-Binding Proteins,Female,Humans,MAP Kinase Kinase Kinases,Male,Middle Aged,Nuclear Proteins,Polymorphism,Single Nucleotide,Promoter Regions,Genetic,Receptors,Thyrotropin,Sarcoma,Signal Transduction,Soft Tissue Neoplasms,Tumor Suppressor Protein p53,Tumor Suppressor Proteins,Young Adult"
clme0240,whgu0378,3,0.1741743119266055,Journal article|Journal article|Journal article,Nature Genetics|Nature Genetics|Journal of Pathology,11/03/2012|18/05/2015|01/01/2011,Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Schödel J,Bardella C,Sciesielski LK,Brown JM,Pugh CW,Buckle V,Tomlinson IP,Ratcliffe PJ,Mole DR|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Cell Cycle Checkpoints,Cell Hypoxia,Cell Line,Tumor,Chromosomes,Human,Pair 11,Cyclin D1,Enhancer Elements,Genetic,Gene Expression Regulation,Neoplastic,Genetic Predisposition to Disease,Genetic Variation,Humans,Hypoxia-Inducible Factor 1,Kidney Neoplasms,Molecular Sequence Data,Polymorphism,Single Nucleotide,Von Hippel-Lindau Tumor Suppressor Protein|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
clme0240,corp0784,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clne0009,prhc0003,1,0.25,Journal article,Lancet,25/02/2012,Cost-effectiveness of diagnosis of high blood pressure in primary care,"Wald DS,Simmonds MC,Morris JK,Rothwell PM,Wald NJ",
immd0330,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme1037,whgu0142,3,0.20647773279352227,Journal article|Journal article|Journal article,Science|Science|Proceedings of the National Academy of Sciences of USA,01/01/2013|29/03/2013|11/06/2013,"The structural basis of ZMPSTE24-dependent laminopathies|The structural basis of ZMPSTE24-dependent laminopathies.|Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states.","Quigley A,Dong YY,Pike ACW,Dong L,Shrestha L,Berridge G,Stansfeld PJ,Sansom MSP,Edwards AM,Bountra C,Von Delft F,Bullock AN,Burgess-Brown NA,Carpenter EP|Quigley A,Dong YY,Pike AC,Dong L,Shrestha L,Berridge G,Stansfeld PJ,Sansom MS,Edwards AM,Bountra C,von Delft F,Bullock AN,Burgess-Brown NA,Carpenter EP|Shintre CA,Pike AC,Li Q,Kim JI,Barr AJ,Goubin S,Shrestha L,Yang J,Berridge G,Ross J,Stansfeld PJ,Sansom MS,Edwards AM,Bountra C,Marsden BD,von Delft F,Bullock AN,Gileadi O,Burgess-Brown NA,Carpenter EP","|Amino Acid Sequence,Catalytic Domain,Crystallography,X-Ray,Humans,Lamin Type A,Membrane Proteins,Metabolism,Inborn Errors,Metalloendopeptidases,Molecular Sequence Data,Nuclear Proteins,Progeria,Protein Conformation,Protein Precursors,Substrate Specificity,Thermolysin|ABC mitochondrial erythroid,X-ray crystallography,cardiolipin,human membrane protein structure,nucleotide complex,ATP-Binding Cassette Transporters,Adenosine Triphosphatases,Adenosine Triphosphate,Amino Acid Sequence,Animals,Binding Sites,Crystallography,X-Ray,Humans,Lipid Bilayers,Models,Molecular,Molecular Conformation,Molecular Dynamics Simulation,Molecular Sequence Data,Mutation,Nucleotides,Phosphatidylcholines,Phosphatidylethanolamines,Protein Binding,Protein Structure,Tertiary,Sequence Homology,Amino Acid,Sf9 Cells"
raob0047,whgu0274,1,0.045454545454545456,Journal article,Cell Reports,01/05/2013,A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.,"Adam J,Yang M,Bauerschmidt C,Kitagawa M,O'Flaherty L,Maheswaran P,Özkan G,Sahgal N,Baban D,Kato K,Saito K,Iino K,Igarashi K,Stratford M,Pugh C,Tennant DA,Ludwig C,Davies B,Ratcliffe PJ,El-Bahrawy M,Ashrafian H,Soga T,Pollard PJ","Animals,Arginine,Argininosuccinic Acid,Cell Line,Citric Acid Cycle,Fumarate Hydratase,Fumarates,Kidney,Kidney Neoplasms,Metabolome,Mice,Knockout,Transgenic,Mitochondria,Mutation,Protein Isoforms,Urea"
clme0240,clme0301,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0316,raob0097,3,0.3611111111111111,Journal article|Journal article|Journal article,Oncogene|Oncogene|Journal of Clinical Investigation,01/01/2011|30/05/2011|11/05/2015,Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α|Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α.|Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT.,"Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB|Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB|Leszczynska KB,Foskolou IP,Abraham AG,Anbalagan S,Tellier C,Haider S,Span PN,O'Neill EE,Buffa FM,Hammond EM","|Base Sequence,Cell Hypoxia,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Molecular Sequence Data,Nuclear Proteins,Promoter Regions,Genetic,Trans-Activators|Cell Line,Tumor,Humans,Neoplasms,Phosphoric Monoester Hydrolases,Sulfotransferases,Adaptor Proteins,Signal Transducing,Carrier Proteins,Immediate-Early Proteins,Tumor Suppressor Proteins,Nuclear Proteins,Apoptosis,Cell Hypoxia,Radiation Tolerance,Tumor Suppressor Protein p53,Proto-Oncogene Proteins c-akt"
clme0169,molb0003,13,0.8589228753702438,Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,JAMA Pediatrics|The Lancet Global Health|Lancet Diabetes and Endocrinology|Lancet|American Journal of Obstetrics and Gynecology|BJOG: an International Journal of Obstetrics and Gynaecology|BJOG: an International Journal of Obstetrics and Gynaecology|Lancet|Lancet Diabetes and Endocrinology|BJOG: an International Journal of Obstetrics and Gynaecology|Ultrasound in Obstetrics and Gynecology|JAMA Pediatrics|Acta Paediatrica: promoting child health,06/07/2015|19/10/2015|22/09/2014|04/09/2014|14/07/2015|15/04/2015|09/09/2013|04/09/2014|06/07/2014|17/05/2013|02/11/2014|05/01/2015|02/09/2015,"Anthropometric Characterization of Impaired Fetal Growth: Risk Factors for and Prognosis of Newborns With Stunting or Wasting.|Postnatal growth standards for preterm infants: the Preterm Postnatal Follow-up Study of the INTERGROWTH-21(st) Project.|Fetal growth and ethnic variation--authors' reply.|International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project.|Monitoring human growth and development: a continuum from the womb to the classroom.|INTERGROWTH-21st: describing optimal fetal growth, newborn size and postnatal growth and development for the improved phenotypic classification of the preterm birth and fetal growth restriction syndromes|A rapid questionnaire assessment of environmental exposures to pregnant women in the INTERGROWTH-21st Project.|International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project.|The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional Study.|The objectives, design and implementation of the INTERGROWTH-21st Project.|International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown-rump length in the first trimester of pregnancy.|The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention.|Systematic review of the methodological quality of studies designed to create neonatal anthropometric charts.","Victora CG,Villar J,Barros FC,Ismail LC,Chumlea C,Papageorghiou AT,Bertino E,Ohuma EO,Lambert A,Carvalho M,Jaffer YA,Altman DG,Noble JA,Gravett MG,Purwar M,Frederick IO,Pang R,Bhutta ZA,Kennedy SH|Villar J,Giuliani F,Bhutta ZA,Bertino E,Ohuma EO,Ismail LC,Barros FC,Altman DG,Victora C,Noble JA,Gravett MG,Purwar M,Pang R,Lambert A,Papageorghiou AT,Ochieng R,Jaffer YA,Kennedy SH,International Fetal and Newborn Growth Consortium for the 21(st) Century (INTERGROWTH-21(st))|Villar J,Altman DG,Victora CG,Bhutta ZA,Ohuma EO,Kennedy SH,International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st)|Papageorghiou AT,Ohuma EO,Altman DG,Todros T,Cheikh Ismail L,Lambert A,Jaffer YA,Bertino E,Gravett MG,Purwar M,Noble JA,Pang R,Victora CG,Barros FC,Carvalho M,Salomon LJ,Bhutta ZA,Kennedy SH,Villar J,International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st)|Villar J,Papageorghiou AT,Pang R,Salomon LJ,Langer A,Victora C,Purwar M,Chumlea C,Qingqing W,Scherjon SA,Barros FC,Carvalho M,Altman DG,Giuliani F,Bertino E,Jaffer YA,Cheikh Ismail L,Ohuma EO,Lambert A,Noble JA,Gravett MG,Bhutta ZA,Kennedy SH|Hirst JE,Villar J,Papageorghiou AT,Pang R,Ohuma EO,Ismail CL,Barros FC,Lambert A,Carvalho M,Jaffer YA,Bertino E,Gravett MG,Altman DG,Purwar M,Frederick IO,Noble JA,Victora CG,Bhutta ZA,Kennedy SH,Growth IFN|Eskenazi B,Bradman A,Finkton D,Purwar M,Noble JA,Pang R,Burnham O,Ismail LC,Farhi F,Barros FC,Lambert A,Papageorghiou AT,Carvalho M,Jaffer YA,Bertino E,Gravett MG,Altman DG,Ohuma EO,Kennedy SH,Bhutta ZA,Villar J,Consortiu IFNG|Villar J,Cheikh Ismail L,Victora CG,Ohuma EO,Bertino E,Altman DG,Lambert A,Papageorghiou AT,Carvalho M,Jaffer YA,Gravett MG,Purwar M,Frederick IO,Noble AJ,Pang R,Barros FC,Chumlea C,Bhutta ZA,Kennedy SH,International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st)|Villar J,Papageorghiou AT,Pang R,Ohuma EO,Cheikh Ismail L,Barros FC,Lambert A,Carvalho M,Jaffer YA,Bertino E,Gravett MG,Altman DG,Purwar M,Frederick IO,Noble JA,Victora CG,Bhutta ZA,Kennedy SH,International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st)|Villar J,Altman DG,Purwar M,Noble JA,Knight HE,Ruyan P,Cheikh Ismail L,Barros FC,Lambert A,Papageorghiou AT,Carvalho M,Jaffer YA,Bertino E,Gravett MG,Bhutta ZA,Kennedy SH,International Fetal and Newborn Growth Consortium for the 21st Century|Papageorghiou AT,Kennedy SH,Salomon LJ,Ohuma EO,Cheikh Ismail L,Barros FC,Lambert A,Carvalho M,Jaffer YA,Bertino E,Gravett MG,Altman DG,Purwar M,Noble JA,Pang R,Victora CG,Bhutta ZA,Villar J,International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st)|Barros FC,Papageorghiou AT,Victora CG,Noble JA,Pang R,Iams J,Cheikh Ismail L,Goldenberg RL,Lambert A,Kramer MS,Carvalho M,Conde-Agudelo A,Jaffer YA,Bertino E,Gravett MG,Altman DG,Ohuma EO,Purwar M,Frederick IO,Bhutta ZA,Kennedy SH,Villar J,International Fetal and Newborn Growth Consortium for the 21st Century|Giuliani F,Ohuma E,Spada E,Bertino E,Al Dhaheri AS,Altman DG,Conde-Agudelo A,Kennedy SH,Villar J,Cheikh Ismail L","International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st),Humans,Fetal Growth Retardation,Body Weight,Anthropometry,Body Mass Index,Body Height,Prognosis,Risk Factors,Follow-Up Studies,Cross-Sectional Studies,Fetal Development,Gestational Age,Infant,Newborn,Low Birth Weight,England|International Fetal and Newborn Growth Consortium for the 21(st) Century (INTERGROWTH-21(st))|International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st),Humans,Fetal Development,Pregnancy,Female,Male|International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st),Abdomen,Femur,Humans,Ultrasonography,Prenatal,Cephalometry,Prospective Studies,Maternal Age,Fetal Development,Pregnancy,Reference Standards,Adolescent,Adult,Urban Health,Female,Young Adult|Humans,Anthropometry,Child Development,Fetal Development,Gestational Age,Bone Development,Pregnancy,Reference Values,Child,Preschool,Infant,Newborn,Continuity of Patient Care,Female,Male,Growth Charts,continuity of care,growth monitoring,prescriptive standards||Environmental exposure,exposure questionnaire,fetal exposure,fetal growth,low birth weight,maternal exposure,pregnancy,preterm,Clinical Protocols,Female,Fetal Development,Global Health,Growth Charts,Humans,Longitudinal Studies,Maternal Exposure,Multicenter Studies as Topic,Pregnancy,Research Design,Surveys and Questionnaires|International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st),Humans,Birth Weight,Anthropometry,Cephalometry,Body Height,Prospective Studies,Cross-Sectional Studies,Maternal Age,Fetal Development,Gestational Age,Pregnancy,Sex Characteristics,Reference Standards,Adolescent,Adult,Infant,Newborn,Premature,Female,Male,Young Adult|International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st),Humans,Cephalometry,Body Size,Longitudinal Studies,Cross-Sectional Studies,Fetal Development,Gestational Age,Pregnancy,Adult,Infant,Newborn,Female,Male,Congenital Abnormalities,Young Adult,Growth Charts|Fetal,INTERGROWTH-21st,growth,newborn,nutrition,preterm,standards,Body Weights and Measures,Child Development,Clinical Protocols,Cross-Sectional Studies,Female,Fetal Development,Fetal Growth Retardation,Gestational Age,Growth Charts,Humans,Infant,Low Birth Weight,Newborn,Premature,Longitudinal Studies,Multicenter Studies as Topic,Pregnancy,Premature Birth,Prenatal Nutritional Physiological Phenomena,Prospective Studies,Research Design,Ultrasonography,Prenatal|International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st),Humans,Ultrasonography,Prenatal,Crown-Rump Length,Longitudinal Studies,Prospective Studies,Gestational Age,Pregnancy,Pregnancy Trimester,First,Adult,Female,Growth Charts,crown-rump length,dating,gestational age,global health,growth,pregnancy|International Fetal and Newborn Growth Consortium for the 21st Century,Humans,Premature Birth,Anthropometry,Hospitalization,Prevalence,Risk Factors,Prospective Studies,Cross-Sectional Studies,Gestational Age,Pregnancy,Phenotype,Infant,Newborn,Female,Male|Neonatal anthropometric charts,Newborn head circumference,Newborn length,Newborn weight,Systematic review,Anthropometry,Growth Charts,Humans,Infant,Newborn"
clme0667,clme0670,20,3.498088023088023,Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Conference paper|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article,"Oncotarget|Nature Communications|Cancer Research|Modern Pathology|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Biochimica et Biophysica Acta: international journal of biochemistry and biophysics|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Cancer Biology and Therapy|Cancer Treatment Reviews|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Cell Death and Disease|Cancer and Metastasis Reviews|Radiation Oncology|Cancer Treatment Reviews|Oncotarget|Radiotherapy and Oncology|Clinical Cancer Research|Cancer and Metastasis Reviews|Laboratory Investigation|Clinical Cancer Research",|01/01/2012|22/11/2011|01/02/2016|01/06/2012|06/12/2014|01/05/2013|01/09/2012|11/04/2013|01/05/2013|01/01/2012|24/07/2012|27/03/2012|03/01/2015|28/02/2015|26/04/2014|09/02/2016|01/01/2012|01/02/2016|07/11/2011,"The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma.|Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels|Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy|Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.|Dose- and schedule-dependent changes in vascular morphology after PI3K and PI3K/mTOR inhibition: in vitro vs. in vivo effects|The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.|Targeting ATR in DNA damage response and cancer therapeutics.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation|Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies.|NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity.|Drug radiotherapy combinations: review of previous failures and reasons for future optimism.|Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen.|Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cells.|Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.|The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo.","Wang LM,Silva MA,D'Costa Z,Bockelmann R,Soonawalla Z,Liu S,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Harada H,Inoue M,Itasaka S,Hirota K,Morinibu A,Shinomiya K,Zeng L,Ou G,Zhu Y,Yoshimura M,McKenna WG,Muschel RJ,Hiraoka M|Fokas E,Im JH,Hill S,Yameen S,Stratford M,Beech J,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Fokas E,Prevo R,Reaper P,Charlton P,Pollard J,McKenna WG,Muschel R,Brunner T|Fokas E,O'Neill E,Gordon-Weeks A,Mukherjee S,McKenna WG,Muschel RJ|Fokas E,Lechterier T,Hackl W,S-M M,McKenna WG,Hodivala-Dilke K,Muschel RJ|Prevo R,Fokas E,Reaper PM,Charlton PA,Pollard JR,McKenna WG,Muschel RJ,Brunner TB|Fokas E,Prevo R,Hammond EM,Brunner TB,McKenna WG,Muschel RJ|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Fokas E,McKenna WG,Muschel RJ|Fokas E,Yoshimura M,Prevo R,Higgins G,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|Higgins GS,O'Cathail SM,Muschel RJ,McKenna WG|Tiwana GS,Prevo R,Buffa FM,Yu S,Ebner DV,Howarth A,Folkes LK,Budwal B,Chu KY,Durrant L,Muschel RJ,McKenna WG,Higgins GS|Al-Assar O,Demiciorglu F,Lunardi S,Gaspar-Carvalho MM,McKenna WG,Muschel RM,Brunner TB|Hill EJ,Roberts C,Franklin JM,Enescu M,West N,MacGregor TP,Chu KY,Boyle L,Blesing C,Wang LM,Mukherjee S,Anderson EM,Brown G,Dutton S,Love SB,Schnabel JA,Quirke P,Muschel R,McKenna WG,Partridge M,Sharma RA|Fokas E,McKenna WG,Muschel RJ|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Qayum N,Im J,Stratford MR,Bernhard EJ,McKenna WG,Muschel RJ","||Animals,Dose-Response Relationship,Drug,Humans,Mice,Neoplasms,Experimental,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Radiation Tolerance,TOR Serine-Threonine Kinases,Xenograft Model Antitumor Assays|||Animals,Humans,Mice,Carcinoma,Pancreatic Ductal,Pancreatic Neoplasms,Cell Transformation,Neoplastic,Disease Models,Animal,Inflammation,Cancer Vaccines,Immunotherapy,Drug Resistance,Neoplasm,Radiation Tolerance,Neoplastic Cells,Circulating||Antineoplastic Combined Chemotherapy Protocols,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Checkpoints,Cell Cycle Proteins,Cell Hypoxia,Cell Line,Tumor,Combined Modality Therapy,DNA Damage,DNA Repair,Deoxycytidine,Humans,Pancreatic Neoplasms,Phosphorylation,Protein-Serine-Threonine Kinases,Pyrazines,Radiation-Sensitizing Agents,Signal Transduction,Sulfones|ATR,Cancer,Chemotherapy,DNA damage,Radiation,Replication stress,Therapeutics,Animals,Antineoplastic Agents,Ataxia Telangiectasia Mutated Proteins,Clinical Trials as Topic,Combined Modality Therapy,DNA Damage,DNA Replication,Humans,Molecular Targeted Therapy,Neoplasms,Protein Kinase Inhibitors,Protein Kinases,Signal Transduction||Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|Angiogenesis Inhibitors,Animals,Cell Hypoxia,Humans,Neoplasm Invasiveness,Neoplasm Metastasis,Neoplasms,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,TOR Serine-Threonine Kinases,Tumor Microenvironment,Vascular Endothelial Growth Factor A|Cell Line,Tumor,Endothelial Cells,Human Umbilical Vein Endothelial Cells,Humans,Imidazoles,Phosphatidylinositol 3-Kinases,Quinolines,Radiation-Sensitizing Agents,TOR Serine-Threonine Kinases|Humans,Neoplasms,Antineoplastic Combined Chemotherapy Protocols,Radiation-Sensitizing Agents,Treatment Failure,Immunotherapy,Combined Modality Therapy,Signal Transduction,Cell Hypoxia,DNA Repair,Clinical Trials as Topic,Molecular Targeted Therapy,Chemoradiotherapy,Adjuvant|Cell Line,Tumor,HCT116 Cells,Hela Cells,Humans,Neoplasms,DNA Damage,Pyrithiamine,Thiamin Pyrophosphokinase,Thiamine,Radiation-Sensitizing Agents,Colony-Forming Units Assay,Transfection,Radiation Tolerance,High-Throughput Screening Assays|Tumor Cells,Cultured,Fibroblasts,Humans,Adenocarcinoma,Carcinoma,Pancreatic Ductal,Pancreatic Neoplasms,Transforming Growth Factor beta,Cell Survival,Phenotype,Radiation Tolerance,Neoplastic Stem Cells,Antibodies,Neutralizing,Epithelial-Mesenchymal Transition,Pancreatic Stellate Cells,Biomarkers,Tumor||||Animals,Anoxia,Doxorubicin,Drug Delivery Systems,Female,Humans,Immunoenzyme Techniques,Indazoles,Mammary Neoplasms,Animal,Mice,Nude,Transgenic,Microvessels,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Sulfonamides"
bioc0416,clme0621,1,0.125,Journal article,Journal of Cerebral Blood Flow and Metabolism,01/01/2011,Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats,"Nagel S,Papadakis M,Chen R,Hoyte LC,Brooks KJ,Gallichan D,Sibson NR,Pugh C,Buchan AM",
bioc0416,card0039,7,1.0892857142857142,Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article,The FASEB Journal|Methods in Molecular Biology|Methods in Molecular Biology|Clinical and Experimental Metastasis|American Journal of Pathology|Methods in Molecular Biology|Proceedings of the National Academy of Sciences of USA,09/09/2011|01/01/2011|01/01/2011|01/02/2011|16/04/2013|01/01/2011|26/03/2012,VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis.|Detection of brain pathology by magnetic resonance imaging of iron oxide micro-particles.|Molecular MRI approaches to the detection of CNS inflammation.|Vascular co-option in brain metastasis|Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice.|Magnetic resonance imaging of brain inflammation using microparticles of iron oxide.|Molecular MRI enables early and sensitive detection of brain metastases.,"Serres S,Mardiguian S,Campbell SJ,McAteer MA,Akhtar A,Krapitchev A,Choudhury RP,Anthony DC,Sibson NR|Anthony DC,Sibson NR,McAteer MA,Davis B,Choudhury RP|Sibson NR,Anthony DC,van Kasteren S,Dickens A,Perez-Balderas F,McAteer MA,Choudhury RP,Davis BG|Muschel R,Ferjancic S,Carbonell WS,Balasthan L,Choudhury R,Sibson N,Serres S|Mardiguian S,Serres S,Ladds E,Campbell SJ,Wilainam P,McFadyen C,McAteer M,Choudhury RP,Smith P,Saunders F,Watt G,Sibson NR,Anthony DC|McAteer MA,von Zur Muhlen C,Anthony DC,Sibson NR,Choudhury RP|Serres S,Soto MS,Hamilton A,McAteer MA,Carbonell WS,Robson MD,Ansorge O,Khrapitchev A,Bristow C,Balathasan L,Weissensteiner T,Anthony DC,Choudhury RP,Muschel RJ,Sibson NR","Animals,Brain,Contrast Media,Disease Models,Animal,Disease Progression,Encephalomyelitis,Autoimmune,Experimental,Endothelium,Female,Ferric Compounds,Gadolinium DTPA,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Multiple Sclerosis,Translational Medical Research,Vascular Cell Adhesion Molecule-1|Animals,Brain,Cell Line,Contrast Media,Ferric Compounds,Magnetic Resonance Imaging,Male,Mice,Particle Size,Rats,Wistar|Animals,Antibodies,Antigens,CD15,Central Nervous System,Endothelial Cells,Ferric Compounds,Inflammation,Magnetic Resonance Imaging,Mice,Rats,Statistics as Topic,Tumor Necrosis Factor-alpha,Vascular Cell Adhesion Molecule-1||Acute Disease,Animals,Antibodies,Monoclonal,Brain,Contrast Media,Drug Evaluation,Preclinical,Encephalomyelitis,Autoimmune,Experimental,Female,Gadolinium DTPA,Gene Expression Regulation,Interleukin-17,Magnetic Resonance Imaging,Mice,Biozzi,Motor Activity,RNA,Messenger,Remission Induction,Secondary Prevention,Severity of Illness Index,Treatment Outcome,Vascular Cell Adhesion Molecule-1|Animals,Encephalitis,Ferric Compounds,Magnetic Resonance Imaging,Mice,Particle Size,Vascular Cell Adhesion Molecule-1|Animals,Brain Neoplasms,Disease Progression,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Sensitivity and Specificity,Up-Regulation,Vascular Cell Adhesion Molecule-1"
raob0087,raob0095,13,1.8354617604617602,Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper,Journal of Nuclear Medicine|Journal of Nuclear Medicine|Metallomics: integrated biometal science|European Journal of Nuclear Medicine and Molecular Imaging|EJNMMI Research|Journal of Nuclear Medicine|Nuclear Medicine and Biology|EJNMMI Research|Journal of Nuclear Medicine|PLoS One|Nuclear Medicine and Biology|Journal of Magnetic Resonance Imaging|Journal of Labelled Compounds and Radiopharmaceuticals,01/12/2014|12/12/2013|13/03/2015|01/10/2011|20/02/2012|07/10/2011|17/07/2012|01/01/2012|15/04/2011|01/01/2011|01/01/2012|28/09/2012|01/02/2013,"Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.|A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.|A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.|Auger electron therapy using In-111-labelled F3 peptide|111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.|Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality.|Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.|111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin|ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.|Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.|Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical|Subcutaneous tumor volume measurement in the awake, manually restrained mouse using MRI.|Imaging of hypoxia using CuATSM","Cornelissen B,Able S,Kartsonaki C,Kersemans V,Allen PD,Cavallo F,Cazier JB,Iezzi M,Knight J,Muschel R,Smart S,Vallis KA|Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ|Hueting R,Kersemans V,Tredwell M,Cornelissen B,Christlieb M,Gee AD,Passchier J,Smart SC,Gouverneur V,Muschel RJ,Dilworth JR|Cornelissen B,Waller A,Target C,Kersemans V,Smart S,Vallis KA|Cornelissen B,Waller A,Target C,Kersemans V,Smart S,Vallis KA|Kersemans V,Thompson J,Cornelissen B,Woodcock M,Allen PD,Buls N,Muschel RJ,Hill MA,Smart SC|Cornelissen B,Darbar S,Kersemans V,Allen D,Falzone N,Barbeau J,Smart S,Vallis KA|Cornelissen B,Waller A,Target C,Kersemans V,Smart S,Vallis KA|Cornelissen B,Darbar S,Hernandez R,Kersemans V,Tullis I,Barber PR,Smart S,Vojnovic B,Reilly R,Vallis KA|Kersemans V,Cornelissen B,Hueting R,Tredwell M,Hussien K,Allen PD,Falzone N,Hill SA,Dilworth JR,Gouverneur V,Muschel RJ,Smart SC|Cornelissen B,Darbar S,Kersemans V,Allen D,Falzone N,Barbeau J,Smart S,Vallis KA|Kersemans V,Cornelissen B,Allen PD,Beech JS,Smart SC|Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ","Animals,Mice,Inbred BALB C,Mammary Neoplasms,Experimental,Precancerous Conditions,DNA Damage,Disease Progression,Immunoconjugates,Radiopharmaceuticals,Tomography,Emission-Computed,Single-Photon,Magnetic Resonance Imaging,Tissue Distribution,Image Processing,Computer-Assisted,Female|64Cu-ATSM,64Cu-acetate,copper metabolism,hypoxia,Acetates,Animals,Anoxia,Cell Line,Tumor,Copper,Copper Radioisotopes,Female,Humans,Immunohistochemistry,Mice,Inbred CBA,Neoplasm Transplantation,Organometallic Compounds,Oxygen,Positron-Emission Tomography,Prognosis,Thiosemicarbazones,Time Factors|Cell Line,Animals,Humans,Mice,Neoplasms,Anoxia,Copper Radioisotopes,Organometallic Compounds,Thiosemicarbazones,Positron-Emission Tomography,Tomography,Emission-Computed,Single-Photon,Tissue Distribution,Female|||Animals,DNA Breaks,Double-Stranded,Histones,Jejunum,Liver,Mice,Positron-Emission Tomography,Quality Control,Radiation Dosage,Radiation Injuries,Experimental,Reference Standards,Time Factors,Tomography,Emission-Computed,Single-Photon,X-Ray Microtomography|Animals,Bleomycin,Breast Neoplasms,Cell Line,Tumor,Cell Transformation,Neoplastic,DNA Breaks,Double-Stranded,DNA Damage,Dose-Response Relationship,Radiation,Female,Histones,Humans,Immunoconjugates,Indium Radioisotopes,Mice,Molecular Targeted Therapy,Pentetic Acid,Peptide Fragments,Radiometry,Radiopharmaceuticals,tat Gene Products,Human Immunodeficiency Virus||Active Transport,Cell Nucleus,Animals,Antibodies,Monoclonal,Humanized,Cell Line,Tumor,Cell Proliferation,Colony-Forming Units Assay,Dimethylallyltranstransferase,Electrons,Epidermal Growth Factor,Female,Humans,Imidazoles,Mice,Pentetic Acid,Protein Kinase Inhibitors,Protein Transport,Receptor,ErbB-2,Signal Transduction,Trastuzumab|Adenocarcinoma,Anesthesia,Animals,Anoxia,Copper Radioisotopes,Female,Fluorine Radioisotopes,Gases,Mice,Inbred CBA,Misonidazole,Muscles,Neoplasms,Experimental,Organometallic Compounds,Organotechnetium Compounds,Oxygen,Positron-Emission Tomography,Radiation-Sensitizing Agents,Radiopharmaceuticals,Thiosemicarbazones,Tissue Distribution,Tomography,Emission-Computed,Single-Photon||Adenocarcinoma,Animals,Cell Line,Tumor,Humans,Magnetic Resonance Imaging,Mice,Patient Positioning,Reproducibility of Results,Restraint,Physical,Sensitivity and Specificity,Skin Neoplasms,Tumor Burden,Wakefulness|"
clme0946,clme1136,1,0.16666666666666666,Journal article,PLoS One,15/12/2013,Centrosomal localisation of the Cancer/Testis (CT) antigens NY-ESO-1 and MAGE-C1 is regulated by proteasome activity in tumour cells,"Pagotto A,Caballero OL,Volkmar N,Devalle S,Simpson AJ,Lu X,Christianson JC","Cell Line,Tumor,NIH 3T3 Cells,Centrosome,Animals,Humans,Mice,Neoplasms,Proteasome Endopeptidase Complex,Membrane Proteins,Neoplasm Proteins,RNA,Small Interfering,Antigens,Neoplasm,Immunotherapy,Gene Expression Profiling,Antigen Presentation,Gene Expression Regulation,Neoplastic,Protein Structure,Tertiary,Proteasome Inhibitors"
donc0120,raob0096,3,0.2205128205128205,Conference paper|Journal article|Conference paper,Annals of Oncology|Radiotherapy and Oncology|Journal of Clinical Oncology,01/06/2015||20/05/2015,"Clinical outcomes of a phase II study of nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy in locally-advanced pancreatic cancer - functional imaging is prognostic and provides proof of mechanism|ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.|ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)-Mechanism and clinical outcomes.","Wilson J,Hackett S,Durrant L,Dutton S,Chu K-Y,Eccles C,Abraham A,O'Neill E,Partridge M,Hawkins M,McKenna W,Maughan T,Brunner T,Mukherjee S|Wilson JM,Fokas E,Dutton SJ,Patel N,Hawkins MA,Eccles C,Chu KY,Durrant L,Abraham AG,Partridge M,Woodward M,O'Neill E,Maughan T,McKenna WG,Mukherjee S,Brunner TB|Wilson JM,Dutton SJ,Hackett SL,Durrant L,Chu K-Y,Eccles C,Abraham AG,O'Neill E,Partridge M,Hawkins MA,McKenna WG,Maughan T,Brunner TB,Mukherjee S",||
clme0240,immd0082,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clab0101,immd0556,1,0.02127659574468085,Journal article,Cancer Cell,16/06/2014,Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo,"Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW",
clar0295,raob0051,1,0.030303030303030304,Journal article,Physical Review Special Topics: Accelerators and Beams,11/03/2013,Conceptual design of a nonscaling fixed field alternating gradient accelerator for protons and carbon ions for charged particle therapy,"Peach KJ,Aslaninejad M,Barlow RJ,Beard CD,Bliss N,Cobb JH,Easton MJ,Edgecock TR,Fenning R,Gardner ISK,Hill MA,Owen HL,Johnstone CJ,Jones B,Jones T,Kelliher DJ,Khan A,Machida S,McIntosh PA,Pattalwar S,Pasternak J,Pozimski J,Prior CR,Rochford J,Rogers CT,Seviour R,Sheehy SL,Smith SL,Strachan J,Tygier S,Vojnovic B,Wilson P,Witte H,Yokoi T",
immd0036,lina0435,4,0.4075870103393039,Journal article|Conference paper|Journal article|Journal article,Proceedings of the National Academy of Sciences of USA|Environmental and Molecular Mutagenesis|Nature Genetics|Nature Genetics,20/11/2013|01/10/2011|13/07/2014|18/05/2015,"Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline.|The Effect of Advanced Paternal Age on Genetic Risks Is Mediated through Dysregulation of HRAS Signalling in the Testis.|Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.","Giannoulatou E,McVean G,Taylor IB,McGowan SJ,Maher GJ,Iqbal Z,Pfeifer SP,Turner I,Burkitt Wright EM,Shorto J,Itani A,Turner K,Gregory L,Buck D,Rajpert-De Meyts E,Looijenga LH,Kerr B,Wilkie AO,Goriely A|Goriely A,McGowan SJ,Pfeifer S,Itani A,McVean GAT,Wilkie AOM|Rimmer A,Phan H,Mathieson I,Iqbal Z,Twigg SR,Wilkie AO,McVean G,Lunter G|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","RASopathy,male mutation bias,paternal age effect,testis,Adult,Aged,Aging,Carcinogenesis,Codon,Costello Syndrome,Germ Cells,Humans,Male,Middle Aged,Models,Statistical,Mutation,Proto-Oncogene Proteins p21(ras),Selection,Genetic||WGS500 Consortium,Humans,HLA Antigens,Sensitivity and Specificity,Chromosome Mapping,Sequence Analysis,DNA,Genotype,Haplotypes,Mutation,Polymorphism,Single Nucleotide,Genome,Human,Algorithms,Software,Genomic Structural Variation,High-Throughput Nucleotide Sequencing,Exome|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0149,smlea,2,0.14285714285714285,Journal article|Journal article,Gut|Gut,01/01/2011|06/05/2011,Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection|Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.,"Fitzmaurice K,Petrovic D,Ramamurthy N,Simmons R,Merani S,Gaudieri S,Sims S,Dempsey E,Freitas E,Lea S,McKiernan S,Norris S,Long A,Kelleher D,Klenerman P|Fitzmaurice K,Petrovic D,Ramamurthy N,Simmons R,Merani S,Gaudieri S,Sims S,Dempsey E,Freitas E,Lea S,McKiernan S,Norris S,Long A,Kelleher D,Klenerman P","|Adult,Alleles,CD8-Positive T-Lymphocytes,Cohort Studies,DNA Footprinting,Electroporation,Epitopes,T-Lymphocyte,Female,Genetic Fitness,HLA-A3 Antigen,Hepatitis C,Humans,Immunodominant Epitopes,Protein Biosynthesis,Sequence Alignment"
card0027,immd0024,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
awatts,ocms0064,2,0.3333333333333333,Conference paper|Journal article,European Biophysics Journal|Nano Letters: a journal dedicated to nanoscience and nanotechnology,01/07/2013|10/01/2011,Probing GPCR-G alpha interactions: A functional study by EM and SPR|DNA-templated protein arrays for single-molecule imaging.,"Adamson RJ,Sharp TH,Selmi DN,Goddard AD,Gilbert RJ,Turberfield AJ,Watts A|Selmi DN,Adamson RJ,Attrill H,Goddard AD,Gilbert RJ,Watts A,Turberfield AJ","|DNA,Equipment Failure Analysis,Molecular Probe Techniques,Nanotechnology,Protein Array Analysis"
immd0024,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0031,immd0218,5,0.6324786324786325,Conference paper|Journal article|Journal article|Journal article|Conference paper,Clinical and Experimental Rheumatology|Journal of Immunology|PLoS One|Journal of Immunology|Immunology,01/01/2014|12/01/2015|01/01/2015|16/05/2012|01/12/2013,A MOLECULAR BASIS FOR THE KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR3DL2 BINDING TO HLA-B27 FREE HEAVY CHAIN DIMERS|The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.|The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains.|HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.|Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands,"Hatano H,Shaw J,Marquardt K,Zhang Z,Gauthier L,Chanteux S,Rossi B,Li D,Mitchell J,Kollnberger S|Hatano H,Shaw J,Marquardt K,Zhang Z,Gauthier L,Chanteux S,Rossi B,Li D,Mitchell J,Kollnberger S|Zhang Z,Hatano H,Shaw J,Olde Nordkamp M,Jiang G,Li D,Kollnberger S|Giles J,Shaw J,Piper C,Wong-Baeza I,McHugh K,Ridley A,Li D,Lenart I,Antoniou AN,DiGleria K,Kuroki K,Maenaka K,Bowness P,Kollnberger S|Hatano H,Marquardt K,Shaw J,Zhang Z,Li D,Bowness P,Kollnberger S","|Killer Cells,Natural,Cell Line,Humans,HLA-B27 Antigen,Flow Cytometry,Immunoprecipitation,Protein Structure,Tertiary,Protein Binding,Models,Molecular,Receptors,KIR3DL2,Protein Multimerization|Cell Line,Animals,Humans,Rats,Receptors,Immunologic,Antigens,CD,HLA-B7 Antigen,HLA-B27 Antigen,Protein Binding|Antigen Presentation,Flow Cytometry,HLA Antigens,HLA-B27 Antigen,Humans,Immunoglobulin Heavy Chains,Jurkat Cells,Ligands,Lymphocyte Activation,Membrane Glycoproteins,Protein Multimerization,Receptors,Immunologic,Spondylarthritis,Surface Plasmon Resonance|"
clme1037,immd0330,1,0.1111111111111111,Journal article,Expert Review of Precision Medicine and Drug Development,,Regulatory barriers to the advancement of precision medicine,"Pettitt D,Smith J,Meadows N,Arshad Z,Schuh A,DiGiusto D,Bountra C,Holländer G,Barker R,Brindley D",
clne0102,engs0357,8,1.9023809523809523,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper,Med Image Comput Comput Assist Interv|IEEE Transactions on Medical Imaging|Lecture Notes in Computer Science|Lecture Notes in Computer Science|Lecture Notes in Computer Science|Medical Image Analysis|Med Image Comput Comput Assist Interv|Proceedings / IEEE International Symposium on Biomedical Imaging: from nano to macro. IEEE International Symposium on Biomedical Imaging,01/01/2012|01/01/2013|01/01/2013|01/01/2013|01/01/2013|01/01/2012|01/01/2013|01/01/2012,Globally optimal deformable registration on a minimum spanning tree using dense displacement sampling.|MRF-Based deformable registration and ventilation estimation of lung CT|The impact of heterogeneity and uncertainty on prediction of response to therapy using dynamic MRI data|Towards realtime multimodal fusion for image-guided interventions using self-similarities|Edge- and detail-preserving sparse image representations for deformable registration of chest MRI and CT volumes|MIND: Modality independent neighbourhood descriptor for multi-modal deformable registration|The impact of heterogeneity and uncertainty on prediction of response to therapy using dynamic MRI data.|Textural mutual information based on cluster trees for multimodal deformable registration,"Heinrich MP,Jenkinson M,Sir Michael Brady,Schnabel JA|Heinrich MP,Jenkinson M,Brady M,Schnabel JA|Bhushan M,Schnabel JA,Chappell M,Gleeson F,Anderson M,Franklin J,Brady M,Jenkinson M|Heinrich MP,Jenkinson M,Papiez BW,Brady M,Schnabel JA|Heinrich MP,Jenkinson M,Papiez BW,Glesson FV,Brady SM,Schnabel JA|Heinrich MP,Jenkinson M,Bhushan M,Matin T,Gleeson FV,Brady SM,Schnabel JA|Bhushan M,Schnabel JA,Chappell M,Gleeson F,Anderson M,Franklin J,Brady SM,Jenkinson M|Heinrich MP,Jenkinson M,Brady SM,Schnabel JA","Algorithms,Humans,Imaging,Three-Dimensional,Lung,Pattern Recognition,Automated,Radiographic Image Enhancement,Radiographic Image Interpretation,Computer-Assisted,Radiography,Thoracic,Reproducibility of Results,Sensitivity and Specificity,Subtraction Technique,Tomography,X-Ray Computed|||multimodal similarity,discrete optimisation,neurosurgery|||Algorithms,Colorectal Neoplasms,Computer Simulation,Contrast Media,Data Interpretation,Statistical,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Meglumine,Models,Biological,Organometallic Compounds,Outcome Assessment (Health Care),Prognosis,Reproducibility of Results,Sensitivity and Specificity,Treatment Outcome|"
immd0330,immd0556,4,0.43960008245722526,Journal article|Journal article|Journal article|Journal article,Nature Communications|Cancer Cell|New England Journal of Medicine|Blood,|18/01/2011|01/01/2012|27/03/2013,"Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms.|Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.|Germline JAK2 mutation in a family with hereditary thrombocytosis|Impact of isolated germline JAK2V617I mutation on human hematopoiesis.","Tapper W,Jones AV,Kralovics R,Harutyunyan AS,Zoi K,Leung W,Godfrey AL,Guglielmelli P,Callaway A,Ward D,Aranaz P,White HE,Waghorn K,Lin F,Chase A,Baxter EJ,Maclean C,Nangalia J,Chen E,Evans P,Short M,Jack A,Wallis L,Oscier D,Duncombe AS,Schuh A,Mead AJ,Griffiths M,Ewing J,Gale RE,Schnittger S,Haferlach T,Stegelmann F,Döhner K,Grallert H,Strauch K,Tanaka T,Bandinelli S,Giannopoulos A,Pieri L,Mannarelli C,Gisslinger H,Barosi G,Cazzola M,Reiter A,Harrison C,Campbell P,Green AR,Vannucchi A,Cross NC|Goardon N,Marchi E,Atzberger A,Quek L,Schuh A,Soneji S,Woll P,Mead A,Alford KA,Rout R,Chaudhury S,Gilkes A,Knapper S,Beldjord K,Begum S,Rose S,Geddes N,Griffiths M,Standen G,Sternberg A,Cavenagh J,Hunter H,Bowen D,Killick S,Robinson L,Price A,Macintyre E,Virgo P,Burnett A,Craddock C,Enver T,Jacobsen SE,Porcher C,Vyas P|Mead AJ,Rugless MJ,Jacobsen SEW,Schuh A|Mead AJ,Chowdhury O,Pecquet C,Dusa A,Woll P,Atkinson D,Burns A,Score J,Rugless M,Clifford R,Moule S,Bienz N,Vyas P,Cross N,Gale RE,Henderson S,Constantinescu SN,Schuh A,Jacobsen SE","Humans,Myeloproliferative Disorders,Polycythemia Vera,Genetic Predisposition to Disease,GTP-Binding Proteins,Telomerase,Calreticulin,DNA-Binding Proteins,Peptide Elongation Factors,Transcription Factors,Case-Control Studies,Cohort Studies,Gene Frequency,Genotype,Mutation,Polymorphism,Single Nucleotide,Alleles,Proto-Oncogenes,Genes,myb,Adult,Aged,Middle Aged,Female,Male,HSP70 Heat-Shock Proteins,Receptors,Thrombopoietin,Janus Kinase 2,Thrombocythemia,Essential,Genetic Variation|Adult,Aged,80 and over,Animals,Antigens,CD,CD34,CD45,Cell Differentiation,Cell Lineage,Gene Expression Profiling,Graft Survival,Granulocyte-Macrophage Progenitor Cells,Hematopoietic Stem Cells,Humans,Immunophenotyping,Leukemia,Myeloid,Acute,Lymphoid Progenitor Cells,Mice,Inbred NOD,SCID,Middle Aged,Neoplastic Stem Cells,Transplantation,Heterologous,Young Adult||Adult,Amino Acid Substitution,Animals,Cells,Cultured,Family,Female,Germ-Line Mutation,Hematopoiesis,Humans,Isoleucine,Janus Kinase 2,Male,Mice,Inbred NOD,Transgenic,Middle Aged,Myeloproliferative Disorders,Valine"
clab0025,clab0025,1,0.1111111111111111,Journal article,Oncotarget,,FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.,"Wong KK,Gascoyne DM,Soilleux EJ,Lyne L,Spearman H,Roncador G,Pedersen LM,Møller MB,Green TM,Banham AH",
whgu0139,whgu0172,2,0.06451612903225806,Journal article|Journal article,Nature Chemical Biology|Nature Chemical Biology,01/01/2012|01/01/2012,Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.,"Ge W,Wolf A,Feng T,Ho C-H,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TDW,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,Mccullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ","|Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes"
card0039,clne0024,5,0.5468975468975469,Conference paper|Journal article|Journal article|Conference paper|Journal article,Atherosclerosis|Radiology|Journal of the American College of Cardiology Cardiovascular Imaging|European Heart Journal|JACC: Cardiovascular Imaging,01/12/2014|11/06/2014|01/01/2012|01/09/2014|01/04/2012,"IN-VIVO CAROTID PLAQUES CHARACTERISATION USING QUANTITATIVE T2 MAP: HISTOLOGICAL VALIDATION AND LIPID QUANTIFICATION|Black-blood multicontrast imaging of carotid arteries with DANTE-prepared 2D and 3D MR imaging.|Acute 3T Magnetic Resonance Imaging Reveals Features of Carotid Atherosclerotic Plaque Associated with Ipsilateral Cerebral Infarction in Minor Stroke and Transient Ischemic Attack.|Characterisation of carotid plaques by in-vivo quantitative T2 mapping: histological validation and lipid quantification|Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study.","Chai JT,Biasiolli L,Li L,Handa A,Perkins J,Hands L,Sideso E,Jezzard P,Robson MD,Choudhury RP|Li L,Chai JT,Biasiolli L,Robson MD,Choudhury RP,Handa AI,Near J,Jezzard P|Lindsay AC,Biasiolli L,Lee JMS,Kylintireas,MacIntosh,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury R|Chai JT,Biasiolli L,Li L,Handa A,Perkins J,Hands L,Sideso E,Jezzard P,Robson MD,Choudhury RP|Lindsay AC,Biasiolli L,Lee JM,Kylintireas I,MacIntosh BJ,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury RP","|Humans,Carotid Stenosis,Image Interpretation,Computer-Assisted,Imaging,Three-Dimensional,Magnetic Resonance Angiography,Case-Control Studies,Adolescent,Adult,Aged,Middle Aged,Male,Signal-To-Noise Ratio|||Aged,Brain,Carotid Arteries,Case-Control Studies,Cerebral Infarction,Diagnosis,Differential,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Magnetic Resonance Imaging,Male,Plaque,Atherosclerotic,Prospective Studies,Risk Factors"
dops0137,raob0128,1,0.25,Journal article,Journal of Materials Science: Materials in Medicine,01/08/2015,Synthesis and characterization of polystyrene embolization particles doped with tantalum oxide nanoparticles for X-ray contrast.,"Morrison R,Thompson J,Bird L,Hill MA,Townley H","Humans,Neoplasms,Oxides,Tantalum,Polystyrenes,Contrast Media,Tomography,X-Ray Computed,Microscopy,Electron,Transmission,Embolization,Therapeutic,Materials Testing,Particle Size,Metal Nanoparticles"
dpag0225,dpag0225,1,0.5,Book,,01/12/2011,Advances in Genetics,"Friedman T,Dunlap JC,Goodwin SF",Medical
immd0082,whgu0256,1,0.125,Journal article,Nature Genetics,01/01/2012,Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression,"Schödel J,Bardella C,Sciesielski LK,Brown JM,Pugh CW,Buckle V,Tomlinson IP,Ratcliffe PJ,Mole DR",
immd0084,immd0198,1,0.01098901098901099,Journal article,Autophagy,01/01/2012,Guidelines for the use and interpretation of assays for monitoring autophagy,"Klionsky DJ,Abdalla FC,Abeliovich H,Abraham RT,Acevedo-Arozena A,Adeli K,Agholme L,Agnello M,Agostinis P,Aguirre-Ghiso JA,Ahn HJ,Ait-Mohamed O,Ait-Si-Ali S,Akematsu T,Akira S,Al-Younes HM,Al-Zeer MA,Albert ML,Albin RL,Alegre-Abarrategui J,Aleo MF,Alirezaei M,Almasan A,Almonte-Becerril M,Amano A,Amaravadi R,Amarnath S,Amer AO,Andrieu-Abadie N,Anantharam V,Ann DK,Anoopkumar-Dukie S,Aoki H,Apostolova N,Arancia G,Aris JP,Asanuma K,Asare NYO,Ashida H,Askanas V,Askew DS,Auberger P,Baba M,Backues SK,Baehrecke EH,Bahr BA,Bai XY,Bailly Y,Baiocchi R,Baldini G,Balduini W,Ballabio A,Bamber BA,Bampton ETW,Bánhegyi G,Bartholomew CR,Bassham DC,Bast RC,Batoko H,Bay BH,Beau I,Béchet DM,Begley TJ,Behl C,Behrends C,Bekri S,Bellaire B,Bendall LJ,Benetti L,Berliocchi L,Bernardi H,Bernassola F,Besteiro S,Bhatia-Kissova I,Bi X,Biard-Piechaczyk M,Blum JS,Boise LH,Bonaldo P,Boone DL,Bornhauser BC,Bortoluci KR,Bossis I,Bost F,Bourquin JP,Boya P,Boyer-Guittaut M,Bozhkov PV,Brady NR,Brancolini C,Brech A,Brenman JE",
card0027,clne0009,3,0.05092909647080308,Journal article|Journal article|Journal article,Stroke|J Am Coll Cardiol|Circulation,21/11/2013|01/01/2012|22/08/2013,Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants.|Apolipoprotein(a) Genetic Sequence Variants Associated With SystemicAtherosclerosis and Coronary Atherosclerotic Burden But Not With VenousThromboembolism|Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.,"Dichgans M,Malik R,König IR,Rosand J,Clarke R,Gretarsdottir S,Thorleifsson G,Mitchell BD,Assimes TL,Levi C,O'Donnell CJ,Fornage M,Thorsteinsdottir U,Psaty BM,Hengstenberg C,Seshadri S,Erdmann J,Bis JC,Peters A,Boncoraglio GB,März W,Meschia JF,Kathiresan S,Ikram MA,McPherson R,Stefansson K,Sudlow C,Reilly MP,Thompson JR,Sharma P,Hopewell JC,Chambers JC,Watkins H,Rothwell PM,Roberts R,Markus HS,Samani NJ,Farrall M,Schunkert H,METASTROKE Consortium,CARDIoGRAM Consortium,C4D Consortium,International Stroke Genetics Consortium|Helgadóttir A,Gretarsdottir S,Thorleifsson G,Holm H,Patel RS,Gudnason T,Jones GT,van Rij AM,Eapen DJ,Mayosi BM,Keavney B,Strawbridge RJ,Sabater-Lleal M,Gertow K,Baldassarre D,Nyyssönen K,Rauramaa R,Smit AJ,Mannarino E,Giral P,Tremoli E,de Faire U,Humphries SE,Hamsten A,Haraldsdottir V,Olafsson I,Magnusson MK,Samani NJ,Levey AI,Markus HS,Kostulas K,Dichgans M,Berger K,Kuhlenbäumer G,Ringelstein BE,Stoll M,Seedorf U,Rothwell PM,Powell JT,Kuivaniemi H,Onundarson PT,Valdimarsson E,Matthiasson SE,Gudbjartsson DF,Thorgeirsson G,Quyyumi AA,Watkins H,Farrall M,Thorsteinsdottir U,Stefansson K|Sabater-Lleal M,Huang J,Chasman D,Naitza S,Dehghan A,Johnson AD,Teumer A,Reiner AP,Folkersen L,Basu S,Rudnicka AR,Trompet S,Mälarstig A,Baumert J,Bis JC,Guo X,Hottenga JJ,Shin SY,Lopez LM,Lahti J,Tanaka T,Yanek LR,Oudot-Mellakh T,Wilson JF,Navarro P,Huffman JE,Zemunik T,Redline S,Mehra R,Pulanic D,Rudan I,Wright AF,Kolcic I,Polasek O,Wild SH,Campbell H,Curb JD,Wallace R,Liu S,Eaton CB,Becker DM,Becker LC,Bandinelli S,Räikkönen K,Widen E,Palotie A,Fornage M,Green D,Gross M,Davies G,Harris SE,Liewald DC,Starr JM,Williams FM,Grant PJ,Spector TD,Strawbridge RJ,Silveira A,Sennblad B,Rivadeneira F,Uitterlinden AG,Franco OH,Hofman A,van Dongen J,Willemsen G,Boomsma DI,Yao J,Swords Jenny N,Haritunians T,McKnight B,Lumley T,Taylor KD,Rotter JI,Psaty BM,Peters A,Gieger C,Illig T,Grotevendt A,Homuth G,Völzke H,Kocher T,Goel A,Franzosi MG,Seedorf U,Clarke R,Steri M,Tarasov KV,Sanna S,Schlessinger D,Stott DJ,Sattar N,Buckley BM,Rumley A,Lowe GD,McArdle WL,Chen MH,Tofler GH,Song J,Boerwinkle E,Folsom AR,Rose LM,Franco-Cereceda A,Teichert M,Ikram MA,Mosley TH,Bevan S,Dichgans M,Rothwell PM,Sudlow CL,Hopewell JC,Chambers JC,Saleheen D,Kooner JS,Danesh J,Nelson CP,Erdmann J,Reilly MP,Kathiresan S,Schunkert H,Morange PE,Ferrucci L,Eriksson JG,Jacobs D,Deary IJ,Soranzo N,Witteman JC,de Geus EJ,Tracy RP,Hayward C,Koenig W,Cucca F,Jukema JW,Eriksson P,Seshadri S,Markus HS,Watkins H,Samani NJ,VTE Consortium,STROKE Consortium,Wellcome Trust Case Control Consortium 2 (WTCCC2),C4D Consortium,CARDIoGRAM Consortium,Wallaschofski H,Smith NL,Tregouet D,Ridker PM,Tang W,Strachan DP,Hamsten A,O'Donnell CJ","coronary artery disease,genetics,meta-analysis,polymorphism,single nucleotide,stroke,Brain Ischemia,Coronary Artery Disease,Data Interpretation,Statistical,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Phenotype,Polymorphism,Single Nucleotide,Reproducibility of Results,Risk Factors,Stroke||cardiovascular diseases,fibrinogen,gene expression,genome-wide association study,Adolescent,Adult,African Continental Ancestry Group,Aged,80 and over,Cardiovascular Diseases,Coronary Artery Disease,European Continental Ancestry Group,Female,Fibrinogen,Genetic Loci,Genetic Predisposition to Disease,Genome-Wide Association Study,Hispanic Americans,Humans,Male,Middle Aged,Myocardial Infarction,Polymorphism,Single Nucleotide,Risk Factors,Stroke,Venous Thromboembolism,Young Adult"
clme0220,immd0282,4,0.30000000000000004,Journal article|Journal article|Journal article|Journal article,Cancer Cell|Angiogenesis|Cancer Cell|Angiogenesis,12/08/2013|20/08/2013|17/07/2013|01/01/2014,A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis|The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity.|A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.|The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity,"Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SYY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM|Gorsi B,Liu F,Ma X,Chico TJ,v A,Kramer KL,Bridges E,Monteiro R,Harris AL,Patient R,Stringer SE|Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM|Gorsi B,Liu F,Ma X,Chico TJA,Shrinivasan A,Kramer KL,Bridges E,Monteiro R,Harris AL,Patient R,Stringer SE","|Animals,Arteries,Ephrin-B2,Gene Expression Regulation,Developmental,Enzymologic,Glycocalyx,Morpholinos,Oligonucleotides,Antisense,Receptors,Notch,Signal Transduction,Sulfatases,Vascular Endothelial Growth Factor A,Vascular Endothelial Growth Factor Receptor-3,Veins,Zebrafish,Zebrafish Proteins|Animals,Cell Growth Processes,Endothelial Cells,Female,Genetic Predisposition to Disease,HCT116 Cells,Humans,Mice,Nude,Neoplasms,Neovascularization,Pathologic,Receptors,G-Protein-Coupled,Signal Transduction|"
whgu0256,whgu0378,1,0.125,Journal article,Nature Genetics,01/01/2012,Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression,"Schödel J,Bardella C,Sciesielski LK,Brown JM,Pugh CW,Buckle V,Tomlinson IP,Ratcliffe PJ,Mole DR",
immd0237,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0024,immd0282,4,0.5079365079365079,Journal article|Journal article|Journal article|Journal article,Cell Reports|Cell Reports|Developmental Cell|Developmental Cell,11/07/2013|02/07/2013|01/01/2013|09/01/2013,Structural Basis for LMO2-Driven Recruitment of the SCL: E47bHLH Heterodimer to Hematopoietic-Specific Transcriptional Targets|Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets.|Uncoupling VEGFA Functions in Arteriogenesis and Hematopoietic Stem Cell Specification|Uncoupling VEGFA functions in arteriogenesis and hematopoietic stem cell specification.,"ElOmari K,Hoosdally SJ,Tuladhar K,Karia D,Hall-Ponselé E,Platonova O,Vyas P,Patient R,Porcher C,Mancini EJ|El Omari K,Hoosdally SJ,Tuladhar K,Karia D,Hall-Ponselé E,Platonova O,Vyas P,Patient R,Porcher C,Mancini EJ|Leung A,Ciau-Uitz A,Pinheiro P,Monteiro R,Zuo J,Vyas P,Patient R,Porcher C|Leung A,Ciau-Uitz A,Pinheiro P,Monteiro R,Zuo J,Vyas P,Patient R,Porcher C","|Amino Acid Sequence,Animals,Binding Sites,Cell Line,Tumor,DNA,HEK293 Cells,Hematopoiesis,Humans,LIM Domain Proteins,Mice,Molecular Docking Simulation,Molecular Dynamics Simulation,Molecular Sequence Data,Mutation,Protein Multimerization,Transcription,Genetic,Zebrafish||Animals,Aorta,Arteries,Co-Repressor Proteins,Embryonic Development,Endothelial Cells,Endothelium,Vascular,Hematopoiesis,Hematopoietic Stem Cells,Morpholinos,Nuclear Proteins,Protein Isoforms,Receptor,Notch1,Signal Transduction,Transcription Factors,Transcription,Genetic,Vascular Endothelial Growth Factor A,Xenopus Proteins,Xenopus laevis"
clme1358,whgu0142,1,0.07692307692307693,Journal article,Chemistry and Biology,26/08/2015,Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.,"Canning P,Ruan Q,Schwerd T,Hrdinka M,Maki JL,Saleh D,Suebsuwong C,Ray S,Brennan PE,Cuny GD,Uhlig HH,Gyrd-Hansen M,Degterev A,Bullock AN",
card0008,immd0075,1,0.06666666666666667,Journal article,Mammalian Genome,27/04/2012,Nprl3 is required for normal development of the cardiovascular system.,"Kowalczyk MS,Hughes JR,Babbs C,Sanchez-Pulido L,Szumska D,Sharpe JA,Sloane-Stanley JA,Morriss-Kay GM,Smoot LB,Roberts AE,Watkins H,Bhattacharya S,Gibbons RJ,Ponting CP,Wood WG,Higgs DR","Abnormalities,Multiple,Amino Acid Sequence,Animals,Cardiovascular System,Cells,Cultured,DNA Mutational Analysis,Female,GTPase-Activating Proteins,Gene Expression Profiling,Genetic Association Studies,Heart Defects,Congenital,Humans,Intracellular Signaling Peptides and Proteins,Male,Mice,Knockout,Molecular Sequence Annotation,Molecular Sequence Data,Myocardium,Nuclear Proteins,Phenotype,Polymorphism,Single Nucleotide,Promoter Regions,Genetic"
clab0101,immd0024,9,0.3792028157649658,Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Conference paper,British Journal of Haematology|Cancer Cell|Cancer Cell|Blood|Blood|Nature Communications|Blood|New England Journal of Medicine|Haematologica: the hematology journal,15/04/2011|14/05/2014|16/06/2014|03/12/2015|18/11/2011|01/01/2015|12/09/2013|01/01/2011|01/06/2014,"Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee|Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts|Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.|Clinical and biological implications of driver mutations in myelodysplastic syndromes.|Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts|COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES","Pellagatti A,Cazzola M,Giagounidis A,Perry J,Malcovati L,Della Porta MG,Jädersten M,Killick S,Vyas P,Hellström-Lindberg E,Wainscoat JS,Boultwood J|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SE|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Bejar R,Papaemmanuil E,Haferlach T,Garcia-Manero G,Maciejewski JP,Sekeres MA,Walter MJ,Graubert TA,Cazzola M,Malcovati L,Ogawa S,Fenaux P,Hellstrom-Lindberg E,Kern W,Boultwood J,Pellagatti A,Bowen D,Tauro S,Groves MJ,Vyas P,Quek L,Nazha A,Thol F,Heuser M,Shih L-Y,Padron E,Sallman D,Komrokji RS,List AF,Santini V,Fontenay M,Campbell PJ,Tuechler H,Stevenson K,Neuberg DS,Greenberg P,Ebert BL|Malcovati L,Papaemmanuil E,Hellstrom-Lindberg E,Boultwood J,Bowen D,Vyas P,Pascutto C,Della Porta MG,Pellagatti A,Groves MJ,Godfrey AL,Ambaglio I,Galli A,Travaglino E,Conte S,Tauro S,Keenan N,Hyslop A,Hinton J,Mudie LJ,Passerini CG,Cross NCP,Wainscoat JS,Green AR,Futreal PA,Stratton MR,Campbell PJ,Cazzola M|Gerstung M,Pellagatti A,Malcovati L,Giagounidis A,Porta MG,Jädersten M,Dolatshad H,Verma A,Cross NC,Vyas P,Killick S,Hellström-Lindberg E,Cazzola M,Papaemmanuil E,Campbell PJ,Boultwood J|Papaemmanuil E,Gerstung M,Malcovati L,Tauro S,Gundem G,Van Loo P,Yoon CJ,Ellis P,Wedge DC,Pellagatti A,Shlien A,Groves MJ,Forbes SA,Raine K,Hinton J,Mudie LJ,McLaren S,Hardy C,Latimer C,Della Porta MG,O'Meara S,Ambaglio I,Galli A,Butler AP,Walldin G,Teague JW,Quek L,Sternberg A,Gambacorti-Passerini C,Cross NC,Green AR,Boultwood J,Vyas P,Hellstrom-Lindberg E,Bowen D,Cazzola M,Stratton MR,Campbell PJ,Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium|Papaemmanuil E,Cazzola M,Boultwood J,Malcovati L,Vyas P,Bowen D,Pellagatti A,Wainscoat JS,Hellstrom-Lindberg E,Gambacorti-Passerini C,Godfrey AL,Rapado I,Cvejic A,Rance R,McGee C,Ellis P,Mudie LJ,Stephens PJ,McLaren S,Massie CE,Tarpey PS,Varela I,Nik-Zainal S,Davies HR,Shlien A,Jones D,Raine K,Hinton J,Butler AP,Teague JW,Baxter EJ,Score J,Galli A,Della Porta MG,Travaglino E,Groves M,Tauro S,Munshi NC,Anderson KC,El-Naggar A,Fischer A,Mustonen V,Warren AJ,Cross NCP,Green AR,Futreal PA,Stratton MR,Campbell PJ|Pellagatti A,Gerstung M,Papaemmanuil E,Malcovati L,Giagounidis A,Della Porta MG,Jadersten M,Dolatshad H,Verma A,Cross NCP,Vyas P,Killick S,Hellstrom-Lindberg E,Cazzola M,Campbell PJ,Boultwood J","Anemia,Refractory,with Excess of Blasts,Chromosome Deletion,Chromosomes,Human,Pair 5,Disease Progression,Down-Regulation,Gene Expression Regulation,Genomic Instability,Humans,Nuclear Proteins,Sequence Deletion|Chromosomes,Human,Pair 5,Animals,Mice,Inbred NOD,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Genetic Predisposition to Disease,Antigens,CD,Prognosis,Flow Cytometry,Gene Expression Profiling,Mutation,Neoplastic Stem Cells,Heterografts||||Humans,Myelodysplastic Syndromes,Repressor Proteins,Prognosis,Treatment Outcome,Cohort Studies,Gene Expression Profiling,DNA Mutational Analysis,Gene Expression Regulation,Leukemic,Genotype,Mutation,Adult,Aged,80 and over,Middle Aged,Female,Male,Leukemia,Myeloid,Acute,Young Adult,Polycomb Repressive Complex 2|Aged,80 and over,Cohort Studies,Disease Progression,Epistasis,Genetic,Female,Humans,Leukemia,Myeloid,Acute,Myelomonocytic,Chronic,Male,Middle Aged,Mutation,Myelodysplastic Syndromes,Myelodysplastic-Myeloproliferative Diseases,Oncogenes,Prognosis,RNA Splicing,Spliceosomes||"
card0027,corp0784,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
cschof,whgu0172,17,1.6883978029139322,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,The Federation of European Biochemical Societies (FEBS) Journal|Journal of Molecular Biology|Nature Chemical Biology|Proteomics|Biochemical Journal|Nature Chemical Biology|Angewandte Chemie International Edition|Chemistry and Biology|Chem. Sci.|EMBO Reports|Molecular Cell|Journal of Biological Chemistry|Proceedings of the National Academy of Sciences of USA|Proceedings of the National Academy of Sciences of USA|EMBO Reports|Nucleic Acids Research|Journal of Molecular Biology,20/01/2011|01/01/2011|01/01/2012|05/06/2015|21/05/2013|01/01/2012|13/08/2013|27/05/2011|15/07/2013|07/02/2012|30/01/2014|22/02/2011|18/02/2014|18/02/2014|01/01/2012|09/06/2014|13/05/2011,Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.|Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1)|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.|Expanding the yeast protein arginine methylome.|The polyserine domain of the lysyl-5 hydroxylase Jmjd6 mediates subnuclear localization.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans|DNA modification under mild conditions by Suzuki-Miyaura cross-coupling for the generation of functional probes.|A photoreactive small-molecule probe for 2-oxoglutarate oxygenases.|The Ugi four-component reaction enables expedient synthesis and comparison of photoaffinity probes|The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity.|Optimal translational termination requires C4 lysyl hydroxylation of eRF1.|Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors.|Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy.|OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.|The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity|Jumonji domain containing protein 6 (Jmjd6) modulates splicing and specifically interacts with arginine-serine-rich (RS) domains of SR- and SR-like proteins.|Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1).,"Yang M,Chowdhury R,Ge W,Hamed RB,McDonough MA,Claridge TD,Kessler BM,Cockman ME,Ratcliffe PJ,Schofield CJ|Chowdhury R,Flashman E,Mecinović J,Kramer HB,Kessler BM,Frapart YM,Boucher JL,Clifton IJ,McDonough MA,Schofield CJ|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Plank M,Fischer R,Geoghegan V,Charles PD,Konietzny R,Acuto O,Pears C,Schofield CJ,Kessler BM|Wolf A,Mantri M,Heim A,Müller U,Fichter E,Mackeen MM,Schermelleh L,Dadie G,Leonhardt H,Vénien-Bryan C,Kessler BM,Schofield CJ,Böttger A|Ge W,Wolf A,Feng T,Ho C-H,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TDW,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,Mccullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Lercher L,McGouran JF,Kessler BM,Schofield CJ,Davis BG|Rotili D,Altun M,Kawamura A,Wolf A,Fischer R,Leung IK,Mackeen MM,Tian YM,Ratcliffe PJ,Mai A,Kessler BM,Schofield CJ|Bush JT,Walport LJ,McGouran JF,Leung IKH,Berridge G,van Berkel SS,Basak A,Kessler BM,Schofield CJ|Masson N,Singleton RS,Sekirnik R,Trudgian DC,Ambrose LJ,Miranda MX,Tian YM,Kessler BM,Schofield CJ,Ratcliffe PJ|Yamamoto A,Feng T,Wilkins S,Sokolova E,Yates L,Muenzel M,Singh P,Hopkinson R,Fischer R,Cockman M,Shelley J,Trudgian D,Schoedel J,McCullagh JO,Ge W,Kessler B,Gilbert R,Frolova L,Alkalaeva E,Ratcliffe P,Schofield C,Coleman M|Tian YM,Yeoh KK,Lee MK,Eriksson T,Kessler BM,Kramer HB,Edelmann MJ,Willam C,Pugh CW,Schofield CJ,Ratcliffe PJ|Loenarz C,Sekirnik R,Thalhammer A,Ge W,Spivakovsky E,Mackeen MM,McDonough MA,Cockman ME,Kessler BM,Ratcliffe PJ,Wolf A,Schofield CJ|Singleton RS,Liu-Yi P,Formenti F,Ge W,Sekirnik R,Fischer R,Adam J,Pollard PJ,Wolf A,Thalhammer A,Loenarz C,Flashman E,Yamamoto A,Coleman ML,Kessler BM,Wappner P,Schofield CJ,Ratcliffe PJ,Cockman ME|Masson N,Singleton RS,Sekirnik R,Trudgian DC,Ambrose LJ,Miranda MX,Tian YM,Kessler BM,Schofield CJ,Ratcliffe PJ|Heim A,Grimm C,Müller U,Häußler S,Mackeen MM,Merl J,Hauck SM,Kessler BM,Schofield CJ,Wolf A,Böttger A|Chowdhury R,Flashman E,Mecinović J,Kramer HB,Kessler BM,Frapart YM,Boucher JL,Clifton IJ,McDonough MA,Schofield CJ","Amino Acid Sequence,Ankyrin Repeat,HEK293 Cells,Histidine,Humans,Hydroxylation,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Protein Processing,Post-Translational,Protein Structure,Tertiary,Repressor Proteins,Sequence Alignment,Tankyrases||Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes|Arginine,Saccharomyces cerevisiae Proteins,Proteome,Isotope Labeling,Systems Biology,Amino Acid Sequence,Methylation,Molecular Sequence Data,Tandem Mass Spectrometry|Cell Line,Cell Nucleolus,Chromatography,Gel,Electrophoresis,Two-Dimensional,Fluorescence Recovery After Photobleaching,HeLa Cells,Humans,Immunoprecipitation,Jumonji Domain-Containing Histone Demethylases,Microscopy,Electron,Transmission,Procollagen-Lysine,2-Oxoglutarate 5-Dioxygenase,RNA Splicing||DNA,cross-coupling,oligonucleotides,palladium,photoaffinity labeling,Catalysis,Idoxuridine,Molecular Probes,Oligonucleotides,Palladium,Photoaffinity Labels|Cell Line,Cross-Linking Reagents,Dioxygenases,Enzyme Inhibitors,F-Box Proteins,Humans,Hydroxyquinolines,Jumonji Domain-Containing Histone Demethylases,Oxidoreductases,N-Demethylating,Photochemical Processes,Protein Structure,Tertiary,Small Molecule Libraries,Spectrometry,Mass,Matrix-Assisted Laser Desorption-Ionization||Cell Hypoxia,Cell Line,Cysteine,Gene Expression Regulation,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,Mixed Function Oxygenases,Peroxides,Repressor Proteins,Transcription,Genetic|Amino Acid Sequence,Animals,Catalysis,Cell Line,Tumor,Codon,Terminator,Gene Expression Regulation,HeLa Cells,Histone Demethylases,Humans,Hydrolysis,Hydroxylation,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Peptide Chain Termination,Translational,Peptide Termination Factors,Protein Biosynthesis,Protein Processing,Post-Translational,Protein Structure,Tertiary,Sequence Homology,Amino Acid|Animals,Cell Hypoxia,Drosophila melanogaster,Enzyme Inhibitors,Hep G2 Cells,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,K562 Cells,Male,Oxygenases,Protein Structure,Tertiary,Rats,Sprague-Dawley,Ubiquitin-Protein Ligases,p300-CBP Transcription Factors|2-oxoglutarate oxygenase,hypoxia,nonsense readthrough,ribosomal hydroxylation,translation,Chlorophyta,Codon,Terminator,Humans,Hydroxylation,Mass Spectrometry,Oxygenases,Protein Biosynthesis,Protein Processing,Post-Translational,Ribosomal Proteins,Ribosomes,Saccharomyces cerevisiae,Schizosaccharomyces,Species Specificity|2-oxoglutarate oxygenase,hypoxia,ribosome,translational control,Analysis of Variance,Carrier Proteins,Computational Biology,Fluorescent Antibody Technique,Gene Knockdown Techniques,Humans,Hydroxylation,Immunoblotting,Immunoprecipitation,Ketoglutaric Acids,Luciferases,Nuclear Proteins,Proline,Prolyl Hydroxylases,Protein Biosynthesis,Protein Processing,Post-Translational,Ribosomal Proteins,Yeasts||Hela Cells,Humans,RNA-Binding Proteins,Ribonucleoproteins,Nuclear Proteins,RNA,Messenger,Alternative Splicing,Protein Interaction Domains and Motifs,Jumonji Domain-Containing Histone Demethylases,HEK293 Cells|Amino Acid Sequence,Anoxia,Crystallography,X-Ray,Humans,Hypoxia-Inducible Factor 1,Hypoxia-Inducible Factor-Proline Dioxygenases,Molecular Sequence Data,Nitric Oxide,Procollagen-Proline Dioxygenase,Protein Structure,Tertiary,Spectrometry,Mass,Electrospray Ionization,Tandem Mass Spectrometry"
immd0680,ocms0037,2,0.09444444444444444,Journal article|Journal article,Nature Communications|Nature,01/01/2014|18/04/2013,Understanding functional miRNA-target interactions in vivo by site-specific genome engineering.|The African coelacanth genome provides insights into tetrapod evolution.,"Bassett AR,Azzam G,Wheatley L,Tibbit C,Rajakumar T,McGowan S,Stanger N,Ewels PA,Taylor S,Ponting CP,Liu JL,Sauka-Spengler T,Fulga TA|Amemiya CT,Alföldi J,Lee AP,Fan S,Philippe H,Maccallum I,Braasch I,Manousaki T,Schneider I,Rohner N,Organ C,Chalopin D,Smith JJ,Robinson M,Dorrington RA,Gerdol M,Aken B,Biscotti MA,Barucca M,Baurain D,Berlin AM,Blatch GL,Buonocore F,Burmester T,Campbell MS,Canapa A,Cannon JP,Christoffels A,De Moro G,Edkins AL,Fan L,Fausto AM,Feiner N,Forconi M,Gamieldien J,Gnerre S,Gnirke A,Goldstone JV,Haerty W,Hahn ME,Hesse U,Hoffmann S,Johnson J,Karchner SI,Kuraku S,Lara M,Levin JZ,Litman GW,Mauceli E,Miyake T,Mueller MG,Nelson DR,Nitsche A,Olmo E,Ota T,Pallavicini A,Panji S,Picone B,Ponting CP,Prohaska SJ,Przybylski D,Saha NR,Ravi V,Ribeiro FJ,Sauka-Spengler T,Scapigliati G,Searle SM,Sharpe T,Simakov O,Stadler PF,Stegeman JJ,Sumiyama K,Tabbaa D,Tafer H,Turner-Maier J,van Heusden P,White S,Williams L,Yandell M,Brinkmann H,Volff JN,Tabin CJ,Shubin N,Schartl M,Jaffe DB,Postlethwait JH,Venkatesh B,Di Palma F,Lander ES,Meyer A,Lindblad-Toh K","Animals,Zebrafish,Humans,Drosophila,Deoxyribonucleases,Endonucleases,DNA-Binding Proteins,MicroRNAs,Transfection,Genetic Engineering,Sequence Analysis,Base Sequence,Response Elements,Molecular Sequence Data,Transcriptional Activation,HEK293 Cells,Clustered Regularly Interspaced Short Palindromic Repeats|Animals,Genetically Modified,Biological Evolution,Chick Embryo,Conserved Sequence,Enhancer Elements,Genetic,Evolution,Molecular,Extremities,Fishes,Genes,Homeobox,Genome,Genomics,Immunoglobulin M,Mice,Molecular Sequence Annotation,Molecular Sequence Data,Phylogeny,Sequence Alignment,Sequence Analysis,DNA,Vertebrates"
immd0023,whgu0172,2,0.3611111111111111,Journal article|Journal article,Immunity|Immunity,17/10/2013|01/05/2013,Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes.|Processing of human TLR7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes,"Hipp M,Shepherd D,Gileadi U,Aichinger M,Kessler B,Edelmann M,Essalmani R,Seidah N,Reis�e�Sousa C,Cerundolo V|Hipp M,Gileadi U,Sheperd D,Reis E Sousa C,Cerundolo V","Cell Line,Endosomes,Macrophages,Humans,Orthomyxoviridae,Lentivirus,Quinolines,Furin,Proprotein Convertases,Signal Transduction,Autoimmunity,Gene Expression Regulation,Protein Processing,Post-Translational,Amino Acid Sequence,Protein Structure,Tertiary,Genetic Vectors,Molecular Sequence Data,Toll-Like Receptor 7,Feedback,Physiological|"
immd0075,path0511,1,0.058823529411764705,Journal article,Epigenetics and Chromatin,01/01/2011,Generation of bivalent chromatin domains during cell fate decisions.,"De Gobbi M,Garrick D,Lynch M,Vernimmen D,Hughes JR,Goardon N,Luc S,Lower KM,Sloane-Stanley JA,Pina C,Soneji S,Renella R,Enver T,Taylor S,Jacobsen SE,Vyas P,Gibbons RJ,Higgs DR",
robbins,stat0054,2,0.12028542303771661,Journal article|Journal article,Haematologica: the hematology journal|Nature Genetics,11/07/2014|18/05/2015,Erythrocytosis associated with a novel missense mutation in the BPGM gene.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Petousi N,Copley RR,Lappin TR,Haggan SE,Bento CM,Cario H,Percy MJ,Ratcliffe PJ,Robbins PA,McMullin MF|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","WGS Consortium,Humans,Polycythemia,Bisphosphoglycerate Mutase,Genotype,Mutation,Missense|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0237,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0497,newc0612,1,0.0625,Journal article,Journal of Medicinal Chemistry,21/03/2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.","Hewings DS,Fedorov O,Filippakopoulos P,Martin S,Picaud S,Tumber A,Wells C,Olcina MM,Freeman K,Gill A,Ritchie AJ,Sheppard DW,Russell AJ,Hammond EM,Knapp S,Brennan PE,Conway SJ","Acetylation,CREB-Binding Protein,Cell Line,Tumor,Crystallography,X-Ray,Histones,Humans,Inhibitory Concentration 50,Isoxazoles,Ligands,Lysine,Nuclear Proteins,Protein Binding,Structure-Activity Relationship,Transcription Factors"
clme0485,lina0435,1,0.010526315789473684,Journal article,Nature Genetics,01/01/2011,Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.,"Evans DM,Spencer CC,Pointon JJ,Su Z,Harvey D,Kochan G,Oppermann U,Dilthey A,Pirinen M,Stone MA,Appleton L,Moutsianas L,Leslie S,Wordsworth T,Kenna TJ,Karaderi T,Thomas GP,Ward MM,Weisman MH,Farrar C,Bradbury LA,Danoy P,Inman RD,Maksymowych W,Gladman D,Rahman P,Spondyloarthritis Research Consortium of Canada (SPARCC),Morgan A,Marzo-Ortega H,Bowness P,Gaffney K,Gaston JS,Smith M,Bruges-Armas J,Couto AR,Sorrentino R,Paladini F,Ferreira MA,Xu H,Liu Y,Jiang L,Lopez-Larrea C,Díaz-Peña R,López-Vázquez A,Zayats T,Band G,Bellenguez C,Blackburn H,Blackwell JM,Bramon E,Bumpstead SJ,Casas JP,Corvin A,Craddock N,Deloukas P,Dronov S,Duncanson A,Edkins S,Freeman C,Gillman M,Gray E,Gwilliam R,Hammond N,Hunt SE,Jankowski J,Jayakumar A,Langford C,Liddle J,Markus HS,Mathew CG,McCann OT,McCarthy MI,Palmer CN,Peltonen L,Plomin R,Potter SC,Rautanen A,Ravindrarajah R,Ricketts M,Samani N,Sawcer SJ,Strange A,Trembath RC,Viswanathan AC,Waller M,Weston P,Whittaker P,Widaa S,Wood NW,McVean G,Reveille JD,Wordsworth BP,Brown MA,Donnelly P,Australo-Anglo-American Spondyloarthritis Consortium (TASC),Wellcome Trust Case Control Consortium 2 (WTCCC2)","Aminopeptidases,CARD Signaling Adaptor Proteins,CD8-Positive T-Lymphocytes,Case-Control Studies,Core Binding Factor Alpha 3 Subunit,Disease Susceptibility,European Continental Ancestry Group,Genome-Wide Association Study,HLA-B27 Antigen,Humans,Interleukin-12 Subunit p40,Latent TGF-beta Binding Proteins,Membrane Proteins,Meta-Analysis as Topic,Peptide Fragments,Polymorphism,Genetic,Receptors,Peptide,Prostaglandin E,EP4 Subtype,Tumor Necrosis Factor,Type I,Spondylitis,Ankylosing"
clme0497,clme1037,6,0.3135288191891965,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Science Advances|Journal of Medicinal Chemistry|Cancer Research|Proceedings of the National Academy of Sciences of USA|Nature Chemical Biology|Nature Reviews Drug Discovery,01/11/2015|23/03/2015||18/11/2013|21/07/2015|01/03/2015,"Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.|Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.|Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.|RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.|The promise and peril of chemical probes.|Preclinical target validation using patient-derived cells.","Fedorov O,Castex J,Tallant C,Owen DR,Martin S,Aldeghi M,Monteiro O,Filippakopoulos P,Picaud S,Trzupek JD,Gerstenberger BS,Bountra C,Willmann D,Wells C,Philpott M,Rogers C,Biggin PC,Brennan PE,Bunnage ME,Schüle R,Günther T,Knapp S,Müller S|Chen P,Chaikuad A,Bamborough P,Bantscheff M,Bountra C,Chung CW,Fedorov O,Grandi P,Jung D,Lesniak R,Lindon M,Müller S,Philpott M,Prinjha R,Rogers C,Selenski C,Tallant C,Werner T,Willson TM,Knapp S,Drewry DH|Picaud S,Fedorov O,Thanasopoulou A,Leonards K,Jones K,Meier J,Olzscha H,Monteiro O,Martin S,Philpott M,Tumber A,Filippakopoulos P,Yapp C,Wells C,Che KH,Bannister A,Robson S,Kumar U,Parr N,Lee K,Lugo D,Jeffrey P,Taylor S,Vecellio ML,Bountra C,Brennan PE,O'Mahony A,Velichko S,Müller S,Hay D,Daniels DL,Urh M,La Thangue NB,Kouzarides T,Prinjha R,Schwaller J,Knapp S|Picaud S,Wells C,Felletar I,Brotherton D,Martin S,Savitsky P,Diez-Dacal B,Philpott M,Bountra C,Lingard H,Fedorov O,Müller S,Brennan PE,Knapp S,Filippakopoulos P|Arrowsmith CH,Audia JE,Austin C,Baell J,Bennett J,Blagg J,Bountra C,Brennan PE,Brown PJ,Bunnage ME,Buser-Doepner C,Campbell RM,Carter AJ,Cohen P,Copeland RA,Cravatt B,Dahlin JL,Dhanak D,Edwards AM,Frederiksen M,Frye SV,Gray N,Grimshaw CE,Hepworth D,Howe T,Huber KV,Jin J,Knapp S,Kotz JD,Kruger RG,Lowe D,Mader MM,Marsden B,Mueller-Fahrnow A,Müller S,O'Hagan RC,Overington JP,Owen DR,Rosenberg SH,Roth B,Ross R,Schapira M,Schreiber SL,Shoichet B,Sundström M,Superti-Furga G,Taunton J,Toledo-Sherman L,Walpole C,Walters MA,Willson TM,Workman P,Young RN,Zuercher WJ|Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","||Cell Line,Tumor,Animals,Humans,Mice,Oxazepines,Doxorubicin,Antineoplastic Combined Chemotherapy Protocols,Enzyme Inhibitors,Xenograft Model Antitumor Assays,Amino Acid Sequence,Protein Structure,Tertiary,Drug Synergism,Models,Molecular,Molecular Sequence Data,p300-CBP Transcription Factors,Leukemia,Myeloid,Acute|ApoA1,epigenetics,microarray,small molecule inhibitor,Crystallization,Fluorescence Recovery After Photobleaching,Hep G2 Cells,Humans,Models,Molecular,Molecular Structure,Oligonucleotide Array Sequence Analysis,Protein Binding,Protein Structure,Tertiary,Quinazolines,Transcription Factors|Humans,Molecular Probes,Sensitivity and Specificity,Information Dissemination,Molecular Weight,Biomedical Research,Intellectual Property,Internet,Small Molecule Libraries|SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
immd0198,whgu0378,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0220,raob0069,1,0.3333333333333333,Journal article,Future Oncology,01/11/2012,Clinical imaging of tumor angiogenesis.,"Patel N,Harris AL,Gleeson FV,Vallis KA","Animals,Diagnostic Imaging,Humans,Neoplasms,Neovascularization,Pathologic"
clme0195,path0511,1,0.058823529411764705,Journal article,Epigenetics and Chromatin,01/01/2011,Generation of bivalent chromatin domains during cell fate decisions.,"De Gobbi M,Garrick D,Lynch M,Vernimmen D,Hughes JR,Goardon N,Luc S,Lower KM,Sloane-Stanley JA,Pina C,Soneji S,Renella R,Enver T,Taylor S,Jacobsen SE,Vyas P,Gibbons RJ,Higgs DR",
clme0220,clme0975,8,0.6421957671957672,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Cancer Chemotherapy and Pharmacology|Cancer Chemotherapy and Pharmacology|British Journal of Cancer|British Journal of Cancer|Journal of National Cancer Institute|Cancer Chemotherapy and Pharmacology|British Journal of Cancer|British Journal of Cancer,20/10/2013|01/12/2013|01/01/2011|13/03/2012|27/03/2013|01/09/2011|01/01/2011|01/01/2012,"A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours.|A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours|Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer|Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate.|P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma.|A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics.|Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer|Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate","Horsley L,Cummings J,Middleton M,Ward T,Backen A,Clamp A,Dawson M,Farmer H,Fisher N,Halbert G,Halford S,Harris A,Hasan J,Hogg P,Kumaran G,Little R,Parker GJ,Potter P,Saunders M,Roberts C,Shaw D,Smith N,Smythe J,Taylor A,Turner H,Watson Y,Dive C,Jayson GC,Cancer Research UK Drug Development Office Phase I clinical trial|Horsley L,Cummings J,Middleton M,Ward T,Backen A,Clamp A,Dawson M,Farmer H,Fisher N,Halbert G,Halford S,Harris A,Hasan J,Hogg P,Kumaran G,Little R,Parker GJM,Potter P,Saunders M,Roberts C,Shaw D,Smith N,Smythe J,Taylor A,Turner H,Watson Y,Dive C,Jayson GC|Khan OA,Blann AD,Payne MJ,Middleton MR,Protheroe AS,Talbot DC,Taylor M,Han C,Patil M,Harris AL|Khan OA,Blann AD,Payne MJ,Middleton MR,Protheroe AS,Talbot DC,Taylor M,Han C,Patil M,Harris AL|Ong CC,Jubb AM,Jakubiak D,Zhou W,Rudolph J,Haverty PM,Kowanetz M,Yan Y,Tremayne J,Lisle R,Harris AL,Friedman LS,Belvin M,Middleton MR,Blackwood EM,Koeppen H,Hoeflich KP|Mitchell CL,O'Connor JP,Roberts C,Watson Y,Jackson A,Cheung S,Evans J,Spicer J,Harris A,Kelly C,Rudman S,Middleton M,Fielding A,Tessier J,Young H,Parker GJ,Jayson GC|Khan OA,Blann AD,Payne MJ,Middleton MR,Protheroe AS,Talbot DC,Taylor M,Han C,Patil M,Harris AL|Khan OA,Blann AD,Payne MJ,Middleton MR,Protheroe AS,Talbot DC,Taylor M,Han C,Patil M,Harris AL","Adult,Aged,Antineoplastic Agents,Arsenicals,Cell Proliferation,Dose-Response Relationship,Drug,Female,Glutathione,Humans,Infusions,Intravenous,Liver Function Tests,Magnetic Resonance Imaging,Male,Maximum Tolerated Dose,Middle Aged,Neoplasms,Neovascularization,Pathologic||||Animals,Antibodies,Monoclonal,Antineoplastic Agents,Cell Line,Tumor,Cell Proliferation,Female,Gene Expression Regulation,Enzymologic,Neoplastic,Humans,Immunohistochemistry,Immunoprecipitation,Melanoma,Mice,Nude,Proto-Oncogene Proteins B-raf,Signal Transduction,Skin Neoplasms,Transplantation,Heterologous,p21-Activated Kinases|Adult,Aged,Area Under Curve,Cross-Over Studies,Dose-Response Relationship,Drug,Electrocardiography,Fasting,Female,Food-Drug Interactions,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Neoplasms,Quinazolines,Tomography,X-Ray Computed,Treatment Outcome,Young Adult||"
immd0237,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0670,whgu0172,1,0.3333333333333333,Journal article,The Prostate,14/06/2013,Proteomic analysis reveals a proteolytic feedback loop in murine seminal fluid.,"McKee CM,Xu D,Kessler BM,Muschel RJ","metalloproteinase 9,protease nexin 1,seminal fluid,proteomics,Animals,Male,Matrix Metalloproteinase 9,Mice,Knockout,Proteolysis,Proteomics,Semen,Seminal Vesicles,Serpin E2"
gree0184,gree0989,11,2.802694701701802,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Medical Screening|Lancet Oncology|PLoS Medicine|Lancet|British Journal of Cancer|Lancet|BMJ|Circulation|Journal of Thoracic Oncology|Lancet Oncology|Lancet,01/01/2011|01/01/2012|01/01/2012|09/05/2015|27/03/2014|27/04/2013|01/01/2011|12/03/2013|01/11/2013|01/09/2012|26/10/2012,"Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization.|Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies|Ovarian cancer and body size: Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies|Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.|Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom.|The first generation in which many women began smoking - Authors' reply.|Authors' reply|Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study.|RISK REDUCTION BY STOPPING SMOKING|Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies|The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK.","Moser K,Sellars S,Wheaton M,Cooke J,Duncan A,Maxwell A,Michell M,Wilson M,Beral V,Peto R,Richards M,Patnick J|Hamajima N,Hirose K,Tajima K,Rohan T,Friedenreich CM,Calle EE,Gapstur SM,Patel AV,Coates RJ,Liff JM,Talamini R,Chantarakul N,Koetsawang S,Rachawat D,Marcou Y,Kakouri E,Duffy SW,Morabia A,Schuman L,Stewart W,Szklo M,Coogan PF,Palmer JR,Rosenberg L,Band P,Coldman AJ,Gallagher RP,Hislop TG,Yang P,Cummings SR,Canfell K,Sitas F,Chao P,Lissowska J,Horn-Ross PL,John EM,Kolonel LM,Nomura AMY,Ghiasvand R,Hu J,Johnson KC,Mao Y,Beral V,Bull D,Callaghan K,Crossley B,Goodill A,Green J,Hermon C,Key T,Lindgard I,Liu B,Pirie K,Reeves G,Collins R,Doll R,Peto R,Bishop T,Fentiman IS,De Sanjose S,Gonzalez CA,Lee N,Marchbanks P,Ory HW,Peterson HB,Wingo P,Ebeling K,Kunde D,Nishan P,Hopper JL,Eliassen H,Hankinson S,Gajalakshmi V,Martin N,Pardthaisong T,Silpisornkosol S,Theetranont C,Boosiri B,Chutivongse S,Jimakorn P,Virutamasen P,Wongsrichanalai C,Neugut A,Santella R,Baines CJ,Kreiger N,Miller AB,Wall C,Tjonneland A,Jorgensen T,Stahlberg C,Pedersen AT,Flesch-Janys D,Hakansson N,Cauley J,Heuch I,Adami HO,Persson I,Weiderpass E,Magnusson C,Chang-Claude J,Kaaks R,McCredie M,Paul C,Skegg DCG,Spears GFS,Iwasaki M,Tsugane S,Anderson G,Daling JR,Hampton J,Hutchinson WB,Li CI,Malone K,Mandelson M,Newcomb P,Noonan EA,Ray RM,Stanford JL,Tang MTC,Thomas DB,Weiss NS,White E,Izquierdo A,Viladiu P,Fourkala EO,Jacobs I,Menon U,Ryan A,Cuevas HR,Ontiveros P,Palet A,Salazar SB,Aristizabal N,Cuadros A,Tryggvadottir L,Tulinius H,Riboli E,Andrieu N,Bachelot A,Le MG,Bremond A,Gairard B,Lansac J,Piana L,Renaud R,Clavel-Chapelon F,Fournier A,Touillaud M,Mesrine S,Chabbert-Buffet N,Boutron-Ruault MC,Wolk A,Torres-Mejia G,Franceschi S,Romieu I,Boyle P,Lubin F,Modan B,Ron E,Wax Y,Friedman GD,Hiatt RA,Levi F,Kosmelj K,Primic-Zakelj M,Ravnihar B,Stare J,Ekbom A,Erlandsson G,Beeson WL,Fraser G,Peto J,Hanson RL,Leske MC,Mahoney MC,Nasca PC,Varma AO,Weinstein AL,Hartman ML,Olsson H,Goldbohm RA,van den Brandt PA,Palli D,Teitelbaum S,Apelo RA,Baens J,de la Cruz JR,Javier B,Lacaya LB,Ngelangel CA,La Vecchia C,Negri E,Marubini E,Ferraroni M,Pike MC,Gerber M,Richardson S,Segala C,Gatei D,Kenya P,Kungu A,Mati JG,Brinton LA,Freedman M,Hoover R,Schairer C,Ziegler R,Banks E,Spirtas R,Lee HP,Rookus MA,van Leeuwen FE,Schoenberg JA,Graff-Iversen S,Selmer R,Jones L,McPherson K,Neil A,Vessey M,Yeates D,Mabuchi K,Preston D,Hannaford P,Kay C,McCann SE,Rosero-Bixby L,Gao YT,Jin F,Yuan J-M,Wei HY,Yun T,Zhiheng C,Berry G,Cooper Booth J,Jelihovsky T,MacLennan R,Shearman R,Hadjisavvas A,Kyriacou K,Loisidou M,Zhou X,Wang Q-S,Kawai M,Minami Y,Tsuji I,Lund E,Kumle M,Stalsberg H,Shu XO,Zheng W,Monninkhof EM,Onland-Moret NC,Peeters PHM,Katsouyanni K,Trichopoulou A,Trichopoulos D,Tzonou A,Baltzell KA,Dabancens A,Martinez L,Molina R,Salas O,Alexander FE,Anderson K,Folsom AR,Gammon MD,Hulka BS,Millikan R,Chilvers CED,Lumachi F,Bain C,Schofield F,Siskind V,Rebbeck TR,Bernstein LR,Enger S,Haile RW,Paganini-Hill A,Ross RK,Ursin G,Wu AH,Yu MC,Ewertz M,Clarke EA,Bergkvist L,Anderson GL,Gass M,O'Sullivan MJ,Kalache A,Farley TMM,Holck S,Meirik O,Fukao A|Beral V,Hermon C,Peto R,Reeves G,Brinton L,Marchbanks P,Negri E,Ness R,Peeters PHM,Vessey M,Calle EE,Gapstur SM,Patel AV,Maso LD,Talamini R,Chetrit A,Hirsh-Yechezkel G,Lubin F,Sadetzki S,Allen N,Beral V,Bull D,Callaghan K,Crossley B,Gaitskell K,Goodill A,Green J,Hermon C,Key T,Moser K,Reeves G,Collins R,Doll R,Peto R,Gonzalez CA,Lee N,Marchbanks P,Ory HW,Peterson HB,Wingo PA,Martin N,Pardthaisong T,Silpisornkosol S,Theetranont C,Boosiri B,Chutivongse S,Jimakorn P,Virutamasen P,Wongsrichanalai C,Tjonneland A,Titus-Ernstoff L,Byers T,Rohan T,Mosgaard BJ,Vessey M,Yeates D,Freudenheim JL,Chang-Claude J,Kaaks R,Anderson KE,Folsom A,Robien K,Rossing MA,Thomas DB,Weiss NS,Riboli E,Clavel-Chapelon F,Cramer D,Hankinson SE,Tworoger SS,Franceschi S,La Vecchia C,Negri E,Magnusson C,Riman T,Weiderpass E,Wolk A,Schouten LJ,Van den Brandt PA,Chantarakul N,Koetsawang S,Rachawat D,Palli D,Black A,Berrington de Gonzalez A,Brinton LA,Freedman DM,Hartge P,Hsing AW,Lacey JV,Hoover RN,Schairer C,Graff-Iversen S,Selmer R,Bain CJ,Green AC,Purdie DM|Beral V,Gaitskell K,Hermon C,Moser K,Reeves G,Peto R|Bradbury KE,Balkwill A,Spencer EA,Roddam AW,Reeves GK,Green J,Key TJ,Beral V,Pirie K|Pirie K,Peto R,Beral V|Beral V,Peto R|Sweetland S,Parkin L,Balkwill A,Green J,Reeves G,Beral V,Million Women Study Collaborators|Beral V,Pirie K,Peto R|Beral V,Gaitskell K,Hermon C,Moser K,Reeves G,Peto R,Brinton L,Marchbanks P,Negri E,Ness R,Peeters PHM,Vessey M,Calle EE,Gapstur SM,Patel AV,Dal Maso L,Talamini R,Chetrit A,Hirsh-Yechezkel G,Lubin F,Sadetzki S,Banks E,Beral V,Bull D,Callaghan K,Crossley B,Gaitskell K,Goodill A,Green J,Hermon C,Key T,Moser K,Reeves G,Sitas F,Collins R,Doll R,Peto R,Gonzalez A,Lee N,Marchbanks P,Ory HW,Peterson HB,Wingo PA,Martin N,Pardthaisong T,Silpisornkosol S,Theetranont C,Boosiri B,Chutivongse S,Jimakorn P,Virutamasen P,Wongsrichanalai C,Tjonneland A,Titus-Ernstoff L,Byers T,Rohan T,Mosgaard BJ,Vessey M,Yeates D,Freudenheim JL,Chang-Claude J,Kaaks R,Anderson KE,Folsom A,Robien K,Hampton J,Newcomb PA,Rossing MA,Thomas DB,Weiss NS,Riboli E,Clavel-Chapelon F,Cramer D,Hankinson SE,Tworoger SS,Franceschi S,La Vecchia C,Negri E,Adami HO,Magnusson C,Riman T,Weiderpass E,Wolk A,Schouten LJ,van den Brandt PA,Chantarakul N,Koetsawang S,Rachawat D,Palli D,Black A,Brinton LA,Freedman DM,Hartge P,Hsing AW,Jr LJV,Hoover RN,Schairer C,Urban M,Graff-Iversen S,Selmer R,Bain CJ,Green AC,Purdie DM,Siskind V,Webb PM,Moysich K,McCann SE,Hannaford P,Kay C,Binns CW,Lee AH,Zhang M,Ness RB,Nasca P,Coogan PF,Palmer JR,Rosenberg L,Kelsey J,Paffenbarger R,Whittemore A,Katsouyanni K,Trichopoulou A,Trichopoulos D,Tzonou A,Dabancens A,Martinez L,Molina R,Salas O,Goodman MT,Lurie G,Carney ME,Wilkens LR,Hartman L,Manjer J,Olsson H,Grisso JA,Morgan M,Wheeler JE,Bunker CH,Edwards RP,Modugno F,Peeters PHM,Casagrande J,Pike MC,Ross RK,Wu AH,Miller AB,Kumle M,Gram IT,Lund E,McGowan L,Shu XO,Zheng W,Farley TMM,Holck S,Meirik O,Risch HA,Epidemiological CG,Canc NISO,Study NH|Pirie K,Peto R,Reeves GK,Green J,Beral V,Million Women Study Collaborators","Aged,Breast Neoplasms,England,Female,Humans,Mass Screening,Middle Aged,Pilot Projects|||Collaborative Group On Epidemiological Studies Of Ovarian Cancer,Humans,Ovarian Neoplasms,Estrogen Replacement Therapy,Drug Administration Schedule,Incidence,Risk Assessment,Postmenopause,Middle Aged,Female|Million Women Study Collaborators,Humans,Neoplasms,Lymphoma,Non-Hodgkin,Sarcoma,Breast Neoplasms,Incidence,Prospective Studies,Middle Aged,Great Britain,Female,Self Report,Food,Organic|Female,Humans,Smoking,Smoking Cessation||Cohort Studies,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Middle Aged,Postoperative Complications,Prospective Studies,Retrospective Studies,Risk Factors,Smoking,Venous Thromboembolism|Lung cancer,Smoking,smoking cessation||Adult,Age Factors,Aged,Data Collection,Female,Great Britain,Humans,Middle Aged,Proportional Hazards Models,Prospective Studies,Risk Factors,Smoking,Smoking Cessation,Socioeconomic Factors,Time Factors,Young Adult"
clme0485,orms0061,2,0.6,Journal article|Journal article,Therapeutic Advances in Musculoskeletal Disease|Nature Reviews Drug Discovery,01/10/2015|01/03/2015,Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications.|Preclinical target validation using patient-derived cells.,"Cribbs A,Feldmann M,Oppermann U|Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","|SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
clme0220,immd0084,3,0.7916666666666666,Journal article|Journal article|Journal article,Molecular Biology Reports: an international journal on molecular and cellular biology|Molecular Biology Reports: an international journal on molecular and cellular biology|Biochemical Journal,01/01/2012|23/10/2012|18/10/2012,ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia.|ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia.|Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival.,"Pike LRG,Phadwal K,Simon AK,Harris AL|Pike LR,Phadwal K,Simon AK,Harris AL|Pike LR,Singleton DC,Buffa F,Abramczyk O,Phadwal K,Li JL,Simon AK,Murray JT,Harris AL","|Activating Transcription Factor 4,Apoptosis Regulatory Proteins,Autophagy,Breast Neoplasms,Cell Hypoxia,Cell Line,Tumor,Cell Survival,Female,Gene Expression Regulation,Neoplastic,Gene Knockdown Techniques,Genes,Neoplasm,Humans,Oligonucleotide Array Sequence Analysis,Promoter Regions,Genetic,Protein Binding,Proto-Oncogene Proteins,Proto-Oncogene Proteins c-bcl-2,Stress,Physiological|Activating Transcription Factor 4,Animals,Autophagy,Blotting,Western,Breast Neoplasms,Cell Hypoxia,Cell Line,Tumor,Cell Survival,Endoplasmic Reticulum Stress,Female,Gene Expression Regulation,Neoplastic,HCT116 Cells,HT29 Cells,Humans,Intracellular Signaling Peptides and Proteins,MCF-7 Cells,Mice,Multivariate Analysis,Neoplasms,Prognosis,Protein-Serine-Threonine Kinases,RNA Interference,Reverse Transcriptase Polymerase Chain Reaction,Survival Analysis,Transcriptional Activation,Up-Regulation"
clme0220,raob0202,1,0.14285714285714285,Journal article,Journal of National Cancer Institute,18/10/2011,Delta-like ligand 4-notch blockade and tumor radiation response.,"Liu SK,Bham SA,Fokas E,Beech J,Im J,Cho S,Harris AL,Muschel RJ","Adenocarcinoma,Amyloid Precursor Protein Secretases,Animals,Antibodies,Monoclonal,Antineoplastic Agents,Blood Flow Velocity,Carcinoma,Squamous Cell,Cell Line,Tumor,Colorectal Neoplasms,Combined Modality Therapy,Dibenzazepines,Humans,Hypopharyngeal Neoplasms,Immunoblotting,Immunohistochemistry,Intercellular Signaling Peptides and Proteins,Luminescent Measurements,Mice,Nude,Necrosis,Neoplasms,Neovascularization,Pathologic,Radiation,Ionizing,Receptors,Notch,Signal Transduction,Transplantation,Heterologous,Ultrasonography,Doppler"
clme0237,whgu0378,9,0.5202092711194595,Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Annals of Oncology|Nature Genetics|Nature Communications|Journal of Pathology|Haematologica: the hematology journal|Gut|Human Molecular Genetics|Nature Genetics|Nature Genetics,01/06/2012|18/05/2015|01/01/2014|01/01/2011|11/07/2014|19/03/2014|15/07/2013|23/12/2012|01/06/2012,CLINICAL DIAGNOSTIC IMPLEMENTATION OF AN INNOVATIVE CANCER CARE MODEL BASED ON COMPREHENSIVE MOLECULAR PROFILING OF TUMOUR-NORMAL PAIRS|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Erythrocytosis associated with a novel missense mutation in the BPGM gene.|A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS.|DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.|Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1.,"Kaur K,Henderson S,Cutts A,Domingo E,Woods J,Motley C,Dougherty B,Middleton M,Hassan B,Wang Y,Beasley E,Naley M,Schuh A,Tomlinson I,Taylor J|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Petousi N,Copley RR,Lappin TR,Haggan SE,Bento CM,Cario H,Percy MJ,Ratcliffe PJ,Robbins PA,McMullin MF|Rosmarin D,Palles C,Pagnamenta A,Kaur K,Pita G,Martin M,Domingo E,Jones A,Howarth K,Freeman-Mills L,Johnstone E,Wang H,Love S,Scudder C,Julier P,Fernández-Rozadilla C,Ruiz-Ponte C,Carracedo A,Castellvi-Bel S,Castells A,Gonzalez-Neira A,Taylor J,Kerr R,Kerr D,Tomlinson I|Church DN,Briggs SE,Palles C,Domingo E,Kearsey SJ,Grimes JM,Gorman M,Martin L,Howarth KM,Hodgson SV,NSECG Collaborators,Kaur K,Taylor J,Tomlinson IP|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I|Jaeger E,Leedham S,Lewis A,Segditsas S,Becker M,Cuadrado PR,Davis H,Kaur K,Heinimann K,Howarth K,East J,Taylor J,Thomas H,Tomlinson I","|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading|Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid|WGS Consortium,Humans,Polycythemia,Bisphosphoglycerate Mutase,Genotype,Mutation,Missense|Humans,Colorectal Neoplasms,Fluorouracil,Dihydrouracil Dehydrogenase (NADP),Thymidylate Synthase,Proteins,Deoxycytidine,Antimetabolites,Antineoplastic,Polymorphism,Genetic,Adult,Aged,80 and over,Middle Aged,Female,Male,Young Adult,Genetic Association Studies|Adult,Aged,Amino Acid Sequence,DNA Polymerase II,DNA Polymerase III,Endometrial Neoplasms,Female,Germ-Line Mutation,Humans,Microsatellite Repeats,Middle Aged,Molecular Sequence Data,Mutation,Protein Structure,Tertiary,Sequence Alignment,Young Adult|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA|Bone Morphogenetic Proteins,Chromosome Mapping,Chromosomes,Human,Pair 15,Colonic Polyps,Colorectal Neoplasms,DNA Copy Number Variations,Fetal Proteins,Gene Duplication,Gene Expression,Humans,Intercellular Signaling Peptides and Proteins,Microfilament Proteins,Neuroendocrine Secretory Protein 7B2,Nuclear Proteins,Receptors,Immunologic,Syndrome"
bioc0801,claridge,1,0.058823529411764705,Journal article,EMBO Reports,01/04/2011,The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.,"Chowdhury R,Yeoh KK,Tian YM,Hillringhaus L,Bagg EA,Rose NR,Leung IKH,Li XS,Woon ECY,Yang M,McDonough MA,King ON,Clifton IJ,Klose RJ,Claridge TDW,Ratcliffe PJ,Schofield CJ,Kawamura A","Cell Line,Tumor,Crystallography,Glutarates,Histone Demethylases,Humans,Inhibitory Concentration 50,Isocitrate Dehydrogenase,Jumonji Domain-Containing Histone Demethylases,Magnetic Resonance Spectroscopy,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Mutation,Neoplasms,Procollagen-Proline Dioxygenase,Repressor Proteins,Signal Transduction"
cschof,dplb0149,4,0.753968253968254,Journal article|Journal article|Journal article|Journal article,Nature Communications|Angewandte Chemie International Edition|Angewandte Chemie International Edition|Chemical Science,01/01/2015|13/08/2013|13/01/2012|01/01/2011,Generation of a synthetic GlcNAcylated nucleosome reveals regulation of stability by H2A-Thr101 GlcNAcylation.|DNA modification under mild conditions by Suzuki-Miyaura cross-coupling for the generation of functional probes.|Conversion of cysteine into dehydroalanine enables access to synthetic histones bearing diverse post-translational modifications.|Methods for converting cysteine to dehydroalanine on peptides and proteins,"Lercher L,Raj R,Patel NA,Price J,Mohammed S,Robinson CV,Schofield CJ,Davis BG|Lercher L,McGouran JF,Kessler BM,Schofield CJ,Davis BG|Chalker JM,Lercher L,Rose NR,Schofield CJ,Davis BG|Chalker JM,Gunnoo SB,Boutureira O,Gerstberger SC,Fernández-González M,Bernardes GJL,Griffin L,Hailu H,Schofield CJ,Davis BG","Chromatin,Nucleosomes,Animals,Xenopus laevis,N-Acetylglucosaminyltransferases,DNA-Directed RNA Polymerases,Acetylglucosamine,Threonine,Histones,Chromatography,Liquid,Electrophoresis,Circular Dichroism,Chromatin Immunoprecipitation,Gene Expression Regulation,Epigenesis,Genetic,Protein Processing,Post-Translational,Histone Code,Dimerization,Mass Spectrometry|DNA,cross-coupling,oligonucleotides,palladium,photoaffinity labeling,Catalysis,Idoxuridine,Molecular Probes,Oligonucleotides,Palladium,Photoaffinity Labels|Alanine,Alkylation,Cysteine,Histones,Humans,Models,Molecular,Protein Conformation,Protein Processing,Post-Translational|"
clme0497,clme0946,2,0.25,Conference paper|Journal article,Neuro-Oncology|Cancer Cell,01/10/2012|13/05/2013,INHIBITION OF BET BROMODOMAIN TARGETS GENETICALLY DIVERSE GLIOBLASTOMA|Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Cheng Z,Gong Y,Ma Y,Ller-Knapp SM,Knapp S,Wang J|Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","|Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
card0027,clme0946,1,0.05263157894736842,Journal article,Proceedings of the National Academy of Sciences of USA,17/02/2015,"iASPP, a previously unidentified regulator of desmosomes, prevents arrhythmogenic right ventricular cardiomyopathy (ARVC)-induced sudden death.","Notari M,Hu Y,Sutendra G,Dedeić Z,Lu M,Dupays L,Yavari A,Carr CA,Zhong S,Opel A,Tinker A,Clarke K,Watkins H,Ferguson DJ,Kelsell DP,de Noronha S,Sheppard MN,Hollinshead M,Mohun TJ,Lu X","Cell Line,Transformed,Desmosomes,Intermediate Filaments,Animals,Cattle,Humans,Mice,Cardiomyopathy,Hypertrophic,Familial,Disease Models,Animal,Death,Sudden,Desmin,Intracellular Signaling Peptides and Proteins,Repressor Proteins,Amino Acid Substitution,Sequence Deletion,Base Sequence,Mutation,Missense,Female,Male,Desmoplakins,Arrhythmias,Cardiac"
immd0023,path0642,3,0.36250000000000004,Journal article|Journal article|Journal article,Science Signaling|Biophysical Journal|Proceedings of the National Academy of Sciences of USA,01/01/2011|18/01/2012|18/11/2013,Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.|Kinetics and Mechanics of Two-Dimensional Interactions between T Cell Receptors and Different Activating Ligands|Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation.,"Dushek O,Aleksic M,Wheeler RJ,Zhang H,Cordoba SP,Peng YC,Chen JL,Cerundolo V,Dong T,Coombs D,van der Merwe PA|Robert P,Aleksic M,Dushek O,Cerundolo V,Bongrand P,van der Merwell PA|Salio M,Ghadbane H,Dushek O,Shepherd D,Cypen J,Gileadi U,Aichinger MC,Napolitani G,Qi X,van der Merwe PA,Wojno J,Veerapen N,Cox LR,Besra GS,Yuan W,Cresswell P,Cerundolo V","Adaptive Immunity,Animals,Antigens,Humans,Lymphocyte Activation,Mice,Models,Chemical,T-Lymphocytes,Cytotoxic,Thermodynamics||autoreactivity,inflammation,innate immunity,lipid binding proteins,Antigen-Presenting Cells,Antigens,CD1d,Bacteria,Enzyme-Linked Immunosorbent Assay,HEK293 Cells,Humans,Immunity,Innate,Immunoprecipitation,Lipid Metabolism,Natural Killer T-Cells,Saposins,Scintillation Counting"
clme0149,stat0059,5,0.39622132253711206,Conference paper|Journal article|Journal article|Journal article|Journal article,Journal of Hepatology|Journal of Clinical Microbiology|PLoS One|F1000 Research|Emerging Infectious Diseases,01/04/2014|22/07/2015|10/06/2013|01/01/2015|01/04/2016,"A FULLY-AUTOMATED PIPELINE FOR SEQUENCING WHOLE VIRAL GENOMES WITHOUT VIRUS-SPECIFIC PCR AMPLIFICATION TO DETERMINE HCV RESISTANCE TO ANTIVIRAL THERAPY|Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing.|A Modified RNA-Seq Approach for Whole Genome Sequencing of RNA Viruses from Faecal and Blood Samples|ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens.|Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCR.","Bonsall DG,Piazza P,Trebes A,Brown A,Iles J,Halliday J,Hurst J,Batty E,Ansari A,Ip C,Bowden R,Crook D,Klenerman P,Barnes E|Iles JC,Njouom R,Foupouapouognigni Y,Bonsall D,Bowden R,Trebes A,Piazza P,Barnes E,Pépin J,Klenerman P,Pybus OG|Batty EM,Wong THN,Trebes A,Argoud K,Attar M,Buck D,Ip CLC,Golubchik T,Cule M,Bowden R,Manganis C,Klenerman P,Barnes E,Walker AS,Wyllie DH,Wilson DJ,Dingle KE,Peto TEA,Crook DW,Piazza P|Bonsall D,Ansari MA,Ip C,Trebes A,Brown A,Klenerman P,Buck D,Piazza P,Barnes E,Bowden R|Bonsall D,Gregory WF,Ip CL,Donfield S,Iles J,Ansari MA,Piazza P,Trebes A,Brown A,Frater J,Pybus OG,Goulder P,Klenerman P,Bowden R,Gomperts ED,Barnes E,Kapoor A,Sharp CP,Simmonds P","|Humans,Hepacivirus,Hepatitis C,Cluster Analysis,Sequence Analysis,DNA,Phylogeny,Recombination,Genetic,Genotype,Molecular Sequence Data,Aged,Middle Aged,Cameroon,Female,Male,High-Throughput Nucleotide Sequencing||STOP-HCV Consortium|"
immd0237,wolf1833,1,0.05555555555555555,Journal article,Proceedings of the National Academy of Sciences of USA,18/02/2014,OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.,"Singleton RS,Liu-Yi P,Formenti F,Ge W,Sekirnik R,Fischer R,Adam J,Pollard PJ,Wolf A,Thalhammer A,Loenarz C,Flashman E,Yamamoto A,Coleman ML,Kessler BM,Wappner P,Schofield CJ,Ratcliffe PJ,Cockman ME","2-oxoglutarate oxygenase,hypoxia,ribosome,translational control,Analysis of Variance,Carrier Proteins,Computational Biology,Fluorescent Antibody Technique,Gene Knockdown Techniques,Humans,Hydroxylation,Immunoblotting,Immunoprecipitation,Ketoglutaric Acids,Luciferases,Nuclear Proteins,Proline,Prolyl Hydroxylases,Protein Biosynthesis,Protein Processing,Post-Translational,Ribosomal Proteins,Yeasts"
clne0024,univ1923,1,0.1,Conference paper,Neuropathology and Applied Neurobiology,01/03/2013,Magnetic resonance spectroscopy for 2-hydroxyglutarate identifies IDH mutant gliomas,"Larkin SJ,Near J,Kudari M,Khrapitchev A,Sibson N,Jezzard P,Pfeffer I,Al-Qahtani K,Schofield C,McCullagh J,Ansorge O",
clme0240,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0149,clme0219,5,0.6341991341991342,Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Allergy and Clinical Immunology|Journal of Allergy and Clinical Immunology|Journal of Allergy and Clinical Immunology|Journal of Immunology|Journal of Allergy and Clinical Immunology,30/12/2013|19/10/2014|01/04/2014|14/12/2011|01/01/2015,Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.|Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk.|Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells|Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2.|Prostaglandin D<inf>2</inf> and leukotriene E<inf>4</inf> synergize to stimulate diverse T<inf>H</inf>2 functions and T<inf>H</inf>2 cell/neutrophil crosstalk,"Xue L,Salimi M,Panse I,Mjösberg JM,McKenzie AN,Spits H,Klenerman P,Ogg G|Xue L,Fergusson J,Salimi M,Panse I,Ussher JE,Hegazy AN,Vinall SL,Jackson DG,Hunter MG,Pettipher R,Ogg G,Klenerman P|Xue L,Salimi M,Panse I,Mjösberg JM,McKenzie ANJ,Spits H,Klenerman P,Ogg G|Xue L,Barrow A,Fleming VM,Hunter MG,Ogg G,Klenerman P,Pettipher R|Xue L,Fergusson J,Salimi M,Panse I,Ussher JE,Hegazy AN,Vinall SL,Jackson DG,Hunter MG,Pettipher R,Ogg G,Klenerman P","Group 2 innate lymphoid cell,IL-25,IL-33,PGD(2),adaptive type 2 immunity,chemoattractant receptor-homologous molecule expressed on T(H)2 cells,innate type 2 immunity,Chemotaxis,Cytokines,Dose-Response Relationship,Drug,Gene Expression Regulation,Humans,Immunophenotyping,Lymphocyte Activation,Lymphocyte Subsets,Mast Cells,Phenotype,Prostaglandin D2,Receptors,Immunologic,Prostaglandin|Neutrophils,Th2 Cells,Humans,Leukotriene E4,Prostaglandin D2,Cell Adhesion Molecules,Inflammation Mediators,Cluster Analysis,Gene Expression Profiling,Cell Communication,Apoptosis,Chemotaxis,Leukocyte,Gene Expression,Drug Synergism||Animals,CHO Cells,Cells,Cultured,Cricetinae,Cytokines,Drug Synergism,Humans,Inflammation,Leukotriene E4,Lymphocyte Activation,Mast Cells,Prostaglandin D2,Th2 Cells|"
bioc0416,clph0059,1,0.14285714285714285,Journal article,Journal of National Cancer Institute,09/10/2013,Selective permeabilization of the blood-brain barrier at sites of metastasis.,"Connell JJ,Chatain G,Cornelissen B,Vallis KA,Hamilton A,Seymour L,Anthony DC,Sibson NR","Analysis of Variance,Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Blood-Brain Barrier,Brain,Brain Neoplasms,Breast Neoplasms,Contrast Media,Disease Models,Animal,Drug Administration Schedule,Female,Gadolinium DTPA,Gene Expression Regulation,Neoplastic,Humans,Immunohistochemistry,Lymphotoxin-alpha,Magnetic Resonance Imaging,Mice,Inbred BALB C,Permeability,Receptors,Tumor Necrosis Factor,Type I,Tomography,Emission-Computed,Single-Photon,X-Ray Computed,Trastuzumab,Tumor Necrosis Factor-alpha"
immd0180,immd0423,1,0.08333333333333333,Journal article,Frontiers in Oncology,,Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR.,"Aleksic T,Browning L,Woodward M,Phillips R,Page S,Henderson S,Athanasou N,Ansorge O,Whitwell D,Pratap S,Hassan AB,Middleton MR,Macaulay VM",
immd0024,immd0198,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
awatts,ndos0168,2,0.5833333333333333,Conference paper|Conference paper,International Journal of Experimental Pathology: mechanisms and models of disease|Osteoarthritis and Cartilage,01/02/2013|01/04/2013,Glucocorticoids induce senescence and alter matrix protein expression in primary human tenocytes|AGEING AND OSTEOARTHRITIS MARKERS IDENTIFIED BY MALDI IMAGING MASS SPECTROMETRY,"Poulsen RC,Watts AC,Carr AJ,Hulley PA|Poulsen RC,Watts AC,Murphy RJ,Carr AJ,Hulley PA",|
olin0081,whgu0142,1,0.07692307692307693,Journal article,Chemistry and Biology,26/08/2015,Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.,"Canning P,Ruan Q,Schwerd T,Hrdinka M,Maki JL,Saleh D,Suebsuwong C,Ray S,Brennan PE,Cuny GD,Uhlig HH,Gyrd-Hansen M,Degterev A,Bullock AN",
clme0169,immd0023,1,0.058823529411764705,Journal article,International Journal of Cancer,14/08/2014,NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.,"Chen JL,Dawoodji A,Tarlton A,Gnjatic S,Tajar A,Karydis I,Browning J,Pratap S,Verfaille C,Venhaus RR,Pan L,Altman DG,Cebon JS,Old LL,Nathan P,Ottensmeier C,Middleton M,Cerundolo V","CD4-Positive T-Lymphocytes,CD8-Positive T-Lymphocytes,Humans,Fowlpox virus,Melanoma,Cholesterol,Saponins,Phospholipids,Membrane Proteins,Vaccines,Synthetic,Adjuvants,Immunologic,Antigens,Neoplasm,Drug Combinations,Vaccination,Antibody Formation,Fowlpox,ISCOMATRIX,NY-ESO-1,cancer vaccines"
clme0946,ocms0037,1,0.125,Journal article,Cell,22/05/2014,A code for RanGDP binding in ankyrin repeats defines a nuclear import pathway.,"Lu M,Zak J,Chen S,Sanchez-Pulido L,Severson DT,Endicott J,Ponting CP,Schofield CJ,Lu X","Humans,Multiprotein Complexes,ran GTP-Binding Protein,Proteins,Ankyrin Repeat,Active Transport,Cell Nucleus,Protein Transport,Models,Molecular,Cyclin-Dependent Kinase Inhibitor p16"
raob0058,raob0202,1,0.1,Journal article,Cancer Research,22/11/2011,Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.,"Fokas E,Im JH,Hill S,Yameen S,Stratford M,Beech J,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ","Animals,Dose-Response Relationship,Drug,Humans,Mice,Neoplasms,Experimental,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Radiation Tolerance,TOR Serine-Threonine Kinases,Xenograft Model Antitumor Assays"
bioc0192,card0027,6,0.5857614607614607,Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article,Circulation: Cardiovascular Imaging|Circulation. Heart failure|Circulation|J Am Coll Cardiol|Circulation: Cardiovascular Imaging|Circulation,15/10/2012||22/11/2011|11/03/2013|01/03/2013|22/11/2011,"Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.|No Evidence of Myocardial Oxygen Deprivation in Nonischemic Heart Failure.|In Both Hypertrophic And Dilated Cardiomyopathy, Non-contrast T1 Mapping Provides Myocardial Tissue Characterization Beyond That Achieved By Late Gadolinium Enhancement.|Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.|Response to letter regarding article, myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.|Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis","Dass S,Suttie JJ,Piechnik SK,Ferreira VM,Holloway CJ,Banerjee R,Mahmod M,Cochlin L,Karamitsos TD,Robson MD,Watkins H,Neubauer S|Dass S,Holloway CJ,Cochlin LE,Rider OJ,Mahmod M,Robson M,Sever E,Clarke K,Watkins H,Ashrafian H,Karamitsos TD,Neubauer S|Dass S,Suttie JJ,Piechnik SK,Ferreira VM,Holloway C,Karamitsos TD,Robson MD,Watkins H,Neubauer S|Karamitsos TD,Dass S,Suttie J,Sever E,Birks J,Holloway CJ,Robson MD,Jerosch-Herold M,Watkins H,Neubauer S|Dass S,Suttie JJ,Piechnik SK,Ferreira VM,Holloway CJ,Banerjee R,Mahmod M,Cochlin L,Karamitsos TD,Robson MD,Watkins H,Neubauer S|Suttie JJ,Dass S,Bull S,Holloway C,Banerjee R,Cox P,Pitcher A,Franco BR,Francis J,Schneider J,Robson M,Watkins H,Myerson S,Neubauer S","Cardiomyopathy,Dilated,Hypertrophic,Contrast Media,Female,Gadolinium DTPA,Humans,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardium,Severity of Illness Index|Humans,Cardiomyopathy,Dilated,Magnetic Resonance Imaging,Exercise Test,Oxygen Inhalation Therapy,Magnetic Resonance Spectroscopy,Case-Control Studies,Oxygen Consumption,Coronary Circulation,Middle Aged,Female,Male,Heart Failure|Cardiomyopathy,Cardiac MRI,Heart failure,Cardiac hypertrophy,Fibrosis||Cardiomyopathy,Dilated,Hypertrophic,Female,Gadolinium DTPA,Humans,Magnetic Resonance Imaging,Cine,Male,Myocardium|Cardiovascular imaging,Lipids,Magnetic resonance imaging,Magnetic resonance spectroscopy,Aortic stenosis"
path0084,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
bioc0756,path0642,1,0.125,Journal article,Journal of the American Chemical Society,21/08/2014,SpyAvidin hubs enable precise and ultrastable orthogonal nanoassembly.,"Fairhead M,Veggiani G,Lever M,Yan J,Mesner D,Robinson CV,Dushek O,van der Merwe PA,Howarth M","Jurkat Cells,Humans,Biotin,Peptides,Streptavidin,Binding Sites,Models,Molecular,Protein Multimerization,Protein Stability"
clme0237,whgu0274,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
clme0220,clme0237,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
clme0240,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
card0025,clme0621,1,0.09090909090909091,Journal article,BMJ Open,01/01/2016,Markers of achievement for assessing and monitoring gender equity in translational research organisations: a rationale and study protocol.,"Ovseiko PV,Edmunds LD,Pololi LH,Greenhalgh T,Kiparoglou V,Henderson LR,Williamson C,Grant J,Lord GM,Channon KM,Lechler RI,Buchan AM",
clab0035,immd0024,10,0.4380263451767305,Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Conference paper,British Journal of Haematology|Leukemia Research: clinical and laboratory studies|Cancer Cell|Cancer Cell|Blood|Blood|Nature Communications|Blood|New England Journal of Medicine|Haematologica: the hematology journal,15/04/2011|01/05/2013|14/05/2014|16/06/2014|03/12/2015|18/11/2011|01/01/2015|12/09/2013|01/01/2011|01/06/2014,"Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.|Clinical and biological implications of gene mutations in MDS|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee|Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts|Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.|Clinical and biological implications of driver mutations in myelodysplastic syndromes.|Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts|COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES","Pellagatti A,Cazzola M,Giagounidis A,Perry J,Malcovati L,Della Porta MG,Jädersten M,Killick S,Vyas P,Hellström-Lindberg E,Wainscoat JS,Boultwood J|Papaemmanuil E,Gerstung M,Malcovati L,Tauro S,Gundem G,Van-Loo P,Pellagati A,Groves M,Cross N,Gambacorti-Passerini C,Green A,Boultwood J,Vyas P,Hellstrom-Lindberg E,Bowen D,Cazzola M,Stratton MR,Campbell PJ|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SE|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Bejar R,Papaemmanuil E,Haferlach T,Garcia-Manero G,Maciejewski JP,Sekeres MA,Walter MJ,Graubert TA,Cazzola M,Malcovati L,Ogawa S,Fenaux P,Hellstrom-Lindberg E,Kern W,Boultwood J,Pellagatti A,Bowen D,Tauro S,Groves MJ,Vyas P,Quek L,Nazha A,Thol F,Heuser M,Shih L-Y,Padron E,Sallman D,Komrokji RS,List AF,Santini V,Fontenay M,Campbell PJ,Tuechler H,Stevenson K,Neuberg DS,Greenberg P,Ebert BL|Malcovati L,Papaemmanuil E,Hellstrom-Lindberg E,Boultwood J,Bowen D,Vyas P,Pascutto C,Della Porta MG,Pellagatti A,Groves MJ,Godfrey AL,Ambaglio I,Galli A,Travaglino E,Conte S,Tauro S,Keenan N,Hyslop A,Hinton J,Mudie LJ,Passerini CG,Cross NCP,Wainscoat JS,Green AR,Futreal PA,Stratton MR,Campbell PJ,Cazzola M|Gerstung M,Pellagatti A,Malcovati L,Giagounidis A,Porta MG,Jädersten M,Dolatshad H,Verma A,Cross NC,Vyas P,Killick S,Hellström-Lindberg E,Cazzola M,Papaemmanuil E,Campbell PJ,Boultwood J|Papaemmanuil E,Gerstung M,Malcovati L,Tauro S,Gundem G,Van Loo P,Yoon CJ,Ellis P,Wedge DC,Pellagatti A,Shlien A,Groves MJ,Forbes SA,Raine K,Hinton J,Mudie LJ,McLaren S,Hardy C,Latimer C,Della Porta MG,O'Meara S,Ambaglio I,Galli A,Butler AP,Walldin G,Teague JW,Quek L,Sternberg A,Gambacorti-Passerini C,Cross NC,Green AR,Boultwood J,Vyas P,Hellstrom-Lindberg E,Bowen D,Cazzola M,Stratton MR,Campbell PJ,Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium|Papaemmanuil E,Cazzola M,Boultwood J,Malcovati L,Vyas P,Bowen D,Pellagatti A,Wainscoat JS,Hellstrom-Lindberg E,Gambacorti-Passerini C,Godfrey AL,Rapado I,Cvejic A,Rance R,McGee C,Ellis P,Mudie LJ,Stephens PJ,McLaren S,Massie CE,Tarpey PS,Varela I,Nik-Zainal S,Davies HR,Shlien A,Jones D,Raine K,Hinton J,Butler AP,Teague JW,Baxter EJ,Score J,Galli A,Della Porta MG,Travaglino E,Groves M,Tauro S,Munshi NC,Anderson KC,El-Naggar A,Fischer A,Mustonen V,Warren AJ,Cross NCP,Green AR,Futreal PA,Stratton MR,Campbell PJ|Pellagatti A,Gerstung M,Papaemmanuil E,Malcovati L,Giagounidis A,Della Porta MG,Jadersten M,Dolatshad H,Verma A,Cross NCP,Vyas P,Killick S,Hellstrom-Lindberg E,Cazzola M,Campbell PJ,Boultwood J","Anemia,Refractory,with Excess of Blasts,Chromosome Deletion,Chromosomes,Human,Pair 5,Disease Progression,Down-Regulation,Gene Expression Regulation,Genomic Instability,Humans,Nuclear Proteins,Sequence Deletion||Chromosomes,Human,Pair 5,Animals,Mice,Inbred NOD,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Genetic Predisposition to Disease,Antigens,CD,Prognosis,Flow Cytometry,Gene Expression Profiling,Mutation,Neoplastic Stem Cells,Heterografts||||Humans,Myelodysplastic Syndromes,Repressor Proteins,Prognosis,Treatment Outcome,Cohort Studies,Gene Expression Profiling,DNA Mutational Analysis,Gene Expression Regulation,Leukemic,Genotype,Mutation,Adult,Aged,80 and over,Middle Aged,Female,Male,Leukemia,Myeloid,Acute,Young Adult,Polycomb Repressive Complex 2|Aged,80 and over,Cohort Studies,Disease Progression,Epistasis,Genetic,Female,Humans,Leukemia,Myeloid,Acute,Myelomonocytic,Chronic,Male,Middle Aged,Mutation,Myelodysplastic Syndromes,Myelodysplastic-Myeloproliferative Diseases,Oncogenes,Prognosis,RNA Splicing,Spliceosomes||"
engs0357,raob0072,1,0.1111111111111111,Journal article,Lecture Notes in Computer Science,01/01/2013,Personalised estimation of the arterial input function for improved pharmacokinetic modelling of colorectal cancer using dceMRI,"Irving B,Tanner L,Enescu M,Bhushan M,Hill EJ,Franklin J,Anderson EM,Sharma RA,Schnabel JA,Brady M","pharmacokinetic modelling,arterial input function,dceMRI"
clme0195,immd0075,13,1.3924074893115141,Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Philosophical Transactions of the Royal Society of London: Biological Sciences|Nature Methods|Philosophical Transactions of the Royal Society of London: Biological Sciences|Nature Genetics|Blood|Cell Reports|Molecular Cell|Genome Biology: biology for the post-genomic era|Mammalian Genome|Human Mutation|PLoS Genetics|Epigenetics and Chromatin|The EMBO Journal,01/01/2013|23/11/2015|01/01/2013|01/01/2014|18/11/2011|08/08/2014|18/01/2012|29/11/2013|27/04/2012|24/04/2013|01/06/2013|01/01/2011|04/11/2011,"High-resolution analysis of cis-acting regulatory networks at the α-globin locus.|Multiplexed analysis of chromosome conformation at vastly improved sensitivity.|High-resolution analysis of cis-acting regulatory networks at the α-globin locus|Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment|Discovering Regulatory SNPs by Genome-Wide Analysis of Differential Scl/TAL-1 Occupancy in Human Primary Erythroid Cells|ATRX Plays a Key Role in Maintaining Silencing at Interstitial Heterochromatic Loci and Imprinted Genes.|Intragenic enhancers act as alternative promoters.|Chromatin signatures at transcriptional start sites separate two equally populated yet distinct classes of intergenic long noncoding RNAs.|Nprl3 is required for normal development of the cardiovascular system.|Analysis of sequence variation underlying tissue-specific transcription factor binding and gene expression.|Causes and consequences of chromatin variation between inbred mice.|Generation of bivalent chromatin domains during cell fate decisions.|An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment.","Hughes JR,Lower KM,Dunham I,Taylor S,De Gobbi M,Sloane-Stanley JA,McGowan S,Ragoussis J,Vernimmen D,Gibbons RJ,Higgs DR|Davies JO,Telenius JM,McGowan SJ,Roberts NA,Taylor S,Higgs DR,Hughes JR|Hughes JR,Lower KM,Dunham I,Taylor S,De Gobbi M,Sloane-Stanley JA,McGowan S,Ragoussis J,Vernimmen D,Gibbons RJ,Higgs DR|Hughes JR,Roberts N,McGowan S,Hay D,Giannoulatou E,Lynch M,De Gobbi M,Taylor S,Gibbons R,Higgs DR|De Gobbi M,Hughes JR,Lower KM,Derry CJ,Marchi E,Sloane-Stanley J,Roberts N,Taylor S,Porcher C,Gibbons RJ,Higgs DR|Voon HP,Hughes JR,Rode C,De La Rosa-Velázquez IA,Jenuwein T,Feil R,Higgs DR,Gibbons RJ|Kowalczyk MS,Hughes JR,Garrick D,Lynch MD,Sharpe JA,Sloane-Stanley JA,McGowan SJ,De Gobbi M,Hosseini M,Vernimmen D,Brown JM,Gray NE,Collavin L,Gibbons RJ,Flint J,Taylor S,Buckle VJ,Milne TA,Wood WG,Higgs DR|Marques AC,Hughes J,Graham B,Kowalczyk MS,Higgs DR,Ponting CP|Kowalczyk MS,Hughes JR,Babbs C,Sanchez-Pulido L,Szumska D,Sharpe JA,Sloane-Stanley JA,Morriss-Kay GM,Smoot LB,Roberts AE,Watkins H,Bhattacharya S,Gibbons RJ,Ponting CP,Wood WG,Higgs DR|Lower KM,De Gobbi M,Hughes JR,Derry CJ,Ayyub H,Sloane-Stanley JA,Vernimmen D,Garrick D,Gibbons RJ,Higgs DR|Hosseini M,Goodstadt L,Hughes JR,Kowalczyk MS,de Gobbi M,Otto GW,Copley RR,Mott R,Higgs DR,Flint J|De Gobbi M,Garrick D,Lynch M,Vernimmen D,Hughes JR,Goardon N,Luc S,Lower KM,Sloane-Stanley JA,Pina C,Soneji S,Renella R,Enver T,Taylor S,Jacobsen SE,Vyas P,Gibbons RJ,Higgs DR|Lynch MD,Smith AJ,De Gobbi M,Flenley M,Hughes JR,Vernimmen D,Ayyub H,Sharpe JA,Sloane-Stanley JA,Sutherland L,Meek S,Burdon T,Gibbons RJ,Garrick D,Higgs DR","chromatin conformation capture,cis-regulatory elements,α-globin locus,Chromatin Assembly and Disassembly,Chromosomes,Human,Pair 16,Gene Regulatory Networks,Genetic Loci,Genome,Humans,Open Reading Frames,Promoter Regions,Genetic,Protein Interaction Mapping,Regulatory Sequences,Nucleic Acid,Repressor Proteins,alpha-Globins,beta-Globins|Chromosomes,Human,Humans,Reproducibility of Results,Regulatory Sequences,Nucleic Acid,Polymorphism,Single Nucleotide||||Heterochromatin,Animals,Mice,DNA Helicases,Nuclear Proteins,Histones,Chromatin Immunoprecipitation,Chromatin Assembly and Disassembly,Gene Silencing,Gene Knockout Techniques,Genetic Loci,Real-Time Polymerase Chain Reaction|Animals,Cells,Cultured,Enhancer Elements,Genetic,Erythroid Cells,Gene Expression Regulation,Mice,Poly A,Promoter Regions,RNA,RNA Isoforms,Messenger,Transcriptome|Chromatin,Animals,Mice,Inbred C57BL,Histones,RNA,Messenger,Sequence Analysis,DNA,Evolution,Molecular,Gene Expression Regulation,Protein Structure,Tertiary,Transcription Initiation Site,Promoter Regions,Genetic,Genetic Loci,Transcriptome,Long Noncoding|Abnormalities,Multiple,Amino Acid Sequence,Animals,Cardiovascular System,Cells,Cultured,DNA Mutational Analysis,Female,GTPase-Activating Proteins,Gene Expression Profiling,Genetic Association Studies,Heart Defects,Congenital,Humans,Intracellular Signaling Peptides and Proteins,Male,Mice,Knockout,Molecular Sequence Annotation,Molecular Sequence Data,Myocardium,Nuclear Proteins,Phenotype,Polymorphism,Single Nucleotide,Promoter Regions,Genetic|allele specific,polymorphism,transcription factor binding,transcriptional regulation,Base Sequence,Binding Sites,Erythroid Cells,Gene Expression,Genetic Variation,Genome-Wide Association Study,Humans,Intracellular Signaling Peptides and Proteins,Molecular Sequence Data,Nucleoside Diphosphate Kinase D,Polymorphism,Single Nucleotide,Protein Binding,Regulatory Sequences,Nucleic Acid,Transcription Factors|Animals,Chromatin,Deoxyribonuclease I,Mice,Phenotype,Regulatory Sequences,Nucleic Acid||Animals,Cells,Cultured,Chromatin,Chromosome Mapping,Chromosomes,Human,Pair 16,CpG Islands,DNA Methylation,DNA,Recombinant,Embryonic Stem Cells,Gene Expression Regulation,Humans,Mice,Transgenic,Pluripotent Stem Cells,Polycomb-Group Proteins,Recombination,Genetic,Regulatory Sequences,Nucleic Acid,Repressor Proteins,Species Specificity,Transcription,alpha-Globins"
dplb0149,path0473,1,0.09090909090909091,Journal article,Nature Methods,01/04/2013,QuaNCAT: quantitating proteome dynamics in primary cells.,"Howden AJM,Geoghegan V,Katsch K,Efstathiou G,Bhushan B,Boutureira O,Thomas B,Trudgian DC,Kessler BM,Dieterich DC,Davis BG,Acuto O",
raob0096,raob0097,4,0.8888888888888888,Journal article|Journal article|Journal article|Journal article,Nature Cell Biology|Methods in Molecular Biology|Methods in Molecular Biology|Journal of Clinical Investigation,14/09/2014|01/01/2013|01/01/2013|11/05/2015,RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2.|Use of the xCELLigence system for real-time analysis of changes in cellular motility and adhesion in physiological conditions.|Use of the xCELLigence system for real-time analysis of changes in cellular motility and adhesion in physiological conditions|Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT.,"Pefani DE,Latusek R,Pires I,Grawenda AM,Yee KS,Hamilton G,van der Weyden L,Esashi F,Hammond EM,O'Neill E|Scrace S,O'Neill E,Hammond EM,Pires IM|Scrace S,O'Neill E,Hammond EM,Pires IM|Leszczynska KB,Foskolou IP,Abraham AG,Anbalagan S,Tellier C,Haider S,Span PN,O'Neill EE,Buffa FM,Hammond EM","Cells,Cultured,Cell Line,Tumor,Animals,Mice,Knockout,Humans,Chromosome Aberrations,Protein-Serine-Threonine Kinases,Tumor Suppressor Proteins,BRCA2 Protein,Microscopy,Confocal,Blotting,Western,Comet Assay,Signal Transduction,DNA Repair,DNA Replication,RNA Interference,Protein Binding,Phosphorylation,Models,Genetic,Rad51 Recombinase,Cyclin-Dependent Kinase 2,DNA Breaks,Double-Stranded,Ataxia Telangiectasia Mutated Proteins|Cell Adhesion,Cell Movement,Humans,Molecular Biology,Neoplasm Invasiveness,Neoplasm Metastasis,Neoplasms||Cell Line,Tumor,Humans,Neoplasms,Phosphoric Monoester Hydrolases,Sulfotransferases,Adaptor Proteins,Signal Transducing,Carrier Proteins,Immediate-Early Proteins,Tumor Suppressor Proteins,Nuclear Proteins,Apoptosis,Cell Hypoxia,Radiation Tolerance,Tumor Suppressor Protein p53,Proto-Oncogene Proteins c-akt"
clme0237,clme0301,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
donc0136,whgu0172,1,0.06666666666666667,Journal article,The EMBO Journal,27/05/2016,SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development.,"Raducu M,Fung E,Serres S,Infante P,Barberis A,Fischer R,Bristow C,Thézénas ML,Finta C,Christianson JC,Buffa FM,Kessler BM,Sibson NR,Di Marcotullio L,Toftgård R,D'Angiolella V",
clme0621,whgu0172,1,0.07142857142857142,Journal article,Nature Medicine,24/02/2013,Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy.,"Papadakis M,Hadley G,Xilouri M,Hoyte LC,Nagel S,McMenamin MM,Tsaknakis G,Watt SM,Drakesmith CW,Chen R,Wood MJ,Zhao Z,Kessler B,Vekrellis K,Buchan AM","Adenine,Animals,Anoxia,Autophagy,CA1 Region,Hippocampal,CA3 Region,Cells,Cultured,Hypoxia-Ischemia,Brain,Ischemic Preconditioning,Male,Multiprotein Complexes,Neuroprotective Agents,Prosencephalon,Proteins,RNA Interference,RNA,Small Interfering,Rats,Wistar,Sirolimus,TOR Serine-Threonine Kinases,Tumor Suppressor Proteins"
clme0485,clme0494,4,0.42275132275132277,Journal article|Journal article|Journal article|Journal article,Journal of Inherited Metabolic Disease|Structure|PLoS One|Nature Reviews Drug Discovery,29/03/2011|18/06/2013|01/01/2016|01/03/2015,Structural basis of fumarate hydratase deficiency.|Crystal structures of malonyl-coenzyme A decarboxylase provide insights into its catalytic mechanism and disease-causing mutations.|Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding.|Preclinical target validation using patient-derived cells.,"Picaud S,Kavanagh KL,Yue WW,Lee WH,Muller-Knapp S,Gileadi O,Sacchettini J,Oppermann U|Froese DS,Forouhar F,Tran TH,Vollmar M,Kim YS,Lew S,Neely H,Seetharaman J,Shen Y,Xiao R,Acton TB,Everett JK,Cannone G,Puranik S,Savitsky P,Krojer T,Pilka ES,Kiyani W,Lee WH,Marsden BD,Von Delft F,Allerston CK,Spagnolo L,Gileadi O,Montelione GT,Oppermann U,Yue WW,Tong L|Newman JA,Cooper CD,Roos AK,Aitkenhead H,Oppermann UC,Cho HJ,Osman R,Gileadi O|Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","Catalytic Domain,Crystallography,X-Ray,Fumarate Hydratase,Humans,Metabolism,Inborn Errors,Mitochondrial Diseases,Models,Molecular,Mutant Proteins,Mutation,Protein Conformation,Protein Folding,Structure-Activity Relationship|Amino Acid Sequence,Bacterial Proteins,Carboxy-Lyases,Catalytic Domain,Crystallography,X-Ray,Deficiency Diseases,Enzyme Stability,Humans,Hydrogen Bonding,Kinetics,Models,Molecular,Molecular Sequence Data,Mutation,Missense,Protein Structure,Quaternary,Secondary,Structural Homology,Protein||SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
clme0494,immd0082,1,0.07142857142857142,Journal article,Haematologica: the hematology journal,28/05/2013,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary"
gree0989,gree1192,7,0.9503968253968251,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Growth Hormone and IGF Research|Gut|Public Health Nutrition|British Journal of Cancer|Growth Hormone and IGF Research|Public Health Nutrition|Scandinavian Journal of Work Environment and Health,01/01/2015|02/01/2014|01/06/2011|27/03/2014|15/01/2015|01/01/2011|09/07/2012,"The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women|Source of dietary fibre and diverticular disease incidence: a prospective study of UK women.|Development and evaluation of the Oxford WebQ, a low-cost, web-based method for assessment of previous 24 h dietary intakes in large-scale prospective studies.|Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom.|The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women.|Development and evaluation of the oxford WebQ, a low-cost, web-based method for assessment of previous 24 h dietary intakes in large-scale prospective studies|Characteristics of the Million Women Study participants who have and have not worked at night.","Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Crowe FL,Balkwill A,Cairns BJ,Appleby PN,Green J,Reeves GK,Key TJ,Beral V,Million Women Study Collaborators,Million Women Study Collaborators|Liu B,Young H,Crowe FL,Benson VS,Spencer EA,Key TJ,Appleby PN,Beral V|Bradbury KE,Balkwill A,Spencer EA,Roddam AW,Reeves GK,Green J,Key TJ,Beral V,Pirie K|Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Liu B,Young H,Crowe FL,Benson VS,Spencer EA,Key TJ,Appleby PN,Beral V|Wang XS,Travis RC,Reeves G,Green J,Allen NE,Key TJ,Roddam AW,Beral V","|diet,dietary fibre,diverticular disease,prospective,Aged,Diet Surveys,Dietary Fiber,Diverticulitis,Diverticulum,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Intestinal Diseases,Middle Aged,Prospective Studies,Risk,Surveys and Questionnaires|Adult,Aged,80 and over,Diet,Diet Records,Dietary Fats,Dietary Proteins,Energy Intake,Female,Great Britain,Humans,Internet,Interviews as Topic,Male,Micronutrients,Middle Aged,Nutrition Assessment,Prospective Studies,Reproducibility of Results,Surveys and Questionnaires,Young Adult|Million Women Study Collaborators,Humans,Neoplasms,Lymphoma,Non-Hodgkin,Sarcoma,Breast Neoplasms,Incidence,Prospective Studies,Middle Aged,Great Britain,Female,Self Report,Food,Organic|Million Women Study Collaborators,Humans,Birth Weight,Insulin-Like Growth Factor I,Body Weights and Measures,Postnatal Care,Diet,Risk Factors,Cohort Studies,Life Style,Breast Feeding,Postmenopause,Aged,Middle Aged,Great Britain,Female,Surveys and Questionnaires||Anthropometry,Female,Great Britain,Humans,Life Style,Middle Aged,Prospective Studies,Work Schedule Tolerance"
raob0097,whgu0274,1,0.08333333333333333,Journal article,PLoS One,01/01/2011,Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α).,"Thalhammer A,Bencokova Z,Poole R,Loenarz C,Adam J,O'Flaherty L,Schödel J,Mole D,Giaslakiotis K,Schofield CJ,Hammond EM,Ratcliffe PJ,Pollard PJ","Anoxia,Cell Line,Dioxygenases,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Ketoglutaric Acids,Membrane Proteins,Nuclear Proteins,Oxygenases,Transcriptional Activation"
path0084,path0089,7,1.052804755557049,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Immunology|Nature Genetics|Blood|Trends in Immunology|Gut|Gastroenterology|eLife,01/12/2014|18/05/2015|07/02/2013|01/01/2012|07/03/2016|01/04/2014|01/01/2016,Human ILC-T-cell interactions in inflammatory bowel disease|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.|Lymphoid microenvironments and innate lymphoid cells in the gut|Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.|Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease|ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation.,"Schaupp A-L,Owens B,Powrie F,Uhlig H|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Cosgrove C,Ussher JE,Rauch A,Gärtner K,Kurioka A,Hühn MH,Adelmann K,Kang YH,Fergusson JR,Simmonds P,Goulder P,Hansen TH,Fox J,Günthard HF,Khanna N,Powrie F,Steel A,Gazzard B,Phillips RE,Frater J,Uhlig H,Klenerman P|Pearson C,Uhlig HH,Powrie F|Schwerd T,Pandey S,Yang HT,Bagola K,Jameson E,Jung J,Lachmann RH,Shah N,Patel SY,Booth C,Runz H,Düker G,Bettels R,Rohrbach M,Kugathasan S,Chapel H,Keshav S,Elkadri A,Platt N,Muise AM,Koletzko S,Xavier RJ,Marquardt T,Powrie F,Wraith JE,Gyrd-Hansen M,Platt FM,Uhlig HH|Avitzur Y,Guo C,Mastropaolo LA,Bahrami E,Chen H,Zhao Z,Elkadri A,Dhillon S,Murchie R,Fattouh R,Huynh H,Walker JL,Wales PW,Cutz E,Kakuta Y,Dudley J,Kammermeier J,Powrie F,Shah N,Walz C,Nathrath M,Kotlarz D,Puchaka J,Krieger JR,Racek T,Kirchner T,Walters TD,Brumell JH,Griffiths AM,Rezaei N,Rashtian P,Najafi M,Monajemzadeh M,Pelsue S,McGovern DPB,Uhlig HH,Schadt E,Klein C,Snapper SB,Muise AM|Pearson C,Thornton EE,McKenzie B,Schaupp AL,Huskens N,Griseri T,West N,Tung S,Seddon BP,Uhlig HH,Powrie F","|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adult,Anti-HIV Agents,Antiretroviral Therapy,Highly Active,Apoptosis,CD8-Positive T-Lymphocytes,Cells,Cultured,Cohort Studies,Escherichia coli,Female,Flow Cytometry,HIV,HIV Infections,Humans,Immunity,Mucosal,Immunohistochemistry,Interleukin-17,Leukocytes,Mononuclear,Lymphocyte Count,Male,Middle Aged,NK Cell Lectin-Like Receptor Subfamily B,Receptors,CCR5,CCR6,T-Lymphocyte Subsets,Time Factors||||"
bioc0541,mjawood,2,0.3055555555555556,Journal article|Journal article,Cell|Journal of Neuroinflammation,29/08/2013|28/11/2011,The CRTC1-SIK1 pathway regulates entrainment of the circadian clock.|The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation.,"Jagannath A,Butler R,Godinho SI,Couch Y,Brown LA,Vasudevan SR,Flanagan KC,Anthony D,Churchill GC,Wood MJ,Steiner G,Ebeling M,Hossbach M,Wettstein JG,Duffield GE,Gatti S,Hankins MW,Foster RG,Peirson SN|Couch Y,Alvarez-Erviti L,Sibson NR,Wood MJ,Anthony DC","Active Transport,Cell Nucleus,Animals,Circadian Clocks,Circadian Rhythm,Cyclic AMP Response Element-Binding Protein,Gene Knockdown Techniques,Mice,Inbred C57BL,Protein-Serine-Threonine Kinases,RNA,Small Interfering,Rod Opsins,Signal Transduction,Suprachiasmatic Nucleus,Transcription Factors,Transcription,Genetic|Amyloid beta-Peptides,Animals,Cell Death,Cell Line,Cytokines,Female,Inflammation,Interleukin-1beta,Lipopolysaccharides,Mice,Microglia,Parkinson Disease,Serum Albumin,Substantia Nigra,Transcription Factor RelA,Tumor Necrosis Factor-alpha,alpha-Synuclein"
clme0220,raob0182,1,0.06666666666666667,Journal article,Oncogene,,The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.,"da Motta LL,Ledaki I,Purshouse K,Haider S,De Bastiani MA,Baban D,Morotti M,Steers G,Wigfield S,Bridges E,Li JL,Knapp S,Ebner D,Klamt F,Harris AL,McIntyre A",
immd0036,stat0054,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0149,raob0097,1,0.1111111111111111,Journal article,Autophagy,01/04/2012,A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells.,"Phadwal K,Alegre-Abarrategui J,Watson AS,Pike L,Anbalagan S,Hammond EM,Wade-Martins R,McMichael A,Klenerman P,Simon AK","Adult,Animals,Autophagy,B-Lymphocytes,Biological Assay,Cell Aging,Cells,Cultured,HEK293 Cells,Histones,Humans,Mice,Middle Aged,Reproducibility of Results,T-Lymphocytes"
dops0137,ndog0251,1,0.16666666666666666,Journal article,Nanoscale,08/12/2014,A novel biosensor for quantitative monitoring of on-target activity of paclitaxel.,"Townley HE,Zheng Y,Goldsmith J,Zheng YY,Stratford MR,Dobson PJ,Ahmed AA","Silicon Dioxide,Paclitaxel,Tubulin,Antineoplastic Agents,Phytogenic,Drug Monitoring,Fluorescence Resonance Energy Transfer,Sensitivity and Specificity,Reproducibility of Results,Equipment Design,Equipment Failure Analysis,Biosensing Techniques,Particle Size,Nanocapsules,Nanoconjugates"
immd0082,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
claridge,clme0220,1,0.1111111111111111,Conference paper,European Journal of Cancer,01/07/2012,Isoenzyme-specific PFK-2/FBPase-2 Inhibition as an Anti-cancer Strategy,"Williams JG,Manzano A,Bensaad K,Collins JM,Serres S,Claridge TDW,Sibson N,Bartrons R,Russell AJ,Harris AL",
cschof,wolf1917,6,0.9361111111111111,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Antimicrobial Agents and Chemotherapy|Nucleic Acids Research|Journal of Biological Chemistry|Genes and Development|Chemical Communications|Trends in Biochemical Sciences,19/10/2015|17/11/2015|11/06/2012|01/01/2011|01/01/2016|21/01/2016,Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.|The structures of the SNM1A and SNM1B/Apollo nuclease domains reveal a potential basis for their distinct DNA processing activities.|Characterization of the human SNM1A and SNM1B/Apollo DNA repair exonucleases.|Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair|Cephalosporins inhibit human metallo β-lactamase fold DNA repair nucleases SNM1A and SNM1B/apollo.|The Chemical Biology of Human Metallo-β-Lactamase Fold Proteins.,"Brem J,van Berkel SS,Zollman D,Lee SY,Gileadi O,McHugh PJ,Walsh TR,McDonough MA,Schofield CJ|Allerston CK,Lee SY,Newman JA,Schofield CJ,McHugh PJ,Gileadi O|Sengerová B,Allerston CK,Abu M,Lee SY,Hartley J,Kiakos K,Schofield CJ,Hartley JA,Gileadi O,McHugh PJ|Wang AT,Sengerová B,Cattell E,Inagawa T,Hartley JM,Kiakos K,Burgess-Brown NA,Swift LP,Enzlin JH,Schofield CJ,Gileadi O,Hartley JA,McHugh PJ|Lee SY,Brem J,Pettinati I,Claridge TD,Gileadi O,Schofield CJ,McHugh PJ|Pettinati I,Brem J,Lee SY,McHugh PJ,Schofield CJ","|Humans,DNA Damage,DNA Repair Enzymes,Exodeoxyribonucleases,Nuclear Proteins,DNA,Catalytic Domain,Protein Structure,Tertiary,Protein Binding,Models,Molecular|Chelating Agents,DNA,DNA Cleavage,DNA Damage,DNA Repair Enzymes,Single-Stranded,DNA-Binding Proteins,Enzyme Assays,Enzyme Inhibitors,Escherichia coli,Fluorescein,Fluorescent Dyes,Humans,Hydrogen-Ion Concentration,Hydrolysis,Magnesium,Nuclear Proteins,Plasmids,Protein Binding,RNA,Recombinant Proteins,Substrate Specificity|||"
hert0418,stat0059,1,0.03333333333333333,Journal article,European Journal of Human Genetics,10/08/2011,People of the British Isles: preliminary analysis of genotypes and surnames in a UK-control population.,"Winney B,Boumertit A,Day T,Davison D,Echeta C,Evseeva I,Hutnik K,Leslie S,Nicodemus K,Royrvik EC,Tonks S,Yang X,Cheshire J,Longley P,Mateos P,Groom A,Relton C,Bishop DT,Black K,Northwood E,Parkinson L,Frayling TM,Steele A,Sampson JR,King T,Dixon R,Middleton D,Jennings B,Bowden R,Donnelly P,Bodmer W","Adolescent,Adult,Aged,80 and over,Alleles,Female,Gene Frequency,Genetics,Population,Genotype,Great Britain,Haplotypes,Humans,Male,Middle Aged,Names,Young Adult"
immd0023,immd0084,4,0.38181818181818183,Journal article|Journal article|Journal article|Journal article,Proceedings of the National Academy of Sciences of USA|Journal of Innate Immunity|eLife|Journal of Innate Immunity,15/12/2014|10/03/2015|01/01/2014|01/01/2015,Essential role for autophagy during invariant NKT cell development.|Autophagy Controls Acquisition of Aging Features in Macrophages.|Autophagy is a critical regulator of memory CD8(+) T cell formation.|Autophagy Controls Acquisition of Aging Features in Macrophages,"Salio M,Puleston DJ,Mathan TS,Shepherd D,Stranks AJ,Adamopoulou E,Veerapen N,Besra GS,Hollander GA,Simon AK,Cerundolo V|Stranks AJ,Hansen AL,Panse I,Mortensen M,Ferguson DJ,Puleston DJ,Shenderov K,Watson AS,Veldhoen M,Phadwal K,Cerundolo V,Simon AK|Puleston DJ,Zhang H,Powell TJ,Lipina E,Sims S,Panse I,Watson AS,Cerundolo V,Townsend AR,Klenerman P,Simon AK|Stranks AJ,Hansen AL,Panse I,Mortensen M,Ferguson DJP,Puleston DJ,Shenderov K,Watson AS,Veldhoen M,Phadwal K,Cerundolo V,Simon AK","Thymus Gland,CD4-Positive T-Lymphocytes,CD8-Positive T-Lymphocytes,Animals,Mice,Knockout,Superoxides,Microtubule-Associated Proteins,Apoptosis,Cell Differentiation,Cell Survival,Immunologic Memory,Autophagy,Natural Killer T-Cells|Macrophages,Animals,Mice,Knockout,Microtubule-Associated Proteins,Glycolysis,Aging,Autophagy|CD4-Positive T-Lymphocytes,CD8-Positive T-Lymphocytes,Mitochondria,Animals,Mice,Lymphocytic choriomeningitis virus,Reactive Oxygen Species,Microtubule-Associated Proteins,Viral Vaccines,Epitopes,Lymphocyte Count,Immunization,Secondary,Apoptosis,Cell Differentiation,Cell Proliferation,Cell Survival,Immunologic Memory,Phenotype,Autophagy,Glucose Transporter Type 1|"
raob0047,raob0202,4,0.475,Journal article|Journal article|Journal article|Conference paper,"Cancer Research|Radiotherapy and Oncology|Radiotherapy and Oncology|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",22/11/2011|13/03/2014|01/04/2014|01/07/2014,Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.|Regulation of O2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia.|Regulation of O<inf>2</inf> consumption by the PI3K and mTOR pathways contributes to tumor hypoxia|The PI3K/mTOR pathway regulates tumor O-2 consumption and hypoxia,"Fokas E,Im JH,Hill S,Yameen S,Stratford M,Beech J,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|Kelly CJ,Hussien K,Fokas E,Kannan P,Shipley RJ,Ashton TM,Stratford M,Pearson N,Muschel RJ|Kelly CJ,Hussien K,Fokas E,Kannan P,Shipley RJ,Ashton TM,Stratford M,Pearson N,Muschel RJ|Kelly C,Fokas E,Hussien K,Kannan P,Shipley R,Ashton T,Stratford M,Pearson N,Muschel R","Animals,Dose-Response Relationship,Drug,Humans,Mice,Neoplasms,Experimental,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Radiation Tolerance,TOR Serine-Threonine Kinases,Xenograft Model Antitumor Assays|Cell Line,Tumor,HCT116 Cells,Spheroids,Cellular,Animals,Humans,Mice,Neoplasms,Aminopyridines,Imidazoles,Morpholines,Quinolines,Protein Kinase Inhibitors,Signal Transduction,Cell Hypoxia,Oxygen Consumption,Phosphatidylinositol 3-Kinase,TOR Serine-Threonine Kinases||"
raob0047,raob0058,1,0.1,Journal article,Cancer Research,22/11/2011,Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.,"Fokas E,Im JH,Hill S,Yameen S,Stratford M,Beech J,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ","Animals,Dose-Response Relationship,Drug,Humans,Mice,Neoplasms,Experimental,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Radiation Tolerance,TOR Serine-Threonine Kinases,Xenograft Model Antitumor Assays"
clme0621,cschof,2,0.2857142857142857,Journal article|Journal article,Journal of Neurochemistry|Journal of Neurochemistry,01/01/2014|26/06/2014,HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice|HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.,"Chen RL,Ogunshola OO,Yeoh KK,Jani A,Papadakis M,Nagel S,Schofield CI,Buchan AM|Chen RL,Ogunshola OO,Yeoh KK,Jani A,Papadakis M,Nagel S,Schofield CJ,Buchan AM","|Cells,Cultured,Animals,Mice,Inbred C57BL,Rats,Brain Ischemia,Isoquinolines,Glycine,Neuroprotective Agents,Male,Hypoxia-Inducible Factor 1,alpha Subunit,Hypoxia-Inducible Factor-Proline Dioxygenases"
engs0357,raob0087,2,0.14285714285714285,Journal article|Journal article,International Journal of Cancer|International Journal of Cancer,15/06/2012|01/01/2013,G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency.|G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency,"Im JH,Tapmeier T,Balathasan L,Gal A,Yameen S,Hill S,Smart S,Noterdaeme O,Kelly M,Brady M,Fu W,Kruse K,Bernhard EJ,Augustin HG,Muschel RJ|Im JH,Tapmeier T,Balathasan L,Gal A,Yameen S,Hill S,Smart S,Noterdaeme O,Kelly M,Brady M,Fu W,Kruse K,Bernhard EJ,Augustin HG,Muschel RJ","Adenocarcinoma,Angiopoietin-2,Animals,Antigens,CD11b,CD31,Capillary Permeability,Cell Line,Tumor,Cell Proliferation,Cytokines,Female,Granulocyte Colony-Stimulating Factor,Green Fluorescent Proteins,Liver,Liver Neoplasms,Mice,Inbred C57BL,Knockout,Neoplasm Transplantation,Neoplasms,Experimental,Neovascularization,Pathologic,Neutrophils,Receptor Protein-Tyrosine Kinases,Receptor,TIE-2,Statistics,Nonparametric,Vascular Endothelial Growth Factor A|"
clme1037,cschof,3,0.09047619047619047,Journal article|Journal article|Journal article,Journal of Medicinal Chemistry|Nature|Nature,07/01/2016|01/10/2014|01/01/2012,"8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.|Kruidenier et al. reply.|A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.","Bavetsias V,Lanigan RM,Ruda GF,Atrash B,McLaughlin MG,Tumber A,Mok NY,Le Bihan YV,Dempster S,Boxall KJ,Jeganathan F,Hatch SB,Savitsky P,Velupillai S,Krojer T,England KS,Sejberg J,Thai C,Donovan A,Pal A,Scozzafava G,Bennett JM,Kawamura A,Johansson C,Szykowska A,Gileadi C,Burgess-Brown NA,von Delft F,Oppermann U,Walters Z,Shipley J,Raynaud FI,Westaway SM,Prinjha RK,Fedorov O,Burke R,Schofield CJ,Westwood IM,Bountra C,Müller S,van Montfort RL,Brennan PE,Blagg J|Kruidenier L,Chung CW,Cheng Z,Liddle J,Che K,Joberty G,Bantscheff M,Bountra C,Bridges A,Diallo H,Eberhard D,Hutchinson S,Jones E,Katso R,Leveridge M,Mander PK,Mosley J,Ramirez-Molina C,Rowland P,Schofield CJ,Sheppard RJ,Smith JE,Swales C,Tanner R,Thomas P,Tumber A,Drewes G,Oppermann U,Patel DJ,Lee K,Wilson DM|Kruidenier L,Chung C-W,Cheng Z,Liddle J,Che K,Joberty G,Bantscheff M,Bountra C,Bridges A,Diallo H,Eberhard D,Hutchinson S,Jones E,Katso R,Leveridge M,Mander PK,Mosley J,Ramirez-Molina C,Rowland P,Schofield CJ,Sheppard RJ,Smith JE,Swales C,Tanner R,Thomas P,Tumber A,Drewes G,Oppermann U,Patel DJ,Lee K,Wilson DM","|Macrophages,Animals,Humans,Enzyme Inhibitors,Jumonji Domain-Containing Histone Demethylases|Amino Acid Sequence,Animals,Biocatalysis,Catalytic Domain,Cells,Cultured,Enzyme Inhibitors,Evolution,Molecular,Histones,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Lysine,Macrophages,Methylation,Mice,Models,Substrate Specificity,Tumor Necrosis Factor-alpha"
ndos0168,phpc0084,1,0.14285714285714285,Journal article,Trials,10/12/2013,Corticosteroid injection for shoulder pain: single-blind randomized pilot trial in primary care.,"Holt TA,Mant D,Carr A,Gwilym S,Beard D,Toms C,Yu LM,Rees J","Adrenal Cortex Hormones,Adult,Aged,Analgesics,Bursitis,England,Feasibility Studies,Female,General Practice,Humans,Injections,Intra-Articular,Male,Middle Aged,Pain Management,Patient Satisfaction,Pilot Projects,Rotator Cuff,Shoulder Pain,Single-Blind Method,Surveys and Questionnaires,Tendinopathy,Time Factors,Treatment Outcome"
bioc0541,clph0059,1,0.14285714285714285,Journal article,Journal of National Cancer Institute,09/10/2013,Selective permeabilization of the blood-brain barrier at sites of metastasis.,"Connell JJ,Chatain G,Cornelissen B,Vallis KA,Hamilton A,Seymour L,Anthony DC,Sibson NR","Analysis of Variance,Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Blood-Brain Barrier,Brain,Brain Neoplasms,Breast Neoplasms,Contrast Media,Disease Models,Animal,Drug Administration Schedule,Female,Gadolinium DTPA,Gene Expression Regulation,Neoplastic,Humans,Immunohistochemistry,Lymphotoxin-alpha,Magnetic Resonance Imaging,Mice,Inbred BALB C,Permeability,Receptors,Tumor Necrosis Factor,Type I,Tomography,Emission-Computed,Single-Photon,X-Ray Computed,Trastuzumab,Tumor Necrosis Factor-alpha"
bioc0208,clme0149,5,0.6972222222222222,Journal article|Conference paper|Journal article|Journal article|Journal article,PLoS One|Gut|Journal of Proteomics and Bioinformatics|Journal of Proteome Research|Journal of molecular biomarkers & diagnosis,01/01/2012|01/06/2015|02/07/2012|16/03/2011|16/04/2014,Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.|DISCOVERY AND QUANTITATION OF NOVEL LIVER FIBROSIS BIOMARKERS USING PROTEOMICS|New proteomics approaches for discovering biomarkers: Searching for liver fibrosis markers in hepatitis c patients|New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients.|New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients,"Gangadharan B,Bapat M,Rossa J,Antrobus R,Chittenden D,Kampa B,Barnes E,Klenerman P,Dwek RA,Zitzmann N|Gangadharan B,Kumar A,Barnes E,Klenerman P,Zitzmann N|Gangadharan B,Bapat M,Rossa J,Antrobus R,Chittenden D,Kampa B,Barnes E,Klenerman P,Dwek RA,Zitzmann N|Gangadharan B,Antrobus R,Chittenden D,Rossa J,Bapat M,Klenerman P,Barnes E,Dwek RA,Zitzmann N|Gangadharan B,Antrobus R,Bapat M,Rossa J,Kumar A,Chittenden D,Kampa B,Barnes E,Klenerman P,Dwek RA,Zitzmann N","Adult,Aged,Apolipoproteins,Biomarkers,Clusterin,Complement C3d,Female,Hepatitis C,Humans,Lipoproteins,HDL,Liver,Liver Cirrhosis,Male,Middle Aged,Severity of Illness Index,Transcortin|||Biomarkers,Complement C3b,Complement C4b,Electrophoresis,Gel,Two-Dimensional,Polyacrylamide Gel,Hepatitis C,Humans,Hydrogen-Ion Concentration,Liver Cirrhosis,Proteomics|"
chem0489,whgu0142,1,0.125,Journal article,Australian Journal of Chemistry: an international journal for chemical science,01/01/2015,Synthesis of Highly Water-Soluble Adamantyl Phosphoinositide Derivatives,"Gregory M,Yin M-X,McConville MJ,Williams E,Bullock AN,Conway SJ,Burgess AW,Catimel B,Holmes AB",
raob0121,raob0233,3,0.2786037491919845,Conference paper|Journal article|Conference paper,Cancer Research|Cancer Cell|European Journal of Cancer,01/01/2016||01/11/2014,WEE1 inhibition selectively kills histone H3K36me3-deficient cancers by dNTP starvation|Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.|A novel synthetic lethal interaction between the histone mark H3K36me3 and checkpoint kinases,"Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Zalmas L-P,Orlando G,Drobnitzky N,Dianov G,Ying S,La Thangue NB,D'Angiolella V,Ryan A,Humphrey TC|Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Orlando G,Mavrommati I,Pai CC,Zalmas LP,Drobnitzky N,Dianov GL,Verrill C,Macaulay VM,Ying S,La Thangue NB,D'Angiolella V,Ryan AJ,Humphrey TC|Pfister SX,Markkanen E,Jiang Y,Sarkar S,D'Angiolella V,Dianov G,Ryan AJ,Humphrey TC","|Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Neoplasms,Pyrazoles,Pyrimidines,Ribonucleoside Diphosphate Reductase,Histone-Lysine N-Methyltransferase,Nucleotides,Lysine,Cell Cycle Proteins,Nuclear Proteins,Histones,Blotting,Western,Xenograft Model Antitumor Assays,Reverse Transcriptase Polymerase Chain Reaction,Cell Survival,Gene Expression Regulation,Neoplastic,RNA Interference,Amino Acid Sequence,Base Sequence,Sequence Homology,Amino Acid,Nucleic Acid,Methylation,Molecular Sequence Data,Protein-Tyrosine Kinases|"
immd0330,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
univ1923,whgu0172,3,0.13870064154694134,Journal article|Journal article|Journal article,Molecular Cell|Nature Chemical Biology|Oncotarget,30/01/2014|01/01/2012|01/01/2015,Optimal translational termination requires C4 lysyl hydroxylation of eRF1.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.|Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways.,"Yamamoto A,Feng T,Wilkins S,Sokolova E,Yates L,Muenzel M,Singh P,Hopkinson R,Fischer R,Cockman M,Shelley J,Trudgian D,Schoedel J,McCullagh JO,Ge W,Kessler B,Gilbert R,Frolova L,Alkalaeva E,Ratcliffe P,Schofield C,Coleman M|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Valli A,Rodriguez M,Moutsianas L,Fischer R,Fedele V,Huang HL,Van Stiphout R,Jones D,Mccarthy M,Vinaxia M,Igarashi K,Sato M,Soga T,Buffa F,Mccullagh J,Yanes O,Harris A,Kessler B","Amino Acid Sequence,Animals,Catalysis,Cell Line,Tumor,Codon,Terminator,Gene Expression Regulation,HeLa Cells,Histone Demethylases,Humans,Hydrolysis,Hydroxylation,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Peptide Chain Termination,Translational,Peptide Termination Factors,Protein Biosynthesis,Protein Processing,Post-Translational,Protein Structure,Tertiary,Sequence Homology,Amino Acid|Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes|Cell Line,Tumor,HCT116 Cells,Humans,Colorectal Neoplasms,Acetyl-CoA Carboxylase,Acetyl-CoA C-Acyltransferase,Lipids,Fatty Acids,Platelet Activating Factor,Blotting,Western,Proteomics,Genomics,Signal Transduction,Cell Hypoxia,RNA Interference,Aged,Middle Aged,Female,Male,Lipid Metabolism,Basic Helix-Loop-Helix Transcription Factors,Hypoxia-Inducible Factor 1,alpha Subunit,Metabolomics"
clme0975,radi0003,17,3.0595959595959594,Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Conference paper|Conference paper|Conference paper|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Conference paper,European Journal of Nuclear Medicine and Molecular Imaging|European Radiology|British Journal of Surgery|British Journal of Surgery||European Journal of Nuclear Medicine and Molecular Imaging|British Journal of Surgery|British Journal of Surgery|British Journal of Surgery|British Journal of Surgery|British Journal of Surgery|British Journal of Surgery|British Journal of Surgery|Annals of Oncology|European Radiology|European Radiology|British Journal of Surgery,01/10/2014|05/05/2012|01/05/2014|01/02/2012||01/10/2014|01/01/2011|01/05/2011|01/04/2015|01/04/2015|01/05/2014|01/10/2013|01/10/2013|01/01/2012|01/01/2012|01/02/2011|01/12/2014,"Baseline 18F-FDG PET-CT factors associated with progression to metastatic disease during neoadjuvant therapy for esophageal cancer|Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.|A decision tree analysis of selective endoscopic ultrasound in staging oesophageal cancer|Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.|Pulmonary nodules in patients with melanoma--assume nothing.Ann Oncol. 2011 Dec 26. [Epub ahead of print]|The added value of 18F-FDG PET-CT in restaging esophageal cancer after neoadjuvant therapy|Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma|Does metabolic response at repeat PET/CT examination predict pathological response to neoadjuvant chemotherapy in oesophageal cancer?|FDG-avid nodal stage of oesophageal cancer and response to neoadjuvant chemotherapy: new classifications predicting disease progression before surgery, and early recurrence afterwards|Decision theory and cost-benefit analysis of re-staging oesophageal cancer after neoadjuvant chemotherapy with PET-CT rather than CT|The utility of restaging PET-CT In predicting progression to unresectable oesophageal cancer after neoadjuvant chemotherapy|Routine staging endoscopic ultrasound is not required for T2-T4a oesophageal/junctional cancer|Results of restaging oesophageal and junctional cancer after neoadjuvant chemotherapy with PET-CT alone|Pulmonary nodules in patients with melanoma-assume nothing|Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer|Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.|Decision theory and cost-benefit analysis of re-staging oesophageal cancer with PET-CT after neoadjuvant chemotherapy","Findlay JM,Frankin JM,Teoh EJ,Jones GE,Di Carlo S,Middleton MR,Gleeson FV,Gillies RS,Bradley KM|Gillies RS,Middleton MR,Blesing C,Patel K,Warner N,Marshall RE,Maynard ND,Bradley KM,Gleeson FV|Findlay JM,Gillies RS,Braden B,Phillips-Hughes J,Bradley K,Gleeson F,Sgromo B,Marshall REK,Maynard ND,Middleton MR|Gillies RS,Middleton MR,Han C,Marshall RE,Maynard ND,Bradley KM,Gleeson FV|Gleeson FV,Murphy F,Middleton MR|Findlay JM,Franklin JM,Teoh EJ,Jones GE,Di Carlo S,Middleton MR,Gleeson FV,Gillies RS,Bradley KM|Gillies RS,Middleton MR,Han C,Marshall REK,Maynard ND,Bradley KM,Gleeson FV|Gillies RS,Middleton MR,Warren B,Bradley KM,Gleeson FV|Findlay JM,Gillies RS,Franklin JM,Teoh EJ,Jones GE,di Carlo S,Gleeson FV,Sgromo B,Marshall REK,Maynard ND,Bradley KM,Middleton MR|Findlay JM,Gillies RS,Franklin JM,Teoh EJ,Gleeson FV,Sgromo B,Marshall REK,Maynard ND,Bradley KM,Middleton MR|Findlay JM,Gillies RS,Jones G,Di Carlo S,Sgromo B,Marshall REK,Maynard ND,Bradley K,Gleeson F,Middleton MR|Findlay J,Maile E,Maw J,Braden B,Phillips-Hughes J,Bradley K,Gleeson F,Gillies R,Marshall R,Sgromo B,Maynard N,Middleton M|Findlay J,Gillies R,Di Carlo S,Jones G,Marshall R,Sgromo B,Maynard N,Bradley K,Gleeson F,Middleton M|Murphy F,Gleeson FV,Middleton MR|Gillies RS,Middleton MR,Blesing C,Patel K,Warner N,Marshall REK,Maynard ND,Bradley KM,Gleeson FV|Gillies RS,Middleton MR,Maynard ND,Bradley KM,Gleeson FV|Findlay J,Gillies R,Franklin J,Teoh E,Jones G,di Carlo S,Gleeson F,Sgromo B,Marshall R,Bradley K,Middleton M","|Aged,Antineoplastic Agents,Chemotherapy,Adjuvant,Esophageal Neoplasms,Female,Fluorodeoxyglucose F18,Humans,Male,Metabolic Clearance Rate,Multimodal Imaging,Neoadjuvant Therapy,Positron-Emission Tomography,Radiopharmaceuticals,Tissue Distribution,Tomography,X-Ray Computed,Treatment Failure,Treatment Outcome||Adenocarcinoma,Antineoplastic Combined Chemotherapy Protocols,Disease-Free Survival,Esophageal Neoplasms,Female,Fluorodeoxyglucose F18,Humans,Kaplan-Meier Estimate,Lymphatic Metastasis,Male,Middle Aged,Multimodal Imaging,Neoadjuvant Therapy,Positron-Emission Tomography,Radiopharmaceuticals,Tomography,X-Ray Computed,Treatment Outcome||||||||||||Adult,Aged,80 and over,Esophageal Neoplasms,Female,Fluorodeoxyglucose F18,Humans,Image Enhancement,Male,Middle Aged,Neoplasm Staging,Positron-Emission Tomography,Radiopharmaceuticals,Reproducibility of Results,Sensitivity and Specificity,Subtraction Technique,Tomography,X-Ray Computed|"
clme0497,whgu0172,3,0.19835164835164837,Journal article|Journal article|Journal article,Science Advances|ACS Chemical Biology|Cancer Cell,04/02/2016|21/03/2016|13/05/2013,Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response.|Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib.|Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Ghari F,Quirke AM,Munro S,Kawalkowska J,Picaud S,McGouran J,Subramanian V,Muth A,Williams R,Kessler B,Thompson PR,Fillipakopoulos P,Knapp S,Venables PJ,La Thangue NB|Mathea S,Abdul Azeez KR,Salah E,Tallant C,Wolfreys F,Konietzny R,Fischer R,Lou HJ,Brennan PE,Schnapp G,Pautsch A,Kessler BM,Turk BE,Knapp S|Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Cell Line,HL-60 Cells,Animals,Mice,Inbred DBA,Humans,Arthritis,Experimental,Inflammation,Hydrolases,Citrulline,Nuclear Proteins,Recombinant Proteins,Transcription Factors,RNA,Small Interfering,Cytokines,Gene Expression Regulation,Acetylation,Male,E2F1 Transcription Factor,Promoter Regions,Genetic||Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
bioc0804,ocms0037,1,0.07142857142857142,Journal article,eLife,15/12/2012,KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.,"Farcas AM,Blackledge NP,Sudbery I,Long HK,McGouran JF,Rose NR,Lee S,Sims D,Cerase A,Sheahan TW,Koseki H,Brockdorff N,Ponting CP,Kessler BM,Klose RJ","Chicken,Chromatin,CpG island,Demethylase,Epigenetics,Human,Methylation,Mouse,Transcription,Xenopus,Zebrafish,Animals,Cell Line,Tumor,CpG Islands,DNA Methylation,F-Box Proteins,Gene Silencing,Genome,Histones,Humans,Jumonji Domain-Containing Histone Demethylases,Mice,Polycomb-Group Proteins,Ubiquitination"
clme0220,whgu0085,7,0.875,Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article,Nature Medicine|British Journal of Cancer|British Journal of Cancer|British Journal of Surgery|Nature Medicine|Cancer Research|Cancer Research,07/08/2011|01/01/2011|15/03/2011|01/04/2011|01/01/2011|07/07/2011|01/01/2011,Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.|The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis|The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.|The role of hypoxia-inducible MIR-210 in the biology and prognosis of clear cell kidney cancer|Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization|microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer.|microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer,"Korpal M,Ell BJ,Buffa FM,Ibrahim T,Blanco MA,Celià-Terrassa T,Mercatali L,Khan Z,Goodarzi H,Hua Y,Wei Y,Hu G,Garcia BA,Ragoussis J,Amadori D,Harris AL,Kang Y|Gee HE,Buffa FM,Camps C,Ramachandran A,Leek R,Taylor M,Patil M,Sheldon H,Betts G,Homer J,West C,Ragoussis J,Harris AL|Gee HE,Buffa FM,Camps C,Ramachandran A,Leek R,Taylor M,Patil M,Sheldon H,Betts G,Homer J,West C,Ragoussis J,Harris AL|McCormick I,Ragoussis J,Hamdy F,Harris A|Korpal M,Ell BJ,Buffa FM,Ibrahim T,Blanco MA,Celià-Terrassa T,Mercatali L,Khan Z,Goodarzi H,Hua Y,Wei Y,Hu G,Garcia BA,Ragoussis J,Amadori D,Harris AL,Kang Y|Buffa FM,Camps C,Winchester L,Snell CE,Gee HE,Sheldon H,Taylor M,Harris AL,Ragoussis J|Buffa FM,Camps C,Winchester L,Snell CE,Gee HE,Sheldon H,Taylor M,Harris AL,Ragoussis J","Animals,Cadherins,Cell Line,Tumor,Female,Gene Expression Profiling,Gene Expression Regulation,Neoplastic,Humans,Mass Spectrometry,Mice,Inbred BALB C,MicroRNAs,Microarray Analysis,Neoplasm Metastasis,Statistics,Nonparametric,Vesicular Transport Proteins||Breast Neoplasms,Carcinoma,Squamous Cell,Female,Head and Neck Neoplasms,Humans,MicroRNAs,Neoplasms,Prognosis,RNA,Small Nucleolar|||Breast Neoplasms,Disease Progression,Disease-Free Survival,Female,Gene Expression Profiling,Gene Expression Regulation,Neoplastic,Humans,MicroRNAs,Neoplasm Recurrence,Local,Prognosis,RNA,Messenger|"
immd0180,whgu0172,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
clme0240,clme0501,1,0.125,Journal article,Clinical Proteomics,26/04/2012,Detection of BK virus in urine from renal transplant subjects by mass spectrometry.,"Konietzny R,Fischer R,Ternette N,Wright CA,Turney BW,Chakera A,Hughes D,Kessler BM,Pugh CW",
clme0220,ndos0097,3,0.5333333333333333,Conference paper|Journal article|Journal article,"British Journal of Urology (BJU) International|Carcinogenesis|European Urology, Supplements",01/06/2012|09/07/2012|01/03/2011,"Hypoxia regulated miRNAs in bladder cancer|CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC.|THE HYPOXIC REGULATION OF FGFR3 IN NON MUSCLE INVASIVE BLADDER CANCER","Blick C,Ramachandran A,Cranston D,Catto J,Harris AL|Biswas S,Charlesworth PJ,Turner GD,Leek R,Thamboo PT,Campo L,Turley H,Dildey P,Protheroe A,Cranston D,Gatter KC,Pezzella F,Harris AL|Blick C,McCormick R,Ramachandran A,Cranston D,Catto JWF,Harris AL","|Adult,Aged,80 and over,Angiogenesis Inhibitors,Antigens,CD31,Basic Helix-Loop-Helix Transcription Factors,Biomarkers,Tumor,Carcinoma,Renal Cell,Cyclin D1,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Kidney Neoplasms,Middle Aged,Prognosis|"
immd0421,immd0423,1,0.1111111111111111,Journal article,Oncogene,28/11/2011,Igf2 ligand dependency of Pten(+/-) developmental and tumour phenotypes in the mouse.,"Church DN,Phillips BR,Stuckey DJ,Barnes DJ,Buffa FM,Manek S,Clarke K,Harris AL,Carter EJ,Hassan AB","Animals,Carcinoma,Cardiomegaly,Cell Line,Tumor,Cell Proliferation,Cell Transformation,Neoplastic,Female,Humans,Insulin-Like Growth Factor II,Longevity,Male,Mammary Neoplasms,Animal,Mice,Inbred C57BL,PTEN Phosphohydrolase,Placenta,Pregnancy,Sex Factors"
gree0184,gree1499,2,0.29166666666666663,Journal article|Journal article,Circulation|British Journal of Cancer,12/03/2013|27/03/2014,"Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study.|Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom.","Sweetland S,Parkin L,Balkwill A,Green J,Reeves G,Beral V,Million Women Study Collaborators|Bradbury KE,Balkwill A,Spencer EA,Roddam AW,Reeves GK,Green J,Key TJ,Beral V,Pirie K","Cohort Studies,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Middle Aged,Postoperative Complications,Prospective Studies,Retrospective Studies,Risk Factors,Smoking,Venous Thromboembolism|Million Women Study Collaborators,Humans,Neoplasms,Lymphoma,Non-Hodgkin,Sarcoma,Breast Neoplasms,Incidence,Prospective Studies,Middle Aged,Great Britain,Female,Self Report,Food,Organic"
phpc0084,prhc0003,4,0.6697802197802198,Journal article|Journal article|Journal article|Journal article,BMJ Open|British Journal of General Practice|British Journal of Biomedical Science|European Journal of Heart Failure,01/01/2014|01/01/2012|01/01/2011|19/06/2012,"Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors.|Incidence and clinical variables associated with streptococcal throat infections: A prospective diagnostic cohort study|Effect of swab type on the analytical sensitivity of five point-of-care tests for group A streptococci.|Development and initial validation of a simple clinical decision tool to predict the presence of heart failure in primary care: the MICE (Male, Infarction, Crepitations, Edema) rule.","Kearley K,Selwood M,Van den Bruel A,Thompson M,Mant D,Hobbs FR,Fitzmaurice D,Heneghan C|Little P,Hobbs FDR,Mant D,McNulty CAM,Mullee M|Lasseter GM,McNulty CA,Hobbs FD,Mant D,Little P,PRImary care Streptococcal Management (PRISM) Investigators Group|Roalfe AK,Mant J,Doust JA,Barton P,Cowie MR,Glasziou P,Mant D,McManus RJ,Holder R,Deeks JJ,Doughty RN,Hoes AW,Fletcher K,Hobbs FD","Humans,Atrial Fibrillation,Blood Pressure Determination,Electrocardiography,Reproducibility of Results,Aged,80 and over,Triage,Primary Health Care,Female,Male||Humans,Pharyngitis,Point-of-Care Systems,Reagent Kits,Diagnostic,Sensitivity and Specificity,Specimen Handling,Streptococcal Infections,Streptococcus pyogenes|Aged,80 and over,Decision Support Techniques,Echocardiography,Edema,Female,Heart Failure,Humans,Logistic Models,Male,Middle Aged,Myocardial Infarction,Natriuretic Peptide,Brain,Primary Health Care,Prospective Studies,ROC Curve,Referral and Consultation,Respiratory Sounds,Sensitivity and Specificity,Sex Factors"
ocms0037,whgu0085,1,0.125,Journal article,Genome Research,16/11/2011,Preparation of high-quality next-generation sequencing libraries from picogram quantities of target DNA.,"Parkinson NJ,Maslau S,Ferneyhough B,Zhang G,Gregory L,Buck D,Ragoussis J,Ponting CP,Fischer MD","Animals,DNA,Bacterial,Escherichia coli K12,Gene Library,Mice,Sequence Analysis"
immd0075,immd0082,2,0.19548872180451127,Journal article|Journal article,Genome Biology: biology for the post-genomic era|Molecular Cell,|18/01/2012,Predicting the three-dimensional folding of cis-regulatory regions in mammalian genomes using bioinformatic data and polymer models.|Intragenic enhancers act as alternative promoters.,"Brackley CA,Brown JM,Waithe D,Babbs C,Davies J,Hughes JR,Buckle VJ,Marenduzzo D|Kowalczyk MS,Hughes JR,Garrick D,Lynch MD,Sharpe JA,Sloane-Stanley JA,McGowan SJ,De Gobbi M,Hosseini M,Vernimmen D,Brown JM,Gray NE,Collavin L,Gibbons RJ,Flint J,Taylor S,Buckle VJ,Milne TA,Wood WG,Higgs DR","|Animals,Cells,Cultured,Enhancer Elements,Genetic,Erythroid Cells,Gene Expression Regulation,Mice,Poly A,Promoter Regions,RNA,RNA Isoforms,Messenger,Transcriptome"
raob0121,raob0122,3,0.2786037491919845,Conference paper|Journal article|Conference paper,Cancer Research|Cancer Cell|European Journal of Cancer,01/01/2016||01/11/2014,WEE1 inhibition selectively kills histone H3K36me3-deficient cancers by dNTP starvation|Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.|A novel synthetic lethal interaction between the histone mark H3K36me3 and checkpoint kinases,"Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Zalmas L-P,Orlando G,Drobnitzky N,Dianov G,Ying S,La Thangue NB,D'Angiolella V,Ryan A,Humphrey TC|Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Orlando G,Mavrommati I,Pai CC,Zalmas LP,Drobnitzky N,Dianov GL,Verrill C,Macaulay VM,Ying S,La Thangue NB,D'Angiolella V,Ryan AJ,Humphrey TC|Pfister SX,Markkanen E,Jiang Y,Sarkar S,D'Angiolella V,Dianov G,Ryan AJ,Humphrey TC","|Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Neoplasms,Pyrazoles,Pyrimidines,Ribonucleoside Diphosphate Reductase,Histone-Lysine N-Methyltransferase,Nucleotides,Lysine,Cell Cycle Proteins,Nuclear Proteins,Histones,Blotting,Western,Xenograft Model Antitumor Assays,Reverse Transcriptase Polymerase Chain Reaction,Cell Survival,Gene Expression Regulation,Neoplastic,RNA Interference,Amino Acid Sequence,Base Sequence,Sequence Homology,Amino Acid,Nucleic Acid,Methylation,Molecular Sequence Data,Protein-Tyrosine Kinases|"
bras2068,raob0128,1,0.3333333333333333,Journal article,Physics in Medicine and Biology,14/05/2015,Improved calibration of mass stopping power in low density tissue for a proton pencil beam algorithm.,"Warren DR,Partridge M,Hill MA,Peach K","Humans,Carcinoma,Non-Small-Cell Lung,Lung Neoplasms,Tomography,X-Ray Computed,Radiotherapy Dosage,Radiotherapy Planning,Computer-Assisted,Calibration,Monte Carlo Method,Phantoms,Imaging,Algorithms,Proton Therapy"
clme0237,immd0036,4,0.20462885738115094,Journal article|Conference paper|Journal article|Journal article,European Journal of Human Genetics|Journal of Medical Genetics|Nature Genetics|American Journal of Human Genetics,01/01/2013|01/09/2011|18/05/2015|,"Next-generation sequencing (NGS) as a diagnostic tool for retinal degeneration reveals a much higher detection rate in early-onset disease|Targeted Capture and Next Generation Sequencing (NGS) of genes involved in Inherited Retinal Degeneration (IRD)|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome.","Shanks ME,Downes SM,Copley RR,Lise S,Broxholme J,Hudspith KAZ,Kwasniewska A,Davies WIL,Hankins MW,Packham ER,Clouston P,Seller A,Wilkie AOM,Taylor JC,Ragoussis J,Németh AH|Shanks M,Downes SM,Kwasniewska A,Packham E,Clouston P,Seller A,Copley R,Lise S,Taylor J,Hudspith K,Wilkie AOM,Ragoussis J,Nemeth AH|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Twigg SR,Hufnagel RB,Miller KA,Zhou Y,McGowan SJ,Taylor J,Craft J,Taylor JC,Santoro SL,Huang T,Hopkin RJ,Brady AF,Clayton-Smith J,Clericuzio CL,Grange DK,Groesser L,Hafner C,Horn D,Temple IK,Dobyns WB,Curry CJ,Jones MC,Wilkie AO","||Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|"
immd0282,immd0316,2,0.1,Journal article|Journal article,Cancer Cell|Cancer Cell,12/08/2013|17/07/2013,A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis|A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.,"Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SYY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM|Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM","|Animals,Cell Growth Processes,Endothelial Cells,Female,Genetic Predisposition to Disease,HCT116 Cells,Humans,Mice,Nude,Neoplasms,Neovascularization,Pathologic,Receptors,G-Protein-Coupled,Signal Transduction"
clme0237,whgu0085,1,0.08333333333333333,Conference paper,Journal of Medical Genetics,01/09/2011,Targeted Capture and Next Generation Sequencing (NGS) of genes involved in Inherited Retinal Degeneration (IRD),"Shanks M,Downes SM,Kwasniewska A,Packham E,Clouston P,Seller A,Copley R,Lise S,Taylor J,Hudspith K,Wilkie AOM,Ragoussis J,Nemeth AH",
ctsu0084,gree1024,2,0.0027914134330684123,Journal article|Journal article,Lancet|Lancet,10/01/2015|01/09/2015,"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013|Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.","Naghavi M,Wang H,Lozano R,Davis A,Liang X,Zhou M,Vollset SE,Ozgoren AA,Abdalla S,Abd-Allah F,Aziz MIA,Abera SF,Aboyans V,Abraham B,Abraham JP,Abuabara KE,Abubakar I,Abu-Raddad LJ,Abu-Rmeileh NME,Achoki T,Adelekan A,Ademi ZN,Adofo K,Adou AK,Adsuar JC,Aernlov J,Agardh EE,Akena D,Al Khabouri MJ,Alasfoor D,Albittar M,Alegretti MA,Aleman AV,Alemu ZA,Alfonso-Cristancho R,Alhabib S,Ali MK,Ali R,Alla F,Al Lami F,Allebeck P,AlMazroa MA,Salman RA-S,Alsharif U,Alvarez E,Alviz-Guzman N,Amankwaa AA,Amare AT,Ameli O,Amini H,Ammar W,Anderson HR,Anderson BO,Antonio CAT,Anwari P,Apfel H,Cunningham SA,Arsenijevic VSA,Artaman A,Asad MM,Asghar RJ,Assadi R,Atkins LS,Atkinson C,Badawi A,Bahit MC,Bakfalouni T,Balakrishnan K,Balalla S,Banerjee A,Barber RM,Barker-Collo SL,Barquera S,Barregard L,Barrero LH,Barrientos-Gutierrez T,Basu A,Basu S,Basulaiman MO,Beardsley J,Bedi N,Beghi E,Bekele T,Bell ML,Benjet C,Bennett DA,Bensenor IM,Benzian H,Bertozzi-Villa A,Beyene TJ,Bhala N,Bhalla A,Bhutta ZA,Bikbov B,Bin Abdulhak A,Biryukov S,Blore JD,Blyth FM,Bohensky MA,Borges G,Bose D,Boufous S,Bourne RR,Boyers LN,Brainin M,Brauer M,Brayne CEG,Brazinova A,Breitborde N,Brenner H,Briggs ADM,Brown JC,Brugha TS,Buckle GC,Bui LN,Bukhman G,Burch M,Nonato IRC,Carabin H,Cardenas R,Carapetis J,Carpenter DO,Caso V,Castaneda-Orjuela CA,Castro RE,Catala-Lopez F,Cavalleri F,Chang J-C,Charlson FC,Che X,Chen H,Chen Y,Chen JS,Chen Z,Chiang PP-C,Chimed-Ochir O,Chowdhury R,Christensen H,Christophi CA,Chuang T-W,Chugh SS,Cirillo M,Coates MM,Coffeng LE,Coggeshall MS,Cohen A,Colistro V,Colquhoun SM,Colomar M,Cooper LT,Cooper C,Coppola LM,Cortinovis M,Courville K,Cowie BC,Criqui MH,Crump JA,Cuevas-Nasu L,Leite IDC,Dabhadkar KC,Dandona L,Dandona R,Dansereau E,Dargan PI,Dayama A,De la Cruz-Gongora V,de la Vega SF,De Leo D,Degenhardt L,del Pozo-Cruz B,Dellavalle RP,Deribe K,Jarlais DCD,Dessalegn M,deVeber GA,Dharmaratne SD,Dherani M,Diaz-Ortega J-L,Diaz-Torne C,Dicker D,Ding EL,Dokova K,Dorsey ER,Driscoll TR,Duan L,Duber HC,Durrani AM,Ebel BE,Edmond KM,Ellenbogen RG,Elshrek Y,Ermakov SP,Erskine HE,Eshrati B,Esteghamati A,Estep K,Fuerst T,Fahimi S,Fahrion AS,Faraon EJA,Farzadfar F,Fay DFJ,Feigl AB,Feigin VL,Felicio MM,Fereshtehnejad S-M,Fernandes JG,Ferrari AJ,Fleming TD,Foigt N,Foreman K,Forouzanfar MH,Fowkes FGR,Fra Paleo U,Franklin RC,Futran ND,Gaffikin L,Gambashidze K,Gankpe FG,Garcia-Guerra FA,Garcia AC,Geleijnse JM,Gessner BD,Gibney KB,Gillum RF,Gilmour S,Abdelmageem I,Ginawi M,Giroud M,Glaser EL,Goenka S,Dantes HG,Gona P,Gonzalez-Medina D,Guinovart C,Gupta R,Gupta R,Gosselin RA,Gotay CC,Goto A,Gowda HN,Graetz N,Greenwell KF,Gugnani HC,Gunnell D,Gutierrez RA,Haagsma J,Hafezi-Nejad N,Hagan H,Hagstromer M,Halasa YA,Hamadeh RR,Hamavid H,Hammami M,Hancock J,Hankey GJ,Hansen GM,Harb HL,Harewood H,Haro JM,Havmoeller R,Hay RJ,Hay SI,Hedayati MT,Pi IBH,Heuton KR,Heydarpour P,Higashi H,Hijar M,Hoek HW,Hoffman HJ,Hornberger JC,Hosgood HD,Hossain M,Hotez PJ,Hoy DG,Hsairi M,Hu G,Huang JJ,Huffman MD,Hughes AJ,Husseini A,Huynh C,Iannarone M,Iburg KM,Idrisov BT,Ikeda N,Innos K,Inoue M,Islami F,Ismayilova S,Jacobsen KH,Jassal S,Jayaraman SP,Jensen PN,Jha V,Jiang G,Jiang Y,Jonas JB,Joseph J,Juel K,Kabagambe EK,Kan H,Karch A,Karimkhani C,Karthikeyan G,Kassebaum N,Kaul A,Kawakami N,Kazanjan K,Kazi DS,Kemp AH,Kengne AP,Keren A,Kereselidze M,Khader YS,Khalifa SEAH,Khan EA,Khan G,Khang Y-H,Kieling C,Kinfu Y,Kinge JM,Kim D,Kim S,Kivipelto M,Knibbs L,Knudsen AK,Kokubo Y,Kosen S,Kotagal M,Kravchenko MA,Krishnaswami S,Krueger H,Defo BK,Kuipers EJ,Bicer BK,Kulkarni C,Kulkarni VS,Kumar K,Kumar RB,Kwan GF,Kyu H,Lai T,Balaji AL,Lalloo R,Lallukka T,Lam H,Lan Q,Lansingh VC,Larson HJ,Larsson A,Lavados PM,Lawrynowicz AEB,Leasher JL,Lee J-T,Leigh J,Leinsalu M,Leung R,Levitz C,Li B,Li Y,Li Y,Liddell C,Lim SS,de Lima GMF,Lind ML,Lipshultz SE,Liu S,Liu Y,Lloyd BK,Lofgren KT,Logroscino G,London SJ,Lortet-Tieulent J,Lotufo PA,Lucas RM,Lunevicius R,Lyons RA,Ma S,Machado VMP,MacIntyre MF,Mackay MT,MacLachlan JH,Magis-Rodriguez C,Mahdi AA,Majdan M,Malekzadeh R,Mangalam S,Mapoma CC,Marape M,Marcenes W,Margono C,Marks GB,Marzan MB,Masci JR,Mashal MTQ,Masiye F,Mason-Jones AJ,Matzopolous R,Mayosi BM,Mazorodze TT,McGrath JJ,Mckay AC,Mckee M,McLain A,Meaney PA,Mehndiratta MM,Mejia-Rodriguez F,Melaku YA,Meltzer M,Memish ZA,Mendoza W,Mensah GA,Meretoja A,Mhimbira FA,Miller TR,Mills EJ,Misganaw A,Mishra SK,Mock CN,Moffitt TE,Ibrahim NM,Mohammad KA,Mokdad AH,Mola GL,Monasta L,Monis JDLC,Hernandez JCM,Montico M,Montine TJ,Mooney MD,Moore AR,Moradi-Lakeh M,Moran AE,Mori R,Moschandreas J,Moturi WN,Moyer ML,Mozaffarian D,Mueller UO,Mukaigawara M,Mullany EC,Murray J,Mustapha A,Naghavi P,Naheed A,Naidoo KS,Naldi L,Nand D,Nangia V,Narayan KMV,Nash D,Nasher J,Nejjari C,Nelson RG,Neuhouser M,Neupane SP,Newcomb PA,Newman L,Newton CR,Ng M,Ngalesoni FN,Nguyen G,Nguyen NTT,Nisar MI,Nolte S,Norheim OF,Norman RE,Norrving B,Nyakarahuka L,Odell S,O'Donnell M,Ohkubo T,Ohno SL,Olusanya BO,Omer SB,Opio JN,Orisakwe OE,Ortblad KF,Ortiz A,Otayza MLK,Pain AW,Pandian JD,Panelo CI,Panniyammakal J,Papachristou C,Paternina Caicedo AJ,Patten SB,Patton GC,Paul VK,Pavlin B,Pearce N,Pellegrini CA,Pereira DM,Peresson SC,Perez-Padilla R,Perez-Ruiz FP,Perico N,Pervaiz A,Pesudovs K,Peterson CB,Petzold M,Phillips BK,Phillips DE,Phillips MR,Plass D,Piel FB,Poenaru D,Polinder S,Popova S,Poulton RG,Pourmalek F,Prabhakaran D,Qato D,Quezada AD,Quistberg DA,Rabito F,Rafay A,Rahimi K,Rahimi-Movaghar V,Rahman SUR,Raju M,Rakovac I,Rana SM,Refaat A,Remuzzi G,Ribeiro AL,Ricci S,Riccio PM,Richardson L,Richardus JH,Roberts B,Roberts DA,Robinson M,Roca A,Rodriguez A,Rojas-Rueda D,Ronfani L,Room R,Roth GA,Rothenbacher D,Rothstein DH,Rowley JT,Roy N,Ruhago GM,Rushton L,Sambandam S,Soreide K,Saeedi MY,Saha S,Sahathevan R,Sahraian MA,Sahle BW,Salomon JA,Salvo D,Samonte GMJ,Sampson U,Sanabria JR,Sandar L,Santos IS,Satpathy M,Sawhney M,Saylan M,Scarborough P,Schoettker B,Schmidt JC,Schneider IJC,Schumacher AE,Schwebel DC,Scott JG,Sepanlou SG,Servan-Mori EE,Shackelford K,Shaheen A,Shahraz S,Shakh-Nazarova M,Shangguan S,She J,Sheikhbahaei S,Shepard DS,Shibuya K,Shinohara Y,Shishani K,Shiue I,Shivakoti R,Shrime MG,Sigfusdottir ID,Silberberg DH,Silva AP,Simard EP,Sindi S,Singh JA,Singh L,Sioson E,Skirbekk V,Sliwa K,So S,Soljak M,Soneji S,Soshnikov SS,Sposato LA,Sreeramareddy CT,Stanaway JRD,Stathopoulou VK,Steenland K,Stein C,Steiner C,Stevens A,Stoeckl H,Straif K,Stroumpoulis K,Sturua L,Sunguya BF,Swaminathan S,Swaroop M,Sykes BL,Tabb KM,Takahashi K,Talongwa RT,Tan F,Tanne D,Tanner M,Tavakkoli M,Ao BT,Teixeira CM,Templin T,Tenkorang EY,Terkawi AS,Thomas BA,Thorne-Lyman AL,Thrift AG,Thurston GD,Tillmann T,Tirschwell DL,Tleyjeh IM,Tonelli M,Topouzis F,Towbin JA,Toyoshima H,Traebert J,Tran BX,Truelsen T,Trujillo U,Trillini M,Dimbuene ZT,Tsilimbaris M,Tuzcu EM,Ubeda C,Uchendu US,Ukwaja KN,Undurraga EA,Vallely AJ,van de Vijver S,van Gool CH,Varakin YY,Vasankari TJ,Vasconcelos AMN,Vavilala MS,Venketasubramanian N,Vijayakumar L,Villalpando S,Violante FS,Vlassov VV,Wagner GR,Waller SG,Wang J,Wang L,Wang X,Wang Y,Warouw TS,Weichenthal S,Weiderpass E,Weintraub RG,Wenzhi W,Werdecker A,Wessells KRR,Westerman R,Whiteford HA,Wilkinson JD,Williams TN,Woldeyohannes SM,Wolfe CDA,Wolock TM,Woolf AD,Wong JQ,Wright JL,Wulf S,Wurtz B,Xu G,Yang YC,Yano Y,Yatsuya H,Yip P,Yonemoto N,Yoon S-J,Younis M,Yu C,Jin KY,Zaki MES,Zamakhshary MF,Zeeb H,Zhang Y,Zhao Y,Zheng Y,Zhu J,Zhu S,Zonies D,Zou XN,Zunt JR,Vos T,Lopez AD,Murray CJL,Colla GBDM2CD|Forouzanfar MH,Alexander L,Anderson HR,Bachman VF,Biryukov S,Brauer M,Burnett R,Casey D,Coates MM,Cohen A,Delwiche K,Estep K,Frostad JJ,Astha KC,Kyu HH,Moradi-Lakeh M,Ng M,Slepak EL,Thomas BA,Wagner J,Aasvang GM,Abbafati C,Abbasoglu Ozgoren A,Abd-Allah F,Abera SF,Aboyans V,Abraham B,Abraham JP,Abubakar I,Abu-Rmeileh NM,Aburto TC,Achoki T,Adelekan A,Adofo K,Adou AK,Adsuar JC,Afshin A,Agardh EE,Al Khabouri MJ,Al Lami FH,Alam SS,Alasfoor D,Albittar MI,Alegretti MA,Aleman AV,Alemu ZA,Alfonso-Cristancho R,Alhabib S,Ali R,Ali MK,Alla F,Allebeck P,Allen PJ,Alsharif U,Alvarez E,Alvis-Guzman N,Amankwaa AA,Amare AT,Ameh EA,Ameli O,Amini H,Ammar W,Anderson BO,Antonio CA,Anwari P,Argeseanu Cunningham S,Arnlöv J,Arsenijevic VS,Artaman A,Asghar RJ,Assadi R,Atkins LS,Atkinson C,Avila MA,Awuah B,Badawi A,Bahit MC,Bakfalouni T,Balakrishnan K,Balalla S,Balu RK,Banerjee A,Barber RM,Barker-Collo SL,Barquera S,Barregard L,Barrero LH,Barrientos-Gutierrez T,Basto-Abreu AC,Basu A,Basu S,Basulaiman MO,Batis Ruvalcaba C,Beardsley J,Bedi N,Bekele T,Bell ML,Benjet C,Bennett DA,Benzian H,Bernabé E,Beyene TJ,Bhala N,Bhalla A,Bhutta ZA,Bikbov B,Bin Abdulhak AA,Blore JD,Blyth FM,Bohensky MA,Bora Başara B,Borges G,Bornstein NM,Bose D,Boufous S,Bourne RR,Brainin M,Brazinova A,Breitborde NJ,Brenner H,Briggs AD,Broday DM,Brooks PM,Bruce NG,Brugha TS,Brunekreef B,Buchbinder R,Bui LN,Bukhman G,Bulloch AG,Burch M,Burney PG,Campos-Nonato IR,Campuzano JC,Cantoral AJ,Caravanos J,Cárdenas R,Cardis E,Carpenter DO,Caso V,Castañeda-Orjuela CA,Castro RE,Catalá-López F,Cavalleri F,Çavlin A,Chadha VK,Chang JC,Charlson FJ,Chen H,Chen W,Chen Z,Chiang PP,Chimed-Ochir O,Chowdhury R,Christophi CA,Chuang TW,Chugh SS,Cirillo M,Claßen TK,Colistro V,Colomar M,Colquhoun SM,Contreras AG,Cooper C,Cooperrider K,Cooper LT,Coresh J,Courville KJ,Criqui MH,Cuevas-Nasu L,Damsere-Derry J,Danawi H,Dandona L,Dandona R,Dargan PI,Davis A,Davitoiu DV,Dayama A,de Castro EF,De la Cruz-Góngora V,De Leo D,de Lima G,Degenhardt L,del Pozo-Cruz B,Dellavalle RP,Deribe K,Derrett S,Des Jarlais DC,Dessalegn M,deVeber GA,Devries KM,Dharmaratne SD,Dherani MK,Dicker D,Ding EL,Dokova K,Dorsey ER,Driscoll TR,Duan L,Durrani AM,Ebel BE,Ellenbogen RG,Elshrek YM,Endres M,Ermakov SP,Erskine HE,Eshrati B,Esteghamati A,Fahimi S,Faraon EJ,Farzadfar F,Fay DF,Feigin VL,Feigl AB,Fereshtehnejad SM,Ferrari AJ,Ferri CP,Flaxman AD,Fleming TD,Foigt N,Foreman KJ,Paleo UF,Franklin RC,Gabbe B,Gaffikin L,Gakidou E,Gamkrelidze A,Gankpé FG,Gansevoort RT,García-Guerra FA,Gasana E,Geleijnse JM,Gessner BD,Gething P,Gibney KB,Gillum RF,Ginawi IA,Giroud M,Giussani G,Goenka S,Goginashvili K,Gomez Dantes H,Gona P,Gonzalez de Cosio T,González-Castell D,Gotay CC,Goto A,Gouda HN,Guerrant RL,Gugnani HC,Guillemin F,Gunnell D,Gupta R,Gupta R,Gutiérrez RA,Hafezi-Nejad N,Hagan H,Hagstromer M,Halasa YA,Hamadeh RR,Hammami M,Hankey GJ,Hao Y,Harb HL,Haregu TN,Haro JM,Havmoeller R,Hay SI,Hedayati MT,Heredia-Pi IB,Hernandez L,Heuton KR,Heydarpour P,Hijar M,Hoek HW,Hoffman HJ,Hornberger JC,Hosgood HD,Hoy DG,Hsairi M,Hu G,Hu H,Huang C,Huang JJ,Hubbell BJ,Huiart L,Husseini A,Iannarone ML,Iburg KM,Idrisov BT,Ikeda N,Innos K,Inoue M,Islami F,Ismayilova S,Jacobsen KH,Jansen HA,Jarvis DL,Jassal SK,Jauregui A,Jayaraman S,Jeemon P,Jensen PN,Jha V,Jiang F,Jiang G,Jiang Y,Jonas JB,Juel K,Kan H,Kany Roseline SS,Karam NE,Karch A,Karema CK,Karthikeyan G,Kaul A,Kawakami N,Kazi DS,Kemp AH,Kengne AP,Keren A,Khader YS,Khalifa SE,Khan EA,Khang YH,Khatibzadeh S,Khonelidze I,Kieling C,Kim D,Kim S,Kim Y,Kimokoti RW,Kinfu Y,Kinge JM,Kissela BM,Kivipelto M,Knibbs LD,Knudsen AK,Kokubo Y,Kose MR,Kosen S,Kraemer A,Kravchenko M,Krishnaswami S,Kromhout H,Ku T,Kuate Defo B,Kucuk Bicer B,Kuipers EJ,Kulkarni C,Kulkarni VS,Kumar GA,Kwan GF,Lai T,Lakshmana Balaji A,Lalloo R,Lallukka T,Lam H,Lan Q,Lansingh VC,Larson HJ,Larsson A,Laryea DO,Lavados PM,Lawrynowicz AE,Leasher JL,Lee JT,Leigh J,Leung R,Levi M,Li Y,Li Y,Liang J,Liang X,Lim SS,Lindsay MP,Lipshultz SE,Liu S,Liu Y,Lloyd BK,Logroscino G,London SJ,Lopez N,Lortet-Tieulent J,Lotufo PA,Lozano R,Lunevicius R,Ma J,Ma S,Machado VM,MacIntyre MF,Magis-Rodriguez C,Mahdi AA,Majdan M,Malekzadeh R,Mangalam S,Mapoma CC,Marape M,Marcenes W,Margolis DJ,Margono C,Marks GB,Martin RV,Marzan MB,Mashal MT,Masiye F,Mason-Jones AJ,Matsushita K,Matzopoulos R,Mayosi BM,Mazorodze TT,McKay AC,McKee M,McLain A,Meaney PA,Medina C,Mehndiratta MM,Mejia-Rodriguez F,Mekonnen W,Melaku YA,Meltzer M,Memish ZA,Mendoza W,Mensah GA,Meretoja A,Mhimbira FA,Micha R,Miller TR,Mills EJ,Misganaw A,Mishra S,Mohamed Ibrahim N,Mohammad KA,Mokdad AH,Mola GL,Monasta L,Montañez Hernandez JC,Montico M,Moore AR,Morawska L,Mori R,Moschandreas J,Moturi WN,Mozaffarian D,Mueller UO,Mukaigawara M,Mullany EC,Murthy KS,Naghavi M,Nahas Z,Naheed A,Naidoo KS,Naldi L,Nand D,Nangia V,Narayan KM,Nash D,Neal B,Nejjari C,Neupane SP,Newton CR,Ngalesoni FN,Ngirabega JD,Nguyen G,Nguyen NT,Nieuwenhuijsen MJ,Nisar MI,Nogueira JR,Nolla JM,Nolte S,Norheim OF,Norman RE,Norrving B,Nyakarahuka L,Oh IH,Ohkubo T,Olusanya BO,Omer SB,Opio JN,Orozco R,Pagcatipunan RS,Pain AW,Pandian JD,Panelo CI,Papachristou C,Park EK,Parry CD,Paternina Caicedo AJ,Patten SB,Paul VK,Pavlin BI,Pearce N,Pedraza LS,Pedroza A,Pejin Stokic L,Pekericli A,Pereira DM,Perez-Padilla R,Perez-Ruiz F,Perico N,Perry SA,Pervaiz A,Pesudovs K,Peterson CB,Petzold M,Phillips MR,Phua HP,Plass D,Poenaru D,Polanczyk GV,Polinder S,Pond CD,Pope CA,Pope D,Popova S,Pourmalek F,Powles J,Prabhakaran D,Prasad NM,Qato DM,Quezada AD,Quistberg DA,Racapé L,Rafay A,Rahimi K,Rahimi-Movaghar V,Rahman SU,Raju M,Rakovac I,Rana SM,Rao M,Razavi H,Reddy KS,Refaat AH,Rehm J,Remuzzi G,Ribeiro AL,Riccio PM,Richardson L,Riederer A,Robinson M,Roca A,Rodriguez A,Rojas-Rueda D,Romieu I,Ronfani L,Room R,Roy N,Ruhago GM,Rushton L,Sabin N,Sacco RL,Saha S,Sahathevan R,Sahraian MA,Salomon JA,Salvo D,Sampson UK,Sanabria JR,Sanchez LM,Sánchez-Pimienta TG,Sanchez-Riera L,Sandar L,Santos IS,Sapkota A,Satpathy M,Saunders JE,Sawhney M,Saylan MI,Scarborough P,Schmidt JC,Schneider IJ,Schöttker B,Schwebel DC,Scott JG,Seedat S,Sepanlou SG,Serdar B,Servan-Mori EE,Shaddick G,Shahraz S,Levy TS,Shangguan S,She J,Sheikhbahaei S,Shibuya K,Shin HH,Shinohara Y,Shiri R,Shishani K,Shiue I,Sigfusdottir ID,Silberberg DH,Simard EP,Sindi S,Singh A,Singh GM,Singh JA,Skirbekk V,Sliwa K,Soljak M,Soneji S,Søreide K,Soshnikov S,Sposato LA,Sreeramareddy CT,Stapelberg NJ,Stathopoulou V,Steckling N,Stein DJ,Stein MB,Stephens N,Stöckl H,Straif K,Stroumpoulis K,Sturua L,Sunguya BF,Swaminathan S,Swaroop M,Sykes BL,Tabb KM,Takahashi K,Talongwa RT,Tandon N,Tanne D,Tanner M,Tavakkoli M,Te Ao BJ,Teixeira CM,Téllez Rojo MM,Terkawi AS,Texcalac-Sangrador JL,Thackway SV,Thomson B,Thorne-Lyman AL,Thrift AG,Thurston GD,Tillmann T,Tobollik M,Tonelli M,Topouzis F,Towbin JA,Toyoshima H,Traebert J,Tran BX,Trasande L,Trillini M,Trujillo U,Dimbuene ZT,Tsilimbaris M,Tuzcu EM,Uchendu US,Ukwaja KN,Uzun SB,van de Vijver S,Van Dingenen R,van Gool CH,van Os J,Varakin YY,Vasankari TJ,Vasconcelos AM,Vavilala MS,Veerman LJ,Velasquez-Melendez G,Venketasubramanian N,Vijayakumar L,Villalpando S,Violante FS,Vlassov VV,Vollset SE,Wagner GR,Waller SG,Wallin MT,Wan X,Wang H,Wang J,Wang L,Wang W,Wang Y,Warouw TS,Watts CH,Weichenthal S,Weiderpass E,Weintraub RG,Werdecker A,Wessells KR,Westerman R,Whiteford HA,Wilkinson JD,Williams HC,Williams TN,Woldeyohannes SM,Wolfe CD,Wong JQ,Woolf AD,Wright JL,Wurtz B,Xu G,Yan LL,Yang G,Yano Y,Ye P,Yenesew M,Yentür GK,Yip P,Yonemoto N,Yoon SJ,Younis MZ,Younoussi Z,Yu C,Zaki ME,Zhao Y,Zheng Y,Zhou M,Zhu J,Zhu S,Zou X,Zunt JR,Lopez AD,Vos T,Murray CJ","|GBD 2013 Risk Factors Collaborators,Humans,Metabolic Diseases,Occupational Diseases,Risk Assessment,Risk Factors,Health Behavior,Sanitation,Environmental Exposure,Occupational Exposure,Nutritional Status,Female,Male,Global Health"
immd0036,immd0499,1,0.03125,Journal article,American Journal of Human Genetics,01/06/2016,"Mutations in CDC45, Encoding an Essential Component of the Pre-initiation Complex, Cause Meier-Gorlin Syndrome and Craniosynostosis","Fenwick AL,Kliszczak M,Cooper F,Murray J,Sanchez-Pulido L,Twigg SRF,Goriely A,McGowan SJ,Miller KA,Taylor IB,Logan C,Bozdogan S,Danda S,Dixon J,Elsayed SM,Elsobky E,Gardham A,Hoffer MJV,Koopmans M,McDonald-McGinn DM,Santen GWE,Savarirayan R,de Silva D,Vanakker O,Wall SA,Wilson LC,Yuregir OO,Zackai EH,Ponting CP,Jackson AP,Wilkie AOM,Niedzwiedz W,Bicknell LS",
ocms0064,path0204,3,0.8666666666666666,Journal article|Journal article|Journal article,Cell|Nucleic Acids Research|Acta Crystallographica Section F: Structural Biology Communications,25/04/2013|20/02/2015|01/03/2015,The long and short of microRNA.|Structural plasticity of Cid1 provides a basis for its distributive RNA terminal uridylyl transferase activity.|Improved crystallization and diffraction of caffeine-induced death suppressor protein 1 (Cid1).,"Yates LA,Norbury CJ,Gilbert RJ|Yates LA,Durrant BP,Fleurdépine S,Harlos K,Norbury CJ,Gilbert RJ|Yates LA,Durrant BP,Barber M,Harlos K,Fleurdépine S,Norbury CJ,Gilbert RJ","Animals,Gene Expression Regulation,Humans,MicroRNAs,RNA Processing,Post-Transcriptional,Ribonuclease III|Schizosaccharomyces,Nucleotidyltransferases,RNA Nucleotidyltransferases,Schizosaccharomyces pombe Proteins,RNA,Fungal,Uridine Triphosphate,Crystallography,X-Ray,Catalytic Domain,Protein Structure,Tertiary,Mutation,Rotation,Models,Molecular,Biocatalysis|Schizosaccharomyces,Nucleotidyltransferases,Schizosaccharomyces pombe Proteins,Crystallization,Crystallography,X-Ray,Amino Acid Substitution"
stat0004,stat0054,6,0.4251010651491845,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Nature Genetics|Nature Communications|Nature Genetics|Molecular Systems Biology|Genetic Epidemiology|PLoS Genetics,18/05/2015|01/01/2014|23/12/2012|01/01/2011|18/07/2011|01/09/2011,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.|Human metabolic profiles are stably controlled by genetic and environmental variation.|Bayesian hierarchical mixture modeling to assign copy number from a targeted CNV array.|A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I|Nicholson G,Rantalainen M,Maher AD,Li JV,Malmodin D,Ahmadi KR,Faber JH,Hallgrímsdóttir IB,Barrett A,Toft H,Krestyaninova M,Viksna J,Neogi SG,Dumas ME,Sarkans U,The Molpage Consortium,Silverman BW,Donnelly P,Nicholson JK,Allen M,Zondervan KT,Lindon JC,Spector TD,McCarthy MI,Holmes E,Baunsgaard D,Holmes CC|Cardin N,Holmes C,Wellcome Trust Case Control Consortium,Donnelly P,Marchini J|Nicholson G,Rantalainen M,Li JV,Maher AD,Malmodin D,Ahmadi KR,Faber JH,Barrett A,Min JL,Rayner NW,Toft H,Krestyaninova M,Viksna J,Neogi SG,Dumas ME,Sarkans U,MolPAGE Consortium,Donnelly P,Illig T,Adamski J,Suhre K,Allen M,Zondervan KT,Spector TD,Nicholson JK,Lindon JC,Baunsgaard D,Holmes E,McCarthy MI,Holmes CC","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA|Aged,Algorithms,Biomarkers,Databases,Genetic,European Continental Ancestry Group,Female,Gene-Environment Interaction,Genetic Variation,Humans,Metabolome,Middle Aged,Models,Statistical,Nuclear Magnetic Resonance,Biomolecular,Research Design,Sample Size,Systems Biology,Twins,Dizygotic,Monozygotic|Algorithms,Bayes Theorem,Cluster Analysis,Cohort Studies,Computer Simulation,DNA Copy Number Variations,Gene Dosage,Genotype,Humans,Models,Genetic,Molecular Epidemiology|Acetyltransferases,Dimethylamines,Female,Genome-Wide Association Study,Haplotypes,Humans,Isobutyrates,Magnetic Resonance Spectroscopy,Metabolic Networks and Pathways,Metabolome,Methylamines,Polymorphism,Single Nucleotide,Quantitative Trait Loci,Selection,Genetic"
immd0036,immd0151,5,0.30611143242722194,Journal article|Journal article|Journal article|Journal article|Journal article,American Journal of Human Genetics|Human Molecular Genetics|Nature Genetics|Human Mutation|Journal of Medical Genetics,01/01/2012|30/01/2013|27/01/2013|09/05/2016|16/09/2014,Mutations in multidomain protein MEGF8 identify a carpenter syndrome subtype associated with defective lateralization|Cellular interference in craniofrontonasal syndrome: males mosaic for mutations in the X-linked EFNB1 gene are more severely affected than true hemizygotes.|Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis.|Identification of Intragenic Exon Deletions and Duplication of TCF12 by Whole Genome or Targeted Sequencing as a Cause of TCF12-Related Craniosynostosis.|De novo and rare inherited mutations implicate the transcriptional coregulator TCF20/SPBP in autism spectrum disorder.,"Twigg SRF,Lloyd D,Jenkins D,Elçioglu NE,Cooper CDO,Al-Sannaa N,Annagür A,Gillessen-Kaesbach G,Hüning I,Knight SJL,Goodship JA,Keavney BD,Beales PL,Gileadi O,McGowan SJ,Wilkie AOM|Twigg SR,Babbs C,van den Elzen ME,Goriely A,Taylor S,McGowan SJ,Giannoulatou E,Lonie L,Ragoussis J,Sadighi Akha E,Knight SJ,Zechi-Ceide RM,Hoogeboom JA,Pober BR,Toriello HV,Wall SA,Rita Passos-Bueno M,Brunner HG,Mathijssen IM,Wilkie AO|Twigg SR,Vorgia E,McGowan SJ,Peraki I,Fenwick AL,Sharma VP,Allegra M,Zaragkoulias A,Sadighi Akha E,Knight SJ,Lord H,Lester T,Izatt L,Lampe AK,Mohammed SN,Stewart FJ,Verloes A,Wilson LC,Healy C,Sharpe PT,Hammond P,Hughes J,Taylor S,Johnson D,Wall SA,Mavrothalassitis G,Wilkie AO|Goos JA,Fenwick AL,Swagemakers SM,McGowan SJ,Knight SJ,Twigg SR,Hoogeboom AJ,van Dooren MF,Magielsen FJ,Wall SA,Mathijssen IM,Wilkie AO,van der Spek PJ,van den Ouweland AM|Babbs C,Lloyd D,Pagnamenta AT,Twigg SR,Green J,McGowan SJ,Mirza G,Naples R,Sharma VP,Volpi EV,Buckle VJ,Wall SA,Knight SJ,Parr JR,Wilkie AO","|Child,Preschool,Craniofacial Abnormalities,Ephrin-B1,Female,Gene Deletion,Hemizygote,Heterozygote,Humans,Infant,Newborn,Male,Mosaicism,Pedigree,Phenotype,Point Mutation,Sex Characteristics,X Chromosome Inactivation|Animals,Core Binding Factor alpha Subunits,Cranial Sutures,Craniosynostoses,Embryonic Development,Fibroblasts,Humans,MAP Kinase Signaling System,Mice,Molecular Sequence Data,Mutation,Osteogenesis,Repressor Proteins,Signal Transduction,Transcription Factor AP-1||International Molecular Genetic Study of Autism Consortium (IMGSAC),Chromosomes,Human,Pair 22,Humans,Transcription Factors,In Situ Hybridization,Fluorescence,Sequence Analysis,DNA,Child Development Disorders,Pervasive,Gene Rearrangement,Mutation,Child,Infant,Male,Chromosome Breakpoints"
bioc0212,card0027,5,0.5071895424836601,Journal article|Journal article|Conference paper|Journal article|Journal article,European Heart Journal|Cell Metabolism|Circulation|Journal of Cardiovascular Magnetic Resonance|Cardiovascular Research,18/05/2015|07/03/2012|22/11/2011|01/01/2013|16/05/2012,"Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction.|Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.|Exercise Acutely Exacerbates Derangement Of Cardiac Energy Metabolism In Hypertrophic Cardiomyopathy, a 31 Phosphorus Magnetic Resonance Study at 3 Telsa|In vivo mouse cardiac hyperpolarized magnetic resonance spectroscopy.|In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart.","Dass S,Cochlin LE,Suttie JJ,Holloway CJ,Rider OJ,Carden L,Tyler DJ,Karamitsos TD,Clarke K,Neubauer S,Watkins H|Ashrafian H,Czibik G,Bellahcene M,Aksentijević D,Smith AC,Mitchell SJ,Dodd MS,Kirwan J,Byrne JJ,Ludwig C,Isackson H,Yavari A,Støttrup NB,Contractor H,Cahill TJ,Sahgal N,Ball DR,Birkler RI,Hargreaves I,Tennant DA,Land J,Lygate CA,Johannsen M,Kharbanda RK,Neubauer S,Redwood C,de Cabo R,Ahmet I,Talan M,Günther UL,Robinson AJ,Viant MR,Pollard PJ,Tyler DJ,Watkins H|Dass S,Cochlin LE,Suttie JJ,Holloway C,Rodgers CT,Tyler D,Karamitsos TD,Clarke K,Watkins H,Neubauer S|Dodd MS,Ball V,Bray R,Ashrafian H,Watkins H,Clarke K,Tyler DJ|Dodd MS,Ball DR,Schroeder MA,Le Page LM,Atherton HJ,Heather LC,Seymour AM,Ashrafian H,Watkins H,Clarke K,Tyler DJ","Humans,Cardiomyopathy,Hypertrophic,Ventricular Dysfunction,Left,Phosphocreatine,Adenosine Triphosphate,Magnetic Resonance Angiography,Magnetic Resonance Imaging,Cine,Stroke Volume,Exercise,Magnetic Resonance Spectroscopy,Case-Control Studies,Prospective Studies,Energy Metabolism,Blood Pressure,Heart Rate,Diastole,Adult,Female,Male|Animals,Antioxidants,Dimethyl Fumarate,Fumarate Hydratase,Fumarates,Male,Mice,Inbred C57BL,Knockout,Models,Biological,Myocardial Infarction,NF-E2-Related Factor 2,Signal Transduction|Energy metabolism,Cardiac MRI,Cardiomyopathy|Animals,Carbon Isotopes,Dichloroacetic Acid,Energy Metabolism,Fasting,Infusions,Intravenous,Magnetic Resonance Spectroscopy,Male,Mice,129 Strain,Inbred BALB C,Inbred C57BL,Myocardium,Pyruvate Dehydrogenase Complex,Pyruvic Acid,Rats,Wistar,Species Specificity,Time Factors|Adenosine Triphosphate,Animals,Bicarbonates,Carbon Dioxide,Cardiomegaly,Citric Acid Cycle,Hydrogen-Ion Concentration,Hypertension,Magnetic Resonance Imaging,Cine,Male,Myocardium,Pyruvate Dehydrogenase Complex,Rats,Inbred SHR,Wistar"
clme0845,gree1024,2,0.30952380952380953,Journal article|Journal article,British Journal of Cancer|British Journal of Cancer,29/10/2013|01/01/2014,Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study.|Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: Prospective study,"Gathani T,Ali R,Balkwill A,Green J,Reeves G,Beral V,Moser KA,Million Women Study Collaborators|Gathani T,Ali R,Balkwill A,Green J,Reeves G,Beral V,Moser KA","African Continental Ancestry Group,Asian Continental Ancestry Group,Breast Neoplasms,Cohort Studies,England,European Continental Ancestry Group,Female,Humans,Incidence,Middle Aged,Proportional Hazards Models,Prospective Studies,Risk Factors|"
card0027,whgu0378,2,0.014988265414977598,Journal article|Journal article,Nature Genetics|The Lancet Diabetes and Endocrinology,18/05/2015|01/01/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Freitag DF,Butterworth AS,Willeit P,Howson JMM,Burgess S,Kaptoge S,Young R,Ho WK,Wood AM,Sweeting M,Spackman S,Staley JR,Ramond A,Harshfield E,Nielsen SF,Grande P,Lange LA,Bown MJ,Jones GT,Scott RA,Bevan S,Porcu E,Thorleifsson G,Zeng L,Kessler T,Nikpay M,Do R,Zhang W,Hopewell JC,Kleber M,Delgado GE,Nelson CP,Goel A,Bis JC,Dehghan A,Ligthart S,Smith AV,Qu L,van 't Hof FNG,de Bakker PIW,Baas AF,van Rij A,Tromp G,Kuivaniemi H,Ritchie MD,Verma SS,Crawford DC,Malinowski J,de Andrade M,Kullo IJ,Peissig PL,McCarty CA,Boettinger EP,Gottesman O,Crosslin DR,Carrell DS,Rasmussen-Torvik LJ,Pacheco JA,Huang J,Timpson NJ,Kettunen J,Ala-Korpela M,Mitchell GF,Parsa A,Wilkinson IB,Gorski M,Li Y,Franceschini N,Keller MF,Ganesh SK,Langefeld CD,Bruijn L,Brown MA,Evans DM,Baltic S,Ferreira MA,Baurecht H,Weidinger S,Franke A,Lubitz SA,Mueller-Nurasyid M,Felix JF,Smith NL,Sudman M,Thompson SD,Zeggini E,Panoutsopoulou K,Nalls MA,Singleton A,Polychronakos C,Bradfield JP,Hakonarson H,Easton DF,Thompson D,Tomlinson IP,Dunlop M,Hemminki K,Morgan G,Eisen T,Goldschmidt H,Allan JM,Henrion M,Whiffin N,Wang Y,Chubb D,Houlston RS,Iles MM,Bishop DT,Law MH,Hayward NK,Luo Y,Nejentsev S,Barbalic M,Crossman D,Sanna S,Soranzo N,Markus HS,Wareham NJ,Rader DJ,Reilly M,Assimes T,Harris TB,Hofman A,Franco OH,Gudnason V,Tracy R,Psaty BM,Farrall M,Watkins H,Hall AS,Samani NJ,Maerz W,Clarke R,Collins R,Kooner JS,Chambers JC,Kathiresan S,McPherson R,Erdmann J,Kastrati A,Schunkert H,Stefansson K,Thorsteinsdottir U,Walston JD,Tybjaerg-Hansen A,Alam DS,Majumder AAS,Di Angelantonio E,Chowdhury R,Nordestgaard BG,Saleheen D,Thompson SG,Danesh J,Consortium I1G,Canc EPI,Consortium A,Netwo EMRG,Consortium UK1,Canc EPI,Consortium METASTROKE,Consor CKDG,Genomic CHAR,Spondyloarthri A-A-A,Consort AAG,Cons AFG,Genomic CHAR,Gene CJA,Ge ARUKO,Consortium IPD,Consortium BCA,Consortium MG,Genomic CHAR,Con MIG","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|"
chem0489,cschof,2,0.19548872180451127,Journal article|Journal article,Journal of Medicinal Chemistry|Journal of the American Chemical Society,27/09/2012|19/06/2014,Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.|Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.,"Hewings DS,Rooney TP,Jennings LE,Hay DA,Schofield CJ,Brennan PE,Knapp S,Conway SJ|Hay DA,Fedorov O,Martin S,Singleton DC,Tallant C,Wells C,Picaud S,Philpott M,Monteiro OP,Rogers CM,Conway SJ,Rooney TP,Tumber A,Yapp C,Filippakopoulos P,Bunnage ME,Müller S,Knapp S,Schofield CJ,Brennan PE","Acetylation,Animals,Histones,Humans,Lysine,Molecular Targeted Therapy,Nuclear Proteins,Protein Binding,Protein Processing,Post-Translational|Hela Cells,Microsomes,Liver,Humans,Isoxazoles,Indoles,Ligands,Crystallography,X-Ray,Fluorescence Recovery After Photobleaching,Drug Evaluation,Preclinical,Binding Sites,Molecular Structure,Protein Structure,Tertiary,Structure-Activity Relationship,Genes,p53,Models,Molecular,E1A-Associated p300 Protein,CREB-Binding Protein,Small Molecule Libraries,Drug Discovery,Chemistry Techniques,Synthetic"
raob0270,whgu0378,5,0.11894219366578748,Journal article|Journal article|Journal article|Journal article|Journal article,Nature Genetics|Nature Genetics|Clinical Cancer Research|Scientific Reports|Human Molecular Genetics,01/01/2012|01/01/2012|14/04/2015|01/01/2015|22/03/2016,"Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk|Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk|Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival.|A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.|Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease.","Dunlop MG,Dobbins SE,Farrington SM,Jones AM,Palles C,Whiffin N,Tenesa A,Spain S,Broderick P,Ooi LY,Domingo E,Smillie C,Henrion M,Frampton M,Martin L,Grimes G,Gorman M,Semple C,Ma YP,Barclay E,Prendergast J,Cazier JB,Olver B,Penegar S,Lubbe S,Chander I,Carvajal-Carmona LG,Ballereau S,Lloyd A,Vijayakrishnan J,Zgaga L,Rudan I,Theodoratou E,Thomas H,Maher E,Evans G,Walker L,Halliday D,Lucassen A,Paterson J,Hodgson S,Homfray T,Side L,Izatt L,Donaldson A,Tomkins S,Morrison P,Brewer C,Henderson A,Davidson R,Murday V,Cook J,Haites N,Bishop T,Sheridan E,Green A,Marks C,Carpenter S,Broughton M,Greenhalge L,Suri M,Starr JM,Deary I,Kirac I,Kovacevia D,Aaltonen LA,Renkonen-Sinisalo L,Mecklin JP,Matsuda K,Nakamura Y,Okada Y,Gallinger S,Duggan DJ,Conti D,Newcomb P,Hopper J,Jenkins MA,Schumacher F,Casey G,Easton D,Shah M,Pharoah P,Lindblom A,Liu T,Edler D,Lenander C,Dalén J,Hjern F,Lundqvist N,Lindforss U,Påhlman L,Smedh K,Törnqvist A,Holm J,Janson M,Andersson M,Ekelund S|Dunlop MG,Dobbins SE,Farrington SM,Jones AM,Palles C,Whiffin N,Tenesa A,Spain S,Broderick P,Ooi L-Y,Domingo E,Smillie C,Henrion M,Frampton M,Martin L,Grimes G,Gorman M,Semple C,Ma YP,Barclay E,Prendergast J,Cazier J-B,Olver B,Penegar S,Lubbe S,Chander I,Carvajal-Carmona LG,Ballereau S,Lloyd A,Vijayakrishnan J,Zgaga L,Rudan I,Theodoratou E,Thomas H,Maher E,Evans G,Walker L,Halliday D,Lucassen A,Paterson J,Hodgson S,Homfray T,Side L,Izatt L,Donaldson A,Tomkins S,Morrison P,Brewer C,Henderson A,Davidson R,Murday V,Cook J,Haites N,Bishop T,Sheridan E,Green A,Marks C,Carpenter S,Broughton M,Greenhalge L,Suri M,Starr JM,Deary I,Kirac I,Kovacević D,Aaltonen LA,Renkonen-Sinisalo L,Mecklin J-P,Matsuda K,Nakamura Y,Okada Y,Gallinger S,Duggan DJ,Conti D,Newcomb P,Hopper J,Jenkins MA,Schumacher F,Casey G,Easton D,Shah M,Pharoah P,Lindblom A,Liu T,Edler D,Lenander C,Dalén J,Hjern F,Lundqvist N,Lindforss U,Påhlman L,Smedh K,Törnqvist A,Holm J,Janson M,Andersson M,Ekelund S,Olsson L,Smith CG,West H,Cheadle JP,MacDonald G,Samuel LM,Ahmad A,Corrie P,Jodrell D,Palmer C,Wilson C,O'Hagan J,Smith D,McDermott R,Walshe J,Cassidy J,McDonald A,Mohammed N,White J,Yosef H,Breathnach O,Grogan L,Thomas R,Eatock M,Henry P,Houston R,Johnston P,Wilson R,Geh I,Danwata F,Hindley A,Susnerwala S,Bradley C,Conn A,Raine A,Twelves C,Falk S,Hopkins K,Tahir S,Dhadda A,Maraveyas A,Sgouros J,Teo M,Ahmad R,Cleator S,Creak A,Lowdell C,Riddle P,Benstead K,Farrugia D,Reed N,Shepherd S,Levine E,Mullamitha S,Saunders M,Valle J,Wilson G,Jones A,Weaver A,Clark PI,Haylock B,Iqbal MI,Myint AS,Smith D,Beesley S,Sevitt T,Nicoll J,Daniel F,Ford V,Talbot T,Butt M,Hamid A,Mack P,Roy R,Osborne R,McKinna F,Alsab H,Basu D,Murray P,Sizer B,Azam FA,Neupane R,Waterston A,Glaholm J,Blesing C,Lowndes S,Medisetti A,Gaya A,Leslie M,Maisey N,Ross P,Dunn G,Al-Salihi O,Wasan HS,Palmer C,Tan LT,Dent J,Hofmann U,Joffe JK,Sherwin E,Soomal R,Chakrabarti A,Joseph S,Van der Voet J,Wadd NJ,Wilson D,Anjarwalia S,Hall J,Hughes R,Polychronis A,Scarffe JH,Hill M,James RD,Shah R,Summers J,Hartley A,Carney D,McCaffrey J,Bystricky B,O'Reilly S,Gupta R,Al-Mishlab T,Gidden F,O'Hara R,Stewart J,Ashford R,Glynne-Jones R,Harrison M,Mawdsley S,Barlow H,Tighe M,Walther J,Neal J,Rees C,Bridgewater J,Karp S,McGovern U,Atherton PJ,El-deeb H,Macmillan C,Patel K,Bessell EM,Dickinson PD,Potter V,Jephcott C,McAdam K,Wrigley J,Osborne R,Muthuramalingam S,O'Callaghan A,Bridgewater J,Melcher L,Braconi C,Geh JI,Palmer D,Narayana P,Steven N,Gaya A,Maisey N,Rudman S,Chakraborti P,Kelly K,Macgregor C,Whillis D,Freebairn A,Gildersleve J,Sharif S,Astras G,Hickish T,Beech D,Ellis R,Kulkarni R,Shankland K,Begent R,Mayer A,Meyer T,Strauss S,Hall V,Raj S,Chau I,Cunningham D,Birtle A,Biswas A,Susnerwala S,Wise M,Cummins S,Essapen S,Middleton G,Topham C,Langley R,McKinna F,Webb A,Wilkins M,Iveson TJ,Dhadda A,Hamid A,Askill C,Wagstaff J,Azzabi A,Bateman A,Prejbisz J,Tsang D,Ali N,Jones A,O'Neill P,Cottrill C,Propper D,Lofts FJ,Kennedy J,Anthoney DA,Cooper R,Crellin A,Melcher A,Seymour M,Baughan C,Alexander E,Cleator S,Crown J,Fennelly D,Adab F,Giridharan S,Pedley I,Wright K,Bliss P,Cogill G,Lo N,Toy E,Bridgewater J,Hochhauser D,Ledermann J,Brewster A,Maughan T,Mort D,Mukherjee S,Dobrowsky W,Calvert P,Leonard G,Ahmad R,Ford H,Moody AM,Goriah S,Wilkins M,Clive S,Dawson L,McLean C,Phillips HA,Gopi K,Tomlinson M,Clenton S,Furniss D,Hornbuckle J,Pledge S,Wadsley J,Abbas M,Marshall E,Harper-Wynne C,Barnes A,Kumar S,Vigneswaran V,Farrugia D,Webb A,Gollins S,Falk S,Genton M,Sparrow G,Bale C,Fuller C,Mullard A,Stuart N,Williams R,Keane M,Maughan T,Seymour M,Wilson R,Wasan H,Adams R,Madi A,Cassidy J,Kennedy J,Hodgkinson E,Rogers P,Pope M,Kaplan R,Meade A,Parmar M,Kenny S,Fisher D,Harper L,Mitchell J,Nichols L,Sydes B,Clement L,Kay E,Courtney C,Gallagher M,Murphy C,Thompson L,Beall S,Hassan S,Gracie R,Griffiths G,Mason M,Parker C,Rudd R,Johnson P,Whelan J,Northover J,Brown J,Aapro M,Stout R,Midgley R,Kerr DJ,Campbell H,Tomlinson IP,Houlston RS|Smith CG,Fisher D,Harris R,Maughan TS,Phipps AI,Richman S,Seymour M,Tomlinson I,Rosmarin D,Kerr D,Chan AT,Peters U,Newcomb PA,Idziaszczyk S,West H,Meade A,Kaplan R,Cheadle JP|Al-Tassan NA,Whiffin N,Hosking FJ,Palles C,Farrington SM,Dobbins SE,Harris R,Gorman M,Tenesa A,Meyer BF,Wakil SM,Kinnersley B,Campbell H,Martin L,Smith CG,Idziaszczyk S,Barclay E,Maughan TS,Kaplan R,Kerr R,Kerr D,Buchanan DD,Win AK,Hopper J,Jenkins M,Lindor NM,Newcomb PA,Gallinger S,Conti D,Schumacher F,Casey G,Dunlop MG,Tomlinson IP,Cheadle JP,Houlston RS|Orlando G,Law PJ,Palin K,Tuupanen S,Gylfe A,Hänninen U,Cajuso T,Tanskanen T,Kondelin J,Kaasinen E,Sarin AP,Kaprio J,Eriksson JG,Rissanen H,Knekt P,Pukkala E,Jousilahti P,Salomaa V,Ripatti S,Palotie A,Järvinen H,Renkonen-Sinisalo L,Lepistö A,Böhm J,Meklin JP,Al-Tassan NA,Palles C,Martin L,Barclay E,Tenesa A,Farrington S,Timofeeva MN,Meyer BF,Wakil SM,Campbell H,Smith CG,Idziaszczyk S,Maughan TS,Kaplan R,Kerr R,Kerr D,Buchanan DD,Win AK,Hopper J,Jenkins M,Lindor NM,Newcomb PA,Gallinger S,Conti D,Schumacher F,Casey G,Taipale J,Cheadle JP,Dunlop MG,Tomlinson IP,Aaltonen LA,Houlston RS","||Humans,Colorectal Neoplasms,Genetic Predisposition to Disease,Cadherins,Neoplasm Staging,Prognosis,Proportional Hazards Models,Genotype,Polymorphism,Single Nucleotide,Adolescent,Adult,Aged,80 and over,Middle Aged,Female,Male,Clinical Trials as Topic,Genome-Wide Association Study,Biomarkers,Tumor|Humans,Colorectal Neoplasms,Genetic Predisposition to Disease,Receptors,Cell Surface,Chromosome Mapping,Gene Frequency,Polymorphism,Single Nucleotide,Middle Aged,Female,Male,Forkhead Transcription Factors,Genome-Wide Association Study,Biomarkers,Tumor|"
chem0489,raob0047,1,0.16666666666666666,Journal article,Organic chemistry frontiers : an international journal of organic chemistry / Royal Society of Chemistry,01/01/2015,Efficient synthesis of 2-nitroimidazole derivatives and the bioreductive clinical candidate Evofosfamide (TH-302),"O'Connor LJ,Cazares-Koerner C,Saha J,Evans CNG,Stratford MRL,Hammond EM,Conway SJ",
robbins,stat0004,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
ndos0461,whgu0172,1,0.14285714285714285,Journal article,Molecular and Cellular Proteomics,01/01/2011,Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis,"Wright CA,Howles S,Trudgian DC,Kessler BM,Reynard JM,Noble JG,Hamdy FC,Turney BW",
immd0198,whgu0172,3,0.43803418803418803,Journal article|Conference paper|Conference paper,PLoS Pathogens|Immunology|Gut,01/05/2011|01/09/2012|01/04/2011,The Antiviral Efficacy of HIV-Specific CD8+ T-Cells to a Conserved Epitope is Heavilydependent on the Infecting HIV-1 Isolate|Identification of novel NOD2-regulated proteins using phosphoproteomics|NOD2 SIGNALLING IN CROHN'S DISEASE,"Ranasinghe SRF,Kramer HB,Wright C,Kessler BM,di Gleria K,Zhang Y,Gillespie GM,Blais ME,Culshaw A,Pichulik T,Simmons A,Rowland-Jones SL,McMichael AJ,Dong T|Steevels TAM,Allan P,Fischer R,Kessler B,Simmons A|Allan P,Brain O,Baker J,Simpson P,Pichulik T,Khatamzas E,Reenares C,Leslie A,Kessler B,Simmons A","||Crohn's disease,NOD2,phosphorylation,signalling"
immd0023,immd0024,1,0.1111111111111111,Journal article,Blood,03/06/2013,Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.,"Mussai F,De Santo C,Abu-Dayyeh I,Booth S,Quek L,McEwen-Smith RM,Qureshi A,Dazzi F,Vyas P,Cerundolo V","Animals,Arginase,Cell Proliferation,Cells,Cultured,Humans,Immune Tolerance,Leukemia,Myeloid,Acute,Mice,Inbred C57BL,Inbred NOD,SCID,Transgenic,T-Lymphocytes,Transplantation,Heterologous,Tumor Escape,Tumor Microenvironment"
clme1358,raob0097,1,0.0625,Journal article,Journal of Medicinal Chemistry,21/03/2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.","Hewings DS,Fedorov O,Filippakopoulos P,Martin S,Picaud S,Tumber A,Wells C,Olcina MM,Freeman K,Gill A,Ritchie AJ,Sheppard DW,Russell AJ,Hammond EM,Knapp S,Brennan PE,Conway SJ","Acetylation,CREB-Binding Protein,Cell Line,Tumor,Crystallography,X-Ray,Histones,Humans,Inhibitory Concentration 50,Isoxazoles,Ligands,Lysine,Nuclear Proteins,Protein Binding,Structure-Activity Relationship,Transcription Factors"
immd0084,immd0151,1,0.09090909090909091,Journal article,Journal of Experimental Medicine,21/02/2011,The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance.,"Mortensen M,Soilleux EJ,Djordjevic G,Tripp R,Lutteropp M,Sadighi-Akha E,Stranks AJ,Glanville J,Knight S,Jacobsen SE,Kranc KR,Simon AK","Animals,Apoptosis,Autophagy,Cell Proliferation,DNA Damage,Female,Hematopoietic Stem Cells,Male,Mice,Knockout,Microtubule-Associated Proteins,Mitochondria,Myeloproliferative Disorders,Reactive Oxygen Species,Stem Cells"
darby,donc0228,2,0.4,Conference paper|Journal article,Medical Physics|Medical Physics,01/06/2015|01/06/2015,Robustness Analysis of Proton Breast Treatments Using An Alpha-Stable Distribution Parameterization|SU-F-BRD-04: Robustness Analysis of Proton Breast Treatments Using An Alpha-Stable Distribution Parameterization.,"Van den Heuvel F,Hackett S,Fiorini F,Taylor C,Darby S,Vallis K|Van den Heuvel F,Hackett S,Fiorini F,Taylor C,Darby S,Vallis K",|
raob0097,raob0233,2,0.2857142857142857,Journal article|Journal article,Molecular Cell|International Journal of Radiation: Oncology - Biology - Physics,|23/01/2016,Replication stress and chromatin context link ATM activation to a role in DNA replication|Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality.,"Olcina MM,Foskolou IP,Anbalagan S,Senra JM,Pires IM,Jiang Y,Ryan AJ,Hammond EM|Jiang Y,Verbiest T,Devery AM,Bokobza SM,Weber AM,Leszczynska KB,Hammond EM,Ryan AJ",|
hert0418,immd0180,1,0.04,Journal article,Cancer Research,28/08/2014,Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.,"Gao S,Bajrami I,Verrill C,Kigozi A,Ouaret D,Aleksic T,Asher R,Han C,Allen P,Bailey D,Feller S,Kashima T,Athanasou N,Blay JY,Schmitz S,Machiels JP,Upile N,Jones TM,Thalmann G,Ashraf SQ,Wilding JL,Bodmer WF,Middleton MR,Ashworth A,Lord CJ,Macaulay VM","Cell Line,Tumor,Animals,Humans,Mice,Carcinoma,Squamous Cell,Head and Neck Neoplasms,Isoxazoles,Pyrimidines,ras Proteins,Receptor,IGF Type 1,Insulin-Like Growth Factor I,Adaptor Proteins,Signal Transducing,Phosphoproteins,Antineoplastic Agents,Xenograft Model Antitumor Assays,Inhibitory Concentration 50,MAP Kinase Signaling System,Gene Expression,Drug Resistance,Neoplasm,Male,Wnt Proteins"
bioc0192,bioc0212,8,1.5999999999999999,Journal article|Journal article|Journal article|Journal article|Chapter|Journal article|Journal article|Journal article,Circulation|Magnetic Resonance in Medicine|Circulation|Magnetic Resonance in Medicine||Circulation|Magnetic Resonance in Medicine|Magnetic Resonance in Medicine,01/01/2012|21/03/2014|01/01/2012|20/05/2015|18/09/2015|24/02/2012|01/03/2015|07/01/2016,Effects of catecholamine stress on diastolic function and myocardial energetics in obesity.|Accelerated human cardiac diffusion tensor imaging using simultaneous multislice imaging.|Effects of catecholamine stress on diastolic function and myocardialenergetics in obesity|Cardiac perfusion imaging using hyperpolarized (13) c urea using flow sensitizing gradients.|Magnetic resonance imaging|Effects of catecholamine stress on diastolic function and myocardial energetics in obesity.|Accelerated human cardiac diffusion tensor imaging using simultaneous multislice imaging|Simultaneous assessment of cardiac metabolism and perfusion using copolarized [1-(13) C]pyruvate and (13) C-urea.,"Rider O,Francis JM,Ali MK,Holloway CJ,Pegg T,Robson MD,Tyler DJ,Byrne JP,Clarke K,Neubauer S|Lau AZ,Tunnicliffe EM,Frost R,Koopmans PJ,Tyler DJ,Robson MD|Rider OJ,Francis JM,Ali MK,Holloway CJ,Pegg T,Robson MD,Tyler DJ,Byrne JP,Clarke K,Neubauer SN|Lau AZ,Miller JJ,Robson MD,Tyler DJ|Ferreira VM,Robson MD,Karamitsos TD,Bissell MM,Tyler DJ,Neubauer S|Rider OJ,Francis JM,Ali MK,Holloway C,Pegg T,Robson MD,Tyler D,Byrne J,Clarke K,Neubauer S|Lau AZ,Tunnicliffe EM,Frost R,Koopmans PJ,Tyler DJ,Robson MD|Lau AZ,Miller JJ,Robson MD,Tyler DJ","|Heart Ventricles,Humans,Image Interpretation,Computer-Assisted,Imaging,Three-Dimensional,Image Enhancement,Sensitivity and Specificity,Reproducibility of Results,Algorithms,Adult,Male,Diffusion Tensor Imaging||||Adult,Body Mass Index,Catecholamines,Diastole,Energy Metabolism,Exercise Test,Female,Humans,Male,Middle Aged,Myocardium,Obesity,Stress,Physiological,Ventricular Function,Left||"
clme0220,whgu0142,2,0.3333333333333333,Journal article|Journal article,Angiogenesis|Angiogenesis,01/01/2015|04/01/2015,A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis|A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis.,"Kerr G,Sheldon H,Chaikuad A,Alfano I,von Delft F,Bullock AN,Harris AL|Kerr G,Sheldon H,Chaikuad A,Alfano I,von Delft F,Bullock AN,Harris AL","|Chick Embryo,Animals,Humans,Aminopyridines,Phenols,Activin Receptors,Type II,Protein Kinase Inhibitors,Neovascularization,Physiologic,Receptors,Notch,Growth Differentiation Factors,Human Umbilical Vein Endothelial Cells"
immd0237,robbins,11,0.9582015703578887,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Nature Genetics|The Journal of Physiology|Haematologica: the hematology journal|American Journal of Hematology|Journal of Applied Physiology|BMJ Open|The FASEB Journal|American Journal of Hematology|The FASEB Journal|Journal of Clinical Investigation|The Journal of Physiology,18/05/2015|20/05/2013|11/07/2014|01/08/2015|12/09/2013|01/01/2015|21/04/2016|01/10/2012|09/03/2011||01/09/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2.|Erythrocytosis associated with a novel missense mutation in the BPGM gene.|Contrasting roles of HIF-1 and 2 in ventilatory acclimatisation to hypoxia|Tibetans living at sea level have a hyporesponsive hypoxia-inducible factor system and blunted physiological responses to hypoxia.|A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease.|On the pivotal role of PPARα in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury.|A physiological study of Tibetan natives at sea level|Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation.|Clinical iron deficiency disturbs normal human responses to hypoxia.|Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF-2 pathway.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Bishop T,Talbot NP,Turner PJ,Nicholls LG,Pascual A,Hodson EJ,Douglas G,Fielding JW,Smith TG,Demetriades M,Schofield CJ,Robbins PA,Pugh CW,Buckler KJ,Ratcliffe PJ|Petousi N,Copley RR,Lappin TR,Haggan SE,Bento CM,Cario H,Percy MJ,Ratcliffe PJ,Robbins PA,McMullin MF|Hodson EJ,Nicholls LG,Turner PJ,Robbins PA,Pugh CW,Buckler K,Ratcliffe PJ,Bishop T|Petousi N,Croft QP,Cavalleri GL,Cheng HY,Formenti F,Ishida K,Lunn D,McCormack M,Shianna KV,Talbot NP,Ratcliffe PJ,Robbins PA|Nickol AH,Frise MC,Cheng HY,McGahey A,McFadyen BM,Harris-Wright T,Bart NK,Curtis MK,Khandwala S,O'Neill DP,Pollard KA,Hardinge FM,Rahman NM,Armitage AE,Dorrington KL,Drakesmith H,Ratcliffe PJ,Robbins PA|Cole MA,Abd Jamil AH,Heather LC,Murray AJ,Sutton ER,Slingo M,Sebag-Montefiore L,Tan SC,Aksentijević D,Gildea OS,Stuckey DJ,Yeoh KK,Carr CA,Evans RD,Aasum E,Schofield CJ,Ratcliffe PJ,Neubauer S,Robbins PA,Clarke K|Petousi N,Croft QC,Cheng H-Y,Formenti F,Ishida K,Talbot NP,Ratcliffe PJ,Robbins PA|Formenti F,Beer PA,Croft QP,Dorrington KL,Gale DP,Lappin TR,Lucas GS,Maher ER,Maxwell PH,McMullin MF,O'Connor DF,Percy MJ,Pugh CW,Ratcliffe PJ,Smith TG,Talbot NP,Robbins PA|Frise MC,Cheng HY,Nickol AH,Curtis MK,Pollard KA,Roberts DJ,Ratcliffe PJ,Dorrington KL,Robbins PA|Hodson EJ,Nicholls LG,Turner PJ,Llyr R,Fielding JW,Douglas G,Ratnayaka I,Robbins PA,Pugh CW,Buckler KJ,Ratcliffe PJ,Bishop T","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Animals,Anoxia,Carotid Body,Hyperplasia,Hypoxia-Inducible Factor 1,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Inbred C57BL,Transgenic,Pulmonary Ventilation|WGS Consortium,Humans,Polycythemia,Bisphosphoglycerate Mutase,Genotype,Mutation,Missense||EGLN1,EPAS1,erythropoietin,high altitude,hypoxic pulmonary vasoconstriction,Acclimatization,Adult,Altitude,Anoxia,Asian Continental Ancestry Group,Basic Helix-Loop-Helix Transcription Factors,Cells,Cultured,China,Erythropoietin,Gene Expression Regulation,Haplotypes,Hemoglobins,Humans,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Oxygen,Phenotype,Pulmonary Artery,Pulmonary Ventilation,Selection,Genetic,Tibet,Time Factors,Transcription,Vasoconstriction,Young Adult|Humans,Pulmonary Disease,Chronic Obstructive,Pneumonia,Anoxia,Iron,C-Reactive Protein,Hemoglobins,Vital Capacity,Forced Expiratory Volume,Prevalence,Cross-Sectional Studies,Exercise Tolerance,Aged,Female,Male,Ferritins,Hepcidins,Biomarkers|||Basic Helix-Loop-Helix Transcription Factors,Carbon Dioxide,Cardiovascular Physiological Phenomena,Case-Control Studies,Exercise Test,Female,Gene Expression Regulation,Humans,Male,Mutation,Oxygen,von Hippel-Lindau Disease||"
cschof,ocms0064,1,0.047619047619047616,Journal article,Molecular Cell,30/01/2014,Optimal translational termination requires C4 lysyl hydroxylation of eRF1.,"Yamamoto A,Feng T,Wilkins S,Sokolova E,Yates L,Muenzel M,Singh P,Hopkinson R,Fischer R,Cockman M,Shelley J,Trudgian D,Schoedel J,McCullagh JO,Ge W,Kessler B,Gilbert R,Frolova L,Alkalaeva E,Ratcliffe P,Schofield C,Coleman M","Amino Acid Sequence,Animals,Catalysis,Cell Line,Tumor,Codon,Terminator,Gene Expression Regulation,HeLa Cells,Histone Demethylases,Humans,Hydrolysis,Hydroxylation,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Peptide Chain Termination,Translational,Peptide Termination Factors,Protein Biosynthesis,Protein Processing,Post-Translational,Protein Structure,Tertiary,Sequence Homology,Amino Acid"
quee1607,whgu0378,4,0.1710790738313674,Journal article|Journal article|Journal article|Journal article,American Journal of Gastroenterology|Nature Genetics|Nature Communications|American Journal of Gastroenterology,01/11/2013|18/05/2015|01/01/2014|17/09/2013,"Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.|Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations","Mouradov D,Domingo E,Gibbs P,Jorissen RN,Li S,Soo PY,Lipton L,Desai J,Danielsen HE,Oukrif D,Novelli M,Yau C,Holmes CC,Jones IT,McLaughlin S,Molloy P,Hawkins NJ,Ward R,Midgely R,Kerr D,Tomlinson IP,Sieber OM|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC|Mouradov D,Gibbs P,Jorissen RN,Lipton L,Sieber OM,Tomlinson IP,Domingo E,Li S,Soo PY,Desai J,Danielsen HE,Oukrif D,Novelli M,Yau C,Holmes CC,Jones IT,McLaughlin S,Molloy P,Hawkins NJ,Ward R,Midgely R,Kerr D","|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading|"
immd0316,radi0003,1,0.16666666666666666,Journal article,Journal of the National Cancer Institute Monographs,01/05/2015,Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer Metabolism.,"Lord SR,Patel N,Liu D,Fenwick J,Gleeson F,Buffa F,Harris AL","Humans,Breast Neoplasms,Metformin,Hypoglycemic Agents,Chemotherapy,Adjuvant,Neoadjuvant Therapy,Female,Metabolome,Transcriptome,Biomarkers,Tumor"
card0039,radi0003,1,0.058823529411764705,Journal article,JACC: Cardiovascular Imaging,01/01/2012,Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis,"Elkhawad M,Rudd JHF,Sarov-Blat L,Cai G,Wells R,Davies LC,Collier DJ,Marber MS,Choudhury RP,Fayad ZA,Tawakol A,Gleeson FV,Lepore JJ,Davis B,Willette RN,Wilkinson IB,Sprecher DL,Cheriyan J",
clme0439,clme0975,1,0.05,Journal article,Cancer Cell,13/05/2013,Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
whgu0378,whgu0408,12,2.187814407814408,Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper,Gut|Nature Medicine|Cell Reports|Journal of Pathology|Gut|Gut|Nature Genetics|Nature Genetics|Cancer Research|Nature Genetics|Nature Medicine|Gut,27/01/2012|01/12/2014|01/01/2014|01/03/2016|01/01/2013|01/06/2013|01/06/2012|01/01/2012|02/05/2012|16/12/2012|01/01/2015|01/04/2011,A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts.|Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.|A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding.|Progression of Colorectal Cancer can be Initiated through Chromosomal Catastrophes and Punctuated Evolution|A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts|BONE MORPHOGENETIC PROTEIN (BMP) PATHWAY DYSREGULATION SUBVERTS ONCOGENE INDUCED SENESCENCE MECHANISMS IN THE SERRATED PATHWAY OF TUMOURIGENESIS|Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1.|Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1|The continuum model of selection in human tumors: general paradigm or niche product?|Reply to The classification of intestinal polyposis.|Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche|HUMAN AND MOUSE GASTROINTESTINAL TUMOUR DISTRIBUTION IS SELECTED ACCORDING TO A BASAL INTESTINAL WNT SIGNALLING GRADIENT,"Leedham SJ,Rodenas-Cuadrado P,Howarth K,Lewis A,Mallappa S,Segditsas S,Davis H,Jeffery R,Rodriguez-Justo M,Keshav S,Travis SP,Graham TA,East J,Clark S,Tomlinson IP|Davis H,Irshad S,Bansal M,Rafferty H,Boitsova T,Bardella C,Jaeger E,Lewis A,Freeman-Mills L,Giner FC,Rodenas-Cuadrado P,Mallappa S,Clark S,Thomas H,Jeffery R,Poulsom R,Rodriguez-Justo M,Novelli M,Chetty R,Silver A,Sansom OJ,Greten FR,Wang LM,East JE,Tomlinson I,Leedham SJ|Lewis A,Freeman-Mills L,de la Calle-Mustienes E,Giráldez-Pérez RM,Davis H,Jaeger E,Becker M,Hubner NC,Nguyen LN,Zeron-Medina J,Bond G,Stunnenberg HG,Carvajal JJ,Gomez-Skarmeta JL,Leedham S,Tomlinson I|Graham T,Wright N,Cross W,Tomlinson I,Leedham S,Mustonen V|Leedham SJ,Rodenas-Cuadrado P,Howarth K,Lewis A,Mallappa S,Segditsas S,Davis H,Jeffery R,Rodriguez-Justo M,Keshav S,Travis SPL,Graham TA,East J,Clark S,Tomlinson IPM|Boitsova T,Rafferty H,Davis H,Bardella C,Gill P,East J,Tomlinson I,Chetty R,Silver A,Leedham S|Jaeger E,Leedham S,Lewis A,Segditsas S,Becker M,Cuadrado PR,Davis H,Kaur K,Heinimann K,Howarth K,East J,Taylor J,Thomas H,Tomlinson I|Jaeger E,Leedham S,Lewis A,Segditsas S,Becker M,Cuadrado PR,Davis H,Kaur K,Heinimann K,Howarth K,East J,Taylor J,Thomas H,Tomlinson I|Leedham S,Tomlinson I|Tomlinson I,Jaeger E,Leedham S,Thomas H|Davis H,Irshad S,Bansal M,Rafferty H,Boitsova T,Bardella C,Jaeger E,Lewis A,Freeman-Mills L,Giner FC,Rodenas-Cuadrado P,Mallappa S,Clark S,Thomas H,Jeffery R,Poulsom R,Rodriguez-Justo M,Novelli M,Chetty R,Silver A,Sansom OJ,Greten FR,Wang LM,East JE,Tomlinson I,Leedham SJ|Rodenas-Cuadrado P,Howarth K,Lewis A,Mallappa S,Jeffry R,Rodriguez-Justo M,East J,Travis S,Clark S,Tomlinson I,Leedham S","Animals,Biomarkers,Tumor,Cell Count,Genes,APC,Genetic Markers,Homeostasis,Humans,In Situ Hybridization,Intestinal Mucosa,Intestinal Neoplasms,Intestines,Mice,Transgenic,Mutation,Reverse Transcriptase Polymerase Chain Reaction,Stem Cells,Wnt Proteins,Wnt Signaling Pathway,beta Catenin|Intestinal Mucosa,Epithelial Cells,Animals,Humans,Mice,Colorectal Neoplasms,Intercellular Signaling Peptides and Proteins,Receptors,G-Protein-Coupled,Cell Proliferation,Gene Expression Regulation,Neoplastic,Mutation,Stem Cell Niche,Carcinogenesis|Cell Line,Tumor,Animals,Mice,Transgenic,Humans,Colonic Neoplasms,Genetic Predisposition to Disease,Intercellular Signaling Peptides and Proteins,Homeodomain Proteins,Risk,Organ Specificity,Gene Expression Regulation,Neoplastic,Base Sequence,Polymorphism,Single Nucleotide,Enhancer Elements,Genetic,Genetic Association Studies,Transcription Factor 7-Like 2 Protein||||Bone Morphogenetic Proteins,Chromosome Mapping,Chromosomes,Human,Pair 15,Colonic Polyps,Colorectal Neoplasms,DNA Copy Number Variations,Fetal Proteins,Gene Duplication,Gene Expression,Humans,Intercellular Signaling Peptides and Proteins,Microfilament Proteins,Neuroendocrine Secretory Protein 7B2,Nuclear Proteins,Receptors,Immunologic,Syndrome||Animals,Humans,Mice,Mutant Strains,Models,Genetic,Neoplasms|Colonic Polyps,Gene Duplication,Humans,Intercellular Signaling Peptides and Proteins||carcinogenesis,'just right' hypothesis,stem cells,wnt signalling"
raob0202,raob0270,1,0.06666666666666667,Journal article,Radiotherapy and Oncology,,ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.,"Wilson JM,Fokas E,Dutton SJ,Patel N,Hawkins MA,Eccles C,Chu KY,Durrant L,Abraham AG,Partridge M,Woodward M,O'Neill E,Maughan T,McKenna WG,Mukherjee S,Brunner TB",
bioc0416,raob0189,3,1.5,Journal article|Journal article|Journal article,Clinical Oncology|Clinical Oncology|Clinical Oncology,01/02/2016|01/01/2015|06/03/2015,"Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits (vol 27, pg 420, 2015)|Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits|Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits.","Ray KJ,Sibson NR,Kiltie AE|Ray KJ,Sibson NR,Kiltie AE|Ray KJ,Sibson NR,Kiltie AE","||Humans,Breast Neoplasms,Prostatic Neoplasms,Risk Assessment,Adult,Female,Male,Dose Hypofractionation"
clme0237,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0036,immd0082,2,0.08060288335517693,Journal article|Journal article,Nature Genetics|Journal of Medical Genetics,18/05/2015|16/09/2014,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|De novo and rare inherited mutations implicate the transcriptional coregulator TCF20/SPBP in autism spectrum disorder.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Babbs C,Lloyd D,Pagnamenta AT,Twigg SR,Green J,McGowan SJ,Mirza G,Naples R,Sharma VP,Volpi EV,Buckle VJ,Wall SA,Knight SJ,Parr JR,Wilkie AO","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|International Molecular Genetic Study of Autism Consortium (IMGSAC),Chromosomes,Human,Pair 22,Humans,Transcription Factors,In Situ Hybridization,Fluorescence,Sequence Analysis,DNA,Child Development Disorders,Pervasive,Gene Rearrangement,Mutation,Child,Infant,Male,Chromosome Breakpoints"
clme0946,clme0975,1,0.05,Journal article,Cancer Cell,13/05/2013,Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
immd0031,immd0316,1,0.05,Journal article,Cancer Cell,17/07/2013,A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.,"Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM","Animals,Cell Growth Processes,Endothelial Cells,Female,Genetic Predisposition to Disease,HCT116 Cells,Humans,Mice,Nude,Neoplasms,Neovascularization,Pathologic,Receptors,G-Protein-Coupled,Signal Transduction"
clme0497,clme1358,28,2.4361972569892134,Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Conference paper|Conference paper,Cancer Research|ACS National Meeting Book of Abstracts|Proceedings of the National Academy of Sciences of USA|Nature Chemical Biology|Journal of Medicinal Chemistry|Journal of Medicinal Chemistry|Angewandte Chemie International Edition|Oncotarget|Science Advances|MedChemComm|Journal of the American Chemical Society|Journal of Medicinal Chemistry|Angewandte Chemie International Edition|MedChemComm|MedChemComm|Angewandte Chemie International Edition|ACS Chemical Biology|Proceedings of the National Academy of Sciences of USA|Drug Discovery Today: Therapeutic Strategies|Journal of Medicinal Chemistry|Journal of Medicinal Chemistry|Journal of Medicinal Chemistry|Cancer Research|ACS National Meeting Book of Abstracts|Journal of Medicinal Chemistry|Journal of Medicinal Chemistry|ACS National Meeting Book of Abstracts|ACS National Meeting Book of Abstracts,10/04/2013|08/09/2013|18/11/2013|21/07/2015|13/01/2016|27/04/2016|12/05/2014|01/06/2016|01/11/2015|01/01/2013|19/06/2014|21/03/2013|13/04/2015|01/04/2014|01/07/2015|18/05/2015|21/03/2016|10/08/2015|01/01/2012|14/05/2015|27/09/2012|08/12/2013||19/08/2012|26/04/2016|25/10/2012|25/03/2012|25/03/2012,"PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.|Chemical probes for bromodomains outside the BET family|RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.|The promise and peril of chemical probes.|Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.|Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.|A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interaction.|BET inhibition as a new strategy for the treatment of gastric cancer.|Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.|The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains|Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.|Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.|LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.|Machine-assisted synthesis of modulators of the histone reader BRD9 using flow methods of chemistry and frontal affinity chromatography|Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains|LP99: Discovery and synthesis of the first selective BRD7/9 bromodomain inhibitor|Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib.|CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.|The therapeutic potential of acetyl-lysine and methyl-lysine effector domains|Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.|Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.|[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.|Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.|Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction|Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit.|Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit.|Developing chemical probes for the BET bromodomains|3,5-Dimethylisoxazoles inhibit the bromodomain-histone protein-protein interaction","Picaud S,Da Costa D,Thanasopoulou A,Filippakopoulos P,Fish PV,Philpott M,Fedorov O,Brennan P,Bunnage ME,Owen DR,Bradner JE,Taniere P,O'Sullivan B,Müller S,Schwaller J,Stankovic T,Knapp S|Brennan PE,Martin SJ,Monteiro O,Fedorov O,Knapp S,Hay D,Wells C,Filippakopoulos P,Picaud S,Muller-Knapp S,Keates T,Yapp C,Philpott M,Schofield C,Burgess-Brown N,Shrestha L,Strain-Damerell C|Picaud S,Wells C,Felletar I,Brotherton D,Martin S,Savitsky P,Diez-Dacal B,Philpott M,Bountra C,Lingard H,Fedorov O,Müller S,Brennan PE,Knapp S,Filippakopoulos P|Arrowsmith CH,Audia JE,Austin C,Baell J,Bennett J,Blagg J,Bountra C,Brennan PE,Brown PJ,Bunnage ME,Buser-Doepner C,Campbell RM,Carter AJ,Cohen P,Copeland RA,Cravatt B,Dahlin JL,Dhanak D,Edwards AM,Frederiksen M,Frye SV,Gray N,Grimshaw CE,Hepworth D,Howe T,Huber KV,Jin J,Knapp S,Kotz JD,Kruger RG,Lowe D,Mader MM,Marsden B,Mueller-Fahrnow A,Müller S,O'Hagan RC,Overington JP,Owen DR,Rosenberg SH,Roth B,Ross R,Schapira M,Schreiber SL,Shoichet B,Sundström M,Superti-Furga G,Taunton J,Toledo-Sherman L,Walpole C,Walters MA,Willson TM,Workman P,Young RN,Zuercher WJ|Chaikuad A,Lang S,Brennan PE,Temperini C,Fedorov O,Hollander J,Nachane R,Abell C,Müller S,Siegal G,Knapp S|Sutherell CL,Tallant C,Monteiro OP,Yapp C,Fuchs JE,Fedorov O,Siejka P,Müller S,Knapp S,Brenton JD,Brennan PE,Ley SV|Rooney TP,Filippakopoulos P,Fedorov O,Picaud S,Cortopassi WA,Hay DA,Martin S,Tumber A,Rogers CM,Philpott M,Wang M,Thompson AL,Heightman TD,Pryde DC,Cook A,Paton RS,Müller S,Knapp S,Brennan PE,Conway SJ|Montenegro RC,Clark PG,Howarth A,Wan X,Ceroni A,Siejka P,Nunez-Alonso GA,Monteiro O,Rogers C,Gamble V,Burbano R,Brennan PE,Tallant C,Ebner D,Fedorov O,O'Neill E,Knapp S,Dixon D,Müller S|Fedorov O,Castex J,Tallant C,Owen DR,Martin S,Aldeghi M,Monteiro O,Filippakopoulos P,Picaud S,Trzupek JD,Gerstenberger BS,Bountra C,Willmann D,Wells C,Philpott M,Rogers C,Biggin PC,Brennan PE,Bunnage ME,Schüle R,Günther T,Knapp S,Müller S|Hay D,Fedorov O,Filippakopoulos P,Martin S,Philpott M,Picaud S,Hewings DS,Uttakar S,Heightman TD,Conway SJ,Knapp S,Brennan PE|Hay DA,Fedorov O,Martin S,Singleton DC,Tallant C,Wells C,Picaud S,Philpott M,Monteiro OP,Rogers CM,Conway SJ,Rooney TP,Tumber A,Yapp C,Filippakopoulos P,Bunnage ME,Müller S,Knapp S,Schofield CJ,Brennan PE|Hewings DS,Fedorov O,Filippakopoulos P,Martin S,Picaud S,Tumber A,Wells C,Olcina MM,Freeman K,Gill A,Ritchie AJ,Sheppard DW,Russell AJ,Hammond EM,Knapp S,Brennan PE,Conway SJ|Clark PG,Vieira LC,Tallant C,Fedorov O,Singleton DC,Rogers CM,Monteiro OP,Bennett JM,Baronio R,Müller S,Daniels DL,Méndez J,Knapp S,Brennan PE,Dixon DJ|Guetzoyan L,Ingham RJ,Nikbin N,Rossignol J,Wolling M,Baumert M,Burgess-Brown NA,Strain-Damerell CM,Shrestha L,Brennan PE,Fedorov O,Knapp S,Ley SV|Hay DA,Rogers CM,Fedorov O,Tallant C,Martin S,Monteiro OP,Mueller S,Knapp S,Schofield CJ,Brennan PE|Clark PGK,Vieira LCC,Tallant C,Fedorov O,Singleton DC,Rogers CM,Monteiro OP,Bennett JM,Baronio R,Müller S,Daniels DL,Méndez J,Knapp S,Brennan PE,Dixon DJ|Mathea S,Abdul Azeez KR,Salah E,Tallant C,Wolfreys F,Konietzny R,Fischer R,Lou HJ,Brennan PE,Schnapp G,Pautsch A,Kessler BM,Turk BE,Knapp S|Hammitzsch A,Tallant C,Fedorov O,O'Mahony A,Brennan PE,Hay DA,Martinez FO,Al-Mossawi MH,de Wit J,Vecellio M,Wells C,Wordsworth P,Müller S,Knapp S,Bowness P|Brennan P,Filippakopoulos P,Knapp S|Bennett J,Fedorov O,Tallant C,Monteiro O,Meier J,Gamble V,Savitsky P,Nunez-Alonso GA,Haendler B,Rogers C,Brennan PE,Müller S,Knapp S|Hewings DS,Rooney TP,Jennings LE,Hay DA,Schofield CJ,Brennan PE,Knapp S,Conway SJ|Fedorov O,Lingard H,Wells C,Monteiro OP,Picaud S,Keates T,Yapp C,Philpott M,Martin SJ,Felletar I,Marsden BD,Filippakopoulos P,Müller S,Knapp S,Brennan PE|Picaud S,Fedorov O,Thanasopoulou A,Leonards K,Jones K,Meier J,Olzscha H,Monteiro O,Martin S,Philpott M,Tumber A,Filippakopoulos P,Yapp C,Wells C,Che KH,Bannister A,Robson S,Kumar U,Parr N,Lee K,Lugo D,Jeffrey P,Taylor S,Vecellio ML,Bountra C,Brennan PE,O'Mahony A,Velichko S,Müller S,Hay D,Daniels DL,Urh M,La Thangue NB,Kouzarides T,Prinjha R,Schwaller J,Knapp S|Rooney TPC,Fedorov O,Filippakopoulos P,Wang M,Philpott M,Cook A,Heightman TD,Knapp S,Pryde D,Brennan PE,Conway SJ|Gerstenberger BS,Trzupek JD,Tallant C,Fedorov O,Filippakopoulos P,Brennan PE,Fedele V,Martin S,Picaud S,Rogers C,Parikh M,Taylor A,Samas B,O'Mahony A,Berg E,Pallares G,Torrey AD,Treiber DK,Samardjiev IJ,Nasipak BT,Padilla-Benavides T,Wu Q,Imbalzano AN,Nickerson JA,Bunnage ME,Müller S,Knapp S,Owen DR|Fish PV,Filippakopoulos P,Bish G,Brennan PE,Bunnage ME,Cook AS,Federov O,Gerstenberger BS,Jones H,Knapp S,Marsden B,Nocka K,Owen DR,Philpott M,Picaud S,Primiano MJ,Ralph MJ,Sciammetta N,Trzupek JD|Hewings DS,Wang M,Philpott M,Fedorov O,Uttarkar S,Filippakopoulos P,Picaud S,Vuppusetty C,Marsden B,Heightman TD,Knapp S,Brennan P,Conway SJ|Hewings DS,Wang M,Philpott M,Fedorov O,Uttarkar S,Filippakopoulos P,Picaud S,Vuppusetty C,Marsden B,Heightman TD,Knapp S,Brennan P,Conway SJ","Animals,Apoptosis,Cell Growth Processes,Child,Down-Regulation,Humans,Mice,Inbred NOD,Models,Molecular,Molecular Targeted Therapy,Nuclear Proteins,Phosphorylation,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,Protein Interaction Mapping,Protein Structure,Tertiary,Quinazolines,Structure-Activity Relationship,Transcription Factors,Xenograft Model Antitumor Assays||ApoA1,epigenetics,microarray,small molecule inhibitor,Crystallization,Fluorescence Recovery After Photobleaching,Hep G2 Cells,Humans,Models,Molecular,Molecular Structure,Oligonucleotide Array Sequence Analysis,Protein Binding,Protein Structure,Tertiary,Quinazolines,Transcription Factors|Humans,Molecular Probes,Sensitivity and Specificity,Information Dissemination,Molecular Weight,Biomedical Research,Intellectual Property,Internet,Small Molecule Libraries|||||||Hela Cells,Microsomes,Liver,Humans,Isoxazoles,Indoles,Ligands,Crystallography,X-Ray,Fluorescence Recovery After Photobleaching,Drug Evaluation,Preclinical,Binding Sites,Molecular Structure,Protein Structure,Tertiary,Structure-Activity Relationship,Genes,p53,Models,Molecular,E1A-Associated p300 Protein,CREB-Binding Protein,Small Molecule Libraries,Drug Discovery,Chemistry Techniques,Synthetic|Acetylation,CREB-Binding Protein,Cell Line,Tumor,Crystallography,X-Ray,Histones,Humans,Inhibitory Concentration 50,Isoxazoles,Ligands,Lysine,Nuclear Proteins,Protein Binding,Structure-Activity Relationship,Transcription Factors|Humans,Lactams,Chromosomal Proteins,Non-Histone,Transcription Factors,Models,Molecular,Drug Discovery|||||CD4-Positive T-Lymphocytes,Cells,Cultured,Humans,Arthritis,Psoriatic,Spondylitis,Ankylosing,Azepines,Triazoles,Isoxazoles,Benzimidazoles,Recombinant Proteins,Immunosuppressive Agents,Interleukin-17,Calorimetry,Crystallography,X-Ray,Drug Evaluation,Preclinical,Gene Expression Regulation,Molecular Structure,Protein Conformation,Protein Structure,Tertiary,Structure-Activity Relationship,Kinetics,Models,Molecular,Adult,Aged,Middle Aged,Female,Male,p300-CBP Transcription Factors,Th17 Cells|||Acetylation,Animals,Histones,Humans,Lysine,Molecular Targeted Therapy,Nuclear Proteins,Protein Binding,Protein Processing,Post-Translational|CREB-Binding Protein,Cell Line,Tumor,Chromatin Assembly and Disassembly,Crystallography,X-Ray,Humans,Molecular Docking Simulation,Nuclear Proteins,Phthalazines,Protein Structure,Tertiary,Proteins,Structure-Activity Relationship,Transcription Factors,Triazoles|Cell Line,Tumor,Animals,Humans,Mice,Oxazepines,Doxorubicin,Antineoplastic Combined Chemotherapy Protocols,Enzyme Inhibitors,Xenograft Model Antitumor Assays,Amino Acid Sequence,Protein Structure,Tertiary,Drug Synergism,Models,Molecular,Molecular Sequence Data,p300-CBP Transcription Factors,Leukemia,Myeloid,Acute|||Crystallography,X-Ray,Humans,Models,Molecular,Molecular Probes,Molecular Structure,Nuclear Proteins,Protein Binding,Quinazolinones,Structure-Activity Relationship,Sulfonamides,Transcription Factors||"
bioc0416,raob0095,1,0.14285714285714285,Journal article,Journal of National Cancer Institute,09/10/2013,Selective permeabilization of the blood-brain barrier at sites of metastasis.,"Connell JJ,Chatain G,Cornelissen B,Vallis KA,Hamilton A,Seymour L,Anthony DC,Sibson NR","Analysis of Variance,Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Blood-Brain Barrier,Brain,Brain Neoplasms,Breast Neoplasms,Contrast Media,Disease Models,Animal,Drug Administration Schedule,Female,Gadolinium DTPA,Gene Expression Regulation,Neoplastic,Humans,Immunohistochemistry,Lymphotoxin-alpha,Magnetic Resonance Imaging,Mice,Inbred BALB C,Permeability,Receptors,Tumor Necrosis Factor,Type I,Tomography,Emission-Computed,Single-Photon,X-Ray Computed,Trastuzumab,Tumor Necrosis Factor-alpha"
clme0301,immd0036,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clab0025,immd0316,2,0.1,Journal article|Journal article,Cancer Cell|Cancer Cell,12/08/2013|17/07/2013,A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis|A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.,"Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SYY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM|Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM","|Animals,Cell Growth Processes,Endothelial Cells,Female,Genetic Predisposition to Disease,HCT116 Cells,Humans,Mice,Nude,Neoplasms,Neovascularization,Pathologic,Receptors,G-Protein-Coupled,Signal Transduction"
raob0095,raob0189,1,0.3333333333333333,Journal article,Current Molecular Medicine,11/11/2013,Can γH2AX be used to personalise cancer treatment?,"Shah K,Cornelissen B,Kiltie AE,Vallis KA","Antineoplastic Agents,Biomarkers,Tumor,DNA Damage,Diagnostic Imaging,Drug Monitoring,Histones,Humans,Neoplasms"
clme0946,dpag0048,1,0.09090909090909091,Journal article,Proceedings of the National Academy of Sciences of USA,23/06/2014,"STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression.","Turnquist C,Wang Y,Severson DT,Zhong S,Sun B,Ma J,Constaninescu SN,Ansorge O,Stolp HB,Molnár Z,Szele FG,Lu X","Astrocytes,Animals,Humans,Mice,Encephalitis,Neoplasms,Experimental,Tumor Suppressor Proteins,Apoptosis,Cell Polarity,Transcription,Genetic,Gene Expression Regulation,STAT1 Transcription Factor"
raob0051,raob0270,1,0.06666666666666667,Conference paper,Journal of Clinical Oncology,20/05/2015,Use of FLIM histology-based HER2-HER3 heterodimer quantification and a Bayesian latent class proportional hazards model to predict cetuximab response in the COIN and new EPOC trials.,"Ng T,Weitsman G,Barber P,Lawler K,Rowley M,Elshtein G,Rodriguez-Justo M,Jasani B,Pugh SA,Bridgewater JA,Primrose JN,Fisher D,Adams RA,Maughan T,Vojnovic B,Coolen A",
immd0031,smlea,1,0.0625,Journal article,Journal of Biological Chemistry,21/01/2013,Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.,"Whiteman P,de Madrid BH,Taylor P,Li D,Heslop R,Viticheep N,Tan JZ,Shimizu H,Callaghan J,Masiero M,Li JL,Banham AH,Harris AL,Lea SM,Redfield C,Baron M,Handford PA","Amino Acid Sequence,Animals,Antibodies,Monoclonal,Blotting,Western,Calcium-Binding Proteins,Cell Line,Tumor,Drosophila Proteins,Flow Cytometry,HEK293 Cells,Humans,Intercellular Signaling Peptides and Proteins,Ligands,Membrane Proteins,Mice,Models,Molecular,Molecular Sequence Data,Mutation,Protein Binding,Protein Structure,Secondary,Tertiary,Receptor,Notch1,Receptors,Notch,Sequence Homology,Amino Acid"
clme0193,clme0219,1,0.09090909090909091,Journal article,Journal of Allergy and Clinical Immunology,19/10/2014,Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk.,"Xue L,Fergusson J,Salimi M,Panse I,Ussher JE,Hegazy AN,Vinall SL,Jackson DG,Hunter MG,Pettipher R,Ogg G,Klenerman P","Neutrophils,Th2 Cells,Humans,Leukotriene E4,Prostaglandin D2,Cell Adhesion Molecules,Inflammation Mediators,Cluster Analysis,Gene Expression Profiling,Cell Communication,Apoptosis,Chemotaxis,Leukocyte,Gene Expression,Drug Synergism"
raob0087,xxxx0009,1,0.07692307692307693,Journal article,PLoS One,01/01/2015,Improving In Vivo High-Resolution CT Imaging of the Tumour Vasculature in Xenograft Mouse Models through Reduction of Motion and Bone-Streak Artefacts.,"Kersemans V,Kannan P,Beech JS,Bates R,Irving B,Gilchrist S,Allen PD,Thompson J,Kinchesh P,Casteleyn C,Schnabel J,Partridge M,Muschel RJ,Smart SC","Animals,Mice,Inbred CBA,Neoplasms,Adenocarcinoma,Disease Models,Animal,Tomography,X-Ray Computed,Magnetic Resonance Imaging,Fluoroscopy,Transplantation,Heterologous,Artifacts,Image Processing,Computer-Assisted,Female"
chem0068,whgu0172,1,0.1,Journal article,ChemBioChem: a European journal of chemical biology,08/02/2011,The chemoselective one-step alkylation and isolation of thiophosphorylated cdk2 substrates in the presence of native cysteine.,"Lee SE,Elphick LM,Kramer HB,Jones AM,Child ES,Anderson AA,Bonnac L,Suwaki N,Kessler BM,Gouverneur V,Mann DJ","Alkylation,Chlorides,Cyclin-Dependent Kinase 2,Cysteine,Electrophoresis,Polyacrylamide Gel,Hydrogen-Ion Concentration,Peptides,Phosphorus Compounds,Signal Transduction,Substrate Specificity"
immd0024,stat0004,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
cschof,whgu0256,1,0.08333333333333333,Journal article,PLoS One,01/01/2011,Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α).,"Thalhammer A,Bencokova Z,Poole R,Loenarz C,Adam J,O'Flaherty L,Schödel J,Mole D,Giaslakiotis K,Schofield CJ,Hammond EM,Ratcliffe PJ,Pollard PJ","Anoxia,Cell Line,Dioxygenases,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Ketoglutaric Acids,Membrane Proteins,Nuclear Proteins,Oxygenases,Transcriptional Activation"
raob0189,stat0004,1,0.06666666666666667,Journal article,Nature Communications,01/01/2014,Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.,"Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC","Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading"
orie1154,orie1154,1,1.0,Book,,01/01/2013,The Immunological Barriers to Regenerative Medicine,Fairchild PJ,Stem cells
clme0975,immd0330,3,0.20952380952380953,Conference paper|Journal article|Journal article,Annals of Oncology|Journal of Clinical Oncology|Annals of Oncology,01/06/2012|20/05/2013|24/02/2014,CLINICAL DIAGNOSTIC IMPLEMENTATION OF AN INNOVATIVE CANCER CARE MODEL BASED ON COMPREHENSIVE MOLECULAR PROFILING OF TUMOUR-NORMAL PAIRS|DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib (AZD6244; ARRY-142886) in wt BRAF advanced melanoma|DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma.,"Kaur K,Henderson S,Cutts A,Domingo E,Woods J,Motley C,Dougherty B,Middleton M,Hassan B,Wang Y,Beasley E,Naley M,Schuh A,Tomlinson I,Taylor J|Gupta A,Love S,Schuh A,Collins L,Thomason A,Asher R,Lisle R,Churchman M,Shanyinde M,Plummer R,Nathan PD,Danson S,Ottensmeier CHH,Lorigan P,Larkin JMG,Middleton MR|Gupta A,Love S,Schuh A,Shanyinde M,Larkin JM,Plummer R,Nathan PD,Danson S,Ottensmeier CH,Lorigan P,Collins L,Wise A,Asher R,Lisle R,Middleton MR","||Humans,Melanoma,Skin Neoplasms,Taxoids,Benzimidazoles,GTP Phosphohydrolases,Proto-Oncogene Proteins B-raf,Membrane Proteins,Antineoplastic Combined Chemotherapy Protocols,Disease-Free Survival,Treatment Outcome,Proportional Hazards Models,Double-Blind Method,DNA Mutational Analysis,Aged,Middle Aged,Male,Kaplan-Meier Estimate,BRAF,MEK,melanoma,phase II,selumetinib,trial"
clme0497,ndog0251,1,0.5,Journal article,Cancer Research,23/01/2014,The structural basis of PI3K cancer mutations: from mechanism to therapy.,"Liu S,Knapp S,Ahmed AA","Enzyme Activation,Humans,Mutation,Neoplasms,Phosphatidylinositol 3-Kinases"
cschof,whgu0274,1,0.08333333333333333,Journal article,PLoS One,01/01/2011,Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α).,"Thalhammer A,Bencokova Z,Poole R,Loenarz C,Adam J,O'Flaherty L,Schödel J,Mole D,Giaslakiotis K,Schofield CJ,Hammond EM,Ratcliffe PJ,Pollard PJ","Anoxia,Cell Line,Dioxygenases,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Ketoglutaric Acids,Membrane Proteins,Nuclear Proteins,Oxygenases,Transcriptional Activation"
cschof,univ1923,15,1.7207862030442675,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article,Biochemical Journal|Nature Chemical Biology|Angewandte Chemie International Edition|The Federation of European Biochemical Societies (FEBS) Journal|Nature Communications|ChemBioChem: a European journal of chemical biology|Biochemical Journal|Tomography|Molecular Cell|ChemMedChem: chemistry enabling drug discovery|Journal of Biological Chemistry|Phytochemistry|Neuropathology and Applied Neurobiology|Cancer Research|MedChemComm,24/10/2012|01/01/2012|07/01/2013|01/09/2012|01/01/2014|07/03/2011|14/08/2014|01/06/2016|30/01/2014|06/02/2014|25/06/2015|18/07/2015|01/03/2013|01/01/2016|01/01/2012,"Investigations on the oxygen dependence of a 2-oxoglutarate histone demethylase.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.|Substrate selectivity analyses of factor inhibiting hypoxia-inducible factor.|Kinetic investigations on the reaction of a 2-oxoglutarate dependent histone demethylase with oxygen|Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases.|The 2-oxoglutarate-dependent oxygenase JMJD6 catalyses oxidation of lysine residues to give 5S-hydroxylysine residues.|Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen.|Improved localisation for 2-hydroxyglutarate detection at 3T using long-TE semi-LASER|Optimal translational termination requires C4 lysyl hydroxylation of eRF1.|A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.|Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.|The broad spectrum 2-oxoglutarate oxygenase inhibitor N-oxalylglycine is present in rhubarb and spinach leaves.|Magnetic resonance spectroscopy for 2-hydroxyglutarate identifies IDH mutant gliomas|Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.|Self-hydroxylation of the splicing factor lysyl hydroxylase, JMJD6","Sánchez-Fernández EM,Tarhonskaya H,Al-Qahtani K,Hopkinson RJ,McCullagh JS,Schofield CJ,Flashman E|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Yang M,Hardy AP,Chowdhury R,Loik ND,Scotti JS,McCullagh JS,Claridge TD,McDonough MA,Ge W,Schofield CJ|Sanchez-Fernandez EM,Tarhonskaya H,Al-Qahtani K,Hopkinson J,McCullagh JSO,Candela-Lena JI,Schofield CJ,Flashman E|Tarhonskaya H,Rydzik AM,Leung IK,Loik ND,Chan MC,Kawamura A,McCullagh JS,Claridge TD,Flashman E,Schofield CJ|Mantri M,Loik ND,Hamed RB,Claridge TD,McCullagh JS,Schofield CJ|Tarhonskaya H,Chowdhury R,Leung IK,Loik ND,McCullagh JS,Claridge TD,Schofield CJ,Flashman E|Berrington A,Voets NATALIE,Plaha P,Larkin SARAH,Mccullagh JAMES,Stacey R,Yildirim M,Schofield CHRISTOPHER,Jezzard PETER,Cadoux-Hudson T,Ansorge OLAF,emir UZAY|Yamamoto A,Feng T,Wilkins S,Sokolova E,Yates L,Muenzel M,Singh P,Hopkinson R,Fischer R,Cockman M,Shelley J,Trudgian D,Schoedel J,McCullagh JO,Ge W,Kessler B,Gilbert R,Frolova L,Alkalaeva E,Ratcliffe P,Schofield C,Coleman M|Schiller R,Scozzafava G,Tumber A,Wickens JR,Bush JT,Rai G,Lejeune C,Choi H,Yeh TL,Chan MC,Mott BT,McCullagh JS,Maloney DJ,Schofield CJ,Kawamura A|Tarhonskaya H,Hardy AP,Howe EA,Loik ND,Kramer HB,McCullagh JS,Schofield CJ,Flashman E|Al-Qahtani K,Jabeen B,Sekirnik R,Riaz N,Claridge TD,Schofield CJ,McCullagh JS|Larkin SJ,Near J,Kudari M,Khrapitchev A,Sibson N,Jezzard P,Pfeffer I,Al-Qahtani K,Schofield C,McCullagh J,Ansorge O|Emir UE,Larkin SJ,de Pennington N,Voets N,Plaha P,Stacey R,Al-Qahtani K,Mccullagh J,Schofield CJ,Clare S,Jezzard P,Cadoux-Hudson T,Ansorge O|Mantri M,Webby CJ,Loik ND,Hamed RB,Nielsen ML,McDonough MA,McCullagh JSO,Boettger A,Schofield CJ,Wolf A","Biocatalysis,Dose-Response Relationship,Drug,Histones,Humans,Iron,Jumonji Domain-Containing Histone Demethylases,Ketoglutaric Acids,Kinetics,Lysine,Molecular Structure,Oxygen,Peptides,Spectrophotometry,Substrate Specificity,Succinates|Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes|Amino Acid Sequence,Ankyrins,Binding Sites,Biocatalysis,Catalytic Domain,Hydroxylation,Hypoxia-Inducible Factor 1,Magnetic Resonance Spectroscopy,Molecular Sequence Data,Peptides,Spectrometry,Mass,Matrix-Assisted Laser Desorption-Ionization,Substrate Specificity||Alcohol Oxidoreductases,Ascorbic Acid,Glutarates,Oxygenases,Succinic Acid,gamma-Aminobutyric Acid|Animals,Catalysis,Humans,Hydroxylysine,Jumonji Domain-Containing Histone Demethylases,Ketoglutaric Acids,Magnetic Resonance Spectroscopy,Molecular Structure,Oxidation-Reduction,Oxygenases,Stereoisomerism|Cations,Divalent,Oxygen,Iron,Manganese,Zinc,Water,Ketoglutaric Acids,Isoquinolines,Oligopeptides,Mutagenesis,Site-Directed,Catalytic Domain,Protein Binding,Hydroxylation,Kinetics,Hypoxia-Inducible Factor-Proline Dioxygenases||Amino Acid Sequence,Animals,Catalysis,Cell Line,Tumor,Codon,Terminator,Gene Expression Regulation,HeLa Cells,Histone Demethylases,Humans,Hydrolysis,Hydroxylation,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Peptide Chain Termination,Translational,Peptide Termination Factors,Protein Biosynthesis,Protein Processing,Post-Translational,Protein Structure,Tertiary,Sequence Homology,Amino Acid|2-oxoglutarate (2OG) oxygenases,cell permeability,epigenetics,inhibitors,jmjc histone demethylases,structure-activity relationships,Cell Membrane Permeability,Cell Survival,Dose-Response Relationship,Drug,Enzyme Inhibitors,Esters,HeLa Cells,Humans,Hydroxyquinolines,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Molecular Structure,Structure-Activity Relationship|Animals,Humans,Escherichia coli,Anoxia,Oxygen,Mixed Function Oxygenases,Ankyrins,Recombinant Proteins,Repressor Proteins,Signal Transduction,Gene Expression,Transcription,Genetic,Gene Expression Regulation,Amino Acid Sequence,Protein Structure,Tertiary,Kinetics,Molecular Sequence Data,Hypoxia-Inducible Factor 1,alpha Subunit,Biocatalysis,Hypoxia-Inducible Factor-Proline Dioxygenases|Humans,Escherichia coli,Brassica,Spinacia oleracea,Rheum,Plant Leaves,Ketoglutaric Acids,Oxygenases,Alanine,Amino Acids,Dicarboxylic,Enzyme Inhibitors,Chromatography,Liquid,Magnetic Resonance Spectroscopy,Tandem Mass Spectrometry,HEK293 Cells||Humans,Glioma,Brain Neoplasms,Glutarates,Isocitrate Dehydrogenase,Case-Control Studies,Mutation,Adult,Middle Aged,Female,Male|"
bioc0192,bioc0541,1,0.07142857142857142,Journal article,Proceedings of the National Academy of Sciences of USA,26/03/2012,Molecular MRI enables early and sensitive detection of brain metastases.,"Serres S,Soto MS,Hamilton A,McAteer MA,Carbonell WS,Robson MD,Ansorge O,Khrapitchev A,Bristow C,Balathasan L,Weissensteiner T,Anthony DC,Choudhury RP,Muschel RJ,Sibson NR","Animals,Brain Neoplasms,Disease Progression,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Sensitivity and Specificity,Up-Regulation,Vascular Cell Adhesion Molecule-1"
cschof,ocms0037,1,0.125,Journal article,Cell,22/05/2014,A code for RanGDP binding in ankyrin repeats defines a nuclear import pathway.,"Lu M,Zak J,Chen S,Sanchez-Pulido L,Severson DT,Endicott J,Ponting CP,Schofield CJ,Lu X","Humans,Multiprotein Complexes,ran GTP-Binding Protein,Proteins,Ankyrin Repeat,Active Transport,Cell Nucleus,Protein Transport,Models,Molecular,Cyclin-Dependent Kinase Inhibitor p16"
raob0009,raob0051,24,2.8054505135387493,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Report|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Science Signaling|Radiation and Environmental Biophysics|Biochemical Society Transactions|PLoS One|Integrative Biology|Journal of Microscopy|PLoS One|European Journal of Cancer|International Journal of Cancer|International Journal of Cancer||Journal of Microscopy|MIAAB|Journal of Nuclear Medicine|Radiation Measurements|Proceedings of SPIE - The International Society for Optical Engineering|Oncotarget|Nature Protocols|Radiation Research|Oncotarget|Progress in Biomedical Optics and Imaging - Proceedings of SPIE|Radiation and Environmental Biophysics|Biophysical Journal|ChemPhysChem: a European journal of chemical physics and physical chemistry,01/01/2011|01/11/2013|01/12/2014|01/01/2012|04/05/2011|01/01/2013|01/01/2012|01/11/2014|01/01/2013|01/12/2013|01/01/2012|01/08/2013|01/01/2011|15/04/2011|01/01/2011|01/01/2014||01/01/2012|23/07/2012|08/09/2011|01/01/2011|01/01/2013|10/03/2015|01/01/2011,"A targeted siRNA screen identifies regulators of Cdc42 activity at the natural killer cell immunological synapse.|Broadbeam irradiation of mammalian cells using a vertical microbeam facility|Imaging tumour heterogeneity of the consequences of a PKCα-substrate interaction in breast cancer patients.|A multi-functional imaging approach to high-content protein interaction screening.|The challenges of integrating molecular imaging into the optimization of cancer therapy.|The gray institute 'open' high-content, fluorescence lifetime microscopes|In situ biological dose mapping estimates the radiation burden delivered to 'spared' tissue between synchrotron X-ray microbeam radiotherapy tracks.|Her2-3 heterodimer is a new and better than HER2 IHC score for clinical outcome prognosis|Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies|Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies|The Gamma-H2AX Assay as a High Throughput Triage Tool:  Comparison of Two Prototype Devices|The gray institute 'open' high-content, fluorescence lifetime microscopes|Learning to Count Cells:  Applications to lens-free imaging of large fields|ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.|A portable microfluidic fluorescence spectrometer device for γ-H2AX-based biological dosimetry|The Gray Institute Open Microscopes applied to radiobiology and protein interaction studies|HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status|Use of the mouse aortic ring assay to study angiogenesis.|A focused scanning vertical beam for charged particle irradiation of living cells with single counted particles.|Assessment of EGFR/HER2 dimerization by FRET-FLIM utilizing Alexa-conjugated secondary antibodies in relation to targeted therapies in cancers.|Bayesian analysis of fluorescence lifetime imaging data|Broadbeam irradiation of mammalian cells using a vertical microbeam facility|Effect of phosphorylation on EGFR dimer stability probed by single-molecule dynamics and FRET/FLIM.|How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biology","Carlin LM,Evans R,Milewicz H,Fernandes L,Matthews DR,Perani M,Levitt J,Keppler MD,Monypenny J,Coolen T,Barber PR,Vojnovic B,Suhling K,Fraternali F,Ameer-Beg S,Parker PJ,Thomas NS,Ng T|Jeynes JCG,Merchant MJ,Barazzuol L,Barry M,Guest D,Palitsin VV,Grime GW,Tullis IDC,Barber PR,Vojnovic B,Kirkby KJ|Weitsman G,Lawler K,Kelleher MT,Barrett JE,Barber PR,Shamil E,Festy F,Patel G,Fruhwirth GO,Huang L,Tullis ID,Woodman N,Ofo E,Ameer-Beg SM,Irshad S,Condeelis J,Gillett CE,Ellis PA,Vojnovic B,Coolen AC,Ng T|Matthews DR,Fruhwirth GO,Weitsman G,Carlin LM,Ofo E,Keppler M,Barber PR,Tullis ID,Vojnovic B,Ng T,Ameer-Beg SM|Patel GS,Kiuchi T,Lawler K,Ofo E,Fruhwirth GO,Kelleher M,Shamil E,Zhang R,Selvin PR,Santis G,Spicer J,Woodman N,Gillett CE,Barber PR,Vojnovic B,Kéri G,Schaeffter T,Goh V,O'Doherty MJ,Ellis PA,Ng T|Barber PR,Tullis IDC,Pierce GP,Newman RG,Prentice J,Vojnovic B,Matthews DR,Ameer-Beg SM,Rowley MI|Rothkamm K,Crosbie JC,Daley F,Bourne S,Barber PR,Vojnovic B,Cann L,Rogers PA|Weitsman G,Barber PR,Lawler K,Gillett C,Woodman N,Kholodenko B,Nguyen LK,Santra T,Vojnovic B,Ng T|Akerman S,Fisher M,Daniel RA,Lefley D,Reyes-Aldasoro CC,Lunt SJ,Harris S,Bjorndahl M,Williams LJ,Evans H,Kanthou C,Tozer GM,Barber PR,Vojnovic B,Prise VE|Akerman S,Fisher M,Daniel RA,Lefley D,Reyes-Aldasoro CC,Lunt SJ,Harris S,Bjorndahl M,Williams LJ,Evans H,Barber PR,Prise VE,Vojnovic B,Kanthou C,Tozer GM|Rothkamm K,Horn S,Pope I,Barber P,Barnard S,Moquet J,Tullis IDC,Vojnovic B|Barber PR,Tullis IDC,Pierce GP,Newman RG,Prentice J,Rowley MI,Matthews DR,Ameer-Beg SM,Vojnovic B|Flaccavento G,Lempitsky V,Pope I,Barber P,Zisserman A,Noble A,Vojnovic B|Cornelissen B,Darbar S,Hernandez R,Kersemans V,Tullis I,Barber PR,Smart S,Vojnovic B,Reilly R,Vallis KA|Pope IA,Barber PR,Horn S,Ainsbury E,Rothkamm K,Vojnovic B|Barber PR,Tullis IDC,Rowley MI,Martins CD,Weitsman G,Lawler K,Coffey M,Woodman N,Gillett CE,Ng T,Vojnovic B|Weitsman G,Barber PR,Nguyen LK,Lawler K,Patel G,Woodman N,Kelleher MT,Pinder SE,Rowley M,Ellis PA,Purushotham AD,Coolen AC,Kholodenko BN,Vojnovic B,Gillett C,Ng T|Baker M,Robinson SD,Lechertier T,Barber PR,Tavora B,D'Amico G,Jones DT,Vojnovic B,Hodivala-Dilke K|Merchant MJ,Jeynes JC,Grime GW,Palitsin V,Tullis ID,Barber PR,Vojnovic B,Webb RP,Kirkby KJ|Waterhouse BR,Gijsen M,Barber PR,Tullis ID,Vojnovic B,Kong A|Rowley MI,Barber PR,Coolen ACC,Vojnovic B|Jeynes JCG,Merchant MJ,Barazzuol L,Barry M,Guest D,Palitsin VV,Grime GW,Kirkby KJ,Tullis IDC,Barber PR,Vojnovic B|Coban O,Zanetti-Dominguez LC,Matthews DR,Rolfe DJ,Weitsman G,Barber PR,Barbeau J,Devauges V,Kampmeier F,Winn M,Vojnovic B,Parker PJ,Lidke KA,Lidke DS,Ameer-Beg SM,Martin-Fernandez ML,Ng T|Fruhwirth GO,Fernandes LP,Weitsman G,Patel G,Kelleher M,Lawler K,Brock A,Poland SP,Matthews DR,Keri G,Barber PR,Vojnovic B,Ameer-Beg SM,Coolen ACC,Fraternali F,Ng T","Biological Clocks,Cell Line,Transformed,Cell- and Tissue-Based Therapy,Class Ia Phosphatidylinositol 3-Kinase,Cytoskeleton,Enzyme Activation,Guanine Nucleotide Exchange Factors,Humans,Immunity,Cellular,Innate,Immunological Synapses,Killer Cells,Natural,Neoplasms,Proto-Oncogene Proteins c-akt,RNA,Small Interfering,Rho Guanine Nucleotide Exchange Factors,cdc42 GTP-Binding Protein||Subcellular Fractions,Humans,Breast Neoplasms,Neoplasm Metastasis,Cytoskeletal Proteins,Treatment Outcome,Fluorescence Resonance Energy Transfer,Substrate Specificity,Phosphorylation,Female,Actin Depolymerizing Factors,Protein Kinase C-alpha|Biosensing Techniques,Cell Line,Tumor,Fluorescence Polarization,Fluorescence Resonance Energy Transfer,Green Fluorescent Proteins,Humans,Luminescent Proteins,Photons,Protein Interaction Domains and Motifs,Proteins,Receptors,CXCR4,Sensitivity and Specificity,Small Molecule Libraries|Biomarkers,Tumor,Humans,Molecular Imaging,Neoplasm Proteins,Neoplasms,Systems Integration||Animals,Cells,Cultured,Dose-Response Relationship,Radiation,Female,Fibroblasts,Humans,Mice,Inbred BALB C,Organs at Risk,Radiation Oncology,Radiometry,Radiotherapy,Radiotherapy Dosage,Skin,Synchrotrons,X-Rays|||||||Active Transport,Cell Nucleus,Animals,Antibodies,Monoclonal,Humanized,Cell Line,Tumor,Cell Proliferation,Colony-Forming Units Assay,Dimethylallyltranstransferase,Electrons,Epidermal Growth Factor,Female,Humans,Imidazoles,Mice,Pentetic Acid,Protein Kinase Inhibitors,Protein Transport,Receptor,ErbB-2,Signal Transduction,Trastuzumab||||Animals,Aorta,Cell Movement,Cell Proliferation,Mice,Inbred C57BL,Microscopy,Fluorescence,Phase-Contrast,Neovascularization,Physiologic,Tissue Culture Techniques|Animals,Cell Line,Cell Survival,Cricetinae,Cricetulus,Feedback,Humans,Humidity,Nanotechnology,Particle Accelerators,Radiobiology,Temperature|Animals,Cell Line,Tumor,Fluorescence Resonance Energy Transfer,Humans,Mice,Microscopy,Fluorescence,Molecular Targeted Therapy,Neoplasms,Receptor,Epidermal Growth Factor,ErbB-2|||Cell Line,Tumor,Humans,Receptor,Epidermal Growth Factor,Fluorescence Resonance Energy Transfer,Protein Processing,Post-Translational,Phosphorylation,Receptor-Like Protein Tyrosine Phosphatases,Class 3,Protein Multimerization,Protein Stability|"
clme0975,ndos0097,1,0.125,Journal article,British Journal of Radiology,14/06/2012,High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.,"Leslie T,Ritchie R,Illing R,Ter Haar G,Phillips R,Middleton M,Bch B,Wu F,Cranston D","Aged,80 and over,Feasibility Studies,Female,High-Intensity Focused Ultrasound Ablation,Humans,Intraoperative Care,Liver Neoplasms,Magnetic Resonance Imaging,Male,Middle Aged,Postoperative Care,Prospective Studies,Treatment Outcome"
card0008,ocms0037,1,0.06666666666666667,Journal article,Mammalian Genome,27/04/2012,Nprl3 is required for normal development of the cardiovascular system.,"Kowalczyk MS,Hughes JR,Babbs C,Sanchez-Pulido L,Szumska D,Sharpe JA,Sloane-Stanley JA,Morriss-Kay GM,Smoot LB,Roberts AE,Watkins H,Bhattacharya S,Gibbons RJ,Ponting CP,Wood WG,Higgs DR","Abnormalities,Multiple,Amino Acid Sequence,Animals,Cardiovascular System,Cells,Cultured,DNA Mutational Analysis,Female,GTPase-Activating Proteins,Gene Expression Profiling,Genetic Association Studies,Heart Defects,Congenital,Humans,Intracellular Signaling Peptides and Proteins,Male,Mice,Knockout,Molecular Sequence Annotation,Molecular Sequence Data,Myocardium,Nuclear Proteins,Phenotype,Polymorphism,Single Nucleotide,Promoter Regions,Genetic"
card0039,dplb0149,2,0.34285714285714286,Journal article|Conference paper,Methods in Molecular Biology|European Heart Journal,01/01/2011|01/09/2014,Molecular MRI approaches to the detection of CNS inflammation.|Multimeric microparticles of iron oxide (mMPIO) for dual modality molecular imaging with CT & MRI,"Sibson NR,Anthony DC,van Kasteren S,Dickens A,Perez-Balderas F,McAteer MA,Choudhury RP,Davis BG|Aljabali AAA,Chai JT,Thornton V,Schneider JE,Davis BG,Choudhury RP","Animals,Antibodies,Antigens,CD15,Central Nervous System,Endothelial Cells,Ferric Compounds,Inflammation,Magnetic Resonance Imaging,Mice,Rats,Statistics as Topic,Tumor Necrosis Factor-alpha,Vascular Cell Adhesion Molecule-1|"
clme0993,olin0027,1,0.0625,Journal article,Cell,10/10/2013,A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection.,"Zeron-Medina J,Wang X,Repapi E,Campbell MR,Su D,Castro-Giner F,Davies B,Peterse EF,Sacilotto N,Walker GJ,Terzian T,Tomlinson IP,Box NF,Meinshausen N,De Val S,Bell DA,Bond GL","Animals,Cell Proliferation,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Male,Mice,Polymorphism,Single Nucleotide,Response Elements,Selection,Genetic,Stem Cell Factor,Testicular Neoplasms,Transcription,Tumor Suppressor Protein p53"
lina0435,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clab0127,clme0497,3,0.24206349206349204,Journal article|Journal article|Journal article,Science Advances|Cancer Research|Proceedings of the National Academy of Sciences of USA,04/02/2016||23/02/2012,Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response.|Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.|The p53 cofactor Strap exhibits an unexpected TPR motif and oligonucleotide-binding (OB)-fold structure.,"Ghari F,Quirke AM,Munro S,Kawalkowska J,Picaud S,McGouran J,Subramanian V,Muth A,Williams R,Kessler B,Thompson PR,Fillipakopoulos P,Knapp S,Venables PJ,La Thangue NB|Picaud S,Fedorov O,Thanasopoulou A,Leonards K,Jones K,Meier J,Olzscha H,Monteiro O,Martin S,Philpott M,Tumber A,Filippakopoulos P,Yapp C,Wells C,Che KH,Bannister A,Robson S,Kumar U,Parr N,Lee K,Lugo D,Jeffrey P,Taylor S,Vecellio ML,Bountra C,Brennan PE,O'Mahony A,Velichko S,Müller S,Hay D,Daniels DL,Urh M,La Thangue NB,Kouzarides T,Prinjha R,Schwaller J,Knapp S|Adams CJ,Pike AC,Maniam S,Sharpe TD,Coutts AS,Knapp S,La Thangue NB,Bullock AN","Cell Line,HL-60 Cells,Animals,Mice,Inbred DBA,Humans,Arthritis,Experimental,Inflammation,Hydrolases,Citrulline,Nuclear Proteins,Recombinant Proteins,Transcription Factors,RNA,Small Interfering,Cytokines,Gene Expression Regulation,Acetylation,Male,E2F1 Transcription Factor,Promoter Regions,Genetic|Cell Line,Tumor,Animals,Humans,Mice,Oxazepines,Doxorubicin,Antineoplastic Combined Chemotherapy Protocols,Enzyme Inhibitors,Xenograft Model Antitumor Assays,Amino Acid Sequence,Protein Structure,Tertiary,Drug Synergism,Models,Molecular,Molecular Sequence Data,p300-CBP Transcription Factors,Leukemia,Myeloid,Acute|Amino Acid Motifs,Animals,Carrier Proteins,Chromatin,Crystallography,X-Ray,DNA Damage,E1A-Associated p300 Protein,Genes,p53,Humans,Mice,Models,Molecular,Neoplasm Proteins,Oligonucleotides,Protein Binding,Protein Conformation,Protein Folding,Protein Structure,Tertiary,Tumor Suppressor Protein p53"
immd0282,olin0014,1,0.08333333333333333,Journal article,Proceedings of the National Academy of Sciences of USA,01/07/2013,Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development,"Sacilotto N,Monteiro R,Fritzsche M,Becker PW,Sanchez-Del-Campo L,Liu K,Pinheiro P,Ratnayaka I,Davies B,Goding CR,Patient R,Bou-Gharios G,De Val S","CSL,arterial-specific enhancer,Animals,Arteries,Chromatin Immunoprecipitation,Cloning,Molecular,Electrophoretic Mobility Shift Assay,Gene Expression Regulation,Developmental,Gene Knockdown Techniques,Immunoglobulin J Recombination Signal Sequence-Binding Protein,Immunohistochemistry,In Situ Hybridization,Intracellular Signaling Peptides and Proteins,Membrane Proteins,Mice,Transgenic,Receptors,Notch,SOXF Transcription Factors,Zebrafish"
immd0198,stat0004,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
gree1192,whgu0378,1,0.125,Journal article,European Journal of Human Genetics,07/05/2014,"Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP.","Cheng TH,Gorman M,Martin L,Barclay E,Casey G,Saunders B,Thomas H,Clark S,Tomlinson I","Colon Cancer Family Registry,CGEMS,Humans,Adenoma,Adenomatous Polyposis Coli,Colorectal Neoplasms,Genetic Predisposition to Disease,DNA Glycosylases,Adenomatous Polyposis Coli Protein,Phenotype,Germ-Line Mutation,Polymorphism,Single Nucleotide,Alleles,Aged,Middle Aged,Female,Male,Genes,Modifier"
whgu0172,whgu0274,3,0.1525,Journal article|Journal article|Journal article,Cancer Cell|Journal of Pathology|Cell Reports,18/10/2011|01/01/2011|13/03/2013,Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency.,"Adam J,Hatipoglu E,O'Flaherty L,Ternette N,Sahgal N,Lockstone H,Baban D,Nye E,Stamp GW,Wolhuter K,Stevens M,Fischer R,Carmeliet P,Maxwell PH,Pugh CW,Frizzell N,Soga T,Kessler BM,El-Bahrawy M,Ratcliffe PJ,Pollard PJ|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Ternette N,Yang M,Laroyia M,Kitagawa M,O'Flaherty L,Wolhulter K,Igarashi K,Saito K,Kato K,Fischer R,Berquand A,Kessler BM,Lappin T,Frizzell N,Soga T,Adam J,Pollard PJ","Adaptor Proteins,Signal Transducing,Animals,Antioxidants,Cell Hypoxia,Cytoskeletal Proteins,Fumarate Hydratase,Fumarates,Gene Expression Regulation,Neoplastic,Hypoxia-Inducible Factor 1,Kidney Diseases,Cystic,Mice,NF-E2-Related Factor 2,Procollagen-Proline Dioxygenase,Signal Transduction,Succinates|Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid|Aconitate Hydratase,Animals,Cell Line,Cysteine,Fumarate Hydratase,Fumarates,Humans,Iron,Kidney Neoplasms,Leiomyomatosis,Mice,Transgenic,Mitochondria,Neoplastic Syndromes,Hereditary,Proteome,Skin Neoplasms,Succinic Acid,Uterine Neoplasms"
clme0485,cschof,11,0.8674293260031798,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Medicinal Chemistry|Nature|Nature|Angewandte Chemie International Edition|Chemical Science|Nature|Journal of Biological Chemistry|ChemBioChem: a European journal of chemical biology|Journal of Medicinal Chemistry|Biochemical and Biophysical Research Communications|Journal of Biological Chemistry,07/01/2016|11/05/2014|01/01/2012|12/01/2012|01/08/2013|01/10/2014|05/05/2014|22/06/2012|25/06/2012|21/04/2011|13/09/2011,"8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.|Ribosomal oxygenases are structurally conserved from prokaryotes to humans.|A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.|Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylases.|5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation|Kruidenier et al. reply.|Human UTY(KDM6C) is a male-specific Nϵ-methyl lysyl demethylase.|Development and application of a fluoride-detection-based fluorescence assay for γ-butyrobetaine hydroxylase.|Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.|Crystal structure of PHYHD1A, a 2OG oxygenase related to phytanoyl-CoA hydroxylase.|Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family.","Bavetsias V,Lanigan RM,Ruda GF,Atrash B,McLaughlin MG,Tumber A,Mok NY,Le Bihan YV,Dempster S,Boxall KJ,Jeganathan F,Hatch SB,Savitsky P,Velupillai S,Krojer T,England KS,Sejberg J,Thai C,Donovan A,Pal A,Scozzafava G,Bennett JM,Kawamura A,Johansson C,Szykowska A,Gileadi C,Burgess-Brown NA,von Delft F,Oppermann U,Walters Z,Shipley J,Raynaud FI,Westaway SM,Prinjha RK,Fedorov O,Burke R,Schofield CJ,Westwood IM,Bountra C,Müller S,van Montfort RL,Brennan PE,Blagg J|Chowdhury R,Sekirnik R,Brissett NC,Krojer T,Ho CH,Ng SS,Clifton IJ,Ge W,Kershaw NJ,Fox GC,Muniz JR,Vollmar M,Phillips C,Pilka ES,Kavanagh KL,von Delft F,Oppermann U,McDonough MA,Doherty AJ,Schofield CJ|Kruidenier L,Chung C-W,Cheng Z,Liddle J,Che K,Joberty G,Bantscheff M,Bountra C,Bridges A,Diallo H,Eberhard D,Hutchinson S,Jones E,Katso R,Leveridge M,Mander PK,Mosley J,Ramirez-Molina C,Rowland P,Schofield CJ,Sheppard RJ,Smith JE,Swales C,Tanner R,Thomas P,Tumber A,Drewes G,Oppermann U,Patel DJ,Lee K,Wilson DM|Woon EC,Tumber A,Kawamura A,Hillringhaus L,Ge W,Rose NR,Ma JH,Chan MC,Walport LJ,Che KH,Ng SS,Marsden BD,Oppermann U,McDonough MA,Schofield CJ|Hopkinson RJ,Tumber A,Yapp C,Chowdhury R,Aik W,Che KH,Li XS,Kristensen JBL,King ONF,Chan MC,Yeoh KK,Choi H,Walport LJ,Thinnes CC,Bush JT,Lejeune C,Rydzik AM,Rose NR,Bagg EA,McDonough MA,Krojer TJ,Yue WW,Ng SS,Olsen L,Brennan PE,Oppermann U,Müller S,Klose RJ,Ratcliffe PJ,Schofield CJ,Kawamura A|Kruidenier L,Chung CW,Cheng Z,Liddle J,Che K,Joberty G,Bantscheff M,Bountra C,Bridges A,Diallo H,Eberhard D,Hutchinson S,Jones E,Katso R,Leveridge M,Mander PK,Mosley J,Ramirez-Molina C,Rowland P,Schofield CJ,Sheppard RJ,Smith JE,Swales C,Tanner R,Thomas P,Tumber A,Drewes G,Oppermann U,Patel DJ,Lee K,Wilson DM|Walport LJ,Hopkinson RJ,Vollmar M,Madden SK,Gileadi C,Oppermann U,Schofield CJ,Johansson C|Rydzik AM,Leung IK,Kochan GT,Thalhammer A,Oppermann U,Claridge TD,Schofield CJ|Rose NR,Woon EC,Tumber A,Walport LJ,Chowdhury R,Li XS,King ON,Lejeune C,Ng SS,Krojer T,Chan MC,Rydzik AM,Hopkinson RJ,Che KH,Daniel M,Strain-Damerell C,Gileadi C,Kochan G,Leung IK,Dunford J,Yeoh KK,Ratcliffe PJ,Burgess-Brown N,von Delft F,Muller S,Marsden B,Brennan PE,McDonough MA,Oppermann U,Klose RJ,Schofield CJ,Kawamura A|Zhang Z,Kochan GT,Ng SS,Kavanagh KL,Oppermann U,Schofield CJ,McDonough MA|Hillringhaus L,Yue WW,Rose NR,Ng SS,Gileadi C,Loenarz C,Bello SH,Bray JE,Schofield CJ,Oppermann U","|Ribosomes,Prokaryotic Cells,Humans,Oxygenases,Sequence Alignment,Phylogeny,Amino Acid Sequence,Catalytic Domain,Conserved Sequence,Protein Structure,Tertiary,Protein Folding,Models,Molecular,Eukaryota|Amino Acid Sequence,Animals,Biocatalysis,Catalytic Domain,Cells,Cultured,Enzyme Inhibitors,Evolution,Molecular,Histones,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Lysine,Macrophages,Methylation,Mice,Models,Substrate Specificity,Tumor Necrosis Factor-alpha|Binding Sites,Cross-Linking Reagents,Humans,Jumonji Domain-Containing Histone Demethylases,Ketoglutaric Acids,Models,Molecular,Molecular Structure,Structure-Activity Relationship,Substrate Specificity||Macrophages,Animals,Humans,Enzyme Inhibitors,Jumonji Domain-Containing Histone Demethylases|Humans,Lysine,Nuclear Proteins,Histones,Crystallography,X-Ray,Sequence Alignment,Species Specificity,Amino Acid Sequence,Protein Structure,Tertiary,Methylation,Models,Molecular,Molecular Sequence Data,Male|Biocatalysis,Fluorescence,Fluorides,Humans,Hydrocarbons,Fluorinated,Magnetic Resonance Spectroscopy,Molecular Structure,Protons,gamma-Butyrobetaine Dioxygenase|Enzyme Inhibitors,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Plant Growth Regulators,Protein Conformation,Substrate Specificity,Succinates|Crystallography,X-Ray,Humans,Iron,Mixed Function Oxygenases,Oxygenases,Phosphorylation,Protein Processing,Post-Translational,Protein Structure,Secondary|Animals,Crystallography,X-Ray,Evolution,Molecular,Humans,Jumonji Domain-Containing Histone Demethylases,Mutagenesis,Structural Homology,Protein,Structure-Activity Relationship"
clph0059,raob0095,1,0.14285714285714285,Journal article,Journal of National Cancer Institute,09/10/2013,Selective permeabilization of the blood-brain barrier at sites of metastasis.,"Connell JJ,Chatain G,Cornelissen B,Vallis KA,Hamilton A,Seymour L,Anthony DC,Sibson NR","Analysis of Variance,Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Blood-Brain Barrier,Brain,Brain Neoplasms,Breast Neoplasms,Contrast Media,Disease Models,Animal,Drug Administration Schedule,Female,Gadolinium DTPA,Gene Expression Regulation,Neoplastic,Humans,Immunohistochemistry,Lymphotoxin-alpha,Magnetic Resonance Imaging,Mice,Inbred BALB C,Permeability,Receptors,Tumor Necrosis Factor,Type I,Tomography,Emission-Computed,Single-Photon,X-Ray Computed,Trastuzumab,Tumor Necrosis Factor-alpha"
immd0452,raob0097,1,0.1111111111111111,Journal article,Nature Cell Biology,14/09/2014,RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2.,"Pefani DE,Latusek R,Pires I,Grawenda AM,Yee KS,Hamilton G,van der Weyden L,Esashi F,Hammond EM,O'Neill E","Cells,Cultured,Cell Line,Tumor,Animals,Mice,Knockout,Humans,Chromosome Aberrations,Protein-Serine-Threonine Kinases,Tumor Suppressor Proteins,BRCA2 Protein,Microscopy,Confocal,Blotting,Western,Comet Assay,Signal Transduction,DNA Repair,DNA Replication,RNA Interference,Protein Binding,Phosphorylation,Models,Genetic,Rad51 Recombinase,Cyclin-Dependent Kinase 2,DNA Breaks,Double-Stranded,Ataxia Telangiectasia Mutated Proteins"
clme0439,olin0014,1,0.05,Journal article,Cancer Cell,13/05/2013,Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
raob0096,raob0121,1,0.08333333333333333,Journal article,Oncotarget,08/07/2014,AKT regulates NPM dependent ARF localization and p53mut stability in tumors.,"Hamilton G,Abraham AG,Morton J,Sampson O,Pefani DE,Khoronenkova S,Grawenda A,Papaspyropoulos A,Jamieson N,McKay C,Sansom O,Dianov GL,O'Neill E","Animals,Mice,Inbred BALB C,Humans,Nude,Pancreatic Neoplasms,Nuclear Proteins,Transfection,Phosphorylation,Mutation,Female,Tumor Suppressor Protein p53,Tumor Suppressor Protein p14ARF,Oncogene Protein v-akt,Proto-Oncogene Proteins c-mdm2,Phosphatidylinositol 3-Kinases"
clme0149,zool0768,1,0.16666666666666666,Journal article,Retrovirology,,Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency.,"Hurst T,Pace M,Katzourakis A,Phillips R,Klenerman P,Frater J,Magiorkinis G",
clab0025,path0041,1,0.0625,Journal article,Journal of Biological Chemistry,21/01/2013,Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.,"Whiteman P,de Madrid BH,Taylor P,Li D,Heslop R,Viticheep N,Tan JZ,Shimizu H,Callaghan J,Masiero M,Li JL,Banham AH,Harris AL,Lea SM,Redfield C,Baron M,Handford PA","Amino Acid Sequence,Animals,Antibodies,Monoclonal,Blotting,Western,Calcium-Binding Proteins,Cell Line,Tumor,Drosophila Proteins,Flow Cytometry,HEK293 Cells,Humans,Intercellular Signaling Peptides and Proteins,Ligands,Membrane Proteins,Mice,Models,Molecular,Molecular Sequence Data,Mutation,Protein Binding,Protein Structure,Secondary,Tertiary,Receptor,Notch1,Receptors,Notch,Sequence Homology,Amino Acid"
corp0784,stat0004,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0975,immd0180,7,0.5892063492063492,Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article,Cancer Research|Oncotarget|Journal of Clinical Oncology|Cancer Research|Annals of Oncology|Frontiers in Oncology|Clinical Cancer Research,28/08/2014||20/05/2011|01/10/2014|26/10/2012||,"Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.|IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide.|Phase I study of OSI-906, dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) in combination with erlotinib (E) in patients with advanced solid tumors.|Inhibition of type 1 insulin-like growth factor receptor (IGF-1R) influences processing of replication-associated DNA double-strand breaks (DSBs) and induces schedule-dependent sensitization of human melanoma to temozolomide (TMZ)|Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors.|Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR.|Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors.","Gao S,Bajrami I,Verrill C,Kigozi A,Ouaret D,Aleksic T,Asher R,Han C,Allen P,Bailey D,Feller S,Kashima T,Athanasou N,Blay JY,Schmitz S,Machiels JP,Upile N,Jones TM,Thalmann G,Ashraf SQ,Wilding JL,Bodmer WF,Middleton MR,Ashworth A,Lord CJ,Macaulay VM|Ramcharan R,Aleksic T,Kamdoum WP,Gao S,Pfister SX,Tanner J,Bridges E,Asher R,Watson AJ,Margison GP,Woodcock M,Repapi E,Li JL,Middleton MR,Macaulay VM|Macaulay VM,Middleton MR,Eckhardt SG,Juergens RA,Rudin CM,Manukyants A,Gogov S,Poondru S,Gedrich R,Gadgeel SM|Ramcharan RN,Aleksic T,Gao S,Tanner J,Darvill N,Bridges E,Asher R,Watson AJ,Margison GP,Repapi E,Li J-L,Middleton MR,Macaulay VM|Macaulay VM,Middleton MR,Protheroe AS,Tolcher A,Dieras V,Sessa C,Bahleda R,Blay JY,LoRusso P,Mery-Mignard D,Soria JC|Aleksic T,Browning L,Woodward M,Phillips R,Page S,Henderson S,Athanasou N,Ansorge O,Whitwell D,Pratap S,Hassan AB,Middleton MR,Macaulay VM|Macaulay VM,Middleton MR,Eckhardt SG,Rudin CM,Juergens RA,Gedrich R,Gogov S,McCarthy S,Poondru S,Stephens AW,Gadgeel SM","Cell Line,Tumor,Animals,Humans,Mice,Carcinoma,Squamous Cell,Head and Neck Neoplasms,Isoxazoles,Pyrimidines,ras Proteins,Receptor,IGF Type 1,Insulin-Like Growth Factor I,Adaptor Proteins,Signal Transducing,Phosphoproteins,Antineoplastic Agents,Xenograft Model Antitumor Assays,Inhibitory Concentration 50,MAP Kinase Signaling System,Gene Expression,Drug Resistance,Neoplasm,Male,Wnt Proteins||||Adult,Aged,Antibodies,Monoclonal,Humanized,Antineoplastic Combined Chemotherapy Protocols,Deoxycytidine,Diarrhea,Doxorubicin,Erlotinib Hydrochloride,Female,Humans,Leiomyosarcoma,Male,Melanoma,Middle Aged,Quinazolines,Receptor,IGF Type 1,Skin Neoplasms,Soft Tissue Neoplasms,Taxoids,Treatment Outcome||"
immd0024,immd0082,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clab0127,clme0485,2,0.6111111111111112,Journal article|Journal article,Oncogene|Proceedings of the National Academy of Sciences of USA,12/08/2013|21/07/2014,Pleiotropic effect of somatic mutations in the E2F subunit DP-1 gene in human cancer.|Lysine methylation-dependent binding of 53BP1 to the pRb tumor suppressor.,"Munro S,Oppermann U,La Thangue NB|Carr SM,Munro S,Zalmas LP,Fedorov O,Johansson C,Krojer T,Sagum CA,Bedford MT,Oppermann U,La Thangue NB","Amino Acid Sequence,Apoptosis,Cell Line,Tumor,E2F1 Transcription Factor,Genetic Pleiotropy,Humans,Models,Molecular,Molecular Sequence Data,Mutation,Phosphoproteins,Protein Multimerization,Protein Structure,Quaternary,Protein Subunits,Retinoblastoma Protein,Transcription Factor DP1|Animals,Binding Sites,Cell Aging,Cell Line,Tumor,Chromatin,Chromosomal Proteins,Non-Histone,DNA Repair,DNA-Binding Proteins,Humans,Intracellular Signaling Peptides and Proteins,Lysine,Methylation,Mice,Models,Molecular,Peptides,Protein Binding,Protein Structure,Tertiary,Retinoblastoma Protein"
lina0435,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
kenn0163,molb0002,2,0.3666666666666667,Journal article|Journal article,PLoS Computational Biology|Blood,01/08/2011|11/04/2013,Boltzmann energy-based image analysis demonstrates that extracellular domain size differences explain protein segregation at immune synapses.|The large ectodomains of CD45 and CD148 regulate their segregation from and inhibition of ligated T-cell receptor.,"Burroughs NJ,Köhler K,Miloserdov V,Dustin ML,van der Merwe PA,Davis DM|Cordoba SP,Choudhuri K,Zhang H,Bridge M,Basat AB,Dustin ML,van der Merwe PA","Cell Communication,Cell Line,Transformed,Computational Biology,Computer Simulation,Extracellular Space,Humans,Image Processing,Computer-Assisted,Immunological Synapses,Intercellular Adhesion Molecule-1,Killer Cells,Natural,Kinetics,Membrane Proteins,Particle Size,Pattern Recognition,Automated,Poisson Distribution,Protein Structure,Tertiary,T-Lymphocytes,Thermodynamics|Animals,Antigens,CD45,CD4-Positive T-Lymphocytes,CD8-Positive T-Lymphocytes,Cell Line,Interleukin-2,Lymphocyte Activation,Mice,Models,Chemical,Mutagenesis,Protein Binding,Protein Structure,Tertiary,Receptor-Like Protein Tyrosine Phosphatases,Class 3,Receptors,Antigen,T-Cell,Signal Transduction,Structure-Activity Relationship"
ndos0168,orms0061,1,0.1,Journal article,Nature Reviews Drug Discovery,01/03/2015,Preclinical target validation using patient-derived cells.,"Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
raob0095,raob0202,2,0.18181818181818182,Journal article|Conference paper,"Cell Death and Disease|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",01/01/2012|01/05/2013,Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation,"Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB","Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|"
immd0316,olin0014,1,0.08333333333333333,Journal article,Current Biology,26/02/2015,"Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.","Vlahov N,Scrace S,Soto MS,Grawenda AM,Bradley L,Pankova D,Papaspyropoulos A,Yee KS,Buffa F,Goding CR,Timpson P,Sibson N,O'Neill E",
clme0240,clme0621,1,0.14285714285714285,Journal article,The Journal of Physiology,01/01/2012,Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: Insights from genetically modified mice,"Chen RL,Nagel S,Papadakis M,Bishop T,Pollard P,Ratcliffe PJ,Pugh CW,Buchan AM","Animals,Body Temperature Regulation,Body Weight,Brain Ischemia,Cerebral Arteries,Cerebral Cortex,Gene Expression Regulation,Genotype,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Knockout,Procollagen-Proline Dioxygenase,Protein Isoforms"
bioc0801,bioc0804,1,0.07142857142857142,Journal article,eLife,15/12/2012,KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.,"Farcas AM,Blackledge NP,Sudbery I,Long HK,McGouran JF,Rose NR,Lee S,Sims D,Cerase A,Sheahan TW,Koseki H,Brockdorff N,Ponting CP,Kessler BM,Klose RJ","Chicken,Chromatin,CpG island,Demethylase,Epigenetics,Human,Methylation,Mouse,Transcription,Xenopus,Zebrafish,Animals,Cell Line,Tumor,CpG Islands,DNA Methylation,F-Box Proteins,Gene Silencing,Genome,Histones,Humans,Jumonji Domain-Containing Histone Demethylases,Mice,Polycomb-Group Proteins,Ubiquitination"
clme0220,darby,1,0.03125,Journal article,Journal of the National Cancer Institute Monographs,01/05/2015,"International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).","Amoroso V,Generali D,Buchholz T,Cristofanilli M,Pedersini R,Curigliano G,Daidone MG,Di Cosimo S,Dowsett M,Fox S,Harris AL,Makris A,Vassalli L,Ravelli A,Cappelletti MR,Hatzis C,Hudis CA,Pedrazzoli P,Sapino A,Semiglazov V,Von Minckwitz G,Simoncini EL,Jacobs MA,Barry P,Kühn T,Darby S,Hermelink K,Symmans F,Gennari A,Schiavon G,Dogliotti L,Berruti A,Bottini A","Humans,Breast Neoplasms,Neoplasm,Residual,Receptor,erbB-2,Antineoplastic Combined Chemotherapy Protocols,Sentinel Lymph Node Biopsy,Prognosis,Chemotherapy,Adjuvant,Neoadjuvant Therapy,Remission Induction,Consensus,International Cooperation,Expert Testimony,Outcome Assessment (Health Care),Female,Molecular Targeted Therapy"
clme0667,raob0072,2,0.19285714285714284,Journal article|Journal article,Clinical Cancer Research|Carcinogenesis,09/02/2016|03/09/2012,Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.|Homologous recombination mediates S-phase-dependent radioresistance in cells deficient in DNA polymerase eta.,"Hill EJ,Roberts C,Franklin JM,Enescu M,West N,MacGregor TP,Chu KY,Boyle L,Blesing C,Wang LM,Mukherjee S,Anderson EM,Brown G,Dutton S,Love SB,Schnabel JA,Quirke P,Muschel R,McKenna WG,Partridge M,Sharma RA|Nicolay NH,Carter R,Hatch SB,Schultz N,Prevo R,McKenna WG,Helleday T,Sharma RA","|Apoptosis,Blotting,Western,Cell Proliferation,Cells,Cultured,DNA Damage,DNA Repair,DNA-Binding Proteins,DNA-Directed DNA Polymerase,Fibroblasts,Flow Cytometry,Gamma Rays,Homologous Recombination,Humans,Neoplasms,Nucleic Acid Synthesis Inhibitors,RNA,Small Interfering,Radiation Tolerance,S Phase,Tumor Stem Cell Assay"
raob0069,raob0202,2,0.18181818181818182,Journal article|Conference paper,"Cell Death and Disease|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",01/01/2012|01/05/2013,Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation,"Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB","Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|"
clme1037,clme1358,5,0.18733834299872035,Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Medicinal Chemistry|Science Advances|Cancer Research|Nature Chemical Biology|Proceedings of the National Academy of Sciences of USA,07/01/2016|01/11/2015||21/07/2015|18/11/2013,"8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.|Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.|Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.|The promise and peril of chemical probes.|RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.","Bavetsias V,Lanigan RM,Ruda GF,Atrash B,McLaughlin MG,Tumber A,Mok NY,Le Bihan YV,Dempster S,Boxall KJ,Jeganathan F,Hatch SB,Savitsky P,Velupillai S,Krojer T,England KS,Sejberg J,Thai C,Donovan A,Pal A,Scozzafava G,Bennett JM,Kawamura A,Johansson C,Szykowska A,Gileadi C,Burgess-Brown NA,von Delft F,Oppermann U,Walters Z,Shipley J,Raynaud FI,Westaway SM,Prinjha RK,Fedorov O,Burke R,Schofield CJ,Westwood IM,Bountra C,Müller S,van Montfort RL,Brennan PE,Blagg J|Fedorov O,Castex J,Tallant C,Owen DR,Martin S,Aldeghi M,Monteiro O,Filippakopoulos P,Picaud S,Trzupek JD,Gerstenberger BS,Bountra C,Willmann D,Wells C,Philpott M,Rogers C,Biggin PC,Brennan PE,Bunnage ME,Schüle R,Günther T,Knapp S,Müller S|Picaud S,Fedorov O,Thanasopoulou A,Leonards K,Jones K,Meier J,Olzscha H,Monteiro O,Martin S,Philpott M,Tumber A,Filippakopoulos P,Yapp C,Wells C,Che KH,Bannister A,Robson S,Kumar U,Parr N,Lee K,Lugo D,Jeffrey P,Taylor S,Vecellio ML,Bountra C,Brennan PE,O'Mahony A,Velichko S,Müller S,Hay D,Daniels DL,Urh M,La Thangue NB,Kouzarides T,Prinjha R,Schwaller J,Knapp S|Arrowsmith CH,Audia JE,Austin C,Baell J,Bennett J,Blagg J,Bountra C,Brennan PE,Brown PJ,Bunnage ME,Buser-Doepner C,Campbell RM,Carter AJ,Cohen P,Copeland RA,Cravatt B,Dahlin JL,Dhanak D,Edwards AM,Frederiksen M,Frye SV,Gray N,Grimshaw CE,Hepworth D,Howe T,Huber KV,Jin J,Knapp S,Kotz JD,Kruger RG,Lowe D,Mader MM,Marsden B,Mueller-Fahrnow A,Müller S,O'Hagan RC,Overington JP,Owen DR,Rosenberg SH,Roth B,Ross R,Schapira M,Schreiber SL,Shoichet B,Sundström M,Superti-Furga G,Taunton J,Toledo-Sherman L,Walpole C,Walters MA,Willson TM,Workman P,Young RN,Zuercher WJ|Picaud S,Wells C,Felletar I,Brotherton D,Martin S,Savitsky P,Diez-Dacal B,Philpott M,Bountra C,Lingard H,Fedorov O,Müller S,Brennan PE,Knapp S,Filippakopoulos P","||Cell Line,Tumor,Animals,Humans,Mice,Oxazepines,Doxorubicin,Antineoplastic Combined Chemotherapy Protocols,Enzyme Inhibitors,Xenograft Model Antitumor Assays,Amino Acid Sequence,Protein Structure,Tertiary,Drug Synergism,Models,Molecular,Molecular Sequence Data,p300-CBP Transcription Factors,Leukemia,Myeloid,Acute|Humans,Molecular Probes,Sensitivity and Specificity,Information Dissemination,Molecular Weight,Biomedical Research,Intellectual Property,Internet,Small Molecule Libraries|ApoA1,epigenetics,microarray,small molecule inhibitor,Crystallization,Fluorescence Recovery After Photobleaching,Hep G2 Cells,Humans,Models,Molecular,Molecular Structure,Oligonucleotide Array Sequence Analysis,Protein Binding,Protein Structure,Tertiary,Quinazolines,Transcription Factors"
clab0025,immd0031,3,0.4458333333333333,Journal article|Journal article|Journal article,Frontiers in Oncology|Journal of Biological Chemistry|Cancer Cell,01/01/2014|21/01/2013|17/07/2013,The notch ligand JAGGED1 as a target for anti-tumor therapy.|Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.|A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.,"Li D,Masiero M,Banham AH,Harris AL|Whiteman P,de Madrid BH,Taylor P,Li D,Heslop R,Viticheep N,Tan JZ,Shimizu H,Callaghan J,Masiero M,Li JL,Banham AH,Harris AL,Lea SM,Redfield C,Baron M,Handford PA|Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM","|Amino Acid Sequence,Animals,Antibodies,Monoclonal,Blotting,Western,Calcium-Binding Proteins,Cell Line,Tumor,Drosophila Proteins,Flow Cytometry,HEK293 Cells,Humans,Intercellular Signaling Peptides and Proteins,Ligands,Membrane Proteins,Mice,Models,Molecular,Molecular Sequence Data,Mutation,Protein Binding,Protein Structure,Secondary,Tertiary,Receptor,Notch1,Receptors,Notch,Sequence Homology,Amino Acid|Animals,Cell Growth Processes,Endothelial Cells,Female,Genetic Predisposition to Disease,HCT116 Cells,Humans,Mice,Nude,Neoplasms,Neovascularization,Pathologic,Receptors,G-Protein-Coupled,Signal Transduction"
bioc0929,bioc0929,1,0.5,Journal article,Cellular and Molecular Life Sciences,,Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway.,"Lopez-Martinez D,Liang CC,Cohn MA",
clme0220,cschof,1,0.125,Journal article,PLoS One,01/01/2014,Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.,"Snell CE,Turley H,McIntyre A,Li D,Masiero M,Schofield CJ,Gatter KC,Harris AL,Pezzella F","Animals,Binding Sites,Breast Neoplasms,Cell Line,Tumor,Female,Gene Expression Regulation,Neoplastic,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,Kaplan-Meier Estimate,MCF-7 Cells,Mice,Inbred BALB C,Neoplasm Transplantation,Neoplasms,Procollagen-Proline Dioxygenase,Prognosis,Proline,Up-Regulation"
bioc0192,card0025,7,0.5236434317316669,Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper,Circulation: Cardiovascular Imaging|Circulation: Cardiovascular Imaging|Heart|Journal of Cardiovascular Magnetic Resonance|Heart|Heart|Circulation,29/03/2011|01/01/2011|01/06/2014|21/10/2011|01/05/2013|01/06/2011|22/11/2011,"Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index.|Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index|121 High Diagnostic Yield in Patients Presenting with Acute Chest Pain, Positive Troponins but non-obstructive Coronaries by Cardiovascular Magnetic Resonance imaging with Conventional and Novel T1 Mapping Techniques.|Multimodal cardiovascular magnetic resonance quantifies regional variation in vascular structure and function in patients with coronary artery disease: relationships with coronary disease severity.|THE USEFULNESS OF EARLY CARDIOVASCULAR MAGNETIC RESONANCE IN PATIENTS PRESENTING WITH ACUTE CHEST PAIN, POSITIVE TROPONIN AND NON-OBSTRUCTIVE CORONARY ARTERIES|DYNAMIC CHANGES OF OEDEMA AND LATE GADOLINIUM ENHANCEMENT AFTER ACUTE MYOCARDIAL INFARCTION AND THEIR RELATIONSHIP TO FUNCTIONAL RECOVERY AND SALVAGE INDEX|CMR T1 Mapping at 3T Characterizes the Extent of Acute Ischemic Myocardial Injury: Comparison to Standard Techniques","Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Banning A,Kardos A,Newton J,Friedrich M,Robson M,Neubauer S|Kylintireas I,Shirodaria C,Lee JM,Cunningon C,Lindsay A,Francis J,Robson MD,Neubauer S,Channon KM,Choudhury RP|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Banning A,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Kardos A,Basagiannia C,Newton J,Friedrich M,Robson M,Neubauer S|Dall'Armellina E,Karia N,Lindsay A,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast B,Banning AP,Channon K,Kharbanda RJ,Neubauer S,Choudhury RP|Dall'Armellina E,Piechnik S,Ferreira V,Karamitsos TD,Francis JM,Cuculi F,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Robson MD,Choudhury RP,Neubauer S","Angioplasty,Balloon,Coronary,Contrast Media,Edema,Cardiac,Female,Gadolinium,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Myocardial Infarction,Myocardium,Recovery of Function,Ventricular Function|||Aged,Analysis of Variance,Aorta,Aortic Diseases,Atherosclerosis,Brachial Artery,Carotid Arteries,Carotid Artery Diseases,Chi-Square Distribution,Compliance,Coronary Angiography,Coronary Artery Disease,England,Female,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Multivariate Analysis,Predictive Value of Tests,Severity of Illness Index,Vasodilation|||Myocardial infarction,STEMI,NSTEMI,Cardiac MRI"
bioc0541,raob0047,4,0.5,Journal article|Journal article|Journal article|Journal article,Neuroimage|Neuroimage|Neuroimage|Neuroimage,01/07/2014|15/07/2013|05/03/2013|01/01/2014,"Corrigendum to Systemic inflammation alters central 5-HT function as determined by pharmacological MRI [Neuroimage 75 (2013) 177-186]|Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.|Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.|Systemic inflammation alters central 5-HT function as determined by pharmacological MRI (vol 75, pg 177, 2013)","Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC|Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC|Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC|Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC","||Animals,Autoradiography,Brain,Brain Chemistry,Chromatography,High Pressure Liquid,Fenfluramine,Fluorobenzenes,Image Processing,Computer-Assisted,Inflammation,Laser-Doppler Flowmetry,Magnetic Resonance Imaging,Male,Microdialysis,Piperidines,Rats,Sprague-Dawley,Serotonin,Serotonin Antagonists,Serotonin Uptake Inhibitors|"
path0084,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
bioc0929,immd0499,1,0.1111111111111111,Journal article,Molecular Cell,05/11/2015,The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription.,"Schwab RA,Nieminuszczy J,Shah F,Langton J,Lopez Martinez D,Liang CC,Cohn MA,Gibbons RJ,Deans AJ,Niedzwiedz W","Hela Cells,Animals,Mice,Knockout,Humans,Leukemia,DNA Damage,Genomic Instability,DNA Helicases,Nucleic Acid Heteroduplexes,DNA Replication,Mutation,Fanconi Anemia Complementation Group Proteins"
raob0095,raob0128,2,0.26785714285714285,Journal article|Journal article,Cancer Research|Journal of Nuclear Medicine,17/05/2011|07/10/2011,"Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.|Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality.","Cornelissen B,Kersemans V,Darbar S,Thompson J,Shah K,Sleeth K,Hill MA,Vallis KA|Kersemans V,Thompson J,Cornelissen B,Woodcock M,Allen PD,Buls N,Muschel RJ,Hill MA,Smart SC","Amino Acid Sequence,Animals,Antibodies,Breast Neoplasms,Carbocyanines,Cell Line,Tumor,DNA Damage,DNA,Neoplasm,Female,Gene Products,tat,Histones,Humans,Immunoconjugates,Indium Radioisotopes,Mice,Inbred BALB C,Nude,Molecular Sequence Data,Pentetic Acid,Transplantation,Heterologous|Animals,DNA Breaks,Double-Stranded,Histones,Jejunum,Liver,Mice,Positron-Emission Tomography,Quality Control,Radiation Dosage,Radiation Injuries,Experimental,Reference Standards,Time Factors,Tomography,Emission-Computed,Single-Photon,X-Ray Microtomography"
raob0058,raob0087,1,0.09090909090909091,Journal article,PLoS One,01/01/2011,"Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.","Kersemans V,Cornelissen B,Hueting R,Tredwell M,Hussien K,Allen PD,Falzone N,Hill SA,Dilworth JR,Gouverneur V,Muschel RJ,Smart SC","Adenocarcinoma,Anesthesia,Animals,Anoxia,Copper Radioisotopes,Female,Fluorine Radioisotopes,Gases,Mice,Inbred CBA,Misonidazole,Muscles,Neoplasms,Experimental,Organometallic Compounds,Organotechnetium Compounds,Oxygen,Positron-Emission Tomography,Radiation-Sensitizing Agents,Radiopharmaceuticals,Thiosemicarbazones,Tissue Distribution,Tomography,Emission-Computed,Single-Photon"
gree0989,gree1499,8,1.3313492063492063,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Growth Hormone and IGF Research|Gut|Public Health Nutrition|British Journal of Cancer|Growth Hormone and IGF Research|American Journal of Clinical Nutrition|Circulation|Annals of Oncology,01/01/2015|02/01/2014|01/06/2011|27/03/2014|15/01/2015|01/03/2015|12/03/2013|11/07/2014,"The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women|Source of dietary fibre and diverticular disease incidence: a prospective study of UK women.|Development and evaluation of the Oxford WebQ, a low-cost, web-based method for assessment of previous 24 h dietary intakes in large-scale prospective studies.|Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom.|The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women.|Tea and coffee and risk of endometrial cancer: cohort study and meta-analysis.|Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study.|Birth weight and adult cancer incidence: large prospective study and meta-analysis.","Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Crowe FL,Balkwill A,Cairns BJ,Appleby PN,Green J,Reeves GK,Key TJ,Beral V,Million Women Study Collaborators,Million Women Study Collaborators|Liu B,Young H,Crowe FL,Benson VS,Spencer EA,Key TJ,Appleby PN,Beral V|Bradbury KE,Balkwill A,Spencer EA,Roddam AW,Reeves GK,Green J,Key TJ,Beral V,Pirie K|Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Yang TO,Crowe F,Cairns BJ,Reeves GK,Beral V|Sweetland S,Parkin L,Balkwill A,Green J,Reeves G,Beral V,Million Women Study Collaborators|Yang TO,Reeves GK,Green J,Beral V,Cairns BJ","|diet,dietary fibre,diverticular disease,prospective,Aged,Diet Surveys,Dietary Fiber,Diverticulitis,Diverticulum,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Intestinal Diseases,Middle Aged,Prospective Studies,Risk,Surveys and Questionnaires|Adult,Aged,80 and over,Diet,Diet Records,Dietary Fats,Dietary Proteins,Energy Intake,Female,Great Britain,Humans,Internet,Interviews as Topic,Male,Micronutrients,Middle Aged,Nutrition Assessment,Prospective Studies,Reproducibility of Results,Surveys and Questionnaires,Young Adult|Million Women Study Collaborators,Humans,Neoplasms,Lymphoma,Non-Hodgkin,Sarcoma,Breast Neoplasms,Incidence,Prospective Studies,Middle Aged,Great Britain,Female,Self Report,Food,Organic|Million Women Study Collaborators,Humans,Birth Weight,Insulin-Like Growth Factor I,Body Weights and Measures,Postnatal Care,Diet,Risk Factors,Cohort Studies,Life Style,Breast Feeding,Postmenopause,Aged,Middle Aged,Great Britain,Female,Surveys and Questionnaires|Humans,Endometrial Neoplasms,Proportional Hazards Models,Risk,Cohort Studies,Prospective Studies,Coffee,Tea,Female,Evidence-Based Practice|Cohort Studies,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Middle Aged,Postoperative Complications,Prospective Studies,Retrospective Studies,Risk Factors,Smoking,Venous Thromboembolism|Million Women Study Collaborators,Humans,Neoplasms,Birth Weight,Body Height,Risk Factors,Prospective Studies,Middle Aged,Female"
clab0127,raob0097,2,0.25,Journal article|Journal article,Oncogene|Oncogene,01/01/2011|30/05/2011,Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α|Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α.,"Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB|Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB","|Base Sequence,Cell Hypoxia,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Molecular Sequence Data,Nuclear Proteins,Promoter Regions,Genetic,Trans-Activators"
clme0621,immd0237,1,0.14285714285714285,Journal article,The Journal of Physiology,01/01/2012,Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: Insights from genetically modified mice,"Chen RL,Nagel S,Papadakis M,Bishop T,Pollard P,Ratcliffe PJ,Pugh CW,Buchan AM","Animals,Body Temperature Regulation,Body Weight,Brain Ischemia,Cerebral Arteries,Cerebral Cortex,Gene Expression Regulation,Genotype,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Knockout,Procollagen-Proline Dioxygenase,Protein Isoforms"
clab0127,raob0233,2,0.13574660633484165,Conference paper|Journal article,Cancer Research|Cancer Cell,01/01/2016|,WEE1 inhibition selectively kills histone H3K36me3-deficient cancers by dNTP starvation|Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.,"Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Zalmas L-P,Orlando G,Drobnitzky N,Dianov G,Ying S,La Thangue NB,D'Angiolella V,Ryan A,Humphrey TC|Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Orlando G,Mavrommati I,Pai CC,Zalmas LP,Drobnitzky N,Dianov GL,Verrill C,Macaulay VM,Ying S,La Thangue NB,D'Angiolella V,Ryan AJ,Humphrey TC","|Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Neoplasms,Pyrazoles,Pyrimidines,Ribonucleoside Diphosphate Reductase,Histone-Lysine N-Methyltransferase,Nucleotides,Lysine,Cell Cycle Proteins,Nuclear Proteins,Histones,Blotting,Western,Xenograft Model Antitumor Assays,Reverse Transcriptase Polymerase Chain Reaction,Cell Survival,Gene Expression Regulation,Neoplastic,RNA Interference,Amino Acid Sequence,Base Sequence,Sequence Homology,Amino Acid,Nucleic Acid,Methylation,Molecular Sequence Data,Protein-Tyrosine Kinases"
clme0731,phpc0084,2,0.2,Journal article|Journal article,Clinical Infectious Diseases|Journal of Infectious Diseases,01/03/2011|29/03/2012,A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults.|Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells.,"Lazarus R,Clutterbuck E,Yu LM,Bowman J,Bateman EA,Diggle L,Angus B,Peto TE,Beverley PC,Mant D,Pollard AJ|Clutterbuck EA,Lazarus R,Yu LM,Bowman J,Bateman EA,Diggle L,Angus B,Peto TE,Beverley PC,Mant D,Pollard AJ","Aged,Antibodies,Bacterial,Female,Heptavalent Pneumococcal Conjugate Vaccine,Humans,Immunization Schedule,Immunization,Secondary,Injections,Intramuscular,Male,Middle Aged,Pneumococcal Vaccines,Vaccination|Aged,B-Lymphocyte Subsets,B-Lymphocytes,Heptavalent Pneumococcal Conjugate Vaccine,Humans,Immunization,Secondary,Immunologic Memory,Leukocytes,Mononuclear,Middle Aged,Pneumococcal Vaccines,Streptococcus pneumoniae,Vaccines,Conjugate"
gree1024,gree1499,2,0.1,Journal article|Other,Diabetologia|Diabetologia,10/08/2012|18/10/2012,Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.|Erratum to: Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.,"Stevens RJ,Ali R,Bankhead CR,Bethel MA,Cairns BJ,Camisasca RP,Crowe FL,Farmer AJ,Harrison S,Hirst JA,Home P,Kahn SE,McLellan JH,Perera R,Plüddemann A,Ramachandran A,Roberts NW,Rose PW,Schweizer A,Viberti G,Holman RR|Stevens RJ,Ali R,Bankhead CR,Bethel MA,Cairns BJ,Camisasca RP,Crowe FL,Farmer AJ,Harrison S,Hirst JA,Home P,Kahn SE,McLellan JH,Perera R,Plüddemann A,Ramachandran A,Roberts NW,Rose PW,Schweizer A,Viberti G,Holman RR","Adult,Aged,Diabetes Complications,Diabetes Mellitus,Female,Follow-Up Studies,Humans,Hypoglycemic Agents,Male,Metformin,Middle Aged,Neoplasms,Randomized Controlled Trials as Topic,Risk Factors,Survival Rate|"
immd0316,whgu0378,1,0.05263157894736842,Journal article,Nature Communications,,Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.,"Findlay JM,Castro-Giner F,Makino S,Rayner E,Kartsonaki C,Cross W,Kovac M,Ulahannan D,Palles C,Gillies RS,MacGregor TP,Church D,Maynard ND,Buffa F,Cazier JB,Graham TA,Wang LM,Sharma RA,Middleton M,Tomlinson I",
clme0667,gree1620,4,0.6666666666666666,Journal article|Journal article|Journal article|Conference paper,Oncotarget|Cancer Treatment Reviews|Radiation Oncology|European Journal of Cancer,28/02/2015|03/01/2015|27/03/2012|01/09/2013,"Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen.|Drug radiotherapy combinations: review of previous failures and reasons for future optimism.|NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity.|High throughput screening for genetic determinants of radiosensitivity","Tiwana GS,Prevo R,Buffa FM,Yu S,Ebner DV,Howarth A,Folkes LK,Budwal B,Chu KY,Durrant L,Muschel RJ,McKenna WG,Higgins GS|Higgins GS,O'Cathail SM,Muschel RJ,McKenna WG|Fokas E,Yoshimura M,Prevo R,Higgins G,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|McKenna WG,Tiwana GS,Prevo R,Budwal B,Ebner D,Howarth A,Chu KY,Durrant L,Higgins GS","Cell Line,Tumor,HCT116 Cells,Hela Cells,Humans,Neoplasms,DNA Damage,Pyrithiamine,Thiamin Pyrophosphokinase,Thiamine,Radiation-Sensitizing Agents,Colony-Forming Units Assay,Transfection,Radiation Tolerance,High-Throughput Screening Assays|Humans,Neoplasms,Antineoplastic Combined Chemotherapy Protocols,Radiation-Sensitizing Agents,Treatment Failure,Immunotherapy,Combined Modality Therapy,Signal Transduction,Cell Hypoxia,DNA Repair,Clinical Trials as Topic,Molecular Targeted Therapy,Chemoradiotherapy,Adjuvant|Cell Line,Tumor,Endothelial Cells,Human Umbilical Vein Endothelial Cells,Humans,Imidazoles,Phosphatidylinositol 3-Kinases,Quinolines,Radiation-Sensitizing Agents,TOR Serine-Threonine Kinases|"
immd0198,lina0435,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0670,raob0096,4,0.5222222222222221,Journal article|Conference paper|Conference paper|Journal article,Oncotarget|Modern Pathology|Laboratory Investigation|Biochimica et Biophysica Acta: international journal of biochemistry and biophysics,|01/02/2016|01/02/2016|06/12/2014,The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma.|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.,"Wang LM,Silva MA,D'Costa Z,Bockelmann R,Soonawalla Z,Liu S,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Fokas E,O'Neill E,Gordon-Weeks A,Mukherjee S,McKenna WG,Muschel RJ","|||Animals,Humans,Mice,Carcinoma,Pancreatic Ductal,Pancreatic Neoplasms,Cell Transformation,Neoplastic,Disease Models,Animal,Inflammation,Cancer Vaccines,Immunotherapy,Drug Resistance,Neoplasm,Radiation Tolerance,Neoplastic Cells,Circulating"
clme0220,stat0054,1,0.14285714285714285,Conference paper,Cancer Research,15/11/2015,Distinct roles of copy number and loss-of-heterozygosity in predicting prognosis for breast cancer patients,"van Stiphout RGPM,deWeck A,Winchester L,Haider SA,Ragoussis J,Harris AL,Holmes C,Buffa FM",
ndog0251,raob0047,1,0.16666666666666666,Journal article,Nanoscale,08/12/2014,A novel biosensor for quantitative monitoring of on-target activity of paclitaxel.,"Townley HE,Zheng Y,Goldsmith J,Zheng YY,Stratford MR,Dobson PJ,Ahmed AA","Silicon Dioxide,Paclitaxel,Tubulin,Antineoplastic Agents,Phytogenic,Drug Monitoring,Fluorescence Resonance Energy Transfer,Sensitivity and Specificity,Reproducibility of Results,Equipment Design,Equipment Failure Analysis,Biosensing Techniques,Particle Size,Nanocapsules,Nanoconjugates"
clme0149,path0084,1,0.047619047619047616,Journal article,Blood,07/02/2013,Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.,"Cosgrove C,Ussher JE,Rauch A,Gärtner K,Kurioka A,Hühn MH,Adelmann K,Kang YH,Fergusson JR,Simmonds P,Goulder P,Hansen TH,Fox J,Günthard HF,Khanna N,Powrie F,Steel A,Gazzard B,Phillips RE,Frater J,Uhlig H,Klenerman P","Adult,Anti-HIV Agents,Antiretroviral Therapy,Highly Active,Apoptosis,CD8-Positive T-Lymphocytes,Cells,Cultured,Cohort Studies,Escherichia coli,Female,Flow Cytometry,HIV,HIV Infections,Humans,Immunity,Mucosal,Immunohistochemistry,Interleukin-17,Leukocytes,Mononuclear,Lymphocyte Count,Male,Middle Aged,NK Cell Lectin-Like Receptor Subfamily B,Receptors,CCR5,CCR6,T-Lymphocyte Subsets,Time Factors"
raob0087,raob0128,1,0.125,Journal article,Journal of Nuclear Medicine,07/10/2011,"Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality.","Kersemans V,Thompson J,Cornelissen B,Woodcock M,Allen PD,Buls N,Muschel RJ,Hill MA,Smart SC","Animals,DNA Breaks,Double-Stranded,Histones,Jejunum,Liver,Mice,Positron-Emission Tomography,Quality Control,Radiation Dosage,Radiation Injuries,Experimental,Reference Standards,Time Factors,Tomography,Emission-Computed,Single-Photon,X-Ray Microtomography"
raob0189,whgu0378,1,0.06666666666666667,Journal article,Nature Communications,01/01/2014,Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.,"Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC","Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading"
card0025,card0039,27,2.7131232329761743,Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article,"Heart|Circulation: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|Heart|Heart|European Heart Journal|Arteriosclerosis, Thrombosis and Vascular Biology|Circulation|Heart|Circulation|Heart|European Heart Journal|Journal of the American College of Cardiology|European Heart Journal|International Journal of Cardiology|International Journal of Cardiology|International Journal of Cardiology|Circulation|Circulation|Circulation|European Heart Journal|Circulation: Cardiovascular Imaging|Arteriosclerosis, Thrombosis and Vascular Biology|Circulation|Circulation|Circulation|International Journal of Cardiology",01/08/2013|01/01/2011|21/10/2011|01/05/2013|01/06/2011|01/08/2013|01/01/2012|04/06/2013|12/02/2013|07/02/2012|01/06/2014|01/09/2014|04/11/2014|17/10/2013|15/07/2012|01/01/2013|30/09/2013|26/11/2013|26/11/2013|01/01/2012|01/08/2012|29/03/2011|12/04/2012|07/05/2014|22/11/2011|01/01/2012|08/04/2013,"Relationship of plasma neuropeptide y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction|Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index|Multimodal cardiovascular magnetic resonance quantifies regional variation in vascular structure and function in patients with coronary artery disease: relationships with coronary disease severity.|THE USEFULNESS OF EARLY CARDIOVASCULAR MAGNETIC RESONANCE IN PATIENTS PRESENTING WITH ACUTE CHEST PAIN, POSITIVE TROPONIN AND NON-OBSTRUCTIVE CORONARY ARTERIES|DYNAMIC CHANGES OF OEDEMA AND LATE GADOLINIUM ENHANCEMENT AFTER ACUTE MYOCARDIAL INFARCTION AND THEIR RELATIONSHIP TO FUNCTIONAL RECOVERY AND SALVAGE INDEX|Determination of myocardial injury in relation to angiographic lesions, in acute coronary syndromes: a prospective serial CMR study|A leukocyte-mimetic magnetic resonance imaging contrast agent homes rapidly to activated endothelium and tracks with atherosclerotic lesion macrophage content|Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels.|Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.|Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease.|121 High Diagnostic Yield in Patients Presenting with Acute Chest Pain, Positive Troponins but non-obstructive Coronaries by Cardiovascular Magnetic Resonance imaging with Conventional and Novel T1 Mapping Techniques.|Acute myocardial infarction results in a monocyte genomic response that is conserved between humans and mice|Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction.|Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction.|Heparin administration leads to rapid decrease in plasma matrix metalloproteinase-9.|Heparin administration leads to rapid decrease in plasma matrix metalloproteinase-9|Artifactual elevation of plasma sCD40L by residual platelets in patients with coronary artery disease|The Monocyte Genomic Response is Conserved Between Mice and Humans Following Acute Myocardial Infarction|Integrated Plaque and Plasma Proteo-Lipidomics Reveal Novel Signatures of Coronary Atherosclerotic Plaque Disruption|Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease|Plaque morphology on optical coherence tomography determines biomarker response after stent-induced plaque rupture|Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index.|A leukocyte-mimetic magnetic resonance imaging contrast agent homes rapidly to activated endothelium and tracks with atherosclerotic lesion macrophage content.|Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection.|CMR T1 Mapping at 3T Characterizes the Extent of Acute Ischemic Myocardial Injury: Comparison to Standard Techniques|Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease|Artifactual elevation of plasma sCD40L by residual platelets in patients with coronary artery disease.","Cuculi F,Herring N,De Caterina AR,Banning AP,Prendergast BD,Forfar JC,Choudhury RP,Channon KM,Kharbanda RK|Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Kylintireas I,Shirodaria C,Lee JM,Cunningon C,Lindsay A,Francis J,Robson MD,Neubauer S,Channon KM,Choudhury RP|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Banning A,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Kardos A,Basagiannia C,Newton J,Friedrich M,Robson M,Neubauer S|Dall'Armellina E,Karia N,Lindsay A,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast B,Banning AP,Channon K,Kharbanda RJ,Neubauer S,Choudhury RP|Dall'armellina E,Adlam D,Ruparelia N,Kharbanda RK,Prendergast BP,Forfar JC,Banning AP,Neubauer S,Channon K,Choudhury R|McAteer MA,Mankia K,Ruparelia N,Jefferson A,Nugent HB,Stork LA,Channon KM,Schneider JE,Choudhury RP|Margaritis M,Antonopoulos AS,Digby J,Lee R,Reilly S,Coutinho P,Shirodaria C,Sayeed R,Petrou M,De Silva R,Jalilzadeh S,Demosthenous M,Bakogiannis C,Tousoulis D,Stefanadis C,Choudhury RP,Casadei B,Channon KM,Antoniades C|Cuculi F,Herring N,De Caterina AR,Banning AP,Prendergast BD,Forfar JC,Choudhury RP,Channon KM,Kharbanda RK|Cunnington C,Van Assche T,Shirodaria C,Kylintireas I,Lindsay AC,Lee JM,Antoniades C,Margaritis M,Lee R,Cerrato R,Crabtree MJ,Francis JM,Sayeed R,Ratnatunga C,Pillai R,Choudhury RP,Neubauer S,Channon KM|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Banning A,Kardos A,Newton J,Friedrich M,Robson M,Neubauer S|Ruparelia N,Lee R,Forfar JC,Prendergast BD,Kharbanda RK,Banning AP,Lygate CA,Channon KM,Haining WN,Choudhury RP|Cuculi F,De Maria GL,Meier P,Dall'Armellina E,de Caterina AR,Channon KM,Prendergast BD,Choudhury RP,Forfar JC,Kharbanda RK,Banning AP|Cuculi F,Dall'Armellina E,Manlhiot C,De Caterina AR,Colyer S,Ferreira V,Morovat A,Prendergast BD,Forfar JC,Alp NJ,Choudhury RP,Neubauer S,Channon KM,Banning AP,Kharbanda RK|Lee R,Adlam D,Antoniades C,Digby JE,Kharbanda RK,Choudhury RP,Channon KM|Lee R,Adlam D,Antoniades C,Digby JE,Kharbanda RK,Choudhury RP,Channon KM|Lee R,Antonopoulos AS,Alexopoulou Z,Margaritis M,Kharbanda RK,Choudhury RP,Antoniades C,Channon KM|Ruparelia N,Lee R,Dall'Armellina E,Godec J,Medway D,Forfar C,Prendergast B,Kharbanda RK,Banning AP,Neubauer S,Lygate CA,Channon KM,Haining WN,Choudhury RP|Lee R,Adlam D,Fischer R,Di Gleria K,Valli A,Charles P,McGouran J,Ruparelia N,Dawkins S,Kharbanda RK,Choudhury RP,Antoniades C,Kessler BM,Channon KM|Cunnington C,Van Assche T,Shirodaria C,Kylintireas I,Lindsay AC,Lee JM,Antoniades C,Margaritis M,Lee R,Cerrato R,Crabtree MJ,Francis JM,Sayeed R,Ratnatunga C,Pillai R,Choudhury RP,Neubauer S,Channon KM|Lee R,Adlam D,Antoniades C,Kharbanda RK,Choudhury RP,Channon KM|Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|McAteer MA,Mankia K,Ruparelia N,Jefferson A,Nugent HB,Stork LA,Channon KM,Schneider JE,Choudhury RP|Fan LM,Douglas G,Bendall JK,McNeill E,Crabtree MJ,Hale AB,Mai A,Li JM,McAteer MA,Schneider JE,Choudhury RP,Channon KM|Dall'Armellina E,Piechnik S,Ferreira V,Karamitsos TD,Francis JM,Cuculi F,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Robson MD,Choudhury RP,Neubauer S|Cunnington C,Van Assche T,Shirodaria C,Kylintireas I,Lindsay AC,Lee JM,Antoniades C,Margaritis M,Lee R,Cerrato R,Crabtree MJ,Francis JM,Sayeed R,Ratnatunga C,Pillai R,Choudhury RP,Neubauer S,Channon KM|Lee R,Antonopoulos AS,Alexopoulou Z,Margaritis M,Kharbanda RK,Choudhury RP,Antoniades C,Channon KM","||Aged,Analysis of Variance,Aorta,Aortic Diseases,Atherosclerosis,Brachial Artery,Carotid Arteries,Carotid Artery Diseases,Chi-Square Distribution,Compliance,Coronary Angiography,Coronary Artery Disease,England,Female,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Multivariate Analysis,Predictive Value of Tests,Severity of Illness Index,Vasodilation|||||5,6,7,8-tetrahydrobiopterin,adiponectin,atherosclerosis,endothelium,nitric oxide synthase type III,superoxides,Adiponectin,Adipose Tissue,Aged,Aldehydes,Coronary Artery Bypass,Coronary Artery Disease,Female,Gene Expression,Humans,Male,Mammary Arteries,Nitric Oxide,Nitric Oxide Synthase Type III,Oxidation-Reduction,Oxidative Stress,PPAR gamma,Saphenous Vein,Superoxides,Vasodilation|Aged,Analysis of Variance,Biomarkers,Chi-Square Distribution,Coronary Angiography,Coronary Circulation,Electrocardiography,England,Enzyme-Linked Immunosorbent Assay,Female,Hospitals,University,Humans,Male,Microcirculation,Middle Aged,Myocardial Infarction,Neuropeptide Y,No-Reflow Phenomenon,Percutaneous Coronary Intervention,Predictive Value of Tests,Prospective Studies,Risk Factors,Stents,Time Factors,Treatment Outcome,Vascular Resistance|Administration,Oral,Aged,Biopterin,Coronary Artery Disease,Double-Blind Method,Endothelium,Vascular,Female,Humans,Male,Oxidation-Reduction,Treatment Outcome|||Coronary Vessels,Microcirculation,Humans,Myocardial Infarction,Magnetic Resonance Imaging,Cine,Coronary Angiography,Electrocardiography,Prognosis,Follow-Up Studies,Prospective Studies,Recovery of Function,Vascular Resistance,Coronary Circulation,Regional Blood Flow,Middle Aged,Female,Male,Coronary Occlusion|Angioplasty,Blood flow,Magnetic resonance imaging,Microcirculation,Myocardial infarction,Coronary Circulation,Coronary Occlusion,Coronary Vessels,Endothelin-1,Female,Hemorrhage,Humans,Magnetic Resonance Angiography,Male,Microvessels,Middle Aged,Myocardial Infarction,Percutaneous Coronary Intervention,Prospective Studies,Recovery of Function,Stroke Volume,Vascular Resistance|Heparin,Humans,Matrix Metalloproteinase 9,Time Factors|||Genomics,Myocardial infarction,Gene expression,Leukocytes|Plaque rupture,Proteomics,Lipids,Extracellular matrix|||Angioplasty,Balloon,Coronary,Contrast Media,Edema,Cardiac,Female,Gadolinium,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Myocardial Infarction,Myocardium,Recovery of Function,Ventricular Function|Animals,Antibodies,Antibody Affinity,Aorta,Aortic Diseases,Apolipoproteins E,Atherosclerosis,Binding Sites,Antibody,Biomimetic Materials,Contrast Media,Disease Models,Animal,Disease Progression,Endothelium,Vascular,Female,Ferric Compounds,Flow Cytometry,Humans,Immunohistochemistry,Leukocytes,Ligands,Macrophages,Magnetic Resonance Imaging,Mice,Inbred C57BL,Knockout,P-Selectin,Particle Size,Spectroscopy,Near-Infrared,Time Factors,Vascular Cell Adhesion Molecule-1|Muscle,Smooth,Vascular,Endothelium,Animals,Mice,Inbred C57BL,Transgenic,Aneurysm,Dissecting,Aortic Aneurysm,Disease Models,Animal,Disease Susceptibility,Reactive Oxygen Species,Matrix Metalloproteinases,Cyclophilins,NADPH Oxidase,Angiotensin II,Membrane Glycoproteins,Vascular Cell Adhesion Molecule-1,Signal Transduction,Male|Myocardial infarction,STEMI,NSTEMI,Cardiac MRI||Cardiovascular disease,Platelets,Pre-analytic,Soluble CD40 ligand,Adult,Aged,Artifacts,Biomarkers,Blood Platelets,CD40 Ligand,Coronary Artery Disease,Female,Humans,Male,Middle Aged,Platelet Activation"
raob0047,raob0061,4,3.0833333333333335,Journal article|Journal article|Journal article|Journal article,Journal of Pharmaceutical and Biomedical Analysis|Journal of Pharmaceutical and Biomedical Analysis|Clinical Cancer Research|Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences,24/12/2011|01/01/2012|10/01/2012|01/09/2011,"A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation.|A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation|Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors.|Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection.","Stratford MR,Folkes LK|Stratford MRL,Folkes LK|Patterson DM,Zweifel M,Middleton MR,Price PM,Folkes LK,Stratford MR,Ross P,Halford S,Peters J,Balkissoon J,Chaplin DJ,Padhani AR,Rustin GJ|Stratford MR,Folkes LK","Chromatography,High Pressure Liquid,Glucuronides,Hydrogen-Ion Concentration,Isomerism,Limit of Detection,Metals,Heavy,Oxidation-Reduction,Spectrometry,Fluorescence,Stilbenes||Adult,Aged,Angiogenesis Inhibitors,Antineoplastic Agents,Diphosphates,Female,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Neoplasms,Stilbenes,Treatment Outcome,Young Adult|Animals,Antineoplastic Agents,Chromatography,High Pressure Liquid,Diphosphates,Humans,Linear Models,Mice,Reproducibility of Results,Sensitivity and Specificity,Spectrometry,Fluorescence,Stilbenes"
clme0667,raob0270,4,0.28644688644688643,Journal article|Journal article|Journal article|Conference paper,British Journal of Cancer|Radiotherapy and Oncology|British Journal of Cancer|Journal of Clinical Oncology,19/07/2011||01/01/2011|20/05/2015,"Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.|ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.|Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers|ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)-Mechanism and clinical outcomes.","Harrington KJ,Billingham LJ,Brunner TB,Burnet NG,Chan CS,Hoskin P,Mackay RI,Maughan TS,Macdougall J,McKenna WG,Nutting CM,Oliver A,Plummer R,Stratford IJ,Illidge T|Wilson JM,Fokas E,Dutton SJ,Patel N,Hawkins MA,Eccles C,Chu KY,Durrant L,Abraham AG,Partridge M,Woodward M,O'Neill E,Maughan T,McKenna WG,Mukherjee S,Brunner TB|Harrington KJ,Billingham LJ,Brunner TB,Burnet NG,Chan CS,Hoskin P,MacKay RI,Maughan TS,MacDougall J,McKenna WG,Nutting CM,Oliver A,Plummer R,Stratford IJ,Illidge T|Wilson JM,Dutton SJ,Hackett SL,Durrant L,Chu K-Y,Eccles C,Abraham AG,O'Neill E,Partridge M,Hawkins MA,McKenna WG,Maughan T,Brunner TB,Mukherjee S","Algorithms,Clinical Trials as Topic,Drug Evaluation,Preclinical,Drugs,Investigational,Humans,Models,Biological,Neoplasms,Practice Guidelines as Topic,Radiation-Sensitizing Agents|||"
card0027,stat0054,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clne0102,wadh1179,2,0.10476190476190475,Journal article|Journal article,BMC Psychiatry|Neuroimage,30/05/2014|01/01/2011,"Study protocol: The Whitehall II imaging sub-study.|Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner","Filippini N,Zsoldos E,Haapakoski R,Sexton CE,Mahmood A,Allan CL,Topiwala A,Valkanova V,Brunner EJ,Shipley MJ,Auerbach E,Moeller S,Uğurbil K,Xu J,Yacoub E,Andersson J,Bijsterbosch J,Clare S,Griffanti L,Hess AT,Jenkinson M,Miller KL,Salimi-Khorshidi G,Sotiropoulos SN,Voets NL,Smith SM,Geddes JR,Singh-Manoux A,Mackay CE,Kivimäki M,Ebmeier KP|Miller KL,Stagg CJ,Douaud G,Jbabdi S,Smith SM,Behrens TE,Jenkinson M,Chance SA,Esiri MM,Voets NL,Jenkinson N,Aziz TZ,Turner MR,Johansen-Berg H,McNab JA","Brain,Humans,Magnetic Resonance Imaging,Retrospective Studies,Longitudinal Studies,Cognition,Cognition Disorders,Aging,Adult,Aged,80 and over,Middle Aged,Female,Male,Neuroimaging|Anisotropy,Artifacts,Autopsy,Brain,Brain Mapping,Diffusion Magnetic Resonance Imaging,Humans,Image Interpretation,Computer-Assisted,Tissue Fixation"
immd0024,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
anat0115,clme0220,3,1.0909090909090908,Journal article|Journal article|Journal article,Oncogene|Cell Metabolism|Cell Metabolism,05/10/2015|12/04/2016|,PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer.|Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot.|Amino Acid Sensing by mTORC1: intracellular Transporters Mark the Spot,"Fan SJ,Snell C,Turley H,Li JL,McCormick R,Perera SM,Heublein S,Kazi S,Azad A,Wilson C,Harris AL,Goberdhan DC|Goberdhan DC,Wilson C,Harris AL|Goberdhan DCI,Wilson C,Harris AL",||
immd0024,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0149,molb0002,1,1.0,Journal article,New England Journal of Medicine,06/11/2013,Mutant prolactin receptor and familial hyperprolactinemia,Newey PJ,
path0089,whgu0378,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0198,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0316,whgu0172,1,0.058823529411764705,Journal article,Oncotarget,01/01/2015,Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways.,"Valli A,Rodriguez M,Moutsianas L,Fischer R,Fedele V,Huang HL,Van Stiphout R,Jones D,Mccarthy M,Vinaxia M,Igarashi K,Sato M,Soga T,Buffa F,Mccullagh J,Yanes O,Harris A,Kessler B","Cell Line,Tumor,HCT116 Cells,Humans,Colorectal Neoplasms,Acetyl-CoA Carboxylase,Acetyl-CoA C-Acyltransferase,Lipids,Fatty Acids,Platelet Activating Factor,Blotting,Western,Proteomics,Genomics,Signal Transduction,Cell Hypoxia,RNA Interference,Aged,Middle Aged,Female,Male,Lipid Metabolism,Basic Helix-Loop-Helix Transcription Factors,Hypoxia-Inducible Factor 1,alpha Subunit,Metabolomics"
ocms0064,univ1923,1,0.047619047619047616,Journal article,Molecular Cell,30/01/2014,Optimal translational termination requires C4 lysyl hydroxylation of eRF1.,"Yamamoto A,Feng T,Wilkins S,Sokolova E,Yates L,Muenzel M,Singh P,Hopkinson R,Fischer R,Cockman M,Shelley J,Trudgian D,Schoedel J,McCullagh JO,Ge W,Kessler B,Gilbert R,Frolova L,Alkalaeva E,Ratcliffe P,Schofield C,Coleman M","Amino Acid Sequence,Animals,Catalysis,Cell Line,Tumor,Codon,Terminator,Gene Expression Regulation,HeLa Cells,Histone Demethylases,Humans,Hydrolysis,Hydroxylation,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Peptide Chain Termination,Translational,Peptide Termination Factors,Protein Biosynthesis,Protein Processing,Post-Translational,Protein Structure,Tertiary,Sequence Homology,Amino Acid"
stat0054,whgu0378,7,0.5085059744161626,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Nature Genetics|Nature Communications|American Journal of Gastroenterology|Haematologica: the hematology journal|PLoS One|Nature Genetics|American Journal of Gastroenterology,18/05/2015|01/01/2014|17/09/2013|11/07/2014|01/01/2012|23/12/2012|01/11/2013,"Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.|Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations|Erythrocytosis associated with a novel missense mutation in the BPGM gene.|A novel test for gene-ancestry interactions in genome-wide association data.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.|Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations","Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC|Mouradov D,Gibbs P,Jorissen RN,Lipton L,Sieber OM,Tomlinson IP,Domingo E,Li S,Soo PY,Desai J,Danielsen HE,Oukrif D,Novelli M,Yau C,Holmes CC,Jones IT,McLaughlin S,Molloy P,Hawkins NJ,Ward R,Midgely R,Kerr D|Petousi N,Copley RR,Lappin TR,Haggan SE,Bento CM,Cario H,Percy MJ,Ratcliffe PJ,Robbins PA,McMullin MF|Davies JL,Cazier JB,Dunlop MG,Houlston RS,Tomlinson IP,Holmes CC|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I|Mouradov D,Domingo E,Gibbs P,Jorissen RN,Li S,Soo PY,Lipton L,Desai J,Danielsen HE,Oukrif D,Novelli M,Yau C,Holmes CC,Jones IT,McLaughlin S,Molloy P,Hawkins NJ,Ward R,Midgely R,Kerr D,Tomlinson IP,Sieber OM","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading||WGS Consortium,Humans,Polycythemia,Bisphosphoglycerate Mutase,Genotype,Mutation,Missense|Colorectal Neoplasms,Cytochrome b Group,European Continental Ancestry Group,Genetic Predisposition to Disease,Genome-Wide Association Study,Genotype,Humans,Oxidoreductases,Phenotype|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA|"
clme0670,raob0072,1,0.05,Journal article,Clinical Cancer Research,09/02/2016,Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.,"Hill EJ,Roberts C,Franklin JM,Enescu M,West N,MacGregor TP,Chu KY,Boyle L,Blesing C,Wang LM,Mukherjee S,Anderson EM,Brown G,Dutton S,Love SB,Schnabel JA,Quirke P,Muschel R,McKenna WG,Partridge M,Sharma RA",
dpag0074,ocms0037,3,0.5833333333333333,Journal article|Journal article|Journal article,Genome Biology and Evolution|Nature Communications|Cell Reports,08/03/2012|01/01/2014|11/07/2013,"Identification and properties of 1,119 candidate lincRNA loci in the Drosophila melanogaster genome.|Understanding functional miRNA-target interactions in vivo by site-specific genome engineering.|Highly Efficient Targeted Mutagenesis of Drosophila with the CRISPR/Cas9 System","Young RS,Marques AC,Tibbit C,Haerty W,Bassett AR,Liu JL,Ponting CP|Bassett AR,Azzam G,Wheatley L,Tibbit C,Rajakumar T,McGowan S,Stanger N,Ewels PA,Taylor S,Ponting CP,Liu JL,Sauka-Spengler T,Fulga TA|Bassett AR,Tibbit C,Ponting CP,Liu JL","Animals,Drosophila melanogaster,Evolution,Molecular,Female,Genome,Insect,Male,Mice,Molecular Sequence Annotation,RNA,Untranslated|Animals,Zebrafish,Humans,Drosophila,Deoxyribonucleases,Endonucleases,DNA-Binding Proteins,MicroRNAs,Transfection,Genetic Engineering,Sequence Analysis,Base Sequence,Response Elements,Molecular Sequence Data,Transcriptional Activation,HEK293 Cells,Clustered Regularly Interspaced Short Palindromic Repeats|"
raob0231,raob0270,2,0.13392857142857142,Journal article|Journal article,Lancet Oncology|Lancet Oncology,05/03/2013|01/06/2013,"Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.|Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.","Mukherjee S,Hurt CN,Bridgewater J,Falk S,Cummins S,Wasan H,Crosby T,Jephcott C,Roy R,Radhakrishna G,McDonald A,Ray R,Joseph G,Staffurth J,Abrams RA,Griffiths G,Maughan T|Crosby T,Hurt CN,Falk S,Gollins S,Mukherjee S,Staffurth J,Ray R,Bashir N,Bridgewater JA,Geh JI,Cunningham D,Blazeby J,Roy R,Maughan T,Griffiths G","Adult,Aged,Antineoplastic Agents,Capecitabine,Deoxycytidine,Disease-Free Survival,Drug-Related Side Effects and Adverse Reactions,Female,Fluorouracil,Humans,Kaplan-Meier Estimate,Male,Middle Aged,Pancreatic Neoplasms,Treatment Outcome|Adenocarcinoma,Adult,Aged,80 and over,Antibodies,Monoclonal,Humanized,Antineoplastic Combined Chemotherapy Protocols,Capecitabine,Carcinoma,Squamous Cell,Cetuximab,Chemoradiotherapy,Cisplatin,Deoxycytidine,Esophageal Neoplasms,Female,Fluorouracil,Follow-Up Studies,Humans,Male,Middle Aged,Neoplasm Staging,Prognosis,Survival Rate"
immd0316,immd0423,2,0.25396825396825395,Journal article|Journal article,Oncogene|Oncogene,|28/11/2011,Igf2 ligand depedency of Pten(+/-) developmental and tumour phenotypes in the mouse.|Igf2 ligand dependency of Pten(+/-) developmental and tumour phenotypes in the mouse.,"Church DN,Phillips BR,Stuckey DJ,Barnes DJ,Buffa FM,Manek S,Clarke K,Hassan AB|Church DN,Phillips BR,Stuckey DJ,Barnes DJ,Buffa FM,Manek S,Clarke K,Harris AL,Carter EJ,Hassan AB","|Animals,Carcinoma,Cardiomegaly,Cell Line,Tumor,Cell Proliferation,Cell Transformation,Neoplastic,Female,Humans,Insulin-Like Growth Factor II,Longevity,Male,Mammary Neoplasms,Animal,Mice,Inbred C57BL,PTEN Phosphohydrolase,Placenta,Pregnancy,Sex Factors"
bioc0212,robbins,3,0.33333333333333337,Journal article|Journal article|Conference paper,"Proceedings of the National Academy of Sciences of USA|American Journal of Physiology: Regulatory, Integrative and Comparative Physiology|American Journal of Hematology",10/03/2015|01/06/2011|01/05/2013,Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function.|Endurance exercise training blunts the deleterious effect of high-fat feeding on whole body efficiency.|EXPLORING THE EFFECTS OF IRON DEFICIENCY ON SKELETAL MUSCLE METABOLISM AND FUNCTION,"Lakhal-Littleton S,Wolna M,Carr CA,Miller JJ,Christian HC,Ball V,Santos A,Diaz R,Biggs D,Stillion R,Holdship P,Larner F,Tyler DJ,Clarke K,Davies B,Robbins PA|Edwards LM,Holloway CJ,Murray AJ,Knight NS,Carter EE,Kemp GJ,Thompson CH,Tyler DJ,Neubauer S,Robbins PA,Clarke K|Curtis MK,Cochlin LE,Cole MA,Dodd MS,Tyler DJ,Clarke K,Robbins PA","Heart,Animals,Mice,Inbred C57BL,Knockout,Iron,Cation Transport Proteins,Homeostasis|Dietary Fats,Energy Metabolism,Exercise,Fatty Acids,Humans,Male,Mitochondria,Muscle,Physical Endurance,Young Adult|"
card0027,clme0301,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0494,whgu0142,3,0.19548872180451127,Journal article|Journal article|Journal article,Journal of Biological Chemistry|Journal of Biological Chemistry|Proceedings of the National Academy of Sciences of USA,24/01/2013|27/09/2013|11/06/2013,"Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.|Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.|Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states.","Canning P,Cooper CD,Krojer T,Murray JW,Pike AC,Chaikuad A,Keates T,Thangaratnarajah C,Hojzan V,Ayinampudi V,Marsden BD,Gileadi O,Knapp S,von Delft F,Bullock AN|Canning P,Cooper CD,Krojer T,Murray JW,Pike AC,Chaikuad A,Keates T,Thangaratnarajah C,Hojzan V,Ayinampudi V,Marsden BD,Gileadi O,Knapp S,von Delft F,Bullock AN|Shintre CA,Pike AC,Li Q,Kim JI,Barr AJ,Goubin S,Shrestha L,Yang J,Berridge G,Ross J,Stansfeld PJ,Sansom MS,Edwards AM,Bountra C,Marsden BD,von Delft F,Bullock AN,Gileadi O,Burgess-Brown NA,Carpenter EP","Binding Sites,Calorimetry,Carrier Proteins,Crystallography,X-Ray,Cullin Proteins,Dimerization,Humans,Models,Molecular,Molecular Conformation,Phylogeny,Proteasome Endopeptidase Complex,Protein Binding,Protein Conformation,Protein Interaction Mapping,Protein Structure,Secondary,Tertiary,Substrate Specificity,Ubiquitin,Ubiquitin-Protein Ligases||ABC mitochondrial erythroid,X-ray crystallography,cardiolipin,human membrane protein structure,nucleotide complex,ATP-Binding Cassette Transporters,Adenosine Triphosphatases,Adenosine Triphosphate,Amino Acid Sequence,Animals,Binding Sites,Crystallography,X-Ray,Humans,Lipid Bilayers,Models,Molecular,Molecular Conformation,Molecular Dynamics Simulation,Molecular Sequence Data,Mutation,Nucleotides,Phosphatidylcholines,Phosphatidylethanolamines,Protein Binding,Protein Structure,Tertiary,Sequence Homology,Amino Acid,Sf9 Cells"
gree1620,radi0003,1,0.2,Journal article,Thorax,08/09/2015,18F-Misonidazole PET-CT scan detection of occult bone metastasis.,"McGowan DR,Macpherson RE,Bradley KM,Fenwick JD,Gleeson FV,Higgins GS","Humans,Carcinoma,Non-Small-Cell Lung,Bone Neoplasms,Lung Neoplasms,Misonidazole,Radiopharmaceuticals,Diagnosis,Differential,Positron-Emission Tomography,Tomography,X-Ray Computed,Combined Modality Therapy,Aged,Male,Multimodal Imaging"
clme0195,lina0435,1,0.07142857142857142,Journal article,Haematologica: the hematology journal,28/05/2013,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary"
clme0220,immd0316,58,6.469682750282426,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Patent|Journal article|Journal article|Journal article|Journal article|Journal article|Patent|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Conference paper|Journal article|Journal article,Journal of Clinical Investigation|British Journal of Cancer|British Journal of Cancer|British Journal of Cancer|PLoS One|Oncotarget|Cell Reports|Oncogene|Cancer Cell|Cancer Research|Cancer Research|Molecular Cell|Cancer Research|Cell Metabolism|Nature Communications|Oncogene|Asian Pacific Journal of Tropical Disease|Molecular Cancer|Cancer Cell|Oncogene||European Journal of Cancer|British Journal of Cancer|Clinical Cancer Research|Journal of Molecular Medicine|British Journal of Cancer||Cancer Research|Journal of Molecular Medicine|British Journal of Cancer|Proceedings of the National Academy of Sciences of USA|Oncogene|Journal of the National Cancer Institute Monographs|European Journal of Cancer|Genome Medicine: medicine in the post-genomic era|Journal of Clinical Investigation|British Journal of Cancer|Journal of Empirical Research on Human Research Ethics|Cancer Research|Clinical Cancer Research|Oncotarget|International Journal of Radiation: Oncology - Biology - Physics|Nature Medicine|Oncotarget|Annals of Oncology|European Journal of Cancer|British Journal of Cancer|Biochemical Journal|Journal of the National Cancer Institute Monographs|Nature Medicine|European Journal of Cancer|Oncogene|Journal of Enzyme Inhibition and Medicinal Chemistry|Cancer Research|Cancer Research|Journal of Clinical Oncology|Oncogene|Oncotarget,01/01/2012|29/05/2014|04/02/2014|15/03/2011|01/01/2012|22/01/2016|24/09/2014|30/05/2011|12/08/2013|01/08/2015|01/08/2015|01/01/2011|15/12/2013|20/11/2012|01/01/2014|28/11/2011|01/06/2014|01/01/2014|17/07/2013|||01/01/2012|24/12/2013|01/01/2011|01/06/2013|01/01/2014||15/11/2015|30/01/2013|01/01/2011|08/12/2015|01/01/2011|01/05/2015|01/01/2013|01/01/2011|01/01/2012|09/07/2013|01/01/2014|07/07/2011|02/07/2013|01/01/2015|01/12/2015|07/08/2011|21/01/2015|01/05/2011|01/01/2013|18/06/2013|18/10/2012|01/01/2011|01/01/2011|23/01/2013|24/11/2014|27/10/2014|01/05/2015|01/01/2011|20/05/2015|20/08/2015|01/01/2015,"Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression|COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment.|Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression|The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.|Gene expression analysis in human breast cancer associated blood vessels.|Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth.|Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation.|Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α.|A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis|Genomic alterations underlie a pan-cancer metabolic transcriptome shift|Differential regulation of LC3 A and B, GABARAPL 1 and 2 autophagy genes by micro-environmental stress and role in breast cancer survival|MiR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors|Hypoxia metabolism in breast cancer - How to overcome resistance to anti-angiogenic therapy|Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells.|Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.|Igf2 ligand dependency of Pten(+/-) developmental and tumour phenotypes in the mouse.|Functional comparison of Notch ligands in tumour angiogenesis|Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia.|A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.|Igf2 ligand depedency of Pten(+/-) developmental and tumour phenotypes in the mouse.|Knowledge-based proliferation signatures and methods of use|Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma|Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression.|Close and stable relationship between proliferation and a hypoxia metagene in aromatase inhibitor-treated ER-positive breast cancer|Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts|COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment|HYPOXIA TUMOUR MARKERS|Distinct roles of copy number and loss-of-heterozygosity in predicting prognosis for breast cancer patients|Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts.|The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis|Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer.|Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α|Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer Metabolism.|Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma|Gene expression and hypoxia in breast cancer|Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression|Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer|Informed consent, biobank research, and locality: perceptions of breast cancer patients in three European countries.|microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer.|A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.|Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways.|MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer.|Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.|Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer.|METFORMIN'S EFFECTS ON BREAST CANCER LIPID METABOLISM|An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3|Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer.|Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival.|Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles|Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization|An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3.|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival.|Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.|The non-coding transcriptome of hypoxic breast cancer: Novel insights of clinical relevant long non-coding RNA in hypoxia signalling|microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer|Bioinformatic approaches elucidate a high likelyhood of interaction between miR-182 and the pro-apoptotic gene MTCH2 in breast cancers.|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival|Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition.","Yang J,Staples O,Thomas LW,Briston T,Robson M,Poon E,Simões ML,El-Emir E,Buffa FM,Ahmed A,Annear NP,Shukla D,Pedley BR,Maxwell PH,Harris AL,Ashcroft M|Generali D,Buffa FM,Deb S,Cummings M,Reid LE,Taylor M,Andreis D,Allevi G,Ferrero G,Byrne D,Martinotti M,Bottini A,Harris AL,Lakhani SR,Fox SB|Airley RE,McHugh P,Evans AR,Harris B,Winchester L,Buffa FM,Al-Tameemi W,Leek R,Harris AL|Gee HE,Buffa FM,Camps C,Ramachandran A,Leek R,Taylor M,Patil M,Sheldon H,Betts G,Homer J,West C,Ragoussis J,Harris AL|Jones DT,Lechertier T,Mitter R,Herbert JM,Bicknell R,Jones JL,Li JL,Buffa F,Harris AL,Hodivala-Dilke K|Chen L,Zeng X,Kleibeuker E,Buffa F,Barberis A,Leek RD,Roxanis I,Zhang W,Worth A,Beech JS,Harris AL,Cai S|Bensaad K,Favaro E,Lewis CA,Peck B,Lord S,Collins JM,Pinnick KE,Wigfield S,Buffa FM,Li JL,Zhang Q,Wakelam MJ,Karpe F,Schulze A,Harris AL|Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB|Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SYY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM|Haider S,McIntyre A,van Stiphout RGPM,Winchester LM,Wigfield S,Harris AL,Buffa FM|Zois CE,Haider S,Wigfield S,Giatromanolaki A,Sivridis E,Morten K,Roxanis I,Leek R,Buffa F,Koukourakis M,Harris AL|Moskwa P,Buffa FM,Pan Y,Panchakshari R,Gottipati P,Muschel RJ,Beech J,Kulshrestha R,Abdelmohsen K,Weinstock DM,Gorospe M,Harris AL,Helleday T,Chowdhury D|Harris AL,Buffa FM,Haider S,Bensaad K,McIntyre A,Lord S,Mehta S,Choudhry H,Favaro E,Ledaki I,Singleton D|Favaro E,Bensaad K,Chong MG,Tennant DA,Ferguson DJ,Snell C,Steers G,Turley H,Li JL,Günther UL,Buffa FM,McIntyre A,Harris AL|van den Beucken T,Koch E,Chu K,Rupaimoole R,Prickaerts P,Adriaens M,Voncken JW,Harris AL,Buffa FM,Haider S,Starmans MH,Yao CQ,Ivan M,Ivan C,Pecot CV,Boutros PC,Sood AK,Koritzinsky M,Wouters BG|Church DN,Phillips BR,Stuckey DJ,Barnes DJ,Buffa FM,Manek S,Clarke K,Harris AL,Carter EJ,Hassan AB|Oon CE,Bridges E,Sheldon H,Sainson RCA,Jubb A,Turley H,Leek R,Buffa F,Li J-L,Harris AL|Camps C,Saini HK,Mole DR,Choudhry H,Reczko M,Guerra-Assunção JA,Tian YM,Buffa FM,Harris AL,Hatzigeorgiou AG,Enright AJ,Ragoussis J|Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM|Church DN,Phillips BR,Stuckey DJ,Barnes DJ,Buffa FM,Manek S,Clarke K,Hassan AB|Buffa F,Harris A,Krishnan S,Krishnapuram B,Lambin P,Nuyten D,Rao R,Seigneuric R,Starmans M,Steck H,Wouters B|Betts GNJ,Eustace A,Patiar S,Valentine HR,Irlam J,Ramachandran A,Merve A,Homer JJ,Möller-Levet C,Buffa FM,Hall G,Miller CJ,Harris AL,West CML|Airley RE,McHugh P,Evans AR,Harris B,Winchester L,Buffa FM,Al-Tameemi W,Leek R,Harris AL|Ghazoui Z,Buffa FM,Dunbier AK,Anderson H,Dexter T,Detre S,Salter J,Smith IE,Harris AL,Dowsett M|Kumar K,Wigfield S,Gee HE,Devlin CM,Singleton D,Li JL,Buffa F,Huffman M,Sinn AL,Silver J,Turley H,Leek R,Harris AL,Ivan M|Generali D,Buffa FM,Deb S,Cummings M,Reid LE,Taylor M,Andreis D,Allevi G,Ferrero G,Byrne D,Martinotti M,Bottini A,Harris AL,Lakhani SR,Fox SB|Buffa F,West C,Miller C,Harris A|van Stiphout RGPM,deWeck A,Winchester L,Haider SA,Ragoussis J,Harris AL,Holmes C,Buffa FM|Kumar K,Wigfield S,Gee HE,Devlin CM,Singleton D,Li JL,Buffa F,Huffman M,Sinn AL,Silver J,Turley H,Leek R,Harris AL,Ivan M|Gee HE,Buffa FM,Camps C,Ramachandran A,Leek R,Taylor M,Patil M,Sheldon H,Betts G,Homer J,West C,Ragoussis J,Harris AL|Yang J,AlTahan A,Jones DT,Buffa FM,Bridges E,Interiano RB,Qu C,Vogt N,Li JL,Baban D,Ragoussis J,Nicholson R,Davidoff AM,Harris AL|Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB|Lord SR,Patel N,Liu D,Fenwick J,Gleeson F,Buffa F,Harris AL|Betts GNJ,Eustace A,Patiar S,Valentine HR,Irlam J,Ramachandran A,Merve A,Homer JJ,Möller-Levet C,Buffa FM,Hall G,Miller CJ,Harris AL,West CML|Favaro E,Lord S,Harris AL,Buffa FM|Yang J,Staples O,Thomas LW,Briston T,Robson M,Poon E,Simões ML,El-Emir E,Buffa FM,Ahmed A,Annear NP,Shukla D,Pedley BR,Maxwell PH,Harris AL,Ashcroft M|Blick C,Ramachandran A,Wigfield S,McCormick R,Jubb A,Buffa FM,Turley H,Knowles MA,Cranston D,Catto J,Harris AL|Petersen I,Desmedt C,Harris A,Buffa F,Kollek R|Buffa FM,Camps C,Winchester L,Snell CE,Gee HE,Sheldon H,Taylor M,Harris AL,Ragoussis J|Eustace A,Mani N,Span PN,Irlam JJ,Taylor J,Betts GN,Denley H,Miller CJ,Homer JJ,Rojas AM,Hoskin PJ,Buffa FM,Harris AL,Kaanders JH,West CM|Valli A,Rodriguez M,Moutsianas L,Fischer R,Fedele V,Huang HL,Van Stiphout R,Jones D,Mccarthy M,Vinaxia M,Igarashi K,Sato M,Soga T,Buffa F,Mccullagh J,Yanes O,Harris A,Kessler B|Gee HE,Buffa FM,Harris AL,Toohey JM,Carroll SL,Cooper CL,Beith J,McNeil C,Carmalt H,Mak C,Warrier S,Holliday A,Selinger C,Beckers R,Kennedy C,Graham P,Swarbrick A,Millar EK,O'Toole SA,Molloy T|Korpal M,Ell BJ,Buffa FM,Ibrahim T,Blanco MA,Celià-Terrassa T,Mercatali L,Khan Z,Goodarzi H,Hua Y,Wei Y,Hu G,Garcia BA,Ragoussis J,Amadori D,Harris AL,Kang Y|Leung WY,Roxanis I,Sheldon H,Buffa FM,Li JL,Harris AL,Kong A|Lord SR,Collins J,Fielding B,Buffa F,Karpe F,Harris A|Ramachandran A,Betts G,Bhana S,Helme G,Blick C,Moller-Levet C,Saunders E,Valentine H,Pepper S,Miller CJ,Buffa F,Harris AL,West CML|Blick C,Ramachandran A,Wigfield S,McCormick R,Jubb A,Buffa FM,Turley H,Knowles MA,Cranston D,Catto J,Harris AL|Pike LR,Singleton DC,Buffa F,Abramczyk O,Phadwal K,Li JL,Simon AK,Murray JT,Harris AL|Mehta S,Hughes NP,Buffa FM,Li SP,Adams RF,Adwani A,Taylor NJ,Levitt NC,Padhani AR,Makris A,Harris AL|Korpal M,Ell BJ,Buffa FM,Ibrahim T,Blanco MA,Celià-Terrassa T,Mercatali L,Khan Z,Goodarzi H,Hua Y,Wei Y,Hu G,Garcia BA,Ragoussis J,Amadori D,Harris AL,Kang Y|Ramachandran A,Betts G,Bhana S,Helme G,Blick C,Moller-Levet C,Saunders E,Valentine H,Pepper S,Miller CJ,Buffa F,Harris AL,West CM|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR|Pettersen EO,Ebbesen P,Gieling RG,Williams KJ,Dubois L,Lambin P,Ward C,Meehan J,Kunkler IH,Langdon SP,Ree AH,Flatmark K,Lyng H,Calzada MJ,Peso LD,Landazuri MO,Görlach A,Flamm H,Kieninger J,Urban G,Weltin A,Singleton DC,Haider S,Buffa FM,Harris AL,Scozzafava A,Supuran CT,Moser I,Jobst G,Busk M,Toustrup K,Overgaard J,Alsner J,Pouyssegur J,Chiche J,Mazure N,Marchiq I,Parks S,Ahmed A,Ashcroft M,Pastorekova S,Cao Y,Rouschop KM,Wouters BG,Koritzinsky M,Mujcic H,Cojocari D|Choudhry H,Schodel J,Albukhari A,Haider S,Buffa F,Ratcliffe PJ,Mole DR,Ragousis I,Harris AL|Buffa FM,Camps C,Winchester L,Snell CE,Gee HE,Sheldon H,Taylor M,Harris AL,Ragoussis J|Harris BHL,Wigfield S,Harris AL,Buffa FM|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR|Ledaki I,McIntyre A,Wigfield S,Buffa F,McGowan S,Baban D,Li JL,Harris AL","|Humans,Carcinoma,Intraductal,Noninfiltrating,Breast Neoplasms,Neoplasm Recurrence,Local,Sulfonamides,Pyrazoles,Androstadienes,Antineoplastic Combined Chemotherapy Protocols,Aromatase Inhibitors,Prognosis,Neoadjuvant Therapy,Survival Analysis,Cohort Studies,Drug Resistance,Neoplasm,Middle Aged,Female,Cyclooxygenase 2,Cyclooxygenase 2 Inhibitors||Breast Neoplasms,Carcinoma,Squamous Cell,Female,Head and Neck Neoplasms,Humans,MicroRNAs,Neoplasms,Prognosis,RNA,Small Nucleolar|Angiogenesis Inhibitors,Animals,Antibodies,Monoclonal,Humanized,Antigens,CD31,Aorta,Thoracic,Bevacizumab,Breast Neoplasms,Carcinoma,Ductal,Breast,Cell Line,Tumor,Female,Gene Expression Profiling,Humans,Immunohistochemistry,In Vitro Techniques,Mice,Inbred BALB C,Inbred C57BL,SCID,Microscopy,Confocal,Neoplasms,Experimental,Neovascularization,Pathologic,Oligonucleotide Array Sequence Analysis,RNA Interference,Transplantation,Heterologous,Tumor Burden,Vascular Endothelial Growth Factor A||Cell Line,Tumor,Humans,Glioblastoma,Oxygen,Fatty Acids,Cell Proliferation,Cell Hypoxia,Oxidation-Reduction,Lipid Metabolism,Hypoxia-Inducible Factor 1,alpha Subunit|Base Sequence,Cell Hypoxia,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Molecular Sequence Data,Nuclear Proteins,Promoter Regions,Genetic,Trans-Activators||||||Angiogenesis Inhibitors,Animals,Antibodies,Monoclonal,Humanized,Bevacizumab,Breast Neoplasms,Cell Aging,Cell Hypoxia,Cell Line,Tumor,Cell Proliferation,Female,Glucose,Glycogen,Glycogen Phosphorylase,Glycogen Synthase,HCT116 Cells,Humans,MCF-7 Cells,Mice,Nude,RNA Interference,RNA,Small Interfering,Reactive Oxygen Species,Transplantation,Heterologous,Tumor Suppressor Protein p53|Humans,Breast Neoplasms,Ribonuclease III,Prognosis,Cell Hypoxia,Epigenesis,Genetic,Gene Expression Regulation,Neoplastic,Gene Silencing,RNA Processing,Post-Transcriptional,Phenotype,Female,DEAD-box RNA Helicases,Neoplastic Stem Cells,Promoter Regions,Epithelial-Mesenchymal Transition|Animals,Carcinoma,Cardiomegaly,Cell Line,Tumor,Cell Proliferation,Cell Transformation,Neoplastic,Female,Humans,Insulin-Like Growth Factor II,Longevity,Male,Mammary Neoplasms,Animal,Mice,Inbred C57BL,PTEN Phosphohydrolase,Placenta,Pregnancy,Sex Factors||Breast Neoplasms,Cell Hypoxia,Gene Expression Regulation,Neoplastic,Humans,Hypoxia-Inducible Factor 1,MCF-7 Cells,MicroRNAs,Oligonucleotide Array Sequence Analysis,Protein Binding,RNA,Messenger,Real-Time Polymerase Chain Reaction,Transcriptome|Animals,Cell Growth Processes,Endothelial Cells,Female,Genetic Predisposition to Disease,HCT116 Cells,Humans,Mice,Nude,Neoplasms,Neovascularization,Pathologic,Receptors,G-Protein-Coupled,Signal Transduction||||Anoxia,Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,Biomarkers,Tumor,Breast Neoplasms,Disease Progression,Female,Gene Expression Regulation,Neoplastic,Glucose Transporter Type 1,Humans,Immunohistochemistry,MCF-7 Cells,Prognosis||||||Angiogenesis Inhibitors,Animals,Anoxia,Antibodies,Monoclonal,Humanized,Bevacizumab,Cell Line,Tumor,Dichloroacetic Acid,Drug Resistance,Neoplasm,Drug Therapy,Combination,Female,Humans,Mice,SCID,Neoplasms,Tumor Burden,Xenograft Model Antitumor Assays||Humans,Breast Neoplasms,Tamoxifen,Estrogen Receptor Modulators,Estrogen Receptor alpha,Signal Transduction,Transcription,Genetic,Drug Resistance,Neoplasm,Female,Hypoxia-Inducible Factor 1,alpha Subunit||Humans,Breast Neoplasms,Metformin,Hypoglycemic Agents,Chemotherapy,Adjuvant,Neoadjuvant Therapy,Female,Metabolome,Transcriptome,Biomarkers,Tumor|||||Humans,Breast Neoplasms,Attitude,Altruism,Comprehension,Mental Recall,Perception,Confidentiality,Biomedical Research,Privacy,Informed Consent,Patients,Tissue Donors,Biological Specimen Banks,Tissue and Organ Procurement,Belgium,Germany,Great Britain,Female,Surveys and Questionnaires|Breast Neoplasms,Disease Progression,Disease-Free Survival,Female,Gene Expression Profiling,Gene Expression Regulation,Neoplastic,Humans,MicroRNAs,Neoplasm Recurrence,Local,Prognosis,RNA,Messenger|Carbon Dioxide,Cell Hypoxia,Female,Gene Expression Regulation,Neoplastic,Humans,Laryngeal Neoplasms,Male,Niacinamide,Oxygen,Radiation-Sensitizing Agents,Urinary Bladder Neoplasms|Cell Line,Tumor,HCT116 Cells,Humans,Colorectal Neoplasms,Acetyl-CoA Carboxylase,Acetyl-CoA C-Acyltransferase,Lipids,Fatty Acids,Platelet Activating Factor,Blotting,Western,Proteomics,Genomics,Signal Transduction,Cell Hypoxia,RNA Interference,Aged,Middle Aged,Female,Male,Lipid Metabolism,Basic Helix-Loop-Helix Transcription Factors,Hypoxia-Inducible Factor 1,alpha Subunit,Metabolomics|Humans,Breast Neoplasms,Neoplasm Recurrence,Local,DNA Helicases,DNA Topoisomerases,Type II,DNA-Directed DNA Polymerase,S-Phase Kinase-Associated Proteins,DNA-Binding Proteins,Homeodomain Proteins,Nuclear Proteins,MicroRNAs,Antineoplastic Agents,Hormonal,Genetic Markers,Antigens,Neoplasm,Radiotherapy,Adjuvant,Multivariate Analysis,Case-Control Studies,Prospective Studies,Gene Expression Profiling,DNA Repair,Genes,cdc,Radiation Tolerance,Adult,Aged,80 and over,Middle Aged,Female|Animals,Cadherins,Cell Line,Tumor,Female,Gene Expression Profiling,Gene Expression Regulation,Neoplastic,Humans,Mass Spectrometry,Mice,Inbred BALB C,MicroRNAs,Microarray Analysis,Neoplasm Metastasis,Statistics,Nonparametric,Vesicular Transport Proteins|Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Breast Neoplasms,Quinazolines,Receptor,erbB-2,Neuregulin-1,Antineoplastic Combined Chemotherapy Protocols,Random Allocation,Xenograft Model Antitumor Assays,Signal Transduction,Cell Proliferation,Drug Synergism,Drug Resistance,Neoplasm,Female,Antibodies,Monoclonal,Humanized|||Cell Hypoxia,Cell Line,Tumor,Cell Proliferation,Cell Survival,Gene Expression,Gene Expression Regulation,Neoplastic,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,MicroRNAs,Neoplasm Invasiveness,RNA Interference,RNA,Small Interfering,Receptor,Fibroblast Growth Factor,Type 3,Transcription,Genetic,Urinary Bladder Neoplasms|Activating Transcription Factor 4,Animals,Autophagy,Blotting,Western,Breast Neoplasms,Cell Hypoxia,Cell Line,Tumor,Cell Survival,Endoplasmic Reticulum Stress,Female,Gene Expression Regulation,Neoplastic,HCT116 Cells,HT29 Cells,Humans,Intracellular Signaling Peptides and Proteins,MCF-7 Cells,Mice,Multivariate Analysis,Neoplasms,Prognosis,Protein-Serine-Threonine Kinases,RNA Interference,Reverse Transcriptase Polymerase Chain Reaction,Survival Analysis,Transcriptional Activation,Up-Regulation|||Blotting,Western,Caco-2 Cells,Cell Hypoxia,Cell Line,Tumor,Cell Proliferation,Cell Size,Colorectal Neoplasms,Crk-Associated Substrate Protein,Flow Cytometry,Gene Expression Profiling,Gene Expression Regulation,Neoplastic,HCT116 Cells,Head and Neck Neoplasms,Humans,Immunohistochemistry,Introns,Neoplasms,Oligonucleotide Array Sequence Analysis,Organic Anion Transporters,Sodium-Independent,RNA Interference,RNA-Binding Proteins,Response Elements,Reverse Transcriptase Polymerase Chain Reaction,Spheroids,Cellular|Animals,Humans,Mice,Breast Neoplasms,Cell Adhesion Molecules,Receptors,Cell Surface,Apoptosis,Cell Proliferation,Cell Hypoxia,Cell Survival,Female,Basic Helix-Loop-Helix Transcription Factors,Transcriptional Activation,RNA,Long Noncoding|Animals,Humans,Neoplasms,Neoplasm Metastasis,Cell Hypoxia,Molecular Structure,Structure-Activity Relationship,Dose-Response Relationship,Drug,Drug Discovery|||||Cell Line,Tumor,HCT116 Cells,Animals,Mice,Inbred BALB C,Humans,Nude,Isoenzymes,Carbonic Anhydrases,Antigens,Neoplasm,Cell Hypoxia,Enzyme Induction,Female,Male,Neoplastic Stem Cells,Histone Deacetylase Inhibitors,MCF-7 Cells,Heterografts"
immd0082,immd0151,1,0.07142857142857142,Journal article,Journal of Medical Genetics,16/09/2014,De novo and rare inherited mutations implicate the transcriptional coregulator TCF20/SPBP in autism spectrum disorder.,"Babbs C,Lloyd D,Pagnamenta AT,Twigg SR,Green J,McGowan SJ,Mirza G,Naples R,Sharma VP,Volpi EV,Buckle VJ,Wall SA,Knight SJ,Parr JR,Wilkie AO","International Molecular Genetic Study of Autism Consortium (IMGSAC),Chromosomes,Human,Pair 22,Humans,Transcription Factors,In Situ Hybridization,Fluorescence,Sequence Analysis,DNA,Child Development Disorders,Pervasive,Gene Rearrangement,Mutation,Child,Infant,Male,Chromosome Breakpoints"
card0025,clph0059,2,0.3333333333333333,Journal article|Journal article,Gene Therapy (Basingstoke)|Gene Therapy (Basingstoke),01/01/2012|28/07/2011,RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo|RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo.,"Hibbitt O,Agkatsev S,Owen C,Cioroch M,Seymour L,Channon K,Wade-Martins R|Hibbitt O,Agkatsev S,Owen C,Cioroch M,Seymour L,Channon K,Wade-Martins R","|Animals,Cell Line,Cholesterol,LDL,Female,Gene Knockdown Techniques,Genetic Therapy,Humans,Hydroxymethylglutaryl CoA Reductases,Hyperlipoproteinemia Type II,Liver,Mice,MicroRNAs,RNA Interference,Receptors"
clme0220,path0041,1,0.0625,Journal article,Journal of Biological Chemistry,21/01/2013,Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.,"Whiteman P,de Madrid BH,Taylor P,Li D,Heslop R,Viticheep N,Tan JZ,Shimizu H,Callaghan J,Masiero M,Li JL,Banham AH,Harris AL,Lea SM,Redfield C,Baron M,Handford PA","Amino Acid Sequence,Animals,Antibodies,Monoclonal,Blotting,Western,Calcium-Binding Proteins,Cell Line,Tumor,Drosophila Proteins,Flow Cytometry,HEK293 Cells,Humans,Intercellular Signaling Peptides and Proteins,Ligands,Membrane Proteins,Mice,Models,Molecular,Molecular Sequence Data,Mutation,Protein Binding,Protein Structure,Secondary,Tertiary,Receptor,Notch1,Receptors,Notch,Sequence Homology,Amino Acid"
immd0024,immd0556,6,0.29147861594670105,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Cancer Cell|Proceedings of the National Academy of Sciences of USA|Cancer Cell|Cell Reports|Blood|Blood,18/01/2011|08/10/2012|16/06/2014|27/03/2013|27/03/2013|22/11/2012,Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.|Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21.|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.|Impact of isolated germline JAK2V617I mutation on human hematopoiesis.|Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia.,"Goardon N,Marchi E,Atzberger A,Quek L,Schuh A,Soneji S,Woll P,Mead A,Alford KA,Rout R,Chaudhury S,Gilkes A,Knapper S,Beldjord K,Begum S,Rose S,Geddes N,Griffiths M,Standen G,Sternberg A,Cavenagh J,Hunter H,Bowen D,Killick S,Robinson L,Price A,Macintyre E,Virgo P,Burnett A,Craddock C,Enver T,Jacobsen SE,Porcher C,Vyas P|Roy A,Cowan G,Mead AJ,Filippi S,Bohn G,Chaidos A,Tunstall O,Chan JK,Choolani M,Bennett P,Kumar S,Atkinson D,Wyatt-Ashmead J,Hu M,Stumpf MP,Goudevenou K,O'Connor D,Chou ST,Weiss MJ,Karadimitris A,Jacobsen SE,Vyas P,Roberts I|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Mead AJ,Kharazi S,Atkinson D,Macaulay I,Pecquet C,Loughran S,Lutteropp M,Woll P,Chowdhury O,Luc S,Buza-Vidas N,Ferry H,Clark SA,Goardon N,Vyas P,Constantinescu SN,Sitnicka E,Nerlov C,Jacobsen SE|Mead AJ,Chowdhury O,Pecquet C,Dusa A,Woll P,Atkinson D,Burns A,Score J,Rugless M,Clifford R,Moule S,Bienz N,Vyas P,Cross N,Gale RE,Henderson S,Constantinescu SN,Schuh A,Jacobsen SE|Eyre T,Schwab CJ,Kinstrie R,McGuire AK,Strefford J,Peniket A,Mead A,Littlewood T,Holyoake TL,Copland M,Moorman AV,Harrison CJ,Vyas P","Adult,Aged,80 and over,Animals,Antigens,CD,CD34,CD45,Cell Differentiation,Cell Lineage,Gene Expression Profiling,Graft Survival,Granulocyte-Macrophage Progenitor Cells,Hematopoietic Stem Cells,Humans,Immunophenotyping,Leukemia,Myeloid,Acute,Lymphoid Progenitor Cells,Mice,Inbred NOD,SCID,Middle Aged,Neoplastic Stem Cells,Transplantation,Heterologous,Young Adult|Cell Differentiation,Cell Lineage,Down Syndrome,Flow Cytometry,Gene Expression Profiling,Hematopoietic Stem Cells,Humans,Liver||Animals,Cell Differentiation,Cell Transformation,Neoplastic,Disease Models,Animal,Flow Cytometry,Gene Expression,Humans,Leukemia,Myeloid,Acute,Mice,Microarray Analysis,Multipotent Stem Cells,Myeloid Cells,Signal Transduction,fms-Like Tyrosine Kinase 3|Adult,Amino Acid Substitution,Animals,Cells,Cultured,Family,Female,Germ-Line Mutation,Hematopoiesis,Humans,Isoleucine,Janus Kinase 2,Male,Mice,Inbred NOD,Transgenic,Middle Aged,Myeloproliferative Disorders,Valine|Drug Screening Assays,Antitumor,Gene Amplification,Humans,Male,Oncogene Proteins,Fusion,Plasmids,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,Protein Kinase Inhibitors,Young Adult"
corp0784,immd0198,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0237,univ1923,2,0.07987711213517665,Journal article|Journal article,Molecular Cell|Nature Chemical Biology,30/01/2014|01/01/2012,Optimal translational termination requires C4 lysyl hydroxylation of eRF1.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.,"Yamamoto A,Feng T,Wilkins S,Sokolova E,Yates L,Muenzel M,Singh P,Hopkinson R,Fischer R,Cockman M,Shelley J,Trudgian D,Schoedel J,McCullagh JO,Ge W,Kessler B,Gilbert R,Frolova L,Alkalaeva E,Ratcliffe P,Schofield C,Coleman M|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ","Amino Acid Sequence,Animals,Catalysis,Cell Line,Tumor,Codon,Terminator,Gene Expression Regulation,HeLa Cells,Histone Demethylases,Humans,Hydrolysis,Hydroxylation,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Peptide Chain Termination,Translational,Peptide Termination Factors,Protein Biosynthesis,Protein Processing,Post-Translational,Protein Structure,Tertiary,Sequence Homology,Amino Acid|Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes"
card0018,ctsu0165,1,0.030303030303030304,Journal article,American Heart Journal,01/01/2015,"Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration","Pitcher A,Emberson J,Lacro RV,Sleeper LA,Stylianou M,Mahony L,Pearson GD,Groenink M,Mulder BJ,Zwinderman AH,De Backer J,De Paepe AM,Arbustini E,Erdem G,Jin XY,Flather MD,Mullen MJ,Child AH,Forteza A,Evangelista A,Chiu HH,Wu MH,Sandor G,Bhatt AB,Creager MA,Devereux RB,Loeys B,Forfar JC,Neubauer S,Watkins H,Boileau C,Jondeau G,Dietz HC,Baigent C",
immd0084,path0511,1,0.09090909090909091,Journal article,Journal of Experimental Medicine,21/02/2011,The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance.,"Mortensen M,Soilleux EJ,Djordjevic G,Tripp R,Lutteropp M,Sadighi-Akha E,Stranks AJ,Glanville J,Knight S,Jacobsen SE,Kranc KR,Simon AK","Animals,Apoptosis,Autophagy,Cell Proliferation,DNA Damage,Female,Hematopoietic Stem Cells,Male,Mice,Knockout,Microtubule-Associated Proteins,Mitochondria,Myeloproliferative Disorders,Reactive Oxygen Species,Stem Cells"
clme0237,clme0975,1,0.07142857142857142,Conference paper,Annals of Oncology,01/06/2012,CLINICAL DIAGNOSTIC IMPLEMENTATION OF AN INNOVATIVE CANCER CARE MODEL BASED ON COMPREHENSIVE MOLECULAR PROFILING OF TUMOUR-NORMAL PAIRS,"Kaur K,Henderson S,Cutts A,Domingo E,Woods J,Motley C,Dougherty B,Middleton M,Hassan B,Wang Y,Beasley E,Naley M,Schuh A,Tomlinson I,Taylor J",
claridge,cschof,36,5.363940212860368,Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article,Angewandte Chemie International Edition|Nature Chemical Biology|Nature Communications|Protein Science|Angewandte Chemie International Edition|EMBO Reports|Phytochemistry|Chemistry: A European Journal|Organic and Biomolecular Chemistry|ChemBioChem: a European journal of chemical biology|MedChemComm|Chemical Communications|Nature Chemistry|Bioorganic and Medicinal Chemistry Letters|Angewandte Chemie International Edition|ACS Chemical Biology|Nature Chemical Biology|PLoS One|Bioorganic and Medicinal Chemistry Letters|ChemBioChem: a European journal of chemical biology|The Federation of European Biochemical Societies (FEBS) Journal|Angewandte Chemie International Edition|Chemical Science|Journal of Medicinal Chemistry|Angewandte Chemie International Edition|Organic and Biomolecular Chemistry|Chemical Communications|Proceedings of the National Academy of Sciences of USA|Nature Chemistry|Biochemistry|PLoS One|Journal of the American Chemical Society|Biochemical Journal|Protein Science|Angewandte Chemie International Edition|MedChemComm,20/06/2013|01/01/2012|01/01/2014|01/10/2015|17/03/2014|01/04/2011|18/07/2015|01/01/2015|09/10/2013|22/06/2012||09/12/2013|01/12/2014|01/01/2012|27/08/2014|30/07/2013|01/01/2012|01/01/2015|16/06/2012|07/03/2011|20/01/2011|07/01/2013|01/02/2015|12/12/2012|25/05/2012|17/07/2014|01/01/2016|16/09/2014|01/05/2011|31/03/2014|01/01/2015|11/01/2012|14/08/2014|01/10/2015|06/10/2014|01/05/2011,"Is JmjC oxygenase catalysis limited to demethylation?|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.|Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases.|Studies of JMJD4-catalyzed oxidative modifications of eukaryotic release factor 1|Monitoring conformational changes in the NDM-1 metallo-β-lactamase by 19F NMR spectroscopy.|The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.|The broad spectrum 2-oxoglutarate oxygenase inhibitor N-oxalylglycine is present in rhubarb and spinach leaves.|Cation-π Interactions Contribute to Substrate Recognition in γ-Butyrobetaine Hydroxylase Catalysis.|Stereoselective preparation of lipidated carboxymethyl-proline/pipecolic acid derivatives via coupling of engineered crotonases with an alkylmalonyl-CoA synthetase.|Development and application of a fluoride-detection-based fluorescence assay for γ-butyrobetaine hydroxylase.|Development and application of ligand-based NMR screening assays for γ-butyrobetaine hydroxylase|Fluoromethylated derivatives of carnitine biosynthesis intermediates--synthesis and applications.|Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition.|γ-Butyrobetaine hydroxylase catalyses a Stevens type rearrangement|Oxygenase-catalyzed desymmetrization of N,N-dialkyl-piperidine-4-carboxylic acids.|Binding of (5S)-penicilloic acid to penicillin binding protein 3.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans|Studies on the Glutathione-Dependent Formaldehyde-Activating Enzyme from Paracoccus denitrificans.|γ-Butyrobetaine hydroxylase catalyses a Stevens type rearrangement.|The 2-oxoglutarate-dependent oxygenase JMJD6 catalyses oxidation of lysine residues to give 5S-hydroxylysine residues.|Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.|Substrate selectivity analyses of factor inhibiting hypoxia-inducible factor.|Studying the active-site loop movement of the Sao Paolo metallo-β-lactamase-1†Electronic supplementary information (ESI) available: Procedures for protein expression and purification, (19)F-labelling, crystallisation, data collection, and structure determination, table of crystallographic data, table of crystallographic parameters and refinement statistics, figures showing binding mode and distances, procedures for mass spectrometry measurements, differential scanning fluorimetry measurements, stopped-flow measurements and other kinetics measurements. See DOI: 10.1039/c4sc01752hClick here for additional data file.|Reporter ligand NMR screening method for 2-oxoglutarate oxygenase inhibitors.|Dynamic combinatorial chemistry employing boronic acids/boronate esters leads to potent oxygenase inhibitors.|Comparison of the substrate selectivity and biochemical properties of human and bacterial γ-butyrobetaine hydroxylase.|Cephalosporins inhibit human metallo β-lactamase fold DNA repair nucleases SNM1A and SNM1B/apollo.|Human oxygen sensing may have origins in prokaryotic elongation factor Tu prolyl-hydroxylation.|Stereoselective C-C bond formation catalysed by engineered carboxymethylproline synthases.|Studies on deacetoxycephalosporin C synthase support a consensus mechanism for 2-oxoglutarate dependent oxygenases.|Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.|Crotonase Catalysis Enables Flexible Production of Functionalized Prolines and Carbapenams|Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen.|Applications of 19F-NMR to study protein-ligand interactions and protein conformational changes in solution|Oxygenase-Catalyzed Desymmetrization of N,N-Dialkyl-piperidine-4-carboxylic Acids|An approach to enzyme inhibition employing reversible boronate ester formation","Hopkinson RJ,Walport LJ,Münzel M,Rose NR,Smart TJ,Kawamura A,Claridge TD,Schofield CJ|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Tarhonskaya H,Rydzik AM,Leung IK,Loik ND,Chan MC,Kawamura A,McCullagh JS,Claridge TD,Flashman E,Schofield CJ|Markolovic S,Leung IKH,Coleman ML,Claridge TDW,Wilkins SE,Schofield CJ|Rydzik AM,Brem J,van Berkel SS,Pfeffer I,Makena A,Claridge TD,Schofield CJ|Chowdhury R,Yeoh KK,Tian YM,Hillringhaus L,Bagg EA,Rose NR,Leung IKH,Li XS,Woon ECY,Yang M,McDonough MA,King ON,Clifton IJ,Klose RJ,Claridge TDW,Ratcliffe PJ,Schofield CJ,Kawamura A|Al-Qahtani K,Jabeen B,Sekirnik R,Riaz N,Claridge TD,Schofield CJ,McCullagh JS|Kamps JJ,Khan A,Choi H,Lesniak RK,Brem J,Rydzik AM,McDonough MA,Schofield CJ,Claridge TD,Mecinović J|Hamed RB,Henry L,Gomez-Castellanos JR,Asghar A,Brem J,Claridge TD,Schofield CJ|Rydzik AM,Leung IK,Kochan GT,Thalhammer A,Oppermann U,Claridge TD,Schofield CJ|Khan A,Leśniak RK,Brem J,Rydzik AM,Choi H,Leung IKH,McDonough MA,Schofield CJ,Claridge TDW|Rydzik AM,Leung IK,Thalhammer A,Kochan GT,Claridge TD,Schofield CJ|Brem J,van Berkel SS,Aik W,Rydzik AM,Avison MB,Pettinati I,Umland KD,Kawamura A,Spencer J,Claridge TD,McDonough MA,Schofield CJ|Henry L,Leung IKH,Claridge TDW,Schofield CJ|Rydzik AM,Leung IK,Kochan GT,McDonough MA,Claridge TD,Schofield CJ|van Berkel SS,Nettleship JE,Leung IK,Brem J,Choi H,Stuart DI,Claridge TD,McDonough MA,Owens RJ,Ren J,Schofield CJ|Ge W,Wolf A,Feng T,Ho C-H,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TDW,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,Mccullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Hopkinson RJ,Leung IK,Smart TJ,Rose NR,Henry L,Claridge TD,Schofield CJ|Henry L,Leung IK,Claridge TD,Schofield CJ|Mantri M,Loik ND,Hamed RB,Claridge TD,McCullagh JS,Schofield CJ|Yang M,Chowdhury R,Ge W,Hamed RB,McDonough MA,Claridge TD,Kessler BM,Cockman ME,Ratcliffe PJ,Schofield CJ|Yang M,Hardy AP,Chowdhury R,Loik ND,Scotti JS,McCullagh JS,Claridge TD,McDonough MA,Ge W,Schofield CJ|Brem J,Struwe WB,Rydzik AM,Tarhonskaya H,Pfeffer I,Flashman E,van Berkel SS,Spencer J,Claridge TD,McDonough MA,Benesch JL,Schofield CJ|Leung IK,Demetriades M,Hardy AP,Lejeune C,Smart TJ,Szöllössi A,Kawamura A,Schofield CJ,Claridge TD|Demetriades M,Leung IK,Chowdhury R,Chan MC,McDonough MA,Yeoh KK,Tian YM,Claridge TD,Ratcliffe PJ,Woon EC,Schofield CJ|Rydzik AM,Leung IK,Kochan GT,Loik ND,Henry L,McDonough MA,Claridge TD,Schofield CJ|Lee SY,Brem J,Pettinati I,Claridge TD,Gileadi O,Schofield CJ,McHugh PJ|Scotti JS,Leung IK,Ge W,Bentley MA,Paps J,Kramer HB,Lee J,Aik W,Choi H,Paulsen SM,Bowman LA,Loik ND,Horita S,Ho CH,Kershaw NJ,Tang CM,Claridge TD,Preston GM,McDonough MA,Schofield CJ|Hamed RB,Gomez-Castellanos JR,Thalhammer A,Harding D,Ducho C,Claridge TD,Schofield CJ|Tarhonskaya H,Szöllössi A,Leung IK,Bush JT,Henry L,Chowdhury R,Iqbal A,Claridge TD,Schofield CJ,Flashman E|Chan MC,Atasoylu O,Hodson E,Tumber A,Leung IK,Chowdhury R,Gómez-Pérez V,Demetriades M,Rydzik AM,Holt-Martyn J,Tian YM,Bishop T,Claridge TD,Kawamura A,Pugh CW,Ratcliffe PJ,Schofield CJ|Hamed RB,Henry L,Gomez-Castellanos JR,Mecinović J,Ducho C,Sorensen JL,Claridge TD,Schofield CJ|Tarhonskaya H,Chowdhury R,Leung IK,Loik ND,McCullagh JS,Claridge TD,Schofield CJ,Flashman E|Abboud MI,Brem J,Chowdhury R,Leung IKH,Claridge TDW,Schofield CJ|Rydzik AM,Leung IKH,Kochan GT,McDonough MA,Claridge TDW,Schofield CJ|Leung IKH,Brown T,Schofield CJ,Claridge TDW","demethylation,epigenetics,histone,hydroxylation,methyllysine,Catalysis,Histones,Humans,Hydroxylation,Jumonji Domain-Containing Histone Demethylases,Magnetic Resonance Spectroscopy,Methylation,Substrate Specificity|Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes|Alcohol Oxidoreductases,Ascorbic Acid,Glutarates,Oxygenases,Succinic Acid,gamma-Aminobutyric Acid||beta-Lactamases,Magnetic Resonance Spectroscopy,Drug Resistance,Microbial,Molecular Structure|Cell Line,Tumor,Crystallography,Glutarates,Histone Demethylases,Humans,Inhibitory Concentration 50,Isocitrate Dehydrogenase,Jumonji Domain-Containing Histone Demethylases,Magnetic Resonance Spectroscopy,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Mutation,Neoplasms,Procollagen-Proline Dioxygenase,Repressor Proteins,Signal Transduction|Humans,Escherichia coli,Brassica,Spinacia oleracea,Rheum,Plant Leaves,Ketoglutaric Acids,Oxygenases,Alanine,Amino Acids,Dicarboxylic,Enzyme Inhibitors,Chromatography,Liquid,Magnetic Resonance Spectroscopy,Tandem Mass Spectrometry,HEK293 Cells|Cations,Betaine,Carnitine,Protein Binding,Oxidation-Reduction,Kinetics,Catalysis,Quaternary Ammonium Compounds,gamma-Butyrobetaine Dioxygenase|Bacterial Proteins,Biocatalysis,Coenzyme A Ligases,Enoyl-CoA Hydratase,Lipids,Models,Molecular,Molecular Structure,Pipecolic Acids,Proline,Protein Engineering,Stereoisomerism|Biocatalysis,Fluorescence,Fluorides,Humans,Hydrocarbons,Fluorinated,Magnetic Resonance Spectroscopy,Molecular Structure,Protons,gamma-Butyrobetaine Dioxygenase||Carnitine,Cell Line,Escherichia,Fluorescent Dyes,Fluorine,Humans,Methylation,Molecular Structure|Thienamycins,Rhodanine,beta-Lactamases,Crystallography,Magnetic Resonance Spectroscopy,Biophysics,Hydrolysis,Kinetics,beta-Lactamase Inhibitors||Carboxylic Acids,Piperidines,Carnitine,Catalytic Domain,Oxidation-Reduction,Stereoisomerism,gamma-Butyrobetaine Dioxygenase,Biocatalysis|Coordination Complexes,Inhibitory Concentration 50,Magnetic Resonance Spectroscopy,Models,Molecular,Penicillanic Acid,Penicillin-Binding Proteins,Pseudomonas||Paracoccus denitrificans,Carbon-Sulfur Ligases,Glutathione,Bacterial Proteins,Amino Acid Sequence,Molecular Sequence Data|Butyrates,Catalysis,Enzyme Inhibitors,Methylamines,Methylhydrazines,Oxidation-Reduction,gamma-Butyrobetaine Dioxygenase|Animals,Catalysis,Humans,Hydroxylysine,Jumonji Domain-Containing Histone Demethylases,Ketoglutaric Acids,Magnetic Resonance Spectroscopy,Molecular Structure,Oxidation-Reduction,Oxygenases,Stereoisomerism|Amino Acid Sequence,Ankyrin Repeat,HEK293 Cells,Histidine,Humans,Hydroxylation,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Protein Processing,Post-Translational,Protein Structure,Tertiary,Repressor Proteins,Sequence Alignment,Tankyrases|Amino Acid Sequence,Ankyrins,Binding Sites,Biocatalysis,Catalytic Domain,Hydroxylation,Hypoxia-Inducible Factor 1,Magnetic Resonance Spectroscopy,Molecular Sequence Data,Peptides,Spectrometry,Mass,Matrix-Assisted Laser Desorption-Ionization,Substrate Specificity||Citric Acid Cycle,Enzyme Inhibitors,Humans,Ketoglutaric Acids,Ligands,Magnetic Resonance Spectroscopy,Oxygenases|Boronic Acids,Combinatorial Chemistry Techniques,Enzyme Inhibitors,Esters,Humans,Hypoxia-Inducible Factor-Proline Dioxygenases,Kinetics,Mass Spectrometry,Nuclear Magnetic Resonance,Biomolecular,Oxidation-Reduction,Procollagen-Proline Dioxygenase|Humans,Pseudomonas,Molecular Structure,Substrate Specificity,Models,Molecular,gamma-Butyrobetaine Dioxygenase,Biocatalysis||Humans,Chlamydomonas reinhardtii,Pseudomonas putida,Oxygen,Peptide Elongation Factor Tu,Proline,Protein Structure,Secondary,Tertiary,Substrate Specificity,Hydroxylation,Models,Molecular,Molecular Sequence Data,Hypoxia-Inducible Factor 1,alpha Subunit,Hypoxia-Inducible Factor-Proline Dioxygenases|Amino Acid Sequence,Carbon,Carbon-Carbon Lyases,Catalysis,Catalytic Domain,Models,Molecular,Molecular Sequence Data,Nuclear Magnetic Resonance,Biomolecular,Protein Engineering,Sequence Homology,Amino Acid|Ketoglutaric Acids,Intramolecular Transferases,Oxygenases,Penicillin-Binding Proteins,Crystallography,X-Ray,Nuclear Magnetic Resonance,Biomolecular,Kinetics,Catalysis,Mass Spectrometry|Brain,Hela Cells,Animals,Humans,Mice,Triazoles,Enzyme Inhibitors,Stroke,MCF-7 Cells,Hypoxia-Inducible Factor-Proline Dioxygenases|Biocatalysis,Carbapenems,Carbon-Carbon Lyases,Methylation,Models,Molecular,Proline,Protein Conformation,Protein Engineering|Cations,Divalent,Oxygen,Iron,Manganese,Zinc,Water,Ketoglutaric Acids,Isoquinolines,Oligopeptides,Mutagenesis,Site-Directed,Catalytic Domain,Protein Binding,Hydroxylation,Kinetics,Hypoxia-Inducible Factor-Proline Dioxygenases||biocatalysis,gamma-butyrobetaine hydroxylase,C-H activation,desymmetrisation,oxygenases|"
corp0784,ocms0064,2,0.1875,Journal article|Journal article,Nature Immunology|Science,|01/01/2013,Initiation of T cell signaling by CD45 segregation at 'close contacts'.|Structure of the Repulsive Guidance Molecule (RGM)-neogenin signaling hub,"Chang VT,Fernandes RA,Ganzinger KA,Lee SF,Siebold C,McColl J,Jönsson P,Palayret M,Harlos K,Coles CH,Jones EY,Lui Y,Huang E,Gilbert RJ,Klenerman D,Aricescu AR,Davis SJ|Bell CH,Healey E,van Erp S,Bishop B,Tang C,Gilbert RJC,Aricescu AR,Pasterkamp RJ,Siebold C",|
corp0784,immd0082,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
card0027,clme0240,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
bioc0416,dplb0149,4,0.5432900432900433,Chapter|Journal article|Journal article|Journal article,|Methods in Molecular Biology|Journal of NeuroImmune Pharmacology|Neurology,|01/01/2011|22/09/2015|24/09/2014,Molecular MRI Approaches to the Detection of CNS Inflammation|Molecular MRI approaches to the detection of CNS inflammation.|NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.|A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.,"Sibson NR,Anthony DC,Sander van K,Dickens A,Perez-Balderas F,McAteer MA,Choudhury RP,Davis BG|Sibson NR,Anthony DC,van Kasteren S,Dickens A,Perez-Balderas F,McAteer MA,Choudhury RP,Davis BG|Dickens AM,Larkin JR,Davis BG,Griffin JL,Claridge TD,Sibson NR,Anthony DC|Dickens AM,Larkin JR,Griffin JL,Cavey A,Matthews L,Turner MR,Wilcock GK,Davis BG,Claridge TD,Palace J,Anthony DC,Sibson NR","|Animals,Antibodies,Antigens,CD15,Central Nervous System,Endothelial Cells,Ferric Compounds,Inflammation,Magnetic Resonance Imaging,Mice,Rats,Statistics as Topic,Tumor Necrosis Factor-alpha,Vascular Cell Adhesion Molecule-1|Animals,Mice,Biozzi,Multiple Sclerosis,Relapsing-Remitting,Encephalomyelitis,Autoimmune,Experimental,Disease Models,Animal,Disease Progression,Magnetic Resonance Spectroscopy,Models,Theoretical,Metabolomics|Humans,Multiple Sclerosis,Chronic Progressive,Relapsing-Remitting,Alzheimer Disease,Amyotrophic Lateral Sclerosis,Biological Markers,Magnetic Resonance Spectroscopy,Discriminant Analysis,Case-Control Studies,Cohort Studies,Reproducibility of Results,ROC Curve,Adult,Aged,Middle Aged,Female,Male,Metabolomics"
card0027,gree1192,1,0.0049261083743842365,Journal article,Nature Communications,01/01/2015,Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.,"Wessel J,Chu AY,Willems SM,Wang S,Yaghootkar H,Brody JA,Dauriz M,Hivert MF,Raghavan S,Lipovich L,Hidalgo B,Fox K,Huffman JE,An P,Lu Y,Rasmussen-Torvik LJ,Grarup N,Ehm MG,Li L,Baldridge AS,Stančáková A,Abrol R,Besse C,Boland A,Bork-Jensen J,Fornage M,Freitag DF,Garcia ME,Guo X,Hara K,Isaacs A,Jakobsdottir J,Lange LA,Layton JC,Li M,Hua Zhao J,Meidtner K,Morrison AC,Nalls MA,Peters MJ,Sabater-Lleal M,Schurmann C,Silveira A,Smith AV,Southam L,Stoiber MH,Strawbridge RJ,Taylor KD,Varga TV,Allin KH,Amin N,Aponte JL,Aung T,Barbieri C,Bihlmeyer NA,Boehnke M,Bombieri C,Bowden DW,Burns SM,Chen Y,Chen YD,Cheng CY,Correa A,Czajkowski J,Dehghan A,Ehret GB,Eiriksdottir G,Escher SA,Farmaki AE,Frånberg M,Gambaro G,Giulianini F,Goddard WA,Goel A,Gottesman O,Grove ML,Gustafsson S,Hai Y,Hallmans G,Heo J,Hoffmann P,Ikram MK,Jensen RA,Jørgensen ME,Jørgensen T,Karaleftheri M,Khor CC,Kirkpatrick A,Kraja AT,Kuusisto J,Lange EM,Lee IT,Lee WJ,Leong A,Liao J,Liu C,Liu Y,Lindgren CM,Linneberg A,Malerba G,Mamakou V,Marouli E,Maruthur NM,Matchan A,McKean-Cowdin R,McLeod O,Metcalf GA,Mohlke KL,Muzny DM,Ntalla I,Palmer ND,Pasko D,Peter A,Rayner NW,Renström F,Rice K,Sala CF,Sennblad B,Serafetinidis I,Smith JA,Soranzo N,Speliotes EK,Stahl EA,Stirrups K,Tentolouris N,Thanopoulou A,Torres M,Traglia M,Tsafantakis E,Javad S,Yanek LR,Zengini E,Becker DM,Bis JC,Brown JB,Cupples LA,Hansen T,Ingelsson E,Karter AJ,Lorenzo C,Mathias RA,Norris JM,Peloso GM,Sheu WH,Toniolo D,Vaidya D,Varma R,Wagenknecht LE,Boeing H,Bottinger EP,Dedoussis G,Deloukas P,Ferrannini E,Franco OH,Franks PW,Gibbs RA,Gudnason V,Hamsten A,Harris TB,Hattersley AT,Hayward C,Hofman A,Jansson JH,Langenberg C,Launer LJ,Levy D,Oostra BA,O'Donnell CJ,O'Rahilly S,Padmanabhan S,Pankow JS,Polasek O,Province MA,Rich SS,Ridker PM,Rudan I,Schulze MB,Smith BH,Uitterlinden AG,Walker M,Watkins H,Wong TY,Zeggini E,Laakso M,Borecki IB,Chasman DI,Pedersen O,Psaty BM,Tai ES,van Duijn CM,Wareham NJ,Waterworth DM,Boerwinkle E,Kao WH,Florez JC,Loos RJ,Wilson JG,Frayling TM,Siscovick DS,Dupuis J,Rotter JI,Meigs JB,Scott RA,Goodarzi MO","EPIC-InterAct Consortium,Humans,Diabetes Mellitus,Type 2,Genetic Predisposition to Disease,Insulin,Glucose-6-Phosphatase,Blood Glucose,Oligonucleotide Array Sequence Analysis,Fasting,Polymorphism,Single Nucleotide,African Continental Ancestry Group,European Continental Ancestry Group,Genetic Variation,Genetic Loci,Genetic Association Studies,Mutation Rate,Exome,Glucagon-Like Peptide-1 Receptor"
hert0418,lina0435,2,0.1219806763285024,Journal article|Journal article,Nature|Nature,01/01/2012|30/09/2015,"An integrated map of genetic variation from 1,092 human genomes|A global reference for human genetic variation.","Altshuler DM,Durbin RM,Abecasis GR,Bentley DR,Chakravarti A,Clark AG,Donnelly P,Eichler EE,Flicek P,Gabriel SB,Gibbs RA,Green ED,Hurles ME,Knoppers BM,Korbel JO,Lander ES,Lee C,Lehrach H,Mardis ER,Marth GT,McVean GA,Nickerson DA,Schmidt JP,Sherry ST,Wang J,Wilson RK,Dinh H,Kovar C,Lee S,Lewis L,Muzny D,Reid J,Wang M,Fang X,Guo X,Jian M,Jiang H,Jin X,Li G,Li J,Li Y,Li Z,Liu X,Lu Y,Ma X,Su Z,Tai S,Tang M,Wang B,Wang G,Wu H,Wu R,Yin Y,Zhang W,Zhao J,Zhao M,Zheng X,Zhou Y,Gupta N,Clarke L,Leinonen R,Smith RE,Zheng-Bradley X,Grocock R,Humphray S,James T,Kingsbury Z,Sudbrak R,Albrecht MW,Amstislavskiy VS,Borodina TA,Lienhard M,Mertes F,Sultan M,Timmermann B,Yaspo ML,Fulton L,Fulton R,Weinstock GM,Balasubramaniam S,Burton J,Danecek P,Keane TM,Kolb-Kokocinski A,McCarthy S,Stalker J,Quail M,Davies CJ,Gollub J,Webster T,Wong B,Zhan Y,Auton A|Auton A,Brooks LD,Durbin RM,Garrison EP,Kang HM,Korbel JO,Marchini JL,McCarthy S,McVean GA,Abecasis GR","|1000 Genomes Project Consortium,Humans,Disease Susceptibility,Rare Diseases,Physical Chromosome Mapping,Sequence Analysis,DNA,Genetics,Medical,Population,Genomics,Demography,Genotype,Haplotypes,Polymorphism,Single Nucleotide,Quantitative Trait Loci,Genome,Human,Reference Standards,Internationality,INDEL Mutation,Genetic Variation,Genome-Wide Association Study,High-Throughput Nucleotide Sequencing,Exome,Datasets as Topic"
clme0946,immd0135,1,0.0625,Journal article,Proceedings of the National Academy of Sciences of USA,14/10/2013,ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63.,"Tordella L,Koch S,Salter V,Pagotto A,Doondeea JB,Feller SM,Ratnayaka I,Zhong S,Goldin RD,Lozano G,McKeon FD,Tavassoli M,Fritzsche F,Huber GF,Rössle M,Moch H,Lu X","T53BP2,inflammation,stratified epithelial cell tumor,Animals,Carcinoma,Squamous Cell,Cell Line,Crosses,Genetic,DNA Primers,Disease Models,Animal,Haploinsufficiency,Humans,Immunoblotting,Immunoprecipitation,Mice,Inbred BALB C,Microarray Analysis,Phosphoproteins,RNA,Small Interfering,Real-Time Polymerase Chain Reaction,Signal Transduction,Trans-Activators,Transcription Factor RelA,Tumor Suppressor Proteins"
bioc0192,card0039,37,4.34136737445561,Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Conference paper|Journal article|Journal article|Conference paper|Conference paper|Journal article|Conference paper|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper,Atherosclerosis|Circulation: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Journal of the American College of Cardiology Cardiovascular Imaging|Journal of the American College of Cardiology|Heart|Heart|Heart|Journal of Cardiovascular Magnetic Resonance|Heart|Heart|Journal of Cardiovascular Magnetic Resonance|Journal of Magnetic Resonance Imaging|JACC: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|Proceedings of the National Academy of Sciences of USA|Heart|Circulation|Heart|Journal of Cardiovascular Magnetic Resonance|European Heart Journal|Circulation|Heart|JACC: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|JACC: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|Radiology|Circulation: Cardiovascular Imaging|JACC: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Heart|Circulation|Journal of Cardiovascular Magnetic Resonance|Circulation,01/12/2014|01/01/2011|01/01/2013|21/10/2011|01/01/2012|29/05/2012|01/06/2011|01/06/2011|01/06/2011|01/02/2012|01/05/2013|01/05/2013|01/02/2012|01/05/2011|01/01/2013|01/02/2012|26/03/2012|01/06/2014|22/11/2011|01/05/2012|23/05/2014|01/09/2014|22/11/2011|01/05/2012|01/06/2013|23/05/2014|01/10/2013|21/06/2012|11/06/2014|29/03/2011|01/04/2012|01/02/2012|06/02/2012|01/05/2013|20/11/2012|08/01/2014|22/11/2011,"IN-VIVO CAROTID PLAQUES CHARACTERISATION USING QUANTITATIVE T2 MAP: HISTOLOGICAL VALIDATION AND LIPID QUANTIFICATION|Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index|In-vivo quantitative T2 mapping of carotid arteries in atherosclerotic patients: segmentation and T2 measurement of plaque components.|Multimodal cardiovascular magnetic resonance quantifies regional variation in vascular structure and function in patients with coronary artery disease: relationships with coronary disease severity.|Acute 3T Magnetic Resonance Imaging Reveals Features of Carotid Atherosclerotic Plaque Associated with Ipsilateral Cerebral Infarction in Minor Stroke and Transient Ischemic Attack.|Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla.|DYNAMIC CHANGES OF OEDEMA AND LATE GADOLINIUM ENHANCEMENT AFTER ACUTE MYOCARDIAL INFARCTION AND THEIR RELATIONSHIP TO FUNCTIONAL RECOVERY AND SALVAGE INDEX|OBESITY AND PERIVASCULAR ADIPOSITY IN ATHEROSCLEROSIS|3T MRI OF ACUTE ATHEROSCLEROTIC PLAQUE RUPTURE AND DOWNSTREAM EMBOLIC INJURY|In-vivo T2 mapping of atherosclerotic plaques in carotid arteries.|IN-VIVO QUANTITATIVE T2 MAPPING OF CAROTID PLAQUES IN PATIENTS WITH RECENT CEREBROVASCULAR EVENTS: AHA PLAQUE TYPE CLASSIFICATION AND CORRELATION WITH PLAQUE HISTOLOGY|THE DETECTION OF ACUTE MYOCARDITIS USING CARDIOVASCULAR MRI: A CLINICAL STUDY COMPARING T1-MAPPING, T2-WEIGHTED AND LATE GADOLINIUM ENHANCEMENT IMAGING|Characterization of acute myocardial infarction by pre-contrast T1 mapping.|Loss of fine structure and edge sharpness in fast-spin-echo carotid wall imaging: measurements and comparison with multiple-spin-echo in normal and atherosclerotic subjects.|T Mapping for the Diagnosis of Acute Myocarditis Using CMR. Comparison to T-Weighted and Late Gadolinium Enhanced Imaging|The diagnostic performance of non-contrast T1-mapping in patients with acute myocarditis on cardiovascular magnetic resonance imaging.|Molecular MRI enables early and sensitive detection of brain metastases.|121 High Diagnostic Yield in Patients Presenting with Acute Chest Pain, Positive Troponins but non-obstructive Coronaries by Cardiovascular Magnetic Resonance imaging with Conventional and Novel T1 Mapping Techniques.|T1-Mapping is Superior to T2-Weighted Cardiovascular Magnetic Resonance Imaging for the Detection of Acute Reversible Myocardial Injury|PRE-CONTRAST T1 MAPPING ALLOWS ASSESSMENT OF SEVERITY OF ACUTE ISCHAEMIC MYOCARDIAL INJURY|Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.|Characterisation of carotid plaques by in-vivo quantitative T2 mapping: histological validation and lipid quantification|Non-Contrast T1-Mapping is a Novel Diagnostic Tool for Acute Myocarditis on Cardiovascular Magnetic Resonance Imaging|T1-MAPPING HAS A HIGH DIAGNOSTIC PERFORMANCE IN PATIENTS PRESENTING WITH ACUTE MYOCARDITIS: A CARDIOVASCULAR MAGNETIC RESONANCE STUDY|Diagnostic value of pre-contrast T1 mapping in acute and chronic myocardial infarction.|Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents|T<inf>1</inf> Mapping for the diagnosis of acute myocarditis using CMR: Comparison to T<inf>2</inf>-Weighted and late gadolinium enhanced imaging|Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance.|Black-blood multicontrast imaging of carotid arteries with DANTE-prepared 2D and 3D MR imaging.|Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index.|Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study.|T1-mapping accurately detects acute myocardial edema: a comparison to T2-weighted cardiovascular magnetic resonance imaging.|Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction.|THE USEFULNESS OF EARLY CARDIOVASCULAR MAGNETIC RESONANCE IN PATIENTS PRESENTING WITH ACUTE CHEST PAIN, POSITIVE TROPONIN AND NON-OBSTRUCTIVE CORONARY ARTERIES|Novel Techniques for the Diagnosis of Acute Myocarditis: A Clinical Cardiovascular Magnetic Resonance Study|Non-invasive imaging of carotid arterial restenosis using 3T cardiovascular magnetic resonance.|CMR T1 Mapping at 3T Characterizes the Extent of Acute Ischemic Myocardial Injury: Comparison to Standard Techniques","Chai JT,Biasiolli L,Li L,Handa A,Perkins J,Hands L,Sideso E,Jezzard P,Robson MD,Choudhury RP|Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Biasiolli L,Lindsay AC,Chai JT,Choudhury RP,Robson MD|Kylintireas I,Shirodaria C,Lee JM,Cunningon C,Lindsay A,Francis J,Robson MD,Neubauer S,Channon KM,Choudhury RP|Lindsay AC,Biasiolli L,Lee JMS,Kylintireas,MacIntosh,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury R|Arnold JR,Karamitsos TD,Bhamra-Ariza P,Francis JM,Searle N,Robson MD,Howells RK,Choudhury RP,Rimoldi OE,Camici PG,Banning AP,Neubauer S,Jerosch-Herold M,Selvanayagam JB|Dall'Armellina E,Karia N,Lindsay A,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast B,Banning AP,Channon K,Kharbanda RJ,Neubauer S,Choudhury RP|Kylintireas I,Shirodaria C,Rider O,Lee JM,Bechar I,Digby J,Robson MD,Neubuer S,Choudhury RP|Lindsay AC,Biasiolli L,Lee JM,Kylintireas I,Watt H,Kuker W,Handa A,Robson MD,Neubauer S,Kennedy J,Choudhury RP|Biasiolli L,Lindsay AC,Choudhury RP,Robson MD|Biasiolli L,Chai J,Lindsay A,Handa A,Robson M,Choudhury R|Ferreira V,Piechnik S,Dall'Armellina E,Karamitsos T,Francis J,Ntusi N,Holloway C,Choudhury R,Kardos A,Robson M,Friedrich M,Neubauer S|Dall'armellina E,Piechnik SK,Ferreira V,Francis JM,Robson MD,Cuculi F,Kharbanda R,Banning AP,Choudhury RP,Karamitsos T,Neubauer S|Biasiolli L,Lindsay AC,Choudhury RP,Robson MD|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Robson MD,Neubauer S,Kardos A,Friedrich MG|Ferreira V,Piechnik SK,Dall'armellina E,Karamitsos T,Francis JM,Choudhury RP,Kardos A,Friedrich MG,Robson MD,Neubauer S|Serres S,Soto MS,Hamilton A,McAteer MA,Carbonell WS,Robson MD,Ansorge O,Khrapitchev A,Bristow C,Balathasan L,Weissensteiner T,Anthony DC,Choudhury RP,Muschel RJ,Sibson NR|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Banning A,Kardos A,Newton J,Friedrich M,Robson M,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Friedrich MG,Robson MD,Neubauer S|Dall'Armellina E,Piechnik S,Ferreira VM,Robson MD,Francis JM,Cuculi F,Kharbanda RK,Banning AP,Choudhury RP,Karamitsos TD,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Chai JT,Biasiolli L,Li L,Handa A,Perkins J,Hands L,Sideso E,Jezzard P,Robson MD,Choudhury RP|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Kardos A,Friedrich MG,Robson MD,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Kardos A,Friedrich MG,Robson MD,Neubauer S|Dall'Armellina E,Ferreira VM,Kharbanda RK,Prendergast B,Piechnik SK,Robson MD,Jones M,Francis JM,Choudhury RP,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Friedrich MG,Robson MD,Neubauer S|Li L,Chai JT,Biasiolli L,Robson MD,Choudhury RP,Handa AI,Near J,Jezzard P|Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Lindsay AC,Biasiolli L,Lee JM,Kylintireas I,MacIntosh BJ,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury RP|Ferreira V,Piechnik SK,Dall'armellina E,Karamitsos T,Francis JM,Choudhury RP,Friedrich MG,Robson MD,Neubauer S|Dall'Armellina E,Piechnik SK,Ferreira VM,Si QL,Robson MD,Francis JM,Cuculi F,Kharbanda RK,Banning AP,Choudhury RP,Karamitsos TD,Neubauer S|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Banning A,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Kardos A,Basagiannia C,Newton J,Friedrich M,Robson M,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Lindsay AC,Biasiolli L,Knight S,Cunnington C,Robson MD,Neubauer S,Kennedy J,Handa A,Choudhury RP|Dall'Armellina E,Piechnik S,Ferreira V,Karamitsos TD,Francis JM,Cuculi F,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Robson MD,Choudhury RP,Neubauer S","||Aged,80 and over,Automation,Laboratory,Carotid Arteries,Carotid Artery Diseases,Female,Fibrosis,Humans,Image Interpretation,Computer-Assisted,Least-Squares Analysis,Magnetic Resonance Angiography,Male,Middle Aged,Necrosis,Nonlinear Dynamics,Observer Variation,Plaque,Atherosclerotic,Predictive Value of Tests,Reproducibility of Results,Severity of Illness Index|Aged,Analysis of Variance,Aorta,Aortic Diseases,Atherosclerosis,Brachial Artery,Carotid Arteries,Carotid Artery Diseases,Chi-Square Distribution,Compliance,Coronary Angiography,Coronary Artery Disease,England,Female,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Multivariate Analysis,Predictive Value of Tests,Severity of Illness Index,Vasodilation||Coronary Angiography,Coronary Artery Disease,Coronary Circulation,Electrocardiography,Equipment Design,Female,Follow-Up Studies,Humans,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardium,Oximetry,Oxygen,Oxygen Consumption,Prognosis,Regional Blood Flow,Reproducibility of Results,Severity of Illness Index||||||||Adult,Aged,80 and over,Algorithms,Atherosclerosis,Carotid Arteries,Computer Simulation,Female,Fourier Analysis,Humans,Image Processing,Computer-Assisted,Magnetic Resonance Imaging,Male,Middle Aged,Models,Statistical,Protons|||Animals,Brain Neoplasms,Disease Progression,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Sensitivity and Specificity,Up-Regulation,Vascular Cell Adhesion Molecule-1||Cardiac MRI,Cardiac mapping,Myocardium,Acute coronary syndromes,Troponin||Myocardium,Humans,Myocarditis,Edema,Cardiac,Acute Disease,Contrast Media,Magnetic Resonance Imaging,Stroke Volume,Case-Control Studies,Prospective Studies,Predictive Value of Tests,Ventricular Function,Left,Adult,Middle Aged,England,Female,Male||Cardiac MRI,Cardiac mapping,Myocarditis,Cardiovascular imaging,Magnetic resonance||Adult,Aged,Coronary Artery Disease,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Myocardial Infarction,Myocardium,Percutaneous Coronary Intervention,Predictive Value of Tests,Time Factors,Treatment Outcome|||Acute Disease,Adult,Aged,Contrast Media,Diagnosis,Differential,Edema,Cardiac,Female,Follow-Up Studies,Humans,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardial Contraction,Myocardium,Reproducibility of Results,Takotsubo Cardiomyopathy|Humans,Carotid Stenosis,Image Interpretation,Computer-Assisted,Imaging,Three-Dimensional,Magnetic Resonance Angiography,Case-Control Studies,Adolescent,Adult,Aged,Middle Aged,Male,Signal-To-Noise Ratio|Angioplasty,Balloon,Coronary,Contrast Media,Edema,Cardiac,Female,Gadolinium,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Myocardial Infarction,Myocardium,Recovery of Function,Ventricular Function|Aged,Brain,Carotid Arteries,Case-Control Studies,Cerebral Infarction,Diagnosis,Differential,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Magnetic Resonance Imaging,Male,Plaque,Atherosclerotic,Prospective Studies,Risk Factors||Analysis of Variance,Angioplasty,Balloon,Coronary,Chi-Square Distribution,Contrast Media,Edema,Cardiac,England,Female,Gadolinium DTPA,Humans,Logistic Models,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardial Infarction,Myocardium,Predictive Value of Tests,Prospective Studies,ROC Curve,Recovery of Function,Severity of Illness Index,Time Factors,Treatment Outcome||Cardiac MRI,Myocarditis,Cardiac mapping,Cardiac imaging,Magnetic resonance imaging|Aged,Carotid Artery,Common,Carotid Stenosis,Contrast Media,Endarterectomy,Carotid,Female,Fibrosis,Humans,Lipids,Magnetic Resonance Imaging,Male,Observer Variation,Plaque,Atherosclerotic,Predictive Value of Tests,Recurrence,Reproducibility of Results,Severity of Illness Index,Time Factors,Treatment Outcome|Myocardial infarction,STEMI,NSTEMI,Cardiac MRI"
bioc0416,claridge,4,0.5686868686868687,Conference paper|Journal article|Journal article|Journal article,European Journal of Cancer|Neurology|Journal of NeuroImmune Pharmacology|Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,01/07/2012|24/09/2014|22/09/2015|29/06/2015,Isoenzyme-specific PFK-2/FBPase-2 Inhibition as an Anti-cancer Strategy|A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.|NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.|The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis.,"Williams JG,Manzano A,Bensaad K,Collins JM,Serres S,Claridge TDW,Sibson N,Bartrons R,Russell AJ,Harris AL|Dickens AM,Larkin JR,Griffin JL,Cavey A,Matthews L,Turner MR,Wilcock GK,Davis BG,Claridge TD,Palace J,Anthony DC,Sibson NR|Dickens AM,Larkin JR,Davis BG,Griffin JL,Claridge TD,Sibson NR,Anthony DC|Gray E,Larkin JR,Claridge TD,Talbot K,Sibson NR,Turner MR","|Humans,Multiple Sclerosis,Chronic Progressive,Relapsing-Remitting,Alzheimer Disease,Amyotrophic Lateral Sclerosis,Biological Markers,Magnetic Resonance Spectroscopy,Discriminant Analysis,Case-Control Studies,Cohort Studies,Reproducibility of Results,ROC Curve,Adult,Aged,Middle Aged,Female,Male,Metabolomics|Animals,Mice,Biozzi,Multiple Sclerosis,Relapsing-Remitting,Encephalomyelitis,Autoimmune,Experimental,Disease Models,Animal,Disease Progression,Magnetic Resonance Spectroscopy,Models,Theoretical,Metabolomics|"
chem0068,claridge,2,0.30952380952380953,Journal article|Journal article,Chemistry: A European Journal|Chemistry: A European Journal,08/10/2012|08/10/2012,Synthesis of 3-fluoropyrrolidines and 4-fluoropyrrolidin-2-ones from allylic fluorides.|Conformational analysis of fluorinated pyrrolidines using 19F-1H scalar couplings and heteronuclear NOEs.,"Combettes LE,Schuler M,Patel R,Bonillo B,Odell B,Thompson AL,Claridge TD,Gouverneur V|Combettes LE,Clausen-Thue P,King MA,Odell B,Thompson AL,Gouverneur V,Claridge TD","Amides,Cyclization,Fluorides,Fluorine,Nitrogen,Pyrrolidines,Stereoisomerism|Crystallography,X-Ray,Fluorine Radioisotopes,Halogenation,Magnetic Resonance Spectroscopy,Models,Molecular,Molecular Conformation,Pyrrolidines,Solutions"
clab0035,path0511,5,0.3102299591661294,Journal article|Journal article|Conference paper|Journal article|Journal article,Cancer Cell|Cancer Cell|Blood|British Journal of Haematology|British Journal of Haematology,14/05/2014|16/06/2014|06/12/2014|08/01/2013|01/01/2013,Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|Identification of a Prognostic Gene Expression Signature for AZA Response in MDS and CMML Patients|Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells.|Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells,"Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SE|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Unnikrishnan A,Beck D,Verma A,Richards LA,Thoms JAI,Kumari A,Galbraith S,Kulasekararaj A,Tobiasson M,Woll PS,Pellagatti A,Papaemmanuil E,Wilson SR,Lindeman R,Campbell PJ,Boultwood J,Lynch K,Jacobsen SEW,Mufti GJ,Hellstrom-Lindberg E,MacKenzie KL,Wong JWH,Pimanda JE|Davies C,Yip BH,Fernandez-Mercado M,Woll PS,Agirre X,Prosper F,Jacobsen SE,Wainscoat JS,Pellagatti A,Boultwood J|Davies C,Yip BH,Fernandez-Mercado M,Woll PS,Agirre X,Prosper F,Jacobsen SE,Wainscoat JS,Pellagatti A,Boultwood J","Chromosomes,Human,Pair 5,Animals,Mice,Inbred NOD,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Genetic Predisposition to Disease,Antigens,CD,Prognosis,Flow Cytometry,Gene Expression Profiling,Mutation,Neoplastic Stem Cells,Heterografts|||Antigens,CD34,Case-Control Studies,Cell Culture Techniques,Cell Differentiation,Cell Growth Processes,Cell Lineage,Gene Silencing,Humans,K562 Cells,Myeloid Cells,RNA,Small Interfering,Repressor Proteins,Stem Cells,Transcriptome|"
card0025,whgu0172,3,0.32955465587044536,Conference paper|Journal article|Journal article,Nitric Oxide: Biology and Chemistry|Diabetes|Circulation,01/11/2014|31/12/2014|26/11/2013,Investigating the redox-effector functions of BH4: Insights from in vitro studies of NO-redox balance|Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue.|Integrated Plaque and Plasma Proteo-Lipidomics Reveal Novel Signatures of Coronary Atherosclerotic Plaque Disruption,"Bailey J,McGouran J,McNeill E,Kessler B,Channon K,Crabtree M|Antonopoulos AS,Margaritis M,Coutinho P,Shirodaria C,Psarros C,Herdman L,Sanna F,De Silva R,Petrou M,Sayeed R,Krasopoulos G,Lee R,Digby J,Reilly S,Bakogiannis C,Tousoulis D,Kessler B,Casadei B,Channon KM,Antoniades C|Lee R,Adlam D,Fischer R,Di Gleria K,Valli A,Charles P,McGouran J,Ruparelia N,Dawkins S,Kharbanda RK,Choudhury RP,Antoniades C,Kessler BM,Channon KM","Redox signalling,Nitric oxide,Tetrahydrobiopterin,Reactive oxygen species|Arteries,Adipose Tissue,Humans,Diabetes Mellitus,Type 2,NADPH Oxidase,Genotype,Aged,Middle Aged,Female,Male,Adiponectin,Real-Time Polymerase Chain Reaction|Plaque rupture,Proteomics,Lipids,Extracellular matrix"
chri0963,phys0101,23,6.227380952380952,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article,Biophysical Journal|PLoS One|Biophysical Journal|Proceedings of the National Academy of Sciences of USA|The Journal of Physiology|Philosophical Transactions of the Royal Society of London: Biological Sciences|Proceedings of the National Academy of Sciences of USA|Journal of Cellular Physiology|The Journal of Physiology|The Journal of Physiology|Current Pharmaceutical Design|Journal of Biological Chemistry|Journal of Molecular and Cellular Cardiology|The Journal of Physiology|Biophysical Journal|Cardiovascular Research|The Journal of Physiology|Journal of Molecular and Cellular Cardiology|The Journal of Physiology|Journal of Biological Chemistry|Biophysical Journal|Biophysical Journal|Clinical Cancer Research,31/01/2012|01/01/2012|31/01/2012|19/02/2013|02/12/2013|01/01/2014||04/09/2012|01/03/2014|10/02/2014|23/02/2012|24/07/2014|17/04/2013|15/04/2013|29/01/2013|16/12/2014|01/03/2014|01/08/2013|01/08/2014|23/02/2011|29/01/2013|29/01/2013|12/04/2012,"Role of Cytoplasmic Buffers in Spatial H+-Ca2+ Interactions in Ventricular Myocytes|Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin.|Spatial Localisation and Function of pH-Regulatory Transporters in the Rat Ventricular Myocyte|Extramitochondrial domain rich in carbonic anhydrase activity improves myocardial energetics.|Facilitation by intracellular carbonic anhydrase of Na+ -HCO3- co-transport but not Na+ / H+ exchange activity in the mammalian ventricular myocyte.|The chemistry, physiology and pathology of pH in cancer.|Coupled Ca2+/H+ transport by cytoplasmic buffers regulates local Ca2+ and H+ ion signaling|Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia.|Facilitation by intracellular carbonic anhydrase of Na-HCO co-transport but not Na/H exchange activity in the mammalian ventricular myocyte|Pumping Ca2+ up H+ gradients: a Ca2(+)-H+ exchanger without a membrane.|Acid-extrusion from tissue: the interplay between membrane transporters and pH buffers.|Intracellular carbonic anhydrase activity sensitizes cancer cell pH signaling to dynamic changes in CO2 partial pressure.|H⁺-activated Na⁺ influx in the ventricular myocyte couples Ca²⁺-signalling to intracellular pH.|Sarcolemmal localisation of Na+/H+ exchange and Na+-HCO3- co-transport influences the spatial regulation of intracellular pH in rat ventricular myocytes.|Low and High pH Gating of Connexin43 Channels|Na⁺ ions as spatial intracellular messengers for co-ordinating Ca²⁺ signals during pH heterogeneity in cardiomyocytes.|Facilitation by intracellular carbonic anhydrase of Na<sup>+</sup>-HCO<inf>3</inf><sup>-</sup> co-transport but not Na<sup>+</sup>/H<sup>+</sup> exchange activity in the mammalian ventricular myocyte|H+-activated Na+ influx in the ventricular myocyte couples Ca2+-signalling to intracellular pH|Pumping Ca2+ up H+ gradients: a Ca2+-H+ exchanger without a membrane|Dual role of CO2/HCO3(-) buffer in the regulation of intracellular pH of three-dimensional tumor growths.|Intracellular Na+ Spatially Controls Ca2+ Signaling during Acidosis in the Ventricular Myocyte|An Extra-Mitochondrial Domain Rich in Carbonic Anhydrase Activity Improves Myocardial Energetics|Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.","Swietach P,Youm J-B,Saegusa N,Leem C-H,Spitzer KW,Vaughan-Jones RD|Swietach P,Hulikova A,Patiar S,Vaughan-Jones RD,Harris AL|Garciarena C,Ma Y-L,Swietach P,Vaughan-Jones RD|Schroeder MA,Ali MA,Hulikova A,Supuran CT,Clarke K,Vaughan-Jones RD,Tyler DJ,Swietach P|Villafuerte FC,Swietach P,Youm JB,Ford K,Cardenas R,Supuran CT,Cobden PM,Rohling M,Vaughan-Jones RD|Swietach P,Vaughan-Jones RD,Harris AL,Hulikova A|Swietach P,Youm J-B,Saegusa N,Leem C-H,Spitzer KW,Vaughan-Jones RD|Hulikova A,Harris AL,Vaughan-Jones RD,Swietach P|Villafuerte FC,Swietach P,Youm J-B,Ford K,Cardenas R,Cobden PM,Rohling M,Vaughan-Jones RD,Supuran CT|Swietach P,Leem CH,Spitzer KW,Vaughan-Jones RD|Hulikova A,Harris AL,Vaughan-Jones RD,Swietach P|Hulikova A,Aveyard N,Harris AL,Vaughan-Jones RD,Swietach P|Garciarena CD,Youm JB,Swietach P,Vaughan-Jones RD|Garciarena CD,Ma YL,Swietach P,Huc L,Vaughan-Jones RD|Garciarena CD,Zhuang N,Malik A,Spitzer KW,Swietach P,Moreno A,Vaughan-Jones RD|Swietach P,Spitzer KW,Vaughan-Jones RD|Villafuerte FC,Swietach P,Youm JB,Ford K,Cardenas R,Supuran CT,Cobden PM,Rohling M,Vaughan-Jones RD|Garciarena CD,Youm JB,Swietach P,Vaughan-Jones RD|Swietach P,Leem C-H,Spitzer KW,Vaughan-Jones RD|Hulikova A,Vaughan-Jones RD,Swietach P|Swietach P,Spitzer KW,Vaughan-Jones RD|Schroeder MA,Ali M,Hulikova A,Supuran CT,Clarke K,Vaughan-Jones RD,Tyler DJ,Swietach P|McIntyre A,Patiar S,Wigfield S,Li JL,Ledaki I,Turley H,Leek R,Snell C,Gatter K,Sly WS,Vaughan-Jones RD,Swietach P,Harris AL","|Antibiotics,Antineoplastic,Binding Sites,Cell Nucleus,Cell Proliferation,Doxorubicin,HCT116 Cells,Humans,Hydrogen-Ion Concentration,Models,Chemical||Adenosine Triphosphate,Animals,Carbon Dioxide,Carbonic Anhydrase II,Carbonic Anhydrase IV,Carbonic Anhydrases,Cell Compartmentation,Cytoplasm,Energy Metabolism,Fluorescent Dyes,Hydrogen-Ion Concentration,Kinetics,Male,Mitochondria,Heart,Myocytes,Cardiac,Rats,Wistar|Animals,Bicarbonates,Carbonic Anhydrases,Cells,Cultured,Enzyme Activation,Heart Ventricles,Hydrogen-Ion Concentration,Male,Myocytes,Cardiac,Rats,Sprague-Dawley,Sodium,Sodium-Bicarbonate Symporters,Sodium-Hydrogen Antiporter|buffering,carbonic anhydrase,diffusion,pH regulation,pH sensing,Acid-Base Equilibrium,Carbonic Anhydrases,Humans,Hydrogen-Ion Concentration,Membrane Transport Proteins,Neoplasms,Oxygen,Proton Pumps,Tumor Microenvironment||Acids,Biological Transport,Cation Transport Proteins,Cell Hypoxia,Cell Line,Tumor,Down-Regulation,HCT116 Cells,HT29 Cells,HeLa Cells,Homeostasis,Humans,Hydrogen-Ion Concentration,Neoplasms,Oxygen,Sodium-Hydrogen Antiporter||Animals,Antiporters,Calcium Signaling,Cation Transport Proteins,Cytoplasm,Humans,Myocytes,Cardiac|Acid-Base Equilibrium,Buffers,Cell Membrane,Humans,Hydrogen-Ion Concentration,Membrane Transport Proteins|HCT116 Cells,Cytoplasm,Humans,Neoplasms,Carbon Dioxide,Bicarbonates,Protons,Carbonic Anhydrases,Signal Transduction,Hydrogen-Ion Concentration,Partial Pressure|CA,CBE,CHE,Ca(2+) transient,CaT,Cl(−)/HCO(3)(−) exchange,Cl(−)/OH(−) exchange,DAD,LTCC,MAPK,MCT,NBC,NCX,NHE,Na(+)-HCO(3)(−) co-transport,Na(+)-influx,Na(+)/Ca(2+) exchange,Na(+)/H(+) exchange,PKC,PMCA,RyR,SERCA,SR,acidosis,carbonic anhydrase,delayed after-depolarisation,intracellular pH,mitogen activated protein kinase,monocarboxylic acid transporter,pH regulatory proteins,pH transporters,pH(i),pH(i)-regulation,plasmalemmal Ca(2+) ATPase,protein kinase C,ryanodine receptor,sarcolemmal L-type Ca(2+) channel,sarcoplasmic reticular Ca(2+) ATPase,sarcoplasmic reticulum,t-tubules,transverse tubules,Acid-Base Imbalance,Animals,Cardiomegaly,Cation Transport Proteins,Excitation Contraction Coupling,Heart Failure,Heart Ventricles,Humans,Myocardial Reperfusion Injury,Myocytes,Cardiac,Protons,Sodium-Hydrogen Antiporter|Animals,Calcium,Electric Capacitance,Female,Guinea Pigs,Heart Ventricles,Hydrogen-Ion Concentration,Male,Myocytes,Cardiac,Rats,Sprague-Dawley,Sarcolemma,Sodium-Bicarbonate Symporters,Sodium-Hydrogen Antiporter||Sarcoplasmic Reticulum,Heart Ventricles,Intracellular Space,Myocytes,Cardiac,Animals,Rats,Ions,Sodium,Calcium,Myocardial Contraction,Hydrogen-Ion Concentration||||4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid,Bicarbonates,Biological Transport,Buffers,Carbon Dioxide,Cell Line,Tumor,Diffusion,Disease Progression,HeLa Cells,Humans,Hydrogen-Ion Concentration,Ions,Microscopy,Confocal,Neoplasms,Protons,Spheroids,Cellular|||Angiogenesis Inhibitors,Animals,Antibodies,Monoclonal,Humanized,Antigens,Neoplasm,Bevacizumab,Carbonic Anhydrases,Cell Line,Tumor,Cell Proliferation,Female,Gene Knockdown Techniques,Glioblastoma,HCT116 Cells,HT29 Cells,Humans,Hydrogen-Ion Concentration,Mice,Necrosis,Neoplasm Transplantation,Transfection,Transplantation,Heterologous"
raob0097,raob0202,3,0.38181818181818183,Journal article|Journal article|Conference paper,"Cell Death and Disease|Cancer Treatment Reviews|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",01/01/2012|11/04/2013|01/05/2013,Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|Targeting ATR in DNA damage response and cancer therapeutics.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation,"Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Fokas E,Prevo R,Hammond EM,Brunner TB,McKenna WG,Muschel RJ|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB","Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|ATR,Cancer,Chemotherapy,DNA damage,Radiation,Replication stress,Therapeutics,Animals,Antineoplastic Agents,Ataxia Telangiectasia Mutated Proteins,Clinical Trials as Topic,Combined Modality Therapy,DNA Damage,DNA Replication,Humans,Molecular Targeted Therapy,Neoplasms,Protein Kinase Inhibitors,Protein Kinases,Signal Transduction|"
ndos0461,ndos0532,4,0.6666666666666666,Journal article|Journal article|Journal article|Journal article,"European Urology, Supplements|British Journal of Cancer|Complementary Therapies in Medicine|Journal of Endourology",01/02/2012|12/01/2012|01/02/2011|21/05/2012,"Circulating microRNAs are associated with the development and progression of prostate cancer|Changes in circulating microRNA levels associated with prostate cancer.|Acupuncture in urological practice--a survey of urologists in England.|Flexible cystoscopy findings in patients investigated for profound lower urinary tract symptoms, recurrent urinary tract infection, and pain.","Bryant RJ,Pawlowski T,Catto JWF,Marsden G,Vessella RL,Rhees B,Kuslich C,Visakorpi T,Hamdy FC|Bryant RJ,Pawlowski T,Catto JW,Marsden G,Vessella RL,Rhees B,Kuslich C,Visakorpi T,Hamdy FC|Tempest H,Reynard J,Bryant RJ,Hamdy FC,Larré S|Howles S,Tempest H,Doolub G,Bryant RJ,Hamdy FC,Noble JG,Larré S","|Aged,Biomarkers,Tumor,Humans,Male,MicroRNAs,Neoplasm Metastasis,Prognosis,Prostate-Specific Antigen,Prostatic Neoplasms|Acupuncture Therapy,Adult,Aged,Attitude of Health Personnel,England,Feasibility Studies,Female,Health Knowledge,Attitudes,Practice,Humans,Male,Middle Aged,Physicians,Surveys and Questionnaires,Urology|Adolescent,Adult,Aged,80 and over,Cystoscopy,Demography,Female,Humans,Lower Urinary Tract Symptoms,Male,Middle Aged,Pain,Pliability,Recurrence,Urinary Tract Infections,Young Adult"
awatts,bioc0987,2,0.2111111111111111,Conference paper|Journal article,Biophysical Journal|Structure,29/01/2013|03/02/2015,"Using DEER, Modelling and Simulations to Investigate the Dynamics of PepTSo, a Major Facilitator Superfamily Transporter of Biomedical Importance|Gating topology of the proton-coupled oligopeptide symporters.","Fowler PW,Orwick-Rydmark M,Solcan N,Radestock S,Dijkman P,Kwok J,Samsudin F,Watts A,Forrest L,Newstead S|Fowler PW,Orwick-Rydmark M,Radestock S,Solcan N,Dijkman PM,Lyons JA,Kwok J,Caffrey M,Watts A,Forrest LR,Newstead S","|Bacteria,Symporters,Crystallography,Spectrum Analysis,Electron Spin Resonance Spectroscopy,Protein Conformation,Biological Transport,Active,Models,Molecular,Molecular Dynamics Simulation"
immd0084,ndog0115,1,0.05263157894736842,Conference paper,Journal of Medical Genetics,01/09/2012,Dysregulated mitophagy and mitochondrial transport in severe inherited optic atrophy due to OPA1 mutations,"Poulton J,Liao C,Ashley N,Morten K,Phadwal K,Williams A,Feamley I,Rosser L,Lowndes J,Fratter C,Ferguson D,Quaghebeur G,Moroni I,Bianchi S,Lamperti C,Macleod L,Downes S,Zeviani M,Simon AK,Votruba M",
hert0418,stat0004,5,1.140036231884058,Journal article|Journal article|Journal article|Journal article|Journal article,European Journal of Human Genetics|European Journal of Human Genetics|Nature|Nature|Nature Communications,10/08/2011|01/01/2012|19/03/2015|01/01/2012|13/06/2014,"People of the British Isles: preliminary analysis of genotypes and surnames in a UK-control population.|People of the British Isles: Preliminary analysis of genotypes and surnames in a UK-control population|The fine-scale genetic structure of the British population.|An integrated map of genetic variation from 1,092 human genomes|Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel.","Winney B,Boumertit A,Day T,Davison D,Echeta C,Evseeva I,Hutnik K,Leslie S,Nicodemus K,Royrvik EC,Tonks S,Yang X,Cheshire J,Longley P,Mateos P,Groom A,Relton C,Bishop DT,Black K,Northwood E,Parkinson L,Frayling TM,Steele A,Sampson JR,King T,Dixon R,Middleton D,Jennings B,Bowden R,Donnelly P,Bodmer W|Winney B,Boumertit A,Day T,Davison D,Echeta C,Evseeva I,Hutnik K,Leslie S,Nicodemus K,Royrvik EC,Tonks S,Yang X,Cheshire J,Longley P,Mateos P,Groom A,Relton C,Bishop DT,Black K,Northwood E,Parkinson L,Frayling TM,Steele A,Sampson JR,King T,Dixon R,Middleton D,Jennings B,Bowden R,Donnelly P,Bodmer W|Leslie S,Winney B,Hellenthal G,Davison D,Boumertit A,Day T,Hutnik K,Royrvik EC,Cunliffe B,Lawson DJ,Falush D,Freeman C,Pirinen M,Myers S,Robinson M,Donnelly P,Bodmer W|Altshuler DM,Durbin RM,Abecasis GR,Bentley DR,Chakravarti A,Clark AG,Donnelly P,Eichler EE,Flicek P,Gabriel SB,Gibbs RA,Green ED,Hurles ME,Knoppers BM,Korbel JO,Lander ES,Lee C,Lehrach H,Mardis ER,Marth GT,McVean GA,Nickerson DA,Schmidt JP,Sherry ST,Wang J,Wilson RK,Dinh H,Kovar C,Lee S,Lewis L,Muzny D,Reid J,Wang M,Fang X,Guo X,Jian M,Jiang H,Jin X,Li G,Li J,Li Y,Li Z,Liu X,Lu Y,Ma X,Su Z,Tai S,Tang M,Wang B,Wang G,Wu H,Wu R,Yin Y,Zhang W,Zhao J,Zhao M,Zheng X,Zhou Y,Gupta N,Clarke L,Leinonen R,Smith RE,Zheng-Bradley X,Grocock R,Humphray S,James T,Kingsbury Z,Sudbrak R,Albrecht MW,Amstislavskiy VS,Borodina TA,Lienhard M,Mertes F,Sultan M,Timmermann B,Yaspo ML,Fulton L,Fulton R,Weinstock GM,Balasubramaniam S,Burton J,Danecek P,Keane TM,Kolb-Kokocinski A,McCarthy S,Stalker J,Quail M,Davies CJ,Gollub J,Webster T,Wong B,Zhan Y,Auton A|Delaneau O,Marchini J","Adolescent,Adult,Aged,80 and over,Alleles,Female,Gene Frequency,Genetics,Population,Genotype,Great Britain,Haplotypes,Humans,Male,Middle Aged,Names,Young Adult||Wellcome Trust Case Control Consortium 2,International Multiple Sclerosis Genetics Consortium,Humans,Genetics,Population,Haplotypes,Polymorphism,Single Nucleotide,Algorithms,Principal Component Analysis,European Continental Ancestry Group,Great Britain||1000 Genomes Project Consortium,Humans,Microarray Analysis,Gene Frequency,Haplotypes,Polymorphism,Single Nucleotide,Alleles,Genome,Human,Algorithms,Genome-Wide Association Study"
card0027,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme1358,path0084,1,0.07692307692307693,Journal article,Chemistry and Biology,26/08/2015,Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.,"Canning P,Ruan Q,Schwerd T,Hrdinka M,Maki JL,Saleh D,Suebsuwong C,Ray S,Brennan PE,Cuny GD,Uhlig HH,Gyrd-Hansen M,Degterev A,Bullock AN",
raob0009,raob0087,1,0.1111111111111111,Journal article,Journal of Nuclear Medicine,15/04/2011,ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.,"Cornelissen B,Darbar S,Hernandez R,Kersemans V,Tullis I,Barber PR,Smart S,Vojnovic B,Reilly R,Vallis KA","Active Transport,Cell Nucleus,Animals,Antibodies,Monoclonal,Humanized,Cell Line,Tumor,Cell Proliferation,Colony-Forming Units Assay,Dimethylallyltranstransferase,Electrons,Epidermal Growth Factor,Female,Humans,Imidazoles,Mice,Pentetic Acid,Protein Kinase Inhibitors,Protein Transport,Receptor,ErbB-2,Signal Transduction,Trastuzumab"
path0084,stat0004,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0237,whgu0172,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
whgu0256,whgu0274,1,0.08333333333333333,Journal article,PLoS One,01/01/2011,Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α).,"Thalhammer A,Bencokova Z,Poole R,Loenarz C,Adam J,O'Flaherty L,Schödel J,Mole D,Giaslakiotis K,Schofield CJ,Hammond EM,Ratcliffe PJ,Pollard PJ","Anoxia,Cell Line,Dioxygenases,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Ketoglutaric Acids,Membrane Proteins,Nuclear Proteins,Oxygenases,Transcriptional Activation"
immd0036,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0301,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0975,whgu0378,11,3.3809567021000775,Journal article|Conference paper|Conference paper|Conference paper|Conference paper|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper,Annals of Oncology|Annals of Oncology|British Journal of Surgery|British Journal of Surgery|British Journal of Surgery|Digestive Diseases and Sciences|British Journal of Surgery|Nature Communications|Nature Genetics|Digestive Diseases and Sciences|British Journal of Surgery,11/09/2014|01/06/2012|01/01/2015|01/12/2014|01/12/2014|28/05/2016|01/12/2014||09/09/2012|07/10/2015|01/04/2015,"A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.|CLINICAL DIAGNOSTIC IMPLEMENTATION OF AN INNOVATIVE CANCER CARE MODEL BASED ON COMPREHENSIVE MOLECULAR PROFILING OF TUMOUR-NORMAL PAIRS|Genomic Biomarkers of Oesophageal Cancer Survival and Response to Therapy|Gene set enrichment analysis of genome wide association data identifies novel biological pathways associated with Barrett's Oesophagus, and subsequent progression to dysplasia and adenocarcinoma|Genomic biomarkers of Barrett's Oesophagus metaplasia, dysplasia and malignant progression: a meta-analysis|Erratum to: Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.|Exome sequencing of oesophageal adenocarcinoma demonstrates novel driver genes and pathways of carcinogenesis and response to neoadjuvant chemotherapy|Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.|Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.|Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.|The impact of oesophageal cancer temporal heterogeneity on DNA markers, drivers and targets, and the development of a combined clinical, genomic, pathological and radiological framework","Findlay JM,Middleton MR,Tomlinson I|Kaur K,Henderson S,Cutts A,Domingo E,Woods J,Motley C,Dougherty B,Middleton M,Hassan B,Wang Y,Beasley E,Naley M,Schuh A,Tomlinson I,Taylor J|Findlay J,Tomlinson I,Middleton M|Findlay J,Palles C,Middleton M,Jankowski J,Tomlinson I|Findlay J,Middleton M,Tomlinson I|Findlay JM,Middleton MR,Tomlinson I|Findlay J,Castro F,Gillies R,MacGregor T,Domingo E,Middleton M,Tomlinson I|Findlay JM,Castro-Giner F,Makino S,Rayner E,Kartsonaki C,Cross W,Kovac M,Ulahannan D,Palles C,Gillies RS,MacGregor TP,Church D,Maynard ND,Buffa F,Cazier JB,Graham TA,Wang LM,Sharma RA,Middleton M,Tomlinson I|Su Z,Gay LJ,Strange A,Palles C,Band G,Whiteman DC,Lescai F,Langford C,Nanji M,Edkins S,van der Winkel A,Levine D,Sasieni P,Bellenguez C,Howarth K,Freeman C,Trudgill N,Tucker AT,Pirinen M,Peppelenbosch MP,van der Laan LJ,Kuipers EJ,Drenth JP,Peters WH,Reynolds JV,Kelleher DP,McManus R,Grabsch H,Prenen H,Bisschops R,Krishnadath K,Siersema PD,van Baal JW,Middleton M,Petty R,Gillies R,Burch N,Bhandari P,Paterson S,Edwards C,Penman I,Vaidya K,Ang Y,Murray I,Patel P,Ye W,Mullins P,Wu AH,Bird NC,Dallal H,Shaheen NJ,Murray LJ,Koss K,Bernstein L,Romero Y,Hardie LJ,Zhang R,Winter H,Corley DA,Panter S,Risch HA,Reid BJ,Sargeant I,Gammon MD,Smart H,Dhar A,McMurtry H,Ali H,Liu G,Casson AG,Chow WH,Rutter M,Tawil A,Morris D,Nwokolo C,Isaacs P,Rodgers C,Ragunath K,MacDonald C,Haigh C,Monk D,Davies G,Wajed S,Johnston D,Gibbons M,Cullen S,Church N,Langley R,Griffin M,Alderson D,Deloukas P,Hunt SE,Gray E,Dronov S,Potter SC,Tashakkori-Ghanbaria A,Anderson M,Brooks C,Blackwell JM,Bramon E,Brown MA,Casas JP,Corvin A,Duncanson A,Markus HS,Mathew CG,Palmer CN,Plomin R,Rautanen A,Sawcer SJ,Trembath RC,Viswanathan AC,Wood N,Trynka G,Wijmenga C,Cazier JB,Atherfold P,Nicholson AM,Gellatly NL,Glancy D,Cooper SC,Cunningham D,Lind T,Hapeshi J,Ferry D,Rathbone B,Brown J,Love S,Attwood S,MacGregor S,Watson P,Sanders S,Ek W,Harrison RF,Moayyedi P,de Caestecker J,Barr H,Stupka E,Vaughan TL,Peltonen L,Spencer CC,Tomlinson I,Donnelly P,Jankowski JA,Esophageal Adenocarcinoma Genetics Consortium,Wellcome Trust Case Control Consortium 2|Findlay JM,Middleton MR,Tomlinson I|Findlay JM,Castro-Giner F,Tomlinson I,Middleton MR","Humans,Esophageal Neoplasms,DNA,Neoplasm,Neoplasm Staging,Prognosis,Germ-Line Mutation,Polymorphism,Single Nucleotide,Biomarkers,Tumor||||||||Adult,Aged,Barrett Esophagus,Case-Control Studies,Chromosomes,Human,Pair 16,Female,Gene Frequency,Genetic Loci,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Linkage Disequilibrium,Major Histocompatibility Complex,Male,Middle Aged,Models,Genetic,Polymorphism,Single Nucleotide|Esophagus,Humans,Adenocarcinoma,Esophageal Neoplasms,Precancerous Conditions,Barrett Esophagus,Disease Progression,Genetic Predisposition to Disease,Genetic Markers,Prognosis,Treatment Outcome,Risk Assessment,Risk Factors,Phenotype,Genetic Variation,Genome-Wide Association Study|"
immd0679,mjawood,1,0.05555555555555555,Journal article,Nature Structural and Molecular Biology,12/10/2014,Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7.,"Tan JY,Vance KW,Varela MA,Sirey T,Watson LM,Curtis HJ,Marinello M,Alves S,Steinkraus BR,Cooper S,Nesterova T,Brockdorff N,Fulga TA,Brice A,Sittler A,Oliver PL,Wood MJ,Ponting CP,Marques AC","Cerebellum,Neurons,Retina,Cell Line,Tumor,Fibroblasts,Animals,Humans,Mice,Spinocerebellar Ataxias,Nerve Tissue Proteins,MicroRNAs,RNA,Messenger,Gene Expression Profiling,Signal Transduction,Gene Expression Regulation,Mutation,Female,Male,Feedback,Physiological,Transcription Initiation,Genetic,Long Noncoding"
immd0330,quee1607,3,0.13942641276694162,Journal article|Journal article|Conference paper,Leukemia|Nature Genetics|Blood,01/01/2012|18/05/2015|06/12/2014,Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Towards Response Prediction Using Integrated Genomics in Chronic Lymphocytic Leukaemia: Results on 250 First-Line FCR Treated Patients from UK Clinical Trials,"Knight SJ,Yau C,Clifford R,Timbs AT,Sadighi Akha E,Dréau HM,Burns A,Ciria C,Oscier DG,Pettitt AR,Dutton S,Holmes CC,Taylor J,Cazier JB,Schuh A|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Clifford RM,Robbe P,Weller S,Timbs AT,Titsias M,Burns A,Cabes M,Alsolami R,Yau C,Hamblin A,Mason J,Oates M,Pettitt A,Holmes C,Hillmen P,Taylor J,Knight SJL,Schuh A","Adult,Aged,80 and over,Biomarkers,Tumor,Chromosome Aberrations,Clone Cells,Female,Gene Dosage,Genome,Human,Genomics,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Loss of Heterozygosity,Male,Middle Aged,Neoplasm Recurrence,Local,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Prognosis|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|"
clab0101,immd0700,2,0.0425531914893617,Journal article|Journal article,Cancer Cell|Cancer Cell,14/05/2014|16/06/2014,Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo,"Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SE|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW","Chromosomes,Human,Pair 5,Animals,Mice,Inbred NOD,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Genetic Predisposition to Disease,Antigens,CD,Prognosis,Flow Cytometry,Gene Expression Profiling,Mutation,Neoplastic Stem Cells,Heterografts|"
immd0218,whgu0172,3,0.5269230769230769,Journal article|Journal article|Conference paper,Arthritis and Rheumatism|Clinical and Experimental Rheumatology|Rheumatology,01/11/2013|01/01/2012|01/05/2012,Endoplasmic reticulum aminopeptidase 1 (ERAP1) plays a critical role in determining the length and sequence of peptides bound and presented by HLA-B27|ENDOPLASMIC RETICULUM AMINOPEPTIDASE-1 (ERAP1) PLAYS A CRITICAL ROLE IN PEPTIDE BINDING AND ANTIGEN PRESENTATION BY HLA-B27|INVESTIGATING THE ROLE OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE-1 IN ANKYLOSING SPONDYLITIS,"Chen L,Fischer R,Peng Y,Reeves E,McHugh K,Ternette N,Hanke T,Dong T,Elliott T,Shastri N,Kollnberger S,James E,Kessler B,Bowness P|Chen L,Fisher R,Kollnberger S,Kessler B,Bowness P|Chen L,Fisher R,Kollnberger S,Shastri N,Kessler BM,Bowness P",||
donc0114,raob0233,1,0.06666666666666667,Journal article,Molecular Cell,29/12/2015,Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds.,"Zimmer J,Tacconi EM,Folio C,Badie S,Porru M,Klare K,Tumiati M,Markkanen E,Halder S,Ryan A,Jackson SP,Ramadan K,Kuznetsov SG,Biroccio A,Sale JE,Tarsounas M",
clme0301,stat0054,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clab0101,immd0330,9,0.7988455988455988,Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article,Leukemia|Leukemia|Leukemia|Leukemia Research: clinical and laboratory studies|Oncotarget|Leukemia|Haematologica: the hematology journal|British Journal of Haematology|British Journal of Haematology,01/05/2014|06/12/2014|01/01/2016|01/04/2015||24/12/2013|05/07/2013|01/01/2013|01/10/2013,Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia|Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression.|Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression|TARGETED RE-SEQUENCING ANALYSIS OF 31 GENES COMMONLY MUTATED IN MYELOID DISORDERS IN SERIAL SAMPLES FROM MYELODYSPLASTIC SYNDROME PATIENTS WITH DISEASE PROGRESSION|ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.|Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.|Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.|Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression|Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression,"Pellagatti A,Fernandez-Mercado M,Di Genua C,Larrayoz MJ,Killick S,Dolatshad H,Burns A,Calasanz MJ,Schuh A,Boultwood J|Pellagatti A,Roy S,Di Genua C,Burns A,McGraw K,Valletta S,Larrayoz MJ,Fernandez-Mercado M,Mason J,Killick S,Mecucci C,Calasanz MJ,List A,Schuh A,Boultwood J|Pellagatti A,Roy S,Di Genua C,Burns A,McGraw K,Valletta S,Larrayoz MJ,Fernandez-Mercado M,Mason J,Killick S,Mecucci C,Calasanz MJ,List A,Schuh A,Boultwood J|Pellagatti A,Roy S,Di Genua C,Burns A,McGraw K,Larrayoz MJ,Fernandez-Mercado M,Valletta S,Mason J,Killick S,Mecucci C,Calasanz MJ,List A,Schuh A,Boultwood J|Valletta S,Dolatshad H,Bartenstein M,Yip BH,Bello E,Gordon S,Yu Y,Shaw J,Roy S,Scifo L,Schuh A,Pellagatti A,Fulga TA,Verma A,Boultwood J|Pellagatti A,Fernandez-Mercado M,Di Genua C,Larrayoz MJ,Killick S,Dolatshad H,Burns A,Calasanz MJ,Schuh A,Boultwood J|Fernandez-Mercado M,Burns A,Pellagatti A,Giagounidis A,Germing U,Agirre X,Prosper F,Aul C,Killick S,Wainscoat JS,Schuh A,Boultwood J|Fernandez-Mercado M,Pellagatti A,Di Genua C,Boultwood J,Larrayoz MJ,Aranaz P,Calasanz MJ,Winkelmann N,Cross NCP,Burns A,Schuh A|Fernandez-Mercado M,Pellagatti A,Di Genua C,Larrayoz MJ,Winkelmann N,Aranaz P,Burns A,Schuh A,Calasanz MJ,Cross NCP,Boultwood J","|Humans,Myelodysplastic Syndromes,Disease Progression,GTP Phosphohydrolases,Ribonucleoproteins,Membrane Proteins,Nuclear Proteins,Repressor Proteins,Mutation,Genes,p53,Core Binding Factor Alpha 2 Subunit,High-Throughput Nucleotide Sequencing||||Chromosome Deletion,Chromosomes,Human,Pair 5,Exome,Humans,Leukemia,Myeloid,Acute,Myelodysplastic Syndromes|Adult,Aged,80 and over,Anemia,Macrocytic,Chromosome Deletion,Chromosomes,Human,Pair 5,Cohort Studies,Female,Gene Frequency,Gene Targeting,Humans,Male,Middle Aged,Mutation,Myelodysplastic Syndromes,Polymorphism,Single Nucleotide,Sequence Analysis,DNA,Young Adult||"
clme0494,clme0497,3,0.24285714285714285,Journal article|Journal article|Journal article,Journal of Biological Chemistry|Journal of Biological Chemistry|Nature Reviews Drug Discovery,24/01/2013|27/09/2013|01/03/2015,Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.|Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.|Preclinical target validation using patient-derived cells.,"Canning P,Cooper CD,Krojer T,Murray JW,Pike AC,Chaikuad A,Keates T,Thangaratnarajah C,Hojzan V,Ayinampudi V,Marsden BD,Gileadi O,Knapp S,von Delft F,Bullock AN|Canning P,Cooper CD,Krojer T,Murray JW,Pike AC,Chaikuad A,Keates T,Thangaratnarajah C,Hojzan V,Ayinampudi V,Marsden BD,Gileadi O,Knapp S,von Delft F,Bullock AN|Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","Binding Sites,Calorimetry,Carrier Proteins,Crystallography,X-Ray,Cullin Proteins,Dimerization,Humans,Models,Molecular,Molecular Conformation,Phylogeny,Proteasome Endopeptidase Complex,Protein Binding,Protein Conformation,Protein Interaction Mapping,Protein Structure,Secondary,Tertiary,Substrate Specificity,Ubiquitin,Ubiquitin-Protein Ligases||SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
bioc0192,bioc0416,1,0.07142857142857142,Journal article,Proceedings of the National Academy of Sciences of USA,26/03/2012,Molecular MRI enables early and sensitive detection of brain metastases.,"Serres S,Soto MS,Hamilton A,McAteer MA,Carbonell WS,Robson MD,Ansorge O,Khrapitchev A,Bristow C,Balathasan L,Weissensteiner T,Anthony DC,Choudhury RP,Muschel RJ,Sibson NR","Animals,Brain Neoplasms,Disease Progression,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Sensitivity and Specificity,Up-Regulation,Vascular Cell Adhesion Molecule-1"
clme0237,immd0024,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0485,ndos0159,1,0.07142857142857142,Journal article,Bone,09/04/2011,The relationship between the chemistry and biological activity of the bisphosphonates.,"Ebetino FH,Hogan AM,Sun S,Tsoumpra MK,Duan X,Triffitt JT,Kwaasi AA,Dunford JE,Barnett BL,Oppermann U,Lundy MW,Boyde A,Kashemirov BA,McKenna CE,Russell RG","Animals,Bone and Bones,Dimethylallyltranstransferase,Diphosphonates,Humans,Models,Biological,Osteoclasts,Structure-Activity Relationship"
clne0009,phpc0084,1,0.3333333333333333,Journal article,International Journal of Stroke,10/11/2013,Validation of a TIA recognition tool in primary and secondary care: implications for generalizability.,"Lasserson DS,Mant D,Hobbs FD,Rothwell PM","clinical prediction rules,diagnosis,methodology,prevention,primary care,vascular events,Aged,80 and over,Community Health Planning,Female,Humans,Ischemic Attack,Transient,Male,Middle Aged,Predictive Value of Tests,Primary Health Care,Reproducibility of Results,Retrospective Studies,Secondary Care,Severity of Illness Index"
card0018,whgu0274,2,0.058823529411764705,Journal article|Journal article,Cell Metabolism|Cell Metabolism,01/01/2012|07/03/2012,Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway|Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.,"Ashrafian H,Czibik G,Bellahcene M,Aksentijević D,Smith AC,Mitchell SJ,Dodd MS,Kirwan J,Byrne JJ,Ludwig C,Isackson H,Yavari A,Støttrup NB,Contractor H,Cahill TJ,Sahgal N,Ball DR,Birkler RID,Hargreaves I,Tennant DA,Land J,Lygate CA,Johannsen M,Kharbanda RK,Neubauer S,Redwood C,De Cabo R,Ahmet I,Talan M,Günther UL,Robinson AJ,Viant MR,Pollard PJ,Tyler DJ,Watkins H|Ashrafian H,Czibik G,Bellahcene M,Aksentijević D,Smith AC,Mitchell SJ,Dodd MS,Kirwan J,Byrne JJ,Ludwig C,Isackson H,Yavari A,Støttrup NB,Contractor H,Cahill TJ,Sahgal N,Ball DR,Birkler RI,Hargreaves I,Tennant DA,Land J,Lygate CA,Johannsen M,Kharbanda RK,Neubauer S,Redwood C,de Cabo R,Ahmet I,Talan M,Günther UL,Robinson AJ,Viant MR,Pollard PJ,Tyler DJ,Watkins H","|Animals,Antioxidants,Dimethyl Fumarate,Fumarate Hydratase,Fumarates,Male,Mice,Inbred C57BL,Knockout,Models,Biological,Myocardial Infarction,NF-E2-Related Factor 2,Signal Transduction"
bioc0801,bioc0801,1,0.25,Journal article,Nucleic Acids Research,,Protection of CpG islands from DNA methylation is DNA-encoded and evolutionarily conserved.,"Long HK,King HW,Patient RK,Odom DT,Klose RJ",
dplb0149,univ1923,2,0.3333333333333333,Journal article|Conference paper,Journal of the American Chemical Society|ACS National Meeting Book of Abstracts,27/01/2014|16/03/2014,Synthetic phosphorylation of p38α recapitulates protein kinase activity.|Giving p38a kinase a jump-start: p38a Activation induced by chemical modification,"Chooi KP,Galan SR,Raj R,McCullagh J,Mohammed S,Jones LH,Davis BG|Chooi KP,Galan S,Raj R,McCullagh J,Mohammed S,Jones LH,Davis BG","Activating Transcription Factor 2,Binding Sites,Cysteine,Enzyme Activation,Kinetics,MAP Kinase Signaling System,Mitogen-Activated Protein Kinase 14,Models,Molecular,Phosphorylation,Protein Conformation,Substrate Specificity|"
clme0220,raob0087,1,0.09090909090909091,Journal article,Proceedings of the National Academy of Sciences of USA,20/07/2015,The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions.,"Tapmeier TT,Moshnikova A,Beech J,Allen D,Kinchesh P,Smart S,Harris A,McIntyre A,Engelman DM,Andreev OA,Reshetnyak YK,Muschel RJ","Cell Line,Tumor,Spheroids,Cellular,Animals,Mice,Inbred BALB C,Humans,Neoplasms,Neoplasm Invasiveness,Disease Models,Animal,Acids,Membrane Proteins,Magnetic Resonance Spectroscopy,Sensitivity and Specificity,ROC Curve,Amino Acid Sequence,Hydrogen-Ion Concentration,Molecular Sequence Data,Mutant Proteins,Biomarkers"
clme0240,whgu0172,6,0.5411904761904761,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Transplant International|American Journal of Transplantation|Journal of Pathology|Cancer Cell|Journal of Biological Chemistry|Clinical Proteomics,01/05/2014|01/05/2016|01/01/2011|18/10/2011|22/02/2011|26/04/2012,USING PROTEOMICS AND METABOLOMICS AS NOVEL TOOLS TO IDENTIFY MITOCHONDRIAL DYSFUNCTION AND METABOLIC DYSREGULATION AS CRITICAL FACTORS IN BRAIN DEATH INDUCED KIDNEY INJURY|Using an Integrated -Omics Approach to Identify Key Cellular Processes That Are Disturbed in the Kidney After Brain Death.|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.|Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors.|Detection of BK virus in urine from renal transplant subjects by mass spectrometry.,"Akhtar M,Huang H,Kaisar M,Leuvenink HGD,Kessler B,Fuggle S,Pugh C,Ploeg RJ|Akhtar MZ,Huang H,Kaisar M,Lo Faro ML,Rebolledo R,Morten K,Heather LC,Dona A,Leuvenink HG,Fuggle SV,Kessler BM,Pugh CW,Ploeg RJ|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Adam J,Hatipoglu E,O'Flaherty L,Ternette N,Sahgal N,Lockstone H,Baban D,Nye E,Stamp GW,Wolhuter K,Stevens M,Fischer R,Carmeliet P,Maxwell PH,Pugh CW,Frizzell N,Soga T,Kessler BM,El-Bahrawy M,Ratcliffe PJ,Pollard PJ|Tian YM,Yeoh KK,Lee MK,Eriksson T,Kessler BM,Kramer HB,Edelmann MJ,Willam C,Pugh CW,Schofield CJ,Ratcliffe PJ|Konietzny R,Fischer R,Ternette N,Wright CA,Turney BW,Chakera A,Hughes D,Kessler BM,Pugh CW","||Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid|Adaptor Proteins,Signal Transducing,Animals,Antioxidants,Cell Hypoxia,Cytoskeletal Proteins,Fumarate Hydratase,Fumarates,Gene Expression Regulation,Neoplastic,Hypoxia-Inducible Factor 1,Kidney Diseases,Cystic,Mice,NF-E2-Related Factor 2,Procollagen-Proline Dioxygenase,Signal Transduction,Succinates|Animals,Cell Hypoxia,Drosophila melanogaster,Enzyme Inhibitors,Hep G2 Cells,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,K562 Cells,Male,Oxygenases,Protein Structure,Tertiary,Rats,Sprague-Dawley,Ubiquitin-Protein Ligases,p300-CBP Transcription Factors|"
raob0051,raob0128,2,0.2803030303030303,Journal article|Journal article,British Journal of Radiology|Physical Review Special Topics: Accelerators and Beams,11/04/2012|11/03/2013,Revisiting the ultra-high dose rate effect: implications for charged particle radiotherapy using protons and light ions.|Conceptual design of a nonscaling fixed field alternating gradient accelerator for protons and carbon ions for charged particle therapy,"Wilson P,Jones B,Yokoi T,Hill M,Vojnovic B|Peach KJ,Aslaninejad M,Barlow RJ,Beard CD,Bliss N,Cobb JH,Easton MJ,Edgecock TR,Fenning R,Gardner ISK,Hill MA,Owen HL,Johnstone CJ,Jones B,Jones T,Kelliher DJ,Khan A,Machida S,McIntosh PA,Pattalwar S,Pasternak J,Pozimski J,Prior CR,Rochford J,Rogers CT,Seviour R,Sheehy SL,Smith SL,Strachan J,Tygier S,Vojnovic B,Wilson P,Witte H,Yokoi T","Cell Hypoxia,Cell Survival,Humans,Ions,Neoplasms,Oxygen,Particle Accelerators,Protons,Radiation Tolerance,Radiotherapy Dosage,Radiotherapy,High-Energy,Tumor Cells,Cultured|"
clme0220,whgu0274,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
bioc0416,raob0047,4,0.5,Journal article|Journal article|Journal article|Journal article,Neuroimage|Neuroimage|Neuroimage|Neuroimage,01/07/2014|15/07/2013|05/03/2013|01/01/2014,"Corrigendum to Systemic inflammation alters central 5-HT function as determined by pharmacological MRI [Neuroimage 75 (2013) 177-186]|Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.|Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.|Systemic inflammation alters central 5-HT function as determined by pharmacological MRI (vol 75, pg 177, 2013)","Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC|Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC|Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC|Couch Y,Martin CJ,Howarth C,Raley J,Khrapitchev AA,Stratford M,Sharp T,Sibson NR,Anthony DC","||Animals,Autoradiography,Brain,Brain Chemistry,Chromatography,High Pressure Liquid,Fenfluramine,Fluorobenzenes,Image Processing,Computer-Assisted,Inflammation,Laser-Doppler Flowmetry,Magnetic Resonance Imaging,Male,Microdialysis,Piperidines,Rats,Sprague-Dawley,Serotonin,Serotonin Antagonists,Serotonin Uptake Inhibitors|"
corp0784,immd0024,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0151,stat0004,2,0.08488964346349745,Journal article|Conference paper,PLoS Genetics|Journal of Medical Genetics,01/12/2012|01/09/2012,Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development.|Genomic analysis of sporadic neurological disease using family trios: learning to expect the unexpected,"Lise S,Clarkson Y,Perkins E,Kwasniewska A,Sadighi Akha E,Schnekenberg RP,Suminaite D,Hope J,Baker I,Gregory L,Green A,Allan C,Lamble S,Jayawant S,Quaghebeur G,Cader MZ,Hughes S,Armstrong RJ,Kanapin A,Rimmer A,Lunter G,Mathieson I,Cazier JB,Buck D,Taylor JC,Bentley D,McVean G,Donnelly P,Knight SJ,Jackson M,Ragoussis J,Németh AH|Pagnamenta A,Martin H,Lise S,Hudspith K,Harrison V,Copley R,Rimmer A,Broxholme J,Kanapin A,Cazier JB,Akha ES,Knight SJL,Shears DJ,Stewart H,Kini U,Taylor J,Bentley DR,Keays DA,Blair E,Donnelly P","Adult,Animals,Cerebellum,Chromosome Mapping,Cognition Disorders,Humans,Mice,Knockout,Mutation,Neurons,Purkinje Cells,Spectrin,Spinocerebellar Ataxias|"
clme0667,raob0096,6,0.6658119658119659,Journal article|Conference paper|Journal article|Conference paper|Journal article|Conference paper,Oncotarget|Modern Pathology|Biochimica et Biophysica Acta: international journal of biochemistry and biophysics|Journal of Clinical Oncology|Radiotherapy and Oncology|Laboratory Investigation,|01/02/2016|06/12/2014|20/05/2015||01/02/2016,"The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma.|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.|ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)-Mechanism and clinical outcomes.|ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer","Wang LM,Silva MA,D'Costa Z,Bockelmann R,Soonawalla Z,Liu S,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Fokas E,O'Neill E,Gordon-Weeks A,Mukherjee S,McKenna WG,Muschel RJ|Wilson JM,Dutton SJ,Hackett SL,Durrant L,Chu K-Y,Eccles C,Abraham AG,O'Neill E,Partridge M,Hawkins MA,McKenna WG,Maughan T,Brunner TB,Mukherjee S|Wilson JM,Fokas E,Dutton SJ,Patel N,Hawkins MA,Eccles C,Chu KY,Durrant L,Abraham AG,Partridge M,Woodward M,O'Neill E,Maughan T,McKenna WG,Mukherjee S,Brunner TB|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E","||Animals,Humans,Mice,Carcinoma,Pancreatic Ductal,Pancreatic Neoplasms,Cell Transformation,Neoplastic,Disease Models,Animal,Inflammation,Cancer Vaccines,Immunotherapy,Drug Resistance,Neoplasm,Radiation Tolerance,Neoplastic Cells,Circulating|||"
clme0494,ocms0037,1,0.07142857142857142,Journal article,Haematologica: the hematology journal,28/05/2013,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary"
clab0035,immd0556,1,0.02127659574468085,Journal article,Cancer Cell,16/06/2014,Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo,"Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW",
immd0237,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0494,stat0004,1,0.07142857142857142,Journal article,Haematologica: the hematology journal,28/05/2013,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary"
clme0501,ndos0461,1,0.14285714285714285,Journal article,Molecular and Cellular Proteomics,01/01/2011,Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis,"Wright CA,Howles S,Trudgian DC,Kessler BM,Reynard JM,Noble JG,Hamdy FC,Turney BW",
clme0439,clme0946,1,0.05,Journal article,Cancer Cell,13/05/2013,Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
immd0082,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
raob0047,whgu0172,1,0.2,Journal article,Cell Death and Differentiation,29/08/2014,Cofactor Strap regulates oxidative phosphorylation and mitochondrial p53 activity through ATP synthase.,"Maniam S,Coutts AS,Stratford MR,McGouran J,Kessler B,La Thangue NB","Hela Cells,Mitochondria,Humans,Mitochondrial Proton-Translocating ATPases,Glucose,Neoplasm Proteins,Apoptosis,Oxidative Phosphorylation,Oxygen Consumption,Tumor Suppressor Protein p53,Transcriptional Activation"
raob0121,whgu0172,6,0.9791666666666666,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Molecular Cell|Chemistry and Biology|Nucleic Acids Research|Nucleic Acids Research|Molecular Cell|Nucleic Acids Research,04/03/2011|23/11/2011|23/03/2015|20/09/2011|21/02/2012|05/10/2012,USP47 is a deubiquitylating enzyme that regulates base excision repair by controlling steady-state levels of DNA polymerase β.|Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.|Cells deficient in base-excision repair reveal cancer hallmarks originating from adjustments to genetic instability.|Ubiquitin ligase UBR3 regulates cellular levels of the essential DNA repair protein APE1 and is required for genome stability.|ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage.|Phosphorylation of PNKP by ATM prevents its proteasomal degradation and enhances resistance to oxidative stress.,"Parsons JL,Dianova II,Khoronenkova SV,Edelmann MJ,Kessler BM,Dianov GL|Altun M,Kramer HB,Willems LI,McDermott JL,Leach CA,Goldenberg SJ,Kumar KG,Konietzny R,Fischer R,Kogan E,Mackeen MM,McGouran J,Khoronenkova SV,Parsons JL,Dianov GL,Nicholson B,Kessler BM|Markkanen E,Fischer R,Ledentcova M,Kessler BM,Dianov GL|Meisenberg C,Tait PS,Dianova II,Wright K,Edelmann MJ,Ternette N,Tasaki T,Kessler BM,Parsons JL,Kwon YT,Dianov GL|Khoronenkova SV,Dianova II,Ternette N,Kessler BM,Parsons JL,Dianov GL|Parsons JL,Khoronenkova SV,Dianova II,Ternette N,Kessler BM,Datta PK,Dianov GL","Catalytic Domain,Cytoplasm,DNA Damage,DNA Polymerase beta,DNA Repair,Gene Expression Regulation,Enzymologic,Genome,Glycosylation,HeLa Cells,Humans,Lysine,Models,Biological,Ubiquitin,Ubiquitin Thiolesterase|Aminopyridines,Antibodies,Cell Line,Chromatography,High Pressure Liquid,Enzyme Activation,Enzyme Inhibitors,Humans,Proteomics,RNA Interference,Tandem Mass Spectrometry,Thiocyanates,Thiophenes,Ubiquitin Thiolesterase|Cell Line,Humans,Neoplasms,Genomic Instability,Amino Acids,DNA-Binding Proteins,DNA Primers,Comet Assay,DNA Repair,Base Sequence,Energy Metabolism,Real-Time Polymerase Chain Reaction|Animals,DNA-(Apurinic or Apyrimidinic Site) Lyase,Gene Knockout Techniques,Genomic Instability,HeLa Cells,Humans,Lysine,Mice,Ubiquitin-Protein Ligases,Ubiquitination|Amino Acid Sequence,Ataxia Telangiectasia Mutated Proteins,Casein Kinase II,Cell Cycle Checkpoints,Cell Cycle Proteins,DNA Damage,DNA-Binding Proteins,Down-Regulation,HeLa Cells,Humans,Molecular Sequence Data,Phosphoprotein Phosphatases,Phosphorylation,Protein-Serine-Threonine Kinases,Proto-Oncogene Proteins c-mdm2,Radiation,Ionizing,Serine,Signal Transduction,Tumor Suppressor Protein p53,Tumor Suppressor Proteins,Ubiquitin Thiolesterase|Animals,Ataxia Telangiectasia Mutated Proteins,Carrier Proteins,Cell Cycle Proteins,Cullin Proteins,DNA Damage,DNA Repair Enzymes,DNA-Binding Proteins,Enzyme Stability,HeLa Cells,Humans,Mice,Oxidative Stress,Phosphorylation,Phosphotransferases (Alcohol Group Acceptor),Proteasome Endopeptidase Complex,Protein-Serine-Threonine Kinases,Tumor Suppressor Proteins,Ubiquitin-Protein Ligases,Ubiquitination"
clme0670,xxxx0009,1,0.07692307692307693,Journal article,PLoS One,01/01/2015,Improving In Vivo High-Resolution CT Imaging of the Tumour Vasculature in Xenograft Mouse Models through Reduction of Motion and Bone-Streak Artefacts.,"Kersemans V,Kannan P,Beech JS,Bates R,Irving B,Gilchrist S,Allen PD,Thompson J,Kinchesh P,Casteleyn C,Schnabel J,Partridge M,Muschel RJ,Smart SC","Animals,Mice,Inbred CBA,Neoplasms,Adenocarcinoma,Disease Models,Animal,Tomography,X-Ray Computed,Magnetic Resonance Imaging,Fluoroscopy,Transplantation,Heterologous,Artifacts,Image Processing,Computer-Assisted,Female"
olin0014,raob0096,1,0.08333333333333333,Journal article,Current Biology,26/02/2015,"Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.","Vlahov N,Scrace S,Soto MS,Grawenda AM,Bradley L,Pankova D,Papaspyropoulos A,Yee KS,Buffa F,Goding CR,Timpson P,Sibson N,O'Neill E",
path0089,stat0054,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0494,ndos0168,1,0.1,Journal article,Nature Reviews Drug Discovery,01/03/2015,Preclinical target validation using patient-derived cells.,"Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
donc0120,donc0228,1,0.2,Journal article,Radiotherapy and Oncology,01/11/2015,Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer.,"Robinson M,Sabbagh A,Muirhead R,Durrant L,Van den Heuvel F,Hawkins M",
clab0035,clab0101,79,12.05875814753973,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Conference paper|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article,Leukemia|Leukemia|Proceedings of the National Academy of Sciences of USA|Leukemia|British Journal of Haematology|Leukemia Research: clinical and laboratory studies|Cancer Cell|Advances in Biological Regulation|Journal of Biological Chemistry|Blood|Blood|Blood|Leukemia|Blood|Nature Communications|Blood|Cancer Research|Blood|Haematologica: the hematology journal|Leukemia|Cancer Cell|British Journal of Haematology|Blood|Archives of Toxicology|Journal of Clinical Oncology|Molecular Cell|PLoS One|Haematologica: the hematology journal|The Lancet. Haematology|British Journal of Haematology|Leukemia|Cancer Research|Cancer Research|Blood|Leukemia|Advances in Biological Regulation|Blood|Blood|Journal of Cellular Biochemistry|British Journal of Haematology|British Journal of Haematology|Mediterranean Journal of Hematology and Infectious Diseases|Advances in Biological Regulation|Blood|Molecular Cell|Blood|Leukemia|Current Pharmaceutical Design|Blood|Current Pharmaceutical Design|British Journal of Haematology|Blood|Leukemia|Oncotarget|Leukemia|Blood|European Journal of Haematology|New England Journal of Medicine|Leukemia|Proceedings of the National Academy of Sciences of USA|Haematologica: the hematology journal|Blood|Blood|Nature Medicine|Leukemia Research: clinical and laboratory studies|Advances in Biological Regulation|Leukemia|Cancer Cell|Cancer Cell|British Journal of Haematology|British Journal of Haematology|European Journal of Haematology|International Journal of Cancer|Blood|British Journal of Haematology|Blood|Molecular Cancer Therapeutics|Experimental Hematology|British Journal of Haematology,06/12/2014|20/03/2012|17/11/2015|01/01/2015|01/01/2015|01/05/2013|14/05/2014|13/09/2012|15/07/2011|16/11/2012|12/09/2013|03/12/2015|01/01/2012|18/11/2011|01/01/2015|02/05/2012|10/06/2016|06/12/2014|01/06/2014|01/08/2015|01/01/2015|24/06/2015|16/11/2012|01/04/2015|03/09/2013|15/04/2014|01/01/2012|01/06/2015|01/05/2015|18/04/2013|01/05/2014|01/10/2014|01/02/2011|02/07/2012|01/08/2013|26/09/2015|02/06/2014|03/12/2015|11/01/2016|01/01/2013|15/04/2011|01/01/2015|15/09/2013|16/11/2012|08/05/2014|11/04/2013|01/01/2016|26/02/2016|21/06/2012|07/05/2012|01/10/2013|03/12/2015|22/01/2013|||06/12/2014|01/01/2015|01/01/2011|24/12/2013|16/09/2013|05/07/2013|18/11/2011|16/11/2012|07/07/2014|01/04/2015|12/09/2011|27/11/2014|16/06/2014|16/06/2014|01/01/2011|01/07/2013|01/01/2015|11/05/2016|18/11/2011|08/01/2013|25/03/2015|01/11/2013|11/04/2016|01/01/2013,"Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression.|Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.|Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.|Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells|CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).|Loss of proliferative phenotype and expression of CDKN1C/p57KIP2 in CD34+cells predict poor prognosis of MDS|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.|Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.|Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q.|High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic|Clinical and biological implications of driver mutations in myelodysplastic syndromes.|Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee|Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts|Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts|Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.|Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.|Pexmetinib: a novel dual inhibitor of Tie-2 and p38 MAPK with efficacy in preclinical models of myelodysplastic syndromes and acute myeloid leukemia.|Efficacy of Dual Inhibition of p38 Mitogen Activated Protein Kinase (MAPK) and Tie-2 Kinase in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)|COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES|Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.|Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo, [Cancer Cell, 25, 2014, 794-808]|Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletion.|Activation of the mTOR Signaling Pathway by L-Leucine in RPS14-Deficient Erythroid Cells|Application of CRISPR/Cas9 genome editing to the study and treatment of disease.|Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.|Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability.|Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.|CORRECTION OF MUTATIONS OF THE EPIGENETIC MODIFIER ASXL1 IN MYELOID LEUKEMIA CELLS BY CRISPR/CAS9 GENOME EDITING|Clinical associations of CSNK1A1 mutation in myelodysplastic syndrome.|High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.|Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia|MicroRNA mediated regulation of TGF-beta signaling leads to stem cell alterations in myelodysplastic syndromes|Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.|Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.|Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts|Application of genome editing technologies to the study and treatment of hematological disease.|Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS.|Lineage-Specific Aberrant mRNA Splicing By U2AF1 Mutation Alters Erythroid and Granulomonocytic Differentiation|The Effects of Severe Hypoxia on Glycolytic Flux and Enzyme Activity in a Model of Solid Tumors.|Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells|Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.|Recent Advances in the 5q- Syndrome.|The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.|Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes|Identification of a BRCA1-mRNA Splicing Complex Required for Efficient DNA Repair and Maintenance of Genomic Stability|miR-21 mediates hematopoietic suppression in MDS by activating TGF-beta signaling|Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression|Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes.|Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.|5q- syndrome.|Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression|An Integrative Genomics Approach Uncovers the Basis of Resistance to AZA Therapy in MDS and CMML|Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.|ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.|Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes.|Identification of a Prognostic Gene Expression Signature for AZA Response in MDS and CMML Patients|The molecular pathogenesis of the myelodysplastic syndromes|Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts|Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.|TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients.|Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.|Mir-21 Mediates Hematopoietic Suppression in MDS by Activating TGF-b Signaling|Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes|Reduced translation of GATA1 in Diamond-Blackfan anemia.|TARGETED RE-SEQUENCING ANALYSIS OF 31 GENES COMMONLY MUTATED IN MYELOID DISORDERS IN SERIAL SAMPLES FROM MYELODYSPLASTIC SYNDROME PATIENTS WITH DISEASE PROGRESSION|Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.|Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.|Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo [Cancer Cell, 25 (2014) 794-808]|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome|High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation|The molecular pathogenesis of the myelodysplastic syndromes|Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy.|Del(5q) Myelodysplastic Stem Cells Exhibit Their Clonal Advantage Via Increased Adhesion to the Microenvironment|Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells.|IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.|IL1RAP as functionally relevant target for stem-cell directed therapy in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).|GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome.|Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression","Pellagatti A,Roy S,Di Genua C,Burns A,McGraw K,Valletta S,Larrayoz MJ,Fernandez-Mercado M,Mason J,Killick S,Mecucci C,Calasanz MJ,List A,Schuh A,Boultwood J|Yip BH,Pellagatti A,Vuppusetty C,Giagounidis A,Germing U,Lamikanra AA,Roberts DJ,Fernandez-Mercado M,McDonald EJ,Killick S,Wainscoat JS,Boultwood J|Sundaravel S,Duggan R,Bhagat T,Ebenezer DL,Liu H,Yu Y,Bartenstein M,Unnikrishnan M,Karmakar S,Liu TC,Torregroza I,Quenon T,Anastasi J,McGraw KL,Pellagatti A,Boultwood J,Yajnik V,Artz A,Le Beau MM,Steidl U,List AF,Evans T,Verma A,Wickrema A|Dolatshad H,Pellagatti A,Fernandez-Mercado M,Yip BH,Malcovati L,Attwood M,Przychodzen B,Sahgal N,Kanapin AA,Lockstone H,Scifo L,Vandenberghe P,Papaemmanuil E,Smith CWJ,Campbell PJ,Ogawa S,Maciejewski JP,Cazzola M,Savage KI,Boultwood J|Bello E,Pellagatti A,Shaw J,Mecucci C,Kušec R,Killick S,Giagounidis A,Raynaud S,Calasanz MJ,Fenaux P,Boultwood J|Dietrich S,Andrulis M,Benner A,Pellagatti A,Giese T,Germing U,Baldus S,Boultwood J,Radujkovic A,Dreger P,Ho AD,Luft T|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SE|Boultwood J,Yip BH,Vuppusetty C,Pellagatti A,Wainscoat JS|Zhou L,Opalinska J,Sohal D,Yu Y,Mo Y,Bhagat T,Abdel-Wahab O,Fazzari M,Figueroa M,Alencar C,Zhang J,Kambhampati S,Parmar S,Nischal S,Hueck C,Suzuki M,Freidman E,Pellagatti A,Boultwood J,Steidl U,Sauthararajah Y,Yajnik V,McMahon C,Gore SD,Platanias LC,Levine R,Melnick A,Wickrema A,Greally JM,Verma A|Papaemmanuil E,Gerstung M,Malcovati L,Tauro S,Gundem G,Van Loo P,Pellagatti A,Groves MJ,Cross NCP,Gambacorti-Passerini C,Green AR,Boultwood J,Vyas P,Hellstrom-Lindberg E,Bowen D,Cazzola M,Stratton MR,Campbell P|Papaemmanuil E,Gerstung M,Malcovati L,Tauro S,Gundem G,Van Loo P,Yoon CJ,Ellis P,Wedge DC,Pellagatti A,Shlien A,Groves MJ,Forbes SA,Raine K,Hinton J,Mudie LJ,McLaren S,Hardy C,Latimer C,Della Porta MG,O'Meara S,Ambaglio I,Galli A,Butler AP,Walldin G,Teague JW,Quek L,Sternberg A,Gambacorti-Passerini C,Cross NC,Green AR,Boultwood J,Vyas P,Hellstrom-Lindberg E,Bowen D,Cazzola M,Stratton MR,Campbell PJ,Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium|Bejar R,Papaemmanuil E,Haferlach T,Garcia-Manero G,Maciejewski JP,Sekeres MA,Walter MJ,Graubert TA,Cazzola M,Malcovati L,Ogawa S,Fenaux P,Hellstrom-Lindberg E,Kern W,Boultwood J,Pellagatti A,Bowen D,Tauro S,Groves MJ,Vyas P,Quek L,Nazha A,Thol F,Heuser M,Shih L-Y,Padron E,Sallman D,Komrokji RS,List AF,Santini V,Fontenay M,Campbell PJ,Tuechler H,Stevenson K,Neuberg DS,Greenberg P,Ebert BL|Yip BH,Pellagatti A,Vuppusetty C,Giagounidis A,Germing U,Lamikanra AA,Roberts DJ,Fernandez-Mercado M,McDonald EJ,Killick S,Wainscoat JS,Boultwood J|Malcovati L,Papaemmanuil E,Hellstrom-Lindberg E,Boultwood J,Bowen D,Vyas P,Pascutto C,Della Porta MG,Pellagatti A,Groves MJ,Godfrey AL,Ambaglio I,Galli A,Travaglino E,Conte S,Tauro S,Keenan N,Hyslop A,Hinton J,Mudie LJ,Passerini CG,Cross NCP,Wainscoat JS,Green AR,Futreal PA,Stratton MR,Campbell PJ,Cazzola M|Gerstung M,Pellagatti A,Malcovati L,Giagounidis A,Porta MG,Jädersten M,Dolatshad H,Verma A,Cross NC,Vyas P,Killick S,Hellström-Lindberg E,Cazzola M,Papaemmanuil E,Campbell PJ,Boultwood J|Jerez A,Sugimoto Y,Makishima H,Verma A,Jankowska AM,Przychodzen B,Visconte V,Tiu RV,O'Keefe CL,Mohamedali AM,Kulasekararaj AG,Pellagatti A,McGraw K,Muramatsu H,Moliterno AR,Sekeres MA,McDevitt MA,Kojima S,List A,Boultwood J,Mufti GJ,Maciejewski JP|Bachegowda L,Morrone K,Winski SL,Mantzaris I,Bartenstein M,Ramachandra N,Giricz O,Sukrithan V,Nwankwo G,Shahnaz S,Bhagat T,Bhattacharyya S,Assal A,Shastri A,Gordon-Mitchell S,Pellagatti A,Boultwood J,Schinke C,Yu Y,Guha C,Rizzi J,Garrus J,Brown S,Wollenberg L,Hogeland G,Wright D,Munson M,Rodriguez M,Gross S,Chantry D,Zou Y,Platanias LC,Burgess LE,Pradhan K,Steidl U,Verma A|Bachegowda LS,Mantzaris I,Morrone KA,Keshkar N,Li W,Nwankwo G,Shahnaz S,Bhagat TD,Giricz O,Bhattacharrya S,Yu Y,Schinke CD,Pynadath A,Pellagatti A,Boultwood J,Humphries MJ,Winski SL,Bartenstein M,Guha C,Platanias L,Steidl U,Verma A|Pellagatti A,Gerstung M,Papaemmanuil E,Malcovati L,Giagounidis A,Della Porta MG,Jadersten M,Dolatshad H,Verma A,Cross NCP,Vyas P,Killick S,Hellstrom-Lindberg E,Cazzola M,Campbell PJ,Boultwood J|Dolatshad H,Pellagatti A,Fernandez-Mercado M,Yip BH,Malcovati L,Attwood M,Przychodzen B,Sahgal N,Kanapin AA,Lockstone H,Scifo L,Vandenberghe P,Papaemmanuil E,Smith CW,Campbell PJ,Ogawa S,Maciejewski JP,Cazzola M,Savage KI,Boultwood J|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SW|Cabrero M,Yu Y,Verma A,Yang H,Colla S,Jia Y,Zheng H,Bohannan Z,Ganan-Gomez I,Futreal A,Takahashi K,Chin L,Kantarjian H,Pellagatti A,Bowman T,Boultwood J,Garcia-Manero G,Wei Y|Yip BH,Vuppusetty C,Pellagatti A,Giagounidis A,Germing U,Lamikanra AA,Roberts DJ,Fernandez-Mercado M,McDonald E-J,Mecucci C,Killick S,Wainscoat JS,Boultwood J|Pellagatti A,Dolatshad H,Valletta S,Boultwood J|Pellagatti A,Benner A,Mills KI,Cazzola M,Giagounidis A,Perry J,Malcovati L,Della Porta MG,Jädersten M,Verma A,McDonald EJ,Killick S,Hellström-Lindberg E,Bullinger L,Wainscoat JS,Boultwood J|Savage KI,Gorski JJ,Barros EM,Irwin GW,Manti L,Powell AJ,Pellagatti A,Lukashchuk N,McCance DJ,McCluggage WG,Schettino G,Salto-Tellez M,Boultwood J,Richard DJ,McDade SS,Harkin DP|Fernandez-Mercado M,Yip BH,Pellagatti A,Davies C,Larrayoz MJ,Kondo T,Pérez C,Killick S,McDonald EJ,Odero MD,Agirre X,Prósper F,Calasanz MJ,Wainscoat JS,Boultwood J|Valletta S,Dolatshad H,Bello E,Yip BH,Bartenstein M,Gordon S,Shaw J,Roy S,Scifo L,Pellagatti A,Fulga TA,Verm A,Boultwood J|Boultwood J,Pellagatti A|Liberante FG,Pellagatti A,Boncheva V,Bowen DT,Mills KI,Boultwood J,Guinn BA|Pellagatti A,Fernandez-Mercado M,Di Genua C,Larrayoz MJ,Killick S,Dolatshad H,Burns A,Calasanz MJ,Schuh A,Boultwood J|Bhagat TD,Zhou L,Sokol L,Mantzaris I,Bhattacharyya S,Gordon SAK,Yu Y,Gundabolu K,Nischal S,Polineni R,Schinke C,Chrysofakis G,Wickrema A,Pellagatti A,Boultwood J,Steidl U,Liu G,List AF,Bitzer M,Verma A|Zhou L,McMahon C,Bhagat T,Alencar C,Yu Y,Fazzari M,Sohal D,Heuck C,Gundabolu K,Ng C,Mo Y,Shen W,Wickrema A,Kong G,Friedman E,Sokol L,Mantzaris I,Pellagatti A,Boultwood J,Platanias LC,Steidl U,Yan L,Yingling JM,Lahn MM,List A,Bitzer M,Verma A|Will B,Zhou L,Vogler TO,Ben-Neriah S,Schinke C,Tamari R,Yu Y,Bhagat TD,Bhattacharyya S,Barreyro L,Heuck C,Mo Y,Parekh S,McMahon C,Pellagatti A,Boultwood J,Montagna C,Silverman L,Maciejewski J,Greally JM,Ye BH,List AF,Steidl C,Steidl U,Verma A|Yip BH,Vuppusetty C,Attwood M,Giagounidis A,Germing U,Lamikanra AA,Roberts DJ,MacIejewski JP,Vandenberghe P,Mecucci C,Wainscoat JS,Pellagatti A,Boultwood J|Pellagatti A,Dolatshad H,Yip BH,Valletta S,Boultwood J|Keerthivasan G,Mei Y,Zhao B,Zhang L,Harris CE,Gao J,Basiorka AA,Schipma MJ,McElherne J,Yang J,Verma AK,Pellagatti A,Boultwood J,List AF,Williams DA,Ji P|Yip BH,Roy S,Dolatshad H,Shaw J,Ogawa S,Pellagatti A,Boultwood J|Smith H,Board M,Pellagatti A,Turley H,Boultwood J,Callaghan R|Davies C,Yip BH,Fernandez-Mercado M,Woll PS,Agirre X,Prosper F,Jacobsen SE,Wainscoat JS,Pellagatti A,Boultwood J|Pellagatti A,Cazzola M,Giagounidis A,Perry J,Malcovati L,Della Porta MG,Jädersten M,Killick S,Vyas P,Hellström-Lindberg E,Wainscoat JS,Boultwood J|Pellagatti A,Boultwood J|Boultwood J,Dolatshad H,Varanasi SS,Yip BH,Pellagatti A|Sundaravel S,Bhagat TD,Schinke C,Ebenezer D,Liu H,Yu Y,Pellagatti A,Boultwood J,Yajnik V,Artz A,Verma A,Wickrema A|Savage KI,Gorski JJ,Barros EM,Irwin GW,Manti L,Powell AJ,Pellagatti A,Lukashchuk N,McCance DJ,McCluggage WG,Schettino G,Salto-Tellez M,Boultwood J,Richard DJ,McDade SS,Harkin DP|Bhagat TD,Zhou L,Sokol L,Kessel R,Caceres G,Gundabolu K,Tamari R,Gordon S,Mantzaris I,Jodlowski T,Yu Y,Jing X,Polineni R,Bhatia K,Pellagatti A,Boultwood J,Kambhampati S,Steidl U,Stein C,Ju W,Liu G,Kenny P,List A,Bitzer M,Verma A|Pellagatti A,Roy S,Di Genua C,Burns A,McGraw K,Valletta S,Larrayoz MJ,Fernandez-Mercado M,Mason J,Killick S,Mecucci C,Calasanz MJ,List A,Schuh A,Boultwood J|Yip BH,Dolatshad H,Roy S,Pellagatti A,Boultwood J|Barreyro L,Will B,Bartholdy B,Zhou L,Todorova TI,Stanley RF,Ben-Neriah S,Montagna C,Parekh S,Pellagatti A,Boultwood J,Paietta E,Ketterling RP,Cripe L,Fernandez HF,Greenberg PL,Tallman MS,Steidl C,Mitsiades CS,Verma A,Steidl U|Boultwood J,Pellagatti A,Wainscoat JS|Fernandez-Mercado M,Pellagatti A,Di Genua C,Larrayoz MJ,Winkelmann N,Aranaz P,Burns A,Schuh A,Calasanz MJ,Cross NCP,Boultwood J|Unnikrishnan A,Papaemmanuil E,Beck D,Verma A,Kumari A,Richards LA,Knezevic K,Chandrakanthan V,Thoms JAI,Tursky ML,Huang Y,Galbraith S,Kulasekararaj AG,Tobiasson M,Woll PS,Pellagatti A,Wilson SR,Lindeman R,Boultwood J,Lynch K,Jacobsen SE,Mufti GJ,Hellstrom-Lindberg E,Mackenzie KL,Wong JWH,Campbell PJ,Pimanda JE|Yip BH,Vuppusetty C,Attwood M,Giagounidis A,Germing U,Lamikanra AA,Roberts DJ,Maciejewski JP,Vandenberghe P,Mecucci C,Wainscoat JS,Pellagatti A,Boultwood J|Valletta S,Dolatshad H,Bartenstein M,Yip BH,Bello E,Gordon S,Yu Y,Shaw J,Roy S,Scifo L,Schuh A,Pellagatti A,Fulga TA,Verma A,Boultwood J|Dolatshad H,Pellagatti A,Liberante FG,Llorian M,Repapi E,Steeples V,Roy S,Scifo L,Armstrong RN,Shaw J,Yip BH,Killick S,Kušec R,Taylor S,Mills KI,Savage KI,Smith CW,Boultwood J|Unnikrishnan A,Beck D,Verma A,Richards LA,Thoms JAI,Kumari A,Galbraith S,Kulasekararaj A,Tobiasson M,Woll PS,Pellagatti A,Papaemmanuil E,Wilson SR,Lindeman R,Campbell PJ,Boultwood J,Lynch K,Jacobsen SEW,Mufti GJ,Hellstrom-Lindberg E,MacKenzie KL,Wong JWH,Pimanda JE|Pellagatti A,Boultwood J|Papaemmanuil E,Cazzola M,Boultwood J,Malcovati L,Vyas P,Bowen D,Pellagatti A,Wainscoat JS,Hellstrom-Lindberg E,Gambacorti-Passerini C,Godfrey AL,Rapado I,Cvejic A,Rance R,McGee C,Ellis P,Mudie LJ,Stephens PJ,McLaren S,Massie CE,Tarpey PS,Varela I,Nik-Zainal S,Davies HR,Shlien A,Jones D,Raine K,Hinton J,Butler AP,Teague JW,Baxter EJ,Score J,Galli A,Della Porta MG,Travaglino E,Groves M,Tauro S,Munshi NC,Anderson KC,El-Naggar A,Fischer A,Mustonen V,Warren AJ,Cross NCP,Green AR,Futreal PA,Stratton MR,Campbell PJ|Pellagatti A,Fernandez-Mercado M,Di Genua C,Larrayoz MJ,Killick S,Dolatshad H,Burns A,Calasanz MJ,Schuh A,Boultwood J|Caceres G,McGraw K,Yip BH,Pellagatti A,Johnson J,Zhang L,Liu K,Zhang LM,Fulp WJ,Lee JH,Al Ali NH,Basiorka A,Smith LJ,Daugherty FJ,Littleton N,Wells RA,Sokol L,Wei S,Komrokji RS,Boultwood J,List AF|Fernandez-Mercado M,Burns A,Pellagatti A,Giagounidis A,Germing U,Agirre X,Prosper F,Aul C,Killick S,Wainscoat JS,Schuh A,Boultwood J|Bhagat TD,Zhou L,Sokol L,Mantzaris I,Gundabolu K,Gordon SAK,Yu Y,Nischal S,Polineni R,Schinke C,Chrysofakis G,Wickrema A,Pellagatti A,Boultwood J,Steidl UG,Liu G,List AF,Bitzer M,Verma A|Sundaravel S,Bhagat TD,Schinke C,Ebenezer D,Liu H,Yu Y,Pellagatti A,Boultwood J,Yajnik V,Artz A,Verma A,Wickrema A|Boultwood J,Pellagatti A|Pellagatti A,Roy S,Di Genua C,Burns A,McGraw K,Larrayoz MJ,Fernandez-Mercado M,Valletta S,Mason J,Killick S,Mecucci C,Calasanz MJ,List A,Schuh A,Boultwood J|Boultwood J,Pellagatti A,Wainscoat JS|Dolatshad H,Pellagatti A,Fernandez-Mercado M,Yip BH,Malcovati L,Attwood M,Przychodzen B,Sahgal N,Kanapin AA,Lockstone H,Scifo L,Vandenberghe P,Papaemmanuil E,Smith CW,Campbell PJ,Ogawa S,Maciejewski JP,Cazzola M,Savage KI,Boultwood J|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SW|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Pellagatti A,Cazzola M,Giagounidis A,Perry J,Malcovati L,Della Porta MG,Jädersten M,Killick S,Vyas P,Hellström-Lindberg E,Wainscoat JS,Boultwood J|Liberante FG,Pellagatti A,Boncheva V,Bowen DT,Mills KI,Boultwood J,Guinn BA|Pellagatti A,Boultwood J|Radujkovic A,Dietrich S,Andrulis M,Benner A,Longerich T,Pellagatti A,Nanda K,Giese T,Germing U,Baldus S,Boultwood J,Ho AD,Dreger P,Luft T|Scharenberg C,Giai V,Pellagatti A,Saft L,Karlsson G,Jansson M,Forsblom L,Jadersten M,Karlsson S,Boultwood J,Hellstrom-Lindberg E|Davies C,Yip BH,Fernandez-Mercado M,Woll PS,Agirre X,Prosper F,Jacobsen SE,Wainscoat JS,Pellagatti A,Boultwood J|Schinke C,Giricz O,Li W,Shastri A,Gordon S,Barreyro L,Bhagat T,Bhattacharyya S,Ramachandra N,Bartenstein M,Pellagatti A,Boultwood J,Wickrema A,Yu Y,Will B,Wei S,Steidl U,Verma A|Barreyro L,Mitchell K,Will B,Bartholdy B,Zhou L,Todorova T,Stanley R,Ben-Neriah S,Montagna C,Parekh S,Pellagatti A,Boultwood J,Paietta E,Ketterling R,Cripe L,Fernandez H,Greenberg P,Rowe J,Tallman M,Steidl C,Mitsiades C,Verma A,Steidl U|Botezatu L,Michel LC,Makishima H,Schroeder T,Germing U,Haas R,van der Reijden B,Marneth AE,Bergevoet SM,Jansen JH,Przychodzen B,Wlodarski M,Niemeyer C,Platzbecker U,Ehninger G,Unnikrishnan A,Beck D,Pimanda J,Hellström-Lindberg E,Malcovati L,Boultwood J,Pellagatti A,Papaemmanuil E,Le Coutre P,Kaeda J,Opalka B,Möröy T,Dührsen U,Maciejewski J,Khandanpour C|Fernandez-Mercado M,Pellagatti A,Di Genua C,Boultwood J,Larrayoz MJ,Aranaz P,Calasanz MJ,Winkelmann N,Cross NCP,Burns A,Schuh A","Humans,Myelodysplastic Syndromes,Disease Progression,GTP Phosphohydrolases,Ribonucleoproteins,Membrane Proteins,Nuclear Proteins,Repressor Proteins,Mutation,Genes,p53,Core Binding Factor Alpha 2 Subunit,High-Throughput Nucleotide Sequencing|Anemia,Macrocytic,Case-Control Studies,Cell Differentiation,Cell Proliferation,Chromosome Deletion,Chromosomes,Human,Pair 5,Cri-du-Chat Syndrome,Erythroblasts,Flow Cytometry,Humans,Leucine,Polymerase Chain Reaction,Protein Biosynthesis,RNA,Messenger,Small Interfering,Ribosomal Proteins,Trisomy|Erythroblasts,Animals,Zebrafish,Humans,Myelodysplastic Syndromes,Actins,rac1 GTP-Binding Protein,GTPase-Activating Proteins,Calmodulin-Binding Proteins,Zebrafish Proteins,Gene Expression Regulation,Female,Male||||Chromosomes,Human,Pair 5,Animals,Mice,Inbred NOD,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Genetic Predisposition to Disease,Antigens,CD,Prognosis,Flow Cytometry,Gene Expression Profiling,Mutation,Neoplastic Stem Cells,Heterografts|Anemia,Diamond-Blackfan,Macrocytic,Animals,Chromosome Deletion,Chromosomes,Human,Pair 5,Erythroblasts,Gene Expression Regulation,Haploinsufficiency,Humans,Leucine,Protein Biosynthesis,Ribosomal Proteins,Ribosomes,Signal Transduction,TOR Serine-Threonine Kinases|Apoptosis,Bone Marrow Cells,Chromosome Deletion,Chromosomes,Human,Pair 7,CpG Islands,DNA Methylation,Epigenesis,Genetic,Female,GTPase-Activating Proteins,Genetic Markers,Humans,Leukocytes,Male,Myelodysplastic Syndromes,Stem Cells||Aged,80 and over,Cohort Studies,Disease Progression,Epistasis,Genetic,Female,Humans,Leukemia,Myeloid,Acute,Myelomonocytic,Chronic,Male,Middle Aged,Mutation,Myelodysplastic Syndromes,Myelodysplastic-Myeloproliferative Diseases,Oncogenes,Prognosis,RNA Splicing,Spliceosomes||||Humans,Myelodysplastic Syndromes,Repressor Proteins,Prognosis,Treatment Outcome,Cohort Studies,Gene Expression Profiling,DNA Mutational Analysis,Gene Expression Regulation,Leukemic,Genotype,Mutation,Adult,Aged,80 and over,Middle Aged,Female,Male,Leukemia,Myeloid,Acute,Young Adult,Polycomb Repressive Complex 2|Adult,Aged,Bone Marrow Diseases,Chromosome Aberrations,Chromosome Deletion,Chromosomes,Human,Pair 7,Cohort Studies,Female,Genetic Association Studies,Genome,Humans,Loss of Heterozygosity,Male,Middle Aged,Myelodysplastic Syndromes,Myeloid Cells,Polymorphism,Single Nucleotide||||||||Animals,Humans,Gene Transfer Techniques,Genetic Engineering,Gene Expression Regulation,RNA Editing,Genetic Therapy,CRISPR-Cas Systems,Clustered Regularly Interspaced Short Palindromic Repeats,CRISPR-Associated Proteins|Aged,Antigens,CD34,Biomarkers,Tumor,Female,Follow-Up Studies,Gene Expression Profiling,Hematopoietic Stem Cells,Humans,Male,Myelodysplastic Syndromes,Neoplastic Stem Cells,Oligonucleotide Array Sequence Analysis,Principal Component Analysis,Prognosis,Survival Rate|Humans,DNA Damage,Genomic Instability,DNA Repair Enzymes,Exodeoxyribonucleases,Adaptor Proteins,Signal Transducing,DNA-Binding Proteins,Tumor Suppressor Proteins,BRCA1 Protein,Repressor Proteins,RNA,Messenger,Cell Survival,DNA Repair,Protein Processing,Post-Translational,RNA Splicing,Phosphorylation,Genome,Human,Radiation Tolerance,Basic-Leucine Zipper Transcription Factors,Fanconi Anemia Complementation Group Proteins,HEK293 Cells|Adolescent,Adult,Aged,80 and over,Cytogenetic Analysis,DNA Mutational Analysis,Female,Genes,Neoplasm,Humans,Karyotype,Leukemia,Myeloid,Acute,Male,Middle Aged,Mutation,Neoplasm Metastasis,Prognosis,Young Adult|||PReferentially expressed Antigen of the Melanoma Gene,leukaemia antigens,myelodysplastic syndrome,survival,tumour antigens,Antigens,Neoplasm,Biomarkers,Tumor,Gene Expression Profiling,Humans,Kaplan-Meier Estimate,Myelodysplastic Syndromes|||Anemia,Hematopoiesis,Hematopoietic Stem Cells,Humans,K562 Cells,Myelodysplastic Syndromes,Protein Kinase Inhibitors,Protein-Serine-Threonine Kinases,Pyrazoles,Quinolines,Receptors,Transforming Growth Factor beta,Signal Transduction,Smad7 Protein|Antigens,CD,Azacitidine,Case-Control Studies,Cell Lineage,Chromosome Aberrations,Chromosomes,Human,Pair 7,DNA Methylation,Epigenesis,Genetic,Flow Cytometry,Gene Expression,Hematopoietic Stem Cells,Humans,Karyotyping,Myelodysplastic Syndromes,Primary Cell Culture,Recurrence,STAT3 Transcription Factor|||Granulocytes,Bone Marrow Cells,Chromosomes,Human,Pair 5,Animals,Mice,Knockout,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Lipopolysaccharides,Adaptor Proteins,Signal Transducing,Carrier Proteins,Antigens,CD14,RNA,Messenger,Gene Expression Regulation,Heterozygote,Female,Male,Toll-Like Receptor 4,Immunity,Innate||||Anemia,Refractory,with Excess of Blasts,Chromosome Deletion,Chromosomes,Human,Pair 5,Disease Progression,Down-Regulation,Gene Expression Regulation,Genomic Instability,Humans,Nuclear Proteins,Sequence Deletion||Animals,Humans,Mutation,Myelodysplastic Syndromes,RNA Splicing,RNA-Binding Proteins,Spliceosomes||||||Biomarkers,Tumor,Cohort Studies,Gene Expression Regulation,Leukemic,Gene Knockdown Techniques,HL-60 Cells,Hematopoietic Stem Cells,Humans,Interleukin-1 Receptor Accessory Protein,Leukemia,Myeloid,Acute,Models,Biological,Myelodysplastic Syndromes,Neoplastic Stem Cells,Prognosis,Survival Analysis,Tumor Cells,Cultured,Up-Regulation|Anemia,Macrocytic,Animals,Chromosome Deletion,Chromosomes,Human,Pair 5,Disease Models,Animal,Disease Progression,Erythroid Precursor Cells,Haploinsufficiency,Humans,Mice,MicroRNAs,Myelodysplastic Syndromes,Ribosomal Proteins,Tumor Suppressor Protein p53|||Anemia,Macrocytic,Chromosome Deletion,Chromosomes,Human,Pair 5,Enzyme Activation,Erythroblasts,Humans,Leucine,Ribosomal Proteins,Signal Transduction,TOR Serine-Threonine Kinases||||||Chromosome Deletion,Chromosomes,Human,Pair 5,Exome,Humans,Leukemia,Myeloid,Acute,Myelodysplastic Syndromes|Base Sequence,Dexamethasone,Drug Resistance,Erythroid Precursor Cells,Erythropoiesis,Flow Cytometry,Fluorescent Antibody Technique,Humans,Immunohistochemistry,In Situ Hybridization,Fluorescence,Molecular Sequence Data,Myelodysplastic Syndromes,Oligonucleotides,Real-Time Polymerase Chain Reaction,Sequence Analysis,DNA,Statistics,Nonparametric,Thalidomide,Treatment Outcome,Tumor Suppressor Protein p53|Adult,Aged,80 and over,Anemia,Macrocytic,Chromosome Deletion,Chromosomes,Human,Pair 5,Cohort Studies,Female,Gene Frequency,Gene Targeting,Humans,Male,Middle Aged,Mutation,Myelodysplastic Syndromes,Polymorphism,Single Nucleotide,Sequence Analysis,DNA,Young Adult|||Humans,Anemia,Diamond-Blackfan,Protein Biosynthesis,GATA1 Transcription Factor||Anemia,Diamond-Blackfan,Chromosomes,Human,Pair 5,Cri-du-Chat Syndrome,Humans,Models,Theoretical,Ribosomal Proteins,Trisomy,Tumor Suppressor Protein p53|Hematopoietic Stem Cells,K562 Cells,Stem Cells,Humans,Anemia,Refractory,with Excess of Blasts,Myelodysplastic Syndromes,Ribonucleoprotein,U2 Small Nuclear,Phosphoproteins,RNA,Antigens,CD34,Gene Expression Profiling,Sequence Analysis,Cell Cycle,Cell Differentiation,Cell Proliferation,Gene Expression Regulation,Neoplastic,RNA Splicing,Alternative Splicing,Homeostasis,Heterozygote,Mutation,Point Mutation,Exons,Female,Male,Gene Knockdown Techniques||||||||Antigens,CD34,Case-Control Studies,Cell Culture Techniques,Cell Differentiation,Cell Growth Processes,Cell Lineage,Gene Silencing,Humans,K562 Cells,Myeloid Cells,RNA,Small Interfering,Repressor Proteins,Stem Cells,Transcriptome|Hematopoietic Stem Cells,Cell Line,Tumor,Animals,Humans,Mice,Myelodysplastic Syndromes,Disease Models,Animal,Receptors,Interleukin-8B,Interleukin-8,Antineoplastic Agents,Prognosis,Cluster Analysis,Xenograft Model Antitumor Assays,Gene Expression Profiling,Signal Transduction,Cell Proliferation,Cell Survival,Gene Expression,Neoplastic Stem Cells,Leukemia,Myeloid,Acute,Cell Cycle Checkpoints|||"
immd0082,immd0237,2,0.1341743119266055,Journal article|Journal article,Nature Genetics|Nature Genetics,18/05/2015|01/01/2012,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Schödel J,Bardella C,Sciesielski LK,Brown JM,Pugh CW,Buckle V,Tomlinson IP,Ratcliffe PJ,Mole DR","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|"
quee1607,raob0189,1,0.06666666666666667,Journal article,Nature Communications,01/01/2014,Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.,"Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC","Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading"
clme0237,stat0004,6,0.21829641153045384,Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper,Nature Genetics|Nature Communications|Human Molecular Genetics|PLoS Genetics|Nature Genetics|Journal of Medical Genetics,18/05/2015|01/01/2014|25/01/2014|01/12/2012|23/12/2012|01/09/2012,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.|Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis.|Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.|Genomic analysis of sporadic neurological disease using family trios: learning to expect the unexpected,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC|Martin HC,Kim GE,Pagnamenta AT,Murakami Y,Carvill GL,Meyer E,Copley RR,Rimmer A,Barcia G,Fleming MR,Kronengold J,Brown MR,Hudspith KA,Broxholme J,Kanapin A,Cazier JB,Kinoshita T,Nabbout R,WGS500 Consortium,Bentley D,McVean G,Heavin S,Zaiwalla Z,McShane T,Mefford HC,Shears D,Stewart H,Kurian MA,Scheffer IE,Blair E,Donnelly P,Kaczmarek LK,Taylor JC|Lise S,Clarkson Y,Perkins E,Kwasniewska A,Sadighi Akha E,Schnekenberg RP,Suminaite D,Hope J,Baker I,Gregory L,Green A,Allan C,Lamble S,Jayawant S,Quaghebeur G,Cader MZ,Hughes S,Armstrong RJ,Kanapin A,Rimmer A,Lunter G,Mathieson I,Cazier JB,Buck D,Taylor JC,Bentley D,McVean G,Donnelly P,Knight SJ,Jackson M,Ragoussis J,Németh AH|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I|Pagnamenta A,Martin H,Lise S,Hudspith K,Harrison V,Copley R,Rimmer A,Broxholme J,Kanapin A,Cazier JB,Akha ES,Knight SJL,Shears DJ,Stewart H,Kini U,Taylor J,Bentley DR,Keays DA,Blair E,Donnelly P","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading|Child,Preschool,Chromosomes,Human,Pair 9,Epilepsy,Genetic Predisposition to Disease,Genome-Wide Association Study,High-Throughput Nucleotide Sequencing,Humans,KCNQ2 Potassium Channel,Male,Membrane Proteins,Mutation,NAV1.2 Voltage-Gated Sodium Channel,Nerve Tissue Proteins,Pathology,Molecular,Potassium Channels,Proto-Oncogene Proteins c-cbl,Uniparental Disomy,Young Adult,WGS500 Consortium|Adult,Animals,Cerebellum,Chromosome Mapping,Cognition Disorders,Humans,Mice,Knockout,Mutation,Neurons,Purkinje Cells,Spectrin,Spinocerebellar Ataxias|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA|"
clme0240,robbins,7,0.4703473779909759,Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article,Nature Genetics|The Journal of Physiology|Thorax|American Journal of Hematology|Blood|The FASEB Journal|The Journal of Physiology,18/05/2015|20/05/2013|01/12/2012|01/08/2015|06/11/2013|09/03/2011|01/09/2015,"Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2.|HYPOXIA-INDUCIBLE FACTOR 2 alpha REGULATES NEUTROPHILIC INFLAMMATION IN HUMANS, MICE AND ZEBRAFISH|Contrasting roles of HIF-1 and 2 in ventilatory acclimatisation to hypoxia|Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish.|Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation.|Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF-2 pathway.","Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Bishop T,Talbot NP,Turner PJ,Nicholls LG,Pascual A,Hodson EJ,Douglas G,Fielding JW,Smith TG,Demetriades M,Schofield CJ,Robbins PA,Pugh CW,Buckler KJ,Ratcliffe PJ|Thompson AAR,Elks PM,Marriott HM,Higgins KR,Parmar S,Shaw G,Eamsamarng S,McGrath EE,Formenti F,Van Eeden FJ,Kinnula VL,Pugh CW,Sabroe I,Dockrell DH,Chilvers ER,Robbins PA,Simon MC,Johnson RS,Renshaw SA,Whyte MKB,Walmsley SR|Hodson EJ,Nicholls LG,Turner PJ,Robbins PA,Pugh CW,Buckler K,Ratcliffe PJ,Bishop T|Thompson AA,Elks PM,Marriott HM,Eamsamarng S,Higgins KR,Lewis A,Williams L,Parmar S,Shaw G,McGrath EE,Formenti F,Van Eeden FJ,Kinnula VL,Pugh CW,Sabroe I,Dockrell DH,Chilvers ER,Robbins PA,Percy MJ,Simon MC,Johnson RS,Renshaw SA,Whyte MK,Walmsley SR|Formenti F,Beer PA,Croft QP,Dorrington KL,Gale DP,Lappin TR,Lucas GS,Maher ER,Maxwell PH,McMullin MF,O'Connor DF,Percy MJ,Pugh CW,Ratcliffe PJ,Smith TG,Talbot NP,Robbins PA|Hodson EJ,Nicholls LG,Turner PJ,Llyr R,Fielding JW,Douglas G,Ratnayaka I,Robbins PA,Pugh CW,Buckler KJ,Ratcliffe PJ,Bishop T","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Animals,Anoxia,Carotid Body,Hyperplasia,Hypoxia-Inducible Factor 1,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Inbred C57BL,Transgenic,Pulmonary Ventilation|||Animals,Apoptosis,Basic Helix-Loop-Helix Transcription Factors,Cell Hypoxia,Gene Expression Regulation,Green Fluorescent Proteins,Humans,Immunohistochemistry,Inflammation,Mice,Inbred C57BL,Muramidase,Neutrophils,Phagocytosis,Phenotype,RNA,Respiratory Burst,Zebrafish|Basic Helix-Loop-Helix Transcription Factors,Carbon Dioxide,Cardiovascular Physiological Phenomena,Case-Control Studies,Exercise Test,Female,Gene Expression Regulation,Humans,Male,Mutation,Oxygen,von Hippel-Lindau Disease|"
clme0237,quee1607,5,0.264916608845373,Journal article|Journal article|Journal article|Journal article|Conference paper,Blood|Leukemia|Nature Communications|Nature Genetics|Blood,06/12/2014|01/01/2012|01/01/2014|18/05/2015|06/12/2014,The Identification of Further Minimal Regions of Overlap in Chronic Lymphocytic Leukemia Using High-Resolution SNP Arrays|Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.|Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Towards Response Prediction Using Integrated Genomics in Chronic Lymphocytic Leukaemia: Results on 250 First-Line FCR Treated Patients from UK Clinical Trials,"Knight SJL,Clifford R,Robbe P,Ramos SDC,Burns A,Timbs AT,Alsolami R,Weller S,Hamblin A,Mason J,Oates M,Titsias M,Yau C,Holmes CC,Pettitt AR,Hillmen P,Taylor J,Shuh A|Knight SJ,Yau C,Clifford R,Timbs AT,Sadighi Akha E,Dréau HM,Burns A,Ciria C,Oscier DG,Pettitt AR,Dutton S,Holmes CC,Taylor J,Cazier JB,Schuh A|Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Clifford RM,Robbe P,Weller S,Timbs AT,Titsias M,Burns A,Cabes M,Alsolami R,Yau C,Hamblin A,Mason J,Oates M,Pettitt A,Holmes C,Hillmen P,Taylor J,Knight SJL,Schuh A","|Adult,Aged,80 and over,Biomarkers,Tumor,Chromosome Aberrations,Clone Cells,Female,Gene Dosage,Genome,Human,Genomics,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Loss of Heterozygosity,Male,Middle Aged,Neoplasm Recurrence,Local,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Prognosis|Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|"
clme0135,immd0423,1,0.125,Journal article,EMBO Molecular Medicine,06/06/2012,Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes.,"Haley VL,Barnes DJ,Sandovici I,Constancia M,Graham CF,Pezzella F,Bühnemann C,Carter EJ,Hassan AB","Animals,Carcinoma,Female,Gene Deletion,Homozygote,Humans,Insulin-Like Growth Factor II,Male,Mice,Knockout,Sarcoma,Survival Analysis,Tumor Suppressor Protein p53"
clme0497,orms0061,1,0.1,Journal article,Nature Reviews Drug Discovery,01/03/2015,Preclinical target validation using patient-derived cells.,"Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
clme0667,raob0058,1,0.1,Journal article,Cancer Research,22/11/2011,Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.,"Fokas E,Im JH,Hill S,Yameen S,Stratford M,Beech J,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ","Animals,Dose-Response Relationship,Drug,Humans,Mice,Neoplasms,Experimental,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Radiation Tolerance,TOR Serine-Threonine Kinases,Xenograft Model Antitumor Assays"
bioc0647,bioc0764,3,0.7857142857142856,Journal article|Journal article|Journal article,Current Biology|Philosophical Transactions of the Royal Society of London: Biological Sciences|Current Biology,17/03/2014|27/12/2011|25/02/2014,Dependency of the spindle assembly checkpoint on Cdk1 renders the anaphase transition irreversible|The cell cycle.|Dependency of the spindle assembly checkpoint on Cdk1 renders the anaphase transition irreversible.,"Rattani A,Vinod PK,Godwin J,Tachibana-Konwalski K,Wolna M,Malumbres M,Novák B,Nasmyth K|Hunt T,Nasmyth K,Novák B|Rattani A,Vinod PK,Godwin J,Tachibana-Konwalski K,Wolna M,Malumbres M,Novák B,Nasmyth K","|Animals,Biological Evolution,Cell Cycle,Cell Cycle Checkpoints,DNA Damage,DNA Replication,Eukaryota,Protein Kinases,Systems Biology|Anaphase,Animals,CDC2 Protein Kinase,Cdc20 Proteins,Chromatids,Cyclin B,Female,M Phase Cell Cycle Checkpoints,Male,Mice,Knockout,Nondisjunction,Genetic,Oocytes,Phosphorylation"
clme0219,path0089,2,0.6666666666666666,Journal article|Conference paper,Immunology|Experimental Dermatology,01/12/2014|01/11/2014,The role of FoxP3(+) regulatory T-cells in psoriasiform skin disease|The role of FoxP3+regulatory T cells in psoriasiform skin disease,"Adelmann K,Hegazy AN,Ogg G,Powrie F|Adelmann K,Hegazy AN,Ogg G,Powrie F",|
coml0332,math0111,1,0.09090909090909091,Journal article,PLoS One,13/04/2011,Multiscale modelling of vascular tumour growth in 3D: The roles of domain size and boundary conditions,"Perfahl H,Byrne HM,Chen T,Estrella V,Alarcón T,Lapin A,Gatenby RA,Gillies RJ,Lloyd MC,Maini PK,Reuss M,Owen MR",
clme1358,cschof,10,0.8006576173197066,Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Medicinal Chemistry|Journal of Medicinal Chemistry|Chemical Communications|Journal of Medicinal Chemistry|ACS National Meeting Book of Abstracts|Journal of the American Chemical Society|MedChemComm|Chemical Science|Journal of Medicinal Chemistry|MedChemComm,07/01/2016|02/02/2016|01/01/2015|27/09/2012|08/09/2013|19/06/2014|01/12/2014|01/08/2013|25/06/2012|01/07/2015,"8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.|Recent Progress in Histone Demethylase Inhibitors.|Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.|Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.|Chemical probes for bromodomains outside the BET family|Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.|Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor.|5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation|Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.|Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains","Bavetsias V,Lanigan RM,Ruda GF,Atrash B,McLaughlin MG,Tumber A,Mok NY,Le Bihan YV,Dempster S,Boxall KJ,Jeganathan F,Hatch SB,Savitsky P,Velupillai S,Krojer T,England KS,Sejberg J,Thai C,Donovan A,Pal A,Scozzafava G,Bennett JM,Kawamura A,Johansson C,Szykowska A,Gileadi C,Burgess-Brown NA,von Delft F,Oppermann U,Walters Z,Shipley J,Raynaud FI,Westaway SM,Prinjha RK,Fedorov O,Burke R,Schofield CJ,Westwood IM,Bountra C,Müller S,van Montfort RL,Brennan PE,Blagg J|McAllister TE,England KS,Hopkinson RJ,Brennan PE,Kawamura A,Schofield CJ|Thinnes CC,Tumber A,Yapp C,Scozzafava G,Yeh T,Chan MC,Tran TA,Hsu K,Tarhonskaya H,Walport LJ,Wilkins SE,Martinez ED,Müller S,Pugh CW,Ratcliffe PJ,Brennan PE,Kawamura A,Schofield CJ|Hewings DS,Rooney TP,Jennings LE,Hay DA,Schofield CJ,Brennan PE,Knapp S,Conway SJ|Brennan PE,Martin SJ,Monteiro O,Fedorov O,Knapp S,Hay D,Wells C,Filippakopoulos P,Picaud S,Muller-Knapp S,Keates T,Yapp C,Philpott M,Schofield C,Burgess-Brown N,Shrestha L,Strain-Damerell C|Hay DA,Fedorov O,Martin S,Singleton DC,Tallant C,Wells C,Picaud S,Philpott M,Monteiro OP,Rogers CM,Conway SJ,Rooney TP,Tumber A,Yapp C,Filippakopoulos P,Bunnage ME,Müller S,Knapp S,Schofield CJ,Brennan PE|England KS,Tumber A,Krojer T,Scozzafava G,Ng SS,Daniel M,Szykowska A,Che K,von Delft F,Burgess-Brown NA,Kawamura A,Schofield CJ,Brennan PE|Hopkinson RJ,Tumber A,Yapp C,Chowdhury R,Aik W,Che KH,Li XS,Kristensen JBL,King ONF,Chan MC,Yeoh KK,Choi H,Walport LJ,Thinnes CC,Bush JT,Lejeune C,Rydzik AM,Rose NR,Bagg EA,McDonough MA,Krojer TJ,Yue WW,Ng SS,Olsen L,Brennan PE,Oppermann U,Müller S,Klose RJ,Ratcliffe PJ,Schofield CJ,Kawamura A|Rose NR,Woon EC,Tumber A,Walport LJ,Chowdhury R,Li XS,King ON,Lejeune C,Ng SS,Krojer T,Chan MC,Rydzik AM,Hopkinson RJ,Che KH,Daniel M,Strain-Damerell C,Gileadi C,Kochan G,Leung IK,Dunford J,Yeoh KK,Ratcliffe PJ,Burgess-Brown N,von Delft F,Muller S,Marsden B,Brennan PE,McDonough MA,Oppermann U,Klose RJ,Schofield CJ,Kawamura A|Hay DA,Rogers CM,Fedorov O,Tallant C,Martin S,Monteiro OP,Mueller S,Knapp S,Schofield CJ,Brennan PE","||Humans,Oxyquinoline,Oxygenases,Enzyme Inhibitors,Molecular Structure,Structure-Activity Relationship,Dose-Response Relationship,Drug,Models,Molecular|Acetylation,Animals,Histones,Humans,Lysine,Molecular Targeted Therapy,Nuclear Proteins,Protein Binding,Protein Processing,Post-Translational||Hela Cells,Microsomes,Liver,Humans,Isoxazoles,Indoles,Ligands,Crystallography,X-Ray,Fluorescence Recovery After Photobleaching,Drug Evaluation,Preclinical,Binding Sites,Molecular Structure,Protein Structure,Tertiary,Structure-Activity Relationship,Genes,p53,Models,Molecular,E1A-Associated p300 Protein,CREB-Binding Protein,Small Molecule Libraries,Drug Discovery,Chemistry Techniques,Synthetic|||Enzyme Inhibitors,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Plant Growth Regulators,Protein Conformation,Substrate Specificity,Succinates|"
clab0127,clme1358,1,0.027777777777777776,Journal article,Cancer Research,,Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.,"Picaud S,Fedorov O,Thanasopoulou A,Leonards K,Jones K,Meier J,Olzscha H,Monteiro O,Martin S,Philpott M,Tumber A,Filippakopoulos P,Yapp C,Wells C,Che KH,Bannister A,Robson S,Kumar U,Parr N,Lee K,Lugo D,Jeffrey P,Taylor S,Vecellio ML,Bountra C,Brennan PE,O'Mahony A,Velichko S,Müller S,Hay D,Daniels DL,Urh M,La Thangue NB,Kouzarides T,Prinjha R,Schwaller J,Knapp S","Cell Line,Tumor,Animals,Humans,Mice,Oxazepines,Doxorubicin,Antineoplastic Combined Chemotherapy Protocols,Enzyme Inhibitors,Xenograft Model Antitumor Assays,Amino Acid Sequence,Protein Structure,Tertiary,Drug Synergism,Models,Molecular,Molecular Sequence Data,p300-CBP Transcription Factors,Leukemia,Myeloid,Acute"
clme0946,whgu0172,1,0.05,Journal article,Cancer Cell,13/05/2013,Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
immd0075,immd0654,1,0.05263157894736842,Journal article,Molecular Cell,18/01/2012,Intragenic enhancers act as alternative promoters.,"Kowalczyk MS,Hughes JR,Garrick D,Lynch MD,Sharpe JA,Sloane-Stanley JA,McGowan SJ,De Gobbi M,Hosseini M,Vernimmen D,Brown JM,Gray NE,Collavin L,Gibbons RJ,Flint J,Taylor S,Buckle VJ,Milne TA,Wood WG,Higgs DR","Animals,Cells,Cultured,Enhancer Elements,Genetic,Erythroid Cells,Gene Expression Regulation,Mice,Poly A,Promoter Regions,RNA,RNA Isoforms,Messenger,Transcriptome"
immd0330,immd0423,1,0.07142857142857142,Conference paper,Annals of Oncology,01/06/2012,CLINICAL DIAGNOSTIC IMPLEMENTATION OF AN INNOVATIVE CANCER CARE MODEL BASED ON COMPREHENSIVE MOLECULAR PROFILING OF TUMOUR-NORMAL PAIRS,"Kaur K,Henderson S,Cutts A,Domingo E,Woods J,Motley C,Dougherty B,Middleton M,Hassan B,Wang Y,Beasley E,Naley M,Schuh A,Tomlinson I,Taylor J",
clme0237,corp0784,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0494,immd0499,1,0.14285714285714285,Journal article,Nature Cell Biology,25/01/2016,EXD2 promotes homologous recombination by facilitating DNA end resection.,"Broderick R,Nieminuszczy J,Baddock HT,Deshpande RA,Gileadi O,Paull TT,McHugh PJ,Niedzwiedz W",
immd0024,immd0075,1,0.058823529411764705,Journal article,Epigenetics and Chromatin,01/01/2011,Generation of bivalent chromatin domains during cell fate decisions.,"De Gobbi M,Garrick D,Lynch M,Vernimmen D,Hughes JR,Goardon N,Luc S,Lower KM,Sloane-Stanley JA,Pina C,Soneji S,Renella R,Enver T,Taylor S,Jacobsen SE,Vyas P,Gibbons RJ,Higgs DR",
path0084,whgu0142,1,0.07692307692307693,Journal article,Chemistry and Biology,26/08/2015,Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.,"Canning P,Ruan Q,Schwerd T,Hrdinka M,Maki JL,Saleh D,Suebsuwong C,Ray S,Brennan PE,Cuny GD,Uhlig HH,Gyrd-Hansen M,Degterev A,Bullock AN",
clme0494,immd0151,1,0.06666666666666667,Journal article,American Journal of Human Genetics,09/10/2012,Mutations in multidomain protein MEGF8 identify a Carpenter syndrome subtype associated with defective lateralization.,"Twigg SR,Lloyd D,Jenkins D,Elçioglu NE,Cooper CD,Al-Sannaa N,Annagür A,Gillessen-Kaesbach G,Hüning I,Knight SJ,Goodship JA,Keavney BD,Beales PL,Gileadi O,McGowan SJ,Wilkie AO","Acrocephalosyndactylia,Alleles,Animals,Genetically Modified,Child,Preschool,Facies,Female,Genetic Association Studies,Genotype,Humans,Male,Membrane Proteins,Mutation,Zebrafish"
bras2068,raob0168,1,0.125,Journal article,Medical Physics,01/02/2015,3D calculation of radiation-induced second cancer risk including dose and tissue response heterogeneities.,"Timlin C,Warren DR,Rowland B,Madkhali A,Loken J,Partridge M,Jones B,Kruse J,Miller R","Humans,Meningioma,Neoplasms,Radiation-Induced,Second Primary,Radiotherapy,Computer-Assisted,Radiotherapy Dosage,Radiotherapy Planning,Risk Assessment,Uncertainty,Dose-Response Relationship,Radiation,Models,Biological,Software"
clme0497,raob0182,2,0.12222222222222222,Journal article|Journal article,Oncogene|Oncotarget,|01/06/2016,The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.|BET inhibition as a new strategy for the treatment of gastric cancer.,"da Motta LL,Ledaki I,Purshouse K,Haider S,De Bastiani MA,Baban D,Morotti M,Steers G,Wigfield S,Bridges E,Li JL,Knapp S,Ebner D,Klamt F,Harris AL,McIntyre A|Montenegro RC,Clark PG,Howarth A,Wan X,Ceroni A,Siejka P,Nunez-Alonso GA,Monteiro O,Rogers C,Gamble V,Burbano R,Brennan PE,Tallant C,Ebner D,Fedorov O,O'Neill E,Knapp S,Dixon D,Müller S",|
clme0240,lina0435,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0556,path0511,14,1.5643740729800892,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Blood|Blood|Cancer Cell|Oncotarget|New England Journal of Medicine|Journal of Experimental Medicine|Nature|Cancer Cell|Cell Reports|Cell Stem Cell|Blood|Leukemia|Proceedings of the National Academy of Sciences of USA|Nature Immunology,01/01/2011|06/08/2012|18/01/2011|01/06/2013|01/01/2012|03/02/2014|11/08/2013|16/06/2014|27/03/2013|07/11/2013|27/03/2013|01/01/2012|08/10/2012|01/01/2012,"Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation|Dicer is selectively important for the earliest stages of erythroid development.|Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.|Germline counterparts of oncogenic mutations: who gives a JAK?.|Germline JAK2 mutation in a family with hereditary thrombocytosis|Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate.|Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.|Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells.|Impact of isolated germline JAK2V617I mutation on human hematopoiesis.|Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model|Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21.|The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential","Kharazi S,Mead AJ,Mansour A,Hultquist A,Böiers C,Luc S,Buza-Vidas N,Ma Z,Ferry H,Atkinson D,Reckzeh K,Masson K,Cammenga J,Rönnstrand L,Arai F,Suda T,Nerlov C,Sitnicka E,Jacobsen SEW|Buza-Vidas N,Cismasiu VB,Moore S,Mead AJ,Woll PS,Lutteropp M,Melchiori L,Luc S,Bouriez-Jones T,Atkinson D,O'Carroll D,Jacobsen SE,Nerlov C|Goardon N,Marchi E,Atzberger A,Quek L,Schuh A,Soneji S,Woll P,Mead A,Alford KA,Rout R,Chaudhury S,Gilkes A,Knapper S,Beldjord K,Begum S,Rose S,Geddes N,Griffiths M,Standen G,Sternberg A,Cavenagh J,Hunter H,Bowen D,Killick S,Robinson L,Price A,Macintyre E,Virgo P,Burnett A,Craddock C,Enver T,Jacobsen SE,Porcher C,Vyas P|Mead AJ,Constantinescu SN,Jacobsen SE|Mead AJ,Rugless MJ,Jacobsen SEW,Schuh A|Grover A,Mancini E,Moore S,Mead AJ,Atkinson D,Rasmussen KD,O'Carroll D,Jacobsen SE,Nerlov C|Sanjuan-Pla A,Moore S,Nerlov C,Carella C,Macaulay IC,Jensen CT,Woll PS,Luis TC,Mead A,Matsuoka S,Jones TB,Chowdhury O,Stenson L,Lutteropp M,Green JCA,Facchini R,Boukarabila H,Carrelha J,Tarrant P,Atkinson D,Clark S-A,Jacobsen SEW,Grover A,Gambardella A,Thongjuea S|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Mead AJ,Kharazi S,Atkinson D,Macaulay I,Pecquet C,Loughran S,Lutteropp M,Woll P,Chowdhury O,Luc S,Buza-Vidas N,Ferry H,Clark SA,Goardon N,Vyas P,Constantinescu SN,Sitnicka E,Nerlov C,Jacobsen SE|Böiers C,Carrelha J,Lutteropp M,Luc S,Green JCA,Azzoni E,Woll PS,Mead AJ,Hultquist A,Swiers G,Perdiguero EG,Macaulay IC,Melchiori L,Luis TC,Kharazi S,Bouriez-Jones T,Deng Q,Pontén A,Atkinson D,Jensen CT,Sitnicka E,Geissmann F,Godin I,Sandberg R,de Bruijn MFTR,Jacobsen SEW|Mead AJ,Chowdhury O,Pecquet C,Dusa A,Woll P,Atkinson D,Burns A,Score J,Rugless M,Clifford R,Moule S,Bienz N,Vyas P,Cross N,Gale RE,Henderson S,Constantinescu SN,Schuh A,Jacobsen SE|Reckzeh K,Bereshchenko O,Mead A,Rehn M,Kharazi S,Jacobsen SE,Nerlov C,Cammenga J|Roy A,Cowan G,Mead AJ,Filippi S,Bohn G,Chaidos A,Tunstall O,Chan JK,Choolani M,Bennett P,Kumar S,Atkinson D,Wyatt-Ashmead J,Hu M,Stumpf MP,Goudevenou K,O'Connor D,Chou ST,Weiss MJ,Karadimitris A,Jacobsen SE,Vyas P,Roberts I|Luc S,Luis TC,Boukarabila H,Macaulay IC,Buza-Vidas N,Bouriez-Jones T,Lutteropp M,Woll PS,Loughran SJ,Mead AJ,Hultquist A,Brown J,Mizukami T,Matsuoka S,Ferry H,Anderson K,Duarte S,Atkinson D,Soneji S,Domanski A,Farley A,Sanjuan-Pla A,Carella C,Patient R,De Bruijn M,Enver T,Nerlov C,Blackburn C,Godin I,Jacobsen SEW","|Animals,Biomarkers,Blotting,Western,Cell Differentiation,Cell Lineage,DEAD-box RNA Helicases,Erythroid Cells,Gene Expression Profiling,Gene Expression Regulation,Hematopoietic Stem Cells,Integrases,Megakaryocyte Progenitor Cells,Mice,Knockout,Oligonucleotide Array Sequence Analysis,RNA,Messenger,Real-Time Polymerase Chain Reaction,Reverse Transcriptase Polymerase Chain Reaction,Ribonuclease III,Transcription Factors|Adult,Aged,80 and over,Animals,Antigens,CD,CD34,CD45,Cell Differentiation,Cell Lineage,Gene Expression Profiling,Graft Survival,Granulocyte-Macrophage Progenitor Cells,Hematopoietic Stem Cells,Humans,Immunophenotyping,Leukemia,Myeloid,Acute,Lymphoid Progenitor Cells,Mice,Inbred NOD,SCID,Middle Aged,Neoplastic Stem Cells,Transplantation,Heterologous,Young Adult|Animals,Germ-Line Mutation,Humans,Janus Kinase 2,Mice,Oncogenes||Animals,Cell Lineage,Colony-Forming Units Assay,Erythroid Precursor Cells,Erythropoiesis,Erythropoietin,Gene Expression Profiling,Hematopoietic Stem Cell Transplantation,Hematopoietic Stem Cells,Mice,Congenic,Inbred C57BL,Transgenic,Multipotent Stem Cells,Recombinant Proteins|||Animals,Cell Differentiation,Cell Transformation,Neoplastic,Disease Models,Animal,Flow Cytometry,Gene Expression,Humans,Leukemia,Myeloid,Acute,Mice,Microarray Analysis,Multipotent Stem Cells,Myeloid Cells,Signal Transduction,fms-Like Tyrosine Kinase 3||Adult,Amino Acid Substitution,Animals,Cells,Cultured,Family,Female,Germ-Line Mutation,Hematopoiesis,Humans,Isoleucine,Janus Kinase 2,Male,Mice,Inbred NOD,Transgenic,Middle Aged,Myeloproliferative Disorders,Valine||Cell Differentiation,Cell Lineage,Down Syndrome,Flow Cytometry,Gene Expression Profiling,Hematopoietic Stem Cells,Humans,Liver|"
clme0501,whgu0172,2,0.26785714285714285,Journal article|Journal article,Molecular and Cellular Proteomics|Clinical Proteomics,01/01/2011|26/04/2012,Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis|Detection of BK virus in urine from renal transplant subjects by mass spectrometry.,"Wright CA,Howles S,Trudgian DC,Kessler BM,Reynard JM,Noble JG,Hamdy FC,Turney BW|Konietzny R,Fischer R,Ternette N,Wright CA,Turney BW,Chakera A,Hughes D,Kessler BM,Pugh CW",|
olin0081,path0089,1,0.037037037037037035,Journal article,Gut,07/03/2016,Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.,"Schwerd T,Pandey S,Yang HT,Bagola K,Jameson E,Jung J,Lachmann RH,Shah N,Patel SY,Booth C,Runz H,Düker G,Bettels R,Rohrbach M,Kugathasan S,Chapel H,Keshav S,Elkadri A,Platt N,Muise AM,Koletzko S,Xavier RJ,Marquardt T,Powrie F,Wraith JE,Gyrd-Hansen M,Platt FM,Uhlig HH",
claridge,clme0485,1,0.16666666666666666,Journal article,ChemBioChem: a European journal of chemical biology,22/06/2012,Development and application of a fluoride-detection-based fluorescence assay for γ-butyrobetaine hydroxylase.,"Rydzik AM,Leung IK,Kochan GT,Thalhammer A,Oppermann U,Claridge TD,Schofield CJ","Biocatalysis,Fluorescence,Fluorides,Humans,Hydrocarbons,Fluorinated,Magnetic Resonance Spectroscopy,Molecular Structure,Protons,gamma-Butyrobetaine Dioxygenase"
path0063,smlea,1,0.125,Journal article,Structure,22/06/2015,Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction.,"Chappell PE,Garner LI,Yan J,Metcalfe C,Hatherley D,Johnson S,Robinson CV,Lea SM,Brown MH","CHO Cells,Animals,Humans,Cricetulus,Escherichia coli,Fetal Proteins,Cell Adhesion Molecules,Neuronal,Recombinant Fusion Proteins,Antigens,CD,Differentiation,T-Lymphocyte,Crystallography,X-Ray,Cloning,Molecular,Gene Expression,Binding Sites,Amino Acid Motifs,Protein Structure,Secondary,Protein Binding,Glycosylation,Mutation,Polymorphism,Single Nucleotide,Models,Molecular Sequence Data,Protein Interaction Domains and Motifs,Protein Multimerization,Static Electricity"
quee1607,stat0004,2,0.07584097859327217,Journal article|Journal article,Nature Genetics|Nature Communications,18/05/2015|01/01/2014,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading"
clme0975,immd0316,1,0.05263157894736842,Journal article,Nature Communications,,Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.,"Findlay JM,Castro-Giner F,Makino S,Rayner E,Kartsonaki C,Cross W,Kovac M,Ulahannan D,Palles C,Gillies RS,MacGregor TP,Church D,Maynard ND,Buffa F,Cazier JB,Graham TA,Wang LM,Sharma RA,Middleton M,Tomlinson I",
engs0475,ndog0115,2,0.4,Journal article|Journal article,Transplant International|Transplant International,01/11/2015|01/11/2015,DETERIORATION OF MITOCHONDRIAL FUNCTION IS THE KEY MECHANISM RESPONSIBLE FOR HEPATIC INJURY IN DCD LIVERS|NORMOTHERMIC REGIONAL PERFUSION RESUSCITATES DCD LIVERS BY MITOCHONDRIAL PROTECTION,"Nasralla D,Roy D,Morten K,Morovat R,Coussios C,Friend P|Roy D,Jamieson R,Morten K,Morovat A,Coussios C,Friend P",|
clme0497,raob0096,1,0.25,Journal article,Protein Expression and Purification,01/10/2011,Analysis of conditions affecting auto-phosphorylation of human kinases during expression in bacteria.,"Shrestha A,Hamilton G,O'Neill E,Knapp S,Elkins JM","Cloning,Molecular,Electrophoresis,Polyacrylamide Gel,Escherichia coli,Humans,Mass Spectrometry,Models,Phosphorylation,Protein Structure,Tertiary,Protein-Serine-Threonine Kinases,Recombinant Proteins"
path0089,whgu0172,1,0.2,Journal article,Scientific Reports,15/04/2016,Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes.,"Lochmatter C,Fischer R,Charles PD,Yu Z,Powrie F,Kessler BM",
immd0330,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clne0102,radi0003,3,0.4523809523809524,Journal article|Journal article|Journal article,Lecture Notes in Computer Science|Medical Image Analysis|Med Image Comput Comput Assist Interv,01/01/2013|01/01/2012|01/01/2013,The impact of heterogeneity and uncertainty on prediction of response to therapy using dynamic MRI data|MIND: Modality independent neighbourhood descriptor for multi-modal deformable registration|The impact of heterogeneity and uncertainty on prediction of response to therapy using dynamic MRI data.,"Bhushan M,Schnabel JA,Chappell M,Gleeson F,Anderson M,Franklin J,Brady M,Jenkinson M|Heinrich MP,Jenkinson M,Bhushan M,Matin T,Gleeson FV,Brady SM,Schnabel JA|Bhushan M,Schnabel JA,Chappell M,Gleeson F,Anderson M,Franklin J,Brady SM,Jenkinson M","||Algorithms,Colorectal Neoplasms,Computer Simulation,Contrast Media,Data Interpretation,Statistical,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Meglumine,Models,Biological,Organometallic Compounds,Outcome Assessment (Health Care),Prognosis,Reproducibility of Results,Sensitivity and Specificity,Treatment Outcome"
immd0031,path0041,1,0.0625,Journal article,Journal of Biological Chemistry,21/01/2013,Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.,"Whiteman P,de Madrid BH,Taylor P,Li D,Heslop R,Viticheep N,Tan JZ,Shimizu H,Callaghan J,Masiero M,Li JL,Banham AH,Harris AL,Lea SM,Redfield C,Baron M,Handford PA","Amino Acid Sequence,Animals,Antibodies,Monoclonal,Blotting,Western,Calcium-Binding Proteins,Cell Line,Tumor,Drosophila Proteins,Flow Cytometry,HEK293 Cells,Humans,Intercellular Signaling Peptides and Proteins,Ligands,Membrane Proteins,Mice,Models,Molecular,Molecular Sequence Data,Mutation,Protein Binding,Protein Structure,Secondary,Tertiary,Receptor,Notch1,Receptors,Notch,Sequence Homology,Amino Acid"
ctsu0385,gree0184,1,0.125,Conference paper,European Heart Journal,01/08/2015,"Prevalence, treatment and control of hypertension in middle-aged Mexican adults","Gnatiuc L,Alegre-Diaz J,Herrington W,Lopez Cervantes M,Peto R,Collins R,Tapia-Conyer R,Emberson J,Kuri-Morales P",
clme0485,clme1358,4,0.13287918252855138,Journal article|Journal article|Journal article|Journal article,Journal of Medicinal Chemistry|Nature Chemical Biology|Journal of Medicinal Chemistry|Chemical Science,07/01/2016|23/05/2016|25/06/2012|01/08/2013,"8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.|Structural analysis of human KDM5B guides histone demethylase inhibitor development.|Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.|5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation","Bavetsias V,Lanigan RM,Ruda GF,Atrash B,McLaughlin MG,Tumber A,Mok NY,Le Bihan YV,Dempster S,Boxall KJ,Jeganathan F,Hatch SB,Savitsky P,Velupillai S,Krojer T,England KS,Sejberg J,Thai C,Donovan A,Pal A,Scozzafava G,Bennett JM,Kawamura A,Johansson C,Szykowska A,Gileadi C,Burgess-Brown NA,von Delft F,Oppermann U,Walters Z,Shipley J,Raynaud FI,Westaway SM,Prinjha RK,Fedorov O,Burke R,Schofield CJ,Westwood IM,Bountra C,Müller S,van Montfort RL,Brennan PE,Blagg J|Johansson C,Velupillai S,Tumber A,Szykowska A,Hookway ES,Nowak RP,Strain-Damerell C,Gileadi C,Philpott M,Burgess-Brown N,Wu N,Kopec J,Nuzzi A,Steuber H,Egner U,Badock V,Munro S,LaThangue NB,Westaway S,Brown J,Athanasou N,Prinjha R,Brennan PE,Oppermann U|Rose NR,Woon EC,Tumber A,Walport LJ,Chowdhury R,Li XS,King ON,Lejeune C,Ng SS,Krojer T,Chan MC,Rydzik AM,Hopkinson RJ,Che KH,Daniel M,Strain-Damerell C,Gileadi C,Kochan G,Leung IK,Dunford J,Yeoh KK,Ratcliffe PJ,Burgess-Brown N,von Delft F,Muller S,Marsden B,Brennan PE,McDonough MA,Oppermann U,Klose RJ,Schofield CJ,Kawamura A|Hopkinson RJ,Tumber A,Yapp C,Chowdhury R,Aik W,Che KH,Li XS,Kristensen JBL,King ONF,Chan MC,Yeoh KK,Choi H,Walport LJ,Thinnes CC,Bush JT,Lejeune C,Rydzik AM,Rose NR,Bagg EA,McDonough MA,Krojer TJ,Yue WW,Ng SS,Olsen L,Brennan PE,Oppermann U,Müller S,Klose RJ,Ratcliffe PJ,Schofield CJ,Kawamura A","||Enzyme Inhibitors,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Plant Growth Regulators,Protein Conformation,Substrate Specificity,Succinates|"
clme0670,raob0128,1,0.125,Journal article,Journal of Nuclear Medicine,07/10/2011,"Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality.","Kersemans V,Thompson J,Cornelissen B,Woodcock M,Allen PD,Buls N,Muschel RJ,Hill MA,Smart SC","Animals,DNA Breaks,Double-Stranded,Histones,Jejunum,Liver,Mice,Positron-Emission Tomography,Quality Control,Radiation Dosage,Radiation Injuries,Experimental,Reference Standards,Time Factors,Tomography,Emission-Computed,Single-Photon,X-Ray Microtomography"
immd0100,whgu0172,3,0.25384615384615383,Journal article|Journal article|Journal article,Arthritis and Rheumatism|European Journal of Immunology|PLoS Pathogens,01/11/2013|24/06/2015|01/05/2011,Endoplasmic reticulum aminopeptidase 1 (ERAP1) plays a critical role in determining the length and sequence of peptides bound and presented by HLA-B27|The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated.|The Antiviral Efficacy of HIV-Specific CD8+ T-Cells to a Conserved Epitope is Heavilydependent on the Infecting HIV-1 Isolate,"Chen L,Fischer R,Peng Y,Reeves E,McHugh K,Ternette N,Hanke T,Dong T,Elliott T,Shastri N,Kollnberger S,James E,Kessler B,Bowness P|Jallow S,Leligdowicz A,Kramer HB,Onyango C,Cotten M,Wright C,Whittle HC,McMichael A,Dong T,Kessler BM,Rowland-Jones SL|Ranasinghe SRF,Kramer HB,Wright C,Kessler BM,di Gleria K,Zhang Y,Gillespie GM,Blais ME,Culshaw A,Pichulik T,Simmons A,Rowland-Jones SL,McMichael AJ,Dong T","|T-Lymphocytes,Humans,HIV-2,HIV Infections,Epitopes,T-Lymphocyte,Viral Load,Immunity,Cellular,Amino Acid Motifs,Female,Male,gag Gene Products,Human Immunodeficiency Virus|"
clme0301,ndos0168,2,0.12454212454212454,Journal article|Journal article,Journal of Bone and Mineral Research|PLoS One,25/10/2011|01/01/2012,A mouse model for spondyloepiphyseal dysplasia congenita with secondary osteoarthritis due to a Col2a1 mutation.|A mouse with an N-Ethyl-N-nitrosourea (ENU) Induced Trp589Arg Galnt3 mutation represents a model for hyperphosphataemic familial tumoural calcinosis.,"Esapa CT,Hough TA,Testori S,Head RA,Crane EA,Chan CP,Evans H,Bassett JH,Tylzanowski P,McNally EG,Carr AJ,Boyde A,Howell PG,Clark A,Williams GR,Brown MA,Croucher PI,Nesbit MA,Brown SD,Cox RD,Cheeseman MT,Thakker RV|Esapa CT,Head RA,Jeyabalan J,Evans H,Hough TA,Cheeseman MT,McNally EG,Carr AJ,Thomas GP,Brown MA,Croucher PI,Brown SD,Cox RD,Thakker RV","Amino Acid Sequence,Animals,Base Sequence,Chondrocytes,Chromosomes,Mammalian,Collagen Type II,Disease Models,Animal,Embryo,Genetic Loci,Growth Plate,Male,Mice,Inbred C57BL,Molecular Sequence Data,Mutant Proteins,Mutation,Missense,Organ Size,Osteoarthritis,Osteochondrodysplasias,Osteogenesis,Phenotype,Physical Chromosome Mapping,Protein Processing,Post-Translational|Animals,Apoptosis,Blotting,Western,Bone and Bones,COS Cells,Calcinosis,Cercopithecus aethiops,Disease Models,Animal,Ethylnitrosourea,Fibroblast Growth Factors,Genes,Recessive,Green Fluorescent Proteins,Hyperostosis,Cortical,Congenital,Hyperphosphatemia,Male,Mice,Mutation,Missense,N-Acetylgalactosaminyltransferases,Reverse Transcriptase Polymerase Chain Reaction,Sertoli Cells,Spermatozoa,Testis"
ndos0168,ndos0168,1,0.3333333333333333,Journal article,Journal of Bone and Joint Surgery: American Volume,,An Independent Learning Method for OrthopaedicSurgeons Performing Shoulder Ultrasound toIdentify Full-Thickness Tears of the Rotator Cuff,"Murphy RJ,Daines MT,Carr AJ,Rees JL",
clme0832,ndos0168,1,0.1111111111111111,Journal article,BMJ,21/05/2014,Use of placebo controls in the evaluation of surgery: systematic review.,"Wartolowska K,Judge A,Hopewell S,Collins GS,Dean BJ,Rombach I,Brindley D,Savulescu J,Beard DJ,Carr AJ","Humans,Placebos,Surgical Procedures,Operative,Randomized Controlled Trials as Topic"
clme1136,donc0136,1,0.06666666666666667,Journal article,The EMBO Journal,27/05/2016,SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development.,"Raducu M,Fung E,Serres S,Infante P,Barberis A,Fischer R,Bristow C,Thézénas ML,Finta C,Christianson JC,Buffa FM,Kessler BM,Sibson NR,Di Marcotullio L,Toftgård R,D'Angiolella V",
clme0494,wolf1917,9,1.1702380952380953,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Antimicrobial Agents and Chemotherapy|Nucleic Acids Research|Nucleic Acids Research|Journal of Biological Chemistry|Nature Cell Biology|Genes and Development|Nucleic Acids Research|Chemical Communications|Chemistry and Biology,19/10/2015|17/11/2015|10/12/2014|11/06/2012|25/01/2016|01/01/2011|01/09/2015|01/01/2016|24/01/2013,Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.|The structures of the SNM1A and SNM1B/Apollo nuclease domains reveal a potential basis for their distinct DNA processing activities.|CSB interacts with SNM1A and promotes DNA interstrand crosslink processing.|Characterization of the human SNM1A and SNM1B/Apollo DNA repair exonucleases.|EXD2 promotes homologous recombination by facilitating DNA end resection.|Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair|CSB interacts with SNM1A and promotes DNA interstrand crosslink processing|Cephalosporins inhibit human metallo β-lactamase fold DNA repair nucleases SNM1A and SNM1B/apollo.|A small molecule inhibitor of the BLM helicase modulates chromosome stability in human cells.,"Brem J,van Berkel SS,Zollman D,Lee SY,Gileadi O,McHugh PJ,Walsh TR,McDonough MA,Schofield CJ|Allerston CK,Lee SY,Newman JA,Schofield CJ,McHugh PJ,Gileadi O|Iyama T,Lee SY,Berquist BR,Gileadi O,Bohr VA,Seidman MM,McHugh PJ,Wilson DM|Sengerová B,Allerston CK,Abu M,Lee SY,Hartley J,Kiakos K,Schofield CJ,Hartley JA,Gileadi O,McHugh PJ|Broderick R,Nieminuszczy J,Baddock HT,Deshpande RA,Gileadi O,Paull TT,McHugh PJ,Niedzwiedz W|Wang AT,Sengerová B,Cattell E,Inagawa T,Hartley JM,Kiakos K,Burgess-Brown NA,Swift LP,Enzlin JH,Schofield CJ,Gileadi O,Hartley JA,McHugh PJ|Iyama T,Lee SY,Berquist BR,Gileadi O,Bohr VA,Seidman MM,McHugh PJ,Wilson DM|Lee SY,Brem J,Pettinati I,Claridge TD,Gileadi O,Schofield CJ,McHugh PJ|Nguyen GH,Dexheimer TS,Rosenthal AS,Chu WK,Singh DK,Mosedale G,Bachrati CZ,Schultz L,Sakurai M,Savitsky P,Abu M,McHugh PJ,Bohr VA,Harris CC,Jadhav A,Gileadi O,Maloney DJ,Simeonov A,Hickson ID","|Humans,DNA Damage,DNA Repair Enzymes,Exodeoxyribonucleases,Nuclear Proteins,DNA,Catalytic Domain,Protein Structure,Tertiary,Protein Binding,Models,Molecular|Cell Line,Hela Cells,Humans,DNA Damage,DNA Repair Enzymes,Exonucleases,DNA Helicases,DNA-Binding Proteins,DNA,Cross-Linking Reagents,DNA Repair|Chelating Agents,DNA,DNA Cleavage,DNA Damage,DNA Repair Enzymes,Single-Stranded,DNA-Binding Proteins,Enzyme Assays,Enzyme Inhibitors,Escherichia coli,Fluorescein,Fluorescent Dyes,Humans,Hydrogen-Ion Concentration,Hydrolysis,Magnesium,Nuclear Proteins,Plasmids,Protein Binding,RNA,Recombinant Proteins,Substrate Specificity|||||Antineoplastic Agents,Cell Line,Cell Proliferation,Chromosomal Instability,DNA,Enzyme Inhibitors,High-Throughput Screening Assays,Humans,Protein Binding,RecQ Helicases,Small Molecule Libraries"
clme0240,stat0004,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
cschof,immd0031,1,0.125,Journal article,PLoS One,01/01/2014,Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.,"Snell CE,Turley H,McIntyre A,Li D,Masiero M,Schofield CJ,Gatter KC,Harris AL,Pezzella F","Animals,Binding Sites,Breast Neoplasms,Cell Line,Tumor,Female,Gene Expression Regulation,Neoplastic,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,Kaplan-Meier Estimate,MCF-7 Cells,Mice,Inbred BALB C,Neoplasm Transplantation,Neoplasms,Procollagen-Proline Dioxygenase,Prognosis,Proline,Up-Regulation"
bras2068,clme0670,1,0.16666666666666666,Journal article,Journal of the Royal Society Interface,,Estimating oxygen distribution from vasculature in three-dimensional tumour tissue.,"Grimes DR,Kannan P,Warren DR,Markelc B,Bates R,Muschel R,Partridge M",
clme0149,whgu0378,2,0.125,Journal article|Conference paper,Clinical Cancer Research|European Journal of Cancer,01/07/2015|01/09/2015,POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer.|POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer,"van Gool IC,Eggink FA,Freeman-Mills L,Stelloo E,Marchi E,de Bruyn M,Palles C,Nout RA,de Kroon CD,Osse EM,Klenerman P,Creutzberg CL,Tomlinson IP,Smit VT,Nijman HW,Bosse T,Church DN|Van Gool I,Eggink F,Freeman-Mills L,Stelloo E,Marchi E,Palles C,De Bruyn M,Nout R,De Kroon C,Osse M,Klenerman P,Creutzberg C,Tomlinson I,Smit V,Nijman H,Bosse T,Church D","Lymphocytes,Tumor-Infiltrating,Humans,Endometrial Neoplasms,DNA Polymerase II,Fluorescent Antibody Technique,Immunohistochemistry,Cohort Studies,Polymerase Chain Reaction,DNA Mutational Analysis,Mutation,Female|"
clme0195,immd0654,1,0.05263157894736842,Journal article,Molecular Cell,18/01/2012,Intragenic enhancers act as alternative promoters.,"Kowalczyk MS,Hughes JR,Garrick D,Lynch MD,Sharpe JA,Sloane-Stanley JA,McGowan SJ,De Gobbi M,Hosseini M,Vernimmen D,Brown JM,Gray NE,Collavin L,Gibbons RJ,Flint J,Taylor S,Buckle VJ,Milne TA,Wood WG,Higgs DR","Animals,Cells,Cultured,Enhancer Elements,Genetic,Erythroid Cells,Gene Expression Regulation,Mice,Poly A,Promoter Regions,RNA,RNA Isoforms,Messenger,Transcriptome"
clme0237,immd0180,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
clne0013,clne0102,15,1.9883089133089131,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Neuroimage|Lecture Notes in Computer Science|Neuroimage|Biological Psychiatry|Trends in Cognitive Sciences|Proceedings of the National Academy of Sciences of USA|Neuroimage|Proceedings of the National Academy of Sciences of USA|Neuroimage|Neuroimage|Trends in Cognitive Sciences|Proceedings of the National Academy of Sciences of USA|BMC Psychiatry|Neuroimage|Neuroimage,18/04/2014|01/01/2013|01/01/2012|01/09/2013|01/01/2013|01/01/2012|02/06/2014|07/02/2012|01/01/2014|01/01/2011|01/12/2013|07/02/2012|30/05/2014|15/01/2015|01/01/2011,"Optimizing full-brain coverage in human brain MRI through population distributions of brain size.|Multimodal surface matching: Fast and generalisable cortical registration using discrete optimisation|FSL|Resting functional connectivity reveals residual functional activity in Alzheimer's disease|Functional connectomics from resting-state fMRI|Temporally-independent functional modes of spontaneous brain activity|MSM: a new flexible framework for Multimodal Surface Matching.|Temporally-independent functional modes of spontaneous brain activity.|Optimizing full-brain coverage in human brain MRI through population distributions of brain size|A Bayesian model of shape and appearance for subcortical brain segmentation|Functional connectomics from resting-state fMRI|Temporally-independent functional modes of spontaneous brain activity|Study protocol: The Whitehall II imaging sub-study.|Large-scale probabilistic functional modes from resting state fMRI.|Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner","Mennes M,Jenkinson M,Valabregue R,Buitelaar JK,Beckmann C,Smith S|Robinson EC,Jbabdi S,Andersson J,Smith S,Glasser MF,Van Essen DC,Burgess G,Harms MP,Barch DM,Jenkinson M|Jenkinson M,Beckmann CF,Behrens TEJ,Woolrich MW,Smith SM|Zamboni G,Wilcock GK,Douaud G,Drazich E,McCulloch E,Filippini N,Tracey I,Brooks JCW,Smith SM,Jenkinson M,MacKay CE|Smith SM,Beckmann CF,Jenkinson M,Miller KL,Robinson EC,Salimi-Khorshidi G,Woolrich MW,Vidaurre D,Glasser MF,Barch DM,Van Essen DC,Nichols TE,Uǧurbil K|Smith SM,Miller KL,Moeller S,Xu J,Auerbach EJ,Woolrich MW,Beckmann CF,Jenkinson M,Andersson J,Glasser MF,Van Essen DC,Feinberg DA,Yacoubb ES,Ugurbil K|Robinson EC,Jbabdi S,Glasser MF,Andersson J,Burgess GC,Harms MP,Smith SM,Van Essen DC,Jenkinson M|Smith SM,Miller KL,Moeller S,Xu J,Auerbach EJ,Woolrich MW,Beckmann CF,Jenkinson M,Andersson J,Glasser MF,Van Essen DC,Feinberg DA,Yacoub ES,Ugurbil K|Mennes M,Jenkinson M,Valabregue R,Buitelaar JK,Beckmann C,Smith S|Patenaude B,Smith SM,Kennedy DN,Jenkinson M|Smith SM,Vidaurre D,Beckmann CF,Glasser MF,Jenkinson M,Miller KL,Nichols TE,Robinson EC,Salimi-Khorshidi G,Woolrich MW,Barch DM,Uǧurbil K,Van Essen DC|Smith SM,Miller KL,Moeller S,Xu J,Auerbach EJ,Woolrich MW,Beckmann CF,Jenkinson M,Andersson J,Glasser MF,Van Essen DC,Feinberg DA,Yacoubb ES,Ugurbil K|Filippini N,Zsoldos E,Haapakoski R,Sexton CE,Mahmood A,Allan CL,Topiwala A,Valkanova V,Brunner EJ,Shipley MJ,Auerbach E,Moeller S,Uğurbil K,Xu J,Yacoub E,Andersson J,Bijsterbosch J,Clare S,Griffanti L,Hess AT,Jenkinson M,Miller KL,Salimi-Khorshidi G,Sotiropoulos SN,Voets NL,Smith SM,Geddes JR,Singh-Manoux A,Mackay CE,Kivimäki M,Ebmeier KP|Harrison SJ,Woolrich MW,Robinson EC,Glasser MF,Beckmann CF,Jenkinson M,Smith SM|Miller KL,Stagg CJ,Douaud G,Jbabdi S,Smith SM,Behrens TE,Jenkinson M,Chance SA,Esiri MM,Voets NL,Jenkinson N,Aziz TZ,Turner MR,Johansen-Berg H,McNab JA","Brain,Humans,Magnetic Resonance Imaging,Diffusion Magnetic Resonance Imaging,Demography,Adolescent,Adult,Aged,80 and over,Middle Aged,Child,Preschool,Female,Male,Young Adult,Neuroimaging||||||Cerebral Cortex,Humans,Magnetic Resonance Imaging,Brain Mapping,Data Interpretation,Statistical,Image Processing,Computer-Assisted,Adult,Young Adult|Adult,Brain,Brain Mapping,Cognition,Gyrus Cinguli,Humans,Magnetic Resonance Imaging,Motor Activity,Nerve Net,Reproducibility of Results,Time Factors,Visual Pathways||Adolescent,Adult,Aged,Algorithms,Artificial Intelligence,Bayes Theorem,Brain,Female,Humans,Image Processing,Computer-Assisted,Linear Models,Magnetic Resonance Imaging,Male,Middle Aged,Models,Neurological,Statistical,Reproducibility of Results,Thalamus,Young Adult|||Brain,Humans,Magnetic Resonance Imaging,Retrospective Studies,Longitudinal Studies,Cognition,Cognition Disorders,Aging,Adult,Aged,80 and over,Middle Aged,Female,Male,Neuroimaging|Brain,Humans,Magnetic Resonance Imaging,Probability,Computer Simulation,Image Processing,Computer-Assisted,Signal Processing,Connectome|Anisotropy,Artifacts,Autopsy,Brain,Brain Mapping,Diffusion Magnetic Resonance Imaging,Humans,Image Interpretation,Computer-Assisted,Tissue Fixation"
immd0316,raob0096,2,0.19444444444444442,Journal article|Journal article,Current Biology|Journal of Clinical Investigation,26/02/2015|11/05/2015,"Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.|Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT.","Vlahov N,Scrace S,Soto MS,Grawenda AM,Bradley L,Pankova D,Papaspyropoulos A,Yee KS,Buffa F,Goding CR,Timpson P,Sibson N,O'Neill E|Leszczynska KB,Foskolou IP,Abraham AG,Anbalagan S,Tellier C,Haider S,Span PN,O'Neill EE,Buffa FM,Hammond EM","|Cell Line,Tumor,Humans,Neoplasms,Phosphoric Monoester Hydrolases,Sulfotransferases,Adaptor Proteins,Signal Transducing,Carrier Proteins,Immediate-Early Proteins,Tumor Suppressor Proteins,Nuclear Proteins,Apoptosis,Cell Hypoxia,Radiation Tolerance,Tumor Suppressor Protein p53,Proto-Oncogene Proteins c-akt"
prhc0057,prhc0057,1,0.5,Book,,11/12/2015,Global Health,"Nicholson BD,McKimm J,Allen AK",
bioc0416,clme1136,1,0.06666666666666667,Journal article,The EMBO Journal,27/05/2016,SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development.,"Raducu M,Fung E,Serres S,Infante P,Barberis A,Fischer R,Bristow C,Thézénas ML,Finta C,Christianson JC,Buffa FM,Kessler BM,Sibson NR,Di Marcotullio L,Toftgård R,D'Angiolella V",
raob0122,raob0233,3,0.2786037491919845,Conference paper|Journal article|Conference paper,Cancer Research|Cancer Cell|European Journal of Cancer,01/01/2016||01/11/2014,WEE1 inhibition selectively kills histone H3K36me3-deficient cancers by dNTP starvation|Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.|A novel synthetic lethal interaction between the histone mark H3K36me3 and checkpoint kinases,"Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Zalmas L-P,Orlando G,Drobnitzky N,Dianov G,Ying S,La Thangue NB,D'Angiolella V,Ryan A,Humphrey TC|Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Orlando G,Mavrommati I,Pai CC,Zalmas LP,Drobnitzky N,Dianov GL,Verrill C,Macaulay VM,Ying S,La Thangue NB,D'Angiolella V,Ryan AJ,Humphrey TC|Pfister SX,Markkanen E,Jiang Y,Sarkar S,D'Angiolella V,Dianov G,Ryan AJ,Humphrey TC","|Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Neoplasms,Pyrazoles,Pyrimidines,Ribonucleoside Diphosphate Reductase,Histone-Lysine N-Methyltransferase,Nucleotides,Lysine,Cell Cycle Proteins,Nuclear Proteins,Histones,Blotting,Western,Xenograft Model Antitumor Assays,Reverse Transcriptase Polymerase Chain Reaction,Cell Survival,Gene Expression Regulation,Neoplastic,RNA Interference,Amino Acid Sequence,Base Sequence,Sequence Homology,Amino Acid,Nucleic Acid,Methylation,Molecular Sequence Data,Protein-Tyrosine Kinases|"
immd0316,immd0421,1,0.1111111111111111,Journal article,Oncogene,28/11/2011,Igf2 ligand dependency of Pten(+/-) developmental and tumour phenotypes in the mouse.,"Church DN,Phillips BR,Stuckey DJ,Barnes DJ,Buffa FM,Manek S,Clarke K,Harris AL,Carter EJ,Hassan AB","Animals,Carcinoma,Cardiomegaly,Cell Line,Tumor,Cell Proliferation,Cell Transformation,Neoplastic,Female,Humans,Insulin-Like Growth Factor II,Longevity,Male,Mammary Neoplasms,Animal,Mice,Inbred C57BL,PTEN Phosphohydrolase,Placenta,Pregnancy,Sex Factors"
clme0237,immd0423,1,0.07142857142857142,Conference paper,Annals of Oncology,01/06/2012,CLINICAL DIAGNOSTIC IMPLEMENTATION OF AN INNOVATIVE CANCER CARE MODEL BASED ON COMPREHENSIVE MOLECULAR PROFILING OF TUMOUR-NORMAL PAIRS,"Kaur K,Henderson S,Cutts A,Domingo E,Woods J,Motley C,Dougherty B,Middleton M,Hassan B,Wang Y,Beasley E,Naley M,Schuh A,Tomlinson I,Taylor J",
clme1358,olin0081,1,0.07692307692307693,Journal article,Chemistry and Biology,26/08/2015,Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.,"Canning P,Ruan Q,Schwerd T,Hrdinka M,Maki JL,Saleh D,Suebsuwong C,Ray S,Brennan PE,Cuny GD,Uhlig HH,Gyrd-Hansen M,Degterev A,Bullock AN",
clme0237,immd0151,14,0.9502822862474446,Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Clinical Genetics: an international journal of genetics and molecular medicine|Blood|Leukemia|American Journal of Human Genetics|Blood|American Journal of Medical Genetics Part A|Journal of Medical Genetics|Blood|Human Molecular Genetics|Human Molecular Genetics|European Journal of Human Genetics|Journal of Human Genetics|British Journal of Haematology|PLoS Genetics,08/03/2016|16/11/2012|01/01/2012|15/01/2014|12/12/2013|10/08/2012|01/09/2012|27/08/2015|20/08/2015|08/04/2015|22/08/2012|01/12/2011|16/05/2014|01/12/2012,"A de novo frameshift in HNRNPK causing a Kabuki-like syndrome with nodular heterotopia.|SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features|Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.|Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation.|SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.|A novel nonsense CDK5RAP2 mutation in a Somali child with primary microcephaly and sensorineural hearing loss.|Genomic analysis of sporadic neurological disease using family trios: learning to expect the unexpected|Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.|Mutations in PIGY: expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies.|Germline recessive mutations in PI4KA are associated with perisylvian polymicrogyria, cerebellar hypoplasia and arthrogryposis.|Dual copy number variants involving 16p11 and 6q22 in a case of childhood apraxia of speech and pervasive developmental disorder.|Exome sequencing can detect pathogenic mosaic mutations present at low allele frequencies.|Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co-express gamma and beta globins.|Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development.","Lange L,Pagnamenta AT,Lise S,Clasper S,Stewart H,Akha ES,Quaghebeur G,Knight SJ,Keays DA,Taylor JC,Kini U|Clifford R,Ackroyd S,Burns A,Timbs A,Maelfait J,Dreau H,Henderson S,Ross M,Bentley D,Hillmen P,Knight S,Taylor J,Hatton CSR,Rehwinkel J,Crow Y,Schuh A|Knight SJ,Yau C,Clifford R,Timbs AT,Sadighi Akha E,Dréau HM,Burns A,Ciria C,Oscier DG,Pettitt AR,Dutton S,Holmes CC,Taylor J,Cazier JB,Schuh A|Howard MF,Murakami Y,Pagnamenta AT,Daumer-Haas C,Fischer B,Hecht J,Keays DA,Knight SJ,Kölsch U,Krüger U,Leiz S,Maeda Y,Mitchell D,Mundlos S,Phillips JA,Robinson PN,Kini U,Taylor JC,Horn D,Kinoshita T,Krawitz PM|Clifford R,Louis T,Robbe P,Ackroyd S,Burns A,Timbs AT,Wright Colopy G,Dreau H,Sigaux F,Judde JG,Rotger M,Telenti A,Lin YL,Pasero P,Maelfait J,Titsias M,Cohen DR,Henderson SJ,Ross MT,Bentley D,Hillmen P,Pettitt A,Rehwinkel J,Knight SJ,Taylor JC,Crow YJ,Benkirane M,Schuh A|Pagnamenta AT,Murray JE,Yoon G,Sadighi Akha E,Harrison V,Bicknell LS,Ajilogba K,Stewart H,Kini U,Taylor JC,Keays DA,Jackson AP,Knight SJ|Pagnamenta A,Martin H,Lise S,Hudspith K,Harrison V,Copley R,Rimmer A,Broxholme J,Kanapin A,Cazier JB,Akha ES,Knight SJL,Shears DJ,Stewart H,Kini U,Taylor J,Bentley DR,Keays DA,Blair E,Donnelly P|Guièze R,Robbe P,Clifford R,de Guibert S,Pereira B,Timbs A,Dilhuydy MS,Cabes M,Ysebaert L,Burns A,Nguyen-Khac F,Davi F,Véronèse L,Combes P,Le Garff-Tavernier M,Leblond V,Merle-Béral H,Alsolami R,Hamblin A,Mason J,Pettitt A,Hillmen P,Taylor J,Knight SJ,Tournilhac O,Schuh A|Ilkovski B,Pagnamenta AT,O'Grady GL,Kinoshita T,Howard MF,Lek M,Thomas B,Turner A,Christodoulou J,Sillence D,Knight SJ,Popitsch N,Keays DA,Anzilotti C,Goriely A,Waddell LB,Brilot F,North KN,Kanzawa N,Macarthur DG,Taylor JC,Kini U,Murakami Y,Clarke NF|Pagnamenta AT,Howard MF,Wisniewski E,Popitsch N,Knight SJ,Keays DA,Quaghebeur G,Cox H,Cox P,Balla T,Taylor JC,Kini U|Newbury DF,Mari F,Sadighi Akha E,Macdermot KD,Canitano R,Monaco AP,Taylor JC,Renieri A,Fisher SE,Knight SJ|Pagnamenta AT,Lise S,Harrison V,Stewart H,Jayawant S,Quaghebeur G,Deng AT,Murphy VE,Sadighi Akha E,Rimmer A,Mathieson I,Knight SJ,Kini U,Taylor JC,Keays DA|Yang CT,French A,Goh PA,Pagnamenta A,Mettananda S,Taylor J,Knight S,Nathwani A,Roberts DJ,Watt SM,Carpenter L|Lise S,Clarkson Y,Perkins E,Kwasniewska A,Sadighi Akha E,Schnekenberg RP,Suminaite D,Hope J,Baker I,Gregory L,Green A,Allan C,Lamble S,Jayawant S,Quaghebeur G,Cader MZ,Hughes S,Armstrong RJ,Kanapin A,Rimmer A,Lunter G,Mathieson I,Cazier JB,Buck D,Taylor JC,Bentley D,McVean G,Donnelly P,Knight SJ,Jackson M,Ragoussis J,Németh AH","||Adult,Aged,80 and over,Biomarkers,Tumor,Chromosome Aberrations,Clone Cells,Female,Gene Dosage,Genome,Human,Genomics,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Loss of Heterozygosity,Male,Middle Aged,Neoplasm Recurrence,Local,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Prognosis|Abnormalities,Multiple,Alkaline Phosphatase,Amino Acid Sequence,Animals,Asian Continental Ancestry Group,CHO Cells,Child,Preschool,Chromosome Mapping,Consanguinity,Cricetinae,Cricetulus,European Continental Ancestry Group,Exome,Female,Homozygote,Humans,Intellectual Disability,Molecular Sequence Data,Mutation,Missense,Pakistan,Pedigree,Phosphorus Metabolism Disorders,Phylogeny,Polymorphism,Single Nucleotide,Receptors,Cell Surface,Saudi Arabia,United States|Adult,Autoimmune Diseases of the Nervous System,Cohort Studies,Comparative Genomic Hybridization,DNA Damage,Gene Frequency,Germ-Line Mutation,HeLa Cells,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Male,Monomeric GTP-Binding Proteins,Nervous System Malformations,Young Adult,Hela Cells|Child,Codon,Nonsense,Female,Hearing Loss,Sensorineural,Humans,Intracellular Signaling Peptides and Proteins,Microcephaly,Nerve Tissue Proteins,Pedigree,Polymorphism,Single Nucleotide,Sequence Analysis,DNA,Somalia||Humans,Neoplasm Recurrence,Local,Ribonucleoprotein,U2 Small Nuclear,Phosphoproteins,Prognosis,Treatment Outcome,Salvage Therapy,Prospective Studies,Mutation,Tumor Suppressor Protein p53,Leukemia,Lymphocytic,Chronic,B-Cell,Kaplan-Meier Estimate,High-Throughput Nucleotide Sequencing,Ataxia Telangiectasia Mutated Proteins||Brain,Cerebellum,Humans,Arthrogryposis,Nervous System Malformations,Fetal Diseases,Phosphotransferases (Alcohol Group Acceptor),Pedigree,Sequence Alignment,Developmental Disabilities,Amino Acid Sequence,Base Sequence,Germ-Line Mutation,Mutation,Missense,Polymorphism,Single Nucleotide,Molecular Sequence Data,Infant,Female,Male,Exome,Polymicrogyria|Apraxias,Chromosomes,Human,Pair 16,Humans,Sequence Deletion|1-Alkyl-2-acetylglycerophosphocholine Esterase,Amino Acid Sequence,Base Sequence,Child,Classical Lissencephalies and Subcortical Band Heterotopias,Exome,Female,Gene Frequency,Humans,Magnetic Resonance Imaging,Microtubule-Associated Proteins,Molecular Sequence Data,Mosaicism,Sequence Analysis,DNA|Erythroblasts,Cell Line,Humans,Cell Culture Techniques,Karyotyping,Immunophenotyping,Cell Differentiation,Erythropoiesis,Gene Expression,Cell Lineage,beta-Globins,gamma-Globins,DNA Copy Number Variations,Induced Pluripotent Stem Cells|Adult,Animals,Cerebellum,Chromosome Mapping,Cognition Disorders,Humans,Mice,Knockout,Mutation,Neurons,Purkinje Cells,Spectrin,Spinocerebellar Ataxias"
cschof,cschof,1,0.125,Chapter,,06/05/2015,Introduction to structural studies on 2-oxoglutarate-dependent oxygenases and related enzymes,"Aik WS,Chowdhury R,Clifton IJ,Hopkinson RJ,Leissing T,McDonough MA,Nowak R,Schofield CJ,Walport LJ",
immd0023,orie1154,1,0.1111111111111111,Journal article,Gene Therapy (Basingstoke),10/11/2011,Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.,"Silk KM,Silk JD,Ichiryu N,Davies TJ,Nolan KF,Leishman AJ,Carpenter L,Watt SM,Cerundolo V,Fairchild PJ","Antigen Presentation,Antigens,CD,Neoplasm,Cell Differentiation,Cross-Priming,Dendritic Cells,Humans,Induced Pluripotent Stem Cells,Neoplasms,Receptors,G-Protein-Coupled"
clme1358,newc0612,1,0.0625,Journal article,Journal of Medicinal Chemistry,21/03/2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.","Hewings DS,Fedorov O,Filippakopoulos P,Martin S,Picaud S,Tumber A,Wells C,Olcina MM,Freeman K,Gill A,Ritchie AJ,Sheppard DW,Russell AJ,Hammond EM,Knapp S,Brennan PE,Conway SJ","Acetylation,CREB-Binding Protein,Cell Line,Tumor,Crystallography,X-Ray,Histones,Humans,Inhibitory Concentration 50,Isoxazoles,Ligands,Lysine,Nuclear Proteins,Protein Binding,Structure-Activity Relationship,Transcription Factors"
ocms0064,whgu0172,1,0.047619047619047616,Journal article,Molecular Cell,30/01/2014,Optimal translational termination requires C4 lysyl hydroxylation of eRF1.,"Yamamoto A,Feng T,Wilkins S,Sokolova E,Yates L,Muenzel M,Singh P,Hopkinson R,Fischer R,Cockman M,Shelley J,Trudgian D,Schoedel J,McCullagh JO,Ge W,Kessler B,Gilbert R,Frolova L,Alkalaeva E,Ratcliffe P,Schofield C,Coleman M","Amino Acid Sequence,Animals,Catalysis,Cell Line,Tumor,Codon,Terminator,Gene Expression Regulation,HeLa Cells,Histone Demethylases,Humans,Hydrolysis,Hydroxylation,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Peptide Chain Termination,Translational,Peptide Termination Factors,Protein Biosynthesis,Protein Processing,Post-Translational,Protein Structure,Tertiary,Sequence Homology,Amino Acid"
clab0035,immd0700,2,0.0425531914893617,Journal article|Journal article,Cancer Cell|Cancer Cell,14/05/2014|16/06/2014,Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo,"Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SE|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW","Chromosomes,Human,Pair 5,Animals,Mice,Inbred NOD,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Genetic Predisposition to Disease,Antigens,CD,Prognosis,Flow Cytometry,Gene Expression Profiling,Mutation,Neoplastic Stem Cells,Heterografts|"
clme0220,radi0003,2,0.5,Journal article|Journal article,Journal of the National Cancer Institute Monographs|Future Oncology,01/05/2015|01/11/2012,Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer Metabolism.|Clinical imaging of tumor angiogenesis.,"Lord SR,Patel N,Liu D,Fenwick J,Gleeson F,Buffa F,Harris AL|Patel N,Harris AL,Gleeson FV,Vallis KA","Humans,Breast Neoplasms,Metformin,Hypoglycemic Agents,Chemotherapy,Adjuvant,Neoadjuvant Therapy,Female,Metabolome,Transcriptome,Biomarkers,Tumor|Animals,Diagnostic Imaging,Humans,Neoplasms,Neovascularization,Pathologic"
raob0069,raob0097,2,0.18181818181818182,Journal article|Conference paper,"Cell Death and Disease|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",01/01/2012|01/05/2013,Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation,"Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB","Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|"
bioc0212,card0018,16,3.491302161890397,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Chapter|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article,"International Journal of Cardiovascular Imaging|International Journal of Obesity|Journal of Cardiovascular Magnetic Resonance|European Heart Journal|Circulation|Cell Metabolism||American Journal of Clinical Nutrition|American Journal of Physiology: Regulatory, Integrative and Comparative Physiology|Circulation|Expert Opinion on Therapeutic Targets|Circulation|Cell Metabolism|International Journal of Obesity|Radiology|International Journal of Cardiovascular Imaging",27/12/2012|16/10/2012|03/02/2015|18/05/2015|04/10/2011|07/03/2012|18/09/2015|26/01/2011|01/06/2011|24/02/2012|01/06/2016|22/11/2011|01/01/2012|01/07/2013|01/03/2016|01/06/2013,"Effects of weight loss on myocardial energetics and diastolic function in obesity.|Myocardial substrate metabolism in obesity.|Hyperpolarized &lt;sup&gt;13&lt;/sup&gt;C and &lt;sup&gt;31&lt;/sup&gt;P magnetic resonance spectroscopy identify pyruvate dehydrogenase as a therapeutic target in obesity cardiomyopathy|Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction.|Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.|Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.|Magnetic resonance imaging|A high-fat diet impairs cardiac high-energy phosphate metabolism and cognitive function in healthy human subjects.|Endurance exercise training blunts the deleterious effect of high-fat feeding on whole body efficiency.|Effects of catecholamine stress on diastolic function and myocardial energetics in obesity.|Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy.|Exercise Acutely Exacerbates Derangement Of Cardiac Energy Metabolism In Hypertrophic Cardiomyopathy, a 31 Phosphorus Magnetic Resonance Study at 3 Telsa|Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway|Myocardial substrate metabolism in obesity|Science to Practice: Hyperpolarized Metabolic MR Imaging--The Light at the End of the Tunnel for Clinical (13)C MR Spectroscopy?|Effects of weight loss on myocardial energetics and diastolic function in obesity","Rider OJ,Francis JM,Tyler D,Byrne J,Clarke K,Neubauer S|Rider OJ,Cox P,Tyler D,Clarke K,Neubauer S|Lewis AJ,Dodd MS,Sourdon J,Clarke K,Neubauer S,Tyler DJ,Rider O|Dass S,Cochlin LE,Suttie JJ,Holloway CJ,Rider OJ,Carden L,Tyler DJ,Karamitsos TD,Clarke K,Neubauer S,Watkins H|Schroeder MA,Clarke K,Neubauer S,Tyler DJ|Ashrafian H,Czibik G,Bellahcene M,Aksentijević D,Smith AC,Mitchell SJ,Dodd MS,Kirwan J,Byrne JJ,Ludwig C,Isackson H,Yavari A,Støttrup NB,Contractor H,Cahill TJ,Sahgal N,Ball DR,Birkler RI,Hargreaves I,Tennant DA,Land J,Lygate CA,Johannsen M,Kharbanda RK,Neubauer S,Redwood C,de Cabo R,Ahmet I,Talan M,Günther UL,Robinson AJ,Viant MR,Pollard PJ,Tyler DJ,Watkins H|Ferreira VM,Robson MD,Karamitsos TD,Bissell MM,Tyler DJ,Neubauer S|Holloway CJ,Cochlin LE,Emmanuel Y,Murray A,Codreanu I,Edwards LM,Szmigielski C,Tyler DJ,Knight NS,Saxby BK,Lambert B,Thompson C,Neubauer S,Clarke K|Edwards LM,Holloway CJ,Murray AJ,Knight NS,Carter EE,Kemp GJ,Thompson CH,Tyler DJ,Neubauer S,Robbins PA,Clarke K|Rider OJ,Francis JM,Ali MK,Holloway C,Pegg T,Robson MD,Tyler D,Byrne J,Clarke K,Neubauer S|Lewis AJ,Neubauer S,Tyler DJ,Rider OJ|Dass S,Cochlin LE,Suttie JJ,Holloway C,Rodgers CT,Tyler D,Karamitsos TD,Clarke K,Watkins H,Neubauer S|Ashrafian H,Czibik G,Bellahcene M,Aksentijević D,Smith AC,Mitchell SJ,Dodd MS,Kirwan J,Byrne JJ,Ludwig C,Isackson H,Yavari A,Støttrup NB,Contractor H,Cahill TJ,Sahgal N,Ball DR,Birkler RID,Hargreaves I,Tennant DA,Land J,Lygate CA,Johannsen M,Kharbanda RK,Neubauer S,Redwood C,De Cabo R,Ahmet I,Talan M,Günther UL,Robinson AJ,Viant MR,Pollard PJ,Tyler DJ,Watkins H|Rider OJ,Cox P,Tyler D,Clarke K,Neubauer S|Tyler DJ,Neubauer S|Rider OJ,Francis JM,Tyler D,Byrne J,Clarke K,Neubauer S","Adenosine Triphosphate,Adiposity,Adult,Body Mass Index,Diastole,Energy Metabolism,Humans,Magnetic Resonance Imaging,Cine,Magnetic Resonance Spectroscopy,Middle Aged,Myocardium,Obesity,Phosphocreatine,Recovery of Function,Time Factors,Treatment Outcome,Ventricular Function,Left,Weight Loss|Adenosine Triphosphate,Blood Glucose,Body Mass Index,Cardiac Output,Female,Glucose,Heart Failure,Humans,Male,Myocardium,Obesity,Ventricular Dysfunction,Weight Loss||Humans,Cardiomyopathy,Hypertrophic,Ventricular Dysfunction,Left,Phosphocreatine,Adenosine Triphosphate,Magnetic Resonance Angiography,Magnetic Resonance Imaging,Cine,Stroke Volume,Exercise,Magnetic Resonance Spectroscopy,Case-Control Studies,Prospective Studies,Energy Metabolism,Blood Pressure,Heart Rate,Diastole,Adult,Female,Male|Animals,Bicarbonates,Carbon Isotopes,Cardiomyopathies,Cardiovascular Diseases,Diagnostic Techniques,Cardiovascular,Energy Metabolism,Forecasting,Glycolysis,Heart Failure,Humans,Magnetic Resonance Spectroscopy,Myocardial Ischemia,Myocardium,Neoplasms,Experimental,Pyruvate Dehydrogenase Complex,Sensitivity and Specificity,Urea|Animals,Antioxidants,Dimethyl Fumarate,Fumarate Hydratase,Fumarates,Male,Mice,Inbred C57BL,Knockout,Models,Biological,Myocardial Infarction,NF-E2-Related Factor 2,Signal Transduction||Adenosine Triphosphate,Adult,Affect,Attention,Cognition,Cross-Over Studies,Diet,Carbohydrate-Restricted,Dietary Carbohydrates,Dietary Fats,Echocardiography,Energy Intake,Energy Metabolism,Fatty Acids,Nonesterified,Heart,Humans,Magnetic Resonance Imaging,Magnetic Resonance Spectroscopy,Male,Phosphocreatine,Reference Values,Young Adult|Dietary Fats,Energy Metabolism,Exercise,Fatty Acids,Humans,Male,Mitochondria,Muscle,Physical Endurance,Young Adult|Adult,Body Mass Index,Catecholamines,Diastole,Energy Metabolism,Exercise Test,Female,Humans,Male,Middle Aged,Myocardium,Obesity,Stress,Physiological,Ventricular Function,Left||Energy metabolism,Cardiac MRI,Cardiomyopathy|||Animals,Humans,Cardiovascular Diseases,Carbon Isotopes,Magnetic Resonance Spectroscopy|"
chem0068,raob0095,4,0.3727272727272728,Journal article|Journal article|Journal article|Conference paper,Journal of Nuclear Medicine|Metallomics: integrated biometal science|PLoS One|Journal of Labelled Compounds and Radiopharmaceuticals,12/12/2013|13/03/2015|01/01/2011|01/02/2013,"A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.|A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.|Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.|Imaging of hypoxia using CuATSM","Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ|Hueting R,Kersemans V,Tredwell M,Cornelissen B,Christlieb M,Gee AD,Passchier J,Smart SC,Gouverneur V,Muschel RJ,Dilworth JR|Kersemans V,Cornelissen B,Hueting R,Tredwell M,Hussien K,Allen PD,Falzone N,Hill SA,Dilworth JR,Gouverneur V,Muschel RJ,Smart SC|Hueting R,Kersemans V,Cornelissen B,Tredwell M,Hussien K,Christlieb M,Gee AD,Passchier J,Smart SC,Dilworth JR,Gouverneur V,Muschel RJ","64Cu-ATSM,64Cu-acetate,copper metabolism,hypoxia,Acetates,Animals,Anoxia,Cell Line,Tumor,Copper,Copper Radioisotopes,Female,Humans,Immunohistochemistry,Mice,Inbred CBA,Neoplasm Transplantation,Organometallic Compounds,Oxygen,Positron-Emission Tomography,Prognosis,Thiosemicarbazones,Time Factors|Cell Line,Animals,Humans,Mice,Neoplasms,Anoxia,Copper Radioisotopes,Organometallic Compounds,Thiosemicarbazones,Positron-Emission Tomography,Tomography,Emission-Computed,Single-Photon,Tissue Distribution,Female|Adenocarcinoma,Anesthesia,Animals,Anoxia,Copper Radioisotopes,Female,Fluorine Radioisotopes,Gases,Mice,Inbred CBA,Misonidazole,Muscles,Neoplasms,Experimental,Organometallic Compounds,Organotechnetium Compounds,Oxygen,Positron-Emission Tomography,Radiation-Sensitizing Agents,Radiopharmaceuticals,Thiosemicarbazones,Tissue Distribution,Tomography,Emission-Computed,Single-Photon|"
lina0435,stat0059,3,0.22878787878787876,Journal article|Journal article|Journal article,Science|PLoS Genetics|Science,01/01/2012|01/07/2011|01/01/2013,A fine-scale chimpanzee genetic map from population sequencing.|Recombination and population structure in Salmonella enterica.|Multiple Instances of Ancient Balancing Selection Shared Between Humans and Chimpanzees,"Auton A,Fledel-Alon A,Pfeifer S,Venn O,Ségurel L,Street T,Leffler EM,Bowden R,Aneas I,Broxholme J,Humburg P,Iqbal Z,Lunter G,Maller J,Hernandez RD,Melton C,Venkat A,Nobrega MA,Bontrop R,Myers S,Donnelly P,Przeworski M,McVean G|Didelot X,Bowden R,Street T,Golubchik T,Spencer C,McVean G,Sangal V,Anjum MF,Achtman M,Falush D,Donnelly P|Leffler EM,Gao Z,Pfeifer S,Ségurel L,Auton A,Venn O,Bowden R,Bontrop R,Wall JD,Sella G,Donnelly P,Mcvean G,Przeworski M","Animals,Base Sequence,Chromosome Mapping,Chromosomes,Human,Pair 2,Mammalian,CpG Islands,Evolution,Molecular,Female,Genetic Variation,Haplotypes,High-Throughput Nucleotide Sequencing,Histone-Lysine N-Methyltransferase,Humans,Male,Pan troglodytes,Polymorphism,Single Nucleotide,Recombination,Genetic,Sequence Analysis,DNA,Species Specificity|Genetic Linkage,Genome,Bacterial,Recombination,Genetic,Salmonella enterica|"
immd0679,ocms0037,2,0.1388888888888889,Journal article|Journal article,Nature Structural and Molecular Biology|Nature Communications,12/10/2014|01/01/2014,Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7.|Understanding functional miRNA-target interactions in vivo by site-specific genome engineering.,"Tan JY,Vance KW,Varela MA,Sirey T,Watson LM,Curtis HJ,Marinello M,Alves S,Steinkraus BR,Cooper S,Nesterova T,Brockdorff N,Fulga TA,Brice A,Sittler A,Oliver PL,Wood MJ,Ponting CP,Marques AC|Bassett AR,Azzam G,Wheatley L,Tibbit C,Rajakumar T,McGowan S,Stanger N,Ewels PA,Taylor S,Ponting CP,Liu JL,Sauka-Spengler T,Fulga TA","Cerebellum,Neurons,Retina,Cell Line,Tumor,Fibroblasts,Animals,Humans,Mice,Spinocerebellar Ataxias,Nerve Tissue Proteins,MicroRNAs,RNA,Messenger,Gene Expression Profiling,Signal Transduction,Gene Expression Regulation,Mutation,Female,Male,Feedback,Physiological,Transcription Initiation,Genetic,Long Noncoding|Animals,Zebrafish,Humans,Drosophila,Deoxyribonucleases,Endonucleases,DNA-Binding Proteins,MicroRNAs,Transfection,Genetic Engineering,Sequence Analysis,Base Sequence,Response Elements,Molecular Sequence Data,Transcriptional Activation,HEK293 Cells,Clustered Regularly Interspaced Short Palindromic Repeats"
clme0220,immd0423,2,0.25396825396825395,Journal article|Journal article,Oncogene|Oncogene,|28/11/2011,Igf2 ligand depedency of Pten(+/-) developmental and tumour phenotypes in the mouse.|Igf2 ligand dependency of Pten(+/-) developmental and tumour phenotypes in the mouse.,"Church DN,Phillips BR,Stuckey DJ,Barnes DJ,Buffa FM,Manek S,Clarke K,Hassan AB|Church DN,Phillips BR,Stuckey DJ,Barnes DJ,Buffa FM,Manek S,Clarke K,Harris AL,Carter EJ,Hassan AB","|Animals,Carcinoma,Cardiomegaly,Cell Line,Tumor,Cell Proliferation,Cell Transformation,Neoplastic,Female,Humans,Insulin-Like Growth Factor II,Longevity,Male,Mammary Neoplasms,Animal,Mice,Inbred C57BL,PTEN Phosphohydrolase,Placenta,Pregnancy,Sex Factors"
immd0031,immd0100,1,0.2,Journal article,Proceedings of the National Academy of Sciences of USA,23/07/2012,HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.,"Rajapaksa US,Li D,Peng YC,McMichael AJ,Dong T,Xu XN","Alleles,Amino Acid Sequence,Cell Line,Cytoplasm,Down-Regulation,Epitopes,HIV Infections,HIV-1,HLA-A Antigens,HLA-B Antigens,HLA-B7 Antigen,HLA-C Antigens,Humans,Molecular Sequence Data,Polymorphism,Genetic,Protein Structure,Tertiary,Recombinant Proteins,Sequence Alignment,T-Lymphocytes,Cytotoxic,gag Gene Products,Human Immunodeficiency Virus,nef Gene Products"
bioc0192,clme0670,1,0.07142857142857142,Journal article,Proceedings of the National Academy of Sciences of USA,26/03/2012,Molecular MRI enables early and sensitive detection of brain metastases.,"Serres S,Soto MS,Hamilton A,McAteer MA,Carbonell WS,Robson MD,Ansorge O,Khrapitchev A,Bristow C,Balathasan L,Weissensteiner T,Anthony DC,Choudhury RP,Muschel RJ,Sibson NR","Animals,Brain Neoplasms,Disease Progression,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Sensitivity and Specificity,Up-Regulation,Vascular Cell Adhesion Molecule-1"
clme0301,immd0198,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
ndog0251,raob0051,3,0.4,Journal article|Journal article|Journal article,Cancer|International Journal of Gynecological Cancer|Proceedings of SPIE - The International Society for Optical Engineering,10/09/2014|01/11/2014|01/01/2014,Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer.|A PROSPECTIVE PILOT STUDY OF NEAR INFRARED (PIONIR) IMAGING OF SENTINEL NODES IN GYNAECOLOGICAL CANCERS|A novel multiwavelength fluorescence image-guided surgery imaging system,"Liu S,Zheng Y,Volpi D,El-Kasti M,Klotz D,Tullis I,Henricks A,Campo L,Myers K,Laios A,Thomas P,Ng T,Dhar S,Becker C,Vojnovic B,Ahmed AA|Laios A,Pathiraja P,Ahmed A,Vojnovic B,Haldar K,Volpi D,Tullis I|Volpi D,Tullis IDC,Laios A,Pathiraja PNJ,Haldar K,Ahmed AA,Vojnovic B","Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Peritoneal Neoplasms,Ovarian Neoplasms,Peptides,Cyclic,Tumor Markers,Biological,Fluorescent Dyes,Microscopy,Fluorescence,Blotting,Western,Flow Cytometry,Immunohistochemistry,Feasibility Studies,Gene Expression Regulation,Neoplastic,Female,Proto-Oncogene Proteins c-met,Individualized Medicine,Molecular Targeted Therapy,Optical Imaging,Heterografts||Image-guided surgery,Fluorescence,Widefield imaging,Laparoscopy,Near infrared,Lymph nodes"
clme0220,smlea,1,0.0625,Journal article,Journal of Biological Chemistry,21/01/2013,Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.,"Whiteman P,de Madrid BH,Taylor P,Li D,Heslop R,Viticheep N,Tan JZ,Shimizu H,Callaghan J,Masiero M,Li JL,Banham AH,Harris AL,Lea SM,Redfield C,Baron M,Handford PA","Amino Acid Sequence,Animals,Antibodies,Monoclonal,Blotting,Western,Calcium-Binding Proteins,Cell Line,Tumor,Drosophila Proteins,Flow Cytometry,HEK293 Cells,Humans,Intercellular Signaling Peptides and Proteins,Ligands,Membrane Proteins,Mice,Models,Molecular,Molecular Sequence Data,Mutation,Protein Binding,Protein Structure,Secondary,Tertiary,Receptor,Notch1,Receptors,Notch,Sequence Homology,Amino Acid"
immd0237,stat0004,2,0.035490101400289714,Journal article|Journal article,Nature Genetics|Nature Genetics,18/05/2015|23/12/2012,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA"
chem0489,clme0497,9,0.7591051492367283,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Conference paper,Angewandte Chemie International Edition|Journal of Medicinal Chemistry|Journal of Medicinal Chemistry|MedChemComm|Journal of the American Chemical Society|Journal of Medicinal Chemistry|ACS National Meeting Book of Abstracts|ACS National Meeting Book of Abstracts|ACS National Meeting Book of Abstracts,12/05/2014|27/09/2012|18/08/2011|01/01/2013|19/06/2014|21/03/2013|19/08/2012|25/03/2012|25/03/2012,"A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interaction.|Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.|3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.|The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains|Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.|Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.|Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction|Developing chemical probes for the BET bromodomains|3,5-Dimethylisoxazoles inhibit the bromodomain-histone protein-protein interaction","Rooney TP,Filippakopoulos P,Fedorov O,Picaud S,Cortopassi WA,Hay DA,Martin S,Tumber A,Rogers CM,Philpott M,Wang M,Thompson AL,Heightman TD,Pryde DC,Cook A,Paton RS,Müller S,Knapp S,Brennan PE,Conway SJ|Hewings DS,Rooney TP,Jennings LE,Hay DA,Schofield CJ,Brennan PE,Knapp S,Conway SJ|Hewings DS,Wang M,Philpott M,Fedorov O,Uttarkar S,Filippakopoulos P,Picaud S,Vuppusetty C,Marsden B,Knapp S,Conway SJ,Heightman TD|Hay D,Fedorov O,Filippakopoulos P,Martin S,Philpott M,Picaud S,Hewings DS,Uttakar S,Heightman TD,Conway SJ,Knapp S,Brennan PE|Hay DA,Fedorov O,Martin S,Singleton DC,Tallant C,Wells C,Picaud S,Philpott M,Monteiro OP,Rogers CM,Conway SJ,Rooney TP,Tumber A,Yapp C,Filippakopoulos P,Bunnage ME,Müller S,Knapp S,Schofield CJ,Brennan PE|Hewings DS,Fedorov O,Filippakopoulos P,Martin S,Picaud S,Tumber A,Wells C,Olcina MM,Freeman K,Gill A,Ritchie AJ,Sheppard DW,Russell AJ,Hammond EM,Knapp S,Brennan PE,Conway SJ|Rooney TPC,Fedorov O,Filippakopoulos P,Wang M,Philpott M,Cook A,Heightman TD,Knapp S,Pryde D,Brennan PE,Conway SJ|Hewings DS,Wang M,Philpott M,Fedorov O,Uttarkar S,Filippakopoulos P,Picaud S,Vuppusetty C,Marsden B,Heightman TD,Knapp S,Brennan P,Conway SJ|Hewings DS,Wang M,Philpott M,Fedorov O,Uttarkar S,Filippakopoulos P,Picaud S,Vuppusetty C,Marsden B,Heightman TD,Knapp S,Brennan P,Conway SJ","|Acetylation,Animals,Histones,Humans,Lysine,Molecular Targeted Therapy,Nuclear Proteins,Protein Binding,Protein Processing,Post-Translational|CREB-Binding Protein,Crystallography,X-Ray,Cytotoxins,HeLa Cells,Histones,Humans,Isoxazoles,Ligands,Lysine,Models,Molecular,Molecular Mimicry,Molecular Structure,Nuclear Proteins,Phenylethyl Alcohol,Protein Binding,Protein Structure,Tertiary,Protein-Serine-Threonine Kinases,Stereoisomerism,Structure-Activity Relationship,Transcription Factors||Hela Cells,Microsomes,Liver,Humans,Isoxazoles,Indoles,Ligands,Crystallography,X-Ray,Fluorescence Recovery After Photobleaching,Drug Evaluation,Preclinical,Binding Sites,Molecular Structure,Protein Structure,Tertiary,Structure-Activity Relationship,Genes,p53,Models,Molecular,E1A-Associated p300 Protein,CREB-Binding Protein,Small Molecule Libraries,Drug Discovery,Chemistry Techniques,Synthetic|Acetylation,CREB-Binding Protein,Cell Line,Tumor,Crystallography,X-Ray,Histones,Humans,Inhibitory Concentration 50,Isoxazoles,Ligands,Lysine,Nuclear Proteins,Protein Binding,Structure-Activity Relationship,Transcription Factors|||"
path0089,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
bioc0416,whgu0172,1,0.06666666666666667,Journal article,The EMBO Journal,27/05/2016,SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development.,"Raducu M,Fung E,Serres S,Infante P,Barberis A,Fischer R,Bristow C,Thézénas ML,Finta C,Christianson JC,Buffa FM,Kessler BM,Sibson NR,Di Marcotullio L,Toftgård R,D'Angiolella V",
clme0301,immd0330,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0237,robbins,2,0.12028542303771661,Journal article|Journal article,Haematologica: the hematology journal|Nature Genetics,11/07/2014|18/05/2015,Erythrocytosis associated with a novel missense mutation in the BPGM gene.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Petousi N,Copley RR,Lappin TR,Haggan SE,Bento CM,Cario H,Percy MJ,Ratcliffe PJ,Robbins PA,McMullin MF|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","WGS Consortium,Humans,Polycythemia,Bisphosphoglycerate Mutase,Genotype,Mutation,Missense|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
raob0072,whgu0378,1,0.05263157894736842,Journal article,Nature Communications,,Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.,"Findlay JM,Castro-Giner F,Makino S,Rayner E,Kartsonaki C,Cross W,Kovac M,Ulahannan D,Palles C,Gillies RS,MacGregor TP,Church D,Maynard ND,Buffa F,Cazier JB,Graham TA,Wang LM,Sharma RA,Middleton M,Tomlinson I",
clme0301,immd0082,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clab0101,path0511,5,0.3102299591661294,Journal article|Journal article|Conference paper|Journal article|Journal article,Cancer Cell|Cancer Cell|Blood|British Journal of Haematology|British Journal of Haematology,14/05/2014|16/06/2014|06/12/2014|08/01/2013|01/01/2013,Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|Identification of a Prognostic Gene Expression Signature for AZA Response in MDS and CMML Patients|Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells.|Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells,"Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SE|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Unnikrishnan A,Beck D,Verma A,Richards LA,Thoms JAI,Kumari A,Galbraith S,Kulasekararaj A,Tobiasson M,Woll PS,Pellagatti A,Papaemmanuil E,Wilson SR,Lindeman R,Campbell PJ,Boultwood J,Lynch K,Jacobsen SEW,Mufti GJ,Hellstrom-Lindberg E,MacKenzie KL,Wong JWH,Pimanda JE|Davies C,Yip BH,Fernandez-Mercado M,Woll PS,Agirre X,Prosper F,Jacobsen SE,Wainscoat JS,Pellagatti A,Boultwood J|Davies C,Yip BH,Fernandez-Mercado M,Woll PS,Agirre X,Prosper F,Jacobsen SE,Wainscoat JS,Pellagatti A,Boultwood J","Chromosomes,Human,Pair 5,Animals,Mice,Inbred NOD,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Genetic Predisposition to Disease,Antigens,CD,Prognosis,Flow Cytometry,Gene Expression Profiling,Mutation,Neoplastic Stem Cells,Heterografts|||Antigens,CD34,Case-Control Studies,Cell Culture Techniques,Cell Differentiation,Cell Growth Processes,Cell Lineage,Gene Silencing,Humans,K562 Cells,Myeloid Cells,RNA,Small Interfering,Repressor Proteins,Stem Cells,Transcriptome|"
bioc0541,claridge,6,0.6755050505050505,Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article,AIDS|AIDS|Journal of NeuroVirology|Journal of NeuroImmune Pharmacology|Neurology|Journal of NeuroImmune Pharmacology,01/01/2015|21/01/2015|01/10/2013|01/03/2014|24/09/2014|22/09/2015,Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients|Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients.|A metabolomics approach to the differentiation of cognitive states in HIV-infected patients|Longitudinal changes in CSF metabolites as a prognostic marker for cognition in HIV-infected patients|A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.|NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.,"Dickens AM,Anthony DC,Deutsch R,Mielke MM,Claridge TDW,Grant I,Franklin D,Rosario D,Marcotte T,Letendre S,McArthur JC,Haughey NJ|Dickens AM,Anthony DC,Deutsch R,Mielke MM,Claridge TD,Grant I,Franklin D,Rosario D,Marcotte T,Letendre S,McArthur JC,Haughey NJ|Dickens AM,Anthony DC,Mielke MM,Claridge TDW,Deutsch R,Grant I,Letendre S,Marcotte T,Haughey NJ|Dickens AM,Anthony DC,Mielke MM,Claridge TDW,Deutsch R,Grant I,Letendre S,Marcotte T,McArthur JC,Haughey NJ|Dickens AM,Larkin JR,Griffin JL,Cavey A,Matthews L,Turner MR,Wilcock GK,Davis BG,Claridge TD,Palace J,Anthony DC,Sibson NR|Dickens AM,Larkin JR,Davis BG,Griffin JL,Claridge TD,Sibson NR,Anthony DC","|Cerebrospinal Fluid,Humans,HIV Infections,AIDS Dementia Complex,Prognosis,Magnetic Resonance Spectroscopy,Longitudinal Studies,Energy Metabolism,Glycolysis,Metabolome,Biomarkers|||Humans,Multiple Sclerosis,Chronic Progressive,Relapsing-Remitting,Alzheimer Disease,Amyotrophic Lateral Sclerosis,Biological Markers,Magnetic Resonance Spectroscopy,Discriminant Analysis,Case-Control Studies,Cohort Studies,Reproducibility of Results,ROC Curve,Adult,Aged,Middle Aged,Female,Male,Metabolomics|Animals,Mice,Biozzi,Multiple Sclerosis,Relapsing-Remitting,Encephalomyelitis,Autoimmune,Experimental,Disease Models,Animal,Disease Progression,Magnetic Resonance Spectroscopy,Models,Theoretical,Metabolomics"
clme0439,ocms0064,3,0.5208333333333333,Journal article|Journal article|Journal article,Nature Immunology|Proc Natl Acad Sci USA|Science,||01/01/2013,Initiation of T cell signaling by CD45 segregation at 'close contacts'.|Structural insights into proteoglycan-shaped Hedgehog signalling|Structure of the Repulsive Guidance Molecule (RGM)-neogenin signaling hub,"Chang VT,Fernandes RA,Ganzinger KA,Lee SF,Siebold C,McColl J,Jönsson P,Palayret M,Harlos K,Coles CH,Jones EY,Lui Y,Huang E,Gilbert RJ,Klenerman D,Aricescu AR,Davis SJ|Whalen DM,Malinauskas T,Gilbert RJ,Siebold C|Bell CH,Healey E,van Erp S,Bishop B,Tang C,Gilbert RJC,Aricescu AR,Pasterkamp RJ,Siebold C","|Chromatography,Affinity,Escherichia coli,Glycosaminoglycans,Hedgehog Proteins,Humans,Models,Molecular,Mutagenesis,Site-Directed,Polymerization,Protein Conformation,Proteoglycans,Signal Transduction,Ultracentrifugation|"
clme0670,raob0058,3,0.2742424242424243,Journal article|Journal article|Journal article,Blood|Cancer Research|PLoS One,10/02/2012|22/11/2011|01/01/2011,"Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice.|Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.|Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.","Gil-Bernabé AM,Ferjancic S,Tlalka M,Zhao L,Allen PD,Im JH,Watson K,Hill SA,Amirkhosravi A,Francis JL,Pollard JW,Ruf W,Muschel RJ|Fokas E,Im JH,Hill S,Yameen S,Stratford M,Beech J,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|Kersemans V,Cornelissen B,Hueting R,Tredwell M,Hussien K,Allen PD,Falzone N,Hill SA,Dilworth JR,Gouverneur V,Muschel RJ,Smart SC","Animals,Blood Coagulation,Cell Movement,Cell Survival,Cells,Cultured,Humans,Macrophages,Melanoma,Experimental,Mice,Inbred C57BL,SCID,Transgenic,Monocytes,Neoplasm Metastasis,Neoplasms,Neoplastic Stem Cells,Stem Cell Niche,Thromboplastin|Animals,Dose-Response Relationship,Drug,Humans,Mice,Neoplasms,Experimental,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Radiation Tolerance,TOR Serine-Threonine Kinases,Xenograft Model Antitumor Assays|Adenocarcinoma,Anesthesia,Animals,Anoxia,Copper Radioisotopes,Female,Fluorine Radioisotopes,Gases,Mice,Inbred CBA,Misonidazole,Muscles,Neoplasms,Experimental,Organometallic Compounds,Organotechnetium Compounds,Oxygen,Positron-Emission Tomography,Radiation-Sensitizing Agents,Radiopharmaceuticals,Thiosemicarbazones,Tissue Distribution,Tomography,Emission-Computed,Single-Photon"
immd0082,immd0330,3,0.14250764525993884,Journal article|Journal article|Journal article,Leukemia|Leukaemia|Nature Genetics,22/10/2012||18/05/2015,Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.|Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Lutz C,Woll PS,Hall G,Castor A,Dreau H,Cazzaniga G,Zuna J,Jensen C,Clark SA,Biondi A,Mitchell C,Ferry H,Schuh A,Buckle V,Jacobsen SE,Enver T|Lutz C,Woll PS,Hall G,Castor A,Dreau H,Cassaniga G,Zuna J,Jensen C,Clark SA,Biondi A,Mitchell C,Ferry H,Schuh A,Buckle V,Jaconsen SE,Enver T|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Cell Cycle,Child,Preschool,Female,Humans,Infant,Male,Neoplasm,Residual,Precursor Cell Lymphoblastic Leukemia-Lymphoma||Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
dops0137,raob0047,1,0.16666666666666666,Journal article,Nanoscale,08/12/2014,A novel biosensor for quantitative monitoring of on-target activity of paclitaxel.,"Townley HE,Zheng Y,Goldsmith J,Zheng YY,Stratford MR,Dobson PJ,Ahmed AA","Silicon Dioxide,Paclitaxel,Tubulin,Antineoplastic Agents,Phytogenic,Drug Monitoring,Fluorescence Resonance Energy Transfer,Sensitivity and Specificity,Reproducibility of Results,Equipment Design,Equipment Failure Analysis,Biosensing Techniques,Particle Size,Nanocapsules,Nanoconjugates"
clme1358,raob0182,1,0.05555555555555555,Journal article,Oncotarget,01/06/2016,BET inhibition as a new strategy for the treatment of gastric cancer.,"Montenegro RC,Clark PG,Howarth A,Wan X,Ceroni A,Siejka P,Nunez-Alonso GA,Monteiro O,Rogers C,Gamble V,Burbano R,Brennan PE,Tallant C,Ebner D,Fedorov O,O'Neill E,Knapp S,Dixon D,Müller S",
univ1923,wolf1833,5,0.7063492063492063,Journal article|Journal article|Journal article|Journal article|Journal article,Biochemical Journal|Nature Communications|Journal of Biological Chemistry|Biochemical Journal|The Federation of European Biochemical Societies (FEBS) Journal,24/10/2012|01/01/2014|25/06/2015|14/08/2014|01/09/2012,Investigations on the oxygen dependence of a 2-oxoglutarate histone demethylase.|Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases.|Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.|Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen.|Kinetic investigations on the reaction of a 2-oxoglutarate dependent histone demethylase with oxygen,"Sánchez-Fernández EM,Tarhonskaya H,Al-Qahtani K,Hopkinson RJ,McCullagh JS,Schofield CJ,Flashman E|Tarhonskaya H,Rydzik AM,Leung IK,Loik ND,Chan MC,Kawamura A,McCullagh JS,Claridge TD,Flashman E,Schofield CJ|Tarhonskaya H,Hardy AP,Howe EA,Loik ND,Kramer HB,McCullagh JS,Schofield CJ,Flashman E|Tarhonskaya H,Chowdhury R,Leung IK,Loik ND,McCullagh JS,Claridge TD,Schofield CJ,Flashman E|Sanchez-Fernandez EM,Tarhonskaya H,Al-Qahtani K,Hopkinson J,McCullagh JSO,Candela-Lena JI,Schofield CJ,Flashman E","Biocatalysis,Dose-Response Relationship,Drug,Histones,Humans,Iron,Jumonji Domain-Containing Histone Demethylases,Ketoglutaric Acids,Kinetics,Lysine,Molecular Structure,Oxygen,Peptides,Spectrophotometry,Substrate Specificity,Succinates|Alcohol Oxidoreductases,Ascorbic Acid,Glutarates,Oxygenases,Succinic Acid,gamma-Aminobutyric Acid|Animals,Humans,Escherichia coli,Anoxia,Oxygen,Mixed Function Oxygenases,Ankyrins,Recombinant Proteins,Repressor Proteins,Signal Transduction,Gene Expression,Transcription,Genetic,Gene Expression Regulation,Amino Acid Sequence,Protein Structure,Tertiary,Kinetics,Molecular Sequence Data,Hypoxia-Inducible Factor 1,alpha Subunit,Biocatalysis,Hypoxia-Inducible Factor-Proline Dioxygenases|Cations,Divalent,Oxygen,Iron,Manganese,Zinc,Water,Ketoglutaric Acids,Isoquinolines,Oligopeptides,Mutagenesis,Site-Directed,Catalytic Domain,Protein Binding,Hydroxylation,Kinetics,Hypoxia-Inducible Factor-Proline Dioxygenases|"
card0027,clme0195,1,0.06666666666666667,Journal article,Mammalian Genome,27/04/2012,Nprl3 is required for normal development of the cardiovascular system.,"Kowalczyk MS,Hughes JR,Babbs C,Sanchez-Pulido L,Szumska D,Sharpe JA,Sloane-Stanley JA,Morriss-Kay GM,Smoot LB,Roberts AE,Watkins H,Bhattacharya S,Gibbons RJ,Ponting CP,Wood WG,Higgs DR","Abnormalities,Multiple,Amino Acid Sequence,Animals,Cardiovascular System,Cells,Cultured,DNA Mutational Analysis,Female,GTPase-Activating Proteins,Gene Expression Profiling,Genetic Association Studies,Heart Defects,Congenital,Humans,Intracellular Signaling Peptides and Proteins,Male,Mice,Knockout,Molecular Sequence Annotation,Molecular Sequence Data,Myocardium,Nuclear Proteins,Phenotype,Polymorphism,Single Nucleotide,Promoter Regions,Genetic"
clme0220,robbins,1,0.2,Journal article,Pharmaceuticals,16/04/2015,Does amifostine reduce metabolic rate? Effect of the drug on gas exchange and acute ventilatory hypoxic response in humans.,"Pandit JJ,Allen C,Little E,Formenti F,Harris AL,Robbins PA",
clme1358,whgu0172,1,0.07692307692307693,Journal article,ACS Chemical Biology,21/03/2016,Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib.,"Mathea S,Abdul Azeez KR,Salah E,Tallant C,Wolfreys F,Konietzny R,Fischer R,Lou HJ,Brennan PE,Schnapp G,Pautsch A,Kessler BM,Turk BE,Knapp S",
ndos0159,whgu0142,4,0.455988455988456,Journal article|Journal article|Journal article|Journal article,Journal of Biological Chemistry|Bone|PLoS One|Journal of Biological Chemistry,01/01/2012|01/01/2011|01/01/2013|12/09/2012,Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva|A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date|A new class of small molecule inhibitor of BMP signaling.|Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva.,"Chaikuad A,Alfano I,Kerr G,Sanvitale CE,Boergermann JH,Triffitt JT,Von Delft F,Knapp S,Knaus P,Bullock AN|Gregson CL,Hollingworth P,Williams M,Petrie KA,Bullock AN,Brown MA,Tobias JH,Triffitt JT|Sanvitale CE,Kerr G,Chaikuad A,Ramel MC,Mohedas AH,Reichert S,Wang Y,Triffitt JT,Cuny GD,Yu PB,Hill CS,Bullock AN|Chaikuad A,Alfano I,Kerr G,Sanvitale CE,Boergermann JH,Triffitt JT,von Delft F,Knapp S,Knaus P,Bullock AN","||Activin Receptors,Type I,Aminopyridines,Animals,Body Patterning,Bone Morphogenetic Proteins,Humans,Models,Molecular,Molecular Conformation,Neovascularization,Physiologic,Phenols,Protein Binding,Protein Kinase Inhibitors,Pyrazoles,Pyrimidines,Signal Transduction,Smad Proteins,Zebrafish|Activin Receptors,Type I,Amino Acid Motifs,Animals,Bone Morphogenetic Protein 4,Catalytic Domain,Crystallography,X-Ray,Enzyme Activation,Gene Expression Regulation,Genes,Reporter,Humans,Hydrogen Bonding,Hydrophobic and Hydrophilic Interactions,Luciferases,Firefly,Mice,Models,Molecular,Mutation,Missense,Myositis Ossificans,Protein Binding,Pyrazoles,Pyrimidines,Signal Transduction,Tacrolimus,Tacrolimus Binding Protein 1A"
bioc0416,mjawood,1,0.25,Journal article,Journal of Neuroinflammation,28/11/2011,The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation.,"Couch Y,Alvarez-Erviti L,Sibson NR,Wood MJ,Anthony DC","Amyloid beta-Peptides,Animals,Cell Death,Cell Line,Cytokines,Female,Inflammation,Interleukin-1beta,Lipopolysaccharides,Mice,Microglia,Parkinson Disease,Serum Albumin,Substantia Nigra,Transcription Factor RelA,Tumor Necrosis Factor-alpha,alpha-Synuclein"
clme0220,clph0059,2,0.25,Journal article|Journal article,Cancer Gene Therapy|Cancer Gene Therapy,01/08/2013|12/07/2013,Combining virotherapy and angiotherapy for the treatment of breast cancer|Combining virotherapy and angiotherapy for the treatment of breast cancer.,"Bazan-Peregrino M,Sainson RCA,Carlisle RC,Thoma C,Waters RA,Arvanitis C,Harris AL,Hernandez-Alcoceba R,Seymour LW|Bazan-Peregrino M,Sainson RC,Carlisle RC,Thoma C,Waters RA,Arvanitis C,Harris AL,Hernandez-Alcoceba R,Seymour LW","|Adenoviridae,Animals,Breast Neoplasms,Cell Growth Processes,Combined Modality Therapy,Embolization,Therapeutic,Female,Gene Expression,Human Umbilical Vein Endothelial Cells,Humans,Immunohistochemistry,Intercellular Signaling Peptides and Proteins,Mice,Nude,Neovascularization,Pathologic,Oncolytic Virotherapy,Receptors,Estrogen,Signal Transduction,Transgenes,Vascular Endothelial Growth Factor A,Vascular Endothelial Growth Factor Receptor-1,Xenograft Model Antitumor Assays"
lina0435,stat0004,18,0.7665105852620442,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Nature|Nature Genetics|Human Molecular Genetics|PLoS Genetics|Haematologica: the hematology journal|PLoS Biology|Nature Genetics|Nature Genetics|Nature Genetics|Nature Genetics|Nature Genetics|Science|PLoS One|PLoS Genetics|Science|Biological Psychiatry|Nature|Bulletin of Mathematical Biology,01/01/2011|01/01/2012|25/01/2014|01/12/2012|28/05/2013|01/07/2015|18/05/2015|23/12/2012|01/01/2011|28/10/2012|29/09/2013|01/01/2013|16/05/2013|01/07/2011|01/01/2012|15/10/2012|01/01/2012|01/04/2011,"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.|Bayesian refinement of association signals for 14 loci in 3 common diseases|Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis.|Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development.|Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.|Where Next for Genetics and Genomics?|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.|Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.|Bayesian refinement of association signals for 14 loci in 3 common diseases.|Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.|Multiple Instances of Ancient Balancing Selection Shared Between Humans and Chimpanzees|A Candidate-Interactome Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis|Recombination and population structure in Salmonella enterica.|A fine-scale chimpanzee genetic map from population sequencing.|Genome-Wide Association Study Implicates HLA-C*01:02 as a Risk Factor at the Major Histocompatibility Complex Locus in Schizophrenia|An integrated map of genetic variation from 1,092 human genomes|Experiments with the Site Frequency Spectrum","International Multiple Sclerosis Genetics Consortium,Wellcome Trust Case Control Consortium 2,Sawcer S,Hellenthal G,Pirinen M,Spencer CC,Patsopoulos NA,Moutsianas L,Dilthey A,Su Z,Freeman C,Hunt SE,Edkins S,Gray E,Booth DR,Potter SC,Goris A,Band G,Oturai AB,Strange A,Saarela J,Bellenguez C,Fontaine B,Gillman M,Hemmer B,Gwilliam R,Zipp F,Jayakumar A,Martin R,Leslie S,Hawkins S,Giannoulatou E,D'alfonso S,Blackburn H,Martinelli Boneschi F,Liddle J,Harbo HF,Perez ML,Spurkland A,Waller MJ,Mycko MP,Ricketts M,Comabella M,Hammond N,Kockum I,McCann OT,Ban M,Whittaker P,Kemppinen A,Weston P,Hawkins C,Widaa S,Zajicek J,Dronov S,Robertson N,Bumpstead SJ,Barcellos LF,Ravindrarajah R,Abraham R,Alfredsson L,Ardlie K,Aubin C,Baker A,Baker K,Baranzini SE,Bergamaschi L,Bergamaschi R,Bernstein A,Berthele A,Boggild M,Bradfield JP,Brassat D,Broadley SA,Buck D,Butzkueven H,Capra R,Carroll WM,Cavalla P,Celius EG,Cepok S,Chiavacci R,Clerget-Darpoux F,Clysters K,Comi G,Cossburn M,Cournu-Rebeix I,Cox MB,Cozen W,Cree BA,Cross AH,Cusi D,Daly MJ,Davis E,de Bakker PI,Debouverie M,D'hooghe MB,Dixon K,Dobosi R,Dubois B,Ellinghaus D,Elovaara I,Esposito F,Fontenille C,Foote S,Franke A,Galimberti D,Ghezzi A,Glessner J,Gomez R,Gout O,Graham C,Grant SF,Guerini FR,Hakonarson H,Hall P,Hamsten A,Hartung HP,Heard RN,Heath S,Hobart J,Hoshi M,Infante-Duarte C,Ingram G,Ingram W,Islam T,Jagodic M,Kabesch M,Kermode AG,Kilpatrick TJ,Kim C,Klopp N,Koivisto K,Larsson M,Lathrop M,Lechner-Scott JS,Leone MA,Leppä V,Liljedahl U,Bomfim IL,Lincoln RR,Link J,Liu J,Lorentzen AR,Lupoli S,Macciardi F,Mack T,Marriott M,Martinelli V,Mason D,McCauley JL,Mentch F,Mero IL,Mihalova T,Montalban X,Mottershead J,Myhr KM,Naldi P,Ollier W,Page A,Palotie A,Pelletier J,Piccio L,Pickersgill T,Piehl F,Pobywajlo S,Quach HL,Ramsay PP,Reunanen M,Reynolds R,Rioux JD,Rodegher M,Roesner S,Rubio JP,Rückert IM,Salvetti M,Salvi E,Santaniello A,Schaefer CA,Schreiber S,Schulze C,Scott RJ,Sellebjerg F,Selmaj KW,Sexton D,Shen L,Simms-Acuna B,Skidmore S,Sleiman PM,Smestad C,Sørensen PS,Søndergaard HB,Stankovich J,Strange RC,Sulonen AM,Sundqvist E,Syvänen AC,Taddeo F,Taylor B,Blackwell JM,Tienari P,Bramon E,Tourbah A,Brown MA,Tronczynska E,Casas JP,Tubridy N,Corvin A,Vickery J,Jankowski J,Villoslada P,Markus HS,Wang K,Mathew CG,Wason J,Palmer CN,Wichmann HE,Plomin R,Willoughby E,Rautanen A,Winkelmann J,Wittig M,Trembath RC,Yaouanq J,Viswanathan AC,Zhang H,Wood NW,Zuvich R,Deloukas P,Langford C,Duncanson A,Oksenberg JR,Pericak-Vance MA,Haines JL,Olsson T,Hillert J,Ivinson AJ,De Jager PL,Peltonen L,Stewart GJ,Hafler DA,Hauser SL,McVean G,Donnelly P,Compston A|Maller JB,McVean G,Byrnes J,Vukcevic D,Palin K,Su Z,Howson JMM,Auton A,Myers S,Morris A,Pirinen M,Brown MA,Burton PR,Caulfield MJ,Compston A,Farrall M,Hall AS,Hattersley AT,Hill AVS,Mathew CG,Pembrey M,Satsangi J,Stratton MR,Worthington J,Craddock N,Hurles M,Ouwehand W,Parkes M,Rahman N,Duncanson A,Todd JA,Kwiatkowski DP,Samani NJ,Gough SCL,McCarthy MI,Deloukas P,Donnelly P|Martin HC,Kim GE,Pagnamenta AT,Murakami Y,Carvill GL,Meyer E,Copley RR,Rimmer A,Barcia G,Fleming MR,Kronengold J,Brown MR,Hudspith KA,Broxholme J,Kanapin A,Cazier JB,Kinoshita T,Nabbout R,WGS500 Consortium,Bentley D,McVean G,Heavin S,Zaiwalla Z,McShane T,Mefford HC,Shears D,Stewart H,Kurian MA,Scheffer IE,Blair E,Donnelly P,Kaczmarek LK,Taylor JC|Lise S,Clarkson Y,Perkins E,Kwasniewska A,Sadighi Akha E,Schnekenberg RP,Suminaite D,Hope J,Baker I,Gregory L,Green A,Allan C,Lamble S,Jayawant S,Quaghebeur G,Cader MZ,Hughes S,Armstrong RJ,Kanapin A,Rimmer A,Lunter G,Mathieson I,Cazier JB,Buck D,Taylor JC,Bentley D,McVean G,Donnelly P,Knight SJ,Jackson M,Ragoussis J,Németh AH|Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ|Tyler-Smith C,Yang H,Landweber LF,Dunham I,Knoppers BM,Donnelly P,Mardis ER,Snyder M,McVean G|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I|Evans DM,Spencer CC,Pointon JJ,Su Z,Harvey D,Kochan G,Oppermann U,Dilthey A,Pirinen M,Stone MA,Appleton L,Moutsianas L,Leslie S,Wordsworth T,Kenna TJ,Karaderi T,Thomas GP,Ward MM,Weisman MH,Farrar C,Bradbury LA,Danoy P,Inman RD,Maksymowych W,Gladman D,Rahman P,Spondyloarthritis Research Consortium of Canada (SPARCC),Morgan A,Marzo-Ortega H,Bowness P,Gaffney K,Gaston JS,Smith M,Bruges-Armas J,Couto AR,Sorrentino R,Paladini F,Ferreira MA,Xu H,Liu Y,Jiang L,Lopez-Larrea C,Díaz-Peña R,López-Vázquez A,Zayats T,Band G,Bellenguez C,Blackburn H,Blackwell JM,Bramon E,Bumpstead SJ,Casas JP,Corvin A,Craddock N,Deloukas P,Dronov S,Duncanson A,Edkins S,Freeman C,Gillman M,Gray E,Gwilliam R,Hammond N,Hunt SE,Jankowski J,Jayakumar A,Langford C,Liddle J,Markus HS,Mathew CG,McCann OT,McCarthy MI,Palmer CN,Peltonen L,Plomin R,Potter SC,Rautanen A,Ravindrarajah R,Ricketts M,Samani N,Sawcer SJ,Strange A,Trembath RC,Viswanathan AC,Waller M,Weston P,Whittaker P,Widaa S,Wood NW,McVean G,Reveille JD,Wordsworth BP,Brown MA,Donnelly P,Australo-Anglo-American Spondyloarthritis Consortium (TASC),Wellcome Trust Case Control Consortium 2 (WTCCC2)|Wellcome Trust Case Control Consortium,Maller JB,McVean G,Byrnes J,Vukcevic D,Palin K,Su Z,Howson JM,Auton A,Myers S,Morris A,Pirinen M,Brown MA,Burton PR,Caulfield MJ,Compston A,Farrall M,Hall AS,Hattersley AT,Hill AV,Mathew CG,Pembrey M,Satsangi J,Stratton MR,Worthington J,Craddock N,Hurles M,Ouwehand W,Parkes M,Rahman N,Duncanson A,Todd JA,Kwiatkowski DP,Samani NJ,Gough SC,McCarthy MI,Deloukas P,Donnelly P|International Multiple Sclerosis Genetics Consortium (IMSGC),Beecham AH,Patsopoulos NA,Xifara DK,Davis MF,Kemppinen A,Cotsapas C,Shah TS,Spencer C,Booth D,Goris A,Oturai A,Saarela J,Fontaine B,Hemmer B,Martin C,Zipp F,D'Alfonso S,Martinelli-Boneschi F,Taylor B,Harbo HF,Kockum I,Hillert J,Olsson T,Ban M,Oksenberg JR,Hintzen R,Barcellos LF,Wellcome Trust Case Control Consortium 2 (WTCCC2),International IBD Genetics Consortium (IIBDGC),Agliardi C,Alfredsson L,Alizadeh M,Anderson C,Andrews R,Søndergaard HB,Baker A,Band G,Baranzini SE,Barizzone N,Barrett J,Bellenguez C,Bergamaschi L,Bernardinelli L,Berthele A,Biberacher V,Binder TM,Blackburn H,Bomfim IL,Brambilla P,Broadley S,Brochet B,Brundin L,Buck D,Butzkueven H,Caillier SJ,Camu W,Carpentier W,Cavalla P,Celius EG,Coman I,Comi G,Corrado L,Cosemans L,Cournu-Rebeix I,Cree BA,Cusi D,Damotte V,Defer G,Delgado SR,Deloukas P,di Sapio A,Dilthey AT,Donnelly P,Dubois B,Duddy M,Edkins S,Elovaara I,Esposito F,Evangelou N,Fiddes B,Field J,Franke A,Freeman C,Frohlich IY,Galimberti D,Gieger C,Gourraud PA,Graetz C,Graham A,Grummel V,Guaschino C,Hadjixenofontos A,Hakonarson H,Halfpenny C,Hall G,Hall P,Hamsten A,Harley J,Harrower T,Hawkins C,Hellenthal G,Hillier C,Hobart J,Hoshi M,Hunt SE,Jagodic M,Jelčić I,Jochim A,Kendall B,Kermode A,Kilpatrick T,Koivisto K,Konidari I,Korn T,Kronsbein H,Langford C,Larsson M,Lathrop M,Lebrun-Frenay C,Lechner-Scott J,Lee MH,Leone MA,Leppä V,Liberatore G,Lie BA,Lill CM,Lindén M,Link J,Luessi F,Lycke J,Macciardi F,Männistö S,Manrique CP,Martin R,Martinelli V,Mason D,Mazibrada G,McCabe C,Mero IL,Mescheriakova J,Moutsianas L,Myhr KM,Nagels G,Nicholas R,Nilsson P,Piehl F,Pirinen M,Price SE,Quach H,Reunanen M,Robberecht W,Robertson NP,Rodegher M,Rog D,Salvetti M,Schnetz-Boutaud NC,Sellebjerg F,Selter RC,Schaefer C,Shaunak S,Shen L,Shields S,Siffrin V,Slee M,Sorensen PS,Sorosina M,Sospedra M,Spurkland A,Strange A,Sundqvist E,Thijs V,Thorpe J,Ticca A,Tienari P,van Duijn C,Visser EM,Vucic S,Westerlind H,Wiley JS,Wilkins A,Wilson JF,Winkelmann J,Zajicek J,Zindler E,Haines JL,Pericak-Vance MA,Ivinson AJ,Stewart G,Hafler D,Hauser SL,Compston A,McVean G,De Jager P,Sawcer SJ,McCauley JL|Leffler EM,Gao Z,Pfeifer S,Ségurel L,Auton A,Venn O,Bowden R,Bontrop R,Wall JD,Sella G,Donnelly P,Mcvean G,Przeworski M|Mechelli R,Umeton R,Policano C,Annibali V,Coarelli G,Ricigliano VAG,Vittori D,Fornasiero A,Buscarinu MC,Romano S,Salvetti M,Ristori G,Sawcer S,Hellenthal G,Pirinen M,Spencer CCA,Patsopoulos NA,Moutsianas L,Dilthey A,Su Z,Freeman C,Hunt SE,Edkins S,Gray E,Booth DR,Potter SC,Goris A,Band G,Oturai AB,Strange A,Saarela J,Bellenguez C,Fontaine B,Gillman M,Hemmer B,Gwilliam R,Zipp F,Jayakumar A,Martin R,Leslie S,Hawkins S,Giannoulatou E,D'alfonso S,Blackburn H,Boneschi FM,Liddle J,Harbo HF,Perez ML,Spurkland A,Waller MJ,Mycko MP,Ricketts M,Comabella M,Hammond N,Kockum I|Didelot X,Bowden R,Street T,Golubchik T,Spencer C,McVean G,Sangal V,Anjum MF,Achtman M,Falush D,Donnelly P|Auton A,Fledel-Alon A,Pfeifer S,Venn O,Ségurel L,Street T,Leffler EM,Bowden R,Aneas I,Broxholme J,Humburg P,Iqbal Z,Lunter G,Maller J,Hernandez RD,Melton C,Venkat A,Nobrega MA,Bontrop R,Myers S,Donnelly P,Przeworski M,McVean G|Strange A,Riley BP,Spencer CCA,Morris DW,Pirinen M,O'Dushlaine CT,Su Z,Maher BS,Freeman C,Cormican P,Bellenguez C,Kenny EM,Band G,Wormley B,Donohoe G,Dilthey A,Moutsianas L,Quinn E,Edkins S,Judge R,Coleman K,Hunt S,Tropea D,Roche S,Cummings L,Kelleher E,McKeon P,Dinan T,McDonald C,Murphy KC,O'Callaghan E,O'Neill FA,Waddington JL,Walsh D,Giannoulatou E,Langford C,Deloukas P,Gray E,Dronov S,Potter S,Pearson R,Vukcevic D,Tashakkori-Ghanbaria A,Blackwell JM,Bramon E,Brown MA,Casas JP,Duncanson A,Jankowski J,Markus HS,Mathew CG,Palmer CNA,Plomin R,Rautanen A,Sawcer SJ,Trembath RC,Viswanathan AC,Wood NW,Stone J,Scolnick E,Purcell S,Sklar P,Ripke S,Walters J,Owen MJ,O'Donovan MC,Peltonen L,McVean G,Kendler KS,Gill M,Donnelly P,Corvin A,Conso ISG,Consortium SGENE,Psychiat SWG,Consor WTCC|Altshuler DM,Durbin RM,Abecasis GR,Bentley DR,Chakravarti A,Clark AG,Donnelly P,Eichler EE,Flicek P,Gabriel SB,Gibbs RA,Green ED,Hurles ME,Knoppers BM,Korbel JO,Lander ES,Lee C,Lehrach H,Mardis ER,Marth GT,McVean GA,Nickerson DA,Schmidt JP,Sherry ST,Wang J,Wilson RK,Dinh H,Kovar C,Lee S,Lewis L,Muzny D,Reid J,Wang M,Fang X,Guo X,Jian M,Jiang H,Jin X,Li G,Li J,Li Y,Li Z,Liu X,Lu Y,Ma X,Su Z,Tai S,Tang M,Wang B,Wang G,Wu H,Wu R,Yin Y,Zhang W,Zhao J,Zhao M,Zheng X,Zhou Y,Gupta N,Clarke L,Leinonen R,Smith RE,Zheng-Bradley X,Grocock R,Humphray S,James T,Kingsbury Z,Sudbrak R,Albrecht MW,Amstislavskiy VS,Borodina TA,Lienhard M,Mertes F,Sultan M,Timmermann B,Yaspo ML,Fulton L,Fulton R,Weinstock GM,Balasubramaniam S,Burton J,Danecek P,Keane TM,Kolb-Kokocinski A,McCarthy S,Stalker J,Quail M,Davies CJ,Gollub J,Webster T,Wong B,Zhan Y,Auton A|Sainudiin R,Thornton K,Harlow J,Booth J,Stillman M,Yoshida R,Griffiths R,McVean G,Donnelly P","Alleles,Cell Differentiation,Europe,Genetic Predisposition to Disease,Genome,Human,Genome-Wide Association Study,HLA-A Antigens,HLA-DR Antigens,HLA-DRB1 Chains,Humans,Immunity,Cellular,Major Histocompatibility Complex,Multiple Sclerosis,Polymorphism,Single Nucleotide,Sample Size,T-Lymphocytes,Helper-Inducer||Child,Preschool,Chromosomes,Human,Pair 9,Epilepsy,Genetic Predisposition to Disease,Genome-Wide Association Study,High-Throughput Nucleotide Sequencing,Humans,KCNQ2 Potassium Channel,Male,Membrane Proteins,Mutation,NAV1.2 Voltage-Gated Sodium Channel,Nerve Tissue Proteins,Pathology,Molecular,Potassium Channels,Proto-Oncogene Proteins c-cbl,Uniparental Disomy,Young Adult,WGS500 Consortium|Adult,Animals,Cerebellum,Chromosome Mapping,Cognition Disorders,Humans,Mice,Knockout,Mutation,Neurons,Purkinje Cells,Spectrin,Spinocerebellar Ataxias|Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary|Genomics,Forecasting|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA|Aminopeptidases,CARD Signaling Adaptor Proteins,CD8-Positive T-Lymphocytes,Case-Control Studies,Core Binding Factor Alpha 3 Subunit,Disease Susceptibility,European Continental Ancestry Group,Genome-Wide Association Study,HLA-B27 Antigen,Humans,Interleukin-12 Subunit p40,Latent TGF-beta Binding Proteins,Membrane Proteins,Meta-Analysis as Topic,Peptide Fragments,Polymorphism,Genetic,Receptors,Peptide,Prostaglandin E,EP4 Subtype,Tumor Necrosis Factor,Type I,Spondylitis,Ankylosing|Bayes Theorem,CTLA-4 Antigen,Coronary Artery Disease,Cyclin-Dependent Kinase 5,Cyclin-Dependent Kinase Inhibitor p15,Diabetes Mellitus,Type 2,Genes,p16,Genetic Loci,Genetic Predisposition to Disease,Genome-Wide Association Study,Graves Disease,Homeodomain Proteins,Humans,Polymorphism,Single Nucleotide,Proteins,Transcription Factor 7-Like 2 Protein,Transcription Factors|Chromosome Mapping,European Continental Ancestry Group,Gene Frequency,Genetic Loci,Genetic Predisposition to Disease,Genetic Variation,Genome-Wide Association Study,Genotype,Humans,Multiple Sclerosis,Polymorphism,Single Nucleotide|||Genetic Linkage,Genome,Bacterial,Recombination,Genetic,Salmonella enterica|Animals,Base Sequence,Chromosome Mapping,Chromosomes,Human,Pair 2,Mammalian,CpG Islands,Evolution,Molecular,Female,Genetic Variation,Haplotypes,High-Throughput Nucleotide Sequencing,Histone-Lysine N-Methyltransferase,Humans,Male,Pan troglodytes,Polymorphism,Single Nucleotide,Recombination,Genetic,Sequence Analysis,DNA,Species Specificity|CACNA1I,genetics,genome-wide association study,HLAC,major histocompatibility complex,polygene score,schizophrenia||"
clme0485,immd0237,2,0.06559139784946236,Journal article|Journal article,Chemical Science|Journal of Medicinal Chemistry,01/08/2013|25/06/2012,5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation|Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.,"Hopkinson RJ,Tumber A,Yapp C,Chowdhury R,Aik W,Che KH,Li XS,Kristensen JBL,King ONF,Chan MC,Yeoh KK,Choi H,Walport LJ,Thinnes CC,Bush JT,Lejeune C,Rydzik AM,Rose NR,Bagg EA,McDonough MA,Krojer TJ,Yue WW,Ng SS,Olsen L,Brennan PE,Oppermann U,Müller S,Klose RJ,Ratcliffe PJ,Schofield CJ,Kawamura A|Rose NR,Woon EC,Tumber A,Walport LJ,Chowdhury R,Li XS,King ON,Lejeune C,Ng SS,Krojer T,Chan MC,Rydzik AM,Hopkinson RJ,Che KH,Daniel M,Strain-Damerell C,Gileadi C,Kochan G,Leung IK,Dunford J,Yeoh KK,Ratcliffe PJ,Burgess-Brown N,von Delft F,Muller S,Marsden B,Brennan PE,McDonough MA,Oppermann U,Klose RJ,Schofield CJ,Kawamura A","|Enzyme Inhibitors,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Plant Growth Regulators,Protein Conformation,Substrate Specificity,Succinates"
olin0027,whgu0378,1,0.0625,Journal article,Cell,10/10/2013,A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection.,"Zeron-Medina J,Wang X,Repapi E,Campbell MR,Su D,Castro-Giner F,Davies B,Peterse EF,Sacilotto N,Walker GJ,Terzian T,Tomlinson IP,Box NF,Meinshausen N,De Val S,Bell DA,Bond GL","Animals,Cell Proliferation,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Male,Mice,Polymorphism,Single Nucleotide,Response Elements,Selection,Genetic,Stem Cell Factor,Testicular Neoplasms,Transcription,Tumor Suppressor Protein p53"
immd0700,path0511,13,0.8522293869414193,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article,Cancer Cell|Blood|Leukemia|Blood|Journal of Experimental Medicine|Nature|Cancer Cell|Cell Reports|PLoS Genetics|The EMBO Journal|Nature Immunology|Haematologica: the hematology journal|Nature Immunology,14/05/2014|06/08/2012|01/01/2012|01/01/2011|03/02/2014|11/08/2013|16/06/2014|27/03/2013|01/01/2011|01/01/2012|19/02/2012|01/06/2014|01/01/2012,"Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.|Dicer is selectively important for the earliest stages of erythroid development.|Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model|Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation|Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate.|Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.|Acute multiple organ failure in adult mice deleted for the developmental regulator Wt1|FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors|The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential.|FLT3-ITD INDUCED MYELOPROLIFERATION CAUSES A CELL EXTRINSIC DEPLETION OF HAEMATOPOIETIC STEM CELLS|The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential","Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SE|Buza-Vidas N,Cismasiu VB,Moore S,Mead AJ,Woll PS,Lutteropp M,Melchiori L,Luc S,Bouriez-Jones T,Atkinson D,O'Carroll D,Jacobsen SE,Nerlov C|Reckzeh K,Bereshchenko O,Mead A,Rehn M,Kharazi S,Jacobsen SE,Nerlov C,Cammenga J|Kharazi S,Mead AJ,Mansour A,Hultquist A,Böiers C,Luc S,Buza-Vidas N,Ma Z,Ferry H,Atkinson D,Reckzeh K,Masson K,Cammenga J,Rönnstrand L,Arai F,Suda T,Nerlov C,Sitnicka E,Jacobsen SEW|Grover A,Mancini E,Moore S,Mead AJ,Atkinson D,Rasmussen KD,O'Carroll D,Jacobsen SE,Nerlov C|Sanjuan-Pla A,Moore S,Nerlov C,Carella C,Macaulay IC,Jensen CT,Woll PS,Luis TC,Mead A,Matsuoka S,Jones TB,Chowdhury O,Stenson L,Lutteropp M,Green JCA,Facchini R,Boukarabila H,Carrelha J,Tarrant P,Atkinson D,Clark S-A,Jacobsen SEW,Grover A,Gambardella A,Thongjuea S|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Mead AJ,Kharazi S,Atkinson D,Macaulay I,Pecquet C,Loughran S,Lutteropp M,Woll P,Chowdhury O,Luc S,Buza-Vidas N,Ferry H,Clark SA,Goardon N,Vyas P,Constantinescu SN,Sitnicka E,Nerlov C,Jacobsen SE|Chau YY,Brownstein D,Mjoseng H,Lee WC,Buza-Vidas N,Nerlov C,Jacobsen SE,Perry P,Berry R,Thornburn A,Sexton D,Morton N,Hohenstein P,Freyer E,Samuel K,van't Hof R,Hastie N|Mancini E,Sanjuan-Pla A,Luciani L,Moore S,Grover A,Zay A,Rasmussen KD,Luc S,Bilbao D,O'Carroll D,Jacobsen SE,Nerlov C|Luc S,Luis TC,Boukarabila H,Macaulay IC,Buza-Vidas N,Bouriez-Jones T,Lutteropp M,Woll PS,Loughran SJ,Mead AJ,Hultquist A,Brown J,Mizukami T,Matsuoka S,Ferry H,Anderson K,Duarte S,Atkinson D,Soneji S,Domanski A,Farley A,Sanjuan-Pla A,Carella C,Patient R,de Bruijn M,Enver T,Nerlov C,Blackburn C,Godin I,Jacobsen SE|Mead AJ,Atkinson D,Kharazi S,Chowdhury O,Clark SA,Matsuoka S,Bouriez-Jones T,Facchini R,Booth C,Woll P,Suda T,Nerlov C,Jacobsen SE|Luc S,Luis TC,Boukarabila H,Macaulay IC,Buza-Vidas N,Bouriez-Jones T,Lutteropp M,Woll PS,Loughran SJ,Mead AJ,Hultquist A,Brown J,Mizukami T,Matsuoka S,Ferry H,Anderson K,Duarte S,Atkinson D,Soneji S,Domanski A,Farley A,Sanjuan-Pla A,Carella C,Patient R,De Bruijn M,Enver T,Nerlov C,Blackburn C,Godin I,Jacobsen SEW","Chromosomes,Human,Pair 5,Animals,Mice,Inbred NOD,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Genetic Predisposition to Disease,Antigens,CD,Prognosis,Flow Cytometry,Gene Expression Profiling,Mutation,Neoplastic Stem Cells,Heterografts|Animals,Biomarkers,Blotting,Western,Cell Differentiation,Cell Lineage,DEAD-box RNA Helicases,Erythroid Cells,Gene Expression Profiling,Gene Expression Regulation,Hematopoietic Stem Cells,Integrases,Megakaryocyte Progenitor Cells,Mice,Knockout,Oligonucleotide Array Sequence Analysis,RNA,Messenger,Real-Time Polymerase Chain Reaction,Reverse Transcriptase Polymerase Chain Reaction,Ribonuclease III,Transcription Factors|||Animals,Cell Lineage,Colony-Forming Units Assay,Erythroid Precursor Cells,Erythropoiesis,Erythropoietin,Gene Expression Profiling,Hematopoietic Stem Cell Transplantation,Hematopoietic Stem Cells,Mice,Congenic,Inbred C57BL,Transgenic,Multipotent Stem Cells,Recombinant Proteins|||Animals,Cell Differentiation,Cell Transformation,Neoplastic,Disease Models,Animal,Flow Cytometry,Gene Expression,Humans,Leukemia,Myeloid,Acute,Mice,Microarray Analysis,Multipotent Stem Cells,Myeloid Cells,Signal Transduction,fms-Like Tyrosine Kinase 3|||Animals,B-Lymphocytes,Cell Lineage,Cell Separation,Flow Cytometry,Hematopoietic Stem Cells,Lymphoid Progenitor Cells,Mice,Inbred C57BL,Transgenic,Myeloid Cells,Oligonucleotide Array Sequence Analysis,Precursor Cells,B-Lymphoid,Real-Time Polymerase Chain Reaction,T-Lymphocytes,Thymus Gland||"
clme0169,clme0975,1,0.058823529411764705,Journal article,International Journal of Cancer,14/08/2014,NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.,"Chen JL,Dawoodji A,Tarlton A,Gnjatic S,Tajar A,Karydis I,Browning J,Pratap S,Verfaille C,Venhaus RR,Pan L,Altman DG,Cebon JS,Old LL,Nathan P,Ottensmeier C,Middleton M,Cerundolo V","CD4-Positive T-Lymphocytes,CD8-Positive T-Lymphocytes,Humans,Fowlpox virus,Melanoma,Cholesterol,Saponins,Phospholipids,Membrane Proteins,Vaccines,Synthetic,Adjuvants,Immunologic,Antigens,Neoplasm,Drug Combinations,Vaccination,Antibody Formation,Fowlpox,ISCOMATRIX,NY-ESO-1,cancer vaccines"
gree1620,raob0202,1,0.125,Journal article,Radiation Oncology,27/03/2012,"NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity.","Fokas E,Yoshimura M,Prevo R,Higgins G,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ","Cell Line,Tumor,Endothelial Cells,Human Umbilical Vein Endothelial Cells,Humans,Imidazoles,Phosphatidylinositol 3-Kinases,Quinolines,Radiation-Sensitizing Agents,TOR Serine-Threonine Kinases"
immd0024,immd0237,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0975,wolf1917,1,0.1111111111111111,Journal article,International Journal of Cancer,15/03/2014,XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection,"Hatch SB,Swift LP,Caporali S,Carter R,Hill EJ,Macgregor TP,D'Atri S,Middleton MR,McHugh PJ,Sharma RA",
clab0058,immd0330,2,0.4,Journal article|Journal article,Transfusion Medicine|Transfusion Medicine,01/01/2011|01/02/2011,Severe haemolysis due to passenger lymphocyte syndrome after an ABO mismatched bowel transplant - a case report|Severe haemolysis due to passenger lymphocyte syndrome after an ABO mismatched bowel transplant - a case report,"Davis SL,Vaidya A,Timbs A,Schuh A,Staves J,Murphy MF|Davis SL,Vaidya A,Timbs A,Schuh A,Staves J,Murphy MF",|
engs0357,raob0051,1,0.2,Journal article,Machine Vision and Applications: an international journal,01/07/2012,Automatic segmentation of adherent biological cell boundaries and nuclei from brightfield microscopy images,"Ali R,Gooding M,Szilagyi T,Vojnovic B,Christlieb M,Brady M","Segmentation,Registration,Cell detection,Level sets,Monogenic signal,Continuous intrinsic dimensionality"
immd0316,whgu0085,6,0.5416666666666666,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Nature Medicine|British Journal of Cancer|British Journal of Cancer|Nature Medicine|Cancer Research|Cancer Research,07/08/2011|01/01/2011|15/03/2011|01/01/2011|07/07/2011|01/01/2011,Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.|The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis|The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.|Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization|microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer.|microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer,"Korpal M,Ell BJ,Buffa FM,Ibrahim T,Blanco MA,Celià-Terrassa T,Mercatali L,Khan Z,Goodarzi H,Hua Y,Wei Y,Hu G,Garcia BA,Ragoussis J,Amadori D,Harris AL,Kang Y|Gee HE,Buffa FM,Camps C,Ramachandran A,Leek R,Taylor M,Patil M,Sheldon H,Betts G,Homer J,West C,Ragoussis J,Harris AL|Gee HE,Buffa FM,Camps C,Ramachandran A,Leek R,Taylor M,Patil M,Sheldon H,Betts G,Homer J,West C,Ragoussis J,Harris AL|Korpal M,Ell BJ,Buffa FM,Ibrahim T,Blanco MA,Celià-Terrassa T,Mercatali L,Khan Z,Goodarzi H,Hua Y,Wei Y,Hu G,Garcia BA,Ragoussis J,Amadori D,Harris AL,Kang Y|Buffa FM,Camps C,Winchester L,Snell CE,Gee HE,Sheldon H,Taylor M,Harris AL,Ragoussis J|Buffa FM,Camps C,Winchester L,Snell CE,Gee HE,Sheldon H,Taylor M,Harris AL,Ragoussis J","Animals,Cadherins,Cell Line,Tumor,Female,Gene Expression Profiling,Gene Expression Regulation,Neoplastic,Humans,Mass Spectrometry,Mice,Inbred BALB C,MicroRNAs,Microarray Analysis,Neoplasm Metastasis,Statistics,Nonparametric,Vesicular Transport Proteins||Breast Neoplasms,Carcinoma,Squamous Cell,Female,Head and Neck Neoplasms,Humans,MicroRNAs,Neoplasms,Prognosis,RNA,Small Nucleolar||Breast Neoplasms,Disease Progression,Disease-Free Survival,Female,Gene Expression Profiling,Gene Expression Regulation,Neoplastic,Humans,MicroRNAs,Neoplasm Recurrence,Local,Prognosis,RNA,Messenger|"
clme0485,ndos0168,7,1.0416666666666667,Conference paper|Journal article|Journal article|Conference paper|Journal article|Conference paper|Journal article,Osteoarthritis and Cartilage|Science Translational Medicine|Osteoarthritis and Cartilage|International Journal of Experimental Pathology: mechanisms and models of disease|Science Translational Medicine|International Journal of Experimental Pathology: mechanisms and models of disease|Nature Reviews Drug Discovery,01/04/2013|01/01/2015|01/04/2014|01/12/2011|28/10/2015|01/10/2013|01/03/2015,EPIGENETIC MODIFYING COMPOUNDS AFFECT THE ACTIVITY OF PRIMARY HUMAN ARTICULAR CHONDROCYTES AND MESENCHYMAL STEM CELLS UNDERGOING CHONDROGENESIS|Inflammation activation and resolution in human tendon disease.|EPIGENETIC MODIFYING COMPOUNDS ALTER ACTIVITY OF PRIMARY HUMAN ARTICULAR CHONDROCYTES AND MESENCHYMAL STEM CELLS UNDERGOING CHONDROGENESIS|Directed differentiation of human induced pluripotent stem cells into chondrocytes|Inflammation activation and resolution in human tendon disease.|Epigenetic modifying compounds alter activity of primary human articular chondrocytes and mesenchymal stem cells undergoing chondrogenesis|Preclinical target validation using patient-derived cells.,"Snelling S,Kramm A,Cain P,Yapp C,Carr A,Price A,Oppermann U|Dakin SG,Martinez FO,Yapp C,Wells G,Oppermann U,Dean BJ,Smith RD,Wheway K,Watkins B,Roche L,Carr AJ|Snelling S,Kramm A,Yapp C,Carr A,Oppermann U|Hala S,Yapp C,Kramm A,Carpenter L,Watt S,Carr A,Dunford J,Oppermann U,Tirlapur U|Dakin SG,Martinez FO,Yapp C,Wells G,Oppermann U,Dean BJ,Smith RDJ,Wheway K,Watkins B,Roche L,Carr AJ|Snelling SJB,Kramm A,Cain P,Yapp C,Carr AJ,Oppermann U|Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","||||||SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
clne0013,clne0024,4,1.25,Journal article|Book|Book|Journal article,Human Brain Mapping|Functional Magnetic Resonance Imaging: An Introduction to Methods|Functional Magnetic Resonance Imaging: An Introduction to Methods|Human Brain Mapping,01/01/2011|22/03/2012|22/03/2012|01/01/2012,Spontaneous blood oxygenation level-dependent fMRI signal is modulated by behavioral state and correlates with evoked response in sensorimotor cortex: A 7.0-T fMRI study|Functional magnetic resonance imaging: An introduction to methods|Preface|Spontaneous blood oxygenation level-dependent fMRI signal is modulated by behavioral state and correlates with evoked response in sensorimotor cortex: A 7.0-T fMRI study,"Donahue MJ,Hoogduin H,Smith SM,Siero JC,Chappell M,Petridou N,Jezzard P,Luijten PR,Hendrikse J|Jezzard P,Matthews PM,Smith SM|Jezzard P,Matthews PM,Smith SM|Donahue MJ,Hoogduin H,Smith SM,Siero JCW,Chappell M,Petridou N,Jezzard P,Luijten PR,Hendrikse J",|||
clab0035,clme0135,1,0.07692307692307693,Journal article,Biology Direct,01/01/2011,"MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival.","Chi J,Ballabio E,Chen XH,Kušec R,Taylor S,Hay D,Tramonti D,Saunders NJ,Littlewood T,Pezzella F,Boultwood J,Wainscoat JS,Hatton CS,Lawrie CH","Adult,Aged,80 and over,Cluster Analysis,Disease-Free Survival,Female,Gene Expression Regulation,Neoplastic,Humans,Male,MicroRNAs,Middle Aged,Monoclonal Gammopathy of Undetermined Significance,Multiple Myeloma,Neoplasms,Plasma Cell,Oligonucleotide Array Sequence Analysis,Prognosis,Translocation,Genetic,Up-Regulation"
gree1192,gree1499,32,2.9758059861652995,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,"Public Health Nutrition|Growth Hormone and IGF Research|Cancer Epidemiology, Biomarkers and Prevention|Diabetologia|Proceedings of the Nutrition Society|BMJ|European Journal of Clinical Nutrition|International Journal of Cancer|PLoS One|Diabetologia|Gut|European Journal of Clinical Nutrition|British Journal of Cancer|American Journal of Clinical Nutrition|Journal of National Cancer Institute|American Journal of Clinical Nutrition|European Heart Journal|BMC Medicine|American Journal of Epidemiology|Lancet Diabetes and Endocrinology|Growth Hormone and IGF Research|International Journal of Cancer|Diabetes|Lancet Diabetes and Endocrinology|American Journal of Clinical Nutrition|European Journal of Clinical Nutrition|American Journal of Clinical Nutrition|Cancer Epidemiology, Biomarkers and Prevention|PLoS Medicine|PLoS One|American Journal of Clinical Nutrition|Diabetes Care",01/06/2011|15/01/2015|02/03/2012|01/07/2012|01/01/2012|01/01/2011|18/12/2013|01/01/2012|01/01/2012|01/09/2011|02/01/2014|01/02/2014|27/03/2014|30/01/2013|01/08/2014|04/06/2014|18/01/2011|01/01/2013|15/08/2013|01/01/2014|01/01/2015|01/01/2012|01/12/2014|05/08/2014|01/07/2012|23/05/2012|01/01/2012|03/07/2012|01/06/2012|01/01/2013|01/01/2012|01/01/2013,"Development and evaluation of the Oxford WebQ, a low-cost, web-based method for assessment of previous 24 h dietary intakes in large-scale prospective studies.|The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women.|Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.|Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study|Risk of ischaemic heart disease among British vegetarians and non-vegetarians: results from the EPIC-Oxford cohort study|Diet and risk of diverticular disease in Oxford cohort of European Prospective Investigation into Cancer and Nutrition (EPIC): prospective study of British vegetarians and non-vegetarians.|Serum concentrations of cholesterol, apolipoprotein A-I and apolipoprotein B in a total of 1694 meat-eaters, fish-eaters, vegetarians and vegans|Fruit and vegetable intake and the risk of gastric adenocarcinoma: A reanalysis of the european prospective investigation into cancer and nutrition (EPIC-EURGAST) study after a longer follow-up|Dietary fibre intake and risks of cancers of the colon and rectum in the European prospective investigation into cancer and nutrition (EPIC)|Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study|Source of dietary fibre and diverticular disease incidence: a prospective study of UK women.|Serum concentrations of cholesterol, apolipoprotein A-I and apolipoprotein B in a total of 1694 meat-eaters, fish-eaters, vegetarians and vegans|Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom.|Risk of hospitalization or death from ischemic heart disease among British vegetarians and nonvegetarians: results from the EPIC-Oxford cohort study.|Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.|Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans.|Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study.|Meat consumption and mortality - results from the European Prospective Investigation into Cancer and Nutrition|Fruit and vegetable consumption and mortality|Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: The EPIC-InterAct case-cohort study|The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women|Fruit and vegetable intake and the risk of gastric adenocarcinoma: A reanalysis of the european prospective investigation into cancer and nutrition (EPIC-EURGAST) study after a longer follow-up|Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity|Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.|Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study|Dietary fibre intake and ischaemic heart disease mortality: the European Prospective Investigation into Cancer and Nutrition-Heart study.|Fatty acid patterns and risk of prostate cancer in a case-control study nested within the European prospective investigation into cancer and nutrition|Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition.|Long-Term Risk of Incident Type 2 Diabetes and Measures of Overall and Regional Obesity: The EPIC-InterAct Case-Cohort Study|Serum uric acid concentrations in meat eaters, fish eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort.|The prospective association between total and type of fish intake and type 2 diabetes in 8 European countries: EPIC-InterAct study|Age at menopause, reproductive life span, and type 2 diabetes risk: Results from the EPIC-InterAct study","Liu B,Young H,Crowe FL,Benson VS,Spencer EA,Key TJ,Appleby PN,Beral V|Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Fedirko V,Riboli E,Tjønneland A,Ferrari P,Olsen A,Bueno-de-Mesquita HB,van Duijnhoven FJ,Norat T,Jansen EH,Dahm CC,Overvad K,Boutron-Ruault MC,Clavel-Chapelon F,Racine A,Lukanova A,Teucher B,Boeing H,Aleksandrova K,Trichopoulou A,Benetou V,Trichopoulos D,Grioni S,Vineis P,Panico S,Palli D,Tumino R,Siersema PD,Peeters PH,Skeie G,Brustad M,Chirlaque MD,Barricarte A,Ramón Quirós J,Sánchez MJ,Dorronsoro M,Bonet C,Palmqvist R,Hallmans G,Key TJ,Crowe F,Khaw KT,Wareham N,Romieu I,McKay J,Wark PA,Romaguera D,Jenab M|Ekelund U,Palla L,Brage S,Franks PW,Peters T,Balkau B,Diaz MJT,Huerta JM,Agnoli C,Arriola L,Ardanaz E,Boeing H,Clavel-Chapelon F,Crowe F,Fagherazzi G,Groop L,Hainaut P,Johnsen NF,Kaaks R,Khaw KT,Key TJ,de Lauzon-Guillain B,May A,Monninkhof E,Navarro C,Nilsson P,Ostergaard JN,Norat T,Overvad K,Palli D,Panico S,Redondo ML,Ricceri F,Rolandsson O,Romaguera D,Romieu I,Sanchez Perez MJ,Slimani N,Spijkerman A,Teucher B,Tjonneland A,Travier N,Tumino R,Vos W,Vigl M,Sharp S,Langenberg C,Forouhi N,Riboli E,Feskens E,Wareham NJ,Consortium I|Crowe FL,Appleby PN,Travis RC,Key TJ|Crowe FL,Appleby PN,Allen NE,Key TJ|Bradbury KE,Crowe FL,Appleby PN,Schmidt JA,Travis RC,Key TJ|Gonzalez CA,Lujan-Barroso L,Bueno-De-Mesquita HB,Jenab M,Duell EJ,Agudo A,Tjønneland A,Boutron-Ruault MC,Clavel-Chapelon F,Touillaud M,Teucher B,Kaaks R,Boeing H,Steffen A,Trichopoulou A,Roukos D,Karapetyan T,Palli D,Tagliabue G,Mattiello A,Tumino R,Ricceri F,Siersema PD,Numans ME,Peeters PPH,Parr CL,Skeie G,Lund E,Quirõs JR,Sánchez-Cantalejo E,Navarro C,Barricarte A,Dorronsoro M,Ehrnström R,Regner S,Khaw KT,Wareham N,Key TJ,Crowe FL,Blaker H,Romieu I,Riboli E|Murphy N,Norat T,Ferrari P,Jenab M,Bueno-de-Mesquita B,Skeie G,Dahm CC,Overvad K,Olsen A,Tjønneland A,Clavel-Chapelon F,Boutron-Ruault MC,Racine A,Kaaks R,Teucher B,Boeing H,Bergmann MM,Trichopoulou A,Trichopoulos D,Lagiou P,Palli D,Pala V,Panico S,Tumino R,Vineis P,Siersema P,van Duijnhoven F,Peeters PHM,Hjartaker A,Engeset D,González CA,Sánchez MJ,Dorronsoro M,Navarro C,Ardanaz E,Quirós JR,Sonestedt E,Ericson U,Nilsson L,Palmqvist R,Khaw KT,Wareham N,Key TJ,Crowe FL,Fedirko V,Wark PA,Chuang SC,Riboli E|Langenberg C,Sharp S,Forouhi NG,Franks PW,Schulze MB,Kerrison N,Ekelund U,Barroso I,Panico S,Tormo MJ,Spranger J,Griffin S,van der Schouw YT,Amiano P,Ardanaz E,Arriola L,Balkau B,Barricarte A,Beulens JWJ,Boeing H,Bueno-de-Mesquita HB,Buijsse B,Chirlaque Lopez MD,Clavel-Chapelon F,Crowe FL,de Lauzon-Guillan B,Deloukas P,Dorronsoro M,Drogan D,Froguel P,Gonzalez C,Grioni S,Groop L,Groves C,Hainaut P,Halkjaer J,Hallmans G,Hansen T,Huerta Castano JM,Kaaks R,Key TJ,Khaw KT,Koulman A,Mattiello A,Navarro C,Nilsson P,Norat T,Overvad K,Palla L,Palli D,Pedersen O,Peeters PH,Quiros JR,Ramachandran A,Rodriguez-Suarez L,Rolandsson O,Romaguera D,Romieu I,Sacerdote C,Sanchez MJ,Sandbaek A,Slimani N,Sluijs I,Spijkerman AMW,Teucher B,Tjonneland A,Tumino R,van der A DL,Verschuren WMM,Tuomilehto J,Feskens E,McCarthy M,Riboli E,Wareham NJ,Consortium I|Crowe FL,Balkwill A,Cairns BJ,Appleby PN,Green J,Reeves GK,Key TJ,Beral V,Million Women Study Collaborators,Million Women Study Collaborators|Bradbury KE,Crowe FL,Appleby PN,Schmidt JA,Travis RC,Key TJ|Bradbury KE,Balkwill A,Spencer EA,Roddam AW,Reeves GK,Green J,Key TJ,Beral V,Pirie K|Crowe FL,Appleby PN,Travis RC,Key TJ|Crowe FL,Appleby PN,Travis RC,Barnett M,Brasky TM,Bueno-de-Mesquita HB,Chajes V,Chavarro JE,Chirlaque MD,English DR,Gibson RA,Giles GG,Goodman GE,Henning SM,Kaaks R,King IB,Kolonel LN,Kristal AR,Neuhouser ML,Park SY,Severi G,Siddiq A,Stampfer MJ,Stattin P,Tangen CM,Tjønneland A,Trichopoulos D,Tumino R,Wilkens LR,Key TJ,Allen NE|Key TJ,Appleby PN,Crowe FL,Bradbury KE,Schmidt JA,Travis RC|Crowe FL,Roddam AW,Key TJ,Appleby PN,Overvad K,Jakobsen MU,Tjønneland A,Hansen L,Boeing H,Weikert C,Linseisen J,Kaaks R,Trichopoulou A,Misirli G,Lagiou P,Sacerdote C,Pala V,Palli D,Tumino R,Panico S,Bueno-de-Mesquita HB,Boer J,van Gils CH,Beulens JW,Barricarte A,Rodríguez L,Larrañaga N,Sánchez MJ,Tormo MJ,Buckland G,Lund E,Hedblad B,Melander O,Jansson JH,Wennberg P,Wareham NJ,Slimani N,Romieu I,Jenab M,Danesh J,Gallo V,Norat T,Riboli E,European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart Study Collaborators|Rohrmann S,Overvad K,Bueno-de-Mesquita HB,Jakobsen MU,Egeberg R,Tjønneland A,Nailler L,Boutron-Ruault MC,Clavel-Chapelon F,Krogh V,Palli D,Panico S,Tumino R,Ricceri F,Bergmann MM,Boeing H,Li K,Kaaks R,Khaw KT,Wareham NJ,Crowe FL,Key TJ,Naska A,Trichopoulou A,Trichopoulos D,Leenders M,Peeters PHM,Engeset D,Parr CL,Skeie G,Jakszyn P,Sánchez MJ,Huerta JM,Redondo ML,Barricarte A,Amiano P,Drake I,Sonestedt E,Hallmans G,Johansson I,Fedirko V,Romieux I,Ferrari P,Norat T,Vergnaud AC,Riboli E,Linseisen AJ|Leenders M,Sluijs I,Ros MM,Boshuizen HC,Siersema PD,Ferrari P,Weikert C,Tjønneland A,Olsen A,Boutron-Ruault MC,Clavel-Chapelon F,Nailler L,Teucher B,Li K,Boeing H,Bergmann MM,Trichopoulou A,Lagiou P,Trichopoulos D,Palli D,Pala V,Panico S,Tumino R,Sacerdote C,Peeters PHM,Van Gils CH,Lund E,Engeset D,Redondo ML,Agudo A,Sánchez MJ,Navarro C,Ardanaz E,Sonestedt E,Ericson U,Nilsson LM,Khaw KT,Wareham NJ,Key TJ,Crowe FL,Romieu I,Gunter MJ,Gallo V,Overvad K,Riboli E,Bas Bueno-De-Mesquita H|Forouhi NG,Koulman A,Sharp SJ,Imamura F,Kröger J,Schulze MB,Crowe FL,Huerta JM,Guevara M,Beulens JWJ,van Woudenbergh GJ,Wang L,Summerhill K,Griffin JL,Feskens EJM,Amiano P,Boeing H,Clavel-Chapelon F,Dartois L,Fagherazzi G,Franks PW,Gonzalez C,Jakobsen MU,Kaaks R,Key TJ,Khaw KT,Kühn T,Mattiello A,Nilsson PM,Overvad K,Pala V,Palli D,Quirós JR,Rolandsson O,Roswall N,Sacerdote C,Sánchez MJ,Slimani N,Spijkerman AMW,Tjonneland A,Tormo MJ,Tumino R,van der A DL,van der Schouw YT,Langenberg C,Riboli E,Wareham NJ|Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Gonzalez CA,Lujan-Barroso L,De Mesquita HBB,Jenab M,Duell EJ,Agudo A,Tjønneland A,Boutron-Ruault MC,Clavel-Chapelon F,Touillaud M,Teucher B,Kaaks R,Boeing H,Steffen A,Trichopoulou A,Roukos D,Karapetyan T,Palli D,Tagliabue G,Mattiello A,Tumino R,Ricceri F,Siersema PD,Numans ME,Peeters PP,Parr CL,Skeie G,Lund E,Quirós JR,Sánchez-Cantalejo E,Navarro C,Barricarte A,Dorronsoro M,Ehrnström R,Regner S,Khaw K-T,Wareham N,Key TJ,Crowe FL,Blaker H,Romieu I,Riboli E|Scott RA,Fall T,Pasko D,Barker A,Sharp SJ,Arriola L,Balkau B,Barricarte A,Barroso I,Boeing H,Clavel-Chapelon F,Crowe FL,Dekker JM,Fagherazzi G,Ferrannini E,Forouhi NG,Franks PW,Gavrila D,Giedraitis V,Grioni S,Groop LC,Kaaks R,Key TJ,Kühn T,Lotta LA,Nilsson PM,Overvad K,Palli D,Panico S,Ramón Quirós J,Rolandsson O,Roswall N,Sacerdote C,Sala N,Sánchez MJ,Schulze MB,Siddiq A,Slimani N,Sluijs I,Spijkerman AMW,Tjonneland A,Tumino R,Van Der A DL,Yaghootkar H,McCarthy MI,Semple RK,Riboli E,Walker M,Ingelsson E,Frayling TM,Savage DB,Langenberg C,Wareham NJ|Forouhi NG,Koulman A,Sharp SJ,Imamura F,Kröger J,Schulze MB,Crowe FL,Huerta JM,Guevara M,Beulens JW,van Woudenbergh GJ,Wang L,Summerhill K,Griffin JL,Feskens EJ,Amiano P,Boeing H,Clavel-Chapelon F,Dartois L,Fagherazzi G,Franks PW,Gonzalez C,Jakobsen MU,Kaaks R,Key TJ,Khaw KT,Kühn T,Mattiello A,Nilsson PM,Overvad K,Pala V,Palli D,Quirós JR,Rolandsson O,Roswall N,Sacerdote C,Sánchez MJ,Slimani N,Spijkerman AM,Tjonneland A,Tormo MJ,Tumino R,van der A DL,van der Schouw YT,Langenberg C,Riboli E,Wareham NJ|Romaguera D,Vergnaud A-C,Peeters PH,van Gils CH,Chan DSM,Ferrari P,Romieu I,Jenab M,Slimani N,Clavel-Chapelon F,Fagherazzi G,Perquier F,Kaaks R,Teucher B,Boeing H,von Ruesten A,Tjonneland A,Olsen A,Dahm CC,Overvad K,Ramon Quiros J,Gonzalez CA,Jose Sanchez M,Navarro C,Barricarte A,Dorronsoro M,Khaw K-T,Wareham NJ,Crowe FL,Key TJ,Trichopoulou A,Lagiou P,Bamia C,Masala G,Vineis P,Tumino R,Sieri S,Panico S,May AM,Bueno-de-Mesquita HB,Buechner FL,Wirfaelt E,Manjer J,Johansson I,Hallmans G,Skeie G,Benjaminsen Borch K,Parr CL,Riboli E,Norat T|Crowe FL,Key TJ,Appleby PN,Overvad K,Schmidt EB,Egeberg R,Tjønneland A,Kaaks R,Teucher B,Boeing H,Weikert C,Trichopoulou A,Ouranos V,Valanou E,Masala G,Sieri S,Panico S,Tumino R,Matullo G,Bueno-de-Mesquita HB,Boer JM,Beulens JW,van der Schouw YT,Quirós JR,Buckland G,Sánchez MJ,Dorronsoro M,Huerta JM,Moreno-Iribas C,Hedblad B,Jansson JH,Wennberg P,Khaw KT,Wareham N,Ferrari P,Illner AK,Chuang SC,Norat T,Danesh J,Riboli E|Dahm CC,Gorst-Rasmussen A,Crowe FL,Roswall N,Tjnøneland A,Drogan D,Boeing H,Teucher B,Kaaks R,Adarakis G,Zylis D,Trichopoulou A,Fedirko V,Chajes V,Jenab M,Palli D,Pala V,Tumino R,Ricceri F,Van Kranen H,Bueno-de-Mesquita HB,Quiroś JR,Śanchez MJ,Lujań-Barroso L,Larranãga N,Chirlaque MD,Ardanaz E,Johansson M,Stattin P,Khaw KT,Wareham N,Wark PA,Norat T,Riboli E,Key TJ,Overvad K|Price AJ,Allen NE,Appleby PN,Crowe FL,Travis RC,Tipper SJ,Overvad K,Grønbæk H,Tjønneland A,Johnsen NF,Rinaldi S,Kaaks R,Lukanova A,Boeing H,Aleksandrova K,Trichopoulou A,Trichopoulos D,Andarakis G,Palli D,Krogh V,Tumino R,Sacerdote C,Bueno-de-Mesquita HB,Argüelles MV,Sánchez MJ,Chirlaque MD,Barricarte A,Larrañaga N,González CA,Stattin P,Johansson M,Khaw KT,Wareham N,Gunter M,Riboli E,Key T|Langenberg C,Sharp SJ,Schulze MB,Rolandsson O,Overvad K,Forouhi NG,Spranger J,Drogan D,Maria Huerta J,Arriola L,de Lauzon-Guillan B,Tormo M-J,Ardanaz E,Balkau B,Beulens JWJ,Boeing H,Bueno-de-Mesquita HB,Clavel-Chapelon F,Crowe FL,Franks PW,Gonzalez CA,Grioni S,Halkjaer J,Hallmans G,Kaaks R,Kerrison ND,Key TJ,Khaw KT,Mattiello A,Nilsson P,Norat T,Palla L,Palli D,Panico S,Ramon Quiros J,Romaguera D,Romieu I,Sacerdote C,Sanchez M-J,Slimani N,Sluijs I,Spijkerman AMW,Teucher B,Tjonneland A,Tumino R,Daphne LVDA,van der Schouw YT,Feskens EJM,Riboli E,Wareham NJ,Consortium I|Schmidt JA,Crowe FL,Appleby PN,Key TJ,Travis RC|Patel PS,Forouhi NG,Kuijsten A,Schulze MB,Van Woudenbergh GJ,Ardanaz E,Amiano P,Arriola L,Balkau B,Barricarte A,Beulens JWJ,Boeing H,Buijsse B,Crowe FL,De Lauzon-Guillan B,Fagherazzi G,Franks PW,Gonzalez C,Grioni S,Halkjaer J,Huerta JM,Key TJ,Kühn T,Masala G,Nilsson P,Overvad K,Panico S,Quirós JR,Rolandsson O,Sacerdote C,Sánchez MJ,Schmidt EB,Slimani N,Spijkerman AMW,Teucher B,Tjonneland A,Tormo MJ,Tumino R,Van Der A DL,Van Der Schouw YT,Sharp SJ,Langenberg C,Feskens EJM,Riboli E,Wareham NJ|Brand JS,Van Der Schouw YT,Onland-Moret NC,Sharp SJ,Ong KK,Khaw KT,Ardanaz E,Amiano P,Boeing H,Chirlaque MD,Clavel-Chapelon F,Crowe FL,De Lauzon-Guillain B,Duell EJ,Fagherazzi G,Franks PW,Grioni S,Groop LC,Kaaks R,Key TJ,Nilsson PM,Overvad K,Palli D,Panico S,Quirós JR,Rolandsson O,Sacerdote C,Sánchez MJ,Slimani N,Teucher B,Tjonneland A,Tumino R,Van Der A DL,Feskens EJM,Langenberg C,Forouhi NG,Riboli E,Wareham NJ","Adult,Aged,80 and over,Diet,Diet Records,Dietary Fats,Dietary Proteins,Energy Intake,Female,Great Britain,Humans,Internet,Interviews as Topic,Male,Micronutrients,Middle Aged,Nutrition Assessment,Prospective Studies,Reproducibility of Results,Surveys and Questionnaires,Young Adult|Million Women Study Collaborators,Humans,Birth Weight,Insulin-Like Growth Factor I,Body Weights and Measures,Postnatal Care,Diet,Risk Factors,Cohort Studies,Life Style,Breast Feeding,Postmenopause,Aged,Middle Aged,Great Britain,Female,Surveys and Questionnaires|Case-Control Studies,Colorectal Neoplasms,DNA,Female,Follow-Up Studies,Genotype,Humans,Male,Middle Aged,Polymerase Chain Reaction,Polymorphism,Genetic,Prognosis,Prospective Studies,Receptors,Calcitriol,Calcium-Sensing,Risk Factors,Survival Rate,Vitamin D|Abdominal obesity,Case-cohort study,Incident diabetes,Obesity,Physical activity||Adult,Age Distribution,Aged,80 and over,Body Mass Index,Diet,Vegetarian,Dietary Fiber,Diverticulum,Female,Great Britain,Humans,Intestinal Diseases,Intestine,Large,Small,Life Style,Male,Middle Aged,Prospective Studies,Risk Factors,Sex Distribution,Young Adult||||Cohort studies,Diabetes mellitus,Epidemiologic research design,Gene-lifestyle interaction,Genetic epidemiology,Type 2 diabetes|diet,dietary fibre,diverticular disease,prospective,Aged,Diet Surveys,Dietary Fiber,Diverticulitis,Diverticulum,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Intestinal Diseases,Middle Aged,Prospective Studies,Risk,Surveys and Questionnaires||Million Women Study Collaborators,Humans,Neoplasms,Lymphoma,Non-Hodgkin,Sarcoma,Breast Neoplasms,Incidence,Prospective Studies,Middle Aged,Great Britain,Female,Self Report,Food,Organic|Adult,Blood Pressure,Body Mass Index,Choice Behavior,Cholesterol,LDL,Cohort Studies,Diet,Vegetarian,England,European Continental Ancestry Group,Female,Follow-Up Studies,Food Habits,Food Preferences,Hospitalization,Humans,Incidence,Life Style,Male,Middle Aged,Myocardial Ischemia,Neoplasms,Nutritional Status,Proportional Hazards Models,Prospective Studies,Risk Factors,Scotland,Smoking,Surveys and Questionnaires|Endogenous Hormones,Nutritional Biomarkers and Prostate Cancer Collaborative Group,Humans,Prostatic Neoplasms,Eicosapentaenoic Acid,Fatty Acids,Unsaturated,Stearic Acids,Logistic Models,Odds Ratio,Risk Assessment,Risk Factors,Case-Control Studies,Prospective Studies,Aged,Middle Aged,Male|Humans,Neoplasms,Diet,Incidence,Proportional Hazards Models,Prospective Studies,Feeding Behavior,Food Habits,Vegetarian,Meat,Seafood,Adult,Middle Aged,Great Britain,Female,Male,Young Adult|Diet,Europe,Female,Fruit,Humans,Life Style,Male,Middle Aged,Myocardial Ischemia,Prospective Studies,Risk Factors,Vegetables|||||||Humans,Diabetes Mellitus,Type 2,Fatty Acids,Phospholipids,Case-Control Studies,Prospective Studies,Middle Aged,Female,Male||Body Mass Index,Diet,Dietary Fiber,Edible Grain,Europe,Female,Follow-Up Studies,Fruit,Humans,Life Style,Male,Middle Aged,Myocardial Ischemia,Neoplasms,Nutritional Status,Prospective Studies,Regression Analysis,Risk Factors,Surveys and Questionnaires,Vegetables||Aged,Case-Control Studies,Humans,Insulin-Like Growth Factor Binding Protein 3,Insulin-Like Growth Factor I,Logistic Models,Male,Middle Aged,Prospective Studies,Prostatic Neoplasms,Risk||Adult,Analysis of Variance,Animals,Body Mass Index,Diet,Vegetarian,Female,Fishes,Food Habits,Great Britain,Humans,Male,Meat,Middle Aged,Prospective Studies,Sex Factors,Smoking,Surveys and Questionnaires,Uric Acid,Young Adult||"
clme0240,clme1358,1,0.058823529411764705,Journal article,Chemical Communications,01/01/2015,Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.,"Thinnes CC,Tumber A,Yapp C,Scozzafava G,Yeh T,Chan MC,Tran TA,Hsu K,Tarhonskaya H,Walport LJ,Wilkins SE,Martinez ED,Müller S,Pugh CW,Ratcliffe PJ,Brennan PE,Kawamura A,Schofield CJ","Humans,Oxyquinoline,Oxygenases,Enzyme Inhibitors,Molecular Structure,Structure-Activity Relationship,Dose-Response Relationship,Drug,Models,Molecular"
clme0494,orms0061,1,0.1,Journal article,Nature Reviews Drug Discovery,01/03/2015,Preclinical target validation using patient-derived cells.,"Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
bioc0801,vacc0036,1,0.2,Journal article,Nucleic Acids Research,10/12/2011,Bio-CAP: a versatile and highly sensitive technique to purify and characterise regions of non-methylated DNA.,"Blackledge NP,Long HK,Zhou JC,Kriaucionis S,Patient R,Klose RJ","Biotinylation,Chromatography,Affinity,CpG Islands,DNA,DNA Methylation,High-Throughput Nucleotide Sequencing,Sequence Analysis,Zinc Fingers"
anat0116,clme0220,3,1.0909090909090908,Journal article|Journal article|Journal article,Oncogene|Cell Metabolism|Cell Metabolism,05/10/2015|12/04/2016|,PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer.|Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot.|Amino Acid Sensing by mTORC1: intracellular Transporters Mark the Spot,"Fan SJ,Snell C,Turley H,Li JL,McCormick R,Perera SM,Heublein S,Kazi S,Azad A,Wilson C,Harris AL,Goberdhan DC|Goberdhan DC,Wilson C,Harris AL|Goberdhan DCI,Wilson C,Harris AL",||
clme0220,whgu0172,4,0.7416806722689075,Journal article|Journal article|Journal article|Journal article,Aging|Journal of Pathology|Oncogene|Oncotarget,16/07/2015|01/01/2011|03/09/2015|01/01/2015,Hypoxia metabolism in ageing.|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Hypoxic regulation of RIOK3 is a major mechanism for cancer cell invasion and metastasis.|Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways.,"Valli A,Harris AL,Kessler BM|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Singleton DC,Rouhi P,Zois CE,Haider S,Li JL,Kessler BM,Cao Y,Harris AL|Valli A,Rodriguez M,Moutsianas L,Fischer R,Fedele V,Huang HL,Van Stiphout R,Jones D,Mccarthy M,Vinaxia M,Igarashi K,Sato M,Soga T,Buffa F,Mccullagh J,Yanes O,Harris A,Kessler B","Humans,Anoxia,Aging,Basic Helix-Loop-Helix Transcription Factors,Hypoxia-Inducible Factor 1,alpha Subunit,Fatty Acid Synthase,Type I|Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid|Cell Line,Tumor,Animals,Zebrafish,Humans,Mice,Breast Neoplasms,Neoplasm Invasiveness,Neoplasm Metastasis,Protein-Serine-Threonine Kinases,Tropomyosin,Cell Movement,Cell Hypoxia,Gene Expression Regulation,Neoplastic,Hypoxia-Inducible Factor 1,alpha Subunit,Actin Cytoskeleton|Cell Line,Tumor,HCT116 Cells,Humans,Colorectal Neoplasms,Acetyl-CoA Carboxylase,Acetyl-CoA C-Acyltransferase,Lipids,Fatty Acids,Platelet Activating Factor,Blotting,Western,Proteomics,Genomics,Signal Transduction,Cell Hypoxia,RNA Interference,Aged,Middle Aged,Female,Male,Lipid Metabolism,Basic Helix-Loop-Helix Transcription Factors,Hypoxia-Inducible Factor 1,alpha Subunit,Metabolomics"
bioc0801,whgu0172,2,0.13392857142857142,Journal article|Journal article,Cell|eLife,21/05/2014|15/12/2012,Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation.|KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.,"Blackledge NP,Farcas AM,Kondo T,King HW,McGouran JF,Hanssen LL,Ito S,Cooper S,Kondo K,Koseki Y,Ishikura T,Long HK,Sheahan TW,Brockdorff N,Kessler BM,Koseki H,Klose RJ|Farcas AM,Blackledge NP,Sudbery I,Long HK,McGouran JF,Rose NR,Lee S,Sims D,Cerase A,Sheahan TW,Koseki H,Brockdorff N,Ponting CP,Kessler BM,Klose RJ","Animals,Mice,F-Box Proteins,Histones,CpG Islands,Protein Structure,Tertiary,Bone Development,Genes,Lethal,Embryonic Stem Cells,Genome-Wide Association Study,Jumonji Domain-Containing Histone Demethylases,Polycomb Repressive Complex 1,Polycomb Repressive Complex 2|Chicken,Chromatin,CpG island,Demethylase,Epigenetics,Human,Methylation,Mouse,Transcription,Xenopus,Zebrafish,Animals,Cell Line,Tumor,CpG Islands,DNA Methylation,F-Box Proteins,Gene Silencing,Genome,Histones,Humans,Jumonji Domain-Containing Histone Demethylases,Mice,Polycomb-Group Proteins,Ubiquitination"
immd0237,whgu0378,9,1.0843284852386734,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Nature Genetics|Nature Genetics|Nature Genetics|Journal of Pathology|Haematologica: the hematology journal|Nature Genetics|Nature Genetics|Nature Communications|Nature Reviews: Cancer,11/03/2012|18/05/2015|01/01/2012|01/01/2011|11/07/2014|23/12/2012|01/01/2012||01/01/2015,Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Erythrocytosis associated with a novel missense mutation in the BPGM gene.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.|Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression|Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.|The mini-driver model of polygenic cancer evolution.,"Schödel J,Bardella C,Sciesielski LK,Brown JM,Pugh CW,Buckle V,Tomlinson IP,Ratcliffe PJ,Mole DR|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Schödel J,Bardella C,Sciesielski LK,Brown JM,Pugh CW,Buckle V,Tomlinson IP,Ratcliffe PJ,Mole DR|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Petousi N,Copley RR,Lappin TR,Haggan SE,Bento CM,Cario H,Percy MJ,Ratcliffe PJ,Robbins PA,McMullin MF|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I|Schödel J,Bardella C,Sciesielski LK,Brown JM,Pugh CW,Buckle V,Tomlinson IP,Ratcliffe PJ,Mole DR|Kovac M,Navas C,Horswell S,Salm M,Bardella C,Rowan A,Stares M,Castro-Giner F,Fisher R,de Bruin EC,Kovacova M,Gorman M,Makino S,Williams J,Jaeger E,Jones A,Howarth K,Larkin J,Pickering L,Gore M,Nicol DL,Hazell S,Stamp G,O'Brien T,Challacombe B,Matthews N,Phillimore B,Begum S,Rabinowitz A,Varela I,Chandra A,Horsfield C,Polson A,Tran M,Bhatt R,Terracciano L,Eppenberger-Castori S,Protheroe A,Maher E,El Bahrawy M,Fleming S,Ratcliffe P,Heinimann K,Swanton C,Tomlinson I|Castro-Giner F,Ratcliffe P,Tomlinson I","Cell Cycle Checkpoints,Cell Hypoxia,Cell Line,Tumor,Chromosomes,Human,Pair 11,Cyclin D1,Enhancer Elements,Genetic,Gene Expression Regulation,Neoplastic,Genetic Predisposition to Disease,Genetic Variation,Humans,Hypoxia-Inducible Factor 1,Kidney Neoplasms,Molecular Sequence Data,Polymorphism,Single Nucleotide,Von Hippel-Lindau Tumor Suppressor Protein|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing||Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid|WGS Consortium,Humans,Polycythemia,Bisphosphoglycerate Mutase,Genotype,Mutation,Missense|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA||Chromosomes,Humans,Carcinoma,Renal Cell,Kidney Neoplasms,Histone-Lysine N-Methyltransferase,Antibodies,Monoclonal,Chromosome Mapping,Sequence Analysis,DNA,Phylogeny,Gene Expression Regulation,Neoplastic,Mutation,Loss of Heterozygosity,Polymorphism,Single Nucleotide,Exons,Adult,Aged,80 and over,Middle Aged,Female,Male,DNA Copy Number Variations,Exome|Humans,Neoplasms,Cell Transformation,Neoplastic,Neoplasm Proteins,Evolution,Molecular,Mutation"
immd0151,immd0330,7,0.9088259688259688,Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper,Blood|Leukemia|Blood|American Journal of Hematology|Blood|Personalized Medicine|Leukemia,16/11/2012|01/01/2012|12/12/2013|01/05/2013|27/08/2015|01/06/2013|10/06/2016,"SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features|Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.|SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.|NOVEL GENE DELETIONS RESULT IN HAEMOCHROMATOSIS|Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.|Clinical application of targeted and genome-wide technologies: Can we predict treatment responses in chronic lymphocytic leukemia?|Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.","Clifford R,Ackroyd S,Burns A,Timbs A,Maelfait J,Dreau H,Henderson S,Ross M,Bentley D,Hillmen P,Knight S,Taylor J,Hatton CSR,Rehwinkel J,Crow Y,Schuh A|Knight SJ,Yau C,Clifford R,Timbs AT,Sadighi Akha E,Dréau HM,Burns A,Ciria C,Oscier DG,Pettitt AR,Dutton S,Holmes CC,Taylor J,Cazier JB,Schuh A|Clifford R,Louis T,Robbe P,Ackroyd S,Burns A,Timbs AT,Wright Colopy G,Dreau H,Sigaux F,Judde JG,Rotger M,Telenti A,Lin YL,Pasero P,Maelfait J,Titsias M,Cohen DR,Henderson SJ,Ross MT,Bentley D,Hillmen P,Pettitt A,Rehwinkel J,Knight SJ,Taylor JC,Crow YJ,Benkirane M,Schuh A|Bignell P,Knight S,Mackie P,Clifford R,Murrin R,Schuh A,Robson K|Guièze R,Robbe P,Clifford R,de Guibert S,Pereira B,Timbs A,Dilhuydy MS,Cabes M,Ysebaert L,Burns A,Nguyen-Khac F,Davi F,Véronèse L,Combes P,Le Garff-Tavernier M,Leblond V,Merle-Béral H,Alsolami R,Hamblin A,Mason J,Pettitt A,Hillmen P,Taylor J,Knight SJ,Tournilhac O,Schuh A|Alsolami R,Knight SJ,Schuh A|Parker H,Rose-Zerilli MJ,Larrayoz M,Clifford R,Edelmann J,Blakemore S,Gibson J,Wang J,Ljungström V,Wojdacz TK,Chaplin T,Roghanian A,Davis Z,Parker A,Tausch E,Ntoufa S,Ramos S,Robbe P,Alsolami R,Steele AJ,Packham G,Rodríguez-Vicente AE,Brown L,McNicholl F,Forconi F,Pettitt A,Hillmen P,Dyer M,Cragg MS,Chelala C,Oakes CC,Rosenquist R,Stamatopoulos K,Stilgenbauer S,Knight S,Schuh A,Oscier DG,Strefford JC","|Adult,Aged,80 and over,Biomarkers,Tumor,Chromosome Aberrations,Clone Cells,Female,Gene Dosage,Genome,Human,Genomics,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Loss of Heterozygosity,Male,Middle Aged,Neoplasm Recurrence,Local,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Prognosis|Adult,Autoimmune Diseases of the Nervous System,Cohort Studies,Comparative Genomic Hybridization,DNA Damage,Gene Frequency,Germ-Line Mutation,HeLa Cells,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Male,Monomeric GTP-Binding Proteins,Nervous System Malformations,Young Adult,Hela Cells||Humans,Neoplasm Recurrence,Local,Ribonucleoprotein,U2 Small Nuclear,Phosphoproteins,Prognosis,Treatment Outcome,Salvage Therapy,Prospective Studies,Mutation,Tumor Suppressor Protein p53,Leukemia,Lymphocytic,Chronic,B-Cell,Kaplan-Meier Estimate,High-Throughput Nucleotide Sequencing,Ataxia Telangiectasia Mutated Proteins||"
card0027,immd0075,1,0.06666666666666667,Journal article,Mammalian Genome,27/04/2012,Nprl3 is required for normal development of the cardiovascular system.,"Kowalczyk MS,Hughes JR,Babbs C,Sanchez-Pulido L,Szumska D,Sharpe JA,Sloane-Stanley JA,Morriss-Kay GM,Smoot LB,Roberts AE,Watkins H,Bhattacharya S,Gibbons RJ,Ponting CP,Wood WG,Higgs DR","Abnormalities,Multiple,Amino Acid Sequence,Animals,Cardiovascular System,Cells,Cultured,DNA Mutational Analysis,Female,GTPase-Activating Proteins,Gene Expression Profiling,Genetic Association Studies,Heart Defects,Congenital,Humans,Intracellular Signaling Peptides and Proteins,Male,Mice,Knockout,Molecular Sequence Annotation,Molecular Sequence Data,Myocardium,Nuclear Proteins,Phenotype,Polymorphism,Single Nucleotide,Promoter Regions,Genetic"
card0027,ocms0037,1,0.06666666666666667,Journal article,Mammalian Genome,27/04/2012,Nprl3 is required for normal development of the cardiovascular system.,"Kowalczyk MS,Hughes JR,Babbs C,Sanchez-Pulido L,Szumska D,Sharpe JA,Sloane-Stanley JA,Morriss-Kay GM,Smoot LB,Roberts AE,Watkins H,Bhattacharya S,Gibbons RJ,Ponting CP,Wood WG,Higgs DR","Abnormalities,Multiple,Amino Acid Sequence,Animals,Cardiovascular System,Cells,Cultured,DNA Mutational Analysis,Female,GTPase-Activating Proteins,Gene Expression Profiling,Genetic Association Studies,Heart Defects,Congenital,Humans,Intracellular Signaling Peptides and Proteins,Male,Mice,Knockout,Molecular Sequence Annotation,Molecular Sequence Data,Myocardium,Nuclear Proteins,Phenotype,Polymorphism,Single Nucleotide,Promoter Regions,Genetic"
dpag0074,immd0680,1,0.08333333333333333,Journal article,Nature Communications,01/01/2014,Understanding functional miRNA-target interactions in vivo by site-specific genome engineering.,"Bassett AR,Azzam G,Wheatley L,Tibbit C,Rajakumar T,McGowan S,Stanger N,Ewels PA,Taylor S,Ponting CP,Liu JL,Sauka-Spengler T,Fulga TA","Animals,Zebrafish,Humans,Drosophila,Deoxyribonucleases,Endonucleases,DNA-Binding Proteins,MicroRNAs,Transfection,Genetic Engineering,Sequence Analysis,Base Sequence,Response Elements,Molecular Sequence Data,Transcriptional Activation,HEK293 Cells,Clustered Regularly Interspaced Short Palindromic Repeats"
immd0036,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0024,lina0435,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0301,clph0059,1,0.07142857142857142,Journal article,Cancer Research,21/08/2012,MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.,"Walls GV,Lemos MC,Javid M,Bazan-Peregrino M,Jeyabalan J,Reed AA,Harding B,Tyler DJ,Stuckey DJ,Piret S,Christie PT,Ansorge O,Clarke K,Seymour L,Thakker RV","Adenoma,Adenoviridae,Animals,Cell Proliferation,Disease Models,Animal,Genetic Therapy,Genetic Vectors,HEK293 Cells,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,129 Strain,Inbred C57BL,Knockout,Pituitary Gland,Pituitary Neoplasms,Proto-Oncogene Proteins"
clme0975,raob0072,8,1.4165204678362573,Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper,Critical Reviews in Oncology Hematology|British Journal of Surgery|International Journal of Cancer|Nature Communications|International Journal of Cancer|Critical Reviews in Oncology Hematology|Journal of Clinical Oncology|Journal of Clinical Oncology,01/01/2012|01/05/2011|26/08/2013||15/03/2014|04/02/2012|20/01/2014|20/05/2012,"Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: What have we learned from a decade of translational research?|Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer|XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.|Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.|XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection|Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: what have we learned from a decade of translational research?|Discovery of prognostic and predictive tissue biomarkers in patients with resectable esophageal cancer|Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy","Hill EJ,Nicolay NH,Middleton MR,Sharma RA|Gillies RS,Delaney D,Warren B,Sharma RA,Middleton MR|Hatch SB,Swift LP,Caporali S,Carter R,Hill EJ,MacGregor TP,D'Atri S,Middleton MR,McHugh PJ,Sharma RA|Findlay JM,Castro-Giner F,Makino S,Rayner E,Kartsonaki C,Cross W,Kovac M,Ulahannan D,Palles C,Gillies RS,MacGregor TP,Church D,Maynard ND,Buffa F,Cazier JB,Graham TA,Wang LM,Sharma RA,Middleton M,Tomlinson I|Hatch SB,Swift LP,Caporali S,Carter R,Hill EJ,Macgregor TP,D'Atri S,Middleton MR,McHugh PJ,Sharma RA|Hill EJ,Nicolay NH,Middleton MR,Sharma RA|MacGregor TP,Gillies RS,Sahgal N,Chetty R,Wang L-M,Turkington RC,Maynard ND,Mchugh PJ,Kennedy RD,Middleton MR,Sharma RA|Sharma RA,Macgregor T,Gillies R,Hatch S,Swift L,Humphrey TIM,Chetty R,McHugh PJ,Middleton MR","||DNA repair,cell cycle,cytotoxic chemotherapy,tissue biomarker,Antineoplastic Agents,Biomarkers,Tumor,Cohort Studies,DNA Damage,DNA-Binding Proteins,Drug Resistance,Neoplasm,Endonucleases,Humans,Immunoenzyme Techniques,Melanoma,Middle Aged,Organoplatinum Compounds,Patient Selection,S Phase,Tissue Array Analysis,Transcription Factors,Tumor Cells,Cultured|||Animals,Antineoplastic Agents,Biomarkers,Tumor,Clinical Trials as Topic,Combined Modality Therapy,Digestive System Neoplasms,Humans,Organoplatinum Compounds,Radiation Tolerance,Radiation-Sensitizing Agents,Translational Medical Research||"
clme0237,immd0082,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0036,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
raob0189,stat0054,1,0.06666666666666667,Journal article,Nature Communications,01/01/2014,Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.,"Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC","Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading"
quee1607,quee1607,1,1.0,Conference paper,Advances in Neural Information Processing Systems,,Hamming ball auxiliary sampling for factorial hidden Markov models,"Titsias MK,Yau C",
clar0295,raob0168,1,0.030303030303030304,Journal article,Physical Review Special Topics: Accelerators and Beams,11/03/2013,Conceptual design of a nonscaling fixed field alternating gradient accelerator for protons and carbon ions for charged particle therapy,"Peach KJ,Aslaninejad M,Barlow RJ,Beard CD,Bliss N,Cobb JH,Easton MJ,Edgecock TR,Fenning R,Gardner ISK,Hill MA,Owen HL,Johnstone CJ,Jones B,Jones T,Kelliher DJ,Khan A,Machida S,McIntosh PA,Pattalwar S,Pasternak J,Pozimski J,Prior CR,Rochford J,Rogers CT,Seviour R,Sheehy SL,Smith SL,Strachan J,Tygier S,Vojnovic B,Wilson P,Witte H,Yokoi T",
immd0237,stat0054,3,0.14660121251140082,Journal article|Journal article|Journal article,Haematologica: the hematology journal|Nature Genetics|Nature Genetics,11/07/2014|18/05/2015|23/12/2012,Erythrocytosis associated with a novel missense mutation in the BPGM gene.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.,"Petousi N,Copley RR,Lappin TR,Haggan SE,Bento CM,Cario H,Percy MJ,Ratcliffe PJ,Robbins PA,McMullin MF|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I","WGS Consortium,Humans,Polycythemia,Bisphosphoglycerate Mutase,Genotype,Mutation,Missense|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA"
clme0169,ctsu0165,1,0.07142857142857142,Journal article,Trials,30/12/2015,Exploring the role and function of trial steering committees: results of an expert panel meeting.,"Harman NL,Conroy EJ,Lewis SC,Murray G,Norrie J,Sydes MR,Lane JA,Altman DG,Baigent C,Bliss JM,Campbell MK,Elbourne D,Evans S,Sandercock P,Gamble C",
card0027,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0031,immd0282,1,0.05,Journal article,Cancer Cell,17/07/2013,A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.,"Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM","Animals,Cell Growth Processes,Endothelial Cells,Female,Genetic Predisposition to Disease,HCT116 Cells,Humans,Mice,Nude,Neoplasms,Neovascularization,Pathologic,Receptors,G-Protein-Coupled,Signal Transduction"
clme0220,clme0670,5,1.3106893106893105,Journal article|Journal article|Journal article|Journal article|Journal article,Journal of National Cancer Institute|Journal of National Cancer Institute|Journal of the National Cancer Institute|Molecular Cell|Proceedings of the National Academy of Sciences of USA,01/01/2012|18/10/2011|01/03/2012|01/01/2011|20/07/2015,Response: Re: Delta-like ligand 4-notch blockade and tumor radiation response|Delta-like ligand 4-notch blockade and tumor radiation response.|Re: Delta-Like Ligand 4-Notch Blockade and Tumor Radiation Response Response|MiR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors|The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions.,"Liu SK,Muschel RJ,Harris AL|Liu SK,Bham SA,Fokas E,Beech J,Im J,Cho S,Harris AL,Muschel RJ|Liu SK,Muschel RJ,Harris AL|Moskwa P,Buffa FM,Pan Y,Panchakshari R,Gottipati P,Muschel RJ,Beech J,Kulshrestha R,Abdelmohsen K,Weinstock DM,Gorospe M,Harris AL,Helleday T,Chowdhury D|Tapmeier TT,Moshnikova A,Beech J,Allen D,Kinchesh P,Smart S,Harris A,McIntyre A,Engelman DM,Andreev OA,Reshetnyak YK,Muschel RJ","|Adenocarcinoma,Amyloid Precursor Protein Secretases,Animals,Antibodies,Monoclonal,Antineoplastic Agents,Blood Flow Velocity,Carcinoma,Squamous Cell,Cell Line,Tumor,Colorectal Neoplasms,Combined Modality Therapy,Dibenzazepines,Humans,Hypopharyngeal Neoplasms,Immunoblotting,Immunohistochemistry,Intercellular Signaling Peptides and Proteins,Luminescent Measurements,Mice,Nude,Necrosis,Neoplasms,Neovascularization,Pathologic,Radiation,Ionizing,Receptors,Notch,Signal Transduction,Transplantation,Heterologous,Ultrasonography,Doppler|||Cell Line,Tumor,Spheroids,Cellular,Animals,Mice,Inbred BALB C,Humans,Neoplasms,Neoplasm Invasiveness,Disease Models,Animal,Acids,Membrane Proteins,Magnetic Resonance Spectroscopy,Sensitivity and Specificity,ROC Curve,Amino Acid Sequence,Hydrogen-Ion Concentration,Molecular Sequence Data,Mutant Proteins,Biomarkers"
clme0667,raob0202,20,3.681421356421356,Journal article|Conference paper|Journal article|Conference paper|Conference paper|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Conference paper|Journal article,"Oncotarget|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Cancer Research|Modern Pathology|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Biochimica et Biophysica Acta: international journal of biochemistry and biophysics|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Cancer Biology and Therapy|Radiotherapy and Oncology|Cancer Treatment Reviews|Radiotherapy and Oncology|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Cell Death and Disease|Cancer and Metastasis Reviews|Radiation Oncology|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|Laboratory Investigation|Cancer and Metastasis Reviews",|01/05/2013|22/11/2011|01/02/2016|01/06/2012|06/12/2014|01/06/2012|01/09/2012||11/04/2013|03/05/2013|01/05/2013|01/01/2012|24/07/2012|27/03/2012|05/04/2013|01/05/2013|01/05/2013|01/02/2016|01/01/2012,"The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma.|A comprehensive comparison of IMAT and 3D-CRT plan quality for gastrointestinal organ sparing and NTCP using the Eclipse Radiobiological modelling software|Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy|Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.|A comparison of four target volume definitions for pancreatic cancer: Two concepts including the lymphatics (RTOG and German multi-centre neoadjuvant trial) and two concepts only treating the primary tumour (Michigan and UK-SCALOP)|The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.|ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.|Targeting ATR in DNA damage response and cancer therapeutics.|A treatment planning comparison of four target volume contouring guidelines for locally advanced pancreatic cancer radiotherapy.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation|Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies.|NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity.|Comparison of four target volume definitions for pancreatic cancer. Guidelines for treatment of the lymphatics and the primary tumor.|A comprehensive dosimetric comparison of four target volume definitions for pancreatic cancer and their influence on lymphatics and organs at risk|Dose- and schedule-dependent changes in vascular morphology after PI3K and PI3K/mTOR inhibition: in vitro vs. in vivo effects|The Prognostic Role of Desmoplastic Stroma in Pancreatic Cancer|The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies","Wang LM,Silva MA,D'Costa Z,Bockelmann R,Soonawalla Z,Liu S,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Warren S,Fokas E,Partridge M,Eccles CE,McKenna WG,Brunner T|Fokas E,Im JH,Hill S,Yameen S,Stratford M,Beech J,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Fokas E,Prevo R,Reaper P,Charlton P,Pollard J,McKenna WG,Muschel R,Brunner T|Fokas E,O'Neill E,Gordon-Weeks A,Mukherjee S,McKenna WG,Muschel RJ|Fokas E,Eccles C,McKenna WG,Brunner T|Prevo R,Fokas E,Reaper PM,Charlton PA,Pollard JR,McKenna WG,Muschel RJ,Brunner TB|Wilson JM,Fokas E,Dutton SJ,Patel N,Hawkins MA,Eccles C,Chu KY,Durrant L,Abraham AG,Partridge M,Woodward M,O'Neill E,Maughan T,McKenna WG,Mukherjee S,Brunner TB|Fokas E,Prevo R,Hammond EM,Brunner TB,McKenna WG,Muschel RJ|Fokas E,Eccles C,Patel N,Chu KY,Warren S,McKenna WG,Brunner TB|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Fokas E,McKenna WG,Muschel RJ|Fokas E,Yoshimura M,Prevo R,Higgins G,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ|Fokas E,Eccles C,Patel N,Chu KY,Warren S,Gillies McKenna W,Brunner TB|Fokas E,Eccles CE,Patel N,Chu K-Y,Warren S,McKenna WG,Brunner TB|Fokas E,Lechterier T,Hackl W,S-M M,McKenna WG,Hodivala-Dilke K,Muschel RJ|Wang LM,Silva M,D'Costa Z,Bockelmann R,Soonawalla Z,O'Neill E,Mukherjee S,McKenna WG,Muschel R,Fokas E|Fokas E,McKenna WG,Muschel RJ","||Animals,Dose-Response Relationship,Drug,Humans,Mice,Neoplasms,Experimental,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,Radiation Tolerance,TOR Serine-Threonine Kinases,Xenograft Model Antitumor Assays|||Animals,Humans,Mice,Carcinoma,Pancreatic Ductal,Pancreatic Neoplasms,Cell Transformation,Neoplastic,Disease Models,Animal,Inflammation,Cancer Vaccines,Immunotherapy,Drug Resistance,Neoplasm,Radiation Tolerance,Neoplastic Cells,Circulating||Antineoplastic Combined Chemotherapy Protocols,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Checkpoints,Cell Cycle Proteins,Cell Hypoxia,Cell Line,Tumor,Combined Modality Therapy,DNA Damage,DNA Repair,Deoxycytidine,Humans,Pancreatic Neoplasms,Phosphorylation,Protein-Serine-Threonine Kinases,Pyrazines,Radiation-Sensitizing Agents,Signal Transduction,Sulfones||ATR,Cancer,Chemotherapy,DNA damage,Radiation,Replication stress,Therapeutics,Animals,Antineoplastic Agents,Ataxia Telangiectasia Mutated Proteins,Clinical Trials as Topic,Combined Modality Therapy,DNA Damage,DNA Replication,Humans,Molecular Targeted Therapy,Neoplasms,Protein Kinase Inhibitors,Protein Kinases,Signal Transduction|Adenocarcinoma,Carcinoma,Pancreatic Ductal,Humans,Organs at Risk,Pancreatic Neoplasms,Practice Guidelines as Topic,Radiotherapy Dosage,Radiotherapy Planning,Computer-Assisted,Tumor Burden||Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|Angiogenesis Inhibitors,Animals,Cell Hypoxia,Humans,Neoplasm Invasiveness,Neoplasm Metastasis,Neoplasms,Neovascularization,Pathologic,Phosphatidylinositol 3-Kinases,TOR Serine-Threonine Kinases,Tumor Microenvironment,Vascular Endothelial Growth Factor A|Cell Line,Tumor,Endothelial Cells,Human Umbilical Vein Endothelial Cells,Humans,Imidazoles,Phosphatidylinositol 3-Kinases,Quinolines,Radiation-Sensitizing Agents,TOR Serine-Threonine Kinases|Carcinoma,Pancreatic Ductal,Germany,Humans,Imaging,Three-Dimensional,Lymphatic Metastasis,Pancreatic Neoplasms,Practice Guidelines as Topic,Reproducibility of Results,Sensitivity and Specificity,Tomography,X-Ray Computed,Tumor Burden||||"
clme0485,clme0497,1,0.1,Journal article,Nature Reviews Drug Discovery,01/03/2015,Preclinical target validation using patient-derived cells.,"Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
clme0220,phys0101,6,1.5833333333333333,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,PLoS One|Journal of Cellular Physiology|Current Pharmaceutical Design|Clinical Cancer Research|Journal of Biological Chemistry|Philosophical Transactions of the Royal Society of London: Biological Sciences,01/01/2012|04/09/2012|23/02/2012|12/04/2012|24/07/2014|01/01/2014,"Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin.|Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia.|Acid-extrusion from tissue: the interplay between membrane transporters and pH buffers.|Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.|Intracellular carbonic anhydrase activity sensitizes cancer cell pH signaling to dynamic changes in CO2 partial pressure.|The chemistry, physiology and pathology of pH in cancer.","Swietach P,Hulikova A,Patiar S,Vaughan-Jones RD,Harris AL|Hulikova A,Harris AL,Vaughan-Jones RD,Swietach P|Hulikova A,Harris AL,Vaughan-Jones RD,Swietach P|McIntyre A,Patiar S,Wigfield S,Li JL,Ledaki I,Turley H,Leek R,Snell C,Gatter K,Sly WS,Vaughan-Jones RD,Swietach P,Harris AL|Hulikova A,Aveyard N,Harris AL,Vaughan-Jones RD,Swietach P|Swietach P,Vaughan-Jones RD,Harris AL,Hulikova A","Antibiotics,Antineoplastic,Binding Sites,Cell Nucleus,Cell Proliferation,Doxorubicin,HCT116 Cells,Humans,Hydrogen-Ion Concentration,Models,Chemical|Acids,Biological Transport,Cation Transport Proteins,Cell Hypoxia,Cell Line,Tumor,Down-Regulation,HCT116 Cells,HT29 Cells,HeLa Cells,Homeostasis,Humans,Hydrogen-Ion Concentration,Neoplasms,Oxygen,Sodium-Hydrogen Antiporter|Acid-Base Equilibrium,Buffers,Cell Membrane,Humans,Hydrogen-Ion Concentration,Membrane Transport Proteins|Angiogenesis Inhibitors,Animals,Antibodies,Monoclonal,Humanized,Antigens,Neoplasm,Bevacizumab,Carbonic Anhydrases,Cell Line,Tumor,Cell Proliferation,Female,Gene Knockdown Techniques,Glioblastoma,HCT116 Cells,HT29 Cells,Humans,Hydrogen-Ion Concentration,Mice,Necrosis,Neoplasm Transplantation,Transfection,Transplantation,Heterologous|HCT116 Cells,Cytoplasm,Humans,Neoplasms,Carbon Dioxide,Bicarbonates,Protons,Carbonic Anhydrases,Signal Transduction,Hydrogen-Ion Concentration,Partial Pressure|buffering,carbonic anhydrase,diffusion,pH regulation,pH sensing,Acid-Base Equilibrium,Carbonic Anhydrases,Humans,Hydrogen-Ion Concentration,Membrane Transport Proteins,Neoplasms,Oxygen,Proton Pumps,Tumor Microenvironment"
immd0082,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
ndos0159,ndos0168,1,0.2,Journal article,Biomedical Materials,10/05/2011,Improved human tenocyte proliferation and differentiation in vitro by optimized silk degumming.,"Wang X,Qiu Y,Carr AJ,Triffitt JT,Sabokbar A,Xia Z","Animals,Bombyx,Carmine,Cell Differentiation,Cell Proliferation,Gene Expression Regulation,Humans,Materials Testing,Microscopy,Electron,Scanning,Oxazines,Picrates,Silk,Stress,Mechanical,Tendon Injuries,Tendons,Tissue Engineering,Xanthenes"
univ0247,whgu0172,1,0.125,Journal article,Proteomics,05/06/2015,Expanding the yeast protein arginine methylome.,"Plank M,Fischer R,Geoghegan V,Charles PD,Konietzny R,Acuto O,Pears C,Schofield CJ,Kessler BM","Arginine,Saccharomyces cerevisiae Proteins,Proteome,Isotope Labeling,Systems Biology,Amino Acid Sequence,Methylation,Molecular Sequence Data,Tandem Mass Spectrometry"
clab0127,whgu0172,5,0.5197802197802198,Journal article|Journal article|Journal article|Journal article|Journal article,Science Advances|Cell Death and Differentiation|Cell Death and Differentiation|Molecular Cell|The EMBO Journal,04/02/2016|29/08/2014|24/05/2013|25/09/2013|10/02/2012,Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response.|Cofactor Strap regulates oxidative phosphorylation and mitochondrial p53 activity through ATP synthase.|A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.|Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1.|Arginine methylation controls growth regulation by E2F-1.,"Ghari F,Quirke AM,Munro S,Kawalkowska J,Picaud S,McGouran J,Subramanian V,Muth A,Williams R,Kessler B,Thompson PR,Fillipakopoulos P,Knapp S,Venables PJ,La Thangue NB|Maniam S,Coutts AS,Stratford MR,McGouran J,Kessler B,La Thangue NB|New M,Olzscha H,Liu G,Khan O,Stimson L,McGouran J,Kerr D,Coutts A,Kessler B,Middleton M,La Thangue NB|Zheng S,Moehlenbrink J,Lu YC,Zalmas LP,Sagum C,Carr S,McGouran JF,Alexander L,Fedorov O,Munro S,Kessler B,Bedford MT,Yu Q,La Thangue NB|Cho EC,Zheng S,Munro S,Liu G,Carr SM,Moehlenbrink J,Lu YC,Stimson L,Khan O,Konietzny R,McGouran J,Coutts AS,Kessler B,Kerr DJ,Thangue NB","Cell Line,HL-60 Cells,Animals,Mice,Inbred DBA,Humans,Arthritis,Experimental,Inflammation,Hydrolases,Citrulline,Nuclear Proteins,Recombinant Proteins,Transcription Factors,RNA,Small Interfering,Cytokines,Gene Expression Regulation,Acetylation,Male,E2F1 Transcription Factor,Promoter Regions,Genetic|Hela Cells,Mitochondria,Humans,Mitochondrial Proton-Translocating ATPases,Glucose,Neoplasm Proteins,Apoptosis,Oxidative Phosphorylation,Oxygen Consumption,Tumor Suppressor Protein p53,Transcriptional Activation|Apoptosis,Autophagy,Biomarkers,Tumor,Cell Line,DNA Repair Enzymes,DNA-Binding Proteins,Gene Expression Regulation,Neoplastic,Histone Deacetylase Inhibitors,Histone Deacetylases,Humans,RNA,Small Interfering,Transfection,Ubiquitin|Amino Acid Motifs,Apoptosis,Arginine,Cell Line,Tumor,Cell Proliferation,Chromatin Assembly and Disassembly,Cyclin A,DNA Damage,E2F1 Transcription Factor,Gene Expression Regulation,Humans,Methylation,Promoter Regions,Genetic,Protein Binding,Protein Processing,Post-Translational,Protein-Arginine N-Methyltransferases,RNA Interference,Repressor Proteins,Signal Transduction,Transcription,Transfection|Apoptosis,Arginine,Cell Line,Tumor,Cell Transformation,Neoplastic,E2F1 Transcription Factor,Gene Expression Regulation,Humans,Methylation,Protein Methyltransferases,Protein Stability,Protein-Arginine N-Methyltransferases"
clme0975,immd0423,2,0.15476190476190477,Conference paper|Journal article,Annals of Oncology|Frontiers in Oncology,01/06/2012|,CLINICAL DIAGNOSTIC IMPLEMENTATION OF AN INNOVATIVE CANCER CARE MODEL BASED ON COMPREHENSIVE MOLECULAR PROFILING OF TUMOUR-NORMAL PAIRS|Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR.,"Kaur K,Henderson S,Cutts A,Domingo E,Woods J,Motley C,Dougherty B,Middleton M,Hassan B,Wang Y,Beasley E,Naley M,Schuh A,Tomlinson I,Taylor J|Aleksic T,Browning L,Woodward M,Phillips R,Page S,Henderson S,Athanasou N,Ansorge O,Whitwell D,Pratap S,Hassan AB,Middleton MR,Macaulay VM",|
path0002,whgu0385,1,0.08333333333333333,Journal article,Ultramicroscopy,03/06/2014,Multimodal nanoparticles as alignment and correlation markers in fluorescence/soft X-ray cryo-microscopy/tomography of nucleoplasmic reticulum and apoptosis in mammalian cells.,"Hagen C,Werner S,Carregal-Romero S,N Malhas A,G Klupp B,Guttmann P,Rehbein S,Henzler K,C Mettenleiter T,J Vaux D,J Parak W,Schneider G,Grünewald K","Cell Nucleus,Animals,Rabbits,Saquinavir,HIV Protease Inhibitors,Tomography,X-Ray Computed,Cryoelectron Microscopy,Apoptosis,Nanotechnology,Nanoparticles"
card0018,robbins,1,0.1,Journal article,"American Journal of Physiology: Regulatory, Integrative and Comparative Physiology",01/06/2011,Endurance exercise training blunts the deleterious effect of high-fat feeding on whole body efficiency.,"Edwards LM,Holloway CJ,Murray AJ,Knight NS,Carter EE,Kemp GJ,Thompson CH,Tyler DJ,Neubauer S,Robbins PA,Clarke K","Dietary Fats,Energy Metabolism,Exercise,Fatty Acids,Humans,Male,Mitochondria,Muscle,Physical Endurance,Young Adult"
clme0220,clme0240,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
path0089,stat0004,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0220,univ1923,1,0.058823529411764705,Journal article,Oncotarget,01/01/2015,Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways.,"Valli A,Rodriguez M,Moutsianas L,Fischer R,Fedele V,Huang HL,Van Stiphout R,Jones D,Mccarthy M,Vinaxia M,Igarashi K,Sato M,Soga T,Buffa F,Mccullagh J,Yanes O,Harris A,Kessler B","Cell Line,Tumor,HCT116 Cells,Humans,Colorectal Neoplasms,Acetyl-CoA Carboxylase,Acetyl-CoA C-Acyltransferase,Lipids,Fatty Acids,Platelet Activating Factor,Blotting,Western,Proteomics,Genomics,Signal Transduction,Cell Hypoxia,RNA Interference,Aged,Middle Aged,Female,Male,Lipid Metabolism,Basic Helix-Loop-Helix Transcription Factors,Hypoxia-Inducible Factor 1,alpha Subunit,Metabolomics"
bioc0541,raob0069,1,0.14285714285714285,Journal article,Journal of National Cancer Institute,09/10/2013,Selective permeabilization of the blood-brain barrier at sites of metastasis.,"Connell JJ,Chatain G,Cornelissen B,Vallis KA,Hamilton A,Seymour L,Anthony DC,Sibson NR","Analysis of Variance,Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Blood-Brain Barrier,Brain,Brain Neoplasms,Breast Neoplasms,Contrast Media,Disease Models,Animal,Drug Administration Schedule,Female,Gadolinium DTPA,Gene Expression Regulation,Neoplastic,Humans,Immunohistochemistry,Lymphotoxin-alpha,Magnetic Resonance Imaging,Mice,Inbred BALB C,Permeability,Receptors,Tumor Necrosis Factor,Type I,Tomography,Emission-Computed,Single-Photon,X-Ray Computed,Trastuzumab,Tumor Necrosis Factor-alpha"
claridge,whgu0139,2,0.06451612903225806,Journal article|Journal article,Nature Chemical Biology|Nature Chemical Biology,01/01/2012|01/01/2012,Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.,"Ge W,Wolf A,Feng T,Ho C-H,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TDW,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,Mccullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ","|Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes"
immd0036,whgu0085,1,0.08333333333333333,Conference paper,Journal of Medical Genetics,01/09/2011,Targeted Capture and Next Generation Sequencing (NGS) of genes involved in Inherited Retinal Degeneration (IRD),"Shanks M,Downes SM,Kwasniewska A,Packham E,Clouston P,Seller A,Copley R,Lise S,Taylor J,Hudspith K,Wilkie AOM,Ragoussis J,Nemeth AH",
darby,gree0184,7,0.6357466063348416,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,BMJ|Lancet|Lancet|New England Journal of Medicine|Lancet|Radiotherapy and Oncology|Lancet,01/01/2012|12/11/2011|21/06/2014|14/03/2013|04/02/2012|01/01/2011|01/08/2011,"Impact of smoking on mortality and life expectancy in Japanese smokers: a prospective cohort study.|Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.|Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.|Risk of ischemic heart disease in women after radiotherapy for breast cancer.|Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.|Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden|Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","Sakata R,McGale P,Grant EJ,Ozasa K,Peto R,Darby SC|Early Breast Cancer Trialists' Collaborative Group (EBCTCG),Darby S,McGale P,Correa C,Taylor C,Arriagada R,Clarke M,Cutter D,Davies C,Ewertz M,Godwin J,Gray R,Pierce L,Whelan T,Wang Y,Peto R|McGale P,Taylor C,Correa C,Cutter D,Duane F,Ewertz M,Gray R,Mannu G,Peto R,Whelan T,Wang Y,Wang Z,Darby S|Darby SC,Ewertz M,McGale P,Bennet AM,Blom-Goldman U,Brønnum D,Correa C,Cutter D,Gagliardi G,Gigante B,Jensen MB,Nisbet A,Peto R,Rahimi K,Taylor C,Hall P|Early Breast Cancer Trialists' Collaborative Group (EBCTCG),Peto R,Davies C,Godwin J,Gray R,Pan HC,Clarke M,Cutter D,Darby S,McGale P,Taylor C,Wang YC,Bergh J,Di Leo A,Albain K,Swain S,Piccart M,Pritchard K|McGale P,Darby SC,Hall P,Adolfsson J,Bengtsson NO,Bennet AM,Fornander T,Gigante B,Jensen MB,Peto R,Rahimi K,Taylor CW,Ewertz M|Early Breast Cancer Trialists' Collaborative Group (EBCTCG),Davies C,Godwin J,Gray R,Clarke M,Cutter D,Darby S,McGale P,Pan HC,Taylor C,Wang YC,Dowsett M,Ingle J,Peto R","Adult,Aged,Cause of Death,Female,Humans,Japan,Life Expectancy,Male,Middle Aged,Prospective Studies,Risk Factors,Sex Factors,Smoking,Smoking Cessation,Survival Rate,Young Adult|Age Factors,Breast Neoplasms,Estrogen Antagonists,Female,Humans,Lymphatic Metastasis,Mastectomy,Segmental,Neoplasm Grading,Neoplasm Recurrence,Local,Radiotherapy,Adjuvant,Randomized Controlled Trials as Topic,Receptors,Estrogen,Tamoxifen|EBCTCG (Early Breast Cancer Trialists' Collaborative Group),Axilla,Humans,Breast Neoplasms,Lymphatic Metastasis,Neoplasm Recurrence,Local,Lymph Node Excision,Mastectomy,Female,Randomized Controlled Trials as Topic|Adult,Aged,Breast Neoplasms,Case-Control Studies,Chemotherapy,Adjuvant,Female,Heart,Humans,Mastectomy,Middle Aged,Myocardial Ischemia,Radiation Injuries,Radiotherapy Dosage,Radiotherapy,Risk,Risk Factors|Anthracyclines,Antineoplastic Combined Chemotherapy Protocols,Breast Neoplasms,Chemotherapy,Adjuvant,Female,Humans,Neoplasm Recurrence,Local,Randomized Controlled Trials as Topic,Survival Rate,Taxoids||Antineoplastic Agents,Hormonal,Breast Neoplasms,Chemotherapy,Adjuvant,Female,Humans,Neoplasm Recurrence,Local,Neoplasms,Second Primary,Randomized Controlled Trials as Topic,Receptors,Estrogen,Progesterone,Selective Estrogen Receptor Modulators,Tamoxifen"
clme0975,olin0014,2,0.15000000000000002,Journal article|Journal article,Cancer Cell|Cancer Cell,19/06/2013|13/05/2013,Directed phenotype switching as an effective antimelanoma strategy.|Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Sáez-Ayala M,Montenegro MF,Sánchez-Del-Campo L,Fernández-Pérez MP,Chazarra S,Freter R,Middleton M,Piñero-Madrona A,Cabezas-Herrera J,Goding CR,Rodríguez-López JN|Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Apoptosis,Catechin,Cell Differentiation,Cell Line,Tumor,DNA Damage,E2F1 Transcription Factor,Humans,Melanoma,Methotrexate,Microphthalmia-Associated Transcription Factor,Phenotype,Thymine Nucleotides|Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
robbins,whgu0378,2,0.12028542303771661,Journal article|Journal article,Haematologica: the hematology journal|Nature Genetics,11/07/2014|18/05/2015,Erythrocytosis associated with a novel missense mutation in the BPGM gene.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Petousi N,Copley RR,Lappin TR,Haggan SE,Bento CM,Cario H,Percy MJ,Ratcliffe PJ,Robbins PA,McMullin MF|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","WGS Consortium,Humans,Polycythemia,Bisphosphoglycerate Mutase,Genotype,Mutation,Missense|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
raob0202,xxxx0009,1,0.25,Journal article,Acta Oncologica,19/08/2013,Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancer.,"Warren S,Partridge M,Fokas E,Eccles CL,Brunner TB","Humans,Image Processing,Computer-Assisted,Imaging,Three-Dimensional,Neoplasm Staging,Organs at Risk,Pancreatic Neoplasms,Prognosis,Radiobiology,Radiotherapy Dosage,Radiotherapy Planning,Radiotherapy,Conformal,Image-Guided,Intensity-Modulated,Retrospective Studies"
clab0018,clme0220,1,0.09090909090909091,Journal article,Clinical Cancer Research,01/06/2011,Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy.,"Koukourakis MI,Giatromanolaki A,Sivridis E,Gatter KC,Trarbach T,Folprecht G,Shi MM,Lebwohl D,Jalava T,Laurent D,Meinhardt G,Harris AL","Adult,Aged,80 and over,Angiogenesis Inhibitors,Colorectal Neoplasms,Female,Gene Expression Regulation,Neoplastic,Humans,Isoenzymes,Kaplan-Meier Estimate,L-Lactate Dehydrogenase,Lactate Dehydrogenases,Male,Middle Aged,Phthalazines,Prognosis,Pyridines,Treatment Outcome,Tumor Burden"
clme0237,clme0240,2,0.049174311926605506,Journal article|Journal article,Nature Genetics|Journal of Pathology,18/05/2015|01/01/2011,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
bioc0192,card0018,99,12.577349447937685,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Chapter|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Patent|Patent|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper,"Magnetic Resonance in Medicine|JACC: Cardiovascular Imaging|European Heart Journal|Heart|JACC: Cardiovascular Imaging|Magnetic Resonance in Medicine|Magnetic Resonance in Medicine|Heart|Journal of Hepatology|Journal of Cardiovascular Magnetic Resonance|Magnetic Resonance in Medicine|Journal of Thoracic Imaging|Journal of Cardiovascular Magnetic Resonance|NMR in Biomedicine|Heart|JACC: Cardiovascular Imaging||J Am Coll Cardiol|Journal of Cardiovascular Magnetic Resonance|Magnetic Resonance in Medicine|Circulation|Magnetic Resonance in Medicine|Journal of Cardiovascular Magnetic Resonance|Magnetic Resonance in Medicine|European Heart Journal|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Circulation. Heart failure|Journal of Cardiovascular Magnetic Resonance|Journal of the American College of Cardiology|Heart|Journal of Cardiovascular Magnetic Resonance|Heart|Heart|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Heart|Journal of Thoracic Imaging|Hepatology|Journal of Cardiovascular Magnetic Resonance|Circulation|Circulation|Circulation|JACC: Cardiovascular Imaging|JACC: Cardiovascular Imaging|JACC: Cardiovascular Imaging|NMR in Biomedicine|JACC: Cardiovascular Imaging|Journal of Magnetic Resonance Imaging|Circulation: Cardiovascular Imaging|Journal of Hepatology|Journal of Cardiovascular Magnetic Resonance|Circulation: Cardiovascular Imaging|Journal of the American College of Cardiology|JACC: Cardiovascular Imaging|JACC: Cardiovascular Imaging|Magnetic Resonance in Medicine|Journal of Hepatology|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|||Journal of Cardiovascular Magnetic Resonance|Arteriosclerosis, Thrombosis and Vascular Biology|Radiology|Magnetic Resonance in Medicine|Magnetic Resonance in Medicine|Circulation: Cardiovascular Imaging|Magnetic Resonance in Medicine|Journal of Cardiovascular Magnetic Resonance|Journal of the American College of Cardiology Cardiovascular Imaging|Circulation: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Circulation: Cardiovascular Imaging|Heart|Journal of Cardiovascular Magnetic Resonance|Magnetic Resonance in Medicine|Heart|Magnetic Resonance in Medicine|Journal of Cardiovascular Magnetic Resonance|Heart|Heart|Journal of Cardiovascular Magnetic Resonance|Circulation|Journal of Cardiovascular Magnetic Resonance|JACC: Cardiovascular Imaging|Journal of Cardiovascular Magnetic Resonance|Journal of Cardiovascular Magnetic Resonance|Journal of Hepatology|Circulation|Circulation",01/01/2014|12/03/2015|20/09/2015|01/05/2013|01/04/2013|01/10/2013|29/11/2012|01/06/2015|11/09/2013|29/04/2014|04/09/2013|01/05/2014|01/02/2012|01/01/2012|01/06/2014|01/06/2013|18/09/2015|11/03/2013|23/05/2014|16/06/2014|22/11/2011|15/07/2013|01/01/2015|01/01/2015|01/08/2011|01/02/2012|01/02/2012|01/02/2012||21/10/2011|29/05/2012|01/06/2011|29/04/2014|01/06/2011|01/05/2013|06/05/2014|03/02/2015|01/05/2013|26/02/2014|01/12/2014|20/01/2013|22/11/2011|22/11/2011|24/02/2012|01/12/2015|06/12/2015|01/01/2013|19/07/2011|01/01/2013|08/08/2014|29/03/2011|24/03/2015|08/01/2014|01/01/2011||01/10/2013|08/04/2015|30/06/2011|01/04/2012|06/05/2014|04/03/2014|||01/01/2016|01/01/2016|20/06/2016|18/04/2014|01/09/2013|05/04/2013|01/01/2015|14/10/2013|01/01/2012|15/10/2012|03/02/2015|01/02/2012|01/02/2012|04/03/2014|03/02/2015|03/02/2015|03/02/2015|01/02/2012|01/03/2013|01/05/2012|23/05/2014|01/01/2011|01/05/2012|28/04/2015|21/06/2012|24/01/2013|01/07/2013|03/02/2015|22/11/2011|03/02/2015|01/04/2012|03/02/2015|06/02/2012|01/01/2014|20/11/2012|22/11/2011,"Human cardiac <sup>31</sup>P magnetic resonance spectroscopy at 7 tesla|Evidence of a Direct Effect of Myocardial Steatosis on LV Hypertrophy and Diastolic Dysfunction in Adult and Adolescent Obesity.|Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus.|THE USEFULNESS OF EARLY CARDIOVASCULAR MAGNETIC RESONANCE IN PATIENTS PRESENTING WITH ACUTE CHEST PAIN, POSITIVE TROPONIN AND NON-OBSTRUCTIVE CORONARY ARTERIES|Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis|Inversion recovery at 7 T in the human myocardium: Measurement of T <inf>1</inf>, inversion efficiency and B<inf>1</inf><sup>+</sup>|Inversion recovery at 7 T in the human myocardium: measurement of T(1), inversion efficiency and B(1) (+).|RELATIONSHIP BETWEEN CORONARY MICROVASCULAR DYSFUNCTION, MYOCARDIAL OXYGENATION AND ABNORMAL MYOCARDIAL ENERGETICS AT REST AND STRESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS|Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.|Myocardial perfusion and oxygenation are impaired during stress in severe aortic stenosis and correlate with impaired energetics and subclinical left ventricular dysfunction.|Human cardiac 31P magnetic resonance spectroscopy at 7 Tesla.|Myocardial tissue characterization by magnetic resonance imaging: Novel applications of T1 and T2 mapping|The diagnostic performance of non-contrast T1-mapping in patients with acute myocarditis on cardiovascular magnetic resonance imaging.|7 Tesla (T) human cardiovascular magnetic resonance imaging using FLASH and SSFP to assess cardiac function: Validation against 1.5T and 3T|121 High Diagnostic Yield in Patients Presenting with Acute Chest Pain, Positive Troponins but non-obstructive Coronaries by Cardiovascular Magnetic Resonance imaging with Conventional and Novel T1 Mapping Techniques.|Diagnostic value of pre-contrast T1 mapping in acute and chronic myocardial infarction.|Magnetic resonance imaging|Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.|Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents|Aortic 4D flow: quantification of signal-to-noise ratio as a function of field strength and contrast enhancement for 1.5T, 3T, and 7T.|Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis|T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences.|Systolic ShMOLLI myocardial T1-mapping for improved robustness to partial-volume effects and applications in tachyarrhythmias.|Optimized saturation pulse train for human first-pass myocardial perfusion imaging at 7T|Myocardial oxygenation and perfusion in patients with syndrome X: insights from 3 tesla cardiovascular magnetic resonance|T1-mapping accurately detects acute myocardial edema: a comparison to T2-weighted cardiovascular magnetic resonance imaging.|Age and gender dependence of pre-contrast T1-relaxation times in normal human myocardium at 1.5T using ShMOLLI.|Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis.|No Evidence of Myocardial Oxygen Deprivation in Nonischemic Heart Failure.|Multimodal cardiovascular magnetic resonance quantifies regional variation in vascular structure and function in patients with coronary artery disease: relationships with coronary disease severity.|Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla.|DYNAMIC CHANGES OF OEDEMA AND LATE GADOLINIUM ENHANCEMENT AFTER ACUTE MYOCARDIAL INFARCTION AND THEIR RELATIONSHIP TO FUNCTIONAL RECOVERY AND SALVAGE INDEX|Myocardial perfusion and oxygenation are impaired during stress in severe aortic stenosis and correlate with impaired energetics and subclinical left ventricular dysfunction|3T MRI OF ACUTE ATHEROSCLEROTIC PLAQUE RUPTURE AND DOWNSTREAM EMBOLIC INJURY|SEVERITY OF AORTIC FLOWABNORMALITIES IN BICUSPID AORTIC VALVE DISEASE IS PREDICTED BY CUSP FUSION PATTERN|Intercentre reproducibility of cardiac apparent diffusion coefficient and fractional anisotropy in healthy volunteers|Saturation recovery allows T&lt;inf&gt;1&lt;/inf&gt; mapping in the human heart at 7T with a commercial MRI scanner|THE DETECTION OF ACUTE MYOCARDITIS USING CARDIOVASCULAR MRI: A CLINICAL STUDY COMPARING T1-MAPPING, T2-WEIGHTED AND LATE GADOLINIUM ENHANCEMENT IMAGING|Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping.|Multi-parametric MRI predicts clinical outcomes in unselected patients with liver disease - a non-invasive test that meets the AASLD criteria for clinical trials?|Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI.|T1-Mapping is Superior to T2-Weighted Cardiovascular Magnetic Resonance Imaging for the Detection of Acute Reversible Myocardial Injury|Non-Contrast T1-Mapping is a Novel Diagnostic Tool for Acute Myocarditis on Cardiovascular Magnetic Resonance Imaging|Effects of catecholamine stress on diastolic function and myocardial energetics in obesity.|Evidence of a Direct Effect of Myocardial Steatosis on LV Hypertrophy and Diastolic Dysfunction in Adult and Adolescent Obesity|Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents.|T Mapping for the Diagnosis of Acute Myocarditis Using CMR. Comparison to T-Weighted and Late Gadolinium Enhanced Imaging|7 Tesla (T) human cardiovascular magnetic resonance imaging using FLASH and SSFP to assess cardiac function: validation against 1.5 T and 3 T.|Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis|Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload.|Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index.|Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.|Non-invasive imaging of carotid arterial restenosis using 3T cardiovascular magnetic resonance.|Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index|Ectopic and visceral fat deposition in lean and obese type 2 diabetes patients|T<inf>1</inf> Mapping for the diagnosis of acute myocarditis using CMR: Comparison to T<inf>2</inf>-Weighted and late gadolinium enhanced imaging|Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.|Rapid quantification of myocardial lipid content in humans using single breath-hold 1H MRS at 3 Tesla.|WAIST CIRCUMFERENCE GREATER THAN 90CM IS A RISK FACTOR FOR HEPATIC STEATOSIS IN OTHERWISE HEALTHY ADULTS - A 3 TESLA MAGNETIC RESONANCE SPECTROSCOPY STUDY|Intercentre reproducibility of cardiac apparent diffusion coefficient and fractional anisotropy in healthy volunteers.|Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.|Methods for gated mapping of T1 values in abdominal visceral organs|Multi-parametric magnetic resonance diagnosis & staging of liver disease|UK Biobank's cardiovascular magnetic resonance protocol.|Investigating a Liver Fat: Arterial Stiffening Pathway in Adult and Childhood Obesity.|Dilated Cardiomyopathy: Phosphorus 31 MR Spectroscopy at 7 T.|Optimized saturation pulse train for human first-pass myocardial perfusion imaging at 7T.|T1 measurements in the human myocardium: The effects of magnetization transfer on the SASHA and MOLLI sequences|Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.|Aortic 4D flow: Quantification of signal-to-noise ratio as a function of field strength and contrast enhancement for 1.5T, 3T, and 7T|Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.|Acute 3T Magnetic Resonance Imaging Reveals Features of Carotid Atherosclerotic Plaque Associated with Ipsilateral Cerebral Infarction in Minor Stroke and Transient Ischemic Attack.|Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.|Myocardial T1 responds to adenosine - normal values of stress T1 reactivity at 1.5T and 3T|Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy.|Characterization of acute myocardial infarction by pre-contrast T1 mapping.|Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis - A clinical study using myocardial T1-mapping and extracellular volume quantification|Inversion time calculations have varying impact on short, intermediate and long MOLLI T1 values: Implications for studies using T1-mapping sequences|Myocardial skeletal muscle signal spoiling using a crusher coil: A human cardiac phosphorus (&lt;sup&gt;31&lt;/sup&gt;P) MR spectroscopic imaging study at 7 Tesla|7T versus 3T phosphorous magnetic resonance spectroscopy in patients with dilated cardiomyopathy|3D cardiac navigation with rapid multi shot EPI.|Response to letter regarding article, myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.|PRE-CONTRAST T1 MAPPING ALLOWS ASSESSMENT OF SEVERITY OF ACUTE ISCHAEMIC MYOCARDIAL INJURY|Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.|Rapid quantification of myocardial lipid content in humans using single breath-hold 1H MRS at 3 Tesla|T1-MAPPING HAS A HIGH DIAGNOSTIC PERFORMANCE IN PATIENTS PRESENTING WITH ACUTE MYOCARDITIS: A CARDIOVASCULAR MAGNETIC RESONANCE STUDY|Suppression of skeletal muscle signal using a crusher coil: A human cardiac (31) p-MR spectroscopy study at 7 tesla.|Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance.|Human non-contrast T1 values and correlation with histology in diffuse fibrosis.|Human non-contrast T1 values and correlation with histology in diffuse fibrosis|Effect of exercise on myocardial energy metabolism and relationship between coronary microvascular dysfunction and abnormal myocardial energetics in diabetic cardiomyopathy|In Both Hypertrophic And Dilated Cardiomyopathy, Non-contrast T1 Mapping Provides Myocardial Tissue Characterization Beyond That Achieved By Late Gadolinium Enhancement.|Adenosine stress native T1 mapping detects microvascular disease in diabetic cardiomyopathy, without the need for gadolinium-based contrast|Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study.|Systolic ShMOLLI T1-mapping is feasible in tachyarrhythmia, with improved image quality compared to diastolic readout|Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction.|Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease|Novel Techniques for the Diagnosis of Acute Myocarditis: A Clinical Cardiovascular Magnetic Resonance Study|CMR T1 Mapping at 3T Characterizes the Extent of Acute Ischemic Myocardial Injury: Comparison to Standard Techniques","Rodgers CT,Clarke WT,Snyder C,Vaughan JT,Neubauer S,Robson MD|Banerjee R,Rial B,Holloway CJ,Lewandowski AJ,Robson MD,Osuchukwu C,Schneider JE,Leeson P,Rider OJ,Neubauer S|Levelt E,Rodgers CT,Clarke WT,Mahmod M,Ariga R,Francis JM,Liu A,Wijesurendra RS,Dass S,Sabharwal N,Robson MD,Holloway CJ,Rider OJ,Clarke K,Karamitsos TD,Neubauer S|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Banning A,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Kardos A,Basagiannia C,Newton J,Friedrich M,Robson M,Neubauer S|Karamitsos TD,Piechnik SK,Banypersad SM,Fontana M,Ntusi NB,Ferreira VM,Whelan CJ,Myerson SG,Robson MD,Hawkins PN,Neubauer S,Moon JC|Rodgers CT,Piechnik SK,Delabarre LJ,Van De Moortele PF,Snyder CJ,Neubauer S,Robson MD,Vaughan JT|Rodgers CT,Piechnik SK,Delabarre LJ,Van de Moortele PF,Snyder CJ,Neubauer S,Robson MD,Vaughan JT|Levelt E,Holloway C,Rodgers C,Clarke W,Mahmod M,Ariga R,Francis J,Liu A,Robson M,Clarke K,Karamitsos T,Neubauer S|Banerjee R,Pavlides M,Tunnicliffe EM,Piechnik SK,Sarania N,Philips R,Collier JD,Booth JC,Schneider JE,Wang LM,Delaney DW,Fleming KA,Robson MD,Barnes E,Neubauer S|Mahmod M,Francis JM,Pal N,Lewis A,Dass S,De Silva R,Petrou M,Sayeed R,Westaby S,Robson MD,Ashrafian H,Neubauer S,Karamitsos TD|Rodgers CT,Clarke WT,Snyder C,Vaughan JT,Neubauer S,Robson MD|Ferreira VM,Piechnik SK,Robson MD,Neubauer S,Karamitsos TD|Ferreira V,Piechnik SK,Dall'armellina E,Karamitsos T,Francis JM,Choudhury RP,Kardos A,Friedrich MG,Robson MD,Neubauer S|Suttie JJ,Delabarre L,Pitcher A,van de Moortele PF,Dass S,Snyder CJ,Francis JM,Metzger GJ,Weale P,Ugurbil K,Neubauer S,Robson M,Vaughan T|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Banning A,Kardos A,Newton J,Friedrich M,Robson M,Neubauer S|Dall'Armellina E,Ferreira VM,Kharbanda RK,Prendergast B,Piechnik SK,Robson MD,Jones M,Francis JM,Choudhury RP,Neubauer S|Ferreira VM,Robson MD,Karamitsos TD,Bissell MM,Tyler DJ,Neubauer S|Karamitsos TD,Dass S,Suttie J,Sever E,Birks J,Holloway CJ,Robson MD,Jerosch-Herold M,Watkins H,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Hess AT,Bissell MM,Ntusi NA,Lewis AJ,Tunnicliffe EM,Greiser A,Stalder AF,Francis JM,Myerson SG,Neubauer S,Robson MD|Suttie JJ,Dass S,Bull S,Holloway C,Banerjee R,Cox P,Pitcher A,Franco BR,Francis J,Schneider J,Robson M,Watkins H,Myerson S,Neubauer S|Robson MD,Piechnik SK,Tunnicliffe EM,Neubauer S|Ferreira VM,Wijesurendra RS,Liu A,Greiser A,Casadei B,Robson MD,Neubauer S,Piechnik SK|Tao Y,Hess AT,Keith GA,Rodgers CT,Liu A,Francis JM,Neubauer S,Robson MD|Karamitsos TD,Arnold R,Pegg T,Francis J,Birks J,Howells R,Robson MD,Neubauer S,Jerosch-Herold M,Selvanayagam JB|Ferreira V,Piechnik SK,Dall'armellina E,Karamitsos T,Francis JM,Choudhury RP,Friedrich MG,Robson MD,Neubauer S|Piechnik SK,Ferreira V,Lewandowski AJ,Ntusi N,Sado D,Maestrini V,White SK,Lazdam M,Banerjee R,Hofman MB,Moon J,Neubauer S,Leeson P,Robson MD|Karamitsos T,Banypersad SM,Sado D,Maestrini V,Ferreira V,Piechnik SK,Robson MD,Hawkins PN,Neubauer S,Moon J|Dass S,Holloway CJ,Cochlin LE,Rider OJ,Mahmod M,Robson M,Sever E,Clarke K,Watkins H,Ashrafian H,Karamitsos TD,Neubauer S|Kylintireas I,Shirodaria C,Lee JM,Cunningon C,Lindsay A,Francis J,Robson MD,Neubauer S,Channon KM,Choudhury RP|Arnold JR,Karamitsos TD,Bhamra-Ariza P,Francis JM,Searle N,Robson MD,Howells RK,Choudhury RP,Rimoldi OE,Camici PG,Banning AP,Neubauer S,Jerosch-Herold M,Selvanayagam JB|Dall'Armellina E,Karia N,Lindsay A,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast B,Banning AP,Channon K,Kharbanda RJ,Neubauer S,Choudhury RP|Mahmod M,Francis JM,Pal N,Lewis A,Dass S,De Silva R,Petrou M,Sayeed R,Westaby S,Robson MD,Ashrafian H,Neubauer S,Karamitsos TD|Lindsay AC,Biasiolli L,Lee JM,Kylintireas I,Watt H,Kuker W,Handa A,Robson MD,Neubauer S,Kennedy J,Choudhury RP|Bissell MMB,Hess ATH,Glaze SJG,Pitcher AP,Robson MDR,BBarker AJ,Myerson SGM,Neubauer SN|Tunnicliffe EM,Scott AD,Ferreira P,Ariga R,McGill LA,Nielles-Vallespin S,Neubauer S,Pennell DJ,Robson MD,Firmin DN|Rodgers CT,Tao Y,Piechnik SK,Liu A,Francis JM,Neubauer S,Robson MD|Ferreira V,Piechnik S,Dall'Armellina E,Karamitsos T,Francis J,Ntusi N,Holloway C,Choudhury R,Kardos A,Robson M,Friedrich M,Neubauer S|Ferreira VM,Piechnik SK,Robson MD,Neubauer S,Karamitsos TD|Pavlides M,Banerjee R,Sellwood J,Kelly C,Robson MD,Booth J,Collier J,Neubauer S,Barnes E|Piechnik SK,Ferreira VM,Lewandowski AJ,Ntusi NA,Banerjee R,Holloway C,Hofman MB,Sado DM,Maestrini V,White SK,Lazdam M,Karamitsos T,Moon JC,Neubauer S,Leeson P,Robson MD|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Friedrich MG,Robson MD,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Kardos A,Friedrich MG,Robson MD,Neubauer S|Rider OJ,Francis JM,Ali MK,Holloway C,Pegg T,Robson MD,Tyler D,Byrne J,Clarke K,Neubauer S|Banerjee R,Rial B,Holloway CJ,Lewandowski AJ,Robson MD,Osuchukwu C,Schneider JE,Leeson P,Rider OJ,Neubauer S|Liu A,Wijesurendra RS,Francis JM,Robson MD,Neubauer S,Piechnik SK,Ferreira VM|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Robson MD,Neubauer S,Kardos A,Friedrich MG|Suttie JJ,Delabarre L,Pitcher A,van de Moortele PF,Dass S,Snyder CJ,Francis JM,Metzger GJ,Weale P,Ugurbil K,Neubauer S,Robson M,Vaughan T|Karamitsos TD,Piechnik SK,Banypersad SM,Fontana M,Ntusi NB,Ferreira VM,Whelan CJ,Myerson SG,Robson MD,Hawkins PN,Neubauer S,Moon JC|Sado DM,Maestrini V,Piechnik SK,Banypersad SM,White SK,Flett AS,Robson MD,Neubauer S,Ariti C,Arai A,Kellman P,Yamamura J,Schoennagel BP,Shah F,Davis B,Trompeter S,Walker M,Porter J,Moon JC|Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Pavlides M,Banerjee R,Sellwood J,Kelly CJ,Robson MD,Booth JC,Collier J,Neubauer S,Barnes E|Lindsay AC,Biasiolli L,Knight S,Cunnington C,Robson MD,Neubauer S,Kennedy J,Handa A,Choudhury RP|Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Levelt E,Pavlides M,Banerjee R,Mahmod M,Kelly C,Sellwood J,Ariga R,Thomas S,Francis J,Rodgers CT,Clarke W,Sabharwal N,Antoniades C,Schneider J,Robson M,Clarke K,Karamitsos T,Rider O,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Ntusi NA,Piechnik SK,Francis JM,Ferreira VM,Matthews PM,Robson MD,Wordsworth PB,Neubauer S,Karamitsos TD|Rial B,Robson MD,Neubauer S,Schneider JE|Banerjee R,Rial BF,Suttie J,Lewandowski A,Robson MD,Schneider J,Hodson L,Fielding B,Collier JD,Barnes E,Neubauer S|Tunnicliffe EM,Scott AD,Ferreira P,Ariga R,McGill LA,Nielles-Vallespin S,Neubauer S,Pennell DJ,Robson MD,Firmin DN|Ntusi NA,Piechnik SK,Francis JM,Ferreira VM,Rai AB,Matthews PM,Robson MD,Moon J,Wordsworth PB,Neubauer S,Karamitsos TD|Banerjee R,Piechnik SP,Robson MD,Tunnicliffe EJ,Neubauer S|Banerjee R,Piechnik S,Robson MD,Rial B,Tunnicliffe EJ,Neubauer S|Petersen SE,Matthews PM,Francis JM,Robson MD,Zemrak F,Boubertakh R,Young AA,Hudson S,Weale P,Garratt S,Collins R,Piechnik S,Neubauer S|Rider OJ,Banerjee R,Rayner JJ,Shah R,Murthy VL,Robson MD,Neubauer S|Stoll VM,Clarke WT,Levelt E,Liu A,Myerson SG,Robson MD,Neubauer S,Rodgers CT|Tao Y,Hess AT,Keith GA,Rodgers CT,Liu A,Francis JM,Neubauer S,Robson MD|Robson MD,Piechnik SK,Tunnicliffe EM,Neubauer S|Sado DM,White SK,Piechnik SK,Banypersad SM,Treibel T,Captur G,Fontana M,Maestrini V,Flett AS,Robson MD,Lachmann RH,Murphy E,Mehta A,Hughes D,Neubauer S,Elliott PM,Moon JC|Hess AT,Bissell MM,Ntusi NAB,Lewis AJM,Tunnicliffe EM,Greiser A,Stalder AF,Francis JM,Myerson SG,Neubauer S,Robson MD|Moon JC,Messroghli DR,Kellman P,Piechnik SK,Robson MD,Ugander M,Gatehouse PD,Arai AE,Friedrich MG,Neubauer S,Schulz-Menger J,Schelbert EB,Society for Cardiovascular Magnetic Resonance Imaging,Cardiovascular Magnetic Resonance Working Group of the European Society of Cardiology|Lindsay AC,Biasiolli L,Lee JMS,Kylintireas,MacIntosh,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury R|Dass S,Suttie JJ,Piechnik SK,Ferreira VM,Holloway CJ,Banerjee R,Mahmod M,Cochlin L,Karamitsos TD,Robson MD,Watkins H,Neubauer S|Liu A,Wijesurendra RS,Francis JM,Robson MD,Neubauer S,Piechnik SK,Ferreira VM|Dass S,Suttie J,Piechnik SK,Ferreira V,Holloway C,Robson MD,Watkins H,Karamitsos T,Neubauer S|Dall'armellina E,Piechnik SK,Ferreira V,Francis JM,Robson MD,Cuculi F,Kharbanda R,Banning AP,Choudhury RP,Karamitsos T,Neubauer S|Ntusi NA,Piechnik SK,Francis JM,Ferreira VM,Rai AB,Matthews PM,Robson MD,Moon J,Wordsworth PB,Neubauer S,Karamitsos TD|Piechnik SK,Ferreira VM,Greiser A,Spottiswoode BS,Robson MD,Neubauer S|Schaller B,Clarke WT,Neubauer S,Robson MD,Rodgers C|Stoll V,Clarke WT,Levelt E,Myerson SG,Robson MD,Neubauer S,Rodgers C|Hess AT,van der Kouwe AJ,Neubauer S,Robson MD|Dass S,Suttie JJ,Piechnik SK,Ferreira VM,Holloway CJ,Banerjee R,Mahmod M,Cochlin L,Karamitsos TD,Robson MD,Watkins H,Neubauer S|Dall'Armellina E,Piechnik S,Ferreira VM,Robson MD,Francis JM,Cuculi F,Kharbanda RK,Banning AP,Choudhury RP,Karamitsos TD,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Rial B,Robson MD,Neubauer S,Schneider JE|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Kardos A,Friedrich MG,Robson MD,Neubauer S|Schaller B,Clarke WT,Neubauer S,Robson MD,Rodgers CT|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Choudhury RP,Friedrich MG,Robson MD,Neubauer S|Bull S,White SK,Piechnik SK,Flett AS,Ferreira VM,Loudon M,Francis JM,Karamitsos TD,Prendergast BD,Robson MD,Neubauer S,Moon JC,Myerson SG|Bull S,White SK,Piechnik SK,Flett AS,Ferreira VM,Loudon M,Francis JM,Karamitsos TD,Prendergast BD,Robson MD,Neubauer S,Moon JC,Myerson SG|Levelt E,Rodgers C,Clarke WT,Mahmod M,Ariga R,Francis JM,Liu A,Holloway C,Robson MD,Clarke K,Karamitsos TD,Neubauer S|Dass S,Suttie JJ,Piechnik SK,Ferreira VM,Holloway C,Karamitsos TD,Robson MD,Watkins H,Neubauer S|Levelt E,Piechnik SK,Mahmod M,Ferreira VM,Ariga R,Francis JM,Liu A,Sellwood J,Wijesurendra RS,Robson MD,Clarke K,Neubauer S,Karamitsos TD|Lindsay AC,Biasiolli L,Lee JM,Kylintireas I,MacIntosh BJ,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury RP|Wijesurendra RS,Liu A,Casadei B,Robson MD,Neubauer S,Ferreira VM,Piechnik SK|Dall'Armellina E,Piechnik SK,Ferreira VM,Si QL,Robson MD,Francis JM,Cuculi F,Kharbanda RK,Banning AP,Choudhury RP,Karamitsos TD,Neubauer S|Banerjee R,Pavlides M,Tunnicliffe EM,Piechnik SK,Sarania N,Philips R,Collier JD,Booth JC,Schneider JE,Wang LM,Delaney DW,Fleming KA,Robson MD,Barnes E,Neubauer S|Ferreira VM,Piechnik SK,Dall'Armellina E,Karamitsos TD,Francis JM,Ntusi N,Holloway C,Choudhury RP,Kardos A,Robson MD,Friedrich MG,Neubauer S|Dall'Armellina E,Piechnik S,Ferreira V,Karamitsos TD,Francis JM,Cuculi F,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Robson MD,Choudhury RP,Neubauer S","||||||7 T,ShMOLLI,adiabatic pulses,cardiac longitudinal relaxation time T1,inversion recovery,saturation correction,Algorithms,Female,Heart Ventricles,Humans,Image Interpretation,Computer-Assisted,Magnetic Resonance Imaging,Male,Reference Values,Reproducibility of Results,Sensitivity and Specificity,Ventricular Function,Left||(1)H MRS,ANOVA,AUROC,Analysis of Variance,Area Under the Receiver Operating Characteristic Curve,BMI,Body Mass Index,CPA,CoV,Coefficient of Variance,Collagen Proportionate Area,HLC,Hepatic Lipid Content,Iron corrected T1,Liver fibrosis,Liver haemosiderosis,Liver steatosis,MR,Magnetic Resonance,Magnetic resonance T1 mapping,Magnetic resonance T2(⁎) mapping,NAFLD,Non-Alcoholic Fatty Liver Disease,Proton Magnetic Resonance Spectroscopy,Proton magnetic resonance spectroscopy,ROI,Region of interest,shMOLLI,shortened Modified Look Locker Inversion,Adolescent,Adult,Aged,Biopsy,Fatty Liver,Female,Humans,Iron,Liver,Liver Cirrhosis,Liver Diseases,Magnetic Resonance Imaging,Magnetic Resonance Spectroscopy,Male,Middle Aged,Prospective Studies|Myocardium,Humans,Hypertrophy,Left Ventricular,Aortic Valve Stenosis,Ventricular Dysfunction,Left,Phosphocreatine,Adenosine,Adenosine Triphosphate,Vasodilator Agents,Biological Markers,Magnetic Resonance Imaging,Cine,Magnetic Resonance Spectroscopy,Severity of Illness Index,Case-Control Studies,Predictive Value of Tests,Energy Metabolism,Oxygen Consumption,Coronary Circulation,Ventricular Function,Aged,Middle Aged,Female,Male,Myocardial Perfusion Imaging|31P magnetic resonance spectroscopy,7 Tesla,T1,cardiac,field strength,phosphorus,Adult,Algorithms,Humans,Magnetic Resonance Imaging,Magnetic Resonance Spectroscopy,Male,Molecular Imaging,Myocardium,Phosphorus Compounds,Phosphorus Isotopes,Radiopharmaceuticals,Reference Values,Reproducibility of Results,Sensitivity and Specificity,Tissue Engineering,Young Adult|||||Adult,Aged,Coronary Artery Disease,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Myocardial Infarction,Myocardium,Percutaneous Coronary Intervention,Predictive Value of Tests,Time Factors,Treatment Outcome||||Aorta,Humans,Meglumine,Organometallic Compounds,Contrast Media,Imaging,Three-Dimensional,Magnetic Resonance Angiography,Image Enhancement,Aortography,Blood Flow Velocity,Feasibility Studies,Reference Values,Image Processing,Computer-Assisted,Adult,Middle Aged,Male,Young Adult,Signal-To-Noise Ratio|Cardiovascular imaging,Lipids,Magnetic resonance imaging,Magnetic resonance spectroscopy,Aortic stenosis|T1 mapping,cardiac MRI,magnetization transfer,tissue characterization,Heart,Humans,Magnetic Resonance Imaging,Models,Theoretical,Muscle,Skeletal|Myocardium,Heart Conduction System,Humans,Heart Diseases,Atrial Fibrillation,Tachycardia,Sinus,Image Interpretation,Computer-Assisted,Magnetic Resonance Imaging,Feasibility Studies,Reproducibility of Results,Predictive Value of Tests,Sex Factors,Heart Rate,Systole,Time Factors,Adult,Female,Male||||||Humans,Cardiomyopathy,Dilated,Magnetic Resonance Imaging,Exercise Test,Oxygen Inhalation Therapy,Magnetic Resonance Spectroscopy,Case-Control Studies,Oxygen Consumption,Coronary Circulation,Middle Aged,Female,Male,Heart Failure|Aged,Analysis of Variance,Aorta,Aortic Diseases,Atherosclerosis,Brachial Artery,Carotid Arteries,Carotid Artery Diseases,Chi-Square Distribution,Compliance,Coronary Angiography,Coronary Artery Disease,England,Female,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Multivariate Analysis,Predictive Value of Tests,Severity of Illness Index,Vasodilation|Coronary Angiography,Coronary Artery Disease,Coronary Circulation,Electrocardiography,Equipment Design,Female,Follow-Up Studies,Humans,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardium,Oximetry,Oxygen,Oxygen Consumption,Prognosis,Regional Blood Flow,Reproducibility of Results,Severity of Illness Index||||||||Contrast Media,Coronary Circulation,Diagnosis,Differential,Heart Diseases,Humans,Image Interpretation,Computer-Assisted,Magnetic Resonance Imaging,Myocardial Contraction,Myocardium,Predictive Value of Tests,Prognosis||Adolescent,Adult,Age Factors,Aged,Artifacts,Body Size,Child,England,Female,Heart Rate,Hematocrit,Humans,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardial Contraction,Netherlands,Observer Variation,Predictive Value of Tests,Reference Values,Reproducibility of Results,Sex Factors,Time Factors,Ventricular Function,Left,Right,Young Adult|Cardiac MRI,Cardiac mapping,Myocardium,Acute coronary syndromes,Troponin|Cardiac MRI,Cardiac mapping,Myocarditis,Cardiovascular imaging,Magnetic resonance|Adult,Body Mass Index,Catecholamines,Diastole,Energy Metabolism,Exercise Test,Female,Humans,Male,Middle Aged,Myocardium,Obesity,Stress,Physiological,Ventricular Function,Left||||Adult,Cardiac Volume,Cardiovascular Physiological Phenomena,Electrocardiography,Electrodes,Female,Heart,Heart Function Tests,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Observer Variation,Organ Size,Reference Standards,Reproducibility of Results,Young Adult||Myocardium,Humans,Iron Overload,Image Interpretation,Computer-Assisted,Magnetic Resonance Imaging,Prospective Studies,Reproducibility of Results,Adolescent,Adult,Aged,80 and over,Middle Aged,Female,Male|Angioplasty,Balloon,Coronary,Contrast Media,Edema,Cardiac,Female,Gadolinium,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Myocardial Infarction,Myocardium,Recovery of Function,Ventricular Function||Aged,Carotid Artery,Common,Carotid Stenosis,Contrast Media,Endarterectomy,Carotid,Female,Fibrosis,Humans,Lipids,Magnetic Resonance Imaging,Male,Observer Variation,Plaque,Atherosclerotic,Predictive Value of Tests,Recurrence,Reproducibility of Results,Severity of Illness Index,Time Factors,Treatment Outcome||||Myocardium,Humans,Arthritis,Rheumatoid,Cardiomyopathies,Myocarditis,Edema,Cardiac,Fibrosis,Meglumine,Organometallic Compounds,Contrast Media,Magnetic Resonance Imaging,Cine,Stroke Volume,Prospective Studies,Predictive Value of Tests,Myocardial Contraction,Ventricular Function,Left,Right,Adult,Middle Aged,England,Female,Male,Biomechanical Phenomena|Adult,Algorithms,Biomarkers,Cardiac-Gated Imaging Techniques,Female,Humans,Lipids,Magnetic Resonance Spectroscopy,Male,Middle Aged,Myocardium,Reproducibility of Results,Signal Processing,Computer-Assisted||Heart,Humans,Image Interpretation,Computer-Assisted,Observer Variation,Diffusion Magnetic Resonance Imaging,Feasibility Studies,Reproducibility of Results,Predictive Value of Tests,Phantoms,Imaging,Anisotropy,Adult,Middle Aged,England,Female,Male,Young Adult,Healthy Volunteers|Myocardium,Humans,Cardiomyopathies,Myocarditis,Edema,Cardiac,Scleroderma,Diffuse,Fibrosis,Contrast Media,Magnetic Resonance Imaging,Cine,Severity of Illness Index,Case-Control Studies,Prospective Studies,Predictive Value of Tests,Diastole,Ventricular Function,Left,Right,Aged,Middle Aged,England,Female,Male||||Liver,Humans,Cardiovascular Diseases,Triglycerides,Magnetic Resonance Imaging,Body Mass Index,Multivariate Analysis,Linear Models,Risk Factors,Cross-Sectional Studies,Predictive Value of Tests,Age Factors,Adolescent,Adult,Middle Aged,Child,Male,Young Adult,Vascular Stiffness,Pulse Wave Analysis,Pediatric Obesity,Non-alcoholic Fatty Liver Disease,Proton Magnetic Resonance Spectroscopy,Biomarkers||Humans,Magnetic Resonance Angiography,Image Enhancement,Sensitivity and Specificity,Reproducibility of Results,Algorithms,Signal Processing,Computer-Assisted,Pattern Recognition,Automated,Male,Myocardial Perfusion Imaging||MRI,T1 mapping,lipids,Adult,Aged,80 and over,Analysis of Variance,Case-Control Studies,Contrast Media,Diagnosis,Differential,Fabry Disease,Female,Humans,Hypertrophy,Left Ventricular,Magnetic Resonance Imaging,Male,Meglumine,Middle Aged,Myocardium,Organometallic Compounds,Predictive Value of Tests,Prospective Studies,Risk Factors,Young Adult||Consensus,Fibrosis,Heart Diseases,Humans,Magnetic Resonance Imaging,Myocardium,Predictive Value of Tests||Cardiomyopathy,Dilated,Hypertrophic,Contrast Media,Female,Gadolinium DTPA,Humans,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardium,Severity of Illness Index|||||||||Cardiomyopathy,Dilated,Hypertrophic,Female,Gadolinium DTPA,Humans,Magnetic Resonance Imaging,Cine,Male,Myocardium||Myocardium,Humans,Myocarditis,Edema,Cardiac,Acute Disease,Contrast Media,Magnetic Resonance Imaging,Stroke Volume,Case-Control Studies,Prospective Studies,Predictive Value of Tests,Ventricular Function,Left,Adult,Middle Aged,England,Female,Male||||Acute Disease,Adult,Aged,Contrast Media,Diagnosis,Differential,Edema,Cardiac,Female,Follow-Up Studies,Humans,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardial Contraction,Myocardium,Reproducibility of Results,Takotsubo Cardiomyopathy|Aged,80 and over,Aortic Valve,Aortic Valve Stenosis,Asymptomatic Diseases,Biomarkers,Biopsy,Case-Control Studies,Chi-Square Distribution,Collagen,England,Female,Fibrosis,Heart Ventricles,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Multivariate Analysis,Myocardium,Predictive Value of Tests,Prospective Studies,Severity of Illness Index|||Cardiomyopathy,Cardiac MRI,Heart failure,Cardiac hypertrophy,Fibrosis||Aged,Brain,Carotid Arteries,Case-Control Studies,Cerebral Infarction,Diagnosis,Differential,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Magnetic Resonance Imaging,Male,Plaque,Atherosclerotic,Prospective Studies,Risk Factors||Analysis of Variance,Angioplasty,Balloon,Coronary,Chi-Square Distribution,Contrast Media,Edema,Cardiac,England,Female,Gadolinium DTPA,Humans,Logistic Models,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardial Infarction,Myocardium,Predictive Value of Tests,Prospective Studies,ROC Curve,Recovery of Function,Severity of Illness Index,Time Factors,Treatment Outcome||Cardiac MRI,Myocarditis,Cardiac mapping,Cardiac imaging,Magnetic resonance imaging|Myocardial infarction,STEMI,NSTEMI,Cardiac MRI"
immd0180,raob0121,1,0.058823529411764705,Journal article,Cancer Cell,,Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.,"Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Orlando G,Mavrommati I,Pai CC,Zalmas LP,Drobnitzky N,Dianov GL,Verrill C,Macaulay VM,Ying S,La Thangue NB,D'Angiolella V,Ryan AJ,Humphrey TC","Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Neoplasms,Pyrazoles,Pyrimidines,Ribonucleoside Diphosphate Reductase,Histone-Lysine N-Methyltransferase,Nucleotides,Lysine,Cell Cycle Proteins,Nuclear Proteins,Histones,Blotting,Western,Xenograft Model Antitumor Assays,Reverse Transcriptase Polymerase Chain Reaction,Cell Survival,Gene Expression Regulation,Neoplastic,RNA Interference,Amino Acid Sequence,Base Sequence,Sequence Homology,Amino Acid,Nucleic Acid,Methylation,Molecular Sequence Data,Protein-Tyrosine Kinases"
card0027,immd0237,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0993,whgu0378,2,0.11805555555555555,Journal article|Journal article,Nature Reviews: Cancer|Cell,24/03/2016|10/10/2013,The importance of p53 pathway genetics in inherited and somatic cancer genomes.|A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection.,"Stracquadanio G,Wang X,Wallace MD,Grawenda AM,Zhang P,Hewitt J,Zeron-Medina J,Castro-Giner F,Tomlinson IP,Goding CR,Cygan KJ,Fairbrother WG,Thomas LF,Sætrom P,Gemignani F,Landi S,Schuster-Böckler B,Bell DA,Bond GL|Zeron-Medina J,Wang X,Repapi E,Campbell MR,Su D,Castro-Giner F,Davies B,Peterse EF,Sacilotto N,Walker GJ,Terzian T,Tomlinson IP,Box NF,Meinshausen N,De Val S,Bell DA,Bond GL","|Animals,Cell Proliferation,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Male,Mice,Polymorphism,Single Nucleotide,Response Elements,Selection,Genetic,Stem Cell Factor,Testicular Neoplasms,Transcription,Tumor Suppressor Protein p53"
immd0237,raob0047,1,0.045454545454545456,Journal article,Cell Reports,01/05/2013,A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.,"Adam J,Yang M,Bauerschmidt C,Kitagawa M,O'Flaherty L,Maheswaran P,Özkan G,Sahgal N,Baban D,Kato K,Saito K,Iino K,Igarashi K,Stratford M,Pugh C,Tennant DA,Ludwig C,Davies B,Ratcliffe PJ,El-Bahrawy M,Ashrafian H,Soga T,Pollard PJ","Animals,Arginine,Argininosuccinic Acid,Cell Line,Citric Acid Cycle,Fumarate Hydratase,Fumarates,Kidney,Kidney Neoplasms,Metabolome,Mice,Knockout,Transgenic,Mitochondria,Mutation,Protein Isoforms,Urea"
immd0237,immd0330,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
phpc0084,stat0059,1,0.1111111111111111,Journal article,Journal of Infection,01/05/2014,Dynamics of acquisition and loss of carriage of Staphylococcus aureus strains in the community: the effect of clonal complex.,"Miller RR,Walker AS,Godwin H,Fung R,Votintseva A,Bowden R,Mant D,Peto TE,Crook DW,Knox K","Carriage duration,Colonisation,Molecular epidemiology,Staphylococcus aureus,spa-typing,Adolescent,Adult,Aged,80 and over,Carrier State,Genotype,Great Britain,Humans,Male,Middle Aged,Molecular Epidemiology,Molecular Typing,Nasal Mucosa,Staphylococcal Infections,Staphylococcal Protein A,Young Adult"
clme0975,stat0004,1,0.006896551724137931,Journal article,Nature Genetics,09/09/2012,Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.,"Su Z,Gay LJ,Strange A,Palles C,Band G,Whiteman DC,Lescai F,Langford C,Nanji M,Edkins S,van der Winkel A,Levine D,Sasieni P,Bellenguez C,Howarth K,Freeman C,Trudgill N,Tucker AT,Pirinen M,Peppelenbosch MP,van der Laan LJ,Kuipers EJ,Drenth JP,Peters WH,Reynolds JV,Kelleher DP,McManus R,Grabsch H,Prenen H,Bisschops R,Krishnadath K,Siersema PD,van Baal JW,Middleton M,Petty R,Gillies R,Burch N,Bhandari P,Paterson S,Edwards C,Penman I,Vaidya K,Ang Y,Murray I,Patel P,Ye W,Mullins P,Wu AH,Bird NC,Dallal H,Shaheen NJ,Murray LJ,Koss K,Bernstein L,Romero Y,Hardie LJ,Zhang R,Winter H,Corley DA,Panter S,Risch HA,Reid BJ,Sargeant I,Gammon MD,Smart H,Dhar A,McMurtry H,Ali H,Liu G,Casson AG,Chow WH,Rutter M,Tawil A,Morris D,Nwokolo C,Isaacs P,Rodgers C,Ragunath K,MacDonald C,Haigh C,Monk D,Davies G,Wajed S,Johnston D,Gibbons M,Cullen S,Church N,Langley R,Griffin M,Alderson D,Deloukas P,Hunt SE,Gray E,Dronov S,Potter SC,Tashakkori-Ghanbaria A,Anderson M,Brooks C,Blackwell JM,Bramon E,Brown MA,Casas JP,Corvin A,Duncanson A,Markus HS,Mathew CG,Palmer CN,Plomin R,Rautanen A,Sawcer SJ,Trembath RC,Viswanathan AC,Wood N,Trynka G,Wijmenga C,Cazier JB,Atherfold P,Nicholson AM,Gellatly NL,Glancy D,Cooper SC,Cunningham D,Lind T,Hapeshi J,Ferry D,Rathbone B,Brown J,Love S,Attwood S,MacGregor S,Watson P,Sanders S,Ek W,Harrison RF,Moayyedi P,de Caestecker J,Barr H,Stupka E,Vaughan TL,Peltonen L,Spencer CC,Tomlinson I,Donnelly P,Jankowski JA,Esophageal Adenocarcinoma Genetics Consortium,Wellcome Trust Case Control Consortium 2","Adult,Aged,Barrett Esophagus,Case-Control Studies,Chromosomes,Human,Pair 16,Female,Gene Frequency,Genetic Loci,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Linkage Disequilibrium,Major Histocompatibility Complex,Male,Middle Aged,Models,Genetic,Polymorphism,Single Nucleotide"
immd0151,quee1607,1,0.07142857142857142,Journal article,Leukemia,01/01/2012,Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.,"Knight SJ,Yau C,Clifford R,Timbs AT,Sadighi Akha E,Dréau HM,Burns A,Ciria C,Oscier DG,Pettitt AR,Dutton S,Holmes CC,Taylor J,Cazier JB,Schuh A","Adult,Aged,80 and over,Biomarkers,Tumor,Chromosome Aberrations,Clone Cells,Female,Gene Dosage,Genome,Human,Genomics,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Loss of Heterozygosity,Male,Middle Aged,Neoplasm Recurrence,Local,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Prognosis"
phpc0228,phpc0367,7,2.5864468864468866,Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article,Health Technology Assessment|Gut|Journal of Hospital Infection|Pharmacogenomics|PharmacoEconomics|Journal of Crohn's and Colitis|The Patient: Patient Centered Outcomes Research,01/08/2014|01/06/2015|15/05/2014|01/11/2013|14/02/2015|01/09/2011|,Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study.|MANAGEMENT OF LOW-GRADE DYSPLASIA IN ULCERATIVE COLITIS IN THE UK NATIONAL HEALTH SERVICE: THE COST-EFFECTIVENESS OF IMMEDIATE SURGERY VERSUS ONGOING SURVEILLANCE|Management of patients with suspected infectious diarrhoea in hospitals in England.|Issues surrounding the health economic evaluation of genomic technologies.|Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies?|Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.|Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment.,"Pankhurst L,Macfarlane-Smith L,Buchanan J,Anson L,Davies K,O'Connor L,Ashwin H,Pike G,Dingle KE,Peto TE,Wordsworth S,Walker AS,Wilcox MH,Crook DW|Parker B,Buchanan J,Wordsworth S,East J,Keshav S,George B|Buchanan J,Wordsworth S,O'Connor L,Pike G,Walker AS,Wilcox MH,Crook DW|Buchanan J,Wordsworth S,Schuh A|Buchanan J,Wordsworth S|Buchanan J,Wordsworth S,Ahmad T,Perrin A,Vermeire S,Sans M,Taylor J,Jewell D|Buchanan J,Wordsworth S,Schuh A","Feces,Humans,Clostridium difficile,Campylobacter,Salmonella,Norovirus,Cross Infection,Diarrhea,Immunoenzyme Techniques,Microbiological Techniques,Sensitivity and Specificity,Retrospective Studies,Polymerase Chain Reaction,Infection Control,Time Factors,Hospitals,University,State Medicine,England,Workflow||Feces,Humans,Clostridium difficile,Clostridium Infections,Cross Infection,Diarrhea,Disease Outbreaks,Infection Control,Hospitals,University,England,General Practice,Surveys and Questionnaires|Cost-Benefit Analysis,Genomics,Humans,Technology||Adult,Europe,Great Britain,Health Care Costs,Humans,Inflammatory Bowel Diseases,Models,Economic|"
bioc0756,molb0002,1,0.125,Journal article,Journal of the American Chemical Society,21/08/2014,SpyAvidin hubs enable precise and ultrastable orthogonal nanoassembly.,"Fairhead M,Veggiani G,Lever M,Yan J,Mesner D,Robinson CV,Dushek O,van der Merwe PA,Howarth M","Jurkat Cells,Humans,Biotin,Peptides,Streptavidin,Binding Sites,Models,Molecular,Protein Multimerization,Protein Stability"
raob0069,raob0087,8,1.2877344877344876,Journal article|Journal article|Journal article|Conference paper|Conference paper|Conference paper|Journal article|Journal article,Journal of Nuclear Medicine|Nuclear Medicine and Biology|Dermatology and Therapy|European Journal of Nuclear Medicine and Molecular Imaging|EJNMMI Research|EJNMMI Research|Journal of Nuclear Medicine|Nuclear Medicine and Biology,01/12/2014|17/07/2012|01/01/2012|01/10/2011|20/02/2012|01/01/2012|15/04/2011|01/01/2012,Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.|Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.|111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin|Auger electron therapy using In-111-labelled F3 peptide|111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.|111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin|ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.|Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical,"Cornelissen B,Able S,Kartsonaki C,Kersemans V,Allen PD,Cavallo F,Cazier JB,Iezzi M,Knight J,Muschel R,Smart S,Vallis KA|Cornelissen B,Darbar S,Kersemans V,Allen D,Falzone N,Barbeau J,Smart S,Vallis KA|Cornelissen B,Waller A,Target C,Kersemans V,Smart S,Vallis KA|Cornelissen B,Waller A,Target C,Kersemans V,Smart S,Vallis KA|Cornelissen B,Waller A,Target C,Kersemans V,Smart S,Vallis KA|Cornelissen B,Waller A,Target C,Kersemans V,Smart S,Vallis KA|Cornelissen B,Darbar S,Hernandez R,Kersemans V,Tullis I,Barber PR,Smart S,Vojnovic B,Reilly R,Vallis KA|Cornelissen B,Darbar S,Kersemans V,Allen D,Falzone N,Barbeau J,Smart S,Vallis KA","Animals,Mice,Inbred BALB C,Mammary Neoplasms,Experimental,Precancerous Conditions,DNA Damage,Disease Progression,Immunoconjugates,Radiopharmaceuticals,Tomography,Emission-Computed,Single-Photon,Magnetic Resonance Imaging,Tissue Distribution,Image Processing,Computer-Assisted,Female|Animals,Bleomycin,Breast Neoplasms,Cell Line,Tumor,Cell Transformation,Neoplastic,DNA Breaks,Double-Stranded,DNA Damage,Dose-Response Relationship,Radiation,Female,Histones,Humans,Immunoconjugates,Indium Radioisotopes,Mice,Molecular Targeted Therapy,Pentetic Acid,Peptide Fragments,Radiometry,Radiopharmaceuticals,tat Gene Products,Human Immunodeficiency Virus|||||Active Transport,Cell Nucleus,Animals,Antibodies,Monoclonal,Humanized,Cell Line,Tumor,Cell Proliferation,Colony-Forming Units Assay,Dimethylallyltranstransferase,Electrons,Epidermal Growth Factor,Female,Humans,Imidazoles,Mice,Pentetic Acid,Protein Kinase Inhibitors,Protein Transport,Receptor,ErbB-2,Signal Transduction,Trastuzumab|"
immd0198,stat0054,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
bioc0416,univ1923,1,0.1,Conference paper,Neuropathology and Applied Neurobiology,01/03/2013,Magnetic resonance spectroscopy for 2-hydroxyglutarate identifies IDH mutant gliomas,"Larkin SJ,Near J,Kudari M,Khrapitchev A,Sibson N,Jezzard P,Pfeffer I,Al-Qahtani K,Schofield C,McCullagh J,Ansorge O",
immd0679,immd0680,1,0.08333333333333333,Journal article,Nature Communications,01/01/2014,Understanding functional miRNA-target interactions in vivo by site-specific genome engineering.,"Bassett AR,Azzam G,Wheatley L,Tibbit C,Rajakumar T,McGowan S,Stanger N,Ewels PA,Taylor S,Ponting CP,Liu JL,Sauka-Spengler T,Fulga TA","Animals,Zebrafish,Humans,Drosophila,Deoxyribonucleases,Endonucleases,DNA-Binding Proteins,MicroRNAs,Transfection,Genetic Engineering,Sequence Analysis,Base Sequence,Response Elements,Molecular Sequence Data,Transcriptional Activation,HEK293 Cells,Clustered Regularly Interspaced Short Palindromic Repeats"
clme0845,gree1499,6,0.9384920634920634,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Growth Hormone and IGF Research|Gut|British Journal of Cancer|Growth Hormone and IGF Research|Circulation|Annals of Oncology,01/01/2015|02/01/2014|27/03/2014|15/01/2015|12/03/2013|11/07/2014,"The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women|Source of dietary fibre and diverticular disease incidence: a prospective study of UK women.|Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom.|The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women.|Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study.|Birth weight and adult cancer incidence: large prospective study and meta-analysis.","Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Crowe FL,Balkwill A,Cairns BJ,Appleby PN,Green J,Reeves GK,Key TJ,Beral V,Million Women Study Collaborators,Million Women Study Collaborators|Bradbury KE,Balkwill A,Spencer EA,Roddam AW,Reeves GK,Green J,Key TJ,Beral V,Pirie K|Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Sweetland S,Parkin L,Balkwill A,Green J,Reeves G,Beral V,Million Women Study Collaborators|Yang TO,Reeves GK,Green J,Beral V,Cairns BJ","|diet,dietary fibre,diverticular disease,prospective,Aged,Diet Surveys,Dietary Fiber,Diverticulitis,Diverticulum,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Intestinal Diseases,Middle Aged,Prospective Studies,Risk,Surveys and Questionnaires|Million Women Study Collaborators,Humans,Neoplasms,Lymphoma,Non-Hodgkin,Sarcoma,Breast Neoplasms,Incidence,Prospective Studies,Middle Aged,Great Britain,Female,Self Report,Food,Organic|Million Women Study Collaborators,Humans,Birth Weight,Insulin-Like Growth Factor I,Body Weights and Measures,Postnatal Care,Diet,Risk Factors,Cohort Studies,Life Style,Breast Feeding,Postmenopause,Aged,Middle Aged,Great Britain,Female,Surveys and Questionnaires|Cohort Studies,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Middle Aged,Postoperative Complications,Prospective Studies,Retrospective Studies,Risk Factors,Smoking,Venous Thromboembolism|Million Women Study Collaborators,Humans,Neoplasms,Birth Weight,Body Height,Risk Factors,Prospective Studies,Middle Aged,Female"
chem0068,raob0058,1,0.09090909090909091,Journal article,PLoS One,01/01/2011,"Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.","Kersemans V,Cornelissen B,Hueting R,Tredwell M,Hussien K,Allen PD,Falzone N,Hill SA,Dilworth JR,Gouverneur V,Muschel RJ,Smart SC","Adenocarcinoma,Anesthesia,Animals,Anoxia,Copper Radioisotopes,Female,Fluorine Radioisotopes,Gases,Mice,Inbred CBA,Misonidazole,Muscles,Neoplasms,Experimental,Organometallic Compounds,Organotechnetium Compounds,Oxygen,Positron-Emission Tomography,Radiation-Sensitizing Agents,Radiopharmaceuticals,Thiosemicarbazones,Tissue Distribution,Tomography,Emission-Computed,Single-Photon"
immd0330,stat0004,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
path0473,whgu0172,2,0.23376623376623376,Journal article|Journal article,Proteomics|Nature Methods,04/05/2011|01/04/2013,Comparative evaluation of label-free SINQ normalized spectral index quantitation in the central proteomics facilities pipeline.|QuaNCAT: quantitating proteome dynamics in primary cells.,"Trudgian DC,Ridlova G,Fischer R,Mackeen MM,Ternette N,Acuto O,Kessler BM,Thomas B|Howden AJM,Geoghegan V,Katsch K,Efstathiou G,Bhushan B,Boutureira O,Thomas B,Trudgian DC,Kessler BM,Dieterich DC,Davis BG,Acuto O","Chromatography,Liquid,Humans,Proteins,Proteome,Proteomics,Tandem Mass Spectrometry|"
corp0784,lina0435,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme1037,orms0061,1,0.1,Journal article,Nature Reviews Drug Discovery,01/03/2015,Preclinical target validation using patient-derived cells.,"Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
immd0198,immd0237,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
raob0047,raob0097,1,0.16666666666666666,Journal article,Organic chemistry frontiers : an international journal of organic chemistry / Royal Society of Chemistry,01/01/2015,Efficient synthesis of 2-nitroimidazole derivatives and the bioreductive clinical candidate Evofosfamide (TH-302),"O'Connor LJ,Cazares-Koerner C,Saha J,Evans CNG,Stratford MRL,Hammond EM,Conway SJ",
olin0014,whgu0378,1,0.05555555555555555,Journal article,Nature Reviews: Cancer,24/03/2016,The importance of p53 pathway genetics in inherited and somatic cancer genomes.,"Stracquadanio G,Wang X,Wallace MD,Grawenda AM,Zhang P,Hewitt J,Zeron-Medina J,Castro-Giner F,Tomlinson IP,Goding CR,Cygan KJ,Fairbrother WG,Thomas LF,Sætrom P,Gemignani F,Landi S,Schuster-Böckler B,Bell DA,Bond GL",
clme0670,raob0182,1,0.08333333333333333,Journal article,Oncotarget,28/02/2015,Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen.,"Tiwana GS,Prevo R,Buffa FM,Yu S,Ebner DV,Howarth A,Folkes LK,Budwal B,Chu KY,Durrant L,Muschel RJ,McKenna WG,Higgins GS","Cell Line,Tumor,HCT116 Cells,Hela Cells,Humans,Neoplasms,DNA Damage,Pyrithiamine,Thiamin Pyrophosphokinase,Thiamine,Radiation-Sensitizing Agents,Colony-Forming Units Assay,Transfection,Radiation Tolerance,High-Throughput Screening Assays"
olin0014,olin0027,1,0.08333333333333333,Journal article,Proceedings of the National Academy of Sciences of USA,01/07/2013,Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development,"Sacilotto N,Monteiro R,Fritzsche M,Becker PW,Sanchez-Del-Campo L,Liu K,Pinheiro P,Ratnayaka I,Davies B,Goding CR,Patient R,Bou-Gharios G,De Val S","CSL,arterial-specific enhancer,Animals,Arteries,Chromatin Immunoprecipitation,Cloning,Molecular,Electrophoretic Mobility Shift Assay,Gene Expression Regulation,Developmental,Gene Knockdown Techniques,Immunoglobulin J Recombination Signal Sequence-Binding Protein,Immunohistochemistry,In Situ Hybridization,Intracellular Signaling Peptides and Proteins,Membrane Proteins,Mice,Transgenic,Receptors,Notch,SOXF Transcription Factors,Zebrafish"
dplb0149,whgu0172,3,0.4318181818181819,Journal article|Journal article|Journal article,Angewandte Chemie International Edition|Nature Methods|Nature Methods,13/08/2013|01/01/2013|01/04/2013,DNA modification under mild conditions by Suzuki-Miyaura cross-coupling for the generation of functional probes.|QuaNCAT: Quantitating proteome dynamics in primary cells|QuaNCAT: quantitating proteome dynamics in primary cells.,"Lercher L,McGouran JF,Kessler BM,Schofield CJ,Davis BG|Howden AJM,Geoghegan V,Katsch K,Efstathiou G,Bhushan B,Boutureira O,Thomas B,Trudgian DC,Kessler BM,Dieterich DC,Davis BG,Acuto O|Howden AJM,Geoghegan V,Katsch K,Efstathiou G,Bhushan B,Boutureira O,Thomas B,Trudgian DC,Kessler BM,Dieterich DC,Davis BG,Acuto O","DNA,cross-coupling,oligonucleotides,palladium,photoaffinity labeling,Catalysis,Idoxuridine,Molecular Probes,Oligonucleotides,Palladium,Photoaffinity Labels||"
immd0316,whgu0256,4,0.36975524475524474,Conference paper|Journal article|Journal article|Journal article,Cancer Research|Molecular Cancer|Oncogene|Oncogene,01/05/2015|01/01/2014|24/11/2014|20/08/2015,The non-coding transcriptome of hypoxic breast cancer: Novel insights of clinical relevant long non-coding RNA in hypoxia signalling|Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia.|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival.|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival,"Choudhry H,Schodel J,Albukhari A,Haider S,Buffa F,Ratcliffe PJ,Mole DR,Ragousis I,Harris AL|Camps C,Saini HK,Mole DR,Choudhry H,Reczko M,Guerra-Assunção JA,Tian YM,Buffa FM,Harris AL,Hatzigeorgiou AG,Enright AJ,Ragoussis J|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR","|Breast Neoplasms,Cell Hypoxia,Gene Expression Regulation,Neoplastic,Humans,Hypoxia-Inducible Factor 1,MCF-7 Cells,MicroRNAs,Oligonucleotide Array Sequence Analysis,Protein Binding,RNA,Messenger,Real-Time Polymerase Chain Reaction,Transcriptome|Animals,Humans,Mice,Breast Neoplasms,Cell Adhesion Molecules,Receptors,Cell Surface,Apoptosis,Cell Proliferation,Cell Hypoxia,Cell Survival,Female,Basic Helix-Loop-Helix Transcription Factors,Transcriptional Activation,RNA,Long Noncoding|"
ndog0115,whgu0172,1,0.08333333333333333,Journal article,American Journal of Transplantation,01/05/2016,Using an Integrated -Omics Approach to Identify Key Cellular Processes That Are Disturbed in the Kidney After Brain Death.,"Akhtar MZ,Huang H,Kaisar M,Lo Faro ML,Rebolledo R,Morten K,Heather LC,Dona A,Leuvenink HG,Fuggle SV,Kessler BM,Pugh CW,Ploeg RJ",
clab0025,immd0282,2,0.1,Journal article|Journal article,Cancer Cell|Cancer Cell,12/08/2013|17/07/2013,A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis|A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.,"Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SYY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM|Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM","|Animals,Cell Growth Processes,Endothelial Cells,Female,Genetic Predisposition to Disease,HCT116 Cells,Humans,Mice,Nude,Neoplasms,Neovascularization,Pathologic,Receptors,G-Protein-Coupled,Signal Transduction"
raob0051,raob0087,2,0.2777777777777778,Journal article|Journal article,Magnetic Resonance Imaging|Journal of Nuclear Medicine,08/04/2015|15/04/2011,A resistive heating system for homeothermic maintenance in small animals.|ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.,"Kersemans V,Gilchrist S,Allen PD,Beech JS,Kinchesh P,Vojnovic B,Smart SC|Cornelissen B,Darbar S,Hernandez R,Kersemans V,Tullis I,Barber PR,Smart S,Vojnovic B,Reilly R,Vallis KA","Animals,Mice,Inbred BALB C,Inbred CBA,Nude,Magnetic Resonance Imaging,Body Temperature,Heating,Body Temperature Regulation,Female|Active Transport,Cell Nucleus,Animals,Antibodies,Monoclonal,Humanized,Cell Line,Tumor,Cell Proliferation,Colony-Forming Units Assay,Dimethylallyltranstransferase,Electrons,Epidermal Growth Factor,Female,Humans,Imidazoles,Mice,Pentetic Acid,Protein Kinase Inhibitors,Protein Transport,Receptor,ErbB-2,Signal Transduction,Trastuzumab"
clme0497,ndos0168,1,0.1,Journal article,Nature Reviews Drug Discovery,01/03/2015,Preclinical target validation using patient-derived cells.,"Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
gree0989,gree1024,5,0.8761904761904761,Journal article|Journal article|Journal article|Journal article|Journal article,Gut|British Journal of Cancer|British Journal of Cancer|British Journal of Cancer|British Journal of Cancer,23/10/2012|29/10/2013|04/03/2014|21/01/2014|01/01/2014,"Incidence of gastrointestinal cancers by ethnic group in England, 2001-2007.|Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study.|Incidence of thyroid cancer in England by ethnic group, 2001-2007|Incidence of thyroid cancer in England by ethnic group, 2001-2007.|Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: Prospective study","Ali R,Barnes I,Cairns BJ,Finlayson AE,Bhala N,Mallath M,Beral V|Gathani T,Ali R,Balkwill A,Green J,Reeves G,Beral V,Moser KA,Million Women Study Collaborators|Finlayson A,Barnes I,Sayeed S,McIver B,Beral V,Ali R|Finlayson A,Barnes I,Sayeed S,McIver B,Beral V,Ali R|Gathani T,Ali R,Balkwill A,Green J,Reeves G,Beral V,Moser KA","Cancer Epidemiology,Cancer Registries,Gastrointestinal Cancer,Adult,African Continental Ancestry Group,Age Factors,Aged,80 and over,Asian Continental Ancestry Group,Colorectal Neoplasms,England,Esophageal Neoplasms,Ethnic Groups,European Continental Ancestry Group,Female,Gallbladder Neoplasms,Gastrointestinal Neoplasms,Humans,Incidence,Liver Neoplasms,Male,Middle Aged,Pancreatic Neoplasms,Risk Factors,Sex Factors|African Continental Ancestry Group,Asian Continental Ancestry Group,Breast Neoplasms,Cohort Studies,England,European Continental Ancestry Group,Female,Humans,Incidence,Middle Aged,Proportional Hazards Models,Prospective Studies,Risk Factors||England,Ethnic Groups,Female,Humans,Incidence,Male,Middle Aged,Risk,Thyroid Neoplasms|"
clme0240,cschof,5,0.35157563025210087,Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Biological Chemistry|The Journal of Physiology|Chemical Communications|ACS Chemical Biology|PLoS One,22/02/2011|20/05/2013|01/01/2015|17/05/2013|01/01/2015,Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors.|Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2.|Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.|Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.|Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.,"Tian YM,Yeoh KK,Lee MK,Eriksson T,Kessler BM,Kramer HB,Edelmann MJ,Willam C,Pugh CW,Schofield CJ,Ratcliffe PJ|Bishop T,Talbot NP,Turner PJ,Nicholls LG,Pascual A,Hodson EJ,Douglas G,Fielding JW,Smith TG,Demetriades M,Schofield CJ,Robbins PA,Pugh CW,Buckler KJ,Ratcliffe PJ|Thinnes CC,Tumber A,Yapp C,Scozzafava G,Yeh T,Chan MC,Tran TA,Hsu K,Tarhonskaya H,Walport LJ,Wilkins SE,Martinez ED,Müller S,Pugh CW,Ratcliffe PJ,Brennan PE,Kawamura A,Schofield CJ|Chowdhury R,Candela-Lena JI,Chan MC,Greenald DJ,Yeoh KK,Tian YM,McDonough MA,Tumber A,Rose NR,Conejo-Garcia A,Demetriades M,Mathavan S,Kawamura A,Lee MK,van Eeden F,Pugh CW,Ratcliffe PJ,Schofield CJ|Chan MC,Atasoylu O,Hodson E,Tumber A,Leung IK,Chowdhury R,Gómez-Pérez V,Demetriades M,Rydzik AM,Holt-Martyn J,Tian YM,Bishop T,Claridge TD,Kawamura A,Pugh CW,Ratcliffe PJ,Schofield CJ","Animals,Cell Hypoxia,Drosophila melanogaster,Enzyme Inhibitors,Hep G2 Cells,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,K562 Cells,Male,Oxygenases,Protein Structure,Tertiary,Rats,Sprague-Dawley,Ubiquitin-Protein Ligases,p300-CBP Transcription Factors|Animals,Anoxia,Carotid Body,Hyperplasia,Hypoxia-Inducible Factor 1,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Inbred C57BL,Transgenic,Pulmonary Ventilation|Humans,Oxyquinoline,Oxygenases,Enzyme Inhibitors,Molecular Structure,Structure-Activity Relationship,Dose-Response Relationship,Drug,Models,Molecular|Animals,Genetically Modified,Anoxia,Biological Assay,Cell Line,Heterocyclic Compounds,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Hypoxia-Inducible Factor-Proline Dioxygenases,Inhibitory Concentration 50,Models,Molecular,Molecular Structure,Signal Transduction,Small Molecule Libraries,Zebrafish|Brain,Hela Cells,Animals,Humans,Mice,Triazoles,Enzyme Inhibitors,Stroke,MCF-7 Cells,Hypoxia-Inducible Factor-Proline Dioxygenases"
immd0237,whgu0085,1,0.2,Journal article,Blood,29/03/2011,High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq.,"Schödel J,Oikonomopoulos S,Ragoussis J,Pugh CW,Ratcliffe PJ,Mole DR","Basic Helix-Loop-Helix Transcription Factors,Cell Line,Tumor,Chromatin Immunoprecipitation,Chromosome Mapping,Epigenesis,Genetic,Female,Genome,Human,Genome-Wide Association Study,Humans,Oxygen,Response Elements"
immd0082,immd0654,1,0.05263157894736842,Journal article,Molecular Cell,18/01/2012,Intragenic enhancers act as alternative promoters.,"Kowalczyk MS,Hughes JR,Garrick D,Lynch MD,Sharpe JA,Sloane-Stanley JA,McGowan SJ,De Gobbi M,Hosseini M,Vernimmen D,Brown JM,Gray NE,Collavin L,Gibbons RJ,Flint J,Taylor S,Buckle VJ,Milne TA,Wood WG,Higgs DR","Animals,Cells,Cultured,Enhancer Elements,Genetic,Erythroid Cells,Gene Expression Regulation,Mice,Poly A,Promoter Regions,RNA,RNA Isoforms,Messenger,Transcriptome"
clph0059,engs0475,17,4.063492063492063,Journal article|Journal article|Journal article|Conference paper|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Conference paper|Journal article|Journal article,Pharm Res|Journal of National Cancer Institute|Journal of Controlled Release|Human Gene Therapy|Pharmaceutical Research|Human Gene Therapy|Journal of Controlled Release|Human Gene Therapy|Expert Opinion on Drug Delivery|Journal of Controlled Release|Physics in Medicine and Biology|Journal of the Acoustical Society of America|Human Gene Therapy|Journal of Controlled Release|Human Gene Therapy|Ultrasound in Medicine and Biology|Journal of Controlled Release,01/01/2012|29/10/2013|01/01/2012|01/05/2013|20/09/2012|01/12/2014|04/04/2013|01/10/2011|04/11/2012|11/05/2015|07/08/2014|01/11/2013|01/12/2013|01/10/2011|01/12/2013|30/09/2011|21/12/2013,Targeting of Liposomes via PSGL1 for Enhanced Tumor Accumulation|Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.|Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model|Coating of adenovirus type 5 with cleavable PEGylated gold nanoparticles for enhanced protection and circulation|Targeting of liposomes via PSGL1 for enhanced tumor accumulation.|Improving Delivery of Oncolytic Viruses to Solid Tumours|Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound.|Ultrasound-enhanced delivery of polymer-coated oncolytic adenovirus for tumour growth inhibition|Ultrasound-enhanced drug delivery for cancer.|Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours.|Non-invasive and real-time passive acoustic mapping of ultrasound-mediated drug delivery.|Use of micro- and nano-sized inertial cavitation nuclei to trigger and map drug release from cavitation-sensitive liposomes.|Increased Adenovirus density for increased ultrasound-mediated delivery to tumors|Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model.|Goldnanoparticles for the enhancement ofadenovirus stealthing|Cavitation-enhanced extravasation for drug delivery.|Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes.,"Carlisle RC,Seymour LW,Coussios CC|Carlisle R,Choi J,Bazan-Peregrino M,Laga R,Subr V,Kostka L,Ulbrich K,Coussios CC,Seymour LW|Bazan-Peregrino M,Arvanitis CD,Rifai B,Seymour LW,Coussios CC|Mo S,Carlisle R,Coussios C-C,Seymour L|Carlisle R,Seymour LW,Coussios CC|Carlisle R,Mo S,Myers R,Graham S,Laga R,Ulbrich K,Coussios C,Seymour L|Bazan-Peregrino M,Rifai B,Carlisle RC,Choi J,Arvanitis CD,Seymour LW,Coussios CC|Carlisle R,Choi J,Kostka L,Bazan-Peregrino M,Ulbrich K,Coussios C,Seymour L|Mo S,Coussios CC,Seymour L,Carlisle R|Mo S,Carlisle R,Laga R,Myers R,Graham S,Cawood R,Ulbrich K,Seymour L,Coussios CC|Choi JJ,Carlisle RC,Coviello C,Seymour L,Coussios CC|Graham SM,Myers RS,Choi J,Bazan-Peregrino M,Seymour L,Carlisle R,Coussios CC|Carlisle RC,Mo S,Myers R,Graham S,Mylonopoulou E,Cawood R,Seymour LW,Coussios CC|Bazan-Peregrino M,Arvanitis CD,Rifai B,Seymour LW,Coussios CC|Mo S,Myers R,Carlisle R,Coussios C,Seymour L|Arvanitis CD,Bazan-Peregrino M,Rifai B,Seymour LW,Coussios CC|Graham SM,Carlisle R,Choi JJ,Stevenson M,Shah AR,Myers RS,Fisher K,Peregrino MB,Seymour L,Coussios CC","|Acrylamides,Adenoviridae,Adjuvants,Pharmaceutic,Analysis of Variance,Animals,Breast Neoplasms,Combined Modality Therapy,Female,Humans,Mice,Inbred BALB C,SCID,Microbubbles,Oncolytic Virotherapy,Oncolytic Viruses,Pharmaceutical Vehicles,Ultrasonic Therapy,Xenograft Model Antitumor Assays|||Animals,Benzothiazoles,Drug Delivery Systems,Human Umbilical Vein Endothelial Cells,Humans,Liposomes,Membrane Glycoproteins,Mice,Neoplasms,P-Selectin,Surface Properties||Adenoviridae,Animals,Cell Line,Tumor,Drug Delivery Systems,Equipment Design,Female,Humans,Mice,Inbred BALB C,Microbubbles,Neoplasms,Oncolytic Virotherapy,Oncolytic Viruses,Transgenes,Ultrasonics||Acoustics,Animals,Antineoplastic Agents,Drug Delivery Systems,High-Energy Shock Waves,Humans,Nanoparticles,Neoplasms,Pharmaceutical Preparations,Ultrasonic Therapy|Liver,Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Adenoviridae,Neoplasms,Gold,Polyethylene Glycols,Polymethacrylic Acids,Green Fluorescent Proteins,Ultrasonics,Female,Oncolytic Virotherapy,Nanomedicine,Metal Nanoparticles|Animals,Humans,Mice,Liposomes,Ultrasonography,Algorithms,Hep G2 Cells,Ultrasonic Waves|||Acoustics,Adenoviridae,Animals,Breast Neoplasms,Cell Line,Tumor,Cell Survival,Drug Delivery Systems,Humans,Mice||Adenoviridae,Animals,Biocompatible Materials,Cell Survival,Contrast Media,Drug Delivery Systems,Equipment Design,Extravasation of Diagnostic and Therapeutic Materials,High-Energy Shock Waves,Hydrogels,In Vitro Techniques,Luciferases,Macromolecular Substances,Mammary Neoplasms,Experimental,Mice,Microbubbles,Phantoms,Imaging,Phospholipids,Sonication,Sulfur Hexafluoride,Transducers,Tumor Cells,Cultured|Cancer,Drug delivery,Inertial cavitation,Liposomes,Ultrasound,Animals,Female,Firefly Luciferin,Injections,Intravenous,Mice,Inbred C57BL,Transgenic,Microbubbles,Phosphatidylethanolamines,Phospholipids,Sulfur Hexafluoride,Tissue Distribution,Ultrasonic Therapy"
immd0237,whgu0139,3,0.23118279569892472,Journal article|Journal article|Journal article,Nature Chemical Biology|Nature Chemical Biology|EMBO Reports,01/01/2012|01/01/2012|01/01/2011,"Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.|The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adhaerens","Ge W,Wolf A,Feng T,Ho C-H,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TDW,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,Mccullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Loenarz C,Coleman ML,Boleininger A,Schierwater B,Holland PWH,Ratcliffe PJ,Schofield CJ","|Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes|"
clab0025,clme0149,3,0.30000000000000004,Journal article|Journal article|Journal article,Journal of Viral Hepatitis|HIV Medicine|Journal of Viral Hepatitis,01/01/2014|01/04/2013|01/01/2013,Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection|Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C co-infection - a mechanism for poor outcomes?|Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection,"Williams SK,Donaldson E,Van Der Kleij T,Dixon L,Fisher M,Tibble J,Gilleece Y,Klenerman P,Banham AH,Howard M,Webster DP|Williams S,Donaldson E,Van der Kleij T,Dixon L,Fisher M,Tibble J,Gilleece Y,Klenerman P,Banham A,Howard M,Webster D|Williams SK,Donaldson E,Dixon L,Fisher M,Tibble J,Gilleece Y,Howard M,Van der Kleij T,Webster DP,Klenerman P,Banham AH",||
gree1620,raob0122,1,0.16666666666666666,Journal article,Nucleic Acids Research,29/04/2016,A role for human homologous recombination factors in suppressing microhomology-mediated end joining.,"Ahrabi S,Sarkar S,Pfister SX,Pirovano G,Higgins GS,Porter AC,Humphrey TC",
bioc0801,immd0282,4,0.75,Journal article|Journal article|Journal article|Journal article,Nucleic Acids Research|eLife|Nucleic Acids Research|Nucleic Acids Research,10/12/2011|01/01/2013|01/01/2012|,Bio-CAP: a versatile and highly sensitive technique to purify and characterise regions of non-methylated DNA.|Epigenetic conservation at gene regulatory elements revealed by non-methylated DNA profiling in seven vertebrates.|Bio-CAP: A versatile and highly sensitive technique to purify and characterise regions of non-methylated DNA|Protection of CpG islands from DNA methylation is DNA-encoded and evolutionarily conserved.,"Blackledge NP,Long HK,Zhou JC,Kriaucionis S,Patient R,Klose RJ|Long HK,Sims D,Heger A,Blackledge NP,Kutter C,Wright ML,Grützner F,Odom DT,Patient R,Ponting CP,Klose RJ|Blackledge NP,Long HK,Zhou JC,Kriaucionis S,Patient R,Klose RJ|Long HK,King HW,Patient RK,Odom DT,Klose RJ","Biotinylation,Chromatography,Affinity,CpG Islands,DNA,DNA Methylation,High-Throughput Nucleotide Sequencing,Sequence Analysis,Zinc Fingers|Chicken,Chromatin,CpG islands,DNA methylation,Epigenetics,Evolutionary conservation,Human,Mouse,Xenopus,Zebrafish,Animals,Base Sequence,Biological Evolution,Chickens,Chromatin Assembly and Disassembly,Conserved Sequence,CpG Islands,DNA Methylation,Databases,Genetic,Epigenesis,Gene Expression Profiling,Humans,Lizards,Mice,Platypus,Promoter Regions,Species Specificity||"
chem0489,clme1358,9,0.9181960583276374,Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Conference paper|Conference paper,ACS National Meeting Book of Abstracts|Journal of Medicinal Chemistry|MedChemComm|Journal of the American Chemical Society|Journal of Medicinal Chemistry|ACS National Meeting Book of Abstracts|Angewandte Chemie International Edition|ACS National Meeting Book of Abstracts|ACS National Meeting Book of Abstracts,10/08/2014|27/09/2012|01/01/2013|19/06/2014|21/03/2013|19/08/2012|12/05/2014|25/03/2012|25/03/2012,"Optimizing in vivo probes for the BET bromodomains|Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.|The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains|Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.|Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.|Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction|A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interaction.|Developing chemical probes for the BET bromodomains|3,5-Dimethylisoxazoles inhibit the bromodomain-histone protein-protein interaction","Jennings LE,Hewings DS,Humphreys PG,Brennan PE,Conway SJ|Hewings DS,Rooney TP,Jennings LE,Hay DA,Schofield CJ,Brennan PE,Knapp S,Conway SJ|Hay D,Fedorov O,Filippakopoulos P,Martin S,Philpott M,Picaud S,Hewings DS,Uttakar S,Heightman TD,Conway SJ,Knapp S,Brennan PE|Hay DA,Fedorov O,Martin S,Singleton DC,Tallant C,Wells C,Picaud S,Philpott M,Monteiro OP,Rogers CM,Conway SJ,Rooney TP,Tumber A,Yapp C,Filippakopoulos P,Bunnage ME,Müller S,Knapp S,Schofield CJ,Brennan PE|Hewings DS,Fedorov O,Filippakopoulos P,Martin S,Picaud S,Tumber A,Wells C,Olcina MM,Freeman K,Gill A,Ritchie AJ,Sheppard DW,Russell AJ,Hammond EM,Knapp S,Brennan PE,Conway SJ|Rooney TPC,Fedorov O,Filippakopoulos P,Wang M,Philpott M,Cook A,Heightman TD,Knapp S,Pryde D,Brennan PE,Conway SJ|Rooney TP,Filippakopoulos P,Fedorov O,Picaud S,Cortopassi WA,Hay DA,Martin S,Tumber A,Rogers CM,Philpott M,Wang M,Thompson AL,Heightman TD,Pryde DC,Cook A,Paton RS,Müller S,Knapp S,Brennan PE,Conway SJ|Hewings DS,Wang M,Philpott M,Fedorov O,Uttarkar S,Filippakopoulos P,Picaud S,Vuppusetty C,Marsden B,Heightman TD,Knapp S,Brennan P,Conway SJ|Hewings DS,Wang M,Philpott M,Fedorov O,Uttarkar S,Filippakopoulos P,Picaud S,Vuppusetty C,Marsden B,Heightman TD,Knapp S,Brennan P,Conway SJ","|Acetylation,Animals,Histones,Humans,Lysine,Molecular Targeted Therapy,Nuclear Proteins,Protein Binding,Protein Processing,Post-Translational||Hela Cells,Microsomes,Liver,Humans,Isoxazoles,Indoles,Ligands,Crystallography,X-Ray,Fluorescence Recovery After Photobleaching,Drug Evaluation,Preclinical,Binding Sites,Molecular Structure,Protein Structure,Tertiary,Structure-Activity Relationship,Genes,p53,Models,Molecular,E1A-Associated p300 Protein,CREB-Binding Protein,Small Molecule Libraries,Drug Discovery,Chemistry Techniques,Synthetic|Acetylation,CREB-Binding Protein,Cell Line,Tumor,Crystallography,X-Ray,Histones,Humans,Inhibitory Concentration 50,Isoxazoles,Ligands,Lysine,Nuclear Proteins,Protein Binding,Structure-Activity Relationship,Transcription Factors||||"
clme0220,immd0237,6,0.5688461538461538,Journal article|Conference paper|Journal article|Journal article|Conference paper|Journal article,Journal of Pathology|European Journal of Cancer|Oncogene|EMBO Reports|Cancer Research|Oncogene,01/01/2011|01/07/2014|24/11/2014|21/12/2013|01/05/2015|20/08/2015,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Proffered Paper: Hypoxic regulation of the long non-coding transcriptome in breast cancer|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival.|Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2.|The non-coding transcriptome of hypoxic breast cancer: Novel insights of clinical relevant long non-coding RNA in hypoxia signalling|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Choudhry H,Albukhari A,Schodel J,Oikonomopoulos S,Haider S,Ratcliffe P,Ragousis I,Mole D,Harris A|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR|Choudhry H,Schödel J,Oikonomopoulos S,Camps C,Grampp S,Harris AL,Ratcliffe PJ,Ragoussis J,Mole DR|Choudhry H,Schodel J,Albukhari A,Haider S,Buffa F,Ratcliffe PJ,Mole DR,Ragousis I,Harris AL|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid||Animals,Humans,Mice,Breast Neoplasms,Cell Adhesion Molecules,Receptors,Cell Surface,Apoptosis,Cell Proliferation,Cell Hypoxia,Cell Survival,Female,Basic Helix-Loop-Helix Transcription Factors,Transcriptional Activation,RNA,Long Noncoding|Basic Helix-Loop-Helix Transcription Factors,Cell Hypoxia,Gene Expression Regulation,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,MCF-7 Cells,Promoter Regions,Genetic,Protein Binding,RNA Polymerase II,RNA,Messenger,Untranslated,Transcription,Transcriptome||"
immd0024,whgu0210,1,0.1111111111111111,Journal article,Cell Reports,11/07/2013,Structural Basis for LMO2-Driven Recruitment of the SCL: E47bHLH Heterodimer to Hematopoietic-Specific Transcriptional Targets,"ElOmari K,Hoosdally SJ,Tuladhar K,Karia D,Hall-Ponselé E,Platonova O,Vyas P,Patient R,Porcher C,Mancini EJ",
immd0180,immd0237,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
clme0237,immd0421,1,0.07692307692307693,Journal article,Human Molecular Genetics,15/07/2013,DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.,"Church DN,Briggs SE,Palles C,Domingo E,Kearsey SJ,Grimes JM,Gorman M,Martin L,Howarth KM,Hodgson SV,NSECG Collaborators,Kaur K,Taylor J,Tomlinson IP","Adult,Aged,Amino Acid Sequence,DNA Polymerase II,DNA Polymerase III,Endometrial Neoplasms,Female,Germ-Line Mutation,Humans,Microsatellite Repeats,Middle Aged,Molecular Sequence Data,Mutation,Protein Structure,Tertiary,Sequence Alignment,Young Adult"
clme0240,immd0198,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
engs0270,phpc0084,2,0.2857142857142857,Journal article|Journal article,Lancet|Lancet,14/03/2011|14/03/2011,Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies|Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies.,"Fleming S,Thompson M,Stevens R,Heneghan C,Plüddemann A,Maconochie I,Tarassenko L,Mant D|Fleming S,Thompson M,Stevens R,Heneghan C,Plüddemann A,Maconochie I,Tarassenko L,Mant D","|Adolescent,Advanced Cardiac Life Support,Child,Preschool,Heart Rate,Humans,Infant,Newborn,Practice Guidelines as Topic,Reference Values,Respiratory Rate"
bioc0416,raob0096,2,0.25,Journal article|Conference paper,Current Biology|Clinical and Experimental Metastasis,26/02/2015|01/03/2015,"Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.|Cellular adhesion molecules and brain metastasis; how friends become foes","Vlahov N,Scrace S,Soto MS,Grawenda AM,Bradley L,Pankova D,Papaspyropoulos A,Yee KS,Buffa F,Goding CR,Timpson P,Sibson N,O'Neill E|Soto MS,O'Brien E,Serres S,Anthony DC,O'Neill E,Scrace S,Sibson N",|
ctsu0265,gree0184,5,0.35241327300150826,Journal article|Journal article|Journal article|Journal article|Journal article,Lancet|Lancet|Lancet|New England Journal of Medicine|Lancet,21/06/2014|04/02/2012|01/08/2011|14/03/2013|12/11/2011,"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.|Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.|Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials|Risk of ischemic heart disease in women after radiotherapy for breast cancer.|Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.","McGale P,Taylor C,Correa C,Cutter D,Duane F,Ewertz M,Gray R,Mannu G,Peto R,Whelan T,Wang Y,Wang Z,Darby S|Early Breast Cancer Trialists' Collaborative Group (EBCTCG),Peto R,Davies C,Godwin J,Gray R,Pan HC,Clarke M,Cutter D,Darby S,McGale P,Taylor C,Wang YC,Bergh J,Di Leo A,Albain K,Swain S,Piccart M,Pritchard K|Early Breast Cancer Trialists' Collaborative Group (EBCTCG),Davies C,Godwin J,Gray R,Clarke M,Cutter D,Darby S,McGale P,Pan HC,Taylor C,Wang YC,Dowsett M,Ingle J,Peto R|Darby SC,Ewertz M,McGale P,Bennet AM,Blom-Goldman U,Brønnum D,Correa C,Cutter D,Gagliardi G,Gigante B,Jensen MB,Nisbet A,Peto R,Rahimi K,Taylor C,Hall P|Early Breast Cancer Trialists' Collaborative Group (EBCTCG),Darby S,McGale P,Correa C,Taylor C,Arriagada R,Clarke M,Cutter D,Davies C,Ewertz M,Godwin J,Gray R,Pierce L,Whelan T,Wang Y,Peto R","EBCTCG (Early Breast Cancer Trialists' Collaborative Group),Axilla,Humans,Breast Neoplasms,Lymphatic Metastasis,Neoplasm Recurrence,Local,Lymph Node Excision,Mastectomy,Female,Randomized Controlled Trials as Topic|Anthracyclines,Antineoplastic Combined Chemotherapy Protocols,Breast Neoplasms,Chemotherapy,Adjuvant,Female,Humans,Neoplasm Recurrence,Local,Randomized Controlled Trials as Topic,Survival Rate,Taxoids|Antineoplastic Agents,Hormonal,Breast Neoplasms,Chemotherapy,Adjuvant,Female,Humans,Neoplasm Recurrence,Local,Neoplasms,Second Primary,Randomized Controlled Trials as Topic,Receptors,Estrogen,Progesterone,Selective Estrogen Receptor Modulators,Tamoxifen|Adult,Aged,Breast Neoplasms,Case-Control Studies,Chemotherapy,Adjuvant,Female,Heart,Humans,Mastectomy,Middle Aged,Myocardial Ischemia,Radiation Injuries,Radiotherapy Dosage,Radiotherapy,Risk,Risk Factors|Age Factors,Breast Neoplasms,Estrogen Antagonists,Female,Humans,Lymphatic Metastasis,Mastectomy,Segmental,Neoplasm Grading,Neoplasm Recurrence,Local,Radiotherapy,Adjuvant,Randomized Controlled Trials as Topic,Receptors,Estrogen,Tamoxifen"
clab0127,clme1037,1,0.027777777777777776,Journal article,Cancer Research,,Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.,"Picaud S,Fedorov O,Thanasopoulou A,Leonards K,Jones K,Meier J,Olzscha H,Monteiro O,Martin S,Philpott M,Tumber A,Filippakopoulos P,Yapp C,Wells C,Che KH,Bannister A,Robson S,Kumar U,Parr N,Lee K,Lugo D,Jeffrey P,Taylor S,Vecellio ML,Bountra C,Brennan PE,O'Mahony A,Velichko S,Müller S,Hay D,Daniels DL,Urh M,La Thangue NB,Kouzarides T,Prinjha R,Schwaller J,Knapp S","Cell Line,Tumor,Animals,Humans,Mice,Oxazepines,Doxorubicin,Antineoplastic Combined Chemotherapy Protocols,Enzyme Inhibitors,Xenograft Model Antitumor Assays,Amino Acid Sequence,Protein Structure,Tertiary,Drug Synergism,Models,Molecular,Molecular Sequence Data,p300-CBP Transcription Factors,Leukemia,Myeloid,Acute"
clme0237,immd0135,1,0.05555555555555555,Journal article,Blood,22/08/2012,Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.,"Schuh A,Becq J,Humphray S,Alexa A,Burns A,Clifford R,Feller SM,Grocock R,Henderson S,Khrebtukova I,Kingsbury Z,Luo S,McBride D,Murray L,Menju T,Timbs A,Ross M,Taylor J,Bentley D","Alleles,Cell Transformation,Neoplastic,Clonal Deletion,Clone Cells,DNA Mutational Analysis,DNA,Neoplasm,Disease Progression,Evolution,Molecular,Gene Frequency,Genome-Wide Association Study,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Mutation,Neoplasm Proteins,Selection,Genetic,Sequence Analysis"
card0008,raob0182,1,0.14285714285714285,Journal article,Scientific Reports,01/01/2016,Negative autoregulation of BMP dependent transcription by SIN3B splicing reveals a role for RBM39.,"Faherty N,Benson M,Sharma E,Lee A,Howarth A,Lockstone H,Ebner D,Bhattacharya S",
clme0219,immd0023,8,1.0809523809523809,Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article,Journal of Experimental Medicine|Clinical and Experimental Immunology|Journal of Immunological Methods|British Journal of Dermatology|British Journal of Dermatology|European Journal of Immunology|Journal of Immunological Methods|Science Translational Medicine,12/01/2015|13/02/2016|03/12/2013|01/05/2015|01/05/2015||31/01/2014|10/02/2016,Bee venom processes human skin lipids for presentation by CD1a.|Expansion of highly activated iNKT cells with altered phenotype in acute dengue infection.|Combinatorial HLA-peptide bead libraries for high throughput identification of CD8⁺ T cell specificity.|CD1a-restricted T cells and atopic dermatitis|A novel pathway of recognition of skin-lipid antigens by T cells|Elevated and cross-responsive CD1a-reactive T cells in bee and wasp venom allergic individuals.|Combinatorial HLA-peptide bead libraries for high throughput identification of CD8+ T cell specificity|Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase.,"Bourgeois EA,Subramaniam S,Cheng TY,De Jong A,Layre E,Ly D,Salimi M,Legaspi A,Modlin RL,Salio M,Cerundolo V,Moody DB,Ogg G|Kamaladasa A,Wickramasinghe N,Adikari TN,Gomes L,Shyamali NL,Salio M,Cerundolo V,Ogg GS,Neelika Malavige G|Pan X,Huang LC,Dong T,Peng Y,Cerundolo V,McGowan S,Ogg G|Jarrett R,Subramaniam S,Salimi M,Cheung A,Archer C,Lloyd-Lavery A,Salio M,Cerundolo V,Ogg G|Subramaniam S,Bourgeois E,Salio M,Cerundolo V,Moody B,Ogg G|Subramaniam S,Aslam A,Misbah SA,Salio M,Cerundolo V,Moody DB,Ogg G|Pan X,Huang LC,Dong T,Peng Y,Cerundolo V,McGowan S,Ogg G|Jarrett R,Salio M,Lloyd-Lavery A,Subramaniam S,Bourgeois E,Archer C,Cheung KL,Hardman C,Chandler D,Salimi M,Gutowska-Owsiak D,Bernardino de la Serna J,Fallon PG,Jolin H,Mckenzie A,Dziembowski A,Podobas EI,Bal W,Johnson D,Moody DB,Cerundolo V,Ogg G","T-Lymphocyte Subsets,Cell Line,Skin,Animals,Humans,Lipids,Fatty Acids,Lysophospholipids,Bee Venoms,Antigens,CD1,Ligands,Lymphocyte Activation,Antigen Presentation,T-Cell Antigen Receptor Specificity,Phospholipases A2||Bead display,HLA library,T cells,Antigens,Viral,CD8-Positive T-Lymphocytes,Combinatorial Chemistry Techniques,Cytomegalovirus,HLA Antigens,Herpesvirus 4,Human,High-Throughput Screening Assays,Humans,Orthomyxoviridae,Peptide Fragments,Peptide Library,Phosphoproteins,Polymerase Chain Reaction,Trans-Activators,Viral Matrix Proteins|||T-Lymphocytes,Animals,Humans,Hypersensitivity,Insect Bites and Stings,Bee Venoms,Wasp Venoms,Antigens,CD1,Allergens,Enzyme-Linked Immunosorbent Assay,Desensitization,Immunologic,Cell Separation,Cross Reactions,Adult,Middle Aged,Female,Male,Enzyme-Linked Immunospot Assay||"
raob0069,raob0095,22,4.975047175047175,Conference paper|Journal article|Journal article|Chapter|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper|Conference paper,"European Journal of Nuclear Medicine and Molecular Imaging|Cell Death and Disease|Current Molecular Medicine||Nuclear Medicine and Biology|Molecular Cancer Therapeutics|Current Drug Targets|Nuclear Medicine and Biology|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik|EJNMMI Research|Cancer Research|Cancer Research|American Journal of Nuclear Medicine and Molecular Imaging|Journal of Nuclear Medicine|Therapeutic delivery|Journal of National Cancer Institute|Journal of Nuclear Medicine|Journal of the Royal Society Interface|Biomaterials|EJNMMI Research|Cancer Research|Cancer Research",01/10/2011|01/01/2012|11/11/2013|01/01/2012|01/01/2012|29/10/2013|22/04/2015|17/07/2012|01/05/2013|20/02/2012|15/04/2012|17/05/2011|01/01/2014|15/04/2011|01/03/2014|09/10/2013|01/12/2014|01/01/2016|19/11/2012|01/01/2012|15/04/2013|15/04/2013,"Auger electron therapy using In-111-labelled F3 peptide|Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|Can γH2AX be used to personalise cancer treatment?|Auger Emitting Radiopharmaceuticals for Cancer Therapy|Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical|Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.|PET and SPECT Imaging for the Acceleration of Anti-Cancer Drug Development.|Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation|111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.|DNA double-strand break imaging with anti-gamma H2AX antibodies does not alter DNA repair kinetics|Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.|Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.|ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.|Uptake, internalization and nuclear translocation of radioimmunotherapeutic agents.|Selective permeabilization of the blood-brain barrier at sites of metastasis.|Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.|DNA double-strand break repair: a theoretical framework and its application.|Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.|111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin|Imaging DNA damage response (DDR) during oncogenesis|Imaging DNA damage response (DDR) during oncogenesis.","Cornelissen B,Waller A,Target C,Kersemans V,Smart S,Vallis KA|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Shah K,Cornelissen B,Kiltie AE,Vallis KA|Falzone N,Cornelissen B,Vallis KA|Cornelissen B,Darbar S,Kersemans V,Allen D,Falzone N,Barbeau J,Smart S,Vallis KA|Cornelissen B,Waller A,Able S,Vallis KA|Hillyar CR,Knight JC,Vallis KA,Cornelissen B|Cornelissen B,Darbar S,Kersemans V,Allen D,Falzone N,Barbeau J,Smart S,Vallis KA|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB|Cornelissen B,Waller A,Target C,Kersemans V,Smart S,Vallis KA|Cornelissen B,Able S,Szilagyi T,Shah K,Brady M,Vallis K|Cornelissen B,Kersemans V,Darbar S,Thompson J,Shah K,Sleeth K,Hill MA,Vallis KA|Vallis KA,Reilly RM,Scollard D,Merante P,Brade A,Velauthapillai S,Caldwell C,Chan I,Freeman M,Lockwood G,Miller NA,Cornelissen B,Petronis J,Sabate K|Cornelissen B,Darbar S,Hernandez R,Kersemans V,Tullis I,Barber PR,Smart S,Vojnovic B,Reilly R,Vallis KA|Hillyar CR,Cornelissen B,Vallis KA|Connell JJ,Chatain G,Cornelissen B,Vallis KA,Hamilton A,Seymour L,Anthony DC,Sibson NR|Cornelissen B,Able S,Kartsonaki C,Kersemans V,Allen PD,Cavallo F,Cazier JB,Iezzi M,Knight J,Muschel R,Smart S,Vallis KA|Murray PJ,Cornelissen B,Vallis KA,Chapman SJ|Cornelissen B,Able S,Kersemans V,Waghorn PA,Myhra S,Jurkshat K,Crossley A,Vallis KA|Cornelissen B,Waller A,Target C,Kersemans V,Smart S,Vallis KA|Cornelissen B,Able S,Kersemans V,Vallis KA|Cornelissen B,Able S,Kersemans V,Vallis KA","|Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|Antineoplastic Agents,Biomarkers,Tumor,DNA Damage,Diagnostic Imaging,Drug Monitoring,Histones,Humans,Neoplasms|||Animals,Antibodies,Monoclonal,Cell Line,Tumor,Dose-Response Relationship,Radiation,Histones,Humans,Immunoconjugates,Indium Radioisotopes,Mice,Nude,Neoplasms,Experimental,Radioimmunotherapy,Radiopharmaceuticals,Receptor,Epidermal Growth Factor,Xenograft Model Antitumor Assays|Animals,Humans,Neoplasms,Lead Radioisotopes,Antineoplastic Agents,Positron-Emission Tomography,Tomography,Emission-Computed,Single-Photon,Molecular Imaging|Animals,Bleomycin,Breast Neoplasms,Cell Line,Tumor,Cell Transformation,Neoplastic,DNA Breaks,Double-Stranded,DNA Damage,Dose-Response Relationship,Radiation,Female,Histones,Humans,Immunoconjugates,Indium Radioisotopes,Mice,Molecular Targeted Therapy,Pentetic Acid,Peptide Fragments,Radiometry,Radiopharmaceuticals,tat Gene Products,Human Immunodeficiency Virus||||Amino Acid Sequence,Animals,Antibodies,Breast Neoplasms,Carbocyanines,Cell Line,Tumor,DNA Damage,DNA,Neoplasm,Female,Gene Products,tat,Histones,Humans,Immunoconjugates,Indium Radioisotopes,Mice,Inbred BALB C,Nude,Molecular Sequence Data,Pentetic Acid,Transplantation,Heterologous||Active Transport,Cell Nucleus,Animals,Antibodies,Monoclonal,Humanized,Cell Line,Tumor,Cell Proliferation,Colony-Forming Units Assay,Dimethylallyltranstransferase,Electrons,Epidermal Growth Factor,Female,Humans,Imidazoles,Mice,Pentetic Acid,Protein Kinase Inhibitors,Protein Transport,Receptor,ErbB-2,Signal Transduction,Trastuzumab|Active Transport,Cell Nucleus,Animals,Cell-Penetrating Peptides,Endocytosis,Humans,Immunoconjugates,Neoplasms,Radioimmunotherapy,Radiopharmaceuticals,Tumor Microenvironment|Analysis of Variance,Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Blood-Brain Barrier,Brain,Brain Neoplasms,Breast Neoplasms,Contrast Media,Disease Models,Animal,Drug Administration Schedule,Female,Gadolinium DTPA,Gene Expression Regulation,Neoplastic,Humans,Immunohistochemistry,Lymphotoxin-alpha,Magnetic Resonance Imaging,Mice,Inbred BALB C,Permeability,Receptors,Tumor Necrosis Factor,Type I,Tomography,Emission-Computed,Single-Photon,X-Ray Computed,Trastuzumab,Tumor Necrosis Factor-alpha|Animals,Mice,Inbred BALB C,Mammary Neoplasms,Experimental,Precancerous Conditions,DNA Damage,Disease Progression,Immunoconjugates,Radiopharmaceuticals,Tomography,Emission-Computed,Single-Photon,Magnetic Resonance Imaging,Tissue Distribution,Image Processing,Computer-Assisted,Female||Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Breast Neoplasms,Cell Line,Tumor,Graphite,Humans,Mice,Inbred BALB C,Nanocapsules,Oxides,Pentetic Acid,Radiopharmaceuticals,Receptor,ErbB-2,Tomography,Emission-Computed,Single-Photon,Trastuzumab,Treatment Outcome|||"
clme0237,immd0237,4,0.18660121251140083,Journal article|Journal article|Journal article|Journal article,Haematologica: the hematology journal|Nature Genetics|Journal of Pathology|Nature Genetics,11/07/2014|18/05/2015|01/01/2011|23/12/2012,Erythrocytosis associated with a novel missense mutation in the BPGM gene.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.,"Petousi N,Copley RR,Lappin TR,Haggan SE,Bento CM,Cario H,Percy MJ,Ratcliffe PJ,Robbins PA,McMullin MF|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I","WGS Consortium,Humans,Polycythemia,Bisphosphoglycerate Mutase,Genotype,Mutation,Missense|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA"
bioc0801,immd0237,4,0.18323845667299177,Journal article|Journal article|Journal article|Journal article,Chemical Science|EMBO Reports|Journal of Medicinal Chemistry|EMBO Reports,01/08/2013|01/04/2011|25/06/2012|01/04/2011,5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation|The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.|Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.|The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases,"Hopkinson RJ,Tumber A,Yapp C,Chowdhury R,Aik W,Che KH,Li XS,Kristensen JBL,King ONF,Chan MC,Yeoh KK,Choi H,Walport LJ,Thinnes CC,Bush JT,Lejeune C,Rydzik AM,Rose NR,Bagg EA,McDonough MA,Krojer TJ,Yue WW,Ng SS,Olsen L,Brennan PE,Oppermann U,Müller S,Klose RJ,Ratcliffe PJ,Schofield CJ,Kawamura A|Chowdhury R,Yeoh KK,Tian YM,Hillringhaus L,Bagg EA,Rose NR,Leung IKH,Li XS,Woon ECY,Yang M,McDonough MA,King ON,Clifton IJ,Klose RJ,Claridge TDW,Ratcliffe PJ,Schofield CJ,Kawamura A|Rose NR,Woon EC,Tumber A,Walport LJ,Chowdhury R,Li XS,King ON,Lejeune C,Ng SS,Krojer T,Chan MC,Rydzik AM,Hopkinson RJ,Che KH,Daniel M,Strain-Damerell C,Gileadi C,Kochan G,Leung IK,Dunford J,Yeoh KK,Ratcliffe PJ,Burgess-Brown N,von Delft F,Muller S,Marsden B,Brennan PE,McDonough MA,Oppermann U,Klose RJ,Schofield CJ,Kawamura A|Chowdhury R,Yeoh KK,Tian Y-M,Hillringhaus L,Bagg EA,Rose NR,Leung IKH,Li XS,Woon ECY,Yang M,McDonough MA,King ON,Clifton IJ,Klose RJ,Claridge TDW,Ratcliffe PJ,Schofield CJ,Kawamura A","|Cell Line,Tumor,Crystallography,Glutarates,Histone Demethylases,Humans,Inhibitory Concentration 50,Isocitrate Dehydrogenase,Jumonji Domain-Containing Histone Demethylases,Magnetic Resonance Spectroscopy,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Mutation,Neoplasms,Procollagen-Proline Dioxygenase,Repressor Proteins,Signal Transduction|Enzyme Inhibitors,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Plant Growth Regulators,Protein Conformation,Substrate Specificity,Succinates|"
immd0024,immd0700,3,0.09810874704491726,Journal article|Journal article|Journal article,Cancer Cell|Cancer Cell|Cell Reports,14/05/2014|16/06/2014|27/03/2013,Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.,"Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SE|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Mead AJ,Kharazi S,Atkinson D,Macaulay I,Pecquet C,Loughran S,Lutteropp M,Woll P,Chowdhury O,Luc S,Buza-Vidas N,Ferry H,Clark SA,Goardon N,Vyas P,Constantinescu SN,Sitnicka E,Nerlov C,Jacobsen SE","Chromosomes,Human,Pair 5,Animals,Mice,Inbred NOD,Humans,Myelodysplastic Syndromes,Chromosome Deletion,Genetic Predisposition to Disease,Antigens,CD,Prognosis,Flow Cytometry,Gene Expression Profiling,Mutation,Neoplastic Stem Cells,Heterografts||Animals,Cell Differentiation,Cell Transformation,Neoplastic,Disease Models,Animal,Flow Cytometry,Gene Expression,Humans,Leukemia,Myeloid,Acute,Mice,Microarray Analysis,Multipotent Stem Cells,Myeloid Cells,Signal Transduction,fms-Like Tyrosine Kinase 3"
clme0220,immd0421,1,0.1111111111111111,Journal article,Oncogene,28/11/2011,Igf2 ligand dependency of Pten(+/-) developmental and tumour phenotypes in the mouse.,"Church DN,Phillips BR,Stuckey DJ,Barnes DJ,Buffa FM,Manek S,Clarke K,Harris AL,Carter EJ,Hassan AB","Animals,Carcinoma,Cardiomegaly,Cell Line,Tumor,Cell Proliferation,Cell Transformation,Neoplastic,Female,Humans,Insulin-Like Growth Factor II,Longevity,Male,Mammary Neoplasms,Animal,Mice,Inbred C57BL,PTEN Phosphohydrolase,Placenta,Pregnancy,Sex Factors"
raob0095,raob0097,2,0.18181818181818182,Journal article|Conference paper,"Cell Death and Disease|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",01/01/2012|01/05/2013,Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation,"Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB","Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|"
clme0670,gree1620,3,0.5416666666666666,Journal article|Journal article|Journal article,Oncotarget|Cancer Treatment Reviews|Radiation Oncology,28/02/2015|03/01/2015|27/03/2012,"Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen.|Drug radiotherapy combinations: review of previous failures and reasons for future optimism.|NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity.","Tiwana GS,Prevo R,Buffa FM,Yu S,Ebner DV,Howarth A,Folkes LK,Budwal B,Chu KY,Durrant L,Muschel RJ,McKenna WG,Higgins GS|Higgins GS,O'Cathail SM,Muschel RJ,McKenna WG|Fokas E,Yoshimura M,Prevo R,Higgins G,Hackl W,Maira SM,Bernhard EJ,McKenna WG,Muschel RJ","Cell Line,Tumor,HCT116 Cells,Hela Cells,Humans,Neoplasms,DNA Damage,Pyrithiamine,Thiamin Pyrophosphokinase,Thiamine,Radiation-Sensitizing Agents,Colony-Forming Units Assay,Transfection,Radiation Tolerance,High-Throughput Screening Assays|Humans,Neoplasms,Antineoplastic Combined Chemotherapy Protocols,Radiation-Sensitizing Agents,Treatment Failure,Immunotherapy,Combined Modality Therapy,Signal Transduction,Cell Hypoxia,DNA Repair,Clinical Trials as Topic,Molecular Targeted Therapy,Chemoradiotherapy,Adjuvant|Cell Line,Tumor,Endothelial Cells,Human Umbilical Vein Endothelial Cells,Humans,Imidazoles,Phosphatidylinositol 3-Kinases,Quinolines,Radiation-Sensitizing Agents,TOR Serine-Threonine Kinases"
path0002,path0642,1,0.3333333333333333,Journal article,Biophysical Journal,05/08/2014,Biosensor architectures for high-fidelity reporting of cellular signaling.,"Dushek O,Lellouch AC,Vaux DJ,Shahrezaei V","Protein Kinases,Observer Variation,Fluorescence Resonance Energy Transfer,Data Interpretation,Statistical,Sensitivity and Specificity,Biosensing Techniques,Signal Transduction,Protein Binding,Models,Biological,Phosphoprotein Phosphatases"
card0027,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
ctsu0084,gree0184,44,4.444476999608578,Conference paper|Conference paper|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,European Heart Journal|European Heart Journal|International Journal of Epidemiology|European Heart Journal|Diabetologia|European Heart Journal|Public Health|International Journal of Epidemiology|Journal of Epidemiology and Community Health|International Journal of Epidemiology|Journal of Epidemiology and Community Health|International Journal of Cardiology|International Journal of Epidemiology|Journal of Epidemiology and Community Health|International Journal of Epidemiology|International Journal of Epidemiology|Journal of the American College of Cardiology|Diabetologia|New England Journal of Medicine|Diabetic Medicine|Journal of Epidemiology and Community Health|European Respiratory Journal|European Respiratory Journal|Heart Asia|American Journal of Clinical Nutrition|International Journal of Epidemiology|Heart Asia|European Heart Journal|Journal of Psychosomatic Research|Cancer|European Heart Journal|European Respiratory Journal|Journal of Epidemiology and Community Health|International Journal of Epidemiology|J Hypertens|Journal of Psychosomatic Research|Public Health|European Heart Journal|International Journal of COPD|International Journal of Epidemiology|Journal of Epidemiology and Community Health|BMJ Open Respiratory Research|Lancet|BMC Public Health,01/09/2014|01/09/2014|01/12/2011|16/02/2015|01/09/2015|01/08/2015|01/01/2012|17/03/2014|01/08/2011||01/08/2011|01/03/2014|16/05/2012|01/08/2011|05/03/2015|31/01/2012|19/01/2016|01/09/2014|07/04/2016|17/12/2013|01/08/2011|01/09/2013|01/09/2013|01/01/2011|30/01/2013|20/09/2013|16/08/2011|01/09/2014|01/01/2013|01/01/2015|01/08/2015|06/03/2014|01/08/2011|01/06/2013|01/01/2012|01/12/2013|01/08/2011|01/08/2013|01/01/2015|01/06/2013|01/08/2011|09/05/2014|01/01/2015|01/01/2014,"Fresh fruit consumption, blood pressure and cardiovascular disease risk: a prospective cohort study of 0.5 million adults in the China Kadoorie Biobank|The burden of hypertension in china in the 21st century: findings from the china kadoorie biobank study of 0.5 million chinese adults|China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up.|Outdoor temperature, blood pressure, and cardiovascular disease mortality among 23 000 individuals with diagnosed cardiovascular diseases from China.|Body mass index during early adulthood in relation to risk of diabetes in later life among Chinese men and women|Sleep duration and risk of incident of ischaemic heart disease: a 7-year prospective study of 0.5 million Chinese adults|Epidemiology and the control of disease in China, with emphasis on the Chinese Biobank Study|Temporal trends of main reproductive characteristics in ten urban and rural regions of China: the China Kadoorie biobank study of 300 000 women.|PHYSICAL ACTIVITY AND ITS ASSOCIATIONS WITH PREVALENCE OF OVERWEIGHT, HYPERTENSION, DIABETES AND ISCHAEMIC HEART DISEASE IN THE KADOORIE BIOBANK STUDY OF 0.5 MILLION PEOPLE IN CHINA|A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults.|PREVALENCE OF SMOKING AND ITS ASSOCIATION WITH MORTALITY IN CHINA: FINDINGS OF THE KADOORIE BIOBANK STUDY OF 0.5 MILLION PEOPLE|Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5 million people|Alcohol drinking and overall and cause-specific mortality in China: nationally representative prospective study of 220,000 men with 15 years of follow-up.|ADIPOSITY AND ITS CONTRIBUTION TO INDIVIDUAL AND REGIONAL DIFFERENCES IN BLOOD PRESSURE: THE KADOORIE BIOBANK STUDY OF 0.5 MILLION PEOPLE IN CHINA|Blood pressure in relation to general and central adiposity among 500 000 adult Chinese men and women.|Body mass index and mortality in China: a 15-year prospective study of 220 000 men.|Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.|Blood glucose levels at baseline and incidence of type 2 diabetes: a prospective cohort study of 0.5 million adults in the China Kadoorie Biobank|Fresh Fruit Consumption and Major Cardiovascular Disease in China.|Associations of blood glucose and prevalent diabetes with risk of cardiovascular disease in 500 000 adult Chinese: the China Kadoorie Biobank.|PREVALENCE AND PATTERNS OF ALCOHOL CONSUMPTION IN CHINESE MEN AND WOMEN: THE KADOORIE BIOBANK STUDY OF 0.5 MILLION PEOPLE IN CHINA|Geographical variation of prevalence, and under-diagnosis of COPD in urban and rural communities of China: Finding from China Kadoorie Biobank of 0.5M people|Prevalence and determinants of COPD in 320,000 never smokers in China: Results from the China Kadoorie Biobank study|Sex differences in hospital mortality following acute myocardial infarction in China: findings from a study of 45 852 patients in the COMMIT/CCS-2 study.|Physical activity and sedentary leisure time and their associations with BMI, waist circumference, and percentage body fat in 0.5 million adults: the China Kadoorie Biobank study.|Exhaled carbon monoxide and its associations with smoking, indoor household air pollution and chronic respiratory diseases among 512,000 Chinese adults.|Sex differences in hospital mortality following acute myocardial infarction in China: findings from a study of 45,852 patients in COMMIT/CCS-2 study|Diabetes in relation to incidence of cardiovascular disease in Chinese men and women: a prospective cohort study of 0.5 million adults with 7 years of follow-up|Depression, anxiety, and prevalent diabetes in the Chinese population: Findings from the China Kadoorie Biobank of 0.5 million people|Emerging tobacco-related cancer risks in China: A nationwide, prospective study of 0.5 million adults.|Random blood glucose and incidence of cardiovascular disease among adults without diabetes: findings of the China Kadoorie Biobank|Prevalence and correlates of airflow obstruction in ∼317,000 never-smokers in China.|ALCOHOL AND MORTALITY AMONG 220 000 MEN IN CHINA, 1990-2005: A NATIONALLY REPRESENTATIVE PROSPECTIVE STUDY|Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates.|Seasonal variation in blood pressure and its relationship with outdoor temperature in 10 diverse regions of China: the China Kadoorie Biobank|Depression, anxiety, and prevalent diabetes in the Chinese population: Findings from the China Kadoorie Biobank of 0.5million people|Epidemiology and the control of disease in China, with emphasis on the Chinese Biobank Study|Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: findings from the China Biobank study of 0.5 million people|COPD and its association with smoking in the Mainland China: a cross-sectional analysis of 0.5 million men and women from ten diverse areas.|Peak flow as a predictor of cause-specific mortality in China: results from a 15-year prospective study of ~170,000 men.|SEASONAL VARIATION IN BLOOD PRESSURE AMONG CHINESE ADULTS: THE KADOORIE BIOBANK STUDY OF 0.5 MILLION PEOPLE IN CHINA|Regional variations in the prevalence and misdiagnosis of air flow obstruction in China: baseline results from a prospective cohort of the China Kadoorie Biobank (CKB).|Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies.|Patterns and socio-demographic correlates of domain-specific physical activities and their associations with adiposity in the China Kadoorie Biobank study.","Du H,Li L,Bennett D,Guo Y,Bian Z,Chen J,Key T,Collins R,Peto R,Chen Z,Biobank CK|Lewington S,Li L,Clarke R,Kong XL,Guo Y,Collins R,Bian Z,Peto R,Chen Z,Biobank CK|Chen Z,Chen J,Collins R,Guo Y,Peto R,Wu F,Li L,China Kadoorie Biobank (CKB) collaborative group|Yang L,Li L,Lewington S,Guo Y,Sherliker P,Bian Z,Collins R,Peto R,Liu Y,Yang R,Zhang Y,Li G,Liu S,Chen Z|Du H,Li L,Bennett D,Guo Y,Holmes M,Bian Z,Iona A,Yang L,Millwood I,Chen Y,Collins R,Peto R,Chen Z|Chen Y,Li L,Wang J,Gao H,Clarke R,Guo Y,Bian Z,Peto R,Chen J,Chen Z|Li L,Guo Y,Chen Z,Chen J,Peto R|Lewington S,Li L,Murugasen S,Hong LS,Yang L,Guo Y,Bian Z,Collins R,Chen J,He H,Wu M,He T,Ren X,Meng J,Peto R,Chen Z|Du H,Bennett D,Li L,Whitlock G,Collins R,Guo Y,Peto R,Chen J,Chen Z|Millwood IY,Bennett DA,Walters RG,Clarke R,Waterworth D,Johnson T,Chen Y,Yang L,Guo Y,Bian Z,Hacker A,Yeo A,Parish S,Hill MR,Chissoe S,Peto R,Cardon L,Collins R,Li L,Chen Z|Chen Z,Guo Y,Smith M,Chen J,Collins R,Peto R,Li L|Chen Y,Li L,Zhang Q,Clarke R,Chen J,Guo Y,Bian Z,Pan X,Peto R,Tao R,Shi K,Collins R,Ma L,Sun H,Chen Z|Yang L,Zhou M,Sherliker P,Cai Y,Peto R,Wang L,Millwood I,Smith M,Hu Y,Yang G,Chen Z|Hong LS,Li L,Smith M,Lacey B,Guo Y,Lewington S,Whitlock G,Collins R,Chen J,Peto R,Chen Z|Chen Z,Smith M,Du H,Guo Y,Clarke R,Bian Z,Collins R,Chen J,Qian Y,Wang X,Chen X,Tian X,Wang X,Peto R,Li L|Chen Z,Yang GH,Offer A,Zhou MG,Smith M,Peto R,Ge H,Hu YS,Wang J,Whitlock G|Millwood IY,Bennett DA,Walters RG,Clarke R,Waterworth D,Johnson T,Chen Y,Yang L,Guo Y,Bian Z,Hacker A,Yeo A,Parish S,Hill MR,Chissoe S,Peto R,Cardon L,Collins R,Li L,Chen Z|Du H,Li L,Millwood I,Bragg F,Yang L,Chen Y,Guo Y,Bian Z,Chen J,Collins R,Peto R,Chen Z|Du H,Li L,Bennett D,Guo Y,Key TJ,Bian Z,Sherliker P,Gao H,Chen Y,Yang L,Chen J,Wang S,Du R,Su H,Collins R,Peto R,Chen Z|Bragg F,Li L,Smith M,Guo Y,Chen Y,Millwood I,Bian Z,Walters R,Chen J,Yang L,Collins R,Peto R,Lu Y,Yu B,Xie X,Lei Y,Luo G,Chen Z,China Kadoorie Biobank Collaborative Group|Millwood I,Lee L,Yang L,Yu G,Collins R,Lewington S,Chen J,Peto R,Chen Z|Kurmi O,Li L,Smith M,Augustyn M,Guo Y,Collins R,Peto R,Chen Z|Smith M,Li L,Kurmi O,Augustyn M,Guo Y,Collins R,Peto R,Chen Z|Chen Y,Jiang L,Smith M,Pan H,Collins R,Peto R,Chen Z|Du H,Bennett D,Li L,Whitlock G,Guo Y,Collins R,Chen J,Bian Z,Hong LS,Feng S,Chen X,Chen L,Zhou R,Mao E,Peto R,Chen Z,China Kadoorie Biobank Collaborative Group|Zhang Q,Li L,Smith M,Guo Y,Whitlock G,Bian Z,Kurmi O,Collins R,Chen J,Lv S,Pang Z,Chen C,Chen N,Xiong Y,Peto R,Chen Z,China Kadoorie Biobank study collaboration|Chen Y,Jiang L,Smith M,Xie J,Pan H,Collins R,Chen Z|Bragg F,Li L,Smith M,Guo Y,Yang L,Bian Z,Chen Y,Collins R,Peto R,Chen Z,Biobank CK|Mezuk B,Kendler KS,Chen Y,Yu C,Collins R,Peto R,Chen Z,Li L,Guo Y,Bian Z,Chen J,Pang Z,Wang H,Que X,Zhang H,Tan Z|Chen ZM,Peto R,Iona A,Guo Y,Chen YP,Bian Z,Yang L,Zhang WY,Lu F,Chen JS,Collins R,Li LM|Bragg F,Li L,Bennett D,Guo Y,Yang L,Bian Z,Chen Y,Collins R,Peto R,Chen Z,Biobank CK|Smith M,Li L,Augustyn M,Kurmi O,Chen J,Collins R,Guo Y,Han Y,Qin J,Xu G,Wang J,Bian Z,Zhou G,Peto R,Chen Z|Yang L,Zhou M,Sherliker P,Yang G,Peto R,Wang J,Millwood I,Hu Y,Smith M,Chen Z|Millwood IY,Li L,Smith M,Guo Y,Yang L,Bian Z,Lewington S,Whitlock G,Sherliker P,Collins R,Chen J,Peto R,Wang H,Xu J,He J,Yu M,Liu H,Chen Z,China Kadoorie Biobank collaborative group|Lewington S,Li L,Sherliker P,Yu G,Millwood I,Bian Z,Whitlock G,Yang L,Collins R,Chen J,Wu X,Wang S,Hu Y,Jiang L,Yang L,Lacey B,Peto R,Chen Z,on behalf of the China Kadoorie Biobank study collaboration|Mezuk B,Chen Y,Yu C,Guo Y,Bian Z,Collins R,Chen J,Pang Z,Wang H,Peto R,Que X,Zhang H,Tan Z,Kendler KS,Li L,Chen Z|Li L,Guo Y,Chen Z,Chen J,Peto R|Chen Y,Li L,Zhang Q,Guo Y,Whitlock G,Bian Z,Clarke R,Peto R,Collins R,Chen Z|Kurmi OP,Li L,Wang J,Millwood IY,Chen J,Collins R,Guo Y,Bian Z,Li J,Chen B,Xie K,Jia W,Gao Y,Peto R,Chen Z|Smith M,Zhou M,Wang L,Peto R,Yang G,Chen Z|Lewington S,Lee L,Sherliker P,Collins R,Yu G,Millwood I,Chen J,Yang L,Lacey B,Whitlock G,Peto R,Chen Z|Kurmi OP,Li L,Smith M,Augustyn M,Chen J,Collins R,Guo Y,Han Y,Qin J,Xu G,Wang J,Bian Z,Zhou G,Davis K,Peto R,Chen Z,Li L,Chen Z,Chen J,Collins R,Peto R,Chen Z,Lancaster G,Yang X,Williams A,Smith M,Yang L,Chang Y,Millwood I,Chen Y,Lewington S,Sansome S,Walters R,Kurmi O,Guo Y,Bian Z,Hou C,Tan Y,Wang Z,Cai X,Zhou H,Chen X,Pang Z,Li S,Wang S,Lv S,Zhao Z,Liu S,Pang Z,Yang L,He H,Yu B,Wang S,Wang H,Chen C,Zheng X,Hu X,Zhou M,Wu M,Tao R,Wang Y,Hu Y,Ma L,Zhou R,Tang Z,Chen N,Huang Y,Li M,Gan Z,Meng J,Qin J,Wu X,Zhang N,Luo G,Que X,Chen X,Ge P,Ren X,Dong C,Zhang H,Mao E,Li Z,Zhou G,Feng S,Gao Y,He T,Jiang L,Sun H,Yu M,Su D,Lu F,Qian Y,Shi K,Han Y,Chen L,Li G,Liu H,Yin L,Xiong Y,Tan Z,Jia W|Chen Z,Peto R,Zhou M,Iona A,Smith M,Yang L,Guo Y,Chen Y,Bian Z,Lancaster G,Sherliker P,Pang S,Wang H,Su H,Wu M,Wu X,Chen J,Collins R,Li L|Du H,Li L,Whitlock G,Bennett D,Guo Y,Bian Z,Chen J,Sherliker P,Huang Y,Zhang N,Zheng X,Li Z,Hu R,Collins R,Peto R,Chen Z","||Adult,Age Factors,Aged,Blood Pressure,Body Mass Index,Body Weights and Measures,China,Chronic Disease,Data Collection,Databases,Factual,Genetic,Environment,Female,Follow-Up Studies,Genetic Predisposition to Disease,Genetic Testing,Health Behavior,Humans,Life Style,Male,Middle Aged,Prospective Studies,Residence Characteristics,Rural Population,Sex Factors,Smoking,Socioeconomic Factors,Surveys and Questionnaires|China Kadoorie Biobank Study Collaboration,Humans,Cardiovascular Diseases,Epidemiologic Methods,Seasons,Residence Characteristics,Blood Pressure,Adult,Aged,Middle Aged,China,Female,Male,Cold Temperature||||China Kadoorie Biobank study collaboration,Humans,Reproductive History,Cohort Studies,Prospective Studies,Maternal Age,Parity,Breast Feeding,Pregnancy,Menopause,Menarche,Birth Intervals,Adult,Middle Aged,Rural Population,Urban Population,Educational Status,China,Female||China Kadoorie Biobank Collaborative Group|||Adult,Age Factors,Aged,Alcohol Drinking,Cause of Death,China,Follow-Up Studies,Humans,Male,Middle Aged,Proportional Hazards Models,Prospective Studies,Risk Factors,Smoking||China Kadoorie Biobank Collaborative Group|Adult,Aged,Bias (Epidemiology),Body Mass Index,China,Humans,Male,Middle Aged,Mortality,Proportional Hazards Models,Prospective Studies,Risk Factors|China Kadoorie Biobank Collaborative Group,Humans,Coronary Disease,Arterial Occlusive Diseases,Genetic Predisposition to Disease,Benzaldehydes,Oximes,1-Alkyl-2-acetylglycerophosphocholine Esterase,Middle Aged,China,Female,Male,Stroke,Phospholipase A2 Inhibitors||China Kadoorie Biobank Study,Humans,Fruit,Cardiovascular Diseases,Hypertension,Hyperglycemia,Blood Glucose,Body Mass Index,Diet,Diet Surveys,Proportional Hazards Models,Risk Factors,Follow-Up Studies,Blood Pressure,Adult,Aged,Middle Aged,China,Female,Male|Adult,Aged,Asian Continental Ancestry Group,Blood Glucose,Blood Pressure,Cardiovascular Diseases,China,Cross-Sectional Studies,Databases,Factual,Diabetes Complications,Female,Humans,Logistic Models,Male,Middle Aged,Motor Activity,Prevalence,Self Report,Sex Factors||COPD - diagnosis,Epidemiology,Chronic disease|Epidemiology,Air pollution|COMMIT/CCS-2 collaborative group|Adipose Tissue,Adiposity,Adult,Aged,Body Mass Index,China,Cross-Sectional Studies,Female,Humans,Leisure Activities,Male,Middle Aged,Motor Activity,Obesity,Prevalence,Sedentary Lifestyle,Self Report,Sex Factors,Socioeconomic Factors,Waist Circumference|China,Exhaled carbon monoxide,epidemiology,household air pollution,smoking,Adult,Aged,Air Pollution,Indoor,Biomass,Breath Tests,Carbon Monoxide,Coal,Cough,Environmental Exposure,Exhalation,Female,Heating,Humans,Linear Models,Logistic Models,Male,Middle Aged,Odds Ratio,Pulmonary Disease,Chronic Obstructive,Respiration Disorders,Rural Population,Seasons,Smoke,Smoking,Tobacco Products,Tobacco Smoke Pollution,Tuberculosis,Pulmonary||||China Kadoorie Biobank Collaborative Group,Humans,Lung Neoplasms,Risk Factors,Smoking,Smoking Cessation,Sex Characteristics,Adult,Aged,Middle Aged,China,Female,Male||China Kadoorie Biobank collaborative group,Humans,Asthma,Pulmonary Disease,Chronic Obstructive,Vital Capacity,Forced Expiratory Volume,Spirometry,Body Mass Index,Questionnaires,Prevalence,Odds Ratio,Cross-Sectional Studies,Smoking,Air Pollution,Indoor,Respiration,Adult,Aged,Middle Aged,China,Female,Male,Cooking||Alcohol,China,cohort study,descriptive analysis,drinking,Adult,Age Distribution,Aged,Alcohol Drinking,Cross-Sectional Studies,Female,Health Status,Humans,Life Style,Male,Middle Aged,Prevalence,Risk Factors,Rural Population,Sex Distribution,Socioeconomic Factors,Surveys and Questionnaires,Urban Population|||||Lung,Humans,Pulmonary Disease,Chronic Obstructive,Vital Capacity,Forced Expiratory Volume,Health Surveys,Prevalence,Logistic Models,Odds Ratio,Risk Assessment,Risk Factors,Cross-Sectional Studies,Smoking,Smoking Cessation,Age Factors,Sex Factors,Time Factors,Adult,Aged,Middle Aged,China,Female,Male,Protective Factors|COPD,China,Peak expiratory flow rate,cardiovascular disease,lung cancer,mortality,prospective studies,respiratory-tract disease,Adult,Aged,Cardiovascular Diseases,Cause of Death,Follow-Up Studies,Humans,Male,Middle Aged,Mortality,Neoplasms,Peak Expiratory Flow Rate,Population Surveillance,Predictive Value of Tests,Proportional Hazards Models,Prospective Studies,Regression Analysis,Respiratory Tract Diseases,Risk Factors,Smoking,Time Factors|||China Kadoorie Biobank (CKB) collaborative group,Humans,Mortality,Follow-Up Studies,Prospective Studies,Smoking,Smoking Cessation,Age Distribution,Sex Distribution,Adult,Aged,Middle Aged,Rural Health,Urban Health,China,Female,Male|China Kadoorie Biobank Collaborative Group,Adipose Tissue,Humans,Obesity,Body Mass Index,Exercise,Activities of Daily Living,Cross-Sectional Studies,Motor Activity,Demography,Recreation,Retirement,Work,Adult,Aged,Middle Aged,Occupations,Housekeeping,China,Female,Male,Adiposity,Waist Circumference,Sedentary Lifestyle"
raob0069,raob0189,1,0.3333333333333333,Journal article,Current Molecular Medicine,11/11/2013,Can γH2AX be used to personalise cancer treatment?,"Shah K,Cornelissen B,Kiltie AE,Vallis KA","Antineoplastic Agents,Biomarkers,Tumor,DNA Damage,Diagnostic Imaging,Drug Monitoring,Histones,Humans,Neoplasms"
clme0195,immd0556,1,0.5,Journal article,Epigenomics,01/12/2015,Studying epigenomics in single cells: what is feasible and what can we learn?,"Wills QF,Higgs DR,Mead AJ",
bioc0192,clne0024,7,0.800865800865801,Conference paper|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper,Atherosclerosis|Atherosclerosis|Magnetic Resonance in Medicine|JACC: Cardiovascular Imaging|Journal of the American College of Cardiology Cardiovascular Imaging|Radiology|European Heart Journal,01/07/2015|01/12/2014|26/08/2015|01/04/2012|01/01/2012|11/06/2014|01/09/2014,"IN-VIVO CAROTID PLAQUE CHARACTERISATION USING QUANTITATIVE T-2 MAP: HISTOLOGICAL VALIDATION AND LIPID QUANTIFICATION|IN-VIVO CAROTID PLAQUES CHARACTERISATION USING QUANTITATIVE T2 MAP: HISTOLOGICAL VALIDATION AND LIPID QUANTIFICATION|Large dynamic range relative B1+ mapping.|Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study.|Acute 3T Magnetic Resonance Imaging Reveals Features of Carotid Atherosclerotic Plaque Associated with Ipsilateral Cerebral Infarction in Minor Stroke and Transient Ischemic Attack.|Black-blood multicontrast imaging of carotid arteries with DANTE-prepared 2D and 3D MR imaging.|Characterisation of carotid plaques by in-vivo quantitative T2 mapping: histological validation and lipid quantification","Chai JT,Biasiolli L,Li L,Handa A,Perkins J,Hands L,Sideso E,Jezzard P,Robson MD,Choudhury RP|Chai JT,Biasiolli L,Li L,Handa A,Perkins J,Hands L,Sideso E,Jezzard P,Robson MD,Choudhury RP|Padormo F,Hess AT,Aljabar P,Malik SJ,Jezzard P,Robson MD,Hajnal JV,Koopmans PJ|Lindsay AC,Biasiolli L,Lee JM,Kylintireas I,MacIntosh BJ,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury RP|Lindsay AC,Biasiolli L,Lee JMS,Kylintireas,MacIntosh,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury R|Li L,Chai JT,Biasiolli L,Robson MD,Choudhury RP,Handa AI,Near J,Jezzard P|Chai JT,Biasiolli L,Li L,Handa A,Perkins J,Hands L,Sideso E,Jezzard P,Robson MD,Choudhury RP","|||Aged,Brain,Carotid Arteries,Case-Control Studies,Cerebral Infarction,Diagnosis,Differential,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Magnetic Resonance Imaging,Male,Plaque,Atherosclerotic,Prospective Studies,Risk Factors||Humans,Carotid Stenosis,Image Interpretation,Computer-Assisted,Imaging,Three-Dimensional,Magnetic Resonance Angiography,Case-Control Studies,Adolescent,Adult,Aged,Middle Aged,Male,Signal-To-Noise Ratio|"
clme0220,raob0097,2,0.25,Journal article|Journal article,Oncogene|Oncogene,01/01/2011|30/05/2011,Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α|Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α.,"Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB|Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB","|Base Sequence,Cell Hypoxia,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Molecular Sequence Data,Nuclear Proteins,Promoter Regions,Genetic,Trans-Activators"
immd0082,stat0004,2,0.08060288335517693,Journal article|Journal article,Haematologica: the hematology journal|Nature Genetics,28/05/2013|18/05/2015,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0180,raob0233,1,0.058823529411764705,Journal article,Cancer Cell,,Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.,"Pfister SX,Markkanen E,Jiang Y,Sarkar S,Woodcock M,Orlando G,Mavrommati I,Pai CC,Zalmas LP,Drobnitzky N,Dianov GL,Verrill C,Macaulay VM,Ying S,La Thangue NB,D'Angiolella V,Ryan AJ,Humphrey TC","Cell Line,Tumor,Animals,Mice,Inbred BALB C,Humans,Nude,Neoplasms,Pyrazoles,Pyrimidines,Ribonucleoside Diphosphate Reductase,Histone-Lysine N-Methyltransferase,Nucleotides,Lysine,Cell Cycle Proteins,Nuclear Proteins,Histones,Blotting,Western,Xenograft Model Antitumor Assays,Reverse Transcriptase Polymerase Chain Reaction,Cell Survival,Gene Expression Regulation,Neoplastic,RNA Interference,Amino Acid Sequence,Base Sequence,Sequence Homology,Amino Acid,Nucleic Acid,Methylation,Molecular Sequence Data,Protein-Tyrosine Kinases"
clme0220,clne0024,1,0.2,Journal article,Magnetic Resonance in Medicine,01/01/2015,Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain,"Near J,Edden R,Evans CJ,Paquin R,Harris A,Jezzard P",
clme0485,immd0423,2,0.3333333333333333,Journal article|Journal article,Laboratory Investigation|Virchows Archiv: an international journal of pathology,29/01/2015|01/04/2015,Dentine Matrix Protein (DMP-1): A Marker of Bone Formation and Mineralization in Soft Tissue Tumours|Dentine matrix protein 1 (DMP-1) is a marker of bone formation and mineralisation in soft tissue tumours.,"Athanasou N,Lnagaki Y,Kashima T,Hookway E,Tanaka Y,Hassan A,Oppermann U|Inagaki Y,Kashima TG,Hookway ES,Tanaka Y,Hassan AB,Oppermann U,Athanasou NA","|Biomarkers,Tumor,Calcinosis,Extracellular Matrix Proteins,Humans,Immunohistochemistry,Phosphoproteins,Soft Tissue Neoplasms,Tumor Markers,Biological"
clme0670,raob0069,4,0.3496503496503497,Journal article|Conference paper|Journal article|Conference paper,"Cell Death and Disease|International Journal of Radiation: Oncology - Biology - Physics|Journal of Nuclear Medicine|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",01/01/2012|01/11/2015|01/12/2014|01/05/2013,Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|Effect of PI3K-Inhibition on Normal Lung Tissue Following Irradiation in a Murine Model|Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation,"Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Eccles CL,Thompson J,Smart S,Kersemans V,Allen D,Beech J,Gilchrist S,Kinchesh P,Higgins G,Kartsonaki C,Scudamore C,Muschel R,McKenna WG,Vallis KA|Cornelissen B,Able S,Kartsonaki C,Kersemans V,Allen PD,Cavallo F,Cazier JB,Iezzi M,Knight J,Muschel R,Smart S,Vallis KA|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB","Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents||Animals,Mice,Inbred BALB C,Mammary Neoplasms,Experimental,Precancerous Conditions,DNA Damage,Disease Progression,Immunoconjugates,Radiopharmaceuticals,Tomography,Emission-Computed,Single-Photon,Magnetic Resonance Imaging,Tissue Distribution,Image Processing,Computer-Assisted,Female|"
whgu0172,whgu0378,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
hert0418,whgu0378,1,0.0625,Journal article,Cancer Research,22/04/2014,Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.,"Mouradov D,Sloggett C,Jorissen RN,Love CG,Li S,Burgess AW,Arango D,Strausberg RL,Buchanan D,Wormald S,O'Connor L,Wilding JL,Bicknell D,Tomlinson IP,Bodmer WF,Mariadason JM,Sieber OM","Cell Line,Tumor,Humans,Colorectal Neoplasms,Chromosome Aberrations,DNA Mutational Analysis,Gene Frequency,Gene Dosage,Genes,Neoplasm,Microsatellite Instability,DNA Copy Number Variations,Transcriptome,Exome"
clme0946,olin0014,3,1.05,Journal article|Journal article|Journal article,Nature Reviews: Cancer|Nature Reviews: Cancer|Cancer Cell,01/01/2014|17/07/2014|13/05/2013,Cancer: Pathological nuclear reprogramming?|Cancer: pathological nuclear reprogramming?|Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Goding CR,Pei D,Lu X|Goding CR,Pei D,Lu X|Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","|Animals,Humans,Neoplasms,Cell Transformation,Neoplastic,Isocitrate Dehydrogenase,DNA (Cytosine-5-)-Methyltransferase,Proto-Oncogene Proteins,Epigenesis,Genetic,Nuclear Reprogramming,Tumor Microenvironment|Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
card0018,card0027,25,2.461360371654489,Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article|Conference paper|Conference paper|Journal article|Journal article,Journal of Cardiovascular Magnetic Resonance|Cell Metabolism|Computing in cardiology|Circulation. Heart failure|Cardiovascular Research|Circulation: Cardiovascular Imaging|European Heart Journal|Journal of Cardiovascular Magnetic Resonance|American Heart Journal|Circulation Research|American Heart Journal|Circulation|Circulation Research|Circulation|American Heart Journal|Circulation|J Am Coll Cardiol|Circulation|Journal of Cardiovascular Magnetic Resonance|Circulation|Experimental and Clinical Cardiology|Circulation|Circulation|Circulation: Cardiovascular Imaging|Circulation,03/02/2015|07/03/2012|01/01/2014||21/08/2012|15/10/2012|18/05/2015|01/02/2012|01/01/2015|16/01/2013|01/01/2015|03/11/2015|01/01/2013|22/11/2011|02/02/2015|26/11/2013|11/03/2013|22/11/2011|01/02/2012|22/11/2011|01/01/2014|22/11/2011|22/11/2011|01/03/2013|20/11/2012,"Gender specific patterns of age-related decline in aortic stiffness: a cardiovascular magnetic resonance study including normal ranges.|Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.|Electrocardiographic abnormalities of hypertrophic cardiomyopathy|No Evidence of Myocardial Oxygen Deprivation in Nonischemic Heart Failure.|Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction.|Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.|Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction.|Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden.|Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy|Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice.|Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration|Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction.|Living without creatine: Unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice|Exercise Acutely Exacerbates Derangement Of Cardiac Energy Metabolism In Hypertrophic Cardiomyopathy, a 31 Phosphorus Magnetic Resonance Study at 3 Telsa|Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.|Is the Myocardium Oxygen Deprived in Non Ischemic Heart Failure?|Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.|Adaptations to Maintain Energy Homeostasis Compensate for Creatine-Deficiency in GAMT Knockout Mice Following Myocardial Infarction, but May Contribute to Early Mitochondrial Pathology During Aging|Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.|Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis|A novel cardiac phenotype in patients with GFPT1 or DPAGT1 mutations|Elevated Myocardial Creatine Protects Against Ischemia/Reperfusion Injury by Improving Cardiac Energetics|In Both Hypertrophic And Dilated Cardiomyopathy, Non-contrast T1 Mapping Provides Myocardial Tissue Characterization Beyond That Achieved By Late Gadolinium Enhancement.|Response to letter regarding article, myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.|Familial Bicuspid Aortic Valve Disease Frequently Shows Discordance of Leaflet Fusion Pattern and Extent: Insights from Cardiovascular Magnetic Resonance","Nethononda RM,Lewandowski AJ,Stewart R,Kylinterias I,Whitworth P,Francis J,Leeson P,Watkins H,Neubauer S,Rider OJ|Ashrafian H,Czibik G,Bellahcene M,Aksentijević D,Smith AC,Mitchell SJ,Dodd MS,Kirwan J,Byrne JJ,Ludwig C,Isackson H,Yavari A,Støttrup NB,Contractor H,Cahill TJ,Sahgal N,Ball DR,Birkler RI,Hargreaves I,Tennant DA,Land J,Lygate CA,Johannsen M,Kharbanda RK,Neubauer S,Redwood C,de Cabo R,Ahmet I,Talan M,Günther UL,Robinson AJ,Viant MR,Pollard PJ,Tyler DJ,Watkins H|Minchole A,Ariga R,Neubauer S,Watkins H,Rodriguez B|Dass S,Holloway CJ,Cochlin LE,Rider OJ,Mahmod M,Robson M,Sever E,Clarke K,Watkins H,Ashrafian H,Karamitsos TD,Neubauer S|Lygate CA,Bohl S,ten Hove M,Faller KM,Ostrowski PJ,Zervou S,Medway DJ,Aksentijevic D,Sebag-Montefiore L,Wallis J,Clarke K,Watkins H,Schneider JE,Neubauer S|Dass S,Suttie JJ,Piechnik SK,Ferreira VM,Holloway CJ,Banerjee R,Mahmod M,Cochlin L,Karamitsos TD,Robson MD,Watkins H,Neubauer S|Dass S,Cochlin LE,Suttie JJ,Holloway CJ,Rider OJ,Carden L,Tyler DJ,Karamitsos TD,Clarke K,Neubauer S,Watkins H|Dass S,Cochlin LE,Suttie J,Holloway C,Rodgers CT,Tyler D,Karamitsos T,Clarke K,Watkins H,Neubauer S|Kramer CM,Appelbaum E,Desai MY,Desvigne-Nickens P,DiMarco JP,Friedrich MG,Geller N,Heckler S,Ho CY,Jerosch-Herold M,Ivey EA,Keleti J,Kim DY,Kolm P,Kwong RY,Maron MS,Schulz-Menger J,Piechnik S,Watkins H,Weintraub WS,Wu P,Neubauer S|Lygate CA,Aksentijevic D,Dawson D,ten Hove M,Phillips D,de Bono JP,Medway DJ,Sebag-Montefiore L,Hunyor I,Channon KM,Clarke K,Zervou S,Watkins H,Balaban RS,Neubauer S|Pitcher A,Emberson J,Lacro RV,Sleeper LA,Stylianou M,Mahony L,Pearson GD,Groenink M,Mulder BJ,Zwinderman AH,De Backer J,De Paepe AM,Arbustini E,Erdem G,Jin XY,Flather MD,Mullen MJ,Child AH,Forteza A,Evangelista A,Chiu HH,Wu MH,Sandor G,Bhatt AB,Creager MA,Devereux RB,Loeys B,Forfar JC,Neubauer S,Watkins H,Boileau C,Jondeau G,Dietz HC,Baigent C|Pal N,Sivaswamy N,Mahmod M,Yavari A,Rudd A,Singh S,Dawson DK,Francis JM,Dwight JS,Watkins H,Neubauer S,Frenneaux M,Ashrafian H|Lygate CA,Aksentijevic D,Dawson D,Ten Hove M,Phillips D,De Bono JP,Medway DJ,Sebag-Montefiore L,Hunyor I,Channon KM,Clarke K,Zervou S,Watkins H,Balaban RS,Neubauer S|Dass S,Cochlin LE,Suttie JJ,Holloway C,Rodgers CT,Tyler D,Karamitsos TD,Clarke K,Watkins H,Neubauer S|Kramer CM,Appelbaum E,Desai MY,Desvigne-Nickens P,DiMarco JP,Friedrich MG,Geller N,Heckler S,Ho CY,Jerosch-Herold M,Ivey EA,Keleti J,Kim DY,Kolm P,Kwong RY,Maron MS,Schulz-Menger J,Piechnik S,Watkins H,Weintraub WS,Wu P,Neubauer S|Dass S,Holloway CJ,Suttie J,Mahmod M,Dwight JF,Watkins H,Neubauer S,Karamitsos TD|Karamitsos TD,Dass S,Suttie J,Sever E,Birks J,Holloway CJ,Robson MD,Jerosch-Herold M,Watkins H,Neubauer S|Lygate CA,Aksentijevic D,Dawson D,ten Hove M,Makinen K,Faller KM,Medway DJ,Sebag-Montefiore L,Wallis J,Clarke K,Watkins H,Neubauer S|Dass S,Karamitsos T,Suttie J,Sever E,Jerosch-Herold M,Watkins H,Neubauer S|Suttie JJ,Dass S,Bull S,Holloway C,Banerjee R,Cox P,Pitcher A,Franco BR,Francis J,Schneider J,Robson M,Watkins H,Myerson S,Neubauer S|Lewis AJM,Finlayson S,Mahmod M,Karamitsos TD,Dass S,Ashrafian H,Francis JM,Watkins H,Beeson D,Palace J,Neubauer S|Lygate CA,Bohl S,ten Hove M,Medway DJ,Sebag-Montefiore L,Zervou S,Aksentijevic D,Faller KM,Clarke K,Watkins H,Schneider JE,Neubauer S|Dass S,Suttie JJ,Piechnik SK,Ferreira VM,Holloway C,Karamitsos TD,Robson MD,Watkins H,Neubauer S|Dass S,Suttie JJ,Piechnik SK,Ferreira VM,Holloway CJ,Banerjee R,Mahmod M,Cochlin L,Karamitsos TD,Robson MD,Watkins H,Neubauer S|Bissell MM,Pitcher A,Davis A,Francis JM,Prendergast B,Watkins H,Myerson SG,Neubauer S","Aorta,Humans,Aortic Diseases,Magnetic Resonance Imaging,Cine,Risk Factors,Cross-Sectional Studies,Predictive Value of Tests,Age Factors,Sex Factors,Age Distribution,Sex Distribution,Aging,Elasticity,Reference Values,Adult,Aged,80 and over,Middle Aged,Female,Male,Health Status Disparities,Young Adult,Vascular Stiffness,Pulse Wave Analysis|Animals,Antioxidants,Dimethyl Fumarate,Fumarate Hydratase,Fumarates,Male,Mice,Inbred C57BL,Knockout,Models,Biological,Myocardial Infarction,NF-E2-Related Factor 2,Signal Transduction||Humans,Cardiomyopathy,Dilated,Magnetic Resonance Imaging,Exercise Test,Oxygen Inhalation Therapy,Magnetic Resonance Spectroscopy,Case-Control Studies,Oxygen Consumption,Coronary Circulation,Middle Aged,Female,Male,Heart Failure|Animals,Cell Line,Creatine,Disease Models,Animal,Energy Metabolism,Glycogen,Heart Failure,Magnetic Resonance Imaging,Cine,Membrane Transport Proteins,Mice,Inbred C57BL,Transgenic,Mitochondria,Heart,Mitochondrial Membrane Transport Proteins,Myocardial Infarction,Myocardial Reperfusion Injury,Myocardial Stunning,Myocardium,Necrosis,Oxidative Stress,Phosphocreatine,Time Factors,Up-Regulation,Ventricular Function,Left,Ventricular Remodeling|Cardiomyopathy,Dilated,Hypertrophic,Contrast Media,Female,Gadolinium DTPA,Humans,Magnetic Resonance Imaging,Cine,Male,Middle Aged,Myocardium,Severity of Illness Index|Humans,Cardiomyopathy,Hypertrophic,Ventricular Dysfunction,Left,Phosphocreatine,Adenosine Triphosphate,Magnetic Resonance Angiography,Magnetic Resonance Imaging,Cine,Stroke Volume,Exercise,Magnetic Resonance Spectroscopy,Case-Control Studies,Prospective Studies,Energy Metabolism,Blood Pressure,Heart Rate,Diastole,Adult,Female,Male|||Adenylate Kinase,Animals,Creatine,Exercise Tolerance,Female,Glycine,Guanidinoacetate N-Methyltransferase,Heart Failure,Mice,Inbred C57BL,Knockout,Mitochondria,Heart,Myocardial Infarction,Oxygen Consumption,Physical Conditioning,Animal,Physical Exertion,Ventricular Remodeling||Sinoatrial Node,Humans,Hypertension,Benzazepines,Natriuretic Peptide,Brain,Stroke Volume,Exercise Test,Treatment Failure,Endpoint Determination,Cross-Over Studies,Double-Blind Method,Oxygen Consumption,Heart Rate,Exercise Tolerance,Aged,80 and over,Middle Aged,Female,Male,Heart Failure,Cyclic Nucleotide-Gated Cation Channels,Asymptomatic Diseases,Biomarkers||Energy metabolism,Cardiac MRI,Cardiomyopathy|Heart Ventricles,Humans,Cardiomyopathy,Hypertrophic,Biological Markers,Magnetic Resonance Imaging,Cine,Echocardiography,Doppler,Stroke Volume,Severity of Illness Index,Registries,Morbidity,Follow-Up Studies,Prospective Studies,Time Factors,Adolescent,Adult,Aged,Middle Aged,Female,Male,Young Adult,Genetic Testing,Global Health|Heart failure,Hypoxia,Energy metabolism||Energy metabolism,Creatine kinase,Transgenic models,Heart failure,Mitochondria||Cardiovascular imaging,Lipids,Magnetic resonance imaging,Magnetic resonance spectroscopy,Aortic stenosis||Ischemia reperfusion,Infarct size,Creatine kinase,Energy metabolism,Transgenic models|Cardiomyopathy,Cardiac MRI,Heart failure,Cardiac hypertrophy,Fibrosis|Cardiomyopathy,Dilated,Hypertrophic,Female,Gadolinium DTPA,Humans,Magnetic Resonance Imaging,Cine,Male,Myocardium|Aortic valve,Cardiac MRI,Heart valves"
anat0115,anat0116,5,1.3818181818181818,Journal article|Journal article|Journal article|Journal article|Journal article,Oncogene|Cell Metabolism|PLoS One|Cell Metabolism|The Journal of Cell Biology,05/10/2015||23/11/2015|12/04/2016|25/08/2014,PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer.|Amino Acid Sensing by mTORC1: intracellular Transporters Mark the Spot|Fine-Tuning of PI3K/AKT Signalling by the Tumour Suppressor PTEN Is Required for Maintenance of Flight Muscle Function and Mitochondrial Integrity in Ageing Adult Drosophila melanogaster.|Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot.|BMP-regulated exosomes from Drosophila male reproductive glands reprogram female behavior.,"Fan SJ,Snell C,Turley H,Li JL,McCormick R,Perera SM,Heublein S,Kazi S,Azad A,Wilson C,Harris AL,Goberdhan DC|Goberdhan DCI,Wilson C,Harris AL|Mensah LB,Davison C,Fan SJ,Morris JF,Goberdhan DC,Wilson C|Goberdhan DC,Wilson C,Harris AL|Corrigan L,Redhai S,Leiblich A,Fan SJ,Perera SM,Patel R,Gandy C,Wainwright SM,Morris JF,Hamdy F,Goberdhan DC,Wilson C","||Animals,Drosophila melanogaster,Drosophila Proteins,Signal Transduction,Protein Binding,Female,Proto-Oncogene Proteins c-akt,PTEN Phosphohydrolase,Phosphatidylinositol 3-Kinases||Genitalia,Female,Male,Spermatozoa,Membrane Microdomains,Lysosomes,Secretory Vesicles,Vacuoles,Epithelial Cells,Animals,Drosophila melanogaster,Drosophila Proteins,Bone Morphogenetic Proteins,Signal Transduction,Membrane Fusion,Protein Transport,Sexual Behavior,Animal,Exosomes,Multivesicular Bodies,Antigens,CD63"
immd0316,stat0054,1,0.14285714285714285,Conference paper,Cancer Research,15/11/2015,Distinct roles of copy number and loss-of-heterozygosity in predicting prognosis for breast cancer patients,"van Stiphout RGPM,deWeck A,Winchester L,Haider SA,Ragoussis J,Harris AL,Holmes C,Buffa FM",
clme0135,ndos0097,1,0.08333333333333333,Journal article,Carcinogenesis,09/07/2012,"CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC.","Biswas S,Charlesworth PJ,Turner GD,Leek R,Thamboo PT,Campo L,Turley H,Dildey P,Protheroe A,Cranston D,Gatter KC,Pezzella F,Harris AL","Adult,Aged,80 and over,Angiogenesis Inhibitors,Antigens,CD31,Basic Helix-Loop-Helix Transcription Factors,Biomarkers,Tumor,Carcinoma,Renal Cell,Cyclin D1,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Kidney Neoplasms,Middle Aged,Prognosis"
immd0036,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
corp0784,quee1607,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
dplb0149,magd1571,1,0.1111111111111111,Journal article,Chemical Science,01/01/2011,Surface plasmon resonance imaging of glycoarrays identifies novel and unnatural carbohydrate-based ligands for potential ricin sensor development,"Fais M,Karamanska R,Allman S,Fairhurst SA,Innocenti P,Fairbanks AJ,Donohoe TJ,Davis BG,Russell DA,Field RA",
clme0439,clme0497,1,0.05,Journal article,Cancer Cell,13/05/2013,Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
bioc0268,immd0023,1,0.16666666666666666,Journal article,Journal of Immunology,01/01/2011,Diverse endogenous antigens for mouse NKT cells: Self-antigens that are not glycosphingolipids,"Pei B,Speak AO,Shepherd D,Butters T,Cerundolo V,Platt FM,Kronenberg M",
immd0330,phpc0228,2,1.0,Journal article|Journal article,Pharmacogenomics|The Patient: Patient Centered Outcomes Research,01/11/2013|,Issues surrounding the health economic evaluation of genomic technologies.|Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment.,"Buchanan J,Wordsworth S,Schuh A|Buchanan J,Wordsworth S,Schuh A","Cost-Benefit Analysis,Genomics,Humans,Technology|"
clme0149,immd0023,2,0.26666666666666666,Journal article|Journal article,eLife|PLoS One,01/01/2014|01/01/2011,Autophagy is a critical regulator of memory CD8(+) T cell formation.|A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus.,"Puleston DJ,Zhang H,Powell TJ,Lipina E,Sims S,Panse I,Watson AS,Cerundolo V,Townsend AR,Klenerman P,Simon AK|Hutchinson S,Sims S,O'Hara G,Silk J,Gileadi U,Cerundolo V,Klenerman P","CD4-Positive T-Lymphocytes,CD8-Positive T-Lymphocytes,Mitochondria,Animals,Mice,Lymphocytic choriomeningitis virus,Reactive Oxygen Species,Microtubule-Associated Proteins,Viral Vaccines,Epitopes,Lymphocyte Count,Immunization,Secondary,Apoptosis,Cell Differentiation,Cell Proliferation,Cell Survival,Immunologic Memory,Phenotype,Autophagy,Glucose Transporter Type 1|Amino Acid Sequence,Animals,CD8-Positive T-Lymphocytes,Herpesviridae Infections,Immunity,Cellular,Immunodominant Epitopes,Mice,Inbred C57BL,Knockout,Models,Biological,Muromegalovirus,Proteasome Endopeptidase Complex,Time Factors"
immd0452,immd0499,1,0.125,Journal article,Cell Reports,14/05/2014,BRCA2 coordinates the activities of cell-cycle kinases to promote genome stability.,"Yata K,Bleuyard JY,Nakato R,Ralf C,Katou Y,Schwab RA,Niedzwiedz W,Shirahige K,Esashi F","Hela Cells,Humans,Genomic Instability,Exonucleases,Protein-Serine-Threonine Kinases,Cell Cycle Proteins,Proto-Oncogene Proteins,BRCA2 Protein,DNA Replication,Protein Binding,Cyclin-Dependent Kinase 2,HEK293 Cells"
gree1192,ndos0461,1,0.006666666666666667,Journal article,Human Molecular Genetics,12/10/2012,A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.,"Amin Al Olama A,Kote-Jarai Z,Schumacher FR,Wiklund F,Berndt SI,Benlloch S,Giles GG,Severi G,Neal DE,Hamdy FC,Donovan JL,Hunter DJ,Henderson BE,Thun MJ,Gaziano M,Giovannucci EL,Siddiq A,Travis RC,Cox DG,Canzian F,Riboli E,Key TJ,Andriole G,Albanes D,Hayes RB,Schleutker J,Auvinen A,Tammela TL,Weischer M,Stanford JL,Ostrander EA,Cybulski C,Lubinski J,Thibodeau SN,Schaid DJ,Sorensen KD,Batra J,Clements JA,Chambers S,Aitken J,Gardiner RA,Maier C,Vogel W,Dörk T,Brenner H,Habuchi T,Ingles S,John EM,Dickinson JL,Cannon-Albright L,Teixeira MR,Kaneva R,Zhang HW,Lu YJ,Park JY,Cooney KA,Muir KR,Leongamornlert DA,Saunders E,Tymrakiewicz M,Mahmud N,Guy M,Govindasami K,O'Brien LT,Wilkinson RA,Hall AL,Sawyer EJ,Dadaev T,Morrison J,Dearnaley DP,Horwich A,Huddart RA,Khoo VS,Parker CC,Van As N,Woodhouse CJ,Thompson A,Dudderidge T,Ogden C,Cooper CS,Lophatonanon A,Southey MC,Hopper JL,English D,Virtamo J,Le Marchand L,Campa D,Kaaks R,Lindstrom S,Diver WR,Gapstur S,Yeager M,Cox A,Stern MC,Corral R,Aly M,Isaacs W,Adolfsson J,Xu J,Zheng SL,Wahlfors T,Taari K,Kujala P,Klarskov P,Nordestgaard BG,Røder MA,Frikke-Schmidt R,Bojesen SE,FitzGerald LM,Kolb S,Kwon EM,Karyadi DM,Orntoft TF,Borre M,Rinckleb A,Luedeke M,Herkommer K,Meyer A,Serth J,Marthick JR,Patterson B,Wokolorczyk D,Spurdle A,Lose F,McDonnell SK,Joshi AD,Shahabi A,Pinto P,Santos J,Ray A,Sellers TA,Lin HY,Stephenson RA,Teerlink C,Muller H,Rothenbacher D,Tsuchiya N,Narita S,Cao GW,Slavov C,Mitev V,UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology,UK ProtecT Study Collaborators,Australian Prostate Cancer Bioresource,PRACTICAL Consortium,Chanock S,Gronberg H,Haiman CA,Kraft P,Easton DF,Eeles RA","Case-Control Studies,Disease Progression,Genetic Predisposition to Disease,Genome-Wide Association Study,Humans,Male,Odds Ratio,Polymorphism,Single Nucleotide,Prostatic Neoplasms,Quantitative Trait Loci,Reproducibility of Results"
bioc0128,path0107,1,0.1,Journal article,Nucleic Acids Research,29/03/2012,Analysis of C. elegans intestinal gene expression and polyadenylation by fluorescence-activated nuclei sorting and 3'-end-seq.,"Haenni S,Ji Z,Hoque M,Rust N,Sharpe H,Eberhard R,Browne C,Hengartner MO,Mellor J,Tian B,Furger A","Animals,Caenorhabditis elegans,Cell Fractionation,Cell Nucleus,Flow Cytometry,Gene Expression Profiling,High-Throughput Nucleotide Sequencing,Intestines,Polyadenylation,Sequence Analysis,RNA,Transcriptome"
raob0097,raob0128,2,0.3333333333333333,Journal article|Journal article,Radiotherapy and Oncology|Radiotherapy and Oncology,01/01/2012|30/04/2012,Radiosensitization of renal cell carcinoma in vitro through the induction of autophagy|Radiosensitization of renal cell carcinoma in vitro through the induction of autophagy.,"Anbalagan S,Pires IM,Blick C,Hill MA,Ferguson DJP,Chan DA,Hammond EM|Anbalagan S,Pires IM,Blick C,Hill MA,Ferguson DJ,Chan DA,Hammond EM","|Antineoplastic Agents,Autophagy,Carcinoma,Renal Cell,Cell Cycle,Cell Hypoxia,Cell Line,Tumor,Cell Survival,Humans,Kidney Neoplasms,Mutation,Pyridines,Radiation Dosage,Radiation Tolerance,Sirolimus,Thiazoles,Tumor Stem Cell Assay,Von Hippel-Lindau Tumor Suppressor Protein"
clme0220,clne0083,1,0.14285714285714285,Journal article,Histopathology,01/02/2012,Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma.,"Jubb AM,Browning L,Campo L,Turley H,Steers G,Thurston G,Harris AL,Ansorge O","Adult,Aged,Biomarkers,Tumor,Brain Neoplasms,Calcium-Binding Proteins,Cerebrovascular Circulation,DNA,Neoplasm,Endothelium,Vascular,Female,Gene Expression,Glioblastoma,Humans,In Situ Hybridization,Intercellular Signaling Peptides and Proteins,Male,Membrane Proteins,Middle Aged"
lina0435,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0946,ndos0532,2,0.15476190476190477,Journal article|Journal article,Oncotarget|Cell Death and Disease,19/12/2015|01/01/2014,Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.|Nuclear iASPP may facilitate prostate cancer progression.,"Verrill C,Cerundolo L,Mckee C,White M,Kartsonaki C,Fryer E,Morris E,Brewster S,Ratnayaka I,Marsden L,Lilja H,Muschel R,Lu X,Hamdy F,Bryant RJ|Morris EV,Cerundolo L,Lu M,Verrill C,Fritzsche F,White MJ,Thalmann GN,ten Donkelaar CS,Ratnayaka I,Salter V,Hamdy FC,Lu X,Bryant RJ","|Prostate,Epithelium,Cell Line,Tumor,Cell Nucleus,Animals,Humans,Mice,Prostatic Neoplasms,Neoplasm Invasiveness,Disease Progression,Intracellular Signaling Peptides and Proteins,Tumor Suppressor Proteins,Repressor Proteins,Prognosis,Coculture Techniques,Multivariate Analysis,Cohort Studies,Cell Differentiation,Phosphorylation,Phenotype,Adult,Aged,Middle Aged,Male,Biomarkers"
immd0330,path0511,7,0.7022578728461082,Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Conference paper,Leukaemia|New England Journal of Medicine|Leukemia|Cancer Cell|Blood|Blood|British Journal of Haematology,|01/01/2012|22/10/2012|18/01/2011|27/03/2013|18/11/2011|01/04/2012,"Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.|Germline JAK2 mutation in a family with hereditary thrombocytosis|Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.|Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.|Impact of isolated germline JAK2V617I mutation on human hematopoiesis.|Germline Activating JAK2 V617I Mutation, in a Family with Hereditary Thrombocytosis|Germline activating JAK2-mutation in a family with hereditary thrombocytosis","Lutz C,Woll PS,Hall G,Castor A,Dreau H,Cassaniga G,Zuna J,Jensen C,Clark SA,Biondi A,Mitchell C,Ferry H,Schuh A,Buckle V,Jaconsen SE,Enver T|Mead AJ,Rugless MJ,Jacobsen SEW,Schuh A|Lutz C,Woll PS,Hall G,Castor A,Dreau H,Cazzaniga G,Zuna J,Jensen C,Clark SA,Biondi A,Mitchell C,Ferry H,Schuh A,Buckle V,Jacobsen SE,Enver T|Goardon N,Marchi E,Atzberger A,Quek L,Schuh A,Soneji S,Woll P,Mead A,Alford KA,Rout R,Chaudhury S,Gilkes A,Knapper S,Beldjord K,Begum S,Rose S,Geddes N,Griffiths M,Standen G,Sternberg A,Cavenagh J,Hunter H,Bowen D,Killick S,Robinson L,Price A,Macintyre E,Virgo P,Burnett A,Craddock C,Enver T,Jacobsen SE,Porcher C,Vyas P|Mead AJ,Chowdhury O,Pecquet C,Dusa A,Woll P,Atkinson D,Burns A,Score J,Rugless M,Clifford R,Moule S,Bienz N,Vyas P,Cross N,Gale RE,Henderson S,Constantinescu SN,Schuh A,Jacobsen SE|Mead AJ,Rugless M,Woll P,Clifford R,Atkinson D,Moule S,Bienz N,Wainscoat JS,Vyas P,Henderson S,Jacobsen SEW,Schuh A|Mead A,Rugless M,Woll P,Clifford R,Chowdhury O,Dusa A,Pecquet C,Atkinson D,Gatter K,Moule S,Bienz N,Wainscoat J,Vyas P,Gale R,Henderson S,Constantinescu S,Jacobsen S,Schuh A","||Cell Cycle,Child,Preschool,Female,Humans,Infant,Male,Neoplasm,Residual,Precursor Cell Lymphoblastic Leukemia-Lymphoma|Adult,Aged,80 and over,Animals,Antigens,CD,CD34,CD45,Cell Differentiation,Cell Lineage,Gene Expression Profiling,Graft Survival,Granulocyte-Macrophage Progenitor Cells,Hematopoietic Stem Cells,Humans,Immunophenotyping,Leukemia,Myeloid,Acute,Lymphoid Progenitor Cells,Mice,Inbred NOD,SCID,Middle Aged,Neoplastic Stem Cells,Transplantation,Heterologous,Young Adult|Adult,Amino Acid Substitution,Animals,Cells,Cultured,Family,Female,Germ-Line Mutation,Hematopoiesis,Humans,Isoleucine,Janus Kinase 2,Male,Mice,Inbred NOD,Transgenic,Middle Aged,Myeloproliferative Disorders,Valine||"
card0008,clme0195,1,0.06666666666666667,Journal article,Mammalian Genome,27/04/2012,Nprl3 is required for normal development of the cardiovascular system.,"Kowalczyk MS,Hughes JR,Babbs C,Sanchez-Pulido L,Szumska D,Sharpe JA,Sloane-Stanley JA,Morriss-Kay GM,Smoot LB,Roberts AE,Watkins H,Bhattacharya S,Gibbons RJ,Ponting CP,Wood WG,Higgs DR","Abnormalities,Multiple,Amino Acid Sequence,Animals,Cardiovascular System,Cells,Cultured,DNA Mutational Analysis,Female,GTPase-Activating Proteins,Gene Expression Profiling,Genetic Association Studies,Heart Defects,Congenital,Humans,Intracellular Signaling Peptides and Proteins,Male,Mice,Knockout,Molecular Sequence Annotation,Molecular Sequence Data,Myocardium,Nuclear Proteins,Phenotype,Polymorphism,Single Nucleotide,Promoter Regions,Genetic"
raob0128,raob0168,5,0.7386363636363635,Journal article|Journal article|Journal article|Journal article|Journal article,Physical Review Special Topics: Accelerators and Beams|British Journal of Radiology|Physica Medica: an international journal devoted to the applications of physics to medicine and biology|Physica Medica: an international journal devoted to the applications of physics to medicine and biology|Clinical Oncology,11/03/2013|11/04/2012|21/01/2014|01/06/2014|01/04/2011,Conceptual design of a nonscaling fixed field alternating gradient accelerator for protons and carbon ions for charged particle therapy|Revisiting the ultra-high dose rate effect: implications for charged particle radiotherapy using protons and light ions.|Under-response correction for EBT3 films in the presence of proton spread out Bragg peaks.|Under-response correction for EBT3 films in the presence of proton spread out Bragg peaks|Development of an Experimental Beam-line for Radiobiological Studies Relevant to Particle Radiotherapy,"Peach KJ,Aslaninejad M,Barlow RJ,Beard CD,Bliss N,Cobb JH,Easton MJ,Edgecock TR,Fenning R,Gardner ISK,Hill MA,Owen HL,Johnstone CJ,Jones B,Jones T,Kelliher DJ,Khan A,Machida S,McIntosh PA,Pattalwar S,Pasternak J,Pozimski J,Prior CR,Rochford J,Rogers CT,Seviour R,Sheehy SL,Smith SL,Strachan J,Tygier S,Vojnovic B,Wilson P,Witte H,Yokoi T|Wilson P,Jones B,Yokoi T,Hill M,Vojnovic B|Fiorini F,Kirby D,Thompson J,Green S,Parker DJ,Jones B,Hill MA|Fiorini F,Kirby D,Thompson J,Green S,Parker DJ,Jones B,Hill MA|Green S,Parker DJ,Zare E,Ezzawam W,Kirby DJ,Fiorini F,Hill M,Jones B,Palmans H","|Cell Hypoxia,Cell Survival,Humans,Ions,Neoplasms,Oxygen,Particle Accelerators,Protons,Radiation Tolerance,Radiotherapy Dosage,Radiotherapy,High-Energy,Tumor Cells,Cultured|3D dosimetry,EBT3 Gafchromic films,FLUKA Monte Carlo code,Under-response correction,Calibration,Film Dosimetry,Phantoms,Imaging,Protons,Water||"
claridge,clme0240,1,0.0625,Journal article,PLoS One,01/01/2015,Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.,"Chan MC,Atasoylu O,Hodson E,Tumber A,Leung IK,Chowdhury R,Gómez-Pérez V,Demetriades M,Rydzik AM,Holt-Martyn J,Tian YM,Bishop T,Claridge TD,Kawamura A,Pugh CW,Ratcliffe PJ,Schofield CJ","Brain,Hela Cells,Animals,Humans,Mice,Triazoles,Enzyme Inhibitors,Stroke,MCF-7 Cells,Hypoxia-Inducible Factor-Proline Dioxygenases"
whgu0274,whgu0378,7,1.3917528223410576,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Pathology|Journal of Pathology|Biochimica et Biophysica Acta: international journal of biochemistry and biophysics|Journal of Pathology|Molecular and Cellular Biology|BBA: Bioenergetics|Nature,01/01/2012|01/01/2011|13/07/2011|26/07/2011|29/05/2012|01/01/2011|01/01/2011,"The C-terminus of Apc does not influence intestinal adenoma development or progression|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|SDH mutations in cancer.|The C-terminus of Apc does not influence intestinal adenoma development or progression.|Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.|SDH mutations in cancer|Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase","Lewis A,Davis H,Deheragoda M,Pollard P,Nye E,Jeffery R,Segditsas S,East P,Poulsom R,Stamp G,Wright N,Tomlinson I|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Bardella C,Pollard PJ,Tomlinson I|Lewis A,Davis H,Deheragoda M,Pollard P,Nye E,Jeffery R,Segditsas S,East P,Poulsom R,Stamp G,Wright N,Tomlinson I|Bardella C,Olivero M,Lorenzato A,Geuna M,Adam J,O'Flaherty L,Rustin P,Tomlinson I,Pollard PJ,Di Renzo MF|Bardella C,Pollard PJ,Tomlinson I|Frezza C,Zheng L,Folger O,Rajagopalan KN,MacKenzie ED,Jerby L,Micaroni M,Chaneton B,Adam J,Hedley A,Kalna G,Tomlinson IPM,Pollard PJ,Watson DG,Deberardinis RJ,Shlomi T,Ruppin E,Gottlieb E","|Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid|Animals,Genes,Tumor Suppressor,Humans,Isoenzymes,Mitochondria,Mutation,Neoplasms,Protein Subunits,Succinate Dehydrogenase|Adenoma,Adenomatous Polyposis Coli Protein,Animals,Blotting,Western,Cell Movement,Disease Progression,Fluorescent Antibody Technique,Immunohistochemistry,In Situ Hybridization,Intestinal Neoplasms,Mice,Inbred C57BL,Mutant Strains,Oligonucleotide Array Sequence Analysis,Protein Structure,Tertiary,Signal Transduction,Wnt Signaling Pathway|AMP-Activated Protein Kinases,Animals,Apoptosis,Basic Helix-Loop-Helix Transcription Factors,Cell Line,Fumarate Hydratase,Fumarates,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Kidney Neoplasms,Leiomyomatosis,Mice,Mitogen-Activated Protein Kinase 1,Mitogen-Activated Protein Kinase 3,Neoplastic Syndromes,Hereditary,RNA Interference,RNA,Small Interfering,Reactive Oxygen Species,Signal Transduction,Skin Neoplasms,Tumor Suppressor Proteins,Uterine Neoplasms||"
darby,raob0069,2,0.4,Conference paper|Journal article,Medical Physics|Medical Physics,01/06/2015|01/06/2015,Robustness Analysis of Proton Breast Treatments Using An Alpha-Stable Distribution Parameterization|SU-F-BRD-04: Robustness Analysis of Proton Breast Treatments Using An Alpha-Stable Distribution Parameterization.,"Van den Heuvel F,Hackett S,Fiorini F,Taylor C,Darby S,Vallis K|Van den Heuvel F,Hackett S,Fiorini F,Taylor C,Darby S,Vallis K",|
bioc0801,ocms0037,2,0.17142857142857143,Journal article|Journal article,eLife|eLife,01/01/2013|15/12/2012,Epigenetic conservation at gene regulatory elements revealed by non-methylated DNA profiling in seven vertebrates.|KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.,"Long HK,Sims D,Heger A,Blackledge NP,Kutter C,Wright ML,Grützner F,Odom DT,Patient R,Ponting CP,Klose RJ|Farcas AM,Blackledge NP,Sudbery I,Long HK,McGouran JF,Rose NR,Lee S,Sims D,Cerase A,Sheahan TW,Koseki H,Brockdorff N,Ponting CP,Kessler BM,Klose RJ","Chicken,Chromatin,CpG islands,DNA methylation,Epigenetics,Evolutionary conservation,Human,Mouse,Xenopus,Zebrafish,Animals,Base Sequence,Biological Evolution,Chickens,Chromatin Assembly and Disassembly,Conserved Sequence,CpG Islands,DNA Methylation,Databases,Genetic,Epigenesis,Gene Expression Profiling,Humans,Lizards,Mice,Platypus,Promoter Regions,Species Specificity|Chicken,Chromatin,CpG island,Demethylase,Epigenetics,Human,Methylation,Mouse,Transcription,Xenopus,Zebrafish,Animals,Cell Line,Tumor,CpG Islands,DNA Methylation,F-Box Proteins,Gene Silencing,Genome,Histones,Humans,Jumonji Domain-Containing Histone Demethylases,Mice,Polycomb-Group Proteins,Ubiquitination"
clme0975,raob0061,1,0.08333333333333333,Journal article,Clinical Cancer Research,10/01/2012,Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors.,"Patterson DM,Zweifel M,Middleton MR,Price PM,Folkes LK,Stratford MR,Ross P,Halford S,Peters J,Balkissoon J,Chaplin DJ,Padhani AR,Rustin GJ","Adult,Aged,Angiogenesis Inhibitors,Antineoplastic Agents,Diphosphates,Female,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Neoplasms,Stilbenes,Treatment Outcome,Young Adult"
stat0004,stat0059,8,0.561181362497152,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Nature Genetics|PLoS Genetics|BMJ Open|European Journal of Human Genetics|PLoS Genetics|Science|Proceedings of the National Academy of Sciences of USA|Science,01/03/2012|01/03/2012|01/01/2012|10/08/2011|01/07/2011|01/01/2012|01/01/2012|01/01/2013,Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.|Genomic tools for evolution and conservation in the chimpanzee: Pan troglodytes ellioti is a genetically distinct population.|A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance.|People of the British Isles: preliminary analysis of genotypes and surnames in a UK-control population.|Recombination and population structure in Salmonella enterica.|A fine-scale chimpanzee genetic map from population sequencing.|Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease|Multiple Instances of Ancient Balancing Selection Shared Between Humans and Chimpanzees,"Golubchik T,Brueggemann AB,Street T,Gertz RE,Spencer CC,Ho T,Giannoulatou E,Link-Gelles R,Harding RM,Beall B,Peto TE,Moore MR,Donnelly P,Crook DW,Bowden R|Bowden R,MacFie TS,Myers S,Hellenthal G,Nerrienet E,Bontrop RE,Freeman C,Donnelly P,Mundy NI|Eyre DW,Golubchik T,Gordon NC,Bowden R,Piazza P,Batty EM,Ip CL,Wilson DJ,Didelot X,O'Connor L,Lay R,Buck D,Kearns AM,Shaw A,Paul J,Wilcox MH,Donnelly PJ,Peto TE,Walker AS,Crook DW|Winney B,Boumertit A,Day T,Davison D,Echeta C,Evseeva I,Hutnik K,Leslie S,Nicodemus K,Royrvik EC,Tonks S,Yang X,Cheshire J,Longley P,Mateos P,Groom A,Relton C,Bishop DT,Black K,Northwood E,Parkinson L,Frayling TM,Steele A,Sampson JR,King T,Dixon R,Middleton D,Jennings B,Bowden R,Donnelly P,Bodmer W|Didelot X,Bowden R,Street T,Golubchik T,Spencer C,McVean G,Sangal V,Anjum MF,Achtman M,Falush D,Donnelly P|Auton A,Fledel-Alon A,Pfeifer S,Venn O,Ségurel L,Street T,Leffler EM,Bowden R,Aneas I,Broxholme J,Humburg P,Iqbal Z,Lunter G,Maller J,Hernandez RD,Melton C,Venkat A,Nobrega MA,Bontrop R,Myers S,Donnelly P,Przeworski M,McVean G|Young BC,Golubchik T,Batty EM,Fung R,Larner-Svensson H,Votintseva AA,Miller RR,Godwin H,Knox K,Everitt RG,Iqbal Z,Rimmer AJ,Cule M,Ip CLC,Didelot X,Harding RM,Donnelly P,Peto TE,Crook DW,Bowden R,Wilsona DJ|Leffler EM,Gao Z,Pfeifer S,Ségurel L,Auton A,Venn O,Bowden R,Bontrop R,Wall JD,Sella G,Donnelly P,Mcvean G,Przeworski M","Base Sequence,Computational Biology,DNA Primers,Genome,Bacterial,Metagenomics,Molecular Sequence Data,Pneumococcal Vaccines,Pneumonia,Polymorphism,Restriction Fragment Length,Recombination,Genetic,Selection,Sequence Analysis,DNA,Species Specificity,Streptococcus pneumoniae,United States|Animals,Biological Evolution,DNA,Mitochondrial,Genetic Speciation,Genetic Variation,Genome,Haplotypes,Pan troglodytes,Polymorphism,Single Nucleotide,Population Dynamics,Sequence Analysis||Adolescent,Adult,Aged,80 and over,Alleles,Female,Gene Frequency,Genetics,Population,Genotype,Great Britain,Haplotypes,Humans,Male,Middle Aged,Names,Young Adult|Genetic Linkage,Genome,Bacterial,Recombination,Genetic,Salmonella enterica|Animals,Base Sequence,Chromosome Mapping,Chromosomes,Human,Pair 2,Mammalian,CpG Islands,Evolution,Molecular,Female,Genetic Variation,Haplotypes,High-Throughput Nucleotide Sequencing,Histone-Lysine N-Methyltransferase,Humans,Male,Pan troglodytes,Polymorphism,Single Nucleotide,Recombination,Genetic,Sequence Analysis,DNA,Species Specificity||"
clme0195,ocms0037,4,0.42142857142857143,Journal article|Journal article|Journal article|Journal article,Mammalian Genome|Haematologica: the hematology journal|eLife|Genome Biology: biology for the post-genomic era,27/04/2012|28/05/2013|01/01/2014|29/11/2013,Nprl3 is required for normal development of the cardiovascular system.|Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.|Considerations when investigating lncRNA function in vivo.|Chromatin signatures at transcriptional start sites separate two equally populated yet distinct classes of intergenic long noncoding RNAs.,"Kowalczyk MS,Hughes JR,Babbs C,Sanchez-Pulido L,Szumska D,Sharpe JA,Sloane-Stanley JA,Morriss-Kay GM,Smoot LB,Roberts AE,Watkins H,Bhattacharya S,Gibbons RJ,Ponting CP,Wood WG,Higgs DR|Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ|Bassett AR,Akhtar A,Barlow DP,Bird AP,Brockdorff N,Duboule D,Ephrussi A,Ferguson-Smith AC,Gingeras TR,Haerty W,Higgs DR,Miska EA,Ponting CP|Marques AC,Hughes J,Graham B,Kowalczyk MS,Higgs DR,Ponting CP","Abnormalities,Multiple,Amino Acid Sequence,Animals,Cardiovascular System,Cells,Cultured,DNA Mutational Analysis,Female,GTPase-Activating Proteins,Gene Expression Profiling,Genetic Association Studies,Heart Defects,Congenital,Humans,Intracellular Signaling Peptides and Proteins,Male,Mice,Knockout,Molecular Sequence Annotation,Molecular Sequence Data,Myocardium,Nuclear Proteins,Phenotype,Polymorphism,Single Nucleotide,Promoter Regions,Genetic|Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary|Animals,Humans,Mice,Rats,Drosophila melanogaster,Transcription,Genetic,Genotype,Phenotype,Mutation,Genome,Regulatory Elements,Transcriptional,Genetic Loci,RNA,Long Noncoding|Chromatin,Animals,Mice,Inbred C57BL,Histones,RNA,Messenger,Sequence Analysis,DNA,Evolution,Molecular,Gene Expression Regulation,Protein Structure,Tertiary,Transcription Initiation Site,Promoter Regions,Genetic,Genetic Loci,Transcriptome,Long Noncoding"
bioc0416,chem0068,3,0.29292929292929293,Journal article|Journal article|Conference paper,Journal of Nuclear Medicine|Annals of Clinical and Translational Neurology|Journal of Neuroimmunology,16/01/2014|01/09/2014|15/10/2014,Glial activation in the early stages of brain metastasis: TSPO as a diagnostic biomarker.|Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.|Anti-CD20 therapy down-regulates lesion formation and microglial activation in pattern I and pattern II rat models of multiple sclerosis,"O'Brien ER,Kersemans V,Tredwell M,Checa B,Serres S,Soto MS,Gouverneur V,Leppert D,Anthony DC,Sibson NR|Anthony DC,Dickens AM,Seneca N,Couch Y,Campbell S,Checa B,Kersemans V,Warren EA,Tredwell M,Sibson NR,Gouverneur V,Leppert D|Anthony DC,Dickens AM,Seneca N,Couch Y,Campbell S,Checa B,Kersemans V,Warren EA,Tredwell M,Sibson NR,Gouverneur V,Leppert D","SPECT imaging,TSPO,astrocytes,metastasis,microglia,mouse,Acetamides,Animals,Astrocytes,Biomarkers,Tumor,Brain Neoplasms,Female,Gadolinium,Gene Expression Regulation,Neoplastic,Green Fluorescent Proteins,Immunohistochemistry,Ligands,Magnetic Resonance Imaging,Mice,Inbred BALB C,Microglia,Microscopy,Fluorescence,Neoplasm Metastasis,Neoplasm Transplantation,Neuroglia,Protein Binding,Pyrazoles,Pyrimidines,Receptors,GABA,Time Factors,Tomography,Emission-Computed,Single-Photon||"
clme0149,clme0193,1,0.09090909090909091,Journal article,Journal of Allergy and Clinical Immunology,19/10/2014,Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk.,"Xue L,Fergusson J,Salimi M,Panse I,Ussher JE,Hegazy AN,Vinall SL,Jackson DG,Hunter MG,Pettipher R,Ogg G,Klenerman P","Neutrophils,Th2 Cells,Humans,Leukotriene E4,Prostaglandin D2,Cell Adhesion Molecules,Inflammation Mediators,Cluster Analysis,Gene Expression Profiling,Cell Communication,Apoptosis,Chemotaxis,Leukocyte,Gene Expression,Drug Synergism"
clme0240,whgu0274,4,0.2783116883116883,Journal article|Journal article|Journal article|Journal article,Cancer Cell|Cell Reports|Journal of Pathology|The Journal of Physiology,18/10/2011|01/05/2013|01/01/2011|01/01/2012,Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.|A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: Insights from genetically modified mice,"Adam J,Hatipoglu E,O'Flaherty L,Ternette N,Sahgal N,Lockstone H,Baban D,Nye E,Stamp GW,Wolhuter K,Stevens M,Fischer R,Carmeliet P,Maxwell PH,Pugh CW,Frizzell N,Soga T,Kessler BM,El-Bahrawy M,Ratcliffe PJ,Pollard PJ|Adam J,Yang M,Bauerschmidt C,Kitagawa M,O'Flaherty L,Maheswaran P,Özkan G,Sahgal N,Baban D,Kato K,Saito K,Iino K,Igarashi K,Stratford M,Pugh C,Tennant DA,Ludwig C,Davies B,Ratcliffe PJ,El-Bahrawy M,Ashrafian H,Soga T,Pollard PJ|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Chen RL,Nagel S,Papadakis M,Bishop T,Pollard P,Ratcliffe PJ,Pugh CW,Buchan AM","Adaptor Proteins,Signal Transducing,Animals,Antioxidants,Cell Hypoxia,Cytoskeletal Proteins,Fumarate Hydratase,Fumarates,Gene Expression Regulation,Neoplastic,Hypoxia-Inducible Factor 1,Kidney Diseases,Cystic,Mice,NF-E2-Related Factor 2,Procollagen-Proline Dioxygenase,Signal Transduction,Succinates|Animals,Arginine,Argininosuccinic Acid,Cell Line,Citric Acid Cycle,Fumarate Hydratase,Fumarates,Kidney,Kidney Neoplasms,Metabolome,Mice,Knockout,Transgenic,Mitochondria,Mutation,Protein Isoforms,Urea|Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid|Animals,Body Temperature Regulation,Body Weight,Brain Ischemia,Cerebral Arteries,Cerebral Cortex,Gene Expression Regulation,Genotype,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Knockout,Procollagen-Proline Dioxygenase,Protein Isoforms"
clme0149,immd0106,1,0.008771929824561403,Journal article,QJM: an international journal of medicine,15/02/2011,"Proceedings of Research in Clinical Practice 2010: Research in Clinical Practice was held at the Academic Centre of the John Radcliffe Hospital, Oxford, on Wednesday, 10 November 2010.","Klenerman P,Webb A,McPherson T,Brennan N,Petrou A,Prassas E,Sullivan P,Adams E,Rodgers C,Gregg N,Hull J,Kelly S,Goodwin A,Lieske B,Bashir S,Nag S,Snaith A,Shrestha R,Silva M,Morten K,Higgins S,Akram S,Eyo M,Yates T,Baugh V,Lang S,Graham C,McCarthy N,Ashdown H,Walden A,Wainwright E,Dorrell L,Shine B,Hatch R,Griffiths J,Barber V,Young D,Lee R,Brenner T,Pettingill P,Sills G,Brodie M,Waters P,Vincent A,Lang B,Almerie A,Ip V,Ahmed F,Kang J,Eltz S,Kohrgruber N,McNeillis B,Wigley J,Shantikumar S,Eltz S,Thomas G,Ullah M,Pennant S,Glyn-Jones S,Sundar S,Butler D,Dyer R,Alsousou J,Willett K,Badurdeen S,Daish H,Mukherjee S,Worton S,North S,Wilson C,Garner A,Wear H,Sahnan K,Bagenal J,Kreckler S,Brennan N,Davis J,Macklin P,Tse A,Khan J,Readman H,Lloyd-Lavery A,Mitchel E,Wijesurendra R,Owen K,Bunch C,Dwight J,Walden A,Macdonald A,Stott K,Munisamy S,Hallsworth C,Watson N,Connelly K,Sharma R,Orton C,Thomas P,Matar H,Peterson P,Sangle S,D'Cruz D,Blacklock C,Hirst J,Taylor K,Stevens R,Roberts N,Farmer A,Wing L,Bielinska A,Knight K,Babu P,Gandhi P,Cumming T,Sparkes T,Jones G",
bioc0416,raob0069,1,0.14285714285714285,Journal article,Journal of National Cancer Institute,09/10/2013,Selective permeabilization of the blood-brain barrier at sites of metastasis.,"Connell JJ,Chatain G,Cornelissen B,Vallis KA,Hamilton A,Seymour L,Anthony DC,Sibson NR","Analysis of Variance,Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Blood-Brain Barrier,Brain,Brain Neoplasms,Breast Neoplasms,Contrast Media,Disease Models,Animal,Drug Administration Schedule,Female,Gadolinium DTPA,Gene Expression Regulation,Neoplastic,Humans,Immunohistochemistry,Lymphotoxin-alpha,Magnetic Resonance Imaging,Mice,Inbred BALB C,Permeability,Receptors,Tumor Necrosis Factor,Type I,Tomography,Emission-Computed,Single-Photon,X-Ray Computed,Trastuzumab,Tumor Necrosis Factor-alpha"
molb0002,path0642,12,3.904166666666667,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Immunological Reviews|Nature Reviews Immunology|Proceedings of the National Academy of Sciences of USA|Biophysical Journal|Trends in Immunology|Science Signaling|PLOS Comp.Biol|Biophysical Journal|Biophysical Journal|Journal of Immunology|Journal of the American Chemical Society|Proceedings of the National Academy of Sciences of USA,01/11/2012|22/08/2014|29/11/2011|02/03/2011|15/03/2014|01/01/2011||18/01/2012|21/03/2012|01/12/2015|21/08/2014|18/11/2013,Non-catalytic tyrosine-phosphorylated receptors.|Phenotypic models of T cell activation.|Basic residues in the T-cell receptor zeta cytoplasmic domain mediate membrane association and modulate signaling|Ultrasensitivity in multisite phosphorylation of membrane-anchored proteins.|An induced rebinding model of antigen discrimination.|Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.|Systems model of T cell receptor proximal signaling reveals emergent ulrasensitivity.|Kinetics and Mechanics of Two-Dimensional Interactions between T Cell Receptors and Different Activating Ligands|Mechanical modulation of receptor-ligand interactions at cell-cell interfaces.|Costimulation of IL-2 Production through CD28 Is Dependent on the Size of Its Ligand.|SpyAvidin hubs enable precise and ultrastable orthogonal nanoassembly.|Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation.,"Dushek O,Goyette J,van der Merwe PA|Lever M,Maini PK,van der Merwe PA,Dushek O|Zhang H,Cordoba S-P,Dushek O,van der Merwe PA|Dushek O,van der Merwe PA,Shahrezaei V|Dushek O,van der Merwe PA|Dushek O,Aleksic M,Wheeler RJ,Zhang H,Cordoba SP,Peng YC,Chen JL,Cerundolo V,Dong T,Coombs D,van der Merwe PA|Mukhopadhyay H,Cordoba SP,Maini P,van der Merwe PA,Dushek O|Robert P,Aleksic M,Dushek O,Cerundolo V,Bongrand P,van der Merwell PA|Allard JF,Dushek O,Coombs D,van der Merwe PA|Lim HS,Cordoba SP,Dushek O,Goyette J,Taylor A,Rudd CE,van der Merwe PA|Fairhead M,Veggiani G,Lever M,Yan J,Mesner D,Robinson CV,Dushek O,van der Merwe PA,Howarth M|Salio M,Ghadbane H,Dushek O,Shepherd D,Cypen J,Gileadi U,Aichinger MC,Napolitani G,Qi X,van der Merwe PA,Wojno J,Veerapen N,Cox LR,Besra GS,Yuan W,Cresswell P,Cerundolo V","Humans,Immunity,Innate,Immunologic Surveillance,Leukocytes,Ligands,Phosphorylation,Protein Binding,Protein Conformation,Protein Structure,Tertiary,Protein Tyrosine Phosphatases,Protein-Tyrosine Kinases,Receptors,Cell Surface,Signal Transduction|Antigen-Presenting Cells,T-Lymphocytes,Humans,Receptors,Antigen,T-Cell,Lymphocyte Activation,Cell Communication,Signal Transduction,Cell Differentiation,Major Histocompatibility Complex,Protein Binding,Models,Immunological,Adaptive Immunity||Binding Sites,Cell Membrane,Diffusion,Membrane Proteins,Models,Biological,Phosphoproteins,Phosphoric Monoester Hydrolases,Phosphorylation,Phosphotransferases|Animals,Humans,Receptors,Antigen,T-Cell,Lymphocyte Activation,Self Tolerance,Major Histocompatibility Complex,Protein Binding,Models,Immunological|Adaptive Immunity,Animals,Antigens,Humans,Lymphocyte Activation,Mice,Models,Chemical,T-Lymphocytes,Cytotoxic,Thermodynamics|||Biomechanical Phenomena,Cell Communication,Ligands,Models,Biological,Protein Binding,Receptors,Antigen,T-Cell,Cell Surface,Time Factors|CD4-Positive T-Lymphocytes,CD8-Positive T-Lymphocytes,Cell Line,CHO Cells,Animals,Mice,Inbred C57BL,Transgenic,Cricetulus,Multiprotein Complexes,Antigens,CD45,Receptors,Antigen,T-Cell,CD28,CD80,Interleukin-2,Lymphocyte Activation,Signal Transduction,Protein Binding,Phosphorylation,Cricetinae|Jurkat Cells,Humans,Biotin,Peptides,Streptavidin,Binding Sites,Models,Molecular,Protein Multimerization,Protein Stability|autoreactivity,inflammation,innate immunity,lipid binding proteins,Antigen-Presenting Cells,Antigens,CD1d,Bacteria,Enzyme-Linked Immunosorbent Assay,HEK293 Cells,Humans,Immunity,Innate,Immunoprecipitation,Lipid Metabolism,Natural Killer T-Cells,Saposins,Scintillation Counting"
clne0013,wadh1179,2,0.10476190476190475,Journal article|Journal article,BMC Psychiatry|Neuroimage,30/05/2014|01/01/2011,"Study protocol: The Whitehall II imaging sub-study.|Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner","Filippini N,Zsoldos E,Haapakoski R,Sexton CE,Mahmood A,Allan CL,Topiwala A,Valkanova V,Brunner EJ,Shipley MJ,Auerbach E,Moeller S,Uğurbil K,Xu J,Yacoub E,Andersson J,Bijsterbosch J,Clare S,Griffanti L,Hess AT,Jenkinson M,Miller KL,Salimi-Khorshidi G,Sotiropoulos SN,Voets NL,Smith SM,Geddes JR,Singh-Manoux A,Mackay CE,Kivimäki M,Ebmeier KP|Miller KL,Stagg CJ,Douaud G,Jbabdi S,Smith SM,Behrens TE,Jenkinson M,Chance SA,Esiri MM,Voets NL,Jenkinson N,Aziz TZ,Turner MR,Johansen-Berg H,McNab JA","Brain,Humans,Magnetic Resonance Imaging,Retrospective Studies,Longitudinal Studies,Cognition,Cognition Disorders,Aging,Adult,Aged,80 and over,Middle Aged,Female,Male,Neuroimaging|Anisotropy,Artifacts,Autopsy,Brain,Brain Mapping,Diffusion Magnetic Resonance Imaging,Humans,Image Interpretation,Computer-Assisted,Tissue Fixation"
clme0240,whgu0256,1,0.2,Journal article,Blood,29/03/2011,High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq.,"Schödel J,Oikonomopoulos S,Ragoussis J,Pugh CW,Ratcliffe PJ,Mole DR","Basic Helix-Loop-Helix Transcription Factors,Cell Line,Tumor,Chromatin Immunoprecipitation,Chromosome Mapping,Epigenesis,Genetic,Female,Genome,Human,Genome-Wide Association Study,Humans,Oxygen,Response Elements"
clme0195,immd0082,6,0.5279063042220937,Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article,Nature Cell Biology|Blood|Haematologica: the hematology journal|Molecular Cell|British Journal of Haematology|Blood,|23/06/2011|28/05/2013|18/01/2012|01/04/2011|26/01/2011,Expression of alpha- and beta-globin genes occurs within different nuclear domains in haemopoietic cells|Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1α localization in erythroblasts|Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.|Intragenic enhancers act as alternative promoters.|Global gene expression analysis of human erythroid progenitors|Global gene expression analysis of human erythroid progenitors.,"Brown KE,Amoils S,Horn JM,Buckle VJ,Higgs DR,Merkenschlager M,Fisher AG|Renella R,Roberts NA,Brown JM,De Gobbi M,Bird LE,Hassanali T,Sharpe JA,Sloane-Stanley J,Ferguson DJP,Cordell J,Buckle VJ,Higgs DR,Wood WG|Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ|Kowalczyk MS,Hughes JR,Garrick D,Lynch MD,Sharpe JA,Sloane-Stanley JA,McGowan SJ,De Gobbi M,Hosseini M,Vernimmen D,Brown JM,Gray NE,Collavin L,Gibbons RJ,Flint J,Taylor S,Buckle VJ,Milne TA,Wood WG,Higgs DR|Merryweather-Clarke AT,Atzberger A,Soneji S,Gray N,Clark K,Waugh C,McGowan S,Taylor S,Nandi AK,Wood WG,Roberts DJ,Higgs DR,Buckle VJ,Robson KJH|Merryweather-Clarke AT,Atzberger A,Soneji S,Gray N,Clark K,Waugh C,McGowan SJ,Taylor S,Nandi AK,Wood WG,Roberts DJ,Higgs DR,Buckle VJ,Robson KJ","Cell Nucleus/*physiology Cells,Cultured Gene Expression Globins/*genetics Hematopoietic Stem Cells/*physiology Humans Lymphocytes/physiology||Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary|Animals,Cells,Cultured,Enhancer Elements,Genetic,Erythroid Cells,Gene Expression Regulation,Mice,Poly A,Promoter Regions,RNA,RNA Isoforms,Messenger,Transcriptome||Cell Differentiation,Cells,Cultured,Cluster Analysis,Erythroblasts,Erythroid Precursor Cells,Erythropoiesis,Flow Cytometry,Gene Expression Profiling,Gene Expression Regulation,Developmental,Humans,Microarray Analysis,Polymerase Chain Reaction"
clme0497,raob0005,1,0.16666666666666666,Journal article,Nature Chemical Biology,01/10/2014,A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics.,"Chaikuad A,Tacconi EM,Zimmer J,Liang Y,Gray NS,Tarsounas M,Knapp S","Cell Line,Tumor,Humans,Piperazines,Indazoles,Protein-Serine-Threonine Kinases,Mitogen-Activated Protein Kinase 1,Mitogen-Activated Protein Kinase 3,Mitogen-Activated Protein Kinase 8,Intracellular Signaling Peptides and Proteins,Recombinant Proteins,Antineoplastic Agents,Enzyme Inhibitors,MAP Kinase Signaling System,Gene Expression,Gene Expression Regulation,Neoplastic,Binding Sites,Protein Structure,Secondary,Tertiary,Protein Binding,Kinetics"
immd0036,immd0330,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
claridge,whgu0172,3,0.17562724014336917,Journal article|Journal article|Journal article,The Federation of European Biochemical Societies (FEBS) Journal|Nature Chemical Biology|Nature Chemical Biology,20/01/2011|01/01/2012|01/01/2012,Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.,"Yang M,Chowdhury R,Ge W,Hamed RB,McDonough MA,Claridge TD,Kessler BM,Cockman ME,Ratcliffe PJ,Schofield CJ|Ge W,Wolf A,Feng T,Ho C-H,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TDW,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,Mccullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ","Amino Acid Sequence,Ankyrin Repeat,HEK293 Cells,Histidine,Humans,Hydroxylation,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Protein Processing,Post-Translational,Protein Structure,Tertiary,Repressor Proteins,Sequence Alignment,Tankyrases||Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes"
immd0084,immd0316,1,0.125,Journal article,Biochemical Journal,18/10/2012,Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival.,"Pike LR,Singleton DC,Buffa F,Abramczyk O,Phadwal K,Li JL,Simon AK,Murray JT,Harris AL","Activating Transcription Factor 4,Animals,Autophagy,Blotting,Western,Breast Neoplasms,Cell Hypoxia,Cell Line,Tumor,Cell Survival,Endoplasmic Reticulum Stress,Female,Gene Expression Regulation,Neoplastic,HCT116 Cells,HT29 Cells,Humans,Intracellular Signaling Peptides and Proteins,MCF-7 Cells,Mice,Multivariate Analysis,Neoplasms,Prognosis,Protein-Serine-Threonine Kinases,RNA Interference,Reverse Transcriptase Polymerase Chain Reaction,Survival Analysis,Transcriptional Activation,Up-Regulation"
raob0009,raob0069,1,0.1111111111111111,Journal article,Journal of Nuclear Medicine,15/04/2011,ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.,"Cornelissen B,Darbar S,Hernandez R,Kersemans V,Tullis I,Barber PR,Smart S,Vojnovic B,Reilly R,Vallis KA","Active Transport,Cell Nucleus,Animals,Antibodies,Monoclonal,Humanized,Cell Line,Tumor,Cell Proliferation,Colony-Forming Units Assay,Dimethylallyltranstransferase,Electrons,Epidermal Growth Factor,Female,Humans,Imidazoles,Mice,Pentetic Acid,Protein Kinase Inhibitors,Protein Transport,Receptor,ErbB-2,Signal Transduction,Trastuzumab"
clme0301,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
raob0168,xxxx0009,1,0.125,Journal article,Medical Physics,01/02/2015,3D calculation of radiation-induced second cancer risk including dose and tissue response heterogeneities.,"Timlin C,Warren DR,Rowland B,Madkhali A,Loken J,Partridge M,Jones B,Kruse J,Miller R","Humans,Meningioma,Neoplasms,Radiation-Induced,Second Primary,Radiotherapy,Computer-Assisted,Radiotherapy Dosage,Radiotherapy Planning,Risk Assessment,Uncertainty,Dose-Response Relationship,Radiation,Models,Biological,Software"
raob0051,raob0168,2,0.2803030303030303,Journal article|Journal article,British Journal of Radiology|Physical Review Special Topics: Accelerators and Beams,11/04/2012|11/03/2013,Revisiting the ultra-high dose rate effect: implications for charged particle radiotherapy using protons and light ions.|Conceptual design of a nonscaling fixed field alternating gradient accelerator for protons and carbon ions for charged particle therapy,"Wilson P,Jones B,Yokoi T,Hill M,Vojnovic B|Peach KJ,Aslaninejad M,Barlow RJ,Beard CD,Bliss N,Cobb JH,Easton MJ,Edgecock TR,Fenning R,Gardner ISK,Hill MA,Owen HL,Johnstone CJ,Jones B,Jones T,Kelliher DJ,Khan A,Machida S,McIntosh PA,Pattalwar S,Pasternak J,Pozimski J,Prior CR,Rochford J,Rogers CT,Seviour R,Sheehy SL,Smith SL,Strachan J,Tygier S,Vojnovic B,Wilson P,Witte H,Yokoi T","Cell Hypoxia,Cell Survival,Humans,Ions,Neoplasms,Oxygen,Particle Accelerators,Protons,Radiation Tolerance,Radiotherapy Dosage,Radiotherapy,High-Energy,Tumor Cells,Cultured|"
clme0845,gree0989,59,10.63480148380858,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,"Circulation|British Journal of Cancer|Scandinavian Journal of Work Environment and Health|BMC Medicine|British Journal of Cancer|International Journal of Cancer|Journal of Thrombosis and Haemostasis|Biology Letters|European Journal of Cancer|British Journal of Cancer|Journal of Epidemiology and Community Health|Circulation|British Journal of Cancer|European Journal of Preventive Cardiology|Drug Safety|European Journal of Preventive Cardiology|International Journal of Cancer|Thrombosis Research: vascular obstruction, hemorrhage and hemostasis|British Journal of Cancer|British Journal of Cancer|Gut|British Journal of Cancer|Lancet Oncology|International Journal of Cancer|BMC Medicine|Circulation|British Journal of Cancer|International Journal of Cancer|Bone|British Journal of Cancer|Growth Hormone and IGF Research|International Journal of Cancer|BMC Medical Research Methodology|PLoS Medicine|Lancet|British Journal of Cancer|Circulation|International Journal of Obesity|Journal of Epidemiology and Community Health|British Journal of Cancer|BMC Medicine|Journal of National Cancer Institute|British Journal of Cancer|Annals of Oncology|International Journal of Epidemiology|International Journal of Epidemiology|Journal of Medical Screening|Lancet Oncology|British Journal of Cancer|Growth Hormone and IGF Research|PLoS Medicine|British Journal of Cancer|Journal of Bone and Mineral Research|Journal of Immunology|Lancet|International Journal of Epidemiology|British Journal of Cancer|Lancet Oncology|BMC Neurology",16/02/2015|29/11/2011|09/07/2012|02/04/2013|26/04/2011|27/09/2011|10/09/2012|22/08/2012|01/03/2014|29/10/2013|01/08/2011|15/12/2014|01/01/2012|15/12/2014|01/01/2012|30/05/2013|21/10/2014|01/05/2014|01/01/2015|05/03/2015|02/01/2014|27/03/2014|01/08/2011|13/06/2011|01/01/2014|12/03/2013|01/01/2011|01/01/2011|21/03/2012|09/08/2012|01/01/2015|01/01/2011|01/01/2011|01/01/2012|09/05/2015|01/01/2012|01/01/2012|10/07/2012|01/08/2011|10/07/2012|01/01/2014|28/01/2011|01/01/2015|11/07/2014|27/09/2013|01/02/2014|31/10/2013|01/01/2012|01/01/2015|15/01/2015|01/03/2015|01/01/2014|01/06/2011|01/01/2015|26/10/2012|08/05/2013|11/06/2013|01/09/2012|06/05/2012,"Frequent physical activity may not reduce vascular disease risk as much as moderate activity: large prospective study of women in the United Kingdom.|Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohort.|Characteristics of the Million Women Study participants who have and have not worked at night.|Body mass index and incident coronary heart disease in women: a population-based prospective study.|Fluid intake and incidence of renal cell carcinoma in UK women.|Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer.|Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.|The relationship between owning a cat and the risk of developing a brain cancer in a prospective study of UK women: comment on Thomas et al.|Characteristics of women who undergo breast reconstruction following mastectomy for breast cancer in the Million Women Study|Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study.|BODY MASS INDEX AND RISK OF INCIDENT ISCHAEMIC HEART DISEASE IN WOMEN: A PROSPECTIVE COHORT STUDY|Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort.|Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study|Variations in vascular mortality trends, 2001-2010, among 1.3 million women with different lifestyle risk factors for the disease.|Breast Cancer Risk in Relation to Use of Combined and Progestogen-Only Contraceptives: Results from a UK Record-Linkage Study|Coronary heart disease incidence in women by waist circumference within categories of body mass index.|Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis.|Surgery and risk of venous thromboembolism in women with cancer|Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years|Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.|Source of dietary fibre and diverticular disease incidence: a prospective study of UK women.|Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom.|Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk.|Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis.|Hospital admissions in relation to body mass index in UK women: a prospective cohort study.|Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study.|Fluid intake and incidence of renal cell carcinoma in UK women|Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer|Different effects of age, adiposity and physical activity on the risk of ankle, wrist and hip fractures in postmenopausal women.|Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study.|The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women|Menopausal hormone therapy and risk of gastrointestinal cancer: Nested case-control study within a prospective cohort, and meta-analysis|Reported frequency of physical activity in a large epidemiological study: Relationship to specific activities and repeatability over time|Ovarian cancer and body size: Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies|Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.|Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohort|Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: A cohort study|Persistent effects of women's parity and breastfeeding patterns on their body mass index: results from the Million Women Study.|VALIDATION OF NHS HOSPITAL ADMISSION RECORDS FOR ISCHAEMIC HEART DISEASE IN THE MILLION WOMEN STUDY|A short-term increase in cancer risk associated with daytime napping is likely to reflect pre-clinical disease: prospective cohort study.|Marital status and ischemic heart disease incidence and mortality in women: a large prospective study.|Breast cancer risk in relation to the interval between menopause and starting hormone therapy.|Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years.|Birth weight and adult cancer incidence: large prospective study and meta-analysis.|Authors' response to: the case of acoustic neuroma: comment on mobile phone use and risk of brain neoplasms and other cancers.|Authors' response to: The case of acoustic neuroma: Comment on mobile phone use and risk of brain neoplasms and other cancers|Use of research questionnaires in the NHS Bowel Cancer Screening Programme in England: impact on screening uptake.|Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies|Nationwide bowel cancer screening programme in England: Cohort study of lifestyle factors affecting participation and outcomes in women|The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women.|UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.|Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: Prospective study|Body mass index and physical activity in relation to the incidence of hip fracture in postmenopausal women.|Mobile phone use and risk of brain neoplasms and other cancers: Prospective study|The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK.|Mobile phone use and risk of brain neoplasms and other cancers: prospective study.|Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study.|Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies|Incidence of and risk factors for motor neurone disease in UK women: a prospective study.","Armstrong ME,Green J,Reeves GK,Beral V,Cairns BJ|Green J,Roddam A,Pirie K,Kirichek O,Reeves G,Beral V,Million Women Study collaborators|Wang XS,Travis RC,Reeves G,Green J,Allen NE,Key TJ,Roddam AW,Beral V|Canoy D,Cairns BJ,Balkwill A,Wright FL,Green J,Reeves G,Beral V,Million Women Study Collaborators|Allen NE,Balkwill A,Beral V,Green J,Reeves G,Million Women Study Collaborators|Reeves GK,Pirie K,Green J,Bull D,Beral V,Million Women Study Collaborators|Sweetland S,Beral V,Balkwill A,Liu B,Benson VS,Canonico M,Green J,Reeves GK,Million Women Study Collaborators|Benson VS,Green J,Beral V,Million Women Study|Gathani T,Balkwill A,Reeves G,Beral V,Green J,Collaborators MWS|Gathani T,Ali R,Balkwill A,Green J,Reeves G,Beral V,Moser KA,Million Women Study Collaborators|Canoy D,Cairns BJ,Balkwill A,Reeves GK,Green J,Beral V|Canoy D,Beral V,Balkwill A,Wright FL,Kroll ME,Reeves GK,Green J,Cairns BJ|Kroll ME,Murphy F,Pirie K,Reeves GK,Green J,Beral V|Cairns BJ,Balkwill A,Canoy D,Green J,Reeves GK,Beral V|Reeves GK,Kiricheck O,Green J,Beral V|Canoy D,Cairns BJ,Balkwill A,Wright FL,Green J,Reeves G,Beral V,Million Women Study Collaborators|Benson VS,Kirichek O,Beral V,Green J|Sweetland S,Balkwill A,Beral V,Gathani T,Green J,Reeves G,Collaborators MWS|Coffey K,Beral V,Green J,Reeves G,Barnes I|Blanks RG,Benson VS,Alison R,Brown A,Reeves GK,Beral V,Patnick J,Green J|Crowe FL,Balkwill A,Cairns BJ,Appleby PN,Green J,Reeves GK,Key TJ,Beral V,Million Women Study Collaborators,Million Women Study Collaborators|Bradbury KE,Balkwill A,Spencer EA,Roddam AW,Reeves GK,Green J,Key TJ,Beral V,Pirie K|Green J,Cairns BJ,Casabonne D,Wright FL,Reeves G,Beral V,Million Women Study collaborators|Green J,Czanner G,Reeves G,Watson J,Wise L,Roddam A,Beral V|Reeves GK,Balkwill A,Cairns BJ,Green J,Beral V|Sweetland S,Parkin L,Balkwill A,Green J,Reeves G,Beral V,Million Women Study Collaborators|Allen NE,Balkwill A,Beral V,Green J,Reeves G|Reeves GK,Pirie K,Green J,Bull D,Beral V|Armstrong ME,Cairns BJ,Banks E,Green J,Reeves GK,Beral V,Million Women Study Collaborators|Kroll ME,Murphy F,Pirie K,Reeves GK,Green J,Beral V,Million Women Study Collaborators|Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Green J,Czanner G,Reeves G,Watson J,Wise L,Roddam A,Beral V|Armstrong MEG,Cairns BJ,Green J,Reeves GK,Beral V|Beral V,Hermon C,Peto R,Reeves G,Brinton L,Marchbanks P,Negri E,Ness R,Peeters PHM,Vessey M,Calle EE,Gapstur SM,Patel AV,Maso LD,Talamini R,Chetrit A,Hirsh-Yechezkel G,Lubin F,Sadetzki S,Allen N,Beral V,Bull D,Callaghan K,Crossley B,Gaitskell K,Goodill A,Green J,Hermon C,Key T,Moser K,Reeves G,Collins R,Doll R,Peto R,Gonzalez CA,Lee N,Marchbanks P,Ory HW,Peterson HB,Wingo PA,Martin N,Pardthaisong T,Silpisornkosol S,Theetranont C,Boosiri B,Chutivongse S,Jimakorn P,Virutamasen P,Wongsrichanalai C,Tjonneland A,Titus-Ernstoff L,Byers T,Rohan T,Mosgaard BJ,Vessey M,Yeates D,Freudenheim JL,Chang-Claude J,Kaaks R,Anderson KE,Folsom A,Robien K,Rossing MA,Thomas DB,Weiss NS,Riboli E,Clavel-Chapelon F,Cramer D,Hankinson SE,Tworoger SS,Franceschi S,La Vecchia C,Negri E,Magnusson C,Riman T,Weiderpass E,Wolk A,Schouten LJ,Van den Brandt PA,Chantarakul N,Koetsawang S,Rachawat D,Palli D,Black A,Berrington de Gonzalez A,Brinton LA,Freedman DM,Hartge P,Hsing AW,Lacey JV,Hoover RN,Schairer C,Graff-Iversen S,Selmer R,Bain CJ,Green AC,Purdie DM|Beral V,Gaitskell K,Hermon C,Moser K,Reeves G,Peto R|Green J,Roddam A,Pirie K,Kirichek O,Reeves G,Beral V|Parkin L,Sweetland S,Balkwill A,Green J,Reeves G,Beral V|Bobrow KL,Quigley MA,Green J,Reeves GK,Beral V,Million Women Study Collaborators|Wright L,Green J,Canoy D,Cairns B,Balkwill A,Beral V|Cairns BJ,Travis RC,Wang XS,Reeves GK,Green J,Beral V,Million Women Study Collaborators|Floud S,Balkwill A,Canoy D,Wright FL,Reeves GK,Green J,Beral V,Cairns BJ|Beral V,Reeves G,Bull D,Green J,Million Women Study Collaborators|Coffey K,Beral V,Green J,Reeves G,Barnes I|Yang TO,Reeves GK,Green J,Beral V,Cairns BJ|Benson VS,Pirie K,Schüz J,Reeves GK,Beral V,Green J|Benson VS,Pirie K,Schüz J,Reeves GK,Beral V,Green J|Watson J,Shaw K,Macgregor M,Smith S,Halloran S,Patnick J,Beral V,Green J,Bowel Screening Follow-up Study Investigators and Collaborators|Hamajima N,Hirose K,Tajima K,Rohan T,Friedenreich CM,Calle EE,Gapstur SM,Patel AV,Coates RJ,Liff JM,Talamini R,Chantarakul N,Koetsawang S,Rachawat D,Marcou Y,Kakouri E,Duffy SW,Morabia A,Schuman L,Stewart W,Szklo M,Coogan PF,Palmer JR,Rosenberg L,Band P,Coldman AJ,Gallagher RP,Hislop TG,Yang P,Cummings SR,Canfell K,Sitas F,Chao P,Lissowska J,Horn-Ross PL,John EM,Kolonel LM,Nomura AMY,Ghiasvand R,Hu J,Johnson KC,Mao Y,Beral V,Bull D,Callaghan K,Crossley B,Goodill A,Green J,Hermon C,Key T,Lindgard I,Liu B,Pirie K,Reeves G,Collins R,Doll R,Peto R,Bishop T,Fentiman IS,De Sanjose S,Gonzalez CA,Lee N,Marchbanks P,Ory HW,Peterson HB,Wingo P,Ebeling K,Kunde D,Nishan P,Hopper JL,Eliassen H,Hankinson S,Gajalakshmi V,Martin N,Pardthaisong T,Silpisornkosol S,Theetranont C,Boosiri B,Chutivongse S,Jimakorn P,Virutamasen P,Wongsrichanalai C,Neugut A,Santella R,Baines CJ,Kreiger N,Miller AB,Wall C,Tjonneland A,Jorgensen T,Stahlberg C,Pedersen AT,Flesch-Janys D,Hakansson N,Cauley J,Heuch I,Adami HO,Persson I,Weiderpass E,Magnusson C,Chang-Claude J,Kaaks R,McCredie M,Paul C,Skegg DCG,Spears GFS,Iwasaki M,Tsugane S,Anderson G,Daling JR,Hampton J,Hutchinson WB,Li CI,Malone K,Mandelson M,Newcomb P,Noonan EA,Ray RM,Stanford JL,Tang MTC,Thomas DB,Weiss NS,White E,Izquierdo A,Viladiu P,Fourkala EO,Jacobs I,Menon U,Ryan A,Cuevas HR,Ontiveros P,Palet A,Salazar SB,Aristizabal N,Cuadros A,Tryggvadottir L,Tulinius H,Riboli E,Andrieu N,Bachelot A,Le MG,Bremond A,Gairard B,Lansac J,Piana L,Renaud R,Clavel-Chapelon F,Fournier A,Touillaud M,Mesrine S,Chabbert-Buffet N,Boutron-Ruault MC,Wolk A,Torres-Mejia G,Franceschi S,Romieu I,Boyle P,Lubin F,Modan B,Ron E,Wax Y,Friedman GD,Hiatt RA,Levi F,Kosmelj K,Primic-Zakelj M,Ravnihar B,Stare J,Ekbom A,Erlandsson G,Beeson WL,Fraser G,Peto J,Hanson RL,Leske MC,Mahoney MC,Nasca PC,Varma AO,Weinstein AL,Hartman ML,Olsson H,Goldbohm RA,van den Brandt PA,Palli D,Teitelbaum S,Apelo RA,Baens J,de la Cruz JR,Javier B,Lacaya LB,Ngelangel CA,La Vecchia C,Negri E,Marubini E,Ferraroni M,Pike MC,Gerber M,Richardson S,Segala C,Gatei D,Kenya P,Kungu A,Mati JG,Brinton LA,Freedman M,Hoover R,Schairer C,Ziegler R,Banks E,Spirtas R,Lee HP,Rookus MA,van Leeuwen FE,Schoenberg JA,Graff-Iversen S,Selmer R,Jones L,McPherson K,Neil A,Vessey M,Yeates D,Mabuchi K,Preston D,Hannaford P,Kay C,McCann SE,Rosero-Bixby L,Gao YT,Jin F,Yuan J-M,Wei HY,Yun T,Zhiheng C,Berry G,Cooper Booth J,Jelihovsky T,MacLennan R,Shearman R,Hadjisavvas A,Kyriacou K,Loisidou M,Zhou X,Wang Q-S,Kawai M,Minami Y,Tsuji I,Lund E,Kumle M,Stalsberg H,Shu XO,Zheng W,Monninkhof EM,Onland-Moret NC,Peeters PHM,Katsouyanni K,Trichopoulou A,Trichopoulos D,Tzonou A,Baltzell KA,Dabancens A,Martinez L,Molina R,Salas O,Alexander FE,Anderson K,Folsom AR,Gammon MD,Hulka BS,Millikan R,Chilvers CED,Lumachi F,Bain C,Schofield F,Siskind V,Rebbeck TR,Bernstein LR,Enger S,Haile RW,Paganini-Hill A,Ross RK,Ursin G,Wu AH,Yu MC,Ewertz M,Clarke EA,Bergkvist L,Anderson GL,Gass M,O'Sullivan MJ,Kalache A,Farley TMM,Holck S,Meirik O,Fukao A|Blanks RG,Benson VS,Alison R,Brown A,Reeves GK,Beral V,Patnick J,Green J|Bradbury KE,Balkwill A,Tipper SJ,Crowe FL,Reeves GK,Green J,Beral V,Key TJ|Sudlow C,Gallacher J,Allen N,Beral V,Burton P,Danesh J,Downey P,Elliott P,Green J,Landray M,Liu B,Matthews P,Ong G,Pell J,Silman A,Young A,Sprosen T,Peakman T,Collins R|Gathani T,Ali R,Balkwill A,Green J,Reeves G,Beral V,Moser KA|Armstrong ME,Spencer EA,Cairns BJ,Banks E,Pirie K,Green J,Wright FL,Reeves GK,Beral V,Million Women Study Collaborators|Benson VS,Pirie K,Schüz J,Reeves GK,Beral V,Green J|Pirie K,Peto R,Reeves GK,Green J,Beral V,Million Women Study Collaborators|Benson VS,Pirie K,Schüz J,Reeves GK,Beral V,Green J,Million Women Study Collaborators|Murphy F,Kroll ME,Pirie K,Reeves G,Green J,Beral V|Beral V,Gaitskell K,Hermon C,Moser K,Reeves G,Peto R,Brinton L,Marchbanks P,Negri E,Ness R,Peeters PHM,Vessey M,Calle EE,Gapstur SM,Patel AV,Dal Maso L,Talamini R,Chetrit A,Hirsh-Yechezkel G,Lubin F,Sadetzki S,Banks E,Beral V,Bull D,Callaghan K,Crossley B,Gaitskell K,Goodill A,Green J,Hermon C,Key T,Moser K,Reeves G,Sitas F,Collins R,Doll R,Peto R,Gonzalez A,Lee N,Marchbanks P,Ory HW,Peterson HB,Wingo PA,Martin N,Pardthaisong T,Silpisornkosol S,Theetranont C,Boosiri B,Chutivongse S,Jimakorn P,Virutamasen P,Wongsrichanalai C,Tjonneland A,Titus-Ernstoff L,Byers T,Rohan T,Mosgaard BJ,Vessey M,Yeates D,Freudenheim JL,Chang-Claude J,Kaaks R,Anderson KE,Folsom A,Robien K,Hampton J,Newcomb PA,Rossing MA,Thomas DB,Weiss NS,Riboli E,Clavel-Chapelon F,Cramer D,Hankinson SE,Tworoger SS,Franceschi S,La Vecchia C,Negri E,Adami HO,Magnusson C,Riman T,Weiderpass E,Wolk A,Schouten LJ,van den Brandt PA,Chantarakul N,Koetsawang S,Rachawat D,Palli D,Black A,Brinton LA,Freedman DM,Hartge P,Hsing AW,Jr LJV,Hoover RN,Schairer C,Urban M,Graff-Iversen S,Selmer R,Bain CJ,Green AC,Purdie DM,Siskind V,Webb PM,Moysich K,McCann SE,Hannaford P,Kay C,Binns CW,Lee AH,Zhang M,Ness RB,Nasca P,Coogan PF,Palmer JR,Rosenberg L,Kelsey J,Paffenbarger R,Whittemore A,Katsouyanni K,Trichopoulou A,Trichopoulos D,Tzonou A,Dabancens A,Martinez L,Molina R,Salas O,Goodman MT,Lurie G,Carney ME,Wilkens LR,Hartman L,Manjer J,Olsson H,Grisso JA,Morgan M,Wheeler JE,Bunker CH,Edwards RP,Modugno F,Peeters PHM,Casagrande J,Pike MC,Ross RK,Wu AH,Miller AB,Kumle M,Gram IT,Lund E,McGowan L,Shu XO,Zheng W,Farley TMM,Holck S,Meirik O,Risch HA,Epidemiological CG,Canc NISO,Study NH|Doyle P,Brown A,Beral V,Reeves G,Green J","Million Women Study Collaborators,Humans,Cardiovascular Diseases,Exercise,Incidence,Risk Factors,Regression Analysis,Cohort Studies,Longitudinal Studies,Follow-Up Studies,Prospective Studies,Motor Activity,Time Factors,Middle Aged,Great Britain,Female,Physical Exertion|Cohort Studies,Esophageal Neoplasms,Female,Humans,Middle Aged,Reproduction,Risk Factors,Stomach Neoplasms|Anthropometry,Female,Great Britain,Humans,Life Style,Middle Aged,Prospective Studies,Work Schedule Tolerance|Aged,Body Mass Index,Cohort Studies,Coronary Disease,Female,Follow-Up Studies,Humans,Incidence,Middle Aged,Prospective Studies,Survival Analysis|Adult,Aged,Alcohol Drinking,Beverages,Carcinoma,Renal Cell,Coffee,Cohort Studies,Confidence Intervals,Diet Surveys,Drinking,Female,Food Habits,Great Britain,Humans,Incidence,Kidney Neoplasms,Middle Aged,Multivariate Analysis,Odds Ratio,Proportional Hazards Models,Prospective Studies,Surveys and Questionnaires,Tea,Water|Body Mass Index,Breast Neoplasms,Carcinoma,Intraductal,Noninfiltrating,Environmental Exposure,Estrogen Replacement Therapy,Female,Genetic Predisposition to Disease,Great Britain,Humans,Neoplasm Invasiveness,Prospective Studies,Risk Factors|cohort study,deep vein thrombosis,hormone therapy,progestagens,pulmonary embolism,Administration,Oral,Aged,Drug Combinations,Estrogen Replacement Therapy,Estrogens,Female,Great Britain,Hormones,Humans,Medroxyprogesterone Acetate,Middle Aged,Postmenopause,Progestins,Proportional Hazards Models,Prospective Studies,Risk Factors,Venous Thromboembolism|Brain Neoplasms,Female,Humans,Male,Toxoplasma,Toxoplasmosis||African Continental Ancestry Group,Asian Continental Ancestry Group,Breast Neoplasms,Cohort Studies,England,European Continental Ancestry Group,Female,Humans,Incidence,Middle Aged,Proportional Hazards Models,Prospective Studies,Risk Factors||Million Women Study Collaborators*,Humans,Cardiovascular Diseases,Coronary Disease,Hypertension,Risk Factors,Cohort Studies,Follow-Up Studies,Prospective Studies,Age Factors,Menarche,Adolescent,Middle Aged,Child,Great Britain,Female||Million Women Study Collaborators||Abdominal obesity,body mass index,coronary heart disease,fat distribution,obesity,waist circumference,Adiposity,Age Factors,Aged,Apolipoprotein A-I,Apolipoproteins B,Biomarkers,Body Mass Index,Coronary Disease,Female,Great Britain,Hospitalization,Humans,Incidence,Middle Aged,Obesity,Abdominal,Prognosis,Proportional Hazards Models,Prospective Studies,Risk Factors,Sex Factors,Time Factors,Waist Circumference|Humans,Glioma,Neuroma,Acoustic,Meningioma,Pituitary Neoplasms,Central Nervous System Neoplasms,Estrogens,Progestins,Hormone Replacement Therapy,Risk Factors,Prospective Studies,Menopause,Aged,Middle Aged,Great Britain,Female|||Humans,Colorectal Neoplasms,Colonoscopy,Occult Blood,Prognosis,Follow-Up Studies,Prospective Studies,Life Style,Aged,Middle Aged,Patient Participation,National Health Programs,Patient Acceptance of Health Care,England,Female,Early Detection of Cancer|diet,dietary fibre,diverticular disease,prospective,Aged,Diet Surveys,Dietary Fiber,Diverticulitis,Diverticulum,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Intestinal Diseases,Middle Aged,Prospective Studies,Risk,Surveys and Questionnaires|Million Women Study Collaborators,Humans,Neoplasms,Lymphoma,Non-Hodgkin,Sarcoma,Breast Neoplasms,Incidence,Prospective Studies,Middle Aged,Great Britain,Female,Self Report,Food,Organic|Body Height,Female,Humans,Male,Middle Aged,Neoplasms,Prospective Studies,Surveys and Questionnaires|Aged,Case-Control Studies,Cohort Studies,Female,Gastrointestinal Neoplasms,Hormone Replacement Therapy,Humans,Incidence,Menopause,Middle Aged,Prospective Studies,Risk Factors|Million Women Study Collaborators,Humans,Body Mass Index,Patient Admission,Registries,Cohort Studies,Follow-Up Studies,Prospective Studies,Middle Aged,Great Britain,Female|Cohort Studies,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Middle Aged,Postoperative Complications,Prospective Studies,Retrospective Studies,Risk Factors,Smoking,Venous Thromboembolism|||Accidental Falls,Adiposity,Age Factors,Aged,Ankle Injuries,Body Mass Index,Cohort Studies,Female,Fractures,Bone,Great Britain,Hip Fractures,Humans,Middle Aged,Motor Activity,Postmenopause,Proportional Hazards Models,Prospective Studies,Risk Factors,Wrist Injuries|Alcohol Drinking,Female,Great Britain,Hematologic Neoplasms,Humans,Middle Aged,Risk Factors,Sex Factors,Smoking,Surveys and Questionnaires,Women's Health|||||Collaborative Group On Epidemiological Studies Of Ovarian Cancer,Humans,Ovarian Neoplasms,Estrogen Replacement Therapy,Drug Administration Schedule,Incidence,Risk Assessment,Postmenopause,Middle Aged,Female|||Adiposity,Body Mass Index,Breast Feeding,Cross-Sectional Studies,Female,Great Britain,Health Promotion,Humans,Middle Aged,Obesity,Parity,Pregnancy,Prospective Studies,Surveys and Questionnaires,Time Factors||Breast Neoplasms,Cohort Studies,Female,Follow-Up Studies,Great Britain,Humans,Middle Aged,Neoplasms,Prospective Studies,Risk,Risk Factors,Sleep Wake Disorders|Million Women Study Collaborators,Humans,Myocardial Ischemia,Patient Admission,Questionnaires,Incidence,Risk Factors,Cohort Studies,Follow-Up Studies,Prospective Studies,Marital Status,Life Style,Socioeconomic Factors,Aged,Middle Aged,Female|Adult,Aged,Breast Neoplasms,Estrogen Replacement Therapy,Estrogens,Female,Great Britain,Humans,Incidence,Menopause,Middle Aged,Obesity,Progesterone Congeners,Proportional Hazards Models,Prospective Studies,Randomized Controlled Trials as Topic,Research Design,Risk Assessment,Risk Factors,Time Factors|Million Women Study Collaborators,Humans,Papillomaviridae,Papillomavirus Infections,Adenocarcinoma,Cervical Intraepithelial Neoplasia,Carcinoma,Squamous Cell,Anus Neoplasms,Reproductive History,Prognosis,Incidence,Risk Factors,Follow-Up Studies,Prospective Studies,Life Style,Adult,Aged,Middle Aged,England,Uterine Cervical Neoplasms,Female|Million Women Study Collaborators,Humans,Neoplasms,Birth Weight,Body Height,Risk Factors,Prospective Studies,Middle Aged,Female|Brain Neoplasms,Cell Phones,Female,Glioma,Humans,Neoplasms||cancer screening,colorectal neoplasms,questionnaires,utilization,Colorectal Neoplasms,England,Female,Humans,Male,Mass Screening,Surveys and Questionnaires|||Million Women Study Collaborators,Humans,Birth Weight,Insulin-Like Growth Factor I,Body Weights and Measures,Postnatal Care,Diet,Risk Factors,Cohort Studies,Life Style,Breast Feeding,Postmenopause,Aged,Middle Aged,Great Britain,Female,Surveys and Questionnaires|Humans,Neoplasms,Prospective Studies,Aging,Genotype,Phenotype,Research,Access to Information,Databases,Factual,Adult,Aged,Middle Aged,Biological Specimen Banks,Great Britain||Body Height,Body Mass Index,Body Weight,Female,Great Britain,Hip Fractures,Humans,Incidence,Motor Activity,Postmenopause,Risk Factors||Adult,Age Factors,Aged,Data Collection,Female,Great Britain,Humans,Middle Aged,Proportional Hazards Models,Prospective Studies,Risk Factors,Smoking,Smoking Cessation,Socioeconomic Factors,Time Factors,Young Adult|Acoustic neuroma,cellular phone,glioma,meningioma,neoplasms,prospective studies,Adult,Aged,Brain Neoplasms,Cell Phones,Confidence Intervals,Female,Glioma,Great Britain,Humans,Incidence,Middle Aged,Neoplasms,Neuroma,Acoustic,Proportional Hazards Models,Prospective Studies,Regression Analysis,Risk Factors,Time Factors|Adiposity,Aged,Body Mass Index,Body Size,Female,Great Britain,Hematologic Neoplasms,Humans,Middle Aged,Proportional Hazards Models||Aged,80 and over,Comorbidity,Educational Status,Employment,Female,Great Britain,Humans,Incidence,Middle Aged,Motor Neuron Disease,Obesity,Risk Factors,Smoking,Socioeconomic Factors,Women's Health"
immd0082,lina0435,2,0.08060288335517693,Journal article|Journal article,Haematologica: the hematology journal|Nature Genetics,28/05/2013|18/05/2015,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
raob0072,raob0122,1,0.125,Conference paper,Journal of Clinical Oncology,20/05/2012,Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy,"Sharma RA,Macgregor T,Gillies R,Hatch S,Swift L,Humphrey TIM,Chetty R,McHugh PJ,Middleton MR",
immd0282,vacc0036,1,0.2,Journal article,Nucleic Acids Research,10/12/2011,Bio-CAP: a versatile and highly sensitive technique to purify and characterise regions of non-methylated DNA.,"Blackledge NP,Long HK,Zhou JC,Kriaucionis S,Patient R,Klose RJ","Biotinylation,Chromatography,Affinity,CpG Islands,DNA,DNA Methylation,High-Throughput Nucleotide Sequencing,Sequence Analysis,Zinc Fingers"
gree1620,immd0316,4,0.9166666666666665,Journal article|Journal article|Journal article|Journal article,Oncotarget|Clinical Oncology|Lung Cancer|Lung Cancer,28/02/2015|01/06/2014|01/01/2016|01/01/2014,Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen.|Safety and Survival of High Dose Palliative Radiotherapy for Locally Advanced Lung Cancer|Audit of palliative whole brain radiotherapy (WBRT) in patients with non-small cell lung cancer (NSCLC) treated at the Oxford Cancer Centre over 21/2 years|Safety and survival of high dose palliative radiotherapy for locally advanced lung cancer,"Tiwana GS,Prevo R,Buffa FM,Yu S,Ebner DV,Howarth A,Folkes LK,Budwal B,Chu KY,Durrant L,Muschel RJ,McKenna WG,Higgins GS|O'Cathail SM,Buffa FM,Higgins GS,Panakis N|Shakir R,Buffa F,Higgins G,Horne A,Stuart R,Vallis K,Panakis N|O'Cathail SM,Buffa FM,Higgins GS,Panakis N","Cell Line,Tumor,HCT116 Cells,Hela Cells,Humans,Neoplasms,DNA Damage,Pyrithiamine,Thiamin Pyrophosphokinase,Thiamine,Radiation-Sensitizing Agents,Colony-Forming Units Assay,Transfection,Radiation Tolerance,High-Throughput Screening Assays|||"
raob0069,raob0128,2,0.34285714285714286,Journal article|Journal article,Physics in Medicine and Biology|Cancer Research,11/10/2013|17/05/2011,Characterization of single α-tracks by photoresist detection and AFM analysis-focus on biomedical science and technology.|Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.,"Falzone N,Myhra S,Chakalova R,Hill MA,Thomson J,Vallis KA|Cornelissen B,Kersemans V,Darbar S,Thompson J,Shah K,Sleeth K,Hill MA,Vallis KA","Alpha Particles,Epoxy Compounds,Microscopy,Atomic Force,Polymers,Radiobiology,Radiometry,Reproducibility of Results|Amino Acid Sequence,Animals,Antibodies,Breast Neoplasms,Carbocyanines,Cell Line,Tumor,DNA Damage,DNA,Neoplasm,Female,Gene Products,tat,Histones,Humans,Immunoconjugates,Indium Radioisotopes,Mice,Inbred BALB C,Nude,Molecular Sequence Data,Pentetic Acid,Transplantation,Heterologous"
clme0169,clme0832,44,22.101190476190474,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Poster|Poster|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,"European Journal of Cardio-Thoracic Surgery|PLoS Medicine|BJOG: an International Journal of Obstetrics and Gynaecology|British Journal of Surgery|Journal of Clinical Epidemiology|Annals of Internal Medicine|Annals of Internal Medicine|Clinical Chemistry (Washington, DC): international journal of molecular diagnostics and laboratory medicine|||Heart|BMJ|Statistics in Medicine|Annals of Internal Medicine|BMJ|BMJ|Diabetic Medicine|BMJ|British Journal of General Practice|British Journal of General Practice|BMC Medical Research Methodology|European Journal of Clinical Investigation|Advances in Anatomic Pathology|Statistics in Medicine|Statistics in Medicine|BMJ|Journal of Clinical Epidemiology|Journal of Clinical Epidemiology|Annals of Internal Medicine|European Journal of Cardio-Thoracic Surgery|European Journal of Cancer Care|BMC Medicine|BMJ|Diabetic Medicine|European Journal of Cancer|British Journal of Cancer|Cancer Epidemiology|Trials|British Journal of Cancer|Circulation|Trials|BMJ|PLoS One|European Urology",25/10/2012|14/10/2014|27/01/2015|27/01/2015|09/01/2015|06/01/2015|06/01/2015|01/03/2015|||11/06/2012|21/06/2012|09/11/2015|19/05/2015|02/07/2012||12/04/2011|22/06/2011|01/09/2013|01/04/2012|19/03/2014|05/01/2015|01/09/2015|30/07/2014|18/05/2016|01/07/2014|07/03/2016|01/04/2016|01/01/2012|04/10/2012|01/11/2012|06/01/2015|10/09/2012|20/01/2015|15/11/2012|14/06/2012|29/12/2012|31/07/2013|06/01/2015|05/01/2015|05/12/2011|07/01/2015|29/10/2014|05/01/2015,"Design flaws in EuroSCORE II.|Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist.|Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.|Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement.|Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.|Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.|Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.|New guideline for the reporting of studies developing, validating, or updating a prediction model.|Assessing the impact of handling missing data when validating a prognostic model.|Clinical prediction models: a critical review of online risk calculators|Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK.|Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.|Sample size considerations for the external validation of a multivariable prognostic model: a resampling study.|Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD).|Interpreting diagnostic accuracy studies for patient care.|External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges.|External validation of QDSCORE ® for predicting the 10-year risk of developing Type2 diabetes|Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.|Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas).|Predicting the risk of chronic kidney disease in the UK: an evaluation of QKidney® scores using a primary care database.|External validation of multivariable prediction models: a systematic review of methodological conduct and reporting.|Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.|New Guideline for the Reporting of Studies Developing, Validating, or Updating a Multivariable Clinical Prediction Model: The TRIPOD Statement.|STRengthening analytical thinking for observational studies: the STRATOS initiative.|Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model.|Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study.|Adequate sample size for developing prediction models was not simply related to events per variable.|Explicit inclusion of treatment in prognostic modelling was recommended in observational and randomised settings.|QRISK2-2011 predicted cardiovascular disease in adult general practice patients|Calibration of EuroSCORE II.|Identifying women with undetected ovarian cancer: independent and external validation of QCancer(®) (Ovarian) prediction model.|Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.|Authors' reply to Bird.|Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.|Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal).|Identifying patients with undetected colorectal cancer: an independent validation of QCancer (Colorectal).|Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model.|Reporting characteristics of non-primary publications of results of randomized trials: a cross-sectional review.|Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.|Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group.|Reporting of participant flow diagrams in published reports of randomized trials.|Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.|Exploration of analysis methods for diagnostic imaging tests: problems with ROC AUC and confidence scores in CT colonography.|Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement.","Collins GS,Altman DG|Moons KG,de Groot JA,Bouwmeester W,Vergouwe Y,Mallett S,Altman DG,Reitsma JB,Collins GS|Collins GS,Reitsma JB,Altman DG,Moons KG|Collins GS,Reitsma JB,Altman DG,Moons KG|Collins GS,Reitsma JB,Altman DG,Moons KG|Moons KG,Altman DG,Reitsma JB,Ioannidis JP,Macaskill P,Steyerberg EW,Vickers AJ,Ransohoff DF,Collins GS|Collins GS,Reitsma JB,Altman DG,Moons KG|Moons KG,Altman DG,Reitsma JB,Collins GS|Ma J,Altman D,Collins G|Ma J,Altman,Collins|Collins GS,Altman DG|Collins GS,Altman DG|Collins GS,Ogundimu EO,Altman DG|Collins GS,Reitsma JB,Altman DG,Moons KG|Mallett S,Halligan S,Thompson M,Collins GS,Altman DG|Riley RD,Ensor J,Snell KI,Debray TP,Altman DG,Moons KG,Collins GS|Collins GS,Altman DG|Collins GS,Mallett S,Altman DG|Collins GS,Altman DG|Collins G,Altman D|Collins GS,de Groot JA,Dutton S,Omar O,Shanyinde M,Tajar A,Voysey M,Wharton R,Yu LM,Moons KG,Altman DG|Collins GS,Reitsma JB,Altman DG,Moons KG|Moons KG,Altman DG,Reitsma JB,Collins GS,Transparent Reporting of a Multivariate Prediction Model for Individual Prognosis or Development Initiative|Sauerbrei W,Abrahamowicz M,Altman DG,le Cessie S,Carpenter J,STRATOS initiative|Collins GS,Ogundimu EO,Cook JA,Manach YL,Altman DG|Hopewell S,Collins GS,Boutron I,Yu LM,Cook J,Shanyinde M,Wharton R,Shamseer L,Altman DG|Ogundimu EO,Altman DG,Collins GS|Groenwold RH,Moons KG,Pajouheshnia R,Altman DG,Collins GS,Debray TP,Reitsma JB,Riley RD,Peelen LM|Collins GS,Altman DG|Collins GS,Altman DG|Collins GS,Altman DG|Collins GS,Reitsma JB,Altman DG,Moons KG|Collins GS,Altman DG|Collins GS,Reitsma JB,Altman DG,Moons KG|Collins GS,Altman DG|Collins GS,Altman DG|Collins GS,Altman DG|Hopewell S,Collins GS,Hirst A,Kirtley S,Tajar A,Gerry S,Altman DG|Collins GS,Reitsma JB,Altman DG,Moons KG|Collins GS,Reitsma JB,Altman DG,Moons KG,TRIPOD Group|Hopewell S,Hirst A,Collins GS,Mallett S,Yu LM,Altman DG|Collins GS,Reitsma JB,Altman DG,Moons KG|Mallett S,Halligan S,Collins GS,Altman DG|Collins GS,Reitsma JB,Altman DG,Moons KG,members of TRIPOD group","Cardiac Surgical Procedures,Female,Humans,Male,Severity of Illness Index|Decision Support Techniques,Humans,Models,Theoretical|Advisory Committees,Checklist,Decision Support Techniques,Delivery of Health Care,Female,Guidelines as Topic,Humans,Models,Theoretical,Prognosis,Referral and Consultation|Consensus,Decision Support Techniques,Diagnosis,Models,Statistical,Practice Guidelines as Topic,Prognosis,Publishing,Research Design,Risk Assessment,Validation Studies as Topic|Consensus,Decision Support Techniques,Delivery of Health Care,Humans,Medical Records,Models,Statistical,Multivariate Analysis,Practice Guidelines as Topic,Prognosis,Publishing|Humans,Diagnosis,Prognosis,Multivariate Analysis,Models,Statistical,Reproducibility of Results,Decision Support Techniques,Publishing,Guidelines as Topic,Checklist|Checklist,Decision Support Techniques,Diagnosis,Humans,Models,Statistical,Multivariate Analysis,Prognosis,Publishing|Guidelines as Topic,Humans,Models,Theoretical,Probability|||Acute Kidney Injury,Adult,Aged,80 and over,Cardiovascular Diseases,Cataract,Drug-Induced Liver Injury,Female,Great Britain,Humans,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Incidence,Male,Middle Aged,Prospective Studies,Risk Assessment|Adult,Aged,80 and over,Cardiovascular Diseases,Female,Forecasting,Great Britain,Humans,Male,Middle Aged,Prospective Studies,Risk Assessment,Risk Factors|external validation,prognostic model,sample size|Decision Support Techniques,Diagnosis,Humans,Models,Statistical,Prognosis|Area Under Curve,Data Interpretation,Statistical,Diagnostic Techniques and Procedures,False Negative Reactions,False Positive Reactions,Humans,Patient Care,Prevalence,Research Design,Sensitivity and Specificity||Adult,Aged,Cohort Studies,Diabetes Mellitus,Type 2,England,Female,Humans,Male,Middle Aged,Prevalence,Prospective Studies,Risk Assessment,Risk Factors|Female,Great Britain,Hip Fractures,Humans,Incidence,Male,Osteoporosis,Prospective Studies,Risk Assessment|Adult,Age Distribution,Aged,80 and over,Early Detection of Cancer,Female,Humans,Male,Middle Aged,Pancreatic Neoplasms,Prospective Studies,ROC Curve,Risk Assessment,Risk Factors,Sex Distribution|Adult,Aged,Blood Pressure,Body Mass Index,Chronic Disease,Creatinine,Disease Progression,Female,Great Britain,Humans,Incidence,Kidney Diseases,Kidney Failure,Chronic,Male,Middle Aged,Risk Assessment,Risk Factors,Severity of Illness Index,Smoking|Data Interpretation,Statistical,Humans,Outcome Assessment (Health Care),Prognosis,Reproducibility of Results,Validation Studies as Topic|Diagnostic,model development,model validation,predictions models,prognostic,reporting,Checklist,Decision Support Techniques,Humans,Information Dissemination,Models,Statistical,Multivariate Analysis,Practice Guidelines as Topic,Prognosis,Publishing|Checklist,Consensus,Decision Support Techniques,Humans,Multivariate Analysis,Pathology,Predictive Value of Tests,Prognosis,Reproducibility of Results,Research Design|guidance for analysis,level of statistical knowledge,observational studies,Biometry,Biostatistics,Cooperative Behavior,Epidemiologic Methods,Epidemiology,Guidelines as Topic,Humans,Observational Studies as Topic,Research Design,Statistics as Topic||Peer Review,Periodicals as Topic,Publishing,Randomized Controlled Trials as Topic,Research Report,Retrospective Studies||||Cardiac Surgical Procedures,Female,Humans,Male,Severity of Illness Index|Adult,Aged,80 and over,Cohort Studies,Delayed Diagnosis,Early Detection of Cancer,Female,General Practice,Great Britain,Humans,Incidence,Middle Aged,Models,Biological,Ovarian Neoplasms,Predictive Value of Tests,Primary Health Care,Reproducibility of Results,Risk Assessment|Checklist,Diagnosis,Guidelines as Topic,Humans,Models,Theoretical,Multivariate Analysis,Prognosis,Risk Assessment||Consensus Development Conferences as Topic,Diagnostic Techniques and Procedures,Evidence-Based Medicine,Global Health,Humans,Models,Biological,Practice Guidelines as Topic,Precision Medicine,Prognosis,Risk Assessment|Adult,Aged,Cohort Studies,Delayed Diagnosis,Diagnostic Errors,Early Detection of Cancer,Esophageal Neoplasms,General Practice,Great Britain,Humans,Incidence,Middle Aged,Predictive Value of Tests,Primary Health Care,Prognosis,Risk,Stomach Neoplasms|Adult,Aged,80 and over,Cohort Studies,Colorectal Neoplasms,Early Detection of Cancer,Female,General Practice,Great Britain,Humans,Male,Middle Aged,Predictive Value of Tests,Reproducibility of Results,Risk Factors|Adult,Aged,80 and over,Cohort Studies,Delayed Diagnosis,Early Detection of Cancer,Female,Follow-Up Studies,General Practice,Great Britain,Humans,Kidney Neoplasms,Male,Middle Aged,Models,Statistical,Predictive Value of Tests,Primary Health Care,Risk Assessment|Access to Information,Bibliometrics,Cross-Sectional Studies,Humans,Information Dissemination,Multicenter Studies as Topic,Periodicals as Topic,Randomized Controlled Trials as Topic,Reproducibility of Results,Research Design|Humans,Models,Statistical,Multivariate Analysis,Neoplasms,Practice Guidelines as Topic,Prognosis,Research Design|diagnosis,epidemiology,prognosis,research design,risk,statistics,Checklist,Consensus,Diagnosis,Humans,Models,Theoretical,Prognosis,Validation Studies as Topic|Cross-Sectional Studies,Humans,Publications,Randomized Controlled Trials as Topic,Research Design|Advisory Committees,Checklist,Decision Support Techniques,Delivery of Health Care,Guidelines as Topic,Humans,Medical Records,Periodicals as Topic,Prognosis,Publishing,Referral and Consultation|Area Under Curve,Colonic Polyps,Colonography,Computed Tomographic,Diagnostic Imaging,Humans,ROC Curve,Radiographic Image Interpretation,Computer-Assisted,Sensitivity and Specificity|Diagnostic,Model development,Model validation,Prediction models,Prognostic,Transparent reporting,Checklist,Decision Support Techniques,Diagnosis,Humans,Models,Statistical,Multivariate Analysis,Practice Guidelines as Topic,Precision Medicine,Prognosis,Validation Studies as Topic"
raob0051,raob0069,1,0.1111111111111111,Journal article,Journal of Nuclear Medicine,15/04/2011,ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.,"Cornelissen B,Darbar S,Hernandez R,Kersemans V,Tullis I,Barber PR,Smart S,Vojnovic B,Reilly R,Vallis KA","Active Transport,Cell Nucleus,Animals,Antibodies,Monoclonal,Humanized,Cell Line,Tumor,Cell Proliferation,Colony-Forming Units Assay,Dimethylallyltranstransferase,Electrons,Epidermal Growth Factor,Female,Humans,Imidazoles,Mice,Pentetic Acid,Protein Kinase Inhibitors,Protein Transport,Receptor,ErbB-2,Signal Transduction,Trastuzumab"
lina0435,stat0054,2,0.035490101400289714,Journal article|Journal article,Nature Genetics|Nature Genetics,18/05/2015|23/12/2012,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Palles C,Cazier JB,Howarth KM,Domingo E,Jones AM,Broderick P,Kemp Z,Spain SL,Guarino E,Salguero I,Sherborne A,Chubb D,Carvajal-Carmona LG,Ma Y,Kaur K,Dobbins S,Barclay E,Gorman M,Martin L,Kovac MB,Humphray S,CORGI Consortium,WGS500 Consortium,Lucassen A,Holmes CC,Bentley D,Donnelly P,Taylor J,Petridis C,Roylance R,Sawyer EJ,Kerr DJ,Clark S,Grimes J,Kearsey SE,Thomas HJ,McVean G,Houlston RS,Tomlinson I","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Adenoma,Colorectal Neoplasms,DNA Mismatch Repair,DNA Polymerase II,DNA Polymerase III,DNA Replication,Exodeoxyribonucleases,Genetic Linkage,Genome-Wide Association Study,Germ-Line Mutation,Humans,Microsatellite Repeats,Models,Molecular,Pedigree,Schizosaccharomyces,Sequence Analysis,DNA"
clme0237,phpc0228,1,0.14285714285714285,Journal article,Journal of Crohn's and Colitis,01/09/2011,Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.,"Buchanan J,Wordsworth S,Ahmad T,Perrin A,Vermeire S,Sans M,Taylor J,Jewell D","Adult,Europe,Great Britain,Health Care Costs,Humans,Inflammatory Bowel Diseases,Models,Economic"
clme0220,newc0612,3,0.30277777777777776,Conference paper|Journal article|Journal article,European Journal of Cancer|Cancer Research|Cancer Research,01/07/2012|15/04/2013|15/09/2011,Isoenzyme-specific PFK-2/FBPase-2 Inhibition as an Anti-cancer Strategy|Hypoxic trans-activation of sodium dependent bicarbonate co-transporters regulates pH in 3D spheroids and promotes growth|DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo,"Williams JG,Manzano A,Bensaad K,Collins JM,Serres S,Claridge TDW,Sibson N,Bartrons R,Russell AJ,Harris AL|McIntyre A,Hulikova A,Ledaki I,Seden P,Turley H,Jones D,Russell A,Swietach P,Harris AL|Li JL,Sainson RCA,Oon CE,Turley H,Leek R,Sheldon H,Bridges E,Shi W,Snell C,Bowden ET,Wu H,Chowdhury PS,Russell AJ,Montgomery CP,Poulsom R,Harris AL",||
clme0670,raob0097,4,1.3818181818181818,Journal article|Journal article|Journal article|Conference paper,"Cell Death and Disease|Cancer Treatment Reviews|Journal of Clinical Investigation|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",01/01/2012|11/04/2013|01/08/2014|01/05/2013,Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|Targeting ATR in DNA damage response and cancer therapeutics.|Radiation and ATM inhibition: the heart of the matter.|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation,"Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Fokas E,Prevo R,Hammond EM,Brunner TB,McKenna WG,Muschel RJ|Hammond EM,Muschel RJ|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB","Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|ATR,Cancer,Chemotherapy,DNA damage,Radiation,Replication stress,Therapeutics,Animals,Antineoplastic Agents,Ataxia Telangiectasia Mutated Proteins,Clinical Trials as Topic,Combined Modality Therapy,DNA Damage,DNA Replication,Humans,Molecular Targeted Therapy,Neoplasms,Protein Kinase Inhibitors,Protein Kinases,Signal Transduction|Animals,Humans,Sarcoma,Experimental,Gene Deletion,Radiation Tolerance,Ataxia Telangiectasia Mutated Proteins|"
immd0075,immd0151,1,0.038461538461538464,Journal article,Nature Genetics,01/01/2013,Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis,"Twigg SRF,Vorgia E,Mcgowan SJ,Peraki I,Fenwick AL,Sharma VP,Allegra M,Zaragkoulias A,Akha ES,Knight SJL,Lord H,Lester T,Izatt L,Lampe AK,Mohammed SN,Stewart FJ,Verloes A,Wilson LC,Healy C,Sharpe PT,Hammond P,Hughes J,Taylor S,Johnson D,Wall SA,Mavrothalassitis G,Wilkie AOM",
immd0024,whgu0378,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0282,immd0680,1,0.125,Journal article,PLoS Biology,01/02/2015,A novel TGFβ modulator that uncouples R-Smad/I-Smad-mediated negative feedback from R-Smad/ligand-driven positive feedback.,"Gu W,Monteiro R,Zuo J,Simões FC,Martella A,Andrieu-Soler C,Grosveld F,Sauka-Spengler T,Patient R","Embryo,Nonmammalian,Endoderm,Mesoderm,Animals,Zebrafish,Humans,Mice,Transforming Growth Factor beta,Zebrafish Proteins,Membrane Proteins,Microinjections,Sequence Alignment,Signal Transduction,Transcription,Genetic,Gene Expression Regulation,Developmental,Base Sequence,Body Patterning,Molecular Sequence Data,Smad7 Protein,Nodal Signaling Ligands,Feedback,Physiological,LIM Domain Proteins,Morpholinos"
immd0024,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
cschof,robbins,2,0.12406015037593984,Journal article|Journal article,The FASEB Journal|The Journal of Physiology,21/04/2016|20/05/2013,On the pivotal role of PPARα in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury.|Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2.,"Cole MA,Abd Jamil AH,Heather LC,Murray AJ,Sutton ER,Slingo M,Sebag-Montefiore L,Tan SC,Aksentijević D,Gildea OS,Stuckey DJ,Yeoh KK,Carr CA,Evans RD,Aasum E,Schofield CJ,Ratcliffe PJ,Neubauer S,Robbins PA,Clarke K|Bishop T,Talbot NP,Turner PJ,Nicholls LG,Pascual A,Hodson EJ,Douglas G,Fielding JW,Smith TG,Demetriades M,Schofield CJ,Robbins PA,Pugh CW,Buckler KJ,Ratcliffe PJ","|Animals,Anoxia,Carotid Body,Hyperplasia,Hypoxia-Inducible Factor 1,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Inbred C57BL,Transgenic,Pulmonary Ventilation"
clme0149,immd0421,1,0.0625,Journal article,Clinical Cancer Research,01/07/2015,POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer.,"van Gool IC,Eggink FA,Freeman-Mills L,Stelloo E,Marchi E,de Bruyn M,Palles C,Nout RA,de Kroon CD,Osse EM,Klenerman P,Creutzberg CL,Tomlinson IP,Smit VT,Nijman HW,Bosse T,Church DN","Lymphocytes,Tumor-Infiltrating,Humans,Endometrial Neoplasms,DNA Polymerase II,Fluorescent Antibody Technique,Immunohistochemistry,Cohort Studies,Polymerase Chain Reaction,DNA Mutational Analysis,Mutation,Female"
clme0169,clne0009,1,0.25,Journal article,Trials,23/11/2011,Five years of Trials.,"Altman DG,Hrynaszkiewicz I,Furberg CD,Grimshaw JM,Rothwell PM","Clinical Protocols,Clinical Trials as Topic,Humans,Publications"
immd0316,raob0072,1,0.05263157894736842,Journal article,Nature Communications,,Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.,"Findlay JM,Castro-Giner F,Makino S,Rayner E,Kartsonaki C,Cross W,Kovac M,Ulahannan D,Palles C,Gillies RS,MacGregor TP,Church D,Maynard ND,Buffa F,Cazier JB,Graham TA,Wang LM,Sharma RA,Middleton M,Tomlinson I",
clme0497,clme0975,1,0.05,Journal article,Cancer Cell,13/05/2013,Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
whgu0085,whgu0256,1,0.2,Journal article,Blood,29/03/2011,High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq.,"Schödel J,Oikonomopoulos S,Ragoussis J,Pugh CW,Ratcliffe PJ,Mole DR","Basic Helix-Loop-Helix Transcription Factors,Cell Line,Tumor,Chromatin Immunoprecipitation,Chromosome Mapping,Epigenesis,Genetic,Female,Genome,Human,Genome-Wide Association Study,Humans,Oxygen,Response Elements"
ctsu0052,gree0989,1,0.05555555555555555,Journal article,PLoS Medicine,01/03/2015,UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.,"Sudlow C,Gallacher J,Allen N,Beral V,Burton P,Danesh J,Downey P,Elliott P,Green J,Landray M,Liu B,Matthews P,Ong G,Pell J,Silman A,Young A,Sprosen T,Peakman T,Collins R","Humans,Neoplasms,Prospective Studies,Aging,Genotype,Phenotype,Research,Access to Information,Databases,Factual,Adult,Aged,Middle Aged,Biological Specimen Banks,Great Britain"
clme0497,cschof,4,0.3690998329156224,Conference paper|Journal article|Journal article|Journal article,ACS National Meeting Book of Abstracts|MedChemComm|Journal of Medicinal Chemistry|Journal of the American Chemical Society,08/09/2013|01/07/2015|27/09/2012|19/06/2014,Chemical probes for bromodomains outside the BET family|Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains|Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.|Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.,"Brennan PE,Martin SJ,Monteiro O,Fedorov O,Knapp S,Hay D,Wells C,Filippakopoulos P,Picaud S,Muller-Knapp S,Keates T,Yapp C,Philpott M,Schofield C,Burgess-Brown N,Shrestha L,Strain-Damerell C|Hay DA,Rogers CM,Fedorov O,Tallant C,Martin S,Monteiro OP,Mueller S,Knapp S,Schofield CJ,Brennan PE|Hewings DS,Rooney TP,Jennings LE,Hay DA,Schofield CJ,Brennan PE,Knapp S,Conway SJ|Hay DA,Fedorov O,Martin S,Singleton DC,Tallant C,Wells C,Picaud S,Philpott M,Monteiro OP,Rogers CM,Conway SJ,Rooney TP,Tumber A,Yapp C,Filippakopoulos P,Bunnage ME,Müller S,Knapp S,Schofield CJ,Brennan PE","||Acetylation,Animals,Histones,Humans,Lysine,Molecular Targeted Therapy,Nuclear Proteins,Protein Binding,Protein Processing,Post-Translational|Hela Cells,Microsomes,Liver,Humans,Isoxazoles,Indoles,Ligands,Crystallography,X-Ray,Fluorescence Recovery After Photobleaching,Drug Evaluation,Preclinical,Binding Sites,Molecular Structure,Protein Structure,Tertiary,Structure-Activity Relationship,Genes,p53,Models,Molecular,E1A-Associated p300 Protein,CREB-Binding Protein,Small Molecule Libraries,Drug Discovery,Chemistry Techniques,Synthetic"
clme0240,whgu0085,1,0.2,Journal article,Blood,29/03/2011,High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq.,"Schödel J,Oikonomopoulos S,Ragoussis J,Pugh CW,Ratcliffe PJ,Mole DR","Basic Helix-Loop-Helix Transcription Factors,Cell Line,Tumor,Chromatin Immunoprecipitation,Chromosome Mapping,Epigenesis,Genetic,Female,Genome,Human,Genome-Wide Association Study,Humans,Oxygen,Response Elements"
clme0485,clme1037,5,0.6904761904761905,Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Medicinal Chemistry|Current Topics in Behavioral Neurosciences|Nature|Nature|Nature Reviews Drug Discovery,07/01/2016|12/01/2011|01/10/2014|01/01/2012|01/03/2015,"8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.|Animal models of epigenetic regulation in neuropsychiatric disorders.|Kruidenier et al. reply.|A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.|Preclinical target validation using patient-derived cells.","Bavetsias V,Lanigan RM,Ruda GF,Atrash B,McLaughlin MG,Tumber A,Mok NY,Le Bihan YV,Dempster S,Boxall KJ,Jeganathan F,Hatch SB,Savitsky P,Velupillai S,Krojer T,England KS,Sejberg J,Thai C,Donovan A,Pal A,Scozzafava G,Bennett JM,Kawamura A,Johansson C,Szykowska A,Gileadi C,Burgess-Brown NA,von Delft F,Oppermann U,Walters Z,Shipley J,Raynaud FI,Westaway SM,Prinjha RK,Fedorov O,Burke R,Schofield CJ,Westwood IM,Bountra C,Müller S,van Montfort RL,Brennan PE,Blagg J|Bountra C,Oppermann U,Heightman TD|Kruidenier L,Chung CW,Cheng Z,Liddle J,Che K,Joberty G,Bantscheff M,Bountra C,Bridges A,Diallo H,Eberhard D,Hutchinson S,Jones E,Katso R,Leveridge M,Mander PK,Mosley J,Ramirez-Molina C,Rowland P,Schofield CJ,Sheppard RJ,Smith JE,Swales C,Tanner R,Thomas P,Tumber A,Drewes G,Oppermann U,Patel DJ,Lee K,Wilson DM|Kruidenier L,Chung C-W,Cheng Z,Liddle J,Che K,Joberty G,Bantscheff M,Bountra C,Bridges A,Diallo H,Eberhard D,Hutchinson S,Jones E,Katso R,Leveridge M,Mander PK,Mosley J,Ramirez-Molina C,Rowland P,Schofield CJ,Sheppard RJ,Smith JE,Swales C,Tanner R,Thomas P,Tumber A,Drewes G,Oppermann U,Patel DJ,Lee K,Wilson DM|Edwards AM,Arrowsmith CH,Bountra C,Bunnage ME,Feldmann M,Knight JC,Patel DD,Prinos P,Taylor MD,Sundström M,SGC Open Source Target-Discovery Partnership","|Animals,Chromatin,DNA Methylation,Epigenesis,Genetic,Gene Expression Regulation,Histones,Humans,Models,Animal|Macrophages,Animals,Humans,Enzyme Inhibitors,Jumonji Domain-Containing Histone Demethylases|Amino Acid Sequence,Animals,Biocatalysis,Catalytic Domain,Cells,Cultured,Enzyme Inhibitors,Evolution,Molecular,Histones,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Lysine,Macrophages,Methylation,Mice,Models,Substrate Specificity,Tumor Necrosis Factor-alpha|SGC Open Source Target-Discovery Partnership,Cell Line,Humans,Drug Evaluation,Preclinical,Patients,Public-Private Sector Partnerships,Primary Cell Culture,Translational Medical Research"
bioc0365,bioc0673,1,0.1,Journal article,Cell Reports,01/01/2012,The GPS Motif Is a Molecular Switch for Bimodal Activities of Adhesion Class G Protein-Coupled Receptors,"Prömel S,Frickenhaus M,Hughes S,Mestek L,Staunton D,Woollard A,Vakonakis I,Schöneberg T,Schnabel R,Russ AP,Langenhan T",
immd0556,immd0700,11,0.8275597761657925,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Blood|Blood|Leukemia|Nature Immunology|Journal of Experimental Medicine|Nature|Cancer Cell|Cell Reports|Nature Immunology|Nature Cell Biology|Nature Communications,01/01/2011|06/08/2012|01/01/2012|01/01/2012|03/02/2014|11/08/2013|16/06/2014|27/03/2013|||,"Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation|Dicer is selectively important for the earliest stages of erythroid development.|Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model|The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential|Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate.|Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy|Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo|FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.|Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing.|A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors.|Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells.","Kharazi S,Mead AJ,Mansour A,Hultquist A,Böiers C,Luc S,Buza-Vidas N,Ma Z,Ferry H,Atkinson D,Reckzeh K,Masson K,Cammenga J,Rönnstrand L,Arai F,Suda T,Nerlov C,Sitnicka E,Jacobsen SEW|Buza-Vidas N,Cismasiu VB,Moore S,Mead AJ,Woll PS,Lutteropp M,Melchiori L,Luc S,Bouriez-Jones T,Atkinson D,O'Carroll D,Jacobsen SE,Nerlov C|Reckzeh K,Bereshchenko O,Mead A,Rehn M,Kharazi S,Jacobsen SE,Nerlov C,Cammenga J|Luc S,Luis TC,Boukarabila H,Macaulay IC,Buza-Vidas N,Bouriez-Jones T,Lutteropp M,Woll PS,Loughran SJ,Mead AJ,Hultquist A,Brown J,Mizukami T,Matsuoka S,Ferry H,Anderson K,Duarte S,Atkinson D,Soneji S,Domanski A,Farley A,Sanjuan-Pla A,Carella C,Patient R,De Bruijn M,Enver T,Nerlov C,Blackburn C,Godin I,Jacobsen SEW|Grover A,Mancini E,Moore S,Mead AJ,Atkinson D,Rasmussen KD,O'Carroll D,Jacobsen SE,Nerlov C|Sanjuan-Pla A,Moore S,Nerlov C,Carella C,Macaulay IC,Jensen CT,Woll PS,Luis TC,Mead A,Matsuoka S,Jones TB,Chowdhury O,Stenson L,Lutteropp M,Green JCA,Facchini R,Boukarabila H,Carrelha J,Tarrant P,Atkinson D,Clark S-A,Jacobsen SEW,Grover A,Gambardella A,Thongjuea S|Woll PS,Kjällquist U,Chowdhury O,Doolittle H,Wedge DC,Thongjuea S,Erlandsson R,Ngara M,Anderson K,Deng Q,Mead AJ,Stenson L,Giustacchini A,Duarte S,Giannoulatou E,Taylor S,Karimi M,Scharenberg C,Mortera-Blanco T,Macaulay IC,Clark SA,Dybedal I,Josefsen D,Fenaux P,Hokland P,Holm MS,Cazzola M,Malcovati L,Tauro S,Bowen D,Boultwood J,Pellagatti A,Pimanda JE,Unnikrishnan A,Vyas P,Göhring G,Schlegelberger B,Tobiasson M,Kvalheim G,Constantinescu SN,Nerlov C,Nilsson L,Campbell PJ,Sandberg R,Papaemmanuil E,Hellström-Lindberg E,Linnarsson S,Jacobsen SEW|Mead AJ,Kharazi S,Atkinson D,Macaulay I,Pecquet C,Loughran S,Lutteropp M,Woll P,Chowdhury O,Luc S,Buza-Vidas N,Ferry H,Clark SA,Goardon N,Vyas P,Constantinescu SN,Sitnicka E,Nerlov C,Jacobsen SE|Drissen R,Buza-Vidas N,Woll P,Thongjuea S,Gambardella A,Giustacchini A,Mancini E,Zriwil A,Lutteropp M,Grover A,Mead A,Sitnicka E,Jacobsen SE,Nerlov C|Buono M,Facchini R,Matsuoka S,Thongjuea S,Waithe D,Luis TC,Giustacchini A,Besmer P,Mead AJ,Jacobsen SE,Nerlov C|Grover A,Sanjuan-Pla A,Thongjuea S,Carrelha J,Giustacchini A,Gambardella A,Macaulay I,Mancini E,Luis TC,Mead A,Jacobsen SE,Nerlov C","|Animals,Biomarkers,Blotting,Western,Cell Differentiation,Cell Lineage,DEAD-box RNA Helicases,Erythroid Cells,Gene Expression Profiling,Gene Expression Regulation,Hematopoietic Stem Cells,Integrases,Megakaryocyte Progenitor Cells,Mice,Knockout,Oligonucleotide Array Sequence Analysis,RNA,Messenger,Real-Time Polymerase Chain Reaction,Reverse Transcriptase Polymerase Chain Reaction,Ribonuclease III,Transcription Factors|||Animals,Cell Lineage,Colony-Forming Units Assay,Erythroid Precursor Cells,Erythropoiesis,Erythropoietin,Gene Expression Profiling,Hematopoietic Stem Cell Transplantation,Hematopoietic Stem Cells,Mice,Congenic,Inbred C57BL,Transgenic,Multipotent Stem Cells,Recombinant Proteins|||Animals,Cell Differentiation,Cell Transformation,Neoplastic,Disease Models,Animal,Flow Cytometry,Gene Expression,Humans,Leukemia,Myeloid,Acute,Mice,Microarray Analysis,Multipotent Stem Cells,Myeloid Cells,Signal Transduction,fms-Like Tyrosine Kinase 3||Cells,Cultured,Endothelial Cells,Multipotent Stem Cells,Animals,Mice,Transgenic,Stem Cell Factor,Coculture Techniques,Paracrine Communication,Signal Transduction,Cell Differentiation,Cell Movement,Gene Expression Regulation,Developmental,Cell Lineage,Phenotype,Stem Cell Niche,Thymocytes|"
clme0621,dpag0048,2,0.34285714285714286,Journal article|Journal article,Neurobiology of Disease|Cerebral Cortex,21/11/2013|13/03/2012,Blocked angiogenesis in Galectin-3 null mice does not alter cellular and behavioral recovery after middle cerebral artery occlusion stroke.|Ependymal ciliary dysfunction and reactive astrocytosis in a reorganized subventricular zone after stroke.,"Young CC,Al-Dalahmah O,Lewis NJ,Brooks KJ,Jenkins MM,Poirier F,Buchan AM,Szele FG|Young CC,van der Harg JM,Lewis NJ,Brooks KJ,Buchan AM,Szele FG","5-bromo-2-deoxyuridine,ANOVA,Angiogenesis,BrdU,CBF,CSF,Dcx,ECM,GFAP,Gal-3,Galectin-3,H/I,Ischemia,MCA,MCAO,Middle cerebral artery occlusion,Migration,NeuN,Neural repair,Neurogenesis,OB,PCP,PECAM-1,PHi3,RMS,SVZ,Subependymal zone,TUNEL,VEGF,WT,ace tub,acetylated tubulin,analysis of variance,cerebral blood flow,cerebrospinal fluid,doublecortin,extracellular matrix,gamma-tubulin,glial fibrillary acidic protein,hypoxia ischemia,middle cerebral artery,middle cerebral artery occlusion,neuronal nuclei,olfactory bulb,phosphorylated histone H3,planar cell polarity,platelet endothelial cell adhesion molecule-1,rostral migratory stream,subventricular zone,terminal deoxynucleotidyl transferase dUTP nick end labeling,vascular endothelial growth factor,wild type,β-cat,β-catenin,γ-tub,Angiogenesis Inducing Agents,Animals,Brain,Brain Infarction,Cerebral Ventricles,Cerebrovascular Circulation,Disease Models,Animal,Galectin 3,Gene Expression Regulation,Gliosis,Infarction,Middle Cerebral Artery,Male,Mental Disorders,Mice,Knockout,Neovascularization,Pathologic,Recovery of Function,Time Factors,Vascular Endothelial Growth Factor A|Animals,Cilia,Disease Models,Animal,Ependyma,Gliosis,Immunohistochemistry,Lateral Ventricles,Male,Mice,129 Strain,Stroke"
card0027,immd0036,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0237,whgu0408,1,0.07692307692307693,Journal article,Nature Genetics,01/06/2012,Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1.,"Jaeger E,Leedham S,Lewis A,Segditsas S,Becker M,Cuadrado PR,Davis H,Kaur K,Heinimann K,Howarth K,East J,Taylor J,Thomas H,Tomlinson I","Bone Morphogenetic Proteins,Chromosome Mapping,Chromosomes,Human,Pair 15,Colonic Polyps,Colorectal Neoplasms,DNA Copy Number Variations,Fetal Proteins,Gene Duplication,Gene Expression,Humans,Intercellular Signaling Peptides and Proteins,Microfilament Proteins,Neuroendocrine Secretory Protein 7B2,Nuclear Proteins,Receptors,Immunologic,Syndrome"
clme0240,immd0237,16,1.315883419812184,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Nature Genetics|Nature Genetics|The Journal of Physiology|Chemical Communications|Blood|The Journal of Physiology|Cancer Cell|American Journal of Hematology|Journal of Clinical Investigation|ACS Chemical Biology|Journal of Biological Chemistry|PLoS One|The FASEB Journal|Journal of Pathology|The Journal of Physiology|Cell Reports,11/03/2012|18/05/2015|20/05/2013|01/01/2015|29/03/2011|01/01/2012|18/10/2011|01/08/2015|01/03/2011|17/05/2013|22/02/2011|01/01/2015|09/03/2011|01/01/2011|01/09/2015|01/05/2013,Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2.|Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.|High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq.|Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: Insights from genetically modified mice|Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.|Contrasting roles of HIF-1 and 2 in ventilatory acclimatisation to hypoxia|Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice|Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.|Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors.|Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.|Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation.|Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status|Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF-2 pathway.|A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.,"Schödel J,Bardella C,Sciesielski LK,Brown JM,Pugh CW,Buckle V,Tomlinson IP,Ratcliffe PJ,Mole DR|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Bishop T,Talbot NP,Turner PJ,Nicholls LG,Pascual A,Hodson EJ,Douglas G,Fielding JW,Smith TG,Demetriades M,Schofield CJ,Robbins PA,Pugh CW,Buckler KJ,Ratcliffe PJ|Thinnes CC,Tumber A,Yapp C,Scozzafava G,Yeh T,Chan MC,Tran TA,Hsu K,Tarhonskaya H,Walport LJ,Wilkins SE,Martinez ED,Müller S,Pugh CW,Ratcliffe PJ,Brennan PE,Kawamura A,Schofield CJ|Schödel J,Oikonomopoulos S,Ragoussis J,Pugh CW,Ratcliffe PJ,Mole DR|Chen RL,Nagel S,Papadakis M,Bishop T,Pollard P,Ratcliffe PJ,Pugh CW,Buchan AM|Adam J,Hatipoglu E,O'Flaherty L,Ternette N,Sahgal N,Lockstone H,Baban D,Nye E,Stamp GW,Wolhuter K,Stevens M,Fischer R,Carmeliet P,Maxwell PH,Pugh CW,Frizzell N,Soga T,Kessler BM,El-Bahrawy M,Ratcliffe PJ,Pollard PJ|Hodson EJ,Nicholls LG,Turner PJ,Robbins PA,Pugh CW,Buckler K,Ratcliffe PJ,Bishop T|Walmsley SR,Chilvers ER,Thompson AA,Vaughan K,Marriott HM,Parker LC,Shaw G,Parmar S,Schneider M,Sabroe I,Dockrell DH,Milo M,Taylor CT,Johnson RS,Pugh CW,Ratcliffe PJ,Maxwell PH,Carmeliet P,Whyte MKB|Chowdhury R,Candela-Lena JI,Chan MC,Greenald DJ,Yeoh KK,Tian YM,McDonough MA,Tumber A,Rose NR,Conejo-Garcia A,Demetriades M,Mathavan S,Kawamura A,Lee MK,van Eeden F,Pugh CW,Ratcliffe PJ,Schofield CJ|Tian YM,Yeoh KK,Lee MK,Eriksson T,Kessler BM,Kramer HB,Edelmann MJ,Willam C,Pugh CW,Schofield CJ,Ratcliffe PJ|Chan MC,Atasoylu O,Hodson E,Tumber A,Leung IK,Chowdhury R,Gómez-Pérez V,Demetriades M,Rydzik AM,Holt-Martyn J,Tian YM,Bishop T,Claridge TD,Kawamura A,Pugh CW,Ratcliffe PJ,Schofield CJ|Formenti F,Beer PA,Croft QP,Dorrington KL,Gale DP,Lappin TR,Lucas GS,Maher ER,Maxwell PH,McMullin MF,O'Connor DF,Percy MJ,Pugh CW,Ratcliffe PJ,Smith TG,Talbot NP,Robbins PA|Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ|Hodson EJ,Nicholls LG,Turner PJ,Llyr R,Fielding JW,Douglas G,Ratnayaka I,Robbins PA,Pugh CW,Buckler KJ,Ratcliffe PJ,Bishop T|Adam J,Yang M,Bauerschmidt C,Kitagawa M,O'Flaherty L,Maheswaran P,Özkan G,Sahgal N,Baban D,Kato K,Saito K,Iino K,Igarashi K,Stratford M,Pugh C,Tennant DA,Ludwig C,Davies B,Ratcliffe PJ,El-Bahrawy M,Ashrafian H,Soga T,Pollard PJ","Cell Cycle Checkpoints,Cell Hypoxia,Cell Line,Tumor,Chromosomes,Human,Pair 11,Cyclin D1,Enhancer Elements,Genetic,Gene Expression Regulation,Neoplastic,Genetic Predisposition to Disease,Genetic Variation,Humans,Hypoxia-Inducible Factor 1,Kidney Neoplasms,Molecular Sequence Data,Polymorphism,Single Nucleotide,Von Hippel-Lindau Tumor Suppressor Protein|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|Animals,Anoxia,Carotid Body,Hyperplasia,Hypoxia-Inducible Factor 1,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Inbred C57BL,Transgenic,Pulmonary Ventilation|Humans,Oxyquinoline,Oxygenases,Enzyme Inhibitors,Molecular Structure,Structure-Activity Relationship,Dose-Response Relationship,Drug,Models,Molecular|Basic Helix-Loop-Helix Transcription Factors,Cell Line,Tumor,Chromatin Immunoprecipitation,Chromosome Mapping,Epigenesis,Genetic,Female,Genome,Human,Genome-Wide Association Study,Humans,Oxygen,Response Elements|Animals,Body Temperature Regulation,Body Weight,Brain Ischemia,Cerebral Arteries,Cerebral Cortex,Gene Expression Regulation,Genotype,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Knockout,Procollagen-Proline Dioxygenase,Protein Isoforms|Adaptor Proteins,Signal Transducing,Animals,Antioxidants,Cell Hypoxia,Cytoskeletal Proteins,Fumarate Hydratase,Fumarates,Gene Expression Regulation,Neoplastic,Hypoxia-Inducible Factor 1,Kidney Diseases,Cystic,Mice,NF-E2-Related Factor 2,Procollagen-Proline Dioxygenase,Signal Transduction,Succinates|||Animals,Genetically Modified,Anoxia,Biological Assay,Cell Line,Heterocyclic Compounds,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Hypoxia-Inducible Factor-Proline Dioxygenases,Inhibitory Concentration 50,Models,Molecular,Molecular Structure,Signal Transduction,Small Molecule Libraries,Zebrafish|Animals,Cell Hypoxia,Drosophila melanogaster,Enzyme Inhibitors,Hep G2 Cells,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,K562 Cells,Male,Oxygenases,Protein Structure,Tertiary,Rats,Sprague-Dawley,Ubiquitin-Protein Ligases,p300-CBP Transcription Factors|Brain,Hela Cells,Animals,Humans,Mice,Triazoles,Enzyme Inhibitors,Stroke,MCF-7 Cells,Hypoxia-Inducible Factor-Proline Dioxygenases|Basic Helix-Loop-Helix Transcription Factors,Carbon Dioxide,Cardiovascular Physiological Phenomena,Case-Control Studies,Exercise Test,Female,Gene Expression Regulation,Humans,Male,Mutation,Oxygen,von Hippel-Lindau Disease|Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid||Animals,Arginine,Argininosuccinic Acid,Cell Line,Citric Acid Cycle,Fumarate Hydratase,Fumarates,Kidney,Kidney Neoplasms,Metabolome,Mice,Knockout,Transgenic,Mitochondria,Mutation,Protein Isoforms,Urea"
immd0330,stat0054,3,0.13942641276694162,Journal article|Journal article|Conference paper,Leukemia|Nature Genetics|Blood,01/01/2012|18/05/2015|06/12/2014,Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Towards Response Prediction Using Integrated Genomics in Chronic Lymphocytic Leukaemia: Results on 250 First-Line FCR Treated Patients from UK Clinical Trials,"Knight SJ,Yau C,Clifford R,Timbs AT,Sadighi Akha E,Dréau HM,Burns A,Ciria C,Oscier DG,Pettitt AR,Dutton S,Holmes CC,Taylor J,Cazier JB,Schuh A|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Clifford RM,Robbe P,Weller S,Timbs AT,Titsias M,Burns A,Cabes M,Alsolami R,Yau C,Hamblin A,Mason J,Oates M,Pettitt A,Holmes C,Hillmen P,Taylor J,Knight SJL,Schuh A","Adult,Aged,80 and over,Biomarkers,Tumor,Chromosome Aberrations,Clone Cells,Female,Gene Dosage,Genome,Human,Genomics,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Loss of Heterozygosity,Male,Middle Aged,Neoplasm Recurrence,Local,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Prognosis|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|"
bioc0212,bioc0416,1,0.125,Journal article,Magnetic Resonance in Medicine,20/05/2015,Robust and high resolution hyperpolarized metabolic imaging of the rat heart at 7 t with 3d spectral-spatial EPI.,"Miller JJ,Lau AZ,Teh I,Schneider JE,Kinchesh P,Smart S,Ball V,Sibson NR,Tyler DJ",
clme0240,immd0036,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
card0027,path0084,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0084,raob0097,1,0.1111111111111111,Journal article,Autophagy,01/04/2012,A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells.,"Phadwal K,Alegre-Abarrategui J,Watson AS,Pike L,Anbalagan S,Hammond EM,Wade-Martins R,McMichael A,Klenerman P,Simon AK","Adult,Animals,Autophagy,B-Lymphocytes,Biological Assay,Cell Aging,Cells,Cultured,HEK293 Cells,Histones,Humans,Mice,Middle Aged,Reproducibility of Results,T-Lymphocytes"
clme0667,immd0316,1,0.08333333333333333,Journal article,Oncotarget,28/02/2015,Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen.,"Tiwana GS,Prevo R,Buffa FM,Yu S,Ebner DV,Howarth A,Folkes LK,Budwal B,Chu KY,Durrant L,Muschel RJ,McKenna WG,Higgins GS","Cell Line,Tumor,HCT116 Cells,Hela Cells,Humans,Neoplasms,DNA Damage,Pyrithiamine,Thiamin Pyrophosphokinase,Thiamine,Radiation-Sensitizing Agents,Colony-Forming Units Assay,Transfection,Radiation Tolerance,High-Throughput Screening Assays"
chem0489,newc0612,1,0.0625,Journal article,Journal of Medicinal Chemistry,21/03/2013,"Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.","Hewings DS,Fedorov O,Filippakopoulos P,Martin S,Picaud S,Tumber A,Wells C,Olcina MM,Freeman K,Gill A,Ritchie AJ,Sheppard DW,Russell AJ,Hammond EM,Knapp S,Brennan PE,Conway SJ","Acetylation,CREB-Binding Protein,Cell Line,Tumor,Crystallography,X-Ray,Histones,Humans,Inhibitory Concentration 50,Isoxazoles,Ligands,Lysine,Nuclear Proteins,Protein Binding,Structure-Activity Relationship,Transcription Factors"
clme0237,immd0198,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clph0059,raob0069,1,0.14285714285714285,Journal article,Journal of National Cancer Institute,09/10/2013,Selective permeabilization of the blood-brain barrier at sites of metastasis.,"Connell JJ,Chatain G,Cornelissen B,Vallis KA,Hamilton A,Seymour L,Anthony DC,Sibson NR","Analysis of Variance,Animals,Antibodies,Monoclonal,Humanized,Antineoplastic Agents,Blood-Brain Barrier,Brain,Brain Neoplasms,Breast Neoplasms,Contrast Media,Disease Models,Animal,Drug Administration Schedule,Female,Gadolinium DTPA,Gene Expression Regulation,Neoplastic,Humans,Immunohistochemistry,Lymphotoxin-alpha,Magnetic Resonance Imaging,Mice,Inbred BALB C,Permeability,Receptors,Tumor Necrosis Factor,Type I,Tomography,Emission-Computed,Single-Photon,X-Ray Computed,Trastuzumab,Tumor Necrosis Factor-alpha"
raob0072,raob0168,1,0.25,Journal article,Nature Reviews Clinical Oncology,01/02/2011,Intra-arterial brachytherapy of hepatic malignancies: watch the flow.,"Morgan B,Kennedy AS,Lewington V,Jones B,Sharma RA","Animals,Brachytherapy,Diagnostic Imaging,Embolization,Therapeutic,Humans,Infusions,Intra-Arterial,Injections,Liver Neoplasms"
ctsu0052,ctsu0084,5,0.2794187675070028,Journal article|Journal article|Journal article|Journal article|Journal article,Lancet|Chin J Hypert|Chinese Medical Journal|Chinese Journal of Cardiology|Chinese Medical Journal,01/01/2011|01/01/2011|20/05/2012|01/01/2013|01/12/2012,"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.|Survey of treatment of hypertension among patients with ischemic stroke|Underuse of statins in patients with atherosclerotic ischemic stroke in China|ACEI/ARB use among high risk patients with coronary heart disease in China: a cross-sectional study|Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients.","Baigent C,Landray MJ,Reith C,Emberson J,Wheeler DC,Tomson C,Wanner C,Krane V,Cass A,Craig J,Neal B,Jiang L,Hooi LS,Levin A,Agodoa L,Gaziano M,Kasiske B,Walker R,Massy ZA,Feldt-Rasmussen B,Krairittichai U,Ophascharoensuk V,Fellström B,Holdaas H,Tesar V,Wiecek A,Grobbee D,de Zeeuw D,Grönhagen-Riska C,Dasgupta T,Lewis D,Herrington W,Mafham M,Majoni W,Wallendszus K,Grimm R,Pedersen T,Tobert J,Armitage J,Baxter A,Bray C,Chen Y,Chen Z,Hill M,Knott C,Parish S,Simpson D,Sleight P,Young A,Collins R,SHARP Investigators|Li J,Zhang D,Li X,Feng F,Liu J,Gao Y,Zhang H,Wuhai B,Wei X,Li L,Ge L,Pang X,Chen Y,Chen Z,Landray M,Armitage J,Chen F,Jiang L|Xi L,Yan G,Jing L,Fang F,Jia-min L,Hai-bo Z,Dan Z,Wu-han-bi-li-ge H,Fang C,Yi-ping C,Zheng-ming C,Landray M,Armitage J,Li-xin J,Li-ming L,Grp H-TC|Liu JM,Ge L,Li J,Li X,Feng F,Zhang HB,Gao Y,Wuhan BLG,Pang X,Chen YP,Chen ZM,Landray M,Armitage J,Chen F,Jiang LX|Li J,Chen YP,Li X,Armitage J,Feng F,Liu JM,Gao Y,Zhang HB,Zhang D,Hundei WB,Chen ZM,Chen F,Hopewell JC,Valdes-Marquez E,Landray M,Jiang LX,HPS2-THRIVE Collaborative Group","Adult,Aged,Azetidines,Cardiovascular Diseases,Cholesterol,LDL,Confidence Intervals,Dose-Response Relationship,Drug,Double-Blind Method,Drug Administration Schedule,Drug Therapy,Combination,Ezetimibe,Female,Follow-Up Studies,Humans,Hypolipidemic Agents,Kidney Function Tests,Male,Middle Aged,Reference Values,Renal Dialysis,Renal Insufficiency,Chronic,Risk Assessment,Severity of Illness Index,Simvastatin,Survival Analysis,Time Factors,Treatment Outcome||hydroxymethylglutaryl-CoA reductase inhibitors,ischemic stroke,secondary prevention||Aged,80 and over,Atherosclerosis,Atorvastatin Calcium,Cerebrovascular Disorders,Coronary Artery Disease,Cross-Sectional Studies,Female,Heptanoic Acids,Humans,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Male,Middle Aged,Peripheral Vascular Diseases,Pyrroles,Secondary Prevention,Simvastatin"
quee1607,robbins,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
donc0120,raob0202,1,0.06666666666666667,Journal article,Radiotherapy and Oncology,,ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.,"Wilson JM,Fokas E,Dutton SJ,Patel N,Hawkins MA,Eccles C,Chu KY,Durrant L,Abraham AG,Partridge M,Woodward M,O'Neill E,Maughan T,McKenna WG,Mukherjee S,Brunner TB",
immd0237,immd0316,3,0.27884615384615385,Conference paper|Journal article|Journal article,Cancer Research|Oncogene|Oncogene,01/05/2015|20/08/2015|24/11/2014,The non-coding transcriptome of hypoxic breast cancer: Novel insights of clinical relevant long non-coding RNA in hypoxia signalling|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival|Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival.,"Choudhry H,Schodel J,Albukhari A,Haider S,Buffa F,Ratcliffe PJ,Mole DR,Ragousis I,Harris AL|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR|Choudhry H,Albukhari A,Morotti M,Haider S,Moralli D,Smythies J,Schödel J,Green CM,Camps C,Buffa F,Ratcliffe P,Ragoussis J,Harris AL,Mole DR","||Animals,Humans,Mice,Breast Neoplasms,Cell Adhesion Molecules,Receptors,Cell Surface,Apoptosis,Cell Proliferation,Cell Hypoxia,Cell Survival,Female,Basic Helix-Loop-Helix Transcription Factors,Transcriptional Activation,RNA,Long Noncoding"
bioc0416,raob0087,2,0.20192307692307693,Journal article|Journal article,Theranostics|Magnetic Resonance in Medicine,01/01/2015|20/05/2015,Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates.|Robust and high resolution hyperpolarized metabolic imaging of the rat heart at 7 t with 3d spectral-spatial EPI.,"Melemenidis S,Jefferson A,Ruparelia N,Akhtar AM,Xie J,Allen D,Hamilton A,Larkin JR,Perez-Balderas F,Smart SC,Muschel RJ,Chen X,Sibson NR,Choudhury RP|Miller JJ,Lau AZ,Teh I,Schneider JE,Kinchesh P,Smart S,Ball V,Sibson NR,Tyler DJ","Cells,Cultured,Endothelial Cells,Animals,Mice,Inbred C57BL,Humans,Neoplasms,Neovascularization,Pathologic,Ferric Compounds,Oligopeptides,Magnetic Resonance Imaging,Microspheres,Protein Binding,Female|"
clme0240,raob0047,1,0.045454545454545456,Journal article,Cell Reports,01/05/2013,A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.,"Adam J,Yang M,Bauerschmidt C,Kitagawa M,O'Flaherty L,Maheswaran P,Özkan G,Sahgal N,Baban D,Kato K,Saito K,Iino K,Igarashi K,Stratford M,Pugh C,Tennant DA,Ludwig C,Davies B,Ratcliffe PJ,El-Bahrawy M,Ashrafian H,Soga T,Pollard PJ","Animals,Arginine,Argininosuccinic Acid,Cell Line,Citric Acid Cycle,Fumarate Hydratase,Fumarates,Kidney,Kidney Neoplasms,Metabolome,Mice,Knockout,Transgenic,Mitochondria,Mutation,Protein Isoforms,Urea"
immd0316,univ1923,1,0.058823529411764705,Journal article,Oncotarget,01/01/2015,Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways.,"Valli A,Rodriguez M,Moutsianas L,Fischer R,Fedele V,Huang HL,Van Stiphout R,Jones D,Mccarthy M,Vinaxia M,Igarashi K,Sato M,Soga T,Buffa F,Mccullagh J,Yanes O,Harris A,Kessler B","Cell Line,Tumor,HCT116 Cells,Humans,Colorectal Neoplasms,Acetyl-CoA Carboxylase,Acetyl-CoA C-Acyltransferase,Lipids,Fatty Acids,Platelet Activating Factor,Blotting,Western,Proteomics,Genomics,Signal Transduction,Cell Hypoxia,RNA Interference,Aged,Middle Aged,Female,Male,Lipid Metabolism,Basic Helix-Loop-Helix Transcription Factors,Hypoxia-Inducible Factor 1,alpha Subunit,Metabolomics"
raob0097,whgu0256,1,0.08333333333333333,Journal article,PLoS One,01/01/2011,Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α).,"Thalhammer A,Bencokova Z,Poole R,Loenarz C,Adam J,O'Flaherty L,Schödel J,Mole D,Giaslakiotis K,Schofield CJ,Hammond EM,Ratcliffe PJ,Pollard PJ","Anoxia,Cell Line,Dioxygenases,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Ketoglutaric Acids,Membrane Proteins,Nuclear Proteins,Oxygenases,Transcriptional Activation"
raob0005,raob0233,1,0.06666666666666667,Journal article,Molecular Cell,29/12/2015,Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds.,"Zimmer J,Tacconi EM,Folio C,Badie S,Porru M,Klare K,Tumiati M,Markkanen E,Halder S,Ryan A,Jackson SP,Ramadan K,Kuznetsov SG,Biroccio A,Sale JE,Tarsounas M",
cschof,vacc0036,1,0.16666666666666666,Journal article,Chemical Communications,29/11/2013,Structural insights into how 5-hydroxymethylation influences transcription factor binding.,"Lercher L,McDonough MA,El-Sagheer AH,Thalhammer A,Kriaucionis S,Brown T,Schofield CJ","Cytosine,DNA,DNA Methylation,Models,Molecular,Nucleic Acid Conformation,Oxidation-Reduction,Protein Binding,Transcription Factors"
raob0047,raob0095,2,0.26785714285714285,Journal article|Conference paper,Chemical Communications|Journal of Nuclear Medicine,09/02/2015|01/05/2015,Development of an enzymatic pretargeting strategy for dual-modality imaging.|Development of an Enzymatic Pretargeting Strategy for Dual-Modality Imaging,"Knight JC,Mosley M,Stratford MR,Uyeda HT,Benink HA,Cong M,Fan F,Faulkner S,Cornelissen B|Knight J,Mosley M,Stratford M,Uyeda HT,Cong M,Fan F,Faulkner S,Cornelissen B","Cell Line,Tumor,Humans,Halogens,Hydrolases,Ligands,Tomography,Emission-Computed,Single-Photon,Antibodies,Monoclonal,Humanized,Optical Imaging|"
bras2068,xxxx0009,3,0.6583333333333333,Journal article|Journal article|Journal article,Physics in Medicine and Biology|Journal of Instrumentation|Medical Physics,14/05/2015|01/05/2015|01/02/2015,Improved calibration of mass stopping power in low density tissue for a proton pencil beam algorithm.|Simulations of a vacuum window and in-beam ion detection for use in radiobiological experiments with 50 MeV particle beams|3D calculation of radiation-induced second cancer risk including dose and tissue response heterogeneities.,"Warren DR,Partridge M,Hill MA,Peach K|Caldwell L,Warren DR,Abler D,Peach K,Partridge M,Timlin C|Timlin C,Warren DR,Rowland B,Madkhali A,Loken J,Partridge M,Jones B,Kruse J,Miller R","Humans,Carcinoma,Non-Small-Cell Lung,Lung Neoplasms,Tomography,X-Ray Computed,Radiotherapy Dosage,Radiotherapy Planning,Computer-Assisted,Calibration,Monte Carlo Method,Phantoms,Imaging,Algorithms,Proton Therapy|Models and simulations,Analysis and statistical methods,Instrumentation for particle-beam therapy,Instrumentation for hadron therapy|Humans,Meningioma,Neoplasms,Radiation-Induced,Second Primary,Radiotherapy,Computer-Assisted,Radiotherapy Dosage,Radiotherapy Planning,Risk Assessment,Uncertainty,Dose-Response Relationship,Radiation,Models,Biological,Software"
card0018,clne0024,2,0.18181818181818182,Journal article|Journal article,JACC: Cardiovascular Imaging|Journal of the American College of Cardiology Cardiovascular Imaging,01/04/2012|01/01/2012,"Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study.|Acute 3T Magnetic Resonance Imaging Reveals Features of Carotid Atherosclerotic Plaque Associated with Ipsilateral Cerebral Infarction in Minor Stroke and Transient Ischemic Attack.","Lindsay AC,Biasiolli L,Lee JM,Kylintireas I,MacIntosh BJ,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury RP|Lindsay AC,Biasiolli L,Lee JMS,Kylintireas,MacIntosh,Watt H,Jezzard P,Robson MD,Neubauer S,Handa A,Kennedy J,Choudhury R","Aged,Brain,Carotid Arteries,Case-Control Studies,Cerebral Infarction,Diagnosis,Differential,Female,Follow-Up Studies,Great Britain,Humans,Incidence,Magnetic Resonance Imaging,Male,Plaque,Atherosclerotic,Prospective Studies,Risk Factors|"
clme0301,lina0435,5,0.29635379910609266,Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Clinical Endocrinology and Metabolism|Journal of Clinical Endocrinology and Metabolism|Nature Genetics|Nature Genetics|Nature Genetics,01/08/2012|28/02/2013|18/05/2015|01/01/2013|09/12/2012,Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.|Whole-exome sequencing studies of nonfunctioning pituitary adenomas.|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3|Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3.,"Newey PJ,Nesbit MA,Rimmer AJ,Attar M,Head RT,Christie PT,Gorvin CM,Stechman M,Gregory L,Mihai R,Sadler G,McVean G,Buck D,Thakker RV|Newey PJ,Nesbit MA,Rimmer AJ,Head RA,Gorvin CM,Attar M,Gregory L,Wass JA,Buck D,Karavitaki N,Grossman AB,McVean G,Ansorge O,Thakker RV|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Nesbit MA,Hannan FM,Howles SA,Reed AAC,Cranston T,Thakker CE,Gregory L,Rimmer AJ,Rust N,Graham U,Morrison PJ,Hunter SJ,Whyte MP,Mcvean G,Buck D,Thakker RV|Nesbit MA,Hannan FM,Howles SA,Reed AA,Cranston T,Thakker CE,Gregory L,Rimmer AJ,Rust N,Graham U,Morrison PJ,Hunter SJ,Whyte MP,McVean G,Buck D,Thakker RV","Adenoma,Aged,80 and over,Cyclin D1,DNA Mutational Analysis,Exome,Female,Genetic Variation,Humans,Hyperparathyroidism,Primary,Male,Middle Aged,Multiple Endocrine Neoplasia Type 1,Parathyroid Neoplasms,Telomere-Binding Proteins|Adenoma,Adult,Aged,80 and over,DNA Mutational Analysis,Exome,Female,Gene Expression Regulation,Neoplastic,Genetic Association Studies,Humans,Male,Microarray Analysis,Middle Aged,Mutation,Pituitary Neoplasms,Sequence Analysis,DNA,Transcriptome|Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing||Adaptor Protein Complex 2,Adaptor Protein Complex sigma Subunits,Adult,Amino Acid Sequence,Calcium,Conserved Sequence,Female,Humans,Hypercalcemia,Male,Models,Molecular,Molecular Sequence Data,Mutation,Protein Conformation,Receptors,Calcium-Sensing,Sequence Alignment"
clme0195,immd0024,1,0.058823529411764705,Journal article,Epigenetics and Chromatin,01/01/2011,Generation of bivalent chromatin domains during cell fate decisions.,"De Gobbi M,Garrick D,Lynch M,Vernimmen D,Hughes JR,Goardon N,Luc S,Lower KM,Sloane-Stanley JA,Pina C,Soneji S,Renella R,Enver T,Taylor S,Jacobsen SE,Vyas P,Gibbons RJ,Higgs DR",
clab0058,phpc0009,1,1.0,Journal article,Transfusion,01/12/2013,Measuring and monitoring blood utilization.,"Murphy MF,Yazer MH","Erythrocyte Transfusion,Humans,Outcome Assessment (Health Care)"
lina0435,ocms0037,1,0.07142857142857142,Journal article,Haematologica: the hematology journal,28/05/2013,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary"
clme0497,ndos0159,2,0.2222222222222222,Journal article|Journal article,Journal of Biological Chemistry|Journal of Biological Chemistry,01/01/2012|12/09/2012,Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva|Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva.,"Chaikuad A,Alfano I,Kerr G,Sanvitale CE,Boergermann JH,Triffitt JT,Von Delft F,Knapp S,Knaus P,Bullock AN|Chaikuad A,Alfano I,Kerr G,Sanvitale CE,Boergermann JH,Triffitt JT,von Delft F,Knapp S,Knaus P,Bullock AN","|Activin Receptors,Type I,Amino Acid Motifs,Animals,Bone Morphogenetic Protein 4,Catalytic Domain,Crystallography,X-Ray,Enzyme Activation,Gene Expression Regulation,Genes,Reporter,Humans,Hydrogen Bonding,Hydrophobic and Hydrophilic Interactions,Luciferases,Firefly,Mice,Models,Molecular,Mutation,Missense,Myositis Ossificans,Protein Binding,Pyrazoles,Pyrimidines,Signal Transduction,Tacrolimus,Tacrolimus Binding Protein 1A"
immd0282,whgu0210,1,0.1111111111111111,Journal article,Cell Reports,11/07/2013,Structural Basis for LMO2-Driven Recruitment of the SCL: E47bHLH Heterodimer to Hematopoietic-Specific Transcriptional Targets,"ElOmari K,Hoosdally SJ,Tuladhar K,Karia D,Hall-Ponselé E,Platonova O,Vyas P,Patient R,Porcher C,Mancini EJ",
raob0047,raob0189,1,0.16666666666666666,Journal article,Clinical Cancer Research,15/09/2014,Deoxycytidine kinase expression underpins response to gemcitabine in bladder cancer.,"Kerr M,Scott HE,Groselj B,Stratford MR,Karaszi K,Sharma NL,Kiltie AE","Cell Line,Tumor,3T3 Cells,Animals,Humans,Mice,Nude,Deoxycytidine Kinase,RNA,Small Interfering,Messenger,Deoxycytidine,Antimetabolites,Antineoplastic,Radiation-Sensitizing Agents,Female,Urinary Bladder Neoplasms"
clme0497,olin0014,1,0.05,Journal article,Cancer Cell,13/05/2013,Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
bioc0212,clme0301,1,0.07142857142857142,Journal article,Cancer Research,21/08/2012,MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.,"Walls GV,Lemos MC,Javid M,Bazan-Peregrino M,Jeyabalan J,Reed AA,Harding B,Tyler DJ,Stuckey DJ,Piret S,Christie PT,Ansorge O,Clarke K,Seymour L,Thakker RV","Adenoma,Adenoviridae,Animals,Cell Proliferation,Disease Models,Animal,Genetic Therapy,Genetic Vectors,HEK293 Cells,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,129 Strain,Inbred C57BL,Knockout,Pituitary Gland,Pituitary Neoplasms,Proto-Oncogene Proteins"
clme0501,immd0180,2,0.4444444444444444,Journal article|Journal article,Radiotherapy and Oncology|BJU International,30/04/2012|01/05/2011,Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks.|Serial analysis of resected prostate cancer suggests up-regulation of type 1 IGF receptor with disease progression.,"Turney BW,Kerr M,Chitnis MM,Lodhia K,Wang Y,Riedemann J,Rochester M,Protheroe AS,Brewster SF,Macaulay VM|Turney BW,Turner GD,Brewster SF,Macaulay VM","Cell Cycle,Cell Line,Tumor,DNA Breaks,Double-Stranded,DNA Repair,Electrophoresis,Gel,Pulsed-Field,Histones,Homologous Recombination,Humans,Insulin Receptor Substrate Proteins,Male,Prostatic Neoplasms,RNA,Small Interfering,Radiation Dosage,Radiation Tolerance,Receptor,IGF Type 1,Insulin|Aged,80 and over,Androgen Antagonists,Disease Progression,Humans,Immunoblotting,Immunohistochemistry,Male,Middle Aged,Prostate-Specific Antigen,Prostatectomy,Prostatic Neoplasms,Receptor,IGF Type 1,Retrospective Studies,Up-Regulation"
raob0096,raob0270,3,0.2205128205128205,Conference paper|Journal article|Conference paper,Annals of Oncology|Radiotherapy and Oncology|Journal of Clinical Oncology,01/06/2015||20/05/2015,"Clinical outcomes of a phase II study of nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy in locally-advanced pancreatic cancer - functional imaging is prognostic and provides proof of mechanism|ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.|ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)-Mechanism and clinical outcomes.","Wilson J,Hackett S,Durrant L,Dutton S,Chu K-Y,Eccles C,Abraham A,O'Neill E,Partridge M,Hawkins M,McKenna W,Maughan T,Brunner T,Mukherjee S|Wilson JM,Fokas E,Dutton SJ,Patel N,Hawkins MA,Eccles C,Chu KY,Durrant L,Abraham AG,Partridge M,Woodward M,O'Neill E,Maughan T,McKenna WG,Mukherjee S,Brunner TB|Wilson JM,Dutton SJ,Hackett SL,Durrant L,Chu K-Y,Eccles C,Abraham AG,O'Neill E,Partridge M,Hawkins MA,McKenna WG,Maughan T,Brunner TB,Mukherjee S",||
immd0282,immd0556,1,0.034482758620689655,Journal article,Nature Immunology,01/01/2012,The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential,"Luc S,Luis TC,Boukarabila H,Macaulay IC,Buza-Vidas N,Bouriez-Jones T,Lutteropp M,Woll PS,Loughran SJ,Mead AJ,Hultquist A,Brown J,Mizukami T,Matsuoka S,Ferry H,Anderson K,Duarte S,Atkinson D,Soneji S,Domanski A,Farley A,Sanjuan-Pla A,Carella C,Patient R,De Bruijn M,Enver T,Nerlov C,Blackburn C,Godin I,Jacobsen SEW",
bioc0416,clme0670,4,0.48168498168498164,Journal article|Journal article|Conference paper|Conference paper,Theranostics|Proceedings of the National Academy of Sciences of USA|Clinical and Experimental Metastasis|Clinical and Experimental Metastasis,01/01/2015|26/03/2012|01/02/2011|01/02/2011,Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates.|Molecular MRI enables early and sensitive detection of brain metastases.|Vascular co-option in brain metastasis|Vascular co-option in brain metastasis,"Melemenidis S,Jefferson A,Ruparelia N,Akhtar AM,Xie J,Allen D,Hamilton A,Larkin JR,Perez-Balderas F,Smart SC,Muschel RJ,Chen X,Sibson NR,Choudhury RP|Serres S,Soto MS,Hamilton A,McAteer MA,Carbonell WS,Robson MD,Ansorge O,Khrapitchev A,Bristow C,Balathasan L,Weissensteiner T,Anthony DC,Choudhury RP,Muschel RJ,Sibson NR|Muschel R,Ferjancic S,Carbonell WS,Balasthan L,Choudhury R,Sibson N,Serres S|Muschel R,Ferjancic S,Carbonell WS,Balasthan L,Choudhury R,Sibson N,Serres S","Cells,Cultured,Endothelial Cells,Animals,Mice,Inbred C57BL,Humans,Neoplasms,Neovascularization,Pathologic,Ferric Compounds,Oligopeptides,Magnetic Resonance Imaging,Microspheres,Protein Binding,Female|Animals,Brain Neoplasms,Disease Progression,Humans,Immunohistochemistry,Magnetic Resonance Imaging,Mice,Sensitivity and Specificity,Up-Regulation,Vascular Cell Adhesion Molecule-1||"
clme0135,clme0220,6,1.5654761904761905,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,PLoS One|Molecular Cancer Research|Carcinogenesis|Cancer Medicine|New England Journal of Medicine|Virchows Archiv: an international journal of pathology,01/01/2014|24/02/2014|09/07/2012|01/08/2013|29/05/2014|04/10/2014,"Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.|TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC.|CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC.|Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?|When cancer co-opts the vasculature.|JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues.","Snell CE,Turley H,McIntyre A,Li D,Masiero M,Schofield CJ,Gatter KC,Harris AL,Pezzella F|Agorreta J,Hu J,Liu D,Delia D,Turley H,Ferguson DJ,Iborra F,Pajares MJ,Larrayoz M,Zudaire I,Pio R,Montuenga LM,Harris AL,Gatter K,Pezzella F|Biswas S,Charlesworth PJ,Turner GD,Leek R,Thamboo PT,Campo L,Turley H,Dildey P,Protheroe A,Cranston D,Gatter KC,Pezzella F,Harris AL|Donnem T,Hu J,Ferguson M,Adighibe O,Snell C,Harris AL,Gatter KC,Pezzella F|Pezzella F,Harris AL|Adighibe O,Turley H,Leek R,Harris A,Coutts AS,La Thangue N,Gatter K,Pezzella F","Animals,Binding Sites,Breast Neoplasms,Cell Line,Tumor,Female,Gene Expression Regulation,Neoplastic,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,Kaplan-Meier Estimate,MCF-7 Cells,Mice,Inbred BALB C,Neoplasm Transplantation,Neoplasms,Procollagen-Proline Dioxygenase,Prognosis,Proline,Up-Regulation|Cell Line,Tumor,Mitochondria,Humans,Carcinoma,Non-Small-Cell Lung,Lung Neoplasms,RNA,Small Interfering,Adenosine Triphosphate,Prognosis,Immunohistochemistry,Apoptosis,Cell Growth Processes,Down-Regulation,Aged,Middle Aged,Female,Male,HSP90 Heat-Shock Proteins,Gene Knockdown Techniques|Adult,Aged,80 and over,Angiogenesis Inhibitors,Antigens,CD31,Basic Helix-Loop-Helix Transcription Factors,Biomarkers,Tumor,Carcinoma,Renal Cell,Cyclin D1,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Kidney Neoplasms,Middle Aged,Prognosis|Animals,Humans,Neoplasms,Neoplasm Metastasis,Disease Models,Animal,Inflammation,Neovascularization,Pathologic,Angiogenesis Inhibitors,Antineoplastic Agents,Apoptosis,Angiogenesis,cancer,lung cancer,nonangiogenic tumors,tumor growth,vessel co-option|Animals,Humans,Mice,Neoplasms,Brain Neoplasms,Disease Models,Animal,Neovascularization,Pathologic,Plasminogen Activators,Serpins,Cell Death,Fas Ligand Protein|Hela Cells,Cytoskeleton,Humans,Neoplasms,Trans-Activators,Nuclear Proteins,Antibodies,Monoclonal,Blotting,Western,Tissue Array Analysis,Immunohistochemistry,Antibody Specificity,Tumor Suppressor Protein p53,Actin Cytoskeleton,MCF-7 Cells"
clne0024,cschof,1,0.1,Conference paper,Neuropathology and Applied Neurobiology,01/03/2013,Magnetic resonance spectroscopy for 2-hydroxyglutarate identifies IDH mutant gliomas,"Larkin SJ,Near J,Kudari M,Khrapitchev A,Sibson N,Jezzard P,Pfeffer I,Al-Qahtani K,Schofield C,McCullagh J,Ansorge O",
clme0301,immd0237,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clne0024,clne0102,2,0.5,Journal article|Journal article,Magnetic Resonance Imaging|Neuroimage,01/06/2011|07/09/2013,Performance of single spin-echo and doubly refocused diffusion-weighted sequences in the presence of eddy current fields with multiple components.|Optimizing RetroICor and RetroKCor corrections for multi-shot 3D FMRI acquisitions.,"Nunes RG,Drobnjak I,Clare S,Jezzard P,Jenkinson M|Tijssen RH,Jenkinson M,Brooks JC,Jezzard P,Miller KL","Brain,Computer Simulation,Diffusion,Diffusion Magnetic Resonance Imaging,Echo-Planar Imaging,Equipment Design,Humans,Magnetic Resonance Imaging,Motion,Phantoms,Imaging,Reproducibility of Results|3D EPI,Brainstem,Functional MRI,GRE,Physiological noise,SPGR,SSFP,Algorithms,Artifacts,Brain,Brain Mapping,Humans,Image Enhancement,Image Interpretation,Computer-Assisted,Imaging,Three-Dimensional,Magnetic Resonance Imaging,Reproducibility of Results,Sensitivity and Specificity,Signal-To-Noise Ratio"
immd0198,immd0330,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0023,immd0100,6,0.9999999999999999,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Immunological Methods|Nature Immunology|Journal of Immunological Methods|Science Signaling|Nature Immunology|Proceedings of the National Academy of Sciences of USA,03/12/2013|01/01/2011|31/01/2014|01/01/2011|01/01/2011|11/01/2016,Combinatorial HLA-peptide bead libraries for high throughput identification of CD8⁺ T cell specificity.|Reply to Failure to detect production of IL-10 by activated human neutrophils.|Combinatorial HLA-peptide bead libraries for high throughput identification of CD8+ T cell specificity|Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.|Cerundolo et al. respond|Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.,"Pan X,Huang LC,Dong T,Peng Y,Cerundolo V,McGowan S,Ogg G|De Santo C,Salio M,Dong T,Reiter Y,Cerundolo V|Pan X,Huang LC,Dong T,Peng Y,Cerundolo V,McGowan S,Ogg G|Dushek O,Aleksic M,Wheeler RJ,Zhang H,Cordoba SP,Peng YC,Chen JL,Cerundolo V,Dong T,Coombs D,van der Merwe PA|De Santo C,Salio M,Dong T,Reiter Y,Cerundolo V|Nakaya HI,Clutterbuck E,Kazmin D,Wang L,Cortese M,Bosinger SE,Patel NB,Zak DE,Aderem A,Dong T,Del Giudice G,Rappuoli R,Cerundolo V,Pollard AJ,Pulendran B,Siegrist CA","Bead display,HLA library,T cells,Antigens,Viral,CD8-Positive T-Lymphocytes,Combinatorial Chemistry Techniques,Cytomegalovirus,HLA Antigens,Herpesvirus 4,Human,High-Throughput Screening Assays,Humans,Orthomyxoviridae,Peptide Fragments,Peptide Library,Phosphoproteins,Polymerase Chain Reaction,Trans-Activators,Viral Matrix Proteins|||Adaptive Immunity,Animals,Antigens,Humans,Lymphocyte Activation,Mice,Models,Chemical,T-Lymphocytes,Cytotoxic,Thermodynamics||"
clme0621,clne0009,1,1.0,Journal article,Lancet Neurology,01/05/2012,Mobile acute stroke units: bringing the hospital to the patient.,"Rothwell PM,Buchan AM","Critical Care,Emergency Medical Services,Female,Humans,Male,Mobile Health Units,Stroke"
cschof,raob0097,1,0.08333333333333333,Journal article,PLoS One,01/01/2011,Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α).,"Thalhammer A,Bencokova Z,Poole R,Loenarz C,Adam J,O'Flaherty L,Schödel J,Mole D,Giaslakiotis K,Schofield CJ,Hammond EM,Ratcliffe PJ,Pollard PJ","Anoxia,Cell Line,Dioxygenases,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Ketoglutaric Acids,Membrane Proteins,Nuclear Proteins,Oxygenases,Transcriptional Activation"
clme0240,immd0180,1,0.04,Journal article,Journal of Pathology,01/01/2011,Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status,"Bardella C,El-Bahrawy M,Frizzell N,Adam J,Ternette N,Hatipoglu E,Howarth K,O'Flaherty L,Roberts I,Turner G,Taylor J,Giaslakiotis K,Macaulay VM,Harris AL,Chandra A,Lehtonen HJ,Launonen V,Aaltonen LA,Pugh CW,Mihai R,Trudgian D,Kessler B,Baynes JW,Ratcliffe PJ,Tomlinson IP,Pollard PJ","Adult,Aged,Animals,Biomarkers,Tumor,Carcinoma,Renal Cell,Disease Models,Animal,Female,Fumarate Hydratase,Genetic Predisposition to Disease,Germ-Line Mutation,Humans,Kidney Neoplasms,Leiomyomatosis,Loss of Heterozygosity,Male,Mice,Knockout,Transgenic,Middle Aged,Neoplastic Syndromes,Hereditary,Prospective Studies,Sensitivity and Specificity,Succinic Acid"
immd0024,stat0054,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
claridge,newc0612,3,0.3308913308913309,Journal article|Conference paper|Journal article,Tetrahedron-Asymmetry|European Journal of Cancer|Tetrahedron-Asymmetry,31/08/2013|01/07/2012|01/01/2011,Solution phase structures of enantiopure and racemic lithium N-benzyl-N-(α-methylbenzyl)amide in THF: Low temperature 6Li and 15N NMR spectroscopic studies|Isoenzyme-specific PFK-2/FBPase-2 Inhibition as an Anti-cancer Strategy|A systematic study of the solid state and solution phase conformational preferences of β-peptides derived from C(3)-alkyl substituted transpentacin derivatives,"Claridge TDW,Davies SG,Kruchinin D,Odell B,Roberts PM,Russell AJ,Thomson JE,Toms SM|Williams JG,Manzano A,Bensaad K,Collins JM,Serres S,Claridge TDW,Sibson N,Bartrons R,Russell AJ,Harris AL|Abraham E,Claridge TDW,Davies SG,Odell B,Roberts PM,Russell AJ,Smith AD,Smith LJ,Storr HR,Sweet MJ,Thompson AL,Thomson JE,Tranter GE,Watkin DJ",||
card0027,whgu0274,1,0.029411764705882353,Journal article,Cell Metabolism,07/03/2012,Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.,"Ashrafian H,Czibik G,Bellahcene M,Aksentijević D,Smith AC,Mitchell SJ,Dodd MS,Kirwan J,Byrne JJ,Ludwig C,Isackson H,Yavari A,Støttrup NB,Contractor H,Cahill TJ,Sahgal N,Ball DR,Birkler RI,Hargreaves I,Tennant DA,Land J,Lygate CA,Johannsen M,Kharbanda RK,Neubauer S,Redwood C,de Cabo R,Ahmet I,Talan M,Günther UL,Robinson AJ,Viant MR,Pollard PJ,Tyler DJ,Watkins H","Animals,Antioxidants,Dimethyl Fumarate,Fumarate Hydratase,Fumarates,Male,Mice,Inbred C57BL,Knockout,Models,Biological,Myocardial Infarction,NF-E2-Related Factor 2,Signal Transduction"
clme0240,immd0330,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0499,wolf1917,1,0.14285714285714285,Journal article,Nature Cell Biology,25/01/2016,EXD2 promotes homologous recombination by facilitating DNA end resection.,"Broderick R,Nieminuszczy J,Baddock HT,Deshpande RA,Gileadi O,Paull TT,McHugh PJ,Niedzwiedz W",
claridge,immd0237,6,0.39695076955513386,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,The Federation of European Biochemical Societies (FEBS) Journal|Nature Chemical Biology|Nature Chemical Biology|EMBO Reports|Angewandte Chemie International Edition|PLoS One,20/01/2011|01/01/2012|01/01/2012|01/04/2011|25/05/2012|01/01/2015,Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans|The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.|Dynamic combinatorial chemistry employing boronic acids/boronate esters leads to potent oxygenase inhibitors.|Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.,"Yang M,Chowdhury R,Ge W,Hamed RB,McDonough MA,Claridge TD,Kessler BM,Cockman ME,Ratcliffe PJ,Schofield CJ|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Ge W,Wolf A,Feng T,Ho C-H,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TDW,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,Mccullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Chowdhury R,Yeoh KK,Tian YM,Hillringhaus L,Bagg EA,Rose NR,Leung IKH,Li XS,Woon ECY,Yang M,McDonough MA,King ON,Clifton IJ,Klose RJ,Claridge TDW,Ratcliffe PJ,Schofield CJ,Kawamura A|Demetriades M,Leung IK,Chowdhury R,Chan MC,McDonough MA,Yeoh KK,Tian YM,Claridge TD,Ratcliffe PJ,Woon EC,Schofield CJ|Chan MC,Atasoylu O,Hodson E,Tumber A,Leung IK,Chowdhury R,Gómez-Pérez V,Demetriades M,Rydzik AM,Holt-Martyn J,Tian YM,Bishop T,Claridge TD,Kawamura A,Pugh CW,Ratcliffe PJ,Schofield CJ","Amino Acid Sequence,Ankyrin Repeat,HEK293 Cells,Histidine,Humans,Hydroxylation,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Protein Processing,Post-Translational,Protein Structure,Tertiary,Repressor Proteins,Sequence Alignment,Tankyrases|Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes||Cell Line,Tumor,Crystallography,Glutarates,Histone Demethylases,Humans,Inhibitory Concentration 50,Isocitrate Dehydrogenase,Jumonji Domain-Containing Histone Demethylases,Magnetic Resonance Spectroscopy,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Mutation,Neoplasms,Procollagen-Proline Dioxygenase,Repressor Proteins,Signal Transduction|Boronic Acids,Combinatorial Chemistry Techniques,Enzyme Inhibitors,Esters,Humans,Hypoxia-Inducible Factor-Proline Dioxygenases,Kinetics,Mass Spectrometry,Nuclear Magnetic Resonance,Biomolecular,Oxidation-Reduction,Procollagen-Proline Dioxygenase|Brain,Hela Cells,Animals,Humans,Mice,Triazoles,Enzyme Inhibitors,Stroke,MCF-7 Cells,Hypoxia-Inducible Factor-Proline Dioxygenases"
clme0975,raob0122,1,0.125,Conference paper,Journal of Clinical Oncology,20/05/2012,Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy,"Sharma RA,Macgregor T,Gillies R,Hatch S,Swift L,Humphrey TIM,Chetty R,McHugh PJ,Middleton MR",
immd0316,raob0182,1,0.08333333333333333,Journal article,Oncotarget,28/02/2015,Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony formation screen.,"Tiwana GS,Prevo R,Buffa FM,Yu S,Ebner DV,Howarth A,Folkes LK,Budwal B,Chu KY,Durrant L,Muschel RJ,McKenna WG,Higgins GS","Cell Line,Tumor,HCT116 Cells,Hela Cells,Humans,Neoplasms,DNA Damage,Pyrithiamine,Thiamin Pyrophosphokinase,Thiamine,Radiation-Sensitizing Agents,Colony-Forming Units Assay,Transfection,Radiation Tolerance,High-Throughput Screening Assays"
clme0301,stat0004,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
bioc0801,clme0485,2,0.06559139784946236,Journal article|Journal article,Chemical Science|Journal of Medicinal Chemistry,01/08/2013|25/06/2012,5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation|Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.,"Hopkinson RJ,Tumber A,Yapp C,Chowdhury R,Aik W,Che KH,Li XS,Kristensen JBL,King ONF,Chan MC,Yeoh KK,Choi H,Walport LJ,Thinnes CC,Bush JT,Lejeune C,Rydzik AM,Rose NR,Bagg EA,McDonough MA,Krojer TJ,Yue WW,Ng SS,Olsen L,Brennan PE,Oppermann U,Müller S,Klose RJ,Ratcliffe PJ,Schofield CJ,Kawamura A|Rose NR,Woon EC,Tumber A,Walport LJ,Chowdhury R,Li XS,King ON,Lejeune C,Ng SS,Krojer T,Chan MC,Rydzik AM,Hopkinson RJ,Che KH,Daniel M,Strain-Damerell C,Gileadi C,Kochan G,Leung IK,Dunford J,Yeoh KK,Ratcliffe PJ,Burgess-Brown N,von Delft F,Muller S,Marsden B,Brennan PE,McDonough MA,Oppermann U,Klose RJ,Schofield CJ,Kawamura A","|Enzyme Inhibitors,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Plant Growth Regulators,Protein Conformation,Substrate Specificity,Succinates"
raob0058,raob0095,1,0.09090909090909091,Journal article,PLoS One,01/01/2011,"Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.","Kersemans V,Cornelissen B,Hueting R,Tredwell M,Hussien K,Allen PD,Falzone N,Hill SA,Dilworth JR,Gouverneur V,Muschel RJ,Smart SC","Adenocarcinoma,Anesthesia,Animals,Anoxia,Copper Radioisotopes,Female,Fluorine Radioisotopes,Gases,Mice,Inbred CBA,Misonidazole,Muscles,Neoplasms,Experimental,Organometallic Compounds,Organotechnetium Compounds,Oxygen,Positron-Emission Tomography,Radiation-Sensitizing Agents,Radiopharmaceuticals,Thiosemicarbazones,Tissue Distribution,Tomography,Emission-Computed,Single-Photon"
ocms0037,whgu0172,1,0.07142857142857142,Journal article,eLife,15/12/2012,KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.,"Farcas AM,Blackledge NP,Sudbery I,Long HK,McGouran JF,Rose NR,Lee S,Sims D,Cerase A,Sheahan TW,Koseki H,Brockdorff N,Ponting CP,Kessler BM,Klose RJ","Chicken,Chromatin,CpG island,Demethylase,Epigenetics,Human,Methylation,Mouse,Transcription,Xenopus,Zebrafish,Animals,Cell Line,Tumor,CpG Islands,DNA Methylation,F-Box Proteins,Gene Silencing,Genome,Histones,Humans,Jumonji Domain-Containing Histone Demethylases,Mice,Polycomb-Group Proteins,Ubiquitination"
clme0301,immd0024,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0193,kenn0163,1,0.08333333333333333,Journal article,Journal of Biological Chemistry,03/11/2014,Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells.,"Pollitt AY,Poulter NS,Gitz E,Navarro-Nuñez L,Wang YJ,Hughes CE,Thomas SG,Nieswandt B,Douglas MR,Owen DM,Jackson DG,Dustin ML,Watson SP","Lymphoid Tissue,Cells,Cultured,Cell Membrane,Endothelial Cells,Animals,Mice,Inbred C57BL,Transgenic,Humans,src-Family Kinases,Intracellular Signaling Peptides and Proteins,Membrane Glycoproteins,Lectins,C-Type,Cell Adhesion,Signal Transduction,Protein Transport,Platelet Adhesiveness,Protein-Tyrosine Kinases,HEK293 Cells"
immd0180,immd0452,1,0.25,Journal article,International Journal of Cancer,12/11/2014,Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition.,"Lodhia KA,Gao S,Aleksic T,Esashi F,Macaulay VM","Cell Line,Tumor,Humans,Colorectal Neoplasms,Prostatic Neoplasms,Boron Compounds,Isoxazoles,Pyrimidines,Thiazoles,Quinolines,CDC2 Protein Kinase,Receptor,IGF Type 1,BRCA1 Protein,BRCA2 Protein,Histones,Microscopy,Fluorescence,Blotting,Western,Cell Survival,DNA Repair,RNA Interference,Phosphorylation,Male,PTEN Phosphohydrolase,Rad51 Recombinase,DNA Breaks,Double-Stranded,Homologous Recombination"
immd0100,molb0002,1,0.1,Journal article,Science Signaling,01/01/2011,Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.,"Dushek O,Aleksic M,Wheeler RJ,Zhang H,Cordoba SP,Peng YC,Chen JL,Cerundolo V,Dong T,Coombs D,van der Merwe PA","Adaptive Immunity,Animals,Antigens,Humans,Lymphocyte Activation,Mice,Models,Chemical,T-Lymphocytes,Cytotoxic,Thermodynamics"
clme0845,ctsu0052,1,0.05555555555555555,Journal article,PLoS Medicine,01/03/2015,UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.,"Sudlow C,Gallacher J,Allen N,Beral V,Burton P,Danesh J,Downey P,Elliott P,Green J,Landray M,Liu B,Matthews P,Ong G,Pell J,Silman A,Young A,Sprosen T,Peakman T,Collins R","Humans,Neoplasms,Prospective Studies,Aging,Genotype,Phenotype,Research,Access to Information,Databases,Factual,Adult,Aged,Middle Aged,Biological Specimen Banks,Great Britain"
clme1136,whgu0172,1,0.06666666666666667,Journal article,The EMBO Journal,27/05/2016,SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development.,"Raducu M,Fung E,Serres S,Infante P,Barberis A,Fischer R,Bristow C,Thézénas ML,Finta C,Christianson JC,Buffa FM,Kessler BM,Sibson NR,Di Marcotullio L,Toftgård R,D'Angiolella V",
stat0054,stat0059,1,0.06666666666666667,Journal article,PLoS One,01/01/2011,MicroRNA expression in abdominal and gluteal adipose tissue is associated with mRNA expression levels and partly genetically driven.,"Rantalainen M,Herrera BM,Nicholson G,Bowden R,Wills QF,Min JL,Neville MJ,Barrett A,Allen M,Rayner NW,Fleckner J,McCarthy MI,Zondervan KT,Karpe F,Holmes CC,Lindgren CM","Abdominal Fat,Adult,Biomarkers,Buttocks,Case-Control Studies,Female,Follow-Up Studies,Gene Expression Profiling,Genome-Wide Association Study,Genotype,Humans,Male,Metabolic Syndrome X,MicroRNAs,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Quantitative Trait Loci,RNA,Messenger"
whgu0378,whgu0527,1,0.004166666666666667,Journal article,Nature Genetics,28/09/2015,"Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair.","Day FR,Ruth KS,Thompson DJ,Lunetta KL,Pervjakova N,Chasman DI,Stolk L,Finucane HK,Sulem P,Bulik-Sullivan B,Esko T,Johnson AD,Elks CE,Franceschini N,He C,Altmaier E,Brody JA,Franke LL,Huffman JE,Keller MF,McArdle PF,Nutile T,Porcu E,Robino A,Rose LM,Schick UM,Smith JA,Teumer A,Traglia M,Vuckovic D,Yao J,Zhao W,Albrecht E,Amin N,Corre T,Hottenga JJ,Mangino M,Smith AV,Tanaka T,Abecasis GR,Andrulis IL,Anton-Culver H,Antoniou AC,Arndt V,Arnold AM,Barbieri C,Beckmann MW,Beeghly-Fadiel A,Benitez J,Bernstein L,Bielinski SJ,Blomqvist C,Boerwinkle E,Bogdanova NV,Bojesen SE,Bolla MK,Borresen-Dale AL,Boutin TS,Brauch H,Brenner H,Brüning T,Burwinkel B,Campbell A,Campbell H,Chanock SJ,Chapman JR,Chen YD,Chenevix-Trench G,Couch FJ,Coviello AD,Cox A,Czene K,Darabi H,De Vivo I,Demerath EW,Dennis J,Devilee P,Dörk T,Dos-Santos-Silva I,Dunning AM,Eicher JD,Fasching PA,Faul JD,Figueroa J,Flesch-Janys D,Gandin I,Garcia ME,García-Closas M,Giles GG,Girotto GG,Goldberg MS,González-Neira A,Goodarzi MO,Grove ML,Gudbjartsson DF,Guénel P,Guo X,Haiman CA,Hall P,Hamann U,Henderson BE,Hocking LJ,Hofman A,Homuth G,Hooning MJ,Hopper JL,Hu FB,Huang J,Humphreys K,Hunter DJ,Jakubowska A,Jones SE,Kabisch M,Karasik D,Knight JA,Kolcic I,Kooperberg C,Kosma VM,Kriebel J,Kristensen V,Lambrechts D,Langenberg C,Li J,Li X,Lindström S,Liu Y,Luan J,Lubinski J,Mägi R,Mannermaa A,Manz J,Margolin S,Marten J,Martin NG,Masciullo C,Meindl A,Michailidou K,Mihailov E,Milani L,Milne RL,Müller-Nurasyid M,Nalls M,Neale BM,Nevanlinna H,Neven P,Newman AB,Nordestgaard BG,Olson JE,Padmanabhan S,Peterlongo P,Peters U,Petersmann A,Peto J,Pharoah PD,Pirastu NN,Pirie A,Pistis G,Polasek O,Porteous D,Psaty BM,Pylkäs K,Radice P,Raffel LJ,Rivadeneira F,Rudan I,Rudolph A,Ruggiero D,Sala CF,Sanna S,Sawyer EJ,Schlessinger D,Schmidt MK,Schmidt F,Schmutzler RK,Schoemaker MJ,Scott RA,Seynaeve CM,Simard J,Sorice R,Southey MC,Stöckl D,Strauch K,Swerdlow A,Taylor KD,Thorsteinsdottir U,Toland AE,Tomlinson I,Truong T,Tryggvadottir L,Turner ST,Vozzi D,Wang Q,Wellons M,Willemsen G,Wilson JF,Winqvist R,Wolffenbuttel BB,Wright AF,Yannoukakos D,Zemunik T,Zheng W,Zygmunt M,Bergmann S,Boomsma DI,Buring JE,Ferrucci L,Montgomery GW,Gudnason V,Spector TD,van Duijn CM,Alizadeh BZ,Ciullo M,Crisponi L,Easton DF,Gasparini PP,Gieger C,Harris TB,Hayward C,Kardia SL,Kraft P,McKnight B,Metspalu A,Morrison AC,Reiner AP,Ridker PM,Rotter JI,Toniolo D,Uitterlinden AG,Ulivi S,Völzke H,Wareham NJ,Weir DR,Yerges-Armstrong LM,Price AL,Stefansson K,Visser JA,Ong KK,Chang-Claude J,Murabito JM,Perry JR,Murray A","PRACTICAL Consortium,kConFab Investigators,AOCS Investigators,Generation Scotland,EPIC-InterAct Consortium,LifeLines Cohort Study,Hypothalamus,Humans,Breast Neoplasms,Genetic Predisposition to Disease,BRCA1 Protein,Genomics,Age Factors,Signal Transduction,DNA Repair,Aging,Reproduction,Menopause,Genotype,Phenotype,Models,Genetic,Adult,Middle Aged,Female,Gene Regulatory Networks,Genetic Variation,Genome-Wide Association Study"
clne0009,clne0024,1,0.25,Journal article,American Journal of Neuroradiology,03/05/2012,Hemodynamic alterations in vertebrobasilar large artery disease assessed by arterial spin-labeling MR imaging.,"Macintosh BJ,Marquardt L,Schulz UG,Jezzard P,Rothwell PM","Aged,Algorithms,Blood Flow Velocity,Cerebrovascular Circulation,Female,Humans,Image Interpretation,Computer-Assisted,Magnetic Resonance Angiography,Male,Middle Aged,Reproducibility of Results,Sensitivity and Specificity,Spin Labels,Vertebrobasilar Insufficiency"
chem0489,raob0097,4,0.5208333333333333,Journal article|Journal article|Journal article|Journal article,ACS Chem. Biol.|Organic chemistry frontiers : an international journal of organic chemistry / Royal Society of Chemistry|Nature Protocols|Journal of Medicinal Chemistry,01/04/2013|01/01/2015|01/04/2016|21/03/2013,"CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A.|Efficient synthesis of 2-nitroimidazole derivatives and the bioreductive clinical candidate Evofosfamide (TH-302)|Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs.|Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.","Cazares-Körner C,Pires IM,Swallow ID,Grayer SC,O'Connor LJ,Olcina MM,Christlieb M,Conway SJ,Hammond EM|O'Connor LJ,Cazares-Koerner C,Saha J,Evans CNG,Stratford MRL,Hammond EM,Conway SJ|O'Connor LJ,Cazares-Körner C,Saha J,Evans CN,Stratford MR,Hammond EM,Conway SJ|Hewings DS,Fedorov O,Filippakopoulos P,Martin S,Picaud S,Tumber A,Wells C,Olcina MM,Freeman K,Gill A,Ritchie AJ,Sheppard DW,Russell AJ,Hammond EM,Knapp S,Brennan PE,Conway SJ","Aurora Kinase A,Cell Hypoxia,Cell Line,Tumor,Chromatography,High Pressure Liquid,Drug Delivery Systems,Enzyme Activation,Enzyme Inhibitors,Fluorescent Antibody Technique,Furans,Humans,Molecular Structure,Oxidation-Reduction,Prodrugs,Protein Kinases,Pyrimidines|||Acetylation,CREB-Binding Protein,Cell Line,Tumor,Crystallography,X-Ray,Histones,Humans,Inhibitory Concentration 50,Isoxazoles,Ligands,Lysine,Nuclear Proteins,Protein Binding,Structure-Activity Relationship,Transcription Factors"
cschof,immd0237,27,2.289472894915819,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Nature Chemical Biology|Nature Chemical Biology|EMBO Reports|Proceedings of the National Academy of Sciences of USA|The Journal of Physiology|ACS Chemical Biology|Chemical Science|The Federation of European Biochemical Societies (FEBS) Journal|Diabetes|Molecular Aspects of Medicine|Molecular Cell|Proceedings of the National Academy of Sciences of USA|Angewandte Chemie International Edition|EMBO Reports|Endocrine-Related Cancer|Journal of Medicinal Chemistry|EMBO Reports|EMBO Reports|PLoS One|Chemical Communications|Chemistry and Biology|Organic and Biomolecular Chemistry|PLoS One|Journal of Biological Chemistry|Proceedings of the National Academy of Sciences of USA|The FASEB Journal|EMBO Reports,01/01/2012|01/01/2012|01/04/2011|18/02/2014|20/05/2013|17/05/2013|01/08/2013|20/01/2011|05/11/2014|11/01/2016|30/01/2014|18/02/2014|25/05/2012|01/01/2012|01/01/2011|25/06/2012|01/01/2011|01/04/2011|01/01/2015|01/01/2015|27/05/2011|15/11/2012|01/01/2011|22/02/2011|18/02/2014|21/04/2016|07/02/2012,"Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans|The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.|OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.|Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2.|Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.|5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation|Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.|Adipocyte pseudohypoxia suppresses lipolysis and facilitates benign adipose tissue expansion.|Pharmacological targeting of the HIF hydroxylases--A new field in medicine development.|Optimal translational termination requires C4 lysyl hydroxylation of eRF1.|Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth.|Dynamic combinatorial chemistry employing boronic acids/boronate esters leads to potent oxygenase inhibitors.|The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity|Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.|Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.|The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adhaerens|The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases|Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.|Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.|A photoreactive small-molecule probe for 2-oxoglutarate oxygenases.|Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.|Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α).|Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors.|Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy.|On the pivotal role of PPARα in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury.|The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity.","Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Ge W,Wolf A,Feng T,Ho C-H,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TDW,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,Mccullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Chowdhury R,Yeoh KK,Tian YM,Hillringhaus L,Bagg EA,Rose NR,Leung IKH,Li XS,Woon ECY,Yang M,McDonough MA,King ON,Clifton IJ,Klose RJ,Claridge TDW,Ratcliffe PJ,Schofield CJ,Kawamura A|Singleton RS,Liu-Yi P,Formenti F,Ge W,Sekirnik R,Fischer R,Adam J,Pollard PJ,Wolf A,Thalhammer A,Loenarz C,Flashman E,Yamamoto A,Coleman ML,Kessler BM,Wappner P,Schofield CJ,Ratcliffe PJ,Cockman ME|Bishop T,Talbot NP,Turner PJ,Nicholls LG,Pascual A,Hodson EJ,Douglas G,Fielding JW,Smith TG,Demetriades M,Schofield CJ,Robbins PA,Pugh CW,Buckler KJ,Ratcliffe PJ|Chowdhury R,Candela-Lena JI,Chan MC,Greenald DJ,Yeoh KK,Tian YM,McDonough MA,Tumber A,Rose NR,Conejo-Garcia A,Demetriades M,Mathavan S,Kawamura A,Lee MK,van Eeden F,Pugh CW,Ratcliffe PJ,Schofield CJ|Hopkinson RJ,Tumber A,Yapp C,Chowdhury R,Aik W,Che KH,Li XS,Kristensen JBL,King ONF,Chan MC,Yeoh KK,Choi H,Walport LJ,Thinnes CC,Bush JT,Lejeune C,Rydzik AM,Rose NR,Bagg EA,McDonough MA,Krojer TJ,Yue WW,Ng SS,Olsen L,Brennan PE,Oppermann U,Müller S,Klose RJ,Ratcliffe PJ,Schofield CJ,Kawamura A|Yang M,Chowdhury R,Ge W,Hamed RB,McDonough MA,Claridge TD,Kessler BM,Cockman ME,Ratcliffe PJ,Schofield CJ|Michailidou Z,Morton NM,Moreno Navarrete JM,West CC,Stewart KJ,Fernández-Real JM,Schofield CJ,Seckl JR,Ratcliffe PJ|Chan MC,Holt-Martyn JP,Schofield CJ,Ratcliffe PJ|Yamamoto A,Feng T,Wilkins S,Sokolova E,Yates L,Muenzel M,Singh P,Hopkinson R,Fischer R,Cockman M,Shelley J,Trudgian D,Schoedel J,McCullagh JO,Ge W,Kessler B,Gilbert R,Frolova L,Alkalaeva E,Ratcliffe P,Schofield C,Coleman M|Katz MJ,Acevedo JM,Loenarz C,Galagovsky D,Liu-Yi P,Pérez-Pepe M,Thalhammer A,Sekirnik R,Ge W,Melani M,Thomas MG,Simonetta S,Boccaccio GL,Schofield CJ,Cockman ME,Ratcliffe PJ,Wappner P|Demetriades M,Leung IK,Chowdhury R,Chan MC,McDonough MA,Yeoh KK,Tian YM,Claridge TD,Ratcliffe PJ,Woon EC,Schofield CJ|Masson N,Singleton RS,Sekirnik R,Trudgian DC,Ambrose LJ,Miranda MX,Tian YM,Kessler BM,Schofield CJ,Ratcliffe PJ|Astuti D,Ricketts CJ,Chowdhury R,McDonough MA,Gentle D,Kirby G,Schlisio S,Kenchappa RS,Carter BD,Kaelin WG,Ratcliffe PJ,Schofield CJ,Latif F,Maher ER|Rose NR,Woon EC,Tumber A,Walport LJ,Chowdhury R,Li XS,King ON,Lejeune C,Ng SS,Krojer T,Chan MC,Rydzik AM,Hopkinson RJ,Che KH,Daniel M,Strain-Damerell C,Gileadi C,Kochan G,Leung IK,Dunford J,Yeoh KK,Ratcliffe PJ,Burgess-Brown N,von Delft F,Muller S,Marsden B,Brennan PE,McDonough MA,Oppermann U,Klose RJ,Schofield CJ,Kawamura A|Loenarz C,Coleman ML,Boleininger A,Schierwater B,Holland PWH,Ratcliffe PJ,Schofield CJ|Chowdhury R,Yeoh KK,Tian Y-M,Hillringhaus L,Bagg EA,Rose NR,Leung IKH,Li XS,Woon ECY,Yang M,McDonough MA,King ON,Clifton IJ,Klose RJ,Claridge TDW,Ratcliffe PJ,Schofield CJ,Kawamura A|Chan MC,Atasoylu O,Hodson E,Tumber A,Leung IK,Chowdhury R,Gómez-Pérez V,Demetriades M,Rydzik AM,Holt-Martyn J,Tian YM,Bishop T,Claridge TD,Kawamura A,Pugh CW,Ratcliffe PJ,Schofield CJ|Thinnes CC,Tumber A,Yapp C,Scozzafava G,Yeh T,Chan MC,Tran TA,Hsu K,Tarhonskaya H,Walport LJ,Wilkins SE,Martinez ED,Müller S,Pugh CW,Ratcliffe PJ,Brennan PE,Kawamura A,Schofield CJ|Rotili D,Altun M,Kawamura A,Wolf A,Fischer R,Leung IK,Mackeen MM,Tian YM,Ratcliffe PJ,Mai A,Kessler BM,Schofield CJ|Yeoh KK,Chan MC,Thalhammer A,Demetriades M,Chowdhury R,Tian YM,Stolze I,McNeill LA,Lee MK,Woon EC,Mackeen MM,Kawamura A,Ratcliffe PJ,Mecinović J,Schofield CJ|Thalhammer A,Bencokova Z,Poole R,Loenarz C,Adam J,O'Flaherty L,Schödel J,Mole D,Giaslakiotis K,Schofield CJ,Hammond EM,Ratcliffe PJ,Pollard PJ|Tian YM,Yeoh KK,Lee MK,Eriksson T,Kessler BM,Kramer HB,Edelmann MJ,Willam C,Pugh CW,Schofield CJ,Ratcliffe PJ|Loenarz C,Sekirnik R,Thalhammer A,Ge W,Spivakovsky E,Mackeen MM,McDonough MA,Cockman ME,Kessler BM,Ratcliffe PJ,Wolf A,Schofield CJ|Cole MA,Abd Jamil AH,Heather LC,Murray AJ,Sutton ER,Slingo M,Sebag-Montefiore L,Tan SC,Aksentijević D,Gildea OS,Stuckey DJ,Yeoh KK,Carr CA,Evans RD,Aasum E,Schofield CJ,Ratcliffe PJ,Neubauer S,Robbins PA,Clarke K|Masson N,Singleton RS,Sekirnik R,Trudgian DC,Ambrose LJ,Miranda MX,Tian YM,Kessler BM,Schofield CJ,Ratcliffe PJ","Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes||Cell Line,Tumor,Crystallography,Glutarates,Histone Demethylases,Humans,Inhibitory Concentration 50,Isocitrate Dehydrogenase,Jumonji Domain-Containing Histone Demethylases,Magnetic Resonance Spectroscopy,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Mutation,Neoplasms,Procollagen-Proline Dioxygenase,Repressor Proteins,Signal Transduction|2-oxoglutarate oxygenase,hypoxia,ribosome,translational control,Analysis of Variance,Carrier Proteins,Computational Biology,Fluorescent Antibody Technique,Gene Knockdown Techniques,Humans,Hydroxylation,Immunoblotting,Immunoprecipitation,Ketoglutaric Acids,Luciferases,Nuclear Proteins,Proline,Prolyl Hydroxylases,Protein Biosynthesis,Protein Processing,Post-Translational,Ribosomal Proteins,Yeasts|Animals,Anoxia,Carotid Body,Hyperplasia,Hypoxia-Inducible Factor 1,Hypoxia-Inducible Factor-Proline Dioxygenases,Male,Mice,Inbred C57BL,Transgenic,Pulmonary Ventilation|Animals,Genetically Modified,Anoxia,Biological Assay,Cell Line,Heterocyclic Compounds,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Hypoxia-Inducible Factor-Proline Dioxygenases,Inhibitory Concentration 50,Models,Molecular,Molecular Structure,Signal Transduction,Small Molecule Libraries,Zebrafish||Amino Acid Sequence,Ankyrin Repeat,HEK293 Cells,Histidine,Humans,Hydroxylation,Mass Spectrometry,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Protein Processing,Post-Translational,Protein Structure,Tertiary,Repressor Proteins,Sequence Alignment,Tankyrases|Adipose Tissue,Adipocytes,Animals,Humans,Mice,Lipase,Fatty Acids,Nonesterified,Immunoblotting,Immunohistochemistry,Lipolysis,Adult,Middle Aged,Female,Male,Hypoxia-Inducible Factor-Proline Dioxygenases||Amino Acid Sequence,Animals,Catalysis,Cell Line,Tumor,Codon,Terminator,Gene Expression Regulation,HeLa Cells,Histone Demethylases,Humans,Hydrolysis,Hydroxylation,Mixed Function Oxygenases,Models,Molecular,Molecular Sequence Data,Peptide Chain Termination,Translational,Peptide Termination Factors,Protein Biosynthesis,Protein Processing,Post-Translational,Protein Structure,Tertiary,Sequence Homology,Amino Acid|Fat Body,Animals,Genetically Modified,Drosophila,Drosophila Proteins,Ribosomal Proteins,DNA Primers,Body Weights and Measures,Blotting,Western,Chromatography,Liquid,Apoptosis,Protein Biosynthesis,RNA Interference,Protein Processing,Post-Translational,Hydroxylation,Homeostasis,Autophagy,Female,Tandem Mass Spectrometry,Gene Knockdown Techniques,Unfolded Protein Response,Real-Time Polymerase Chain Reaction,Prolyl Hydroxylases|Boronic Acids,Combinatorial Chemistry Techniques,Enzyme Inhibitors,Esters,Humans,Hypoxia-Inducible Factor-Proline Dioxygenases,Kinetics,Mass Spectrometry,Nuclear Magnetic Resonance,Biomolecular,Oxidation-Reduction,Procollagen-Proline Dioxygenase||Adolescent,Adrenal Gland Neoplasms,Adult,Amino Acid Sequence,Animals,Newborn,Base Sequence,Carcinoma,Renal Cell,Child,Preschool,DNA Mutational Analysis,Female,Genetic Predisposition to Disease,Humans,Kidney Neoplasms,Male,Molecular Sequence Data,Phenotype,Pheochromocytoma,Procollagen-Proline Dioxygenase,Rats,Sprague-Dawley,Sequence Homology,Amino Acid,Tumor Cells,Cultured,Young Adult|Enzyme Inhibitors,Humans,Inhibitory Concentration 50,Jumonji Domain-Containing Histone Demethylases,Models,Molecular,Plant Growth Regulators,Protein Conformation,Substrate Specificity,Succinates|||Brain,Hela Cells,Animals,Humans,Mice,Triazoles,Enzyme Inhibitors,Stroke,MCF-7 Cells,Hypoxia-Inducible Factor-Proline Dioxygenases|Humans,Oxyquinoline,Oxygenases,Enzyme Inhibitors,Molecular Structure,Structure-Activity Relationship,Dose-Response Relationship,Drug,Models,Molecular|Cell Line,Cross-Linking Reagents,Dioxygenases,Enzyme Inhibitors,F-Box Proteins,Humans,Hydroxyquinolines,Jumonji Domain-Containing Histone Demethylases,Oxidoreductases,N-Demethylating,Photochemical Processes,Protein Structure,Tertiary,Small Molecule Libraries,Spectrometry,Mass,Matrix-Assisted Laser Desorption-Ionization|Catalytic Domain,Cell Line,Tumor,Humans,Hydrazines,Hypoxia-Inducible Factor-Proline Dioxygenases,Iron,Molecular Docking Simulation,Procollagen-Proline Dioxygenase,Protein Binding,Spectrometry,Mass,Electrospray Ionization|Anoxia,Cell Line,Dioxygenases,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Ketoglutaric Acids,Membrane Proteins,Nuclear Proteins,Oxygenases,Transcriptional Activation|Animals,Cell Hypoxia,Drosophila melanogaster,Enzyme Inhibitors,Hep G2 Cells,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,K562 Cells,Male,Oxygenases,Protein Structure,Tertiary,Rats,Sprague-Dawley,Ubiquitin-Protein Ligases,p300-CBP Transcription Factors|2-oxoglutarate oxygenase,hypoxia,nonsense readthrough,ribosomal hydroxylation,translation,Chlorophyta,Codon,Terminator,Humans,Hydroxylation,Mass Spectrometry,Oxygenases,Protein Biosynthesis,Protein Processing,Post-Translational,Ribosomal Proteins,Ribosomes,Saccharomyces cerevisiae,Schizosaccharomyces,Species Specificity||Cell Hypoxia,Cell Line,Cysteine,Gene Expression Regulation,Humans,Hydroxylation,Hypoxia-Inducible Factor 1,alpha Subunit,Mixed Function Oxygenases,Peroxides,Repressor Proteins,Transcription,Genetic"
clme0301,corp0784,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clne0024,ndos0168,1,0.14285714285714285,Journal article,Bone and Joint Journal,01/06/2013,Non-invasive imaging of cartilage in early osteoarthritis.,"Palmer AJ,Brown CP,McNally EG,Price AJ,Tracey I,Jezzard P,Carr AJ,Glyn-Jones S","Arthroplasty,Cartilage,Imaging,MRI,OA,Osteoarthritis,Articular,Diagnostic Imaging,Early Diagnosis,Humans,Reproducibility of Results"
clme0439,whgu0172,1,0.05,Journal article,Cancer Cell,13/05/2013,Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.,"Lu M,Breyssens H,Salter V,Zhong S,Hu Y,Baer C,Ratnayaka I,Sullivan A,Brown NR,Endicott J,Knapp S,Kessler BM,Middleton MR,Siebold C,Jones EY,Sviderskaya EV,Cebon J,John T,Caballero OL,Goding CR,Lu X","Active Transport,Cell Nucleus,Animals,Antineoplastic Agents,Apoptosis,CDC2 Protein Kinase,Cell Line,Tumor,Cell Proliferation,Cyclin B1,Dimerization,Humans,Imidazoles,Indoles,Intracellular Signaling Peptides and Proteins,M Phase Cell Cycle Checkpoints,Melanoma,Mice,Neoplasm Metastasis,Nocodazole,Phosphorylation,Piperazines,Proto-Oncogene Proteins c-mdm2,Repressor Proteins,Sulfonamides,Triazoles,Tumor Suppressor Protein p53,Xenograft Model Antitumor Assays"
clme0494,lina0435,1,0.07142857142857142,Journal article,Haematologica: the hematology journal,28/05/2013,Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.,"Babbs C,Roberts NA,Sanchez-Pulido L,McGowan SJ,Ahmed MR,Brown JM,Sabry MA,WGS500 Consortium,Bentley DR,McVean GA,Donnelly P,Gileadi O,Ponting CP,Higgs DR,Buckle VJ","Anemia,Dyserythropoietic,Congenital,Endonucleases,Female,Glycoproteins,Homozygote,Humans,Male,Mutation,Missense,Pedigree,Predictive Value of Tests,Protein Structure,Secondary,Tertiary"
bioc0804,whgu0172,2,0.18253968253968253,Journal article|Journal article,Development (Cambridge)|eLife,15/06/2016|15/12/2012,"Functional analysis of AEBP2, a PRC2 Polycomb protein, reveals a Trithorax phenotype in embryonic development and in ES cells.|KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.","Grijzenhout A,Godwin J,Koseki H,Gdula M,Szumska D,McGouran JF,Bhattacharya S,Kessler BM,Brockdorff N,Cooper S|Farcas AM,Blackledge NP,Sudbery I,Long HK,McGouran JF,Rose NR,Lee S,Sims D,Cerase A,Sheahan TW,Koseki H,Brockdorff N,Ponting CP,Kessler BM,Klose RJ","|Chicken,Chromatin,CpG island,Demethylase,Epigenetics,Human,Methylation,Mouse,Transcription,Xenopus,Zebrafish,Animals,Cell Line,Tumor,CpG Islands,DNA Methylation,F-Box Proteins,Gene Silencing,Genome,Histones,Humans,Jumonji Domain-Containing Histone Demethylases,Mice,Polycomb-Group Proteins,Ubiquitination"
immd0198,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
bioc0212,phys0101,2,0.2857142857142857,Journal article|Conference paper,Proceedings of the National Academy of Sciences of USA|Biophysical Journal,19/02/2013|29/01/2013,Extramitochondrial domain rich in carbonic anhydrase activity improves myocardial energetics.|An Extra-Mitochondrial Domain Rich in Carbonic Anhydrase Activity Improves Myocardial Energetics,"Schroeder MA,Ali MA,Hulikova A,Supuran CT,Clarke K,Vaughan-Jones RD,Tyler DJ,Swietach P|Schroeder MA,Ali M,Hulikova A,Supuran CT,Clarke K,Vaughan-Jones RD,Tyler DJ,Swietach P","Adenosine Triphosphate,Animals,Carbon Dioxide,Carbonic Anhydrase II,Carbonic Anhydrase IV,Carbonic Anhydrases,Cell Compartmentation,Cytoplasm,Energy Metabolism,Fluorescent Dyes,Hydrogen-Ion Concentration,Kinetics,Male,Mitochondria,Heart,Myocytes,Cardiac,Rats,Wistar|"
chri0963,newc0612,1,0.125,Journal article,Cancer Research,15/04/2013,Hypoxic trans-activation of sodium dependent bicarbonate co-transporters regulates pH in 3D spheroids and promotes growth,"McIntyre A,Hulikova A,Ledaki I,Seden P,Turley H,Jones D,Russell A,Swietach P,Harris AL",
card0018,card0025,19,1.391322811175752,Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Conference paper,"European Heart Journal|Arteriosclerosis, Thrombosis and Vascular Biology|Heart|Circulation Research|Arteriosclerosis, Thrombosis and Vascular Biology|European Heart Journal|Circulation: Cardiovascular Imaging|European Heart Journal|Circulation: Cardiovascular Imaging|European Heart Journal|Circulation Research|Journal of Cardiovascular Magnetic Resonance|Circulation|Circulation|Circulation|Heart|Heart|Circulation|Circulation",01/08/2013|01/01/2014|01/06/2014|01/01/2013|24/07/2014|16/05/2015|01/01/2011|17/10/2013|29/03/2011|01/08/2015|16/01/2013|21/10/2011|26/11/2013|07/02/2012|01/01/2012|01/05/2013|01/06/2011|01/01/2012|22/11/2011,"Determination of myocardial injury in relation to angiographic lesions, in acute coronary syndromes: a prospective serial CMR study|Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease|121 High Diagnostic Yield in Patients Presenting with Acute Chest Pain, Positive Troponins but non-obstructive Coronaries by Cardiovascular Magnetic Resonance imaging with Conventional and Novel T1 Mapping Techniques.|Living without creatine: Unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice|Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease.|Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and identified through conserved transcriptional responses in mice and humans.|Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index|Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction.|Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index.|Epicardial adipose tissue expansion and differentiation status predict myocardial redox state and coronary calcification|Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice.|Multimodal cardiovascular magnetic resonance quantifies regional variation in vascular structure and function in patients with coronary artery disease: relationships with coronary disease severity.|The Monocyte Genomic Response is Conserved Between Mice and Humans Following Acute Myocardial Infarction|Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease.|Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease|THE USEFULNESS OF EARLY CARDIOVASCULAR MAGNETIC RESONANCE IN PATIENTS PRESENTING WITH ACUTE CHEST PAIN, POSITIVE TROPONIN AND NON-OBSTRUCTIVE CORONARY ARTERIES|DYNAMIC CHANGES OF OEDEMA AND LATE GADOLINIUM ENHANCEMENT AFTER ACUTE MYOCARDIAL INFARCTION AND THEIR RELATIONSHIP TO FUNCTIONAL RECOVERY AND SALVAGE INDEX|Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease|CMR T1 Mapping at 3T Characterizes the Extent of Acute Ischemic Myocardial Injury: Comparison to Standard Techniques","Dall'armellina E,Adlam D,Ruparelia N,Kharbanda RK,Prendergast BP,Forfar JC,Banning AP,Neubauer S,Channon K,Choudhury R|Antonopoulos AS,Margaritis M,Coutinho P,Digby J,Patel R,Psarros C,Ntusi N,Karamitsos TD,Lee R,De Silva R,Petrou M,Sayeed R,Demosthenous M,Bakogiannis C,Wordsworth PB,Tousoulis D,Neubauer S,Channon KM,Antoniades C|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Banning A,Kardos A,Newton J,Friedrich M,Robson M,Neubauer S|Lygate CA,Aksentijevic D,Dawson D,Ten Hove M,Phillips D,De Bono JP,Medway DJ,Sebag-Montefiore L,Hunyor I,Channon KM,Clarke K,Zervou S,Watkins H,Balaban RS,Neubauer S|Antonopoulos AS,Margaritis M,Coutinho P,Digby J,Patel R,Psarros C,Ntusi N,Karamitsos TD,Lee R,De Silva R,Petrou M,Sayeed R,Demosthenous M,Bakogiannis C,Wordsworth PB,Tousoulis D,Neubauer S,Channon KM,Antoniades C|Ruparelia N,Godec J,Lee R,Chai JT,Dall'Armellina E,McAndrew D,Digby JE,Forfar JC,Prendergast BD,Kharbanda RK,Banning AP,Neubauer S,Lygate CA,Channon KM,Haining NW,Choudhury RP|Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Cuculi F,Dall'Armellina E,Manlhiot C,De Caterina AR,Colyer S,Ferreira V,Morovat A,Prendergast BD,Forfar JC,Alp NJ,Choudhury RP,Neubauer S,Channon KM,Banning AP,Kharbanda RK|Dall'Armellina E,Karia N,Lindsay AC,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Neubauer S,Choudhury RP|Antonopoulos A,Herdman L,Sabharwal N,Shirodaria C,Thomas S,Kelion A,Sayeed R,Neubauer S,Channon KM,Antoniades C|Lygate CA,Aksentijevic D,Dawson D,ten Hove M,Phillips D,de Bono JP,Medway DJ,Sebag-Montefiore L,Hunyor I,Channon KM,Clarke K,Zervou S,Watkins H,Balaban RS,Neubauer S|Kylintireas I,Shirodaria C,Lee JM,Cunningon C,Lindsay A,Francis J,Robson MD,Neubauer S,Channon KM,Choudhury RP|Ruparelia N,Lee R,Dall'Armellina E,Godec J,Medway D,Forfar C,Prendergast B,Kharbanda RK,Banning AP,Neubauer S,Lygate CA,Channon KM,Haining WN,Choudhury RP|Cunnington C,Van Assche T,Shirodaria C,Kylintireas I,Lindsay AC,Lee JM,Antoniades C,Margaritis M,Lee R,Cerrato R,Crabtree MJ,Francis JM,Sayeed R,Ratnatunga C,Pillai R,Choudhury RP,Neubauer S,Channon KM|Cunnington C,Van Assche T,Shirodaria C,Kylintireas I,Lindsay AC,Lee JM,Antoniades C,Margaritis M,Lee R,Cerrato R,Crabtree MJ,Francis JM,Sayeed R,Ratnatunga C,Pillai R,Choudhury RP,Neubauer S,Channon KM|Ferreira V,Dall'Armellina E,Piechnik S,Karamitsos T,Francis J,Choudhury R,Channon K,Banning A,Kharbanda R,Forfar C,Ormerod O,Prendergast B,Kardos A,Basagiannia C,Newton J,Friedrich M,Robson M,Neubauer S|Dall'Armellina E,Karia N,Lindsay A,Karamitsos TD,Ferreira V,Robson MD,Kellman P,Francis JM,Forfar C,Prendergast B,Banning AP,Channon K,Kharbanda RJ,Neubauer S,Choudhury RP|Cunnington C,Van Assche T,Shirodaria C,Kylintireas I,Lindsay AC,Lee JM,Antoniades C,Margaritis M,Lee R,Cerrato R,Crabtree MJ,Francis JM,Sayeed R,Ratnatunga C,Pillai R,Choudhury RP,Neubauer S,Channon KM|Dall'Armellina E,Piechnik S,Ferreira V,Karamitsos TD,Francis JM,Cuculi F,Forfar C,Prendergast BD,Banning AP,Channon KM,Kharbanda RK,Robson MD,Choudhury RP,Neubauer S","||||Thigh,Thorax,Brachial Artery,Adipose Tissue,Humans,Myocardial Ischemia,Ventricular Dysfunction,Left,Inflammation,Natriuretic Peptide,Brain,Tumor Necrosis Factor-alpha,Interleukin-6,Coronary Artery Bypass,Organ Culture Techniques,Risk Factors,Cross-Sectional Studies,Organ Specificity,Vasodilation,Aged,Middle Aged,Female,Male,Subcutaneous Fat,Adiponectin,Coronary Artery Disease,Heart Failure|Leukocytes,Mononuclear,Animals,Mice,Inbred C57BL,Humans,Myocardial Infarction,Inflammation,Magnetic Resonance Angiography,Ligation,Case-Control Studies,Gene Expression Profiling,Cell Proliferation,Transcription,Genetic,Phenotype,Aged,Middle Aged,Female,Male,Transcriptional Activation||Angioplasty,Blood flow,Magnetic resonance imaging,Microcirculation,Myocardial infarction,Coronary Circulation,Coronary Occlusion,Coronary Vessels,Endothelin-1,Female,Hemorrhage,Humans,Magnetic Resonance Angiography,Male,Microvessels,Middle Aged,Myocardial Infarction,Percutaneous Coronary Intervention,Prospective Studies,Recovery of Function,Stroke Volume,Vascular Resistance|Angioplasty,Balloon,Coronary,Contrast Media,Edema,Cardiac,Female,Gadolinium,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Myocardial Infarction,Myocardium,Recovery of Function,Ventricular Function||Adenylate Kinase,Animals,Creatine,Exercise Tolerance,Female,Glycine,Guanidinoacetate N-Methyltransferase,Heart Failure,Mice,Inbred C57BL,Knockout,Mitochondria,Heart,Myocardial Infarction,Oxygen Consumption,Physical Conditioning,Animal,Physical Exertion,Ventricular Remodeling|Aged,Analysis of Variance,Aorta,Aortic Diseases,Atherosclerosis,Brachial Artery,Carotid Arteries,Carotid Artery Diseases,Chi-Square Distribution,Compliance,Coronary Angiography,Coronary Artery Disease,England,Female,Humans,Magnetic Resonance Imaging,Male,Middle Aged,Multivariate Analysis,Predictive Value of Tests,Severity of Illness Index,Vasodilation|Genomics,Myocardial infarction,Gene expression,Leukocytes|Administration,Oral,Aged,Biopterin,Coronary Artery Disease,Double-Blind Method,Endothelium,Vascular,Female,Humans,Male,Oxidation-Reduction,Treatment Outcome|||||Myocardial infarction,STEMI,NSTEMI,Cardiac MRI"
claridge,wolf1917,1,0.16666666666666666,Journal article,Chemical Communications,01/01/2016,Cephalosporins inhibit human metallo β-lactamase fold DNA repair nucleases SNM1A and SNM1B/apollo.,"Lee SY,Brem J,Pettinati I,Claridge TD,Gileadi O,Schofield CJ,McHugh PJ",
clab0127,immd0316,2,0.25,Journal article|Journal article,Oncogene|Oncogene,01/01/2011|30/05/2011,Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α|Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α.,"Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB|Coutts AS,Pires IM,Weston L,Buffa FM,Milani M,Li JL,Harris AL,Hammond EM,La Thangue NB","|Base Sequence,Cell Hypoxia,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Molecular Sequence Data,Nuclear Proteins,Promoter Regions,Genetic,Trans-Activators"
clme0667,raob0097,5,0.6675324675324675,Journal article|Journal article|Journal article|Journal article|Conference paper,"Cell Death and Disease|Cancer Treatment Reviews|British Journal of Cancer|British Journal of Cancer|Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik",01/01/2012|11/04/2013|19/06/2012|01/01/2012|01/05/2013,Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.|Targeting ATR in DNA damage response and cancer therapeutics.|Targeting radiation-resistant hypoxic tumour cells through ATR inhibition.|Targeting radiation-resistant hypoxic tumour cells through ATR inhibition|ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation,"Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton PA,Cornelissen B,Vallis KA,Hammond EM,Olcina MM,Gillies McKenna W,Muschel RJ,Brunner TB|Fokas E,Prevo R,Hammond EM,Brunner TB,McKenna WG,Muschel RJ|Pires IM,Olcina MM,Anbalagan S,Pollard JR,Reaper PM,Charlton PA,McKenna WG,Hammond EM|Pires IM,Olcina MM,Anbalagan S,Pollard JR,Reaper PM,Charlton PA,McKenna WG,Hammond EM|Fokas E,Prevo R,Pollard JR,Reaper PM,Charlton P,Cornelissen B,Vallis K,Hammond EM,Olcina MM,McKenna WG,Muschel RJ,Brunner TB","Animals,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Line,Tumor,Cell Survival,DNA Damage,Female,Humans,Isoxazoles,Mice,Inbred BALB C,Pancreatic Neoplasms,Phosphorylation,Protein Kinase Inhibitors,Protein Kinases,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiation-Sensitizing Agents|ATR,Cancer,Chemotherapy,DNA damage,Radiation,Replication stress,Therapeutics,Animals,Antineoplastic Agents,Ataxia Telangiectasia Mutated Proteins,Clinical Trials as Topic,Combined Modality Therapy,DNA Damage,DNA Replication,Humans,Molecular Targeted Therapy,Neoplasms,Protein Kinase Inhibitors,Protein Kinases,Signal Transduction|Ataxia Telangiectasia,Ataxia Telangiectasia Mutated Proteins,Cell Cycle Proteins,Cell Hypoxia,Cell Line,Tumor,Cell Survival,DNA Damage,DNA Replication,HCT116 Cells,HeLa Cells,Histones,Humans,Hypoxia-Inducible Factor 1,alpha Subunit,Phosphorylation,Protein-Serine-Threonine Kinases,Pyrazines,Radiation Tolerance,Radiotherapy,Repressor Proteins,Signal Transduction,Sulfones||"
cschof,whgu0139,3,0.23118279569892472,Journal article|Journal article|Journal article,Nature Chemical Biology|Nature Chemical Biology|EMBO Reports,01/01/2012|01/01/2012|01/01/2011,"Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans|Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans.|The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adhaerens","Ge W,Wolf A,Feng T,Ho C-H,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TDW,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,Mccullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Ge W,Wolf A,Feng T,Ho CH,Sekirnik R,Zayer A,Granatino N,Cockman ME,Loenarz C,Loik ND,Hardy AP,Claridge TD,Hamed RB,Chowdhury R,Gong L,Robinson CV,Trudgian DC,Jiang M,Mackeen MM,McCullagh JS,Gordiyenko Y,Thalhammer A,Yamamoto A,Yang M,Liu-Yi P,Zhang Z,Schmidt-Zachmann M,Kessler BM,Ratcliffe PJ,Preston GM,Coleman ML,Schofield CJ|Loenarz C,Coleman ML,Boleininger A,Schierwater B,Holland PWH,Ratcliffe PJ,Schofield CJ","|Animals,Arginine,Chromosomal Proteins,Non-Histone,Enzyme Inhibitors,Escherichia coli,Escherichia coli Proteins,Histidine,Histone Demethylases,Humans,Hydroxylation,Magnetic Resonance Spectroscopy,Mixed Function Oxygenases,Nuclear Proteins,Oxygenases,Prokaryotic Cells,Ribosomal Proteins,Ribosomes|"
ndos0168,whgu0172,1,0.25,Conference paper,Osteoarthritis and Cartilage,01/04/2012,THE PROTEOME OF YOUNG AND HEALTHY HUMAN HAMSTRING,"Hakimi O,Ternette N,Murphy R,Kessler B,Carr A",
radi0003,raob0069,1,0.3333333333333333,Journal article,Future Oncology,01/11/2012,Clinical imaging of tumor angiogenesis.,"Patel N,Harris AL,Gleeson FV,Vallis KA","Animals,Diagnostic Imaging,Humans,Neoplasms,Neovascularization,Pathologic"
chem0489,immd0023,2,0.18181818181818182,Journal article|Journal article,Current Biology|Current Biology,01/01/2012|20/11/2012,NAADP Activates two-pore channels on t cell cytolytic granules to stimulate exocytosis and killing|NAADP activates two-pore channels on T cell cytolytic granules to stimulate exocytosis and killing.,"Davis LC,Morgan AJ,Chen JL,Snead CM,Bloor-Young D,Shenderov E,Stanton-Humphreys MN,Conway SJ,Churchill GC,Parrington J,Cerundolo V,Galione A|Davis LC,Morgan AJ,Chen JL,Snead CM,Bloor-Young D,Shenderov E,Stanton-Humphreys MN,Conway SJ,Churchill GC,Parrington J,Cerundolo V,Galione A","|Animals,Cytoplasmic Granules,Exocytosis,Humans,Inositol 1,4,5-Trisphosphate,Lymphocyte Activation,NADP,T-Lymphocytes,Cytotoxic"
clme0497,whgu0142,7,0.6912698412698411,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Journal of Biological Chemistry|Proceedings of the National Academy of Sciences of USA|Chemistry and Biology|Journal of Biological Chemistry|Journal of Biological Chemistry|Journal of Medicinal Chemistry|Journal of Biological Chemistry,01/01/2012|23/02/2012|28/01/2011|12/09/2012|24/01/2013|05/12/2011|27/09/2013,"Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva|The p53 cofactor Strap exhibits an unexpected TPR motif and oligonucleotide-binding (OB)-fold structure.|Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.|Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva.|Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.|7,8-dichloro-1-oxo-β-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes.|Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.","Chaikuad A,Alfano I,Kerr G,Sanvitale CE,Boergermann JH,Triffitt JT,Von Delft F,Knapp S,Knaus P,Bullock AN|Adams CJ,Pike AC,Maniam S,Sharpe TD,Coutts AS,Knapp S,La Thangue NB,Bullock AN|Fedorov O,Huber K,Eisenreich A,Filippakopoulos P,King O,Bullock AN,Szklarczyk D,Jensen LJ,Fabbro D,Trappe J,Rauch U,Bracher F,Knapp S|Chaikuad A,Alfano I,Kerr G,Sanvitale CE,Boergermann JH,Triffitt JT,von Delft F,Knapp S,Knaus P,Bullock AN|Canning P,Cooper CD,Krojer T,Murray JW,Pike AC,Chaikuad A,Keates T,Thangaratnarajah C,Hojzan V,Ayinampudi V,Marsden BD,Gileadi O,Knapp S,von Delft F,Bullock AN|Huber K,Brault L,Fedorov O,Gasser C,Filippakopoulos P,Bullock AN,Fabbro D,Trappe J,Schwaller J,Knapp S,Bracher F|Canning P,Cooper CD,Krojer T,Murray JW,Pike AC,Chaikuad A,Keates T,Thangaratnarajah C,Hojzan V,Ayinampudi V,Marsden BD,Gileadi O,Knapp S,von Delft F,Bullock AN","|Amino Acid Motifs,Animals,Carrier Proteins,Chromatin,Crystallography,X-Ray,DNA Damage,E1A-Associated p300 Protein,Genes,p53,Humans,Mice,Models,Molecular,Neoplasm Proteins,Oligonucleotides,Protein Binding,Protein Conformation,Protein Folding,Protein Structure,Tertiary,Tumor Suppressor Protein p53|Alternative Splicing,Catalytic Domain,Endothelial Cells,Heterocyclic Compounds,2-Ring,Humans,Models,Molecular,Nitriles,Phosphorylation,Protein Kinase Inhibitors,Protein-Serine-Threonine Kinases,Protein-Tyrosine Kinases,RNA,Messenger,RNA-Binding Proteins,Substrate Specificity,Thromboplastin|Activin Receptors,Type I,Amino Acid Motifs,Animals,Bone Morphogenetic Protein 4,Catalytic Domain,Crystallography,X-Ray,Enzyme Activation,Gene Expression Regulation,Genes,Reporter,Humans,Hydrogen Bonding,Hydrophobic and Hydrophilic Interactions,Luciferases,Firefly,Mice,Models,Molecular,Mutation,Missense,Myositis Ossificans,Protein Binding,Pyrazoles,Pyrimidines,Signal Transduction,Tacrolimus,Tacrolimus Binding Protein 1A|Binding Sites,Calorimetry,Carrier Proteins,Crystallography,X-Ray,Cullin Proteins,Dimerization,Humans,Models,Molecular,Molecular Conformation,Phylogeny,Proteasome Endopeptidase Complex,Protein Binding,Protein Conformation,Protein Interaction Mapping,Protein Structure,Secondary,Tertiary,Substrate Specificity,Ubiquitin,Ubiquitin-Protein Ligases|Antineoplastic Agents,Carbolines,Cell Line,Tumor,Crystallography,X-Ray,Drug Screening Assays,Antitumor,Humans,Models,Molecular,Molecular Structure,Protein Binding,Protein Kinase Inhibitors,Stereoisomerism,Structure-Activity Relationship|"
bioc0188,univ0247,7,3.5095238095238095,Chapter|Journal article|Journal article|Journal article|Journal article|Chapter|Journal article,Methods in Molecular Biology|J. Cell Sci|DNA Repair|DNA Repair|Cell Cycle|Methods in Molecular Biology|Journal of Cell Science,01/01/2013||15/02/2014|01/05/2014|01/01/2012|01/01/2013|15/05/2011,Investigation of DNA repair pathway activity|Nonhomologous end-joining promotes resistance to DNA damage in the absence of an ADP-ribosyltransferase that signals DNA single strand breaks|Emerging models for DNA repair: Dictyostelium discoideum as a model for nonhomologous end-joining.|Emerging models for DNA repair: Dictyostelium discoideum as a model for nonhomologous end-joining|The role of ADP-ribosylation in regulating DNA double-strand break repair.|Investigation of DNA repair pathway activity.|DNA double-strand break repair pathway choice in Dictyostelium.,"Couto AMC,Lakin ND,Pears CJ|Couto CAM,Hsu DW,Teo R,Rakhimova A,Lempidaki S,Pears C,Lakin N|Pears CJ,Lakin ND|Pears CJ,Lakin ND|Pears CJ,Couto CA,Wang HY,Borer C,Kiely R,Lakin ND|Couto AM,Lakin ND,Pears CJ|Hsu DW,Kiely R,Couto CA,Wang HY,Hudson JJ,Borer C,Pears CJ,Lakin ND","||Dictyostelium,Double strand break repair,Nonhomologous end-joining,DNA Breaks,Double-Stranded,DNA End-Joining Repair,DNA Repair Enzymes,DNA,Protozoan,Humans,Models,Biological||Adenosine Diphosphate,DNA Breaks,Double-Stranded,DNA Repair,Dictyostelium,Genomic Instability,Humans,Poly(ADP-ribose) Polymerase Inhibitors,Poly(ADP-ribose) Polymerases|Buffers,Chromatin,Culture Techniques,DNA Breaks,Double-Stranded,Single-Stranded,DNA Cleavage,DNA End-Joining Repair,DNA,Protozoan,Dictyostelium,Fluorescent Antibody Technique,Indirect,Plasmids,Recombinational DNA Repair,Restriction Mapping|Antigens,Nuclear,DNA Breaks,Double-Stranded,DNA Repair,DNA,Protozoan,DNA-Activated Protein Kinase,DNA-Binding Proteins,Dictyostelium,Recombination,Genetic,Transcription Factors"
immd0135,immd0330,1,0.05555555555555555,Journal article,Blood,22/08/2012,Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.,"Schuh A,Becq J,Humphray S,Alexa A,Burns A,Clifford R,Feller SM,Grocock R,Henderson S,Khrebtukova I,Kingsbury Z,Luo S,McBride D,Murray L,Menju T,Timbs A,Ross M,Taylor J,Bentley D","Alleles,Cell Transformation,Neoplastic,Clonal Deletion,Clone Cells,DNA Mutational Analysis,DNA,Neoplasm,Disease Progression,Evolution,Molecular,Gene Frequency,Genome-Wide Association Study,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Mutation,Neoplasm Proteins,Selection,Genetic,Sequence Analysis"
clme0237,raob0189,1,0.06666666666666667,Journal article,Nature Communications,01/01/2014,Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.,"Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC","Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading"
clme0240,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
immd0452,raob0096,1,0.1111111111111111,Journal article,Nature Cell Biology,14/09/2014,RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2.,"Pefani DE,Latusek R,Pires I,Grawenda AM,Yee KS,Hamilton G,van der Weyden L,Esashi F,Hammond EM,O'Neill E","Cells,Cultured,Cell Line,Tumor,Animals,Mice,Knockout,Humans,Chromosome Aberrations,Protein-Serine-Threonine Kinases,Tumor Suppressor Proteins,BRCA2 Protein,Microscopy,Confocal,Blotting,Western,Comet Assay,Signal Transduction,DNA Repair,DNA Replication,RNA Interference,Protein Binding,Phosphorylation,Models,Genetic,Rad51 Recombinase,Cyclin-Dependent Kinase 2,DNA Breaks,Double-Stranded,Ataxia Telangiectasia Mutated Proteins"
clab0025,clme0220,7,1.1958333333333335,Journal article|Journal article|Journal article|Journal article|Journal article|Journal article|Journal article,Biochemical Society Transactions|Cancer Cell|Cancer Cell|Frontiers in Oncology|Journal of Biological Chemistry|Breast Cancer Research|Breast Cancer Research,01/12/2014|17/07/2013|12/08/2013|01/01/2014|21/01/2013|01/01/2011|01/01/2011,"A review of ELTD1, a pro-angiogenic adhesion GPCR.|A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.|A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis|The notch ligand JAGGED1 as a target for anti-tumor therapy.|Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.|Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers|Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers","Favara DM,Banham AH,Harris AL|Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM|Masiero M,Simões FC,Han HD,Snell C,Peterkin T,Bridges E,Mangala LS,Wu SYY,Pradeep S,Li D,Han C,Dalton H,Lopez-Berestein G,Tuynman JB,Mortensen N,Li JL,Patient R,Sood AK,Banham AH,Harris AL,Buffa FM|Li D,Masiero M,Banham AH,Harris AL|Whiteman P,de Madrid BH,Taylor P,Li D,Heslop R,Viticheep N,Tan JZ,Shimizu H,Callaghan J,Masiero M,Li JL,Banham AH,Harris AL,Lea SM,Redfield C,Baron M,Handford PA|Yan M,Jene N,Byrne D,Millar EKA,O'Toole SA,McNeil CM,Bates GJ,Harris AL,Banham AH,Sutherland RL,Fox SB|Yan M,Jene N,Byrne D,Millar EKA,O'Toole SA,McNeil CM,Bates GJ,Harris AL,Banham AH,Sutherland RL,Fox SB","Cell Line,Tumor,Humans,Neovascularization,Pathologic,Receptors,G-Protein-Coupled|Animals,Cell Growth Processes,Endothelial Cells,Female,Genetic Predisposition to Disease,HCT116 Cells,Humans,Mice,Nude,Neoplasms,Neovascularization,Pathologic,Receptors,G-Protein-Coupled,Signal Transduction|||Amino Acid Sequence,Animals,Antibodies,Monoclonal,Blotting,Western,Calcium-Binding Proteins,Cell Line,Tumor,Drosophila Proteins,Flow Cytometry,HEK293 Cells,Humans,Intercellular Signaling Peptides and Proteins,Ligands,Membrane Proteins,Mice,Models,Molecular,Molecular Sequence Data,Mutation,Protein Binding,Protein Structure,Secondary,Tertiary,Receptor,Notch1,Receptors,Notch,Sequence Homology,Amino Acid||"
quee1607,stat0054,10,2.6934880374168015,Journal article|Journal article|Journal article|Journal article|Conference paper|Journal article|Journal article|Journal article|Journal article|Journal article,Leukemia|Nature Communications|American Journal of Gastroenterology|Blood|Blood|Nature Genetics|Annals of Applied Statistics|American Journal of Gastroenterology|Bioinformatics|Bayesian Analysis,01/01/2012|01/01/2014|17/09/2013|06/12/2014|06/12/2014|18/05/2015|01/09/2013|01/11/2013|06/01/2013|26/05/2011,"Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.|Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.|Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations|The Identification of Further Minimal Regions of Overlap in Chronic Lymphocytic Leukemia Using High-Resolution SNP Arrays|Towards Response Prediction Using Integrated Genomics in Chronic Lymphocytic Leukaemia: Results on 250 First-Line FCR Treated Patients from UK Clinical Trials|Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.|A decision-theoretic approach for segmental classification|Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations|NucleoFinder: a statistical approach for the detection of nucleosome positions.|Hierarchical Bayesian nonparametric mixture models for clustering with variable relevance determination","Knight SJ,Yau C,Clifford R,Timbs AT,Sadighi Akha E,Dréau HM,Burns A,Ciria C,Oscier DG,Pettitt AR,Dutton S,Holmes CC,Taylor J,Cazier JB,Schuh A|Cazier JB,Rao SR,McLean CM,Walker AK,Wright BJ,Jaeger EE,Kartsonaki C,Marsden L,Yau C,Camps C,Kaisaki P,Taylor J,Catto JW,Tomlinson IP,Kiltie AE,Hamdy FC|Mouradov D,Gibbs P,Jorissen RN,Lipton L,Sieber OM,Tomlinson IP,Domingo E,Li S,Soo PY,Desai J,Danielsen HE,Oukrif D,Novelli M,Yau C,Holmes CC,Jones IT,McLaughlin S,Molloy P,Hawkins NJ,Ward R,Midgely R,Kerr D|Knight SJL,Clifford R,Robbe P,Ramos SDC,Burns A,Timbs AT,Alsolami R,Weller S,Hamblin A,Mason J,Oates M,Titsias M,Yau C,Holmes CC,Pettitt AR,Hillmen P,Taylor J,Shuh A|Clifford RM,Robbe P,Weller S,Timbs AT,Titsias M,Burns A,Cabes M,Alsolami R,Yau C,Hamblin A,Mason J,Oates M,Pettitt A,Holmes C,Hillmen P,Taylor J,Knight SJL,Schuh A|Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G|Yau C,Holmes C|Mouradov D,Domingo E,Gibbs P,Jorissen RN,Li S,Soo PY,Lipton L,Desai J,Danielsen HE,Oukrif D,Novelli M,Yau C,Holmes CC,Jones IT,McLaughlin S,Molloy P,Hawkins NJ,Ward R,Midgely R,Kerr D,Tomlinson IP,Sieber OM|Becker J,Yau C,Hancock JM,Holmes CC|Yau C,Holmes C","Adult,Aged,80 and over,Biomarkers,Tumor,Chromosome Aberrations,Clone Cells,Female,Gene Dosage,Genome,Human,Genomics,Humans,Leukemia,Lymphocytic,Chronic,B-Cell,Loss of Heterozygosity,Male,Middle Aged,Neoplasm Recurrence,Local,Oligonucleotide Array Sequence Analysis,Polymorphism,Single Nucleotide,Prognosis|Oxford-Illumina WGS500 Consortium,Humans,Cadherins,Sequence Analysis,DNA,Base Sequence,Mutation,Genome,Molecular Sequence Data,Cyclin-Dependent Kinase Inhibitor p21,Urinary Bladder Neoplasms,Genetic Variation,Neoplasm Grading||||Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing|||Cell Line,Genome,Human,High-Throughput Nucleotide Sequencing,Humans,Models,Statistical,Nucleosomes,Sequence Analysis,DNA|"
dpag0074,immd0679,1,0.08333333333333333,Journal article,Nature Communications,01/01/2014,Understanding functional miRNA-target interactions in vivo by site-specific genome engineering.,"Bassett AR,Azzam G,Wheatley L,Tibbit C,Rajakumar T,McGowan S,Stanger N,Ewels PA,Taylor S,Ponting CP,Liu JL,Sauka-Spengler T,Fulga TA","Animals,Zebrafish,Humans,Drosophila,Deoxyribonucleases,Endonucleases,DNA-Binding Proteins,MicroRNAs,Transfection,Genetic Engineering,Sequence Analysis,Base Sequence,Response Elements,Molecular Sequence Data,Transcriptional Activation,HEK293 Cells,Clustered Regularly Interspaced Short Palindromic Repeats"
corp0784,path0089,1,0.009174311926605505,Journal article,Nature Genetics,18/05/2015,Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.,"Taylor JC,Martin HC,Lise S,Broxholme J,Cazier JB,Rimmer A,Kanapin A,Lunter G,Fiddy S,Allan C,Aricescu AR,Attar M,Babbs C,Becq J,Beeson D,Bento C,Bignell P,Blair E,Buckle VJ,Bull K,Cais O,Cario H,Chapel H,Copley RR,Cornall R,Craft J,Dahan K,Davenport EE,Dendrou C,Devuyst O,Fenwick AL,Flint J,Fugger L,Gilbert RD,Goriely A,Green A,Greger IH,Grocock R,Gruszczyk AV,Hastings R,Hatton E,Higgs D,Hill A,Holmes C,Howard M,Hughes L,Humburg P,Johnson D,Karpe F,Kingsbury Z,Kini U,Knight JC,Krohn J,Lamble S,Langman C,Lonie L,Luck J,McCarthy D,McGowan SJ,McMullin MF,Miller KA,Murray L,Németh AH,Nesbit MA,Nutt D,Ormondroyd E,Oturai AB,Pagnamenta A,Patel SY,Percy M,Petousi N,Piazza P,Piret SE,Polanco-Echeverry G,Popitsch N,Powrie F,Pugh C,Quek L,Robbins PA,Robson K,Russo A,Sahgal N,van Schouwenburg PA,Schuh A,Silverman E,Simmons A,Sørensen PS,Sweeney E,Taylor J,Thakker RV,Tomlinson I,Trebes A,Twigg SR,Uhlig HH,Vyas P,Vyse T,Wall SA,Watkins H,Whyte MP,Witty L,Wright B,Yau C,Buck D,Humphray S,Ratcliffe PJ,Bell JI,Wilkie AO,Bentley D,Donnelly P,McVean G","Humans,Genetic Diseases,Inborn,Molecular Diagnostic Techniques,Sensitivity and Specificity,DNA Mutational Analysis,Base Sequence,Polymorphism,Single Nucleotide,Genome,Human,Molecular Sequence Annotation,High-Throughput Nucleotide Sequencing"
clme0485,stat0004,1,0.010526315789473684,Journal article,Nature Genetics,01/01/2011,Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.,"Evans DM,Spencer CC,Pointon JJ,Su Z,Harvey D,Kochan G,Oppermann U,Dilthey A,Pirinen M,Stone MA,Appleton L,Moutsianas L,Leslie S,Wordsworth T,Kenna TJ,Karaderi T,Thomas GP,Ward MM,Weisman MH,Farrar C,Bradbury LA,Danoy P,Inman RD,Maksymowych W,Gladman D,Rahman P,Spondyloarthritis Research Consortium of Canada (SPARCC),Morgan A,Marzo-Ortega H,Bowness P,Gaffney K,Gaston JS,Smith M,Bruges-Armas J,Couto AR,Sorrentino R,Paladini F,Ferreira MA,Xu H,Liu Y,Jiang L,Lopez-Larrea C,Díaz-Peña R,López-Vázquez A,Zayats T,Band G,Bellenguez C,Blackburn H,Blackwell JM,Bramon E,Bumpstead SJ,Casas JP,Corvin A,Craddock N,Deloukas P,Dronov S,Duncanson A,Edkins S,Freeman C,Gillman M,Gray E,Gwilliam R,Hammond N,Hunt SE,Jankowski J,Jayakumar A,Langford C,Liddle J,Markus HS,Mathew CG,McCann OT,McCarthy MI,Palmer CN,Peltonen L,Plomin R,Potter SC,Rautanen A,Ravindrarajah R,Ricketts M,Samani N,Sawcer SJ,Strange A,Trembath RC,Viswanathan AC,Waller M,Weston P,Whittaker P,Widaa S,Wood NW,McVean G,Reveille JD,Wordsworth BP,Brown MA,Donnelly P,Australo-Anglo-American Spondyloarthritis Consortium (TASC),Wellcome Trust Case Control Consortium 2 (WTCCC2)","Aminopeptidases,CARD Signaling Adaptor Proteins,CD8-Positive T-Lymphocytes,Case-Control Studies,Core Binding Factor Alpha 3 Subunit,Disease Susceptibility,European Continental Ancestry Group,Genome-Wide Association Study,HLA-B27 Antigen,Humans,Interleukin-12 Subunit p40,Latent TGF-beta Binding Proteins,Membrane Proteins,Meta-Analysis as Topic,Peptide Fragments,Polymorphism,Genetic,Receptors,Peptide,Prostaglandin E,EP4 Subtype,Tumor Necrosis Factor,Type I,Spondylitis,Ankylosing"
clme0195,vacc0036,1,0.06666666666666667,Journal article,Stem Cell Reports,13/04/2016,MicroRNAs of the miR-290-295 Family Maintain Bivalency in Mouse Embryonic Stem Cells.,"Graham B,Marcais A,Dharmalingam G,Carroll T,Kanellopoulou C,Graumann J,Nesterova TB,Bermange A,Brazauskas P,Xella B,Kriaucionis S,Higgs DR,Brockdorff N,Mann M,Fisher AG,Merkenschlager M",
